{"786c88a5b4620eac4a69a33b84da76c24568f30b": [["governments, as SARS-CoV-2 has been detected in saliva samples and infection typically spread through respiratory droplets (Centers for Disease Control, 2020).", [["saliva samples", "ANATOMY", 48, 62], ["respiratory droplets", "ANATOMY", 102, 122], ["SARS", "DISEASE", 16, 20], ["infection", "DISEASE", 67, 76], ["SARS-CoV-2", "ORGANISM", 16, 26], ["saliva samples", "ORGANISM_SUBSTANCE", 48, 62], ["SARS-CoV", "SPECIES", 16, 24], ["saliva samples", "PROBLEM", 48, 62], ["infection", "PROBLEM", 67, 76], ["Disease Control", "TREATMENT", 136, 151], ["infection", "OBSERVATION", 67, 76]]]], "ac03f138574464ac7c9bfbeee803ebcf3db5e26c": [["INTRODUCTIONOver the last years, especially in Western countries, vaccine hesitancy has steadily grown and poses an increasing health concern (1).", [["vaccine hesitancy", "PROBLEM", 66, 83]]], ["The recent upsurge of measles in Europe is an impressive example.", [["measles", "DISEASE", 22, 29], ["upsurge", "OBSERVATION_MODIFIER", 11, 18], ["measles", "OBSERVATION", 22, 29]]], ["Anti-vaccinationists argue that possible side effects weigh out the benefits (2) .", [["Anti-vaccinationists", "TREATMENT", 0, 20], ["side effects", "PROBLEM", 41, 53]]], ["Especially sequelaes such as autism, multiple sclerosis (MS) and various neurological syndromes have been emphasized by the anti-vaccination lobby (3, 4) .", [["neurological", "ANATOMY", 73, 85], ["autism", "DISEASE", 29, 35], ["multiple sclerosis", "DISEASE", 37, 55], ["MS", "DISEASE", 57, 59], ["neurological syndromes", "DISEASE", 73, 95], ["autism", "PROBLEM", 29, 35], ["multiple sclerosis (MS)", "PROBLEM", 37, 60], ["various neurological syndromes", "PROBLEM", 65, 95], ["multiple", "OBSERVATION_MODIFIER", 37, 45], ["sclerosis", "OBSERVATION", 46, 55], ["neurological syndromes", "OBSERVATION", 73, 95]]], ["This alarming development is even partly supported by healthcare providers including some MS neurologists, who are afraid of iatrogenic deterioration of preexisting MS. Indeed, studies linking vaccination and disease onset have been published.", [["MS", "DISEASE", 165, 167], ["iatrogenic deterioration", "PROBLEM", 125, 149], ["preexisting MS", "PROBLEM", 153, 167], ["disease onset", "PROBLEM", 209, 222]]], ["Although these studies were often underpowered and lacked an adequate design in order to provide evidence of the suspected link, they caught public awareness leading to a drop of public vaccination coverage rates (5, 6) .INTRODUCTIONEpidemiological studies and pharmacovigilance data have repeatedly demonstrated safety for the vast majority of vaccines.", [["these studies", "TEST", 9, 22], ["public vaccination coverage rates", "TREATMENT", 179, 212], [".INTRODUCTIONEpidemiological studies", "TEST", 220, 256], ["pharmacovigilance data", "TEST", 261, 283]]], ["Lately, a review concluded that there is no significant evidence for a causal relationship between the onset or deterioration of MS and vaccination against measles, mumps and rubella (MMR), influenza, hepatitis A, hepatitis B, human papilloma virus (HPV), diphtheria, tetanus, acellular pertussis, or meningococcal disease (7) .", [["MS", "DISEASE", 129, 131], ["measles, mumps and rubella", "DISEASE", 156, 182], ["influenza, hepatitis A", "DISEASE", 190, 212], ["hepatitis B", "DISEASE", 214, 225], ["human papilloma virus (HPV), diphtheria, tetanus", "DISEASE", 227, 275], ["acellular pertussis", "DISEASE", 277, 296], ["meningococcal disease", "DISEASE", 301, 322], ["hepatitis A", "ORGANISM", 201, 212], ["hepatitis B", "ORGANISM", 214, 225], ["human papilloma virus", "ORGANISM", 227, 248], ["HPV", "ORGANISM", 250, 253], ["diphtheria", "ORGANISM", 256, 266], ["acellular pertussis", "ORGANISM", 277, 296], ["mumps and rubella", "SPECIES", 165, 182], ["human papilloma virus", "SPECIES", 227, 248], ["acellular pertussis", "SPECIES", 277, 296], ["hepatitis A", "SPECIES", 201, 212], ["hepatitis B", "SPECIES", 214, 225], ["human papilloma virus", "SPECIES", 227, 248], ["HPV", "SPECIES", 250, 253], ["deterioration of MS", "PROBLEM", 112, 131], ["vaccination", "TREATMENT", 136, 147], ["measles", "PROBLEM", 156, 163], ["mumps", "PROBLEM", 165, 170], ["rubella", "PROBLEM", 175, 182], ["influenza", "PROBLEM", 190, 199], ["hepatitis A", "PROBLEM", 201, 212], ["hepatitis B", "PROBLEM", 214, 225], ["human papilloma virus (HPV)", "PROBLEM", 227, 254], ["diphtheria", "PROBLEM", 256, 266], ["tetanus", "PROBLEM", 268, 275], ["acellular pertussis", "PROBLEM", 277, 296], ["meningococcal disease", "PROBLEM", 301, 322], ["no significant evidence for", "UNCERTAINTY", 41, 68], ["hepatitis", "OBSERVATION", 201, 210], ["papilloma virus", "OBSERVATION", 233, 248], ["acellular", "ANATOMY", 277, 286], ["pertussis", "OBSERVATION", 287, 296], ["meningococcal disease", "OBSERVATION", 301, 322]]], ["Some studies have even indicated a decreased risk for MS and reduced disease activity in preexisting MS (8) .INTRODUCTIONThe aim of this review is to summarize data on vaccination and disease activity of both MS and acute disseminated encephalomyelitis (ADEM).", [["MS", "DISEASE", 54, 56], ["MS", "DISEASE", 101, 103], ["MS", "DISEASE", 209, 211], ["acute disseminated encephalomyelitis", "DISEASE", 216, 252], ["ADEM", "DISEASE", 254, 258], ["Some studies", "TEST", 0, 12], ["MS", "PROBLEM", 54, 56], ["reduced disease activity", "PROBLEM", 61, 85], ["vaccination", "TREATMENT", 168, 179], ["both MS", "PROBLEM", 204, 211], ["acute disseminated encephalomyelitis", "PROBLEM", 216, 252], ["acute", "OBSERVATION_MODIFIER", 216, 221], ["disseminated", "OBSERVATION_MODIFIER", 222, 234], ["encephalomyelitis", "OBSERVATION", 235, 252]]], ["Moreover, vaccination-induced effects on the immune system are presented and potential interactions between MS and immunizations are discussed.BASIC IMMUNOLOGY OF VACCINATIONVaccine-induced protection is a complex issue and depends on a cascade of mechanisms and mediators (Figure 1) .", [["immune system", "ANATOMY", 45, 58], ["MS", "DISEASE", 108, 110], ["vaccination", "TREATMENT", 10, 21], ["immunizations", "TREATMENT", 115, 128], ["VACCINATIONVaccine-induced protection", "TREATMENT", 163, 200]]], ["Eventually, protection is accomplished either by antibodies or T celldependent factors or by a combination of both including neutralizing or antitoxic antibodies, CD8 + T cells, CD4 + T cells and corresponding cytokines (e.g., interleukin (IL)-2, 3, 4, 5, 9, 13, 17, 21, 22, and 26) (9) .", [["CD8 + T cells", "ANATOMY", 163, 176], ["CD4 + T cells", "ANATOMY", 178, 191], ["T celldependent factors", "GENE_OR_GENE_PRODUCT", 63, 86], ["CD8", "GENE_OR_GENE_PRODUCT", 163, 166], ["CD4", "GENE_OR_GENE_PRODUCT", 178, 181], ["interleukin (IL)-2", "GENE_OR_GENE_PRODUCT", 227, 245], ["3", "GENE_OR_GENE_PRODUCT", 247, 248], ["4", "GENE_OR_GENE_PRODUCT", 250, 251], ["5", "GENE_OR_GENE_PRODUCT", 253, 254], ["antibodies", "PROTEIN", 49, 59], ["T celldependent factors", "PROTEIN", 63, 86], ["antitoxic antibodies", "PROTEIN", 141, 161], ["CD8", "PROTEIN", 163, 166], ["T cells", "CELL_TYPE", 169, 176], ["CD4", "PROTEIN", 178, 181], ["T cells", "CELL_TYPE", 184, 191], ["cytokines", "PROTEIN", 210, 219], ["protection", "TREATMENT", 12, 22], ["T celldependent factors", "PROBLEM", 63, 86], ["neutralizing", "TREATMENT", 125, 137], ["antitoxic antibodies", "TEST", 141, 161], ["CD8", "TEST", 163, 166], ["CD4 + T cells", "PROBLEM", 178, 191], ["corresponding cytokines", "TEST", 196, 219], ["interleukin (IL", "TEST", 227, 242]]], ["Generally, vaccines have to be capable of activating antigen-presenting cells (APCs) of the innate immune system, which subsequently present the vaccine epitope(s) to T cells-the so-called 'immunogenic potential' (10) .", [["antigen-presenting cells", "ANATOMY", 53, 77], ["APCs", "ANATOMY", 79, 83], ["immune system", "ANATOMY", 99, 112], ["T cells", "ANATOMY", 167, 174], ["antigen-presenting cells", "CELL", 53, 77], ["APCs", "CELL", 79, 83], ["immune system", "ANATOMICAL_SYSTEM", 99, 112], ["T cells", "CELL", 167, 174], ["antigen-presenting cells", "CELL_TYPE", 53, 77], ["APCs", "CELL_TYPE", 79, 83], ["T cells", "CELL_TYPE", 167, 174], ["vaccines", "TREATMENT", 11, 19], ["activating antigen", "PROBLEM", 42, 60]]], ["In this context, dendritic cells play a pivotal role due to their enhanced capability to stimulate na\u00efve T cells (11) .BASIC IMMUNOLOGY OF VACCINATIONThe nature of vaccine-induced immunity depends on several parameters, of which the biological properties of the vaccine's epitope are of high importance (9) .", [["dendritic cells", "ANATOMY", 17, 32], ["na\u00efve T cells", "ANATOMY", 99, 112], ["dendritic cells", "CELL", 17, 32], ["na\u00efve T cells", "CELL", 99, 112], ["dendritic cells", "CELL_TYPE", 17, 32], ["na\u00efve T cells", "CELL_TYPE", 99, 112], ["dendritic cells", "PROBLEM", 17, 32], ["vaccine", "TREATMENT", 164, 171], ["the vaccine's epitope", "TREATMENT", 258, 279], ["dendritic cells", "OBSERVATION", 17, 32]]], ["Live vaccines are attenuated variants of pathogens that still can activate APCs, especially immature dendritic cells, patrolling through the body.", [["APCs", "ANATOMY", 75, 79], ["dendritic cells", "ANATOMY", 101, 116], ["body", "ANATOMY", 141, 145], ["APCs", "CELL", 75, 79], ["dendritic cells", "CELL", 101, 116], ["body", "ORGANISM_SUBDIVISION", 141, 145], ["APCs", "CELL_TYPE", 75, 79], ["immature dendritic cells", "CELL_TYPE", 92, 116], ["Live vaccines", "TREATMENT", 0, 13], ["attenuated variants of pathogens", "PROBLEM", 18, 50], ["immature dendritic cells", "PROBLEM", 92, 116], ["dendritic cells", "OBSERVATION", 101, 116], ["body", "ANATOMY", 141, 145]]], ["This immunogenic potential is often lost by subcellular-or subunitbased vaccines (12) , which is why these inactivated vaccine antigens are usually combined with so-called adjuvants to increase and modulate the vaccine's immunogenicity via a longer lasting and more effective activation of immune cells.BASIC IMMUNOLOGY OF VACCINATIONOne of the most widely used adjuvants are aluminum salts, which were originally thought to create a long-lasting depot of the antigen in order to provide its slow release, but have instead been shown to act on dendritic cells via PRRs (pattern recognition receptors) leading to the secretion of pro-inflammatory cytokines (13) .", [["subcellular", "ANATOMY", 44, 55], ["immune cells", "ANATOMY", 290, 302], ["dendritic cells", "ANATOMY", 544, 559], ["aluminum salts", "CHEMICAL", 376, 390], ["aluminum", "CHEMICAL", 376, 384], ["immune cells", "CELL", 290, 302], ["aluminum salts", "SIMPLE_CHEMICAL", 376, 390], ["dendritic cells", "CELL", 544, 559], ["PRRs", "GENE_OR_GENE_PRODUCT", 564, 568], ["pattern recognition receptors", "GENE_OR_GENE_PRODUCT", 570, 599], ["immune cells", "CELL_TYPE", 290, 302], ["dendritic cells", "CELL_TYPE", 544, 559], ["PRRs", "PROTEIN", 564, 568], ["pattern recognition receptors", "PROTEIN", 570, 599], ["pro-inflammatory cytokines", "PROTEIN", 629, 655], ["subunitbased vaccines", "TREATMENT", 59, 80], ["these inactivated vaccine antigens", "PROBLEM", 101, 135], ["adjuvants", "TREATMENT", 172, 181], ["immune cells", "PROBLEM", 290, 302], ["adjuvants", "TREATMENT", 362, 371], ["aluminum salts", "TREATMENT", 376, 390], ["the secretion of pro-inflammatory cytokines", "PROBLEM", 612, 655], ["immune cells", "OBSERVATION", 290, 302]]], ["Similarly, novel adjuvants like squalens or monophosphoryl lipid A (MPLA-a detoxified lipopolysaccharide) aim to enhance the innate immune response, but never reach the immunogenic potential of live attenuated vaccines (14) .", [["squalens", "CHEMICAL", 32, 40], ["monophosphoryl lipid A", "CHEMICAL", 44, 66], ["MPLA", "CHEMICAL", 68, 72], ["lipopolysaccharide", "CHEMICAL", 86, 104], ["squalens", "CHEMICAL", 32, 40], ["squalens", "SIMPLE_CHEMICAL", 32, 40], ["monophosphoryl lipid A", "SIMPLE_CHEMICAL", 44, 66], ["MPLA", "SIMPLE_CHEMICAL", 68, 72], ["lipopolysaccharide", "SIMPLE_CHEMICAL", 86, 104], ["novel adjuvants", "TREATMENT", 11, 26], ["monophosphoryl lipid A (MPLA", "TREATMENT", 44, 72], ["a detoxified lipopolysaccharide)", "TREATMENT", 73, 105], ["live attenuated vaccines", "TREATMENT", 194, 218]]], ["Adjuvants have been added to vaccines for more than 90 years and over the last decades, considerable progress has been made in understanding their mode of action and to improve safety (15) .", [["Adjuvants", "TREATMENT", 0, 9], ["vaccines", "TREATMENT", 29, 37]]], ["Besides the above mentioned aluminum salts, squalene and MPLA, oil emulsions, saponin, Toll-like receptor (TLR) agonists, enterotoxins, polysaccharides, and glycolipid adjuvants (16) are used, all of which stimulate the immune system as well.BASIC IMMUNOLOGY OF VACCINATIONAluminum adjuvants have now been used for decades and lots of experience has been gained on its use, effectiveness, and safety and they still remain the most frequently used adjuvants.", [["immune system", "ANATOMY", 220, 233], ["aluminum salts", "CHEMICAL", 28, 42], ["squalene", "CHEMICAL", 44, 52], ["MPLA", "CHEMICAL", 57, 61], ["saponin", "CHEMICAL", 78, 85], ["aluminum salts", "CHEMICAL", 28, 42], ["squalene", "CHEMICAL", 44, 52], ["MPLA", "CHEMICAL", 57, 61], ["saponin", "CHEMICAL", 78, 85], ["aluminum salts", "SIMPLE_CHEMICAL", 28, 42], ["squalene", "SIMPLE_CHEMICAL", 44, 52], ["MPLA", "SIMPLE_CHEMICAL", 57, 61], ["oil emulsions", "SIMPLE_CHEMICAL", 63, 76], ["saponin", "SIMPLE_CHEMICAL", 78, 85], ["Toll-like receptor", "GENE_OR_GENE_PRODUCT", 87, 105], ["TLR", "GENE_OR_GENE_PRODUCT", 107, 110], ["polysaccharides", "SIMPLE_CHEMICAL", 136, 151], ["glycolipid adjuvants", "SIMPLE_CHEMICAL", 157, 177], ["TLR", "PROTEIN", 107, 110], ["enterotoxins", "PROTEIN", 122, 134], ["aluminum salts", "TREATMENT", 28, 42], ["squalene and MPLA, oil emulsions", "TREATMENT", 44, 76], ["saponin", "TREATMENT", 78, 85], ["Toll-like receptor (TLR) agonists", "TREATMENT", 87, 120], ["enterotoxins", "PROBLEM", 122, 134], ["polysaccharides", "TREATMENT", 136, 151], ["glycolipid adjuvants", "TREATMENT", 157, 177], ["VACCINATIONAluminum adjuvants", "TREATMENT", 262, 291], ["adjuvants", "TREATMENT", 447, 456]]], ["Their effects on the immune system comprise stimulation of macrophages and dendritic cells via PRRs, inflammasome activation, IL-1\u03b2 release and activation of Th2 lymphocytes (15, 16) .", [["immune system", "ANATOMY", 21, 34], ["macrophages", "ANATOMY", 59, 70], ["dendritic cells", "ANATOMY", 75, 90], ["Th2 lymphocytes", "ANATOMY", 158, 173], ["immune system", "ANATOMICAL_SYSTEM", 21, 34], ["macrophages", "CELL", 59, 70], ["dendritic cells", "CELL", 75, 90], ["PRRs", "GENE_OR_GENE_PRODUCT", 95, 99], ["IL-1\u03b2", "GENE_OR_GENE_PRODUCT", 126, 131], ["Th2 lymphocytes", "CELL", 158, 173], ["macrophages", "CELL_TYPE", 59, 70], ["dendritic cells", "CELL_TYPE", 75, 90], ["PRRs", "PROTEIN", 95, 99], ["IL-1\u03b2", "PROTEIN", 126, 131], ["Th2 lymphocytes", "CELL_TYPE", 158, 173], ["the immune system", "TREATMENT", 17, 34], ["macrophages", "PROBLEM", 59, 70], ["dendritic cells", "PROBLEM", 75, 90], ["inflammasome activation", "PROBLEM", 101, 124], ["IL", "TEST", 126, 128], ["activation of Th2 lymphocytes", "TEST", 144, 173], ["macrophages", "OBSERVATION", 59, 70], ["dendritic cells", "OBSERVATION", 75, 90], ["Th2 lymphocytes", "OBSERVATION", 158, 173]]], ["However, besides increased immunogenicity, aluminum adjuvants also increase reactogenicity and based on data from animal models and reports on narcolepsy, silicosis, Guillain-Barr\u00e9-syndrome (GBS) and macrophagic myofasciitis, they are also discussed to induce autoimmunity (17) .", [["macrophagic myofasciitis", "ANATOMY", 200, 224], ["aluminum", "CHEMICAL", 43, 51], ["narcolepsy", "DISEASE", 143, 153], ["silicosis", "DISEASE", 155, 164], ["Guillain-Barr\u00e9-syndrome", "DISEASE", 166, 189], ["GBS", "DISEASE", 191, 194], ["macrophagic myofasciitis", "DISEASE", 200, 224], ["autoimmunity", "DISEASE", 260, 272], ["aluminum", "CHEMICAL", 43, 51], ["aluminum", "SIMPLE_CHEMICAL", 43, 51], ["Guillain-Barr\u00e9", "ORGANISM", 166, 180], ["increased immunogenicity", "PROBLEM", 17, 41], ["aluminum adjuvants", "TREATMENT", 43, 61], ["increase reactogenicity", "PROBLEM", 67, 90], ["narcolepsy", "PROBLEM", 143, 153], ["silicosis", "PROBLEM", 155, 164], ["Guillain", "TEST", 166, 174], ["Barr\u00e9-syndrome", "PROBLEM", 175, 189], ["GBS", "PROBLEM", 191, 194], ["macrophagic myofasciitis", "PROBLEM", 200, 224], ["increased", "OBSERVATION_MODIFIER", 17, 26], ["immunogenicity", "OBSERVATION", 27, 41], ["silicosis", "OBSERVATION", 155, 164], ["macrophagic myofasciitis", "OBSERVATION", 200, 224]]], ["The second most commonly and long used adjuvants are oil emulsions.", [["oil", "ANATOMY", 53, 56], ["oil emulsions", "TREATMENT", 53, 66], ["oil emulsions", "OBSERVATION", 53, 66]]], ["They have a strong reactogenic potential and can cause severe inflammatory local reactions such as ulceration and granulomas.", [["granulomas", "ANATOMY", 114, 124], ["ulceration", "DISEASE", 99, 109], ["granulomas", "DISEASE", 114, 124], ["ulceration", "PATHOLOGICAL_FORMATION", 99, 109], ["granulomas", "PATHOLOGICAL_FORMATION", 114, 124], ["severe inflammatory local reactions", "PROBLEM", 55, 90], ["ulceration", "PROBLEM", 99, 109], ["granulomas", "PROBLEM", 114, 124], ["severe", "OBSERVATION_MODIFIER", 55, 61], ["inflammatory", "OBSERVATION_MODIFIER", 62, 74], ["ulceration", "OBSERVATION", 99, 109], ["granulomas", "OBSERVATION", 114, 124]]], ["The most well-known oil emulsion is complete Freund's adjuvant.", [["oil", "ANATOMY", 20, 23], ["oil", "ORGANISM_SUBSTANCE", 20, 23], ["Freund's adjuvant", "TREATMENT", 45, 62], ["oil emulsion", "OBSERVATION", 20, 32]]], ["However, due to its potent reactogenicity, it is not suitable for human use.", [["human", "ORGANISM", 66, 71], ["human", "SPECIES", 66, 71], ["human", "SPECIES", 66, 71], ["its potent reactogenicity", "PROBLEM", 16, 41], ["potent", "OBSERVATION_MODIFIER", 20, 26], ["reactogenicity", "OBSERVATION", 27, 41]]], ["A possible association between oil emulsions and autoimmunity disorders has been hypothesized from animal models.", [["oil", "ANATOMY", 31, 34], ["autoimmunity disorders", "DISEASE", 49, 71], ["oil", "ORGANISM_SUBSTANCE", 31, 34], ["oil emulsions", "PROBLEM", 31, 44], ["autoimmunity disorders", "PROBLEM", 49, 71], ["possible", "UNCERTAINTY", 2, 10], ["oil emulsions", "OBSERVATION", 31, 44], ["autoimmunity disorders", "OBSERVATION", 49, 71]]], ["Oil emulsions are potent inducers of IL-1\u03b2 and IL-17 (18, 19) .", [["Oil", "SIMPLE_CHEMICAL", 0, 3], ["IL-1\u03b2", "GENE_OR_GENE_PRODUCT", 37, 42], ["IL-17", "GENE_OR_GENE_PRODUCT", 47, 52], ["IL", "PROTEIN", 37, 39], ["Oil emulsions", "TREATMENT", 0, 13], ["IL", "TEST", 37, 39], ["IL", "TEST", 47, 49], ["emulsions", "OBSERVATION", 4, 13], ["potent", "OBSERVATION_MODIFIER", 18, 24], ["IL", "ANATOMY", 47, 49]]], ["IL-17 plays a major role in autoimmunity and MS and may trigger the migration of peripheral lymphocytes into the CNS across the BBB (20, 21) .", [["peripheral lymphocytes", "ANATOMY", 81, 103], ["CNS", "ANATOMY", 113, 116], ["BBB", "ANATOMY", 128, 131], ["autoimmunity", "DISEASE", 28, 40], ["MS", "DISEASE", 45, 47], ["IL-17", "GENE_OR_GENE_PRODUCT", 0, 5], ["peripheral lymphocytes", "CELL", 81, 103], ["CNS", "ANATOMICAL_SYSTEM", 113, 116], ["BBB", "MULTI-TISSUE_STRUCTURE", 128, 131], ["IL-17", "PROTEIN", 0, 5], ["peripheral lymphocytes", "CELL_TYPE", 81, 103], ["peripheral lymphocytes", "ANATOMY", 81, 103], ["CNS", "ANATOMY", 113, 116], ["BBB", "ANATOMY", 128, 131]]], ["Frequently, a combination of adjuvants is used to increase immunogenicity of vaccines.", [["adjuvants", "TREATMENT", 29, 38], ["immunogenicity of vaccines", "TREATMENT", 59, 85]]], ["AS03 is an adjuvant emulsion containing squalene, DL-\u03b1tocopherol, and polysorbate 80.", [["AS03", "CHEMICAL", 0, 4], ["squalene", "CHEMICAL", 40, 48], ["DL-\u03b1tocopherol", "CHEMICAL", 50, 64], ["polysorbate 80", "CHEMICAL", 70, 84], ["squalene", "CHEMICAL", 40, 48], ["DL-\u03b1tocopherol", "CHEMICAL", 50, 64], ["polysorbate 80", "CHEMICAL", 70, 84], ["AS03", "SIMPLE_CHEMICAL", 0, 4], ["squalene", "SIMPLE_CHEMICAL", 40, 48], ["DL-\u03b1tocopherol", "SIMPLE_CHEMICAL", 50, 64], ["polysorbate 80", "SIMPLE_CHEMICAL", 70, 84], ["AS03", "TEST", 0, 4], ["an adjuvant emulsion", "TREATMENT", 8, 28], ["squalene", "TREATMENT", 40, 48], ["\u03b1tocopherol", "TREATMENT", 53, 64], ["polysorbate", "TREATMENT", 70, 81]]], ["It is e.g., used for the pandemic swine flu vaccine Pandemrix R (15) or the FDA-licensed H5N1 monovalent influenza vaccine.", [["Pandemrix R", "CHEMICAL", 52, 63], ["swine", "ORGANISM", 34, 39], ["H5N1", "ORGANISM", 89, 93], ["swine flu vaccine", "SPECIES", 34, 51], ["H5N1 monovalent influenza vaccine", "SPECIES", 89, 122], ["the pandemic swine flu vaccine", "TREATMENT", 21, 51], ["the FDA", "TREATMENT", 72, 79], ["H5N1 monovalent influenza vaccine", "TREATMENT", 89, 122]]], ["In animal studies, autoimmunity was observed in connection with AS03 (22) and in humans, cases of narcolepsy have been reported (23) .", [["autoimmunity", "DISEASE", 19, 31], ["narcolepsy", "DISEASE", 98, 108], ["humans", "ORGANISM", 81, 87], ["humans", "SPECIES", 81, 87], ["humans", "SPECIES", 81, 87], ["animal studies", "TEST", 3, 17], ["autoimmunity", "PROBLEM", 19, 31], ["AS03", "TEST", 64, 68], ["narcolepsy", "PROBLEM", 98, 108]]], ["Oil emulsions are often combined with TLR agonists such as MPLA.", [["MPLA", "CHEMICAL", 59, 63], ["MPLA", "CHEMICAL", 59, 63], ["Oil emulsions", "SIMPLE_CHEMICAL", 0, 13], ["TLR agonists", "GENE_OR_GENE_PRODUCT", 38, 50], ["MPLA", "SIMPLE_CHEMICAL", 59, 63], ["Oil emulsions", "TREATMENT", 0, 13], ["TLR agonists", "TREATMENT", 38, 50], ["emulsions", "OBSERVATION", 4, 13]]], ["Generally, TLR agonist adjuvants activate the inflammatory transcription factor NF\u03baB AS04 is a combination of MPLA and aluminum salts and is used as adjuvant in vaccines against hepatitis B (Fendrix R ) and HPV, as well as in the new recombinant vaccine against Herpes zoster.", [["MPLA", "CHEMICAL", 110, 114], ["aluminum salts", "CHEMICAL", 119, 133], ["hepatitis B", "DISEASE", 178, 189], ["Herpes zoster", "DISEASE", 262, 275], ["MPLA", "CHEMICAL", 110, 114], ["aluminum", "CHEMICAL", 119, 127], ["TLR", "GENE_OR_GENE_PRODUCT", 11, 14], ["NF\u03baB", "GENE_OR_GENE_PRODUCT", 80, 84], ["MPLA", "SIMPLE_CHEMICAL", 110, 114], ["aluminum salts", "SIMPLE_CHEMICAL", 119, 133], ["hepatitis B", "ORGANISM", 178, 189], ["Fendrix R", "ORGANISM", 191, 200], ["HPV", "ORGANISM", 207, 210], ["Herpes zoster", "ORGANISM", 262, 275], ["TLR", "PROTEIN", 11, 14], ["inflammatory transcription factor", "PROTEIN", 46, 79], ["NF\u03baB AS04", "PROTEIN", 80, 89], ["Herpes zoster", "SPECIES", 262, 275], ["hepatitis B", "SPECIES", 178, 189], ["HPV", "SPECIES", 207, 210], ["TLR agonist adjuvants", "TREATMENT", 11, 32], ["MPLA and aluminum salts", "TREATMENT", 110, 133], ["adjuvant in vaccines", "TREATMENT", 149, 169], ["hepatitis B (Fendrix R )", "TREATMENT", 178, 202], ["HPV", "PROBLEM", 207, 210], ["the new recombinant vaccine", "TREATMENT", 226, 253], ["Herpes zoster", "PROBLEM", 262, 275], ["inflammatory", "OBSERVATION_MODIFIER", 46, 58]]], ["Most polysaccharide adjuvants activate NF\u03baB to induce immune processes (e.g., dextran, zymosan) (24) .", [["dextran", "CHEMICAL", 78, 85], ["zymosan", "CHEMICAL", 87, 94], ["NF\u03baB", "GENE_OR_GENE_PRODUCT", 39, 43], ["dextran", "SIMPLE_CHEMICAL", 78, 85], ["zymosan", "SIMPLE_CHEMICAL", 87, 94], ["NF\u03baB", "PROTEIN", 39, 43], ["Most polysaccharide adjuvants", "TREATMENT", 0, 29], ["dextran", "TREATMENT", 78, 85]]], ["However, deltainulin for instance, a polysaccharide adjuvant used for Advax R , acts via NF\u03baB-independent mechanisms to enhance humoral and cellular immune responses.", [["cellular", "ANATOMY", 140, 148], ["deltainulin", "CHEMICAL", 9, 20], ["deltainulin", "CHEMICAL", 9, 20], ["deltainulin", "SIMPLE_CHEMICAL", 9, 20], ["Advax R", "GENE_OR_GENE_PRODUCT", 70, 77], ["NF\u03ba", "GENE_OR_GENE_PRODUCT", 89, 92], ["B", "GENE_OR_GENE_PRODUCT", 92, 93], ["cellular", "CELL", 140, 148], ["NF\u03ba", "PROTEIN", 89, 92], ["deltainulin", "TREATMENT", 9, 20], ["a polysaccharide adjuvant", "TREATMENT", 35, 60]]], ["Although the mechanisms are not yet fully understood, Advax R has so far not shown inflammatory side effects and has proven safety in hepatitis B vaccination and influenza (16) .BASIC IMMUNOLOGY OF VACCINATIONAfter activation of the immune cascade and stimulation of dendritic cells, the latter increase their expression of MHC molecules and chemokine receptors such as CCR7 leading to their migration toward the draining lymph nodes in order to provide co-stimulatory signals for the differentiation of na\u00efve T cells into immune effector cells (25) .", [["dendritic cells", "ANATOMY", 267, 282], ["lymph nodes", "ANATOMY", 422, 433], ["T cells", "ANATOMY", 510, 517], ["immune effector cells", "ANATOMY", 523, 544], ["hepatitis B", "DISEASE", 134, 145], ["influenza", "DISEASE", 162, 171], ["Advax R", "GENE_OR_GENE_PRODUCT", 54, 61], ["hepatitis B", "ORGANISM", 134, 145], ["dendritic cells", "CELL", 267, 282], ["CCR7", "GENE_OR_GENE_PRODUCT", 370, 374], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 422, 433], ["na\u00efve T cells", "CELL", 504, 517], ["immune effector cells", "CELL", 523, 544], ["dendritic cells", "CELL_TYPE", 267, 282], ["MHC molecules", "PROTEIN", 324, 337], ["chemokine receptors", "PROTEIN", 342, 361], ["CCR7", "PROTEIN", 370, 374], ["na\u00efve T cells", "CELL_TYPE", 504, 517], ["immune effector cells", "CELL_TYPE", 523, 544], ["hepatitis B", "SPECIES", 134, 145], ["inflammatory side effects", "PROBLEM", 83, 108], ["hepatitis B vaccination", "TREATMENT", 134, 157], ["influenza", "PROBLEM", 162, 171], ["the immune cascade", "TREATMENT", 229, 247], ["dendritic cells", "PROBLEM", 267, 282], ["chemokine receptors", "TREATMENT", 342, 361], ["CCR7", "PROBLEM", 370, 374], ["the draining lymph nodes", "TREATMENT", 409, 433], ["co-stimulatory signals", "TEST", 454, 476], ["inflammatory", "OBSERVATION", 83, 95], ["dendritic cells", "OBSERVATION", 267, 282], ["draining", "OBSERVATION_MODIFIER", 413, 421], ["lymph nodes", "OBSERVATION", 422, 433]]], ["The activation of the immune cascade has various effects on T and B cells.", [["T", "ANATOMY", 60, 61], ["B cells", "ANATOMY", 66, 73], ["T", "CELL", 60, 61], ["B cells", "CELL", 66, 73], ["T and B cells", "CELL_TYPE", 60, 73], ["the immune cascade", "TREATMENT", 18, 36], ["T and B cells", "TREATMENT", 60, 73]]], ["In short, antigen-recognition by B cells leads to their activation and migration toward the T-B cell border of the lymph node, where they can subsequently receive additional stimuli by activated T helper (TH) cells.", [["B cells", "ANATOMY", 33, 40], ["T-B cell border", "ANATOMY", 92, 107], ["lymph node", "ANATOMY", 115, 125], ["T helper (TH) cells", "ANATOMY", 195, 214], ["B cells", "CELL", 33, 40], ["T-B cell", "CELL", 92, 100], ["lymph node", "MULTI-TISSUE_STRUCTURE", 115, 125], ["T helper (TH) cells", "CELL", 195, 214], ["B cells", "CELL_TYPE", 33, 40], ["activated T helper (TH) cells", "CELL_TYPE", 185, 214], ["lymph node", "OBSERVATION", 115, 125]]], ["These signals include CD40 interaction, secretion of cytokines by TH1 or TH2 cells, and finally the transformation of B cells into plasma cells predominantly secreting low affinity antibodies (26) .", [["TH2 cells", "ANATOMY", 73, 82], ["B cells", "ANATOMY", 118, 125], ["plasma cells", "ANATOMY", 131, 143], ["CD40", "GENE_OR_GENE_PRODUCT", 22, 26], ["TH1", "GENE_OR_GENE_PRODUCT", 66, 69], ["TH2 cells", "CELL", 73, 82], ["B cells", "CELL", 118, 125], ["plasma cells", "CELL", 131, 143], ["CD40", "PROTEIN", 22, 26], ["cytokines", "PROTEIN", 53, 62], ["TH1 or TH2 cells", "CELL_TYPE", 66, 82], ["B cells", "CELL_TYPE", 118, 125], ["plasma cells", "CELL_TYPE", 131, 143], ["low affinity antibodies", "PROTEIN", 168, 191], ["cytokines", "PROBLEM", 53, 62], ["plasma cells", "TEST", 131, 143], ["secreting low affinity antibodies", "PROBLEM", 158, 191], ["TH2 cells", "OBSERVATION", 73, 82]]], ["Later, the germinal center response contributes via affinity maturation (somatic hypermutation and affinity-based selection) and isotype switch to a sustained production of high affinity antibodies by predominantly plasma cells but also memory B cells.", [["germinal center", "ANATOMY", 11, 26], ["plasma cells", "ANATOMY", 215, 227], ["memory B cells", "ANATOMY", 237, 251], ["plasma cells", "CELL", 215, 227], ["memory B cells", "CELL", 237, 251], ["high affinity antibodies", "PROTEIN", 173, 197], ["plasma cells", "CELL_TYPE", 215, 227], ["memory B cells", "CELL_TYPE", 237, 251], ["affinity maturation", "PROBLEM", 52, 71], ["somatic hypermutation", "PROBLEM", 73, 94], ["affinity-based selection", "TREATMENT", 99, 123], ["isotype switch", "TREATMENT", 129, 143], ["high affinity antibodies", "PROBLEM", 173, 197], ["predominantly plasma cells", "PROBLEM", 201, 227], ["affinity maturation", "OBSERVATION", 52, 71], ["plasma cells", "OBSERVATION", 215, 227], ["memory B cells", "OBSERVATION", 237, 251]]], ["Basically, in the lymph nodes, numerous B cells with various affinity compete for the antigens presented by follicular dendritic cells.", [["lymph nodes", "ANATOMY", 18, 29], ["B cells", "ANATOMY", 40, 47], ["follicular dendritic cells", "ANATOMY", 108, 134], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 18, 29], ["B cells", "CELL", 40, 47], ["follicular dendritic cells", "CELL", 108, 134], ["B cells", "CELL_TYPE", 40, 47], ["antigens", "PROTEIN", 86, 94], ["follicular dendritic cells", "CELL_TYPE", 108, 134], ["numerous B cells", "PROBLEM", 31, 47], ["various affinity", "PROBLEM", 53, 69], ["follicular dendritic cells", "PROBLEM", 108, 134], ["lymph nodes", "OBSERVATION", 18, 29], ["numerous", "OBSERVATION_MODIFIER", 31, 39], ["B cells", "OBSERVATION", 40, 47], ["follicular dendritic cells", "OBSERVATION", 108, 134]]], ["These antigens are processed and further presented via MHC II to follicular TH cells, which provide costimulatory signals (e.g., CD40, ICOS, and IL-21) leading to survival and further proliferation of B cells with highest affinity for the antigen (27) .BASIC IMMUNOLOGY OF VACCINATIONIn conclusion, vaccination-induced immune responses, including employed cell types and mediators, vary depending on the type of vaccine administration, kind of vaccine and choice of adjuvant.", [["follicular TH cells", "ANATOMY", 65, 84], ["B cells", "ANATOMY", 201, 208], ["cell", "ANATOMY", 356, 360], ["MHC II", "GENE_OR_GENE_PRODUCT", 55, 61], ["follicular TH cells", "CELL", 65, 84], ["CD40", "GENE_OR_GENE_PRODUCT", 129, 133], ["ICOS", "GENE_OR_GENE_PRODUCT", 135, 139], ["IL-21", "GENE_OR_GENE_PRODUCT", 145, 150], ["B cells", "CELL", 201, 208], ["cell", "CELL", 356, 360], ["antigens", "PROTEIN", 6, 14], ["MHC II", "PROTEIN", 55, 61], ["follicular TH cells", "CELL_TYPE", 65, 84], ["CD40", "PROTEIN", 129, 133], ["ICOS", "PROTEIN", 135, 139], ["IL-21", "PROTEIN", 145, 150], ["B cells", "CELL_TYPE", 201, 208], ["costimulatory signals", "TEST", 100, 121], ["CD40", "TEST", 129, 133], ["ICOS", "TEST", 135, 139], ["IL", "TEST", 145, 147], ["further proliferation of B cells", "PROBLEM", 176, 208], ["highest affinity", "PROBLEM", 214, 230], ["the antigen", "TEST", 235, 246], ["vaccination", "TREATMENT", 299, 310], ["vaccine administration", "TREATMENT", 412, 434], ["vaccine", "TREATMENT", 444, 451], ["adjuvant", "TREATMENT", 466, 474]]], ["While antibodies will directly prevent and reduce infections, CD4 + and CD8 + T cells rather support the organism eventually reducing, controlling and clearing the pathogens.", [["CD4 +", "ANATOMY", 62, 67], ["CD8 + T cells", "ANATOMY", 72, 85], ["infections", "DISEASE", 50, 60], ["CD4", "GENE_OR_GENE_PRODUCT", 62, 65], ["CD8", "GENE_OR_GENE_PRODUCT", 72, 75], ["antibodies", "PROTEIN", 6, 16], ["CD4 + and CD8 + T cells", "CELL_TYPE", 62, 85], ["infections", "PROBLEM", 50, 60], ["CD4", "TEST", 62, 65], ["CD8 + T cells", "PROBLEM", 72, 85], ["the organism", "PROBLEM", 101, 113], ["the pathogens", "PROBLEM", 160, 173], ["infections", "OBSERVATION", 50, 60], ["pathogens", "OBSERVATION", 164, 173]]], ["Antibodies bind to their antigen, neutralize pathogens, activate macrophages and neutrophils as well as the complement system, while CD4 + and CD8 + T cells secrete cytokines, perforins, and granzymes (9) .", [["macrophages", "ANATOMY", 65, 76], ["neutrophils", "ANATOMY", 81, 92], ["CD4 + and CD8 + T cells", "ANATOMY", 133, 156], ["macrophages", "CELL", 65, 76], ["neutrophils", "CELL", 81, 92], ["CD4", "GENE_OR_GENE_PRODUCT", 133, 136], ["CD8", "GENE_OR_GENE_PRODUCT", 143, 146], ["perforins", "GENE_OR_GENE_PRODUCT", 176, 185], ["granzymes", "GENE_OR_GENE_PRODUCT", 191, 200], ["macrophages", "CELL_TYPE", 65, 76], ["neutrophils", "CELL_TYPE", 81, 92], ["CD4", "PROTEIN", 133, 136], ["CD8 + T cells", "CELL_TYPE", 143, 156], ["cytokines", "PROTEIN", 165, 174], ["perforins", "PROTEIN", 176, 185], ["granzymes", "PROTEIN", 191, 200], ["Antibodies bind", "PROBLEM", 0, 15], ["neutralize pathogens", "PROBLEM", 34, 54], ["neutrophils", "TEST", 81, 92], ["the complement system", "TEST", 104, 125], ["CD4", "TEST", 133, 136], ["CD8", "TEST", 143, 146], ["cytokines", "TEST", 165, 174], ["granzymes", "TEST", 191, 200]]], ["The choice of adjuvant seems to be critical, since some may cause problems in autoimmune diseases.", [["autoimmune diseases", "DISEASE", 78, 97], ["adjuvant", "TREATMENT", 14, 22], ["autoimmune diseases", "PROBLEM", 78, 97], ["autoimmune", "OBSERVATION", 78, 88]]], ["Thus, monitoring side effects regarding autoimmunity is essential.Vaccination and MSIn the early days of vaccine development, Louis Pasteur used nerve tissue of infected animals to obtain a rabies virus vaccine (28) .", [["nerve tissue", "ANATOMY", 145, 157], ["autoimmunity", "DISEASE", 40, 52], ["MSIn", "CHEMICAL", 82, 86], ["nerve tissue", "TISSUE", 145, 157], ["rabies virus vaccine", "SPECIES", 190, 210], ["rabies virus", "SPECIES", 190, 202], ["autoimmunity", "PROBLEM", 40, 52], ["Vaccination", "TREATMENT", 66, 77], ["vaccine development", "TREATMENT", 105, 124], ["infected animals", "PROBLEM", 161, 177], ["a rabies virus vaccine", "TREATMENT", 188, 210], ["nerve", "ANATOMY", 145, 150], ["infected", "OBSERVATION", 161, 169]]], ["Although saving countless lives it was recognized that active sensitization with neuronal tissue could occasionally lead to neuroparalytic autoimmune complications (29) with self-limiting autoimmune encephalomyelitis that fulfilled the pathological criteria of MS (29, 30) .", [["neuronal tissue", "ANATOMY", 81, 96], ["autoimmune complications", "DISEASE", 139, 163], ["autoimmune encephalomyelitis", "DISEASE", 188, 216], ["MS", "DISEASE", 261, 263], ["neuronal tissue", "TISSUE", 81, 96], ["active sensitization", "PROBLEM", 55, 75], ["neuronal tissue", "PROBLEM", 81, 96], ["neuroparalytic autoimmune complications", "PROBLEM", 124, 163], ["self-limiting autoimmune encephalomyelitis", "PROBLEM", 174, 216], ["MS", "TEST", 261, 263], ["autoimmune encephalomyelitis", "OBSERVATION", 188, 216]]], ["Advances in processing techniques and increasing insights in immunology led to modern vaccines devoid of neuronal tissue.", [["neuronal tissue", "ANATOMY", 105, 120], ["neuronal tissue", "TISSUE", 105, 120], ["processing techniques", "TREATMENT", 12, 33], ["modern vaccines", "TREATMENT", 79, 94], ["neuronal tissue", "PROBLEM", 105, 120], ["neuronal tissue", "OBSERVATION", 105, 120]]], ["MS is a chronic disease thought to be caused by immune-mediated mechanisms.", [["MS", "DISEASE", 0, 2], ["a chronic disease", "PROBLEM", 6, 23], ["immune-mediated mechanisms", "PROBLEM", 48, 74], ["chronic", "OBSERVATION_MODIFIER", 8, 15], ["disease", "OBSERVATION", 16, 23]]], ["Thus, immune responses caused by vaccinations will affect the immune system.", [["immune system", "ANATOMY", 62, 75], ["immune system", "ANATOMICAL_SYSTEM", 62, 75]]], ["However, their effects on immunology per se, but especially those in MS patients, are scarcely understood.Vaccination and MSThe same means by which infections can induce autoimmunity also apply for vaccination-induced immune activation.", [["MS", "DISEASE", 69, 71], ["infections", "DISEASE", 148, 158], ["autoimmunity", "DISEASE", 170, 182], ["patients", "ORGANISM", 72, 80], ["patients", "SPECIES", 72, 80], ["Vaccination", "TREATMENT", 106, 117], ["vaccination", "TREATMENT", 198, 209], ["immune activation", "PROBLEM", 218, 235]]], ["Possible structural similarities between microbial epitopes and epitopes of the CNS could lead to cross-reaction of antibodies via molecular mimicry as shown for streptococcal antibodies in heart tissue (31) .", [["CNS", "ANATOMY", 80, 83], ["heart tissue", "ANATOMY", 190, 202], ["CNS", "ANATOMICAL_SYSTEM", 80, 83], ["streptococcal antibodies", "GENE_OR_GENE_PRODUCT", 162, 186], ["heart tissue", "TISSUE", 190, 202], ["microbial epitopes", "PROTEIN", 41, 59], ["epitopes", "PROTEIN", 64, 72], ["antibodies", "PROTEIN", 116, 126], ["streptococcal antibodies", "PROTEIN", 162, 186], ["structural similarities between microbial epitopes", "PROBLEM", 9, 59], ["the CNS", "PROBLEM", 76, 83], ["cross-reaction of antibodies via molecular mimicry", "PROBLEM", 98, 148], ["streptococcal antibodies in heart tissue", "PROBLEM", 162, 202], ["microbial epitopes", "OBSERVATION", 41, 59], ["CNS", "ANATOMY", 80, 83], ["heart tissue", "ANATOMY", 190, 202]]], ["Additionally, epitope spreading is a mechanism leading to a broadening of the immune response from the dominant epitope to cryptic (intramolecular) or neighboring molecules (intermolecular) resulting in an increased antibody repertoire and cellular response (32) .", [["cellular", "ANATOMY", 240, 248], ["cellular", "CELL", 240, 248], ["cryptic (intramolecular) or neighboring molecules", "PROTEIN", 123, 172], ["antibody repertoire", "PROTEIN", 216, 235], ["epitope spreading", "PROBLEM", 14, 31], ["the immune response", "PROBLEM", 74, 93], ["the dominant epitope to cryptic (intramolecular) or neighboring molecules", "PROBLEM", 99, 172], ["an increased antibody repertoire", "PROBLEM", 203, 235], ["cellular response", "TEST", 240, 257], ["immune response", "OBSERVATION", 78, 93], ["dominant", "OBSERVATION_MODIFIER", 103, 111], ["epitope", "OBSERVATION", 112, 119], ["increased", "OBSERVATION_MODIFIER", 206, 215], ["antibody repertoire", "OBSERVATION", 216, 235]]], ["Moreover, bystander activation, a process in which activated APCs stimulate autoreactive T cells, can occur (33) .", [["APCs", "ANATOMY", 61, 65], ["autoreactive T cells", "ANATOMY", 76, 96], ["APCs", "CELL", 61, 65], ["autoreactive T cells", "CELL", 76, 96], ["APCs", "CELL_TYPE", 61, 65], ["autoreactive T cells", "CELL_TYPE", 76, 96], ["autoreactive T cells", "PROBLEM", 76, 96]]], ["Bacterial and viral infections can trigger relapses and MRI activity in MS; vaccination has been proven to protect from or weaken infections, thus providing an \"indirect\" protection against MS disease activity (34) .Vaccination and MSSeveral reports on neurological disorders developing after immunization have been published including several cases on encephalomyelitic disorders (impaired consciousness, ataxia and optic neuritis) as well as demyelinating lesions in a patient with transverse myelitis after active immunization against influenza (35) (36) (37) (38) .", [["neurological", "ANATOMY", 253, 265], ["lesions", "ANATOMY", 458, 465], ["Bacterial and viral infections", "DISEASE", 0, 30], ["MS", "DISEASE", 72, 74], ["infections", "DISEASE", 130, 140], ["MS", "DISEASE", 190, 192], ["neurological disorders", "DISEASE", 253, 275], ["encephalomyelitic disorders", "DISEASE", 353, 380], ["impaired consciousness", "DISEASE", 382, 404], ["ataxia", "DISEASE", 406, 412], ["optic neuritis", "DISEASE", 417, 431], ["demyelinating lesions", "DISEASE", 444, 465], ["transverse myelitis", "DISEASE", 484, 503], ["influenza", "DISEASE", 538, 547], ["demyelinating lesions", "CANCER", 444, 465], ["patient", "ORGANISM", 471, 478], ["patient", "SPECIES", 471, 478], ["Bacterial and viral infections", "PROBLEM", 0, 30], ["relapses", "PROBLEM", 43, 51], ["MRI activity", "TEST", 56, 68], ["MS", "PROBLEM", 72, 74], ["vaccination", "TREATMENT", 76, 87], ["weaken infections", "PROBLEM", 123, 140], ["MS disease activity", "PROBLEM", 190, 209], ["Vaccination", "TREATMENT", 216, 227], ["neurological disorders", "PROBLEM", 253, 275], ["immunization", "TREATMENT", 293, 305], ["encephalomyelitic disorders", "PROBLEM", 353, 380], ["impaired consciousness", "PROBLEM", 382, 404], ["ataxia", "PROBLEM", 406, 412], ["optic neuritis", "PROBLEM", 417, 431], ["demyelinating lesions", "PROBLEM", 444, 465], ["transverse myelitis", "PROBLEM", 484, 503], ["active immunization", "TREATMENT", 510, 529], ["influenza", "PROBLEM", 538, 547], ["viral infections", "OBSERVATION", 14, 30], ["optic neuritis", "OBSERVATION", 417, 431], ["demyelinating", "OBSERVATION_MODIFIER", 444, 457], ["lesions", "OBSERVATION", 458, 465]]], ["Immunization against rubella was associated with diffuse myelitis and recurrent relapses with optic neuritis, paraparesis and impaired motor function (39, 40) .", [["rubella", "DISEASE", 21, 28], ["myelitis", "DISEASE", 57, 65], ["optic neuritis", "DISEASE", 94, 108], ["paraparesis", "DISEASE", 110, 121], ["impaired motor function", "DISEASE", 126, 149], ["rubella", "ORGANISM", 21, 28], ["rubella", "SPECIES", 21, 28], ["Immunization", "TREATMENT", 0, 12], ["rubella", "PROBLEM", 21, 28], ["diffuse myelitis", "PROBLEM", 49, 65], ["recurrent relapses", "PROBLEM", 70, 88], ["optic neuritis", "PROBLEM", 94, 108], ["paraparesis", "PROBLEM", 110, 121], ["impaired motor function", "PROBLEM", 126, 149], ["diffuse", "OBSERVATION_MODIFIER", 49, 56], ["myelitis", "OBSERVATION", 57, 65], ["optic neuritis", "OBSERVATION", 94, 108], ["paraparesis", "OBSERVATION", 110, 121], ["impaired", "OBSERVATION_MODIFIER", 126, 134], ["motor function", "OBSERVATION", 135, 149]]], ["Transverse myelitis (41) as well as optic neuritis (42, 43) were reported in patients vaccinated against measles, mumps and rubella.", [["myelitis", "DISEASE", 11, 19], ["optic neuritis", "DISEASE", 36, 50], ["measles, mumps and rubella", "DISEASE", 105, 131], ["patients", "ORGANISM", 77, 85], ["measles", "ORGANISM", 105, 112], ["mumps", "ORGANISM", 114, 119], ["patients", "SPECIES", 77, 85], ["Transverse myelitis", "PROBLEM", 0, 19], ["optic neuritis", "PROBLEM", 36, 50], ["measles", "PROBLEM", 105, 112], ["mumps", "PROBLEM", 114, 119], ["rubella", "PROBLEM", 124, 131], ["myelitis", "OBSERVATION", 11, 19], ["optic neuritis", "OBSERVATION", 36, 50]]], ["Further cases with symptoms suggestive for disseminated encephalitis were reported after vaccination against diphtheriatetanus-poliomyelitis (DTP) (44) and after immunization against smallpox, rabies or typhus (45) .", [["encephalitis", "DISEASE", 56, 68], ["diphtheriatetanus-poliomyelitis", "DISEASE", 109, 140], ["DTP", "DISEASE", 142, 145], ["smallpox", "DISEASE", 183, 191], ["rabies or typhus", "DISEASE", 193, 209], ["diphtheriatetanus-poliomyelitis", "ORGANISM", 109, 140], ["symptoms", "PROBLEM", 19, 27], ["disseminated encephalitis", "PROBLEM", 43, 68], ["vaccination", "TREATMENT", 89, 100], ["diphtheriatetanus", "PROBLEM", 109, 126], ["poliomyelitis (DTP)", "PROBLEM", 127, 146], ["immunization", "TREATMENT", 162, 174], ["smallpox", "PROBLEM", 183, 191], ["typhus", "PROBLEM", 203, 209], ["suggestive for", "UNCERTAINTY", 28, 42], ["disseminated", "OBSERVATION_MODIFIER", 43, 55], ["encephalitis", "OBSERVATION", 56, 68], ["poliomyelitis", "OBSERVATION", 127, 140]]], ["Exacerbations of MS and demyelinating lesions were reported in MS patients and patients without a history of neurological conditions after immunization against hepatitis B (46) .", [["demyelinating lesions", "ANATOMY", 24, 45], ["neurological", "ANATOMY", 109, 121], ["MS", "DISEASE", 17, 19], ["demyelinating lesions", "DISEASE", 24, 45], ["MS", "DISEASE", 63, 65], ["hepatitis B", "DISEASE", 160, 171], ["demyelinating lesions", "CANCER", 24, 45], ["patients", "ORGANISM", 66, 74], ["patients", "ORGANISM", 79, 87], ["hepatitis B", "ORGANISM", 160, 171], ["patients", "SPECIES", 66, 74], ["patients", "SPECIES", 79, 87], ["Exacerbations of MS", "PROBLEM", 0, 19], ["demyelinating lesions", "PROBLEM", 24, 45], ["neurological conditions", "PROBLEM", 109, 132], ["immunization", "TREATMENT", 139, 151], ["hepatitis B", "PROBLEM", 160, 171], ["MS", "OBSERVATION", 17, 19], ["demyelinating", "OBSERVATION_MODIFIER", 24, 37], ["lesions", "OBSERVATION", 38, 45]]], ["Similarly, Tourbah reported on 8 patients with demyelinating lesions and clinical symptoms after vaccination against hepatitis B (47) .Vaccination and MSIn contrast to these case series, a case-control study (evidence class II) (48) including more than 440 patients with MS or optic neuritis and 950 controls without any underlying neuroimmunological disorder did not reveal an elevated risk for the development of MS or optic neuritis after immunization against hepatitis B, tetanus, influenza, measles/mumps/rubella, measles, or rubella (49) .", [["lesions", "ANATOMY", 61, 68], ["demyelinating lesions", "DISEASE", 47, 68], ["hepatitis B", "DISEASE", 117, 128], ["MS", "DISEASE", 271, 273], ["optic neuritis", "DISEASE", 277, 291], ["neuroimmunological disorder", "DISEASE", 332, 359], ["MS", "DISEASE", 415, 417], ["optic neuritis", "DISEASE", 421, 435], ["hepatitis B", "DISEASE", 463, 474], ["tetanus", "DISEASE", 476, 483], ["influenza", "DISEASE", 485, 494], ["measles/mumps/rubella, measles, or rubella", "DISEASE", 496, 538], ["patients", "ORGANISM", 33, 41], ["lesions", "PATHOLOGICAL_FORMATION", 61, 68], ["patients", "ORGANISM", 257, 265], ["hepatitis B", "ORGANISM", 463, 474], ["measles/mumps", "ORGANISM", 496, 509], ["patients", "SPECIES", 33, 41], ["patients", "SPECIES", 257, 265], ["mumps/rubella", "SPECIES", 504, 517], ["hepatitis B", "SPECIES", 463, 474], ["measles/mumps/rubella", "SPECIES", 496, 517], ["demyelinating lesions", "PROBLEM", 47, 68], ["clinical symptoms", "PROBLEM", 73, 90], ["vaccination", "TREATMENT", 97, 108], ["hepatitis B", "PROBLEM", 117, 128], ["Vaccination", "TREATMENT", 135, 146], ["a case-control study", "TEST", 187, 207], ["MS", "PROBLEM", 271, 273], ["optic neuritis", "PROBLEM", 277, 291], ["any underlying neuroimmunological disorder", "PROBLEM", 317, 359], ["an elevated risk", "PROBLEM", 375, 391], ["MS", "PROBLEM", 415, 417], ["optic neuritis", "PROBLEM", 421, 435], ["immunization", "TREATMENT", 442, 454], ["hepatitis B", "PROBLEM", 463, 474], ["tetanus", "PROBLEM", 476, 483], ["influenza", "PROBLEM", 485, 494], ["measles", "PROBLEM", 496, 503], ["mumps", "PROBLEM", 504, 509], ["rubella", "PROBLEM", 510, 517], ["measles", "PROBLEM", 519, 526], ["rubella", "PROBLEM", 531, 538], ["demyelinating", "OBSERVATION_MODIFIER", 47, 60], ["lesions", "OBSERVATION", 61, 68], ["optic neuritis", "OBSERVATION", 277, 291], ["elevated", "OBSERVATION", 378, 386], ["optic neuritis", "OBSERVATION", 421, 435]]], ["While Hernan came to same results for immunization against influenza or tetanus in a case-control study (evidence class II), active immunization against hepatitis B was reported to pose a higher risk for MS (50) .", [["influenza", "DISEASE", 59, 68], ["tetanus", "DISEASE", 72, 79], ["hepatitis B", "DISEASE", 153, 164], ["MS", "DISEASE", 204, 206], ["hepatitis B", "ORGANISM", 153, 164], ["hepatitis B", "SPECIES", 153, 164], ["immunization", "TREATMENT", 38, 50], ["influenza", "PROBLEM", 59, 68], ["tetanus", "PROBLEM", 72, 79], ["active immunization", "TREATMENT", 125, 144], ["hepatitis B", "PROBLEM", 153, 164], ["MS", "PROBLEM", 204, 206]]], ["The latter finding could, however, not be confirmed by Confavreux in a large case-crossover study.", [["crossover study", "TEST", 82, 97]]], ["Additionally, no increased risk was seen for vaccination against tetanus and influenza as well (51) .", [["tetanus", "DISEASE", 65, 72], ["influenza", "DISEASE", 77, 86], ["increased risk", "PROBLEM", 17, 31], ["vaccination", "TREATMENT", 45, 56], ["tetanus", "PROBLEM", 65, 72], ["influenza", "PROBLEM", 77, 86], ["no", "UNCERTAINTY", 14, 16], ["increased", "OBSERVATION_MODIFIER", 17, 26]]], ["Similarly, other class II case-control studies did not report on an increased risk for MS after hepatitis B vaccination (52) (53) (54) .", [["MS", "DISEASE", 87, 89], ["hepatitis B", "DISEASE", 96, 107], ["MS", "PROBLEM", 87, 89], ["hepatitis B vaccination", "TEST", 96, 119]]], ["An even decreased risk for MS was reported after tetanus immunization (8) .", [["MS", "DISEASE", 27, 29], ["tetanus", "DISEASE", 49, 56], ["MS", "PROBLEM", 27, 29], ["tetanus immunization", "TREATMENT", 49, 69], ["decreased", "OBSERVATION_MODIFIER", 8, 17]]], ["In a large class I study, a patient register including 789,082 females vaccinated with the quadrivalent HPV vaccine was analyzed.", [["patient", "ORGANISM", 28, 35], ["HPV", "ORGANISM", 104, 107], ["patient", "SPECIES", 28, 35], ["HPV", "SPECIES", 104, 107], ["the quadrivalent HPV vaccine", "TREATMENT", 87, 115], ["large", "OBSERVATION_MODIFIER", 5, 10]]], ["Thereof, 4,322 patients with MS and 3,300 patients with other demyelinating disorders were studied and no increased risk for CNS manifestations was seen in this large cohort (55).", [["CNS", "ANATOMY", 125, 128], ["MS", "DISEASE", 29, 31], ["demyelinating disorders", "DISEASE", 62, 85], ["patients", "ORGANISM", 15, 23], ["patients", "ORGANISM", 42, 50], ["CNS", "ANATOMICAL_SYSTEM", 125, 128], ["patients", "SPECIES", 15, 23], ["patients", "SPECIES", 42, 50], ["MS", "PROBLEM", 29, 31], ["other demyelinating disorders", "PROBLEM", 56, 85], ["CNS manifestations", "PROBLEM", 125, 143], ["no", "UNCERTAINTY", 103, 105], ["increased", "OBSERVATION_MODIFIER", 106, 115]]], ["Miller et al. performed a prospective class II, randomized, double-blind, placebo-controlled study, which included 104 MS patients, who received either standard influenza vaccination or placebo.", [["MS", "DISEASE", 119, 121], ["patients", "ORGANISM", 122, 130], ["patients", "SPECIES", 122, 130], ["double-blind", "TREATMENT", 60, 72], ["placebo-controlled study", "TEST", 74, 98], ["standard influenza vaccination", "TREATMENT", 152, 182], ["placebo", "TREATMENT", 186, 193], ["et al", "OBSERVATION", 7, 12]]], ["For a 6 months follow-up period, the occurrence of neurological symptoms or influenza was monitored and no differences were seen for relapse rates (56) .", [["neurological", "ANATOMY", 51, 63], ["neurological symptoms", "DISEASE", 51, 72], ["influenza", "DISEASE", 76, 85], ["neurological symptoms", "PROBLEM", 51, 72], ["influenza", "PROBLEM", 76, 85], ["relapse rates", "TEST", 133, 146]]], ["A study by Langer-Gould reported on an increased risk for CNS demyelinating diseases within the first 30 days after vaccination.", [["CNS", "ANATOMY", 58, 61], ["demyelinating diseases", "DISEASE", 62, 84], ["CNS", "ANATOMICAL_SYSTEM", 58, 61], ["A study", "TEST", 0, 7], ["CNS demyelinating diseases", "PROBLEM", 58, 84], ["vaccination", "TREATMENT", 116, 127], ["CNS", "ANATOMY", 58, 61], ["demyelinating diseases", "OBSERVATION", 62, 84]]], ["It was concluded that there is no increased risk for MS, but it seems that the transition from subclinical to overt autoimmunity in patients with existing disease is shortened (53) .Vaccination and MSTwo major questions arise on the topic of \"MS and vaccination\": (i) Can vaccines cause MS and (ii) can vaccines provoke or trigger relapses in patients with MS?Vaccination and MS(i) Overall, the anecdotal reports associating MS onset and vaccination had limited reliability, lacked validity and could not be replicated in larger studies.", [["MS", "DISEASE", 53, 55], ["autoimmunity", "DISEASE", 116, 128], ["MS", "DISEASE", 287, 289], ["MS", "DISEASE", 357, 359], ["MS", "DISEASE", 425, 427], ["patients", "ORGANISM", 132, 140], ["patients", "ORGANISM", 343, 351], ["patients", "SPECIES", 132, 140], ["patients", "SPECIES", 343, 351], ["MS", "PROBLEM", 53, 55], ["the transition from subclinical to overt autoimmunity", "PROBLEM", 75, 128], ["existing disease", "PROBLEM", 146, 162], ["Vaccination", "TREATMENT", 182, 193], ["MS", "PROBLEM", 287, 289], ["MS", "PROBLEM", 357, 359], ["MS onset", "PROBLEM", 425, 433], ["no", "UNCERTAINTY", 31, 33], ["increased", "OBSERVATION_MODIFIER", 34, 43], ["disease", "OBSERVATION", 155, 162]]], ["Therefore, there is consensus that there is yet no evidence that MS can be caused by vaccines neither by inactivated nor by live vaccines (57). (ii) It is more difficult to assess the potency of vaccines to trigger relapses in MS patients.", [["MS", "DISEASE", 65, 67], ["MS", "DISEASE", 227, 229], ["(ii)", "CHEMICAL", 144, 148], ["patients", "ORGANISM", 230, 238], ["patients", "SPECIES", 230, 238], ["MS", "PROBLEM", 65, 67], ["vaccines", "TREATMENT", 85, 93], ["vaccines", "TREATMENT", 195, 203], ["relapses", "PROBLEM", 215, 223], ["no evidence", "UNCERTAINTY", 48, 59]]], ["With respect to live vaccines it seems to be plausible that they may be able to provoke a deterioration of the disease, since they fulfill the criteria of an active infection with a replicative (although attenuated) organism.", [["infection", "DISEASE", 165, 174], ["live vaccines", "TREATMENT", 16, 29], ["a deterioration of the disease", "PROBLEM", 88, 118], ["an active infection", "PROBLEM", 155, 174], ["attenuated) organism", "PROBLEM", 204, 224], ["disease", "OBSERVATION", 111, 118], ["active", "OBSERVATION_MODIFIER", 158, 164], ["infection", "OBSERVATION", 165, 174]]], ["There is class IV evidence that at least the yellow fever (YF) 17D vaccine strain, which is derived from a natural occurring YF-virus and hasn't completely lost its neurotoxicity even after numerous passages, is able to provoke relapses in MS patients.", [["yellow fever", "DISEASE", 45, 57], ["YF", "DISEASE", 59, 61], ["neurotoxicity", "DISEASE", 165, 178], ["MS", "DISEASE", 240, 242], ["yellow fever", "ORGANISM", 45, 57], ["YF) 17D", "ORGANISM", 59, 66], ["YF-virus", "ORGANISM", 125, 133], ["patients", "ORGANISM", 243, 251], ["YF-virus", "SPECIES", 125, 133], ["patients", "SPECIES", 243, 251], ["yellow fever (YF) 17D", "SPECIES", 45, 66], ["YF-virus", "SPECIES", 125, 133], ["the yellow fever (YF) 17D vaccine strain", "PROBLEM", 41, 81], ["virus", "PROBLEM", 128, 133], ["its neurotoxicity", "PROBLEM", 161, 178], ["yellow", "OBSERVATION_MODIFIER", 45, 51], ["fever", "OBSERVATION", 52, 57]]], ["However, it has to be kept in mind that the patient cohort had received immunomodulatory treatment and the sample size of this self-controlled case series study was rather small (58) .", [["patient", "ORGANISM", 44, 51], ["patient", "SPECIES", 44, 51], ["immunomodulatory treatment", "TREATMENT", 72, 98], ["series study", "TEST", 148, 160], ["size", "OBSERVATION_MODIFIER", 114, 118], ["small", "OBSERVATION_MODIFIER", 172, 177]]], ["The underlying potential immunologic mechanisms, which are responsible for this elevated relapse rate, are not understood yet and larger studies are necessary to confirm this association.", [["this elevated relapse rate", "PROBLEM", 75, 101], ["larger studies", "TEST", 130, 144], ["immunologic mechanisms", "OBSERVATION", 25, 47]]], ["Hypotheses may be generated based on observations after infections with helminths, mycobacteria and Epstein-Barr virus, or by the immunologic properties of this particular vaccine strain (59) .", [["infections", "DISEASE", 56, 66], ["helminths", "DISEASE", 72, 81], ["Epstein-Barr virus", "ORGANISM", 100, 118], ["Epstein-Barr virus", "SPECIES", 100, 118], ["infections", "PROBLEM", 56, 66], ["helminths", "PROBLEM", 72, 81], ["mycobacteria", "PROBLEM", 83, 95], ["Epstein-Barr virus", "PROBLEM", 100, 118], ["Barr virus", "OBSERVATION", 108, 118]]], ["Immunological analyzes showed that after immunization against YF, MS patients had a significantly increased MBP-and MOG-specific response shown by increased numbers of cells secreting interferon, IL-1\u03b1, IL-1\u03b2 and tumor necrosis factor compared to unvaccinated MS patients or MS patients vaccinated against influenza (58) .Vaccination and MSStill, there is no evidence for other live vaccines such as MMR to deteriorate MS (57, 60) .", [["cells", "ANATOMY", 168, 173], ["YF", "DISEASE", 62, 64], ["MS", "DISEASE", 66, 68], ["tumor necrosis", "DISEASE", 213, 227], ["MS", "DISEASE", 260, 262], ["MS", "DISEASE", 275, 277], ["influenza", "DISEASE", 306, 315], ["MS", "DISEASE", 419, 421], ["YF", "ORGANISM", 62, 64], ["patients", "ORGANISM", 69, 77], ["MBP", "GENE_OR_GENE_PRODUCT", 108, 111], ["MOG", "GENE_OR_GENE_PRODUCT", 116, 119], ["cells", "CELL", 168, 173], ["interferon", "GENE_OR_GENE_PRODUCT", 184, 194], ["IL-1\u03b1", "GENE_OR_GENE_PRODUCT", 196, 201], ["IL-1\u03b2", "GENE_OR_GENE_PRODUCT", 203, 208], ["tumor necrosis factor", "GENE_OR_GENE_PRODUCT", 213, 234], ["patients", "ORGANISM", 263, 271], ["patients", "ORGANISM", 278, 286], ["MBP", "PROTEIN", 108, 111], ["MOG", "PROTEIN", 116, 119], ["interferon", "PROTEIN", 184, 194], ["IL-1\u03b1, IL-1\u03b2", "PROTEIN", 196, 208], ["tumor necrosis factor", "PROTEIN", 213, 234], ["patients", "SPECIES", 69, 77], ["patients", "SPECIES", 263, 271], ["patients", "SPECIES", 278, 286], ["YF", "SPECIES", 62, 64], ["Immunological analyzes", "TEST", 0, 22], ["immunization", "TREATMENT", 41, 53], ["YF", "PROBLEM", 62, 64], ["a significantly increased MBP", "PROBLEM", 82, 111], ["MOG", "TEST", 116, 119], ["increased numbers of cells", "PROBLEM", 147, 173], ["secreting interferon", "TREATMENT", 174, 194], ["IL", "TEST", 196, 198], ["IL", "TREATMENT", 203, 205], ["tumor necrosis factor", "PROBLEM", 213, 234], ["MS", "PROBLEM", 275, 277], ["influenza", "PROBLEM", 306, 315], ["Vaccination", "TREATMENT", 322, 333], ["other live vaccines", "PROBLEM", 372, 391], ["MMR", "PROBLEM", 400, 403], ["MS", "TEST", 419, 421], ["tumor", "OBSERVATION_MODIFIER", 213, 218], ["necrosis", "OBSERVATION", 219, 227], ["no evidence for", "UNCERTAINTY", 356, 371]]], ["For inactivated vaccines, there is already more evidence available that an association between MS relapses and different kinds of vaccines does not exist (7) .", [["MS", "DISEASE", 95, 97], ["inactivated vaccines", "TREATMENT", 4, 24], ["MS relapses", "PROBLEM", 95, 106], ["vaccines", "TREATMENT", 130, 138]]], ["Even for vaccines, which were publicly accused to be associated with MS disease or relapse rate, like HPV or hepatitis B vaccines, there is no evidence to support any association between vaccination and clinical course of MS, as well as for vaccines containing inactivated neurotropic viruses like TBE (53, 61) .", [["hepatitis B", "DISEASE", 109, 120], ["MS", "DISEASE", 222, 224], ["neurotropic viruses", "DISEASE", 273, 292], ["HPV", "ORGANISM", 102, 105], ["hepatitis B vaccines", "ORGANISM", 109, 129], ["neurotropic viruses", "ORGANISM", 273, 292], ["HPV", "SPECIES", 102, 105], ["hepatitis B", "SPECIES", 109, 120], ["TBE", "SPECIES", 298, 301], ["vaccines", "TREATMENT", 9, 17], ["MS disease", "PROBLEM", 69, 79], ["relapse rate", "PROBLEM", 83, 95], ["hepatitis B vaccines", "TREATMENT", 109, 129], ["vaccination", "TREATMENT", 187, 198], ["MS", "PROBLEM", 222, 224], ["vaccines", "TREATMENT", 241, 249], ["inactivated neurotropic viruses", "PROBLEM", 261, 292], ["no evidence to", "UNCERTAINTY", 140, 154]]], ["It still remains unclear if inactivated vaccines may accelerate an upcoming relapse in patients with active MS by non-specific stimulationAdjuvants and MSBesides effects of vaccines on induction and the disease course of MS, potential immunological effects of adjuvants have to be considered as well.", [["MS", "DISEASE", 108, 110], ["MS", "DISEASE", 221, 223], ["patients", "ORGANISM", 87, 95], ["patients", "SPECIES", 87, 95], ["inactivated vaccines", "TREATMENT", 28, 48], ["active MS", "PROBLEM", 101, 110], ["non-specific stimulationAdjuvants", "TREATMENT", 114, 147], ["vaccines", "TREATMENT", 173, 181], ["induction", "TREATMENT", 185, 194], ["MS", "PROBLEM", 221, 223], ["adjuvants", "TREATMENT", 260, 269]]], ["Most experience on the possible induction of autoimmunity following administration of adjuvant-containing vaccines has been gained from animal models.", [["autoimmunity", "DISEASE", 45, 57], ["autoimmunity", "PROBLEM", 45, 57], ["adjuvant-containing vaccines", "TREATMENT", 86, 114]]], ["However, results from experimental studies cannot be transferred to humans without reservation.", [["humans", "ORGANISM", 68, 74], ["humans", "SPECIES", 68, 74], ["humans", "SPECIES", 68, 74], ["experimental studies", "TEST", 22, 42]]], ["First, the dose ratios tested in animal models are not the same as in humans and second, human immunology differs from animals.", [["humans", "ORGANISM", 70, 76], ["human", "ORGANISM", 89, 94], ["humans", "SPECIES", 70, 76], ["human", "SPECIES", 89, 94], ["humans", "SPECIES", 70, 76], ["human", "SPECIES", 89, 94], ["the dose ratios", "TEST", 7, 22]]], ["Indeed, oil emulsions, aluminum salts and squalene have shown severe side effects in animal models, while they are considered to be safe in humans (17) .", [["oil", "ANATOMY", 8, 11], ["aluminum salts", "CHEMICAL", 23, 37], ["squalene", "CHEMICAL", 42, 50], ["aluminum", "CHEMICAL", 23, 31], ["squalene", "CHEMICAL", 42, 50], ["oil emulsions", "SIMPLE_CHEMICAL", 8, 21], ["aluminum salts", "SIMPLE_CHEMICAL", 23, 37], ["squalene", "SIMPLE_CHEMICAL", 42, 50], ["humans", "ORGANISM", 140, 146], ["humans", "SPECIES", 140, 146], ["humans", "SPECIES", 140, 146], ["oil emulsions", "TREATMENT", 8, 21], ["aluminum salts", "TREATMENT", 23, 37], ["squalene", "TREATMENT", 42, 50], ["severe side effects", "PROBLEM", 62, 81], ["oil emulsions", "OBSERVATION", 8, 21], ["severe", "OBSERVATION_MODIFIER", 62, 68], ["side effects", "OBSERVATION_MODIFIER", 69, 81]]], ["An analysis performed by the European Medicines Agency (EMA) (63) investigated autoimmune disorders following vaccination against pandemic influenza A/H1N1 between October 2009 and December 2010 (64) .", [["autoimmune disorders", "DISEASE", 79, 99], ["influenza", "DISEASE", 139, 148], ["pandemic influenza A/H1N1", "SPECIES", 130, 155], ["pandemic influenza A/H1N1", "SPECIES", 130, 155], ["An analysis", "TEST", 0, 11], ["autoimmune disorders", "PROBLEM", 79, 99], ["vaccination", "TREATMENT", 110, 121], ["pandemic influenza", "PROBLEM", 130, 148]]], ["Thirty percent of the 150 million doses of the distributed vaccines contained aluminum salts and squalene-based adjuvants.", [["aluminum salts", "CHEMICAL", 78, 92], ["squalene", "CHEMICAL", 97, 105], ["aluminum salts", "CHEMICAL", 78, 92], ["squalene", "CHEMICAL", 97, 105], ["aluminum salts", "SIMPLE_CHEMICAL", 78, 92], ["squalene", "SIMPLE_CHEMICAL", 97, 105], ["the distributed vaccines", "TREATMENT", 43, 67], ["aluminum salts", "TREATMENT", 78, 92], ["squalene-based adjuvants", "TREATMENT", 97, 121]]], ["Overall, the study did not suggest a significant difference in the risk for autoimmune disorders for adjuvant and non-adjuvant vaccinations.", [["autoimmune disorders", "DISEASE", 76, 96], ["the study", "TEST", 9, 18], ["autoimmune disorders", "PROBLEM", 76, 96], ["adjuvant and non-adjuvant vaccinations", "TREATMENT", 101, 139], ["significant", "OBSERVATION_MODIFIER", 37, 48], ["difference", "OBSERVATION", 49, 59]]], ["ADEM was reported for 10 people (adjuvant vaccines: 7, non-adjuvant vaccines: 3), MS for 21 people (adjuvant vaccines: 20, nonadjuvant vaccines: 1), MS relapses for 24 patients (adjuvant vaccines: 21, non-adjuvant vaccines: 3), and one case of relapsing remitting MS was reported for adjuvant-containing vaccination (64) .", [["ADEM", "DISEASE", 0, 4], ["MS", "DISEASE", 264, 266], ["people", "ORGANISM", 25, 31], ["people", "ORGANISM", 92, 98], ["patients", "ORGANISM", 168, 176], ["people", "SPECIES", 25, 31], ["people", "SPECIES", 92, 98], ["patients", "SPECIES", 168, 176], ["ADEM", "PROBLEM", 0, 4], ["adjuvant vaccines", "TREATMENT", 33, 50], ["non-adjuvant vaccines", "TREATMENT", 55, 76], ["adjuvant vaccines", "TREATMENT", 100, 117], ["MS relapses", "PROBLEM", 149, 160], ["adjuvant vaccines", "TREATMENT", 178, 195], ["non-adjuvant vaccines", "TREATMENT", 201, 222], ["relapsing remitting MS", "PROBLEM", 244, 266], ["adjuvant-containing vaccination", "TREATMENT", 284, 315]]], ["Statistical analysis revealed only a nonsignificantly increased risk for GBS (15) .", [["GBS", "DISEASE", 73, 76], ["Statistical analysis", "TEST", 0, 20], ["GBS", "TEST", 73, 76], ["nonsignificantly", "OBSERVATION_MODIFIER", 37, 53], ["increased", "OBSERVATION_MODIFIER", 54, 63], ["GBS", "OBSERVATION", 73, 76]]], ["Also, a favorable benefitrisk profile of the vaccines was demonstrated (15, 65) .Adjuvants and MSIn conclusion, following the reports from literature, all of the EMA/FDA-approved vaccines (with exception for Yellow Fever) and adjuvants do not show a significantly increased risk for MS and ADEM.", [["Fever", "DISEASE", 215, 220], ["MS", "DISEASE", 283, 285], ["ADEM", "DISEASE", 290, 294], ["the vaccines", "TREATMENT", 41, 53], ["vaccines", "TREATMENT", 179, 187], ["Yellow Fever", "PROBLEM", 208, 220], ["adjuvants", "TREATMENT", 226, 235], ["MS", "PROBLEM", 283, 285], ["ADEM", "PROBLEM", 290, 294], ["favorable", "OBSERVATION_MODIFIER", 8, 17]]], ["Constant improvement of basic immunological knowledge and technology will further improve the safety of adjuvants.", [["adjuvants", "TREATMENT", 104, 113], ["improvement", "OBSERVATION_MODIFIER", 9, 20]]], ["Table 1 gives an overview of the recommendations of standard vaccinations in the general population and in MS patients.Vaccination and ADEMWhile there is a lot of literature on vaccination and risk for MS or MS relapses available, reports on vaccination and ADEM are scarce.", [["MS", "DISEASE", 107, 109], ["MS", "DISEASE", 202, 204], ["MS", "DISEASE", 208, 210], ["ADEM", "DISEASE", 258, 262], ["patients", "ORGANISM", 110, 118], ["patients", "SPECIES", 110, 118], ["standard vaccinations", "TREATMENT", 52, 73], ["Vaccination", "TREATMENT", 119, 130], ["vaccination", "TREATMENT", 177, 188], ["MS", "PROBLEM", 202, 204], ["MS relapses", "PROBLEM", 208, 219], ["vaccination", "TREATMENT", 242, 253], ["ADEM", "PROBLEM", 258, 262]]], ["Yet, ADEM has been discussed to be a sequelae of vaccinations (68) as well as to be preceded by infections.", [["ADEM", "DISEASE", 5, 9], ["infections", "DISEASE", 96, 106], ["ADEM", "PROBLEM", 5, 9], ["infections", "PROBLEM", 96, 106], ["ADEM", "OBSERVATION", 5, 9], ["infections", "OBSERVATION", 96, 106]]], ["Several cases of ADEM have been reported to be timely related to vaccinations against rabies (69), HPV (70, 71) , hepatitis A and B, diphtheria, tetanus and poliovirus (72) , measles, rubella and booster immunization for Japanese encephalitis (73) .", [["ADEM", "DISEASE", 17, 21], ["rabies", "DISEASE", 86, 92], ["hepatitis A and B", "DISEASE", 114, 131], ["diphtheria, tetanus and poliovirus (72) , measles", "DISEASE", 133, 182], ["rubella", "DISEASE", 184, 191], ["Japanese encephalitis", "DISEASE", 221, 242], ["rabies", "ORGANISM", 86, 92], ["HPV", "ORGANISM", 99, 102], ["hepatitis A", "ORGANISM", 114, 125], ["B", "GENE_OR_GENE_PRODUCT", 130, 131], ["diphtheria", "ORGANISM", 133, 143], ["tetanus", "ORGANISM", 145, 152], ["poliovirus", "ORGANISM", 157, 167], ["rabies", "SPECIES", 86, 92], ["HPV", "SPECIES", 99, 102], ["hepatitis A", "SPECIES", 114, 125], ["ADEM", "PROBLEM", 17, 21], ["vaccinations", "TEST", 65, 77], ["rabies", "TEST", 86, 92], ["HPV", "TEST", 99, 102], ["hepatitis A", "TEST", 114, 125], ["diphtheria", "PROBLEM", 133, 143], ["tetanus", "PROBLEM", 145, 152], ["poliovirus", "PROBLEM", 157, 167], ["measles", "PROBLEM", 175, 182], ["rubella", "PROBLEM", 184, 191], ["booster immunization", "TREATMENT", 196, 216], ["Japanese encephalitis", "PROBLEM", 221, 242], ["ADEM", "OBSERVATION", 17, 21]]], ["ADEM has been reported following vaccination against influenza, including eight cases after vaccination against H1N1.", [["ADEM", "DISEASE", 0, 4], ["influenza", "DISEASE", 53, 62], ["H1N1", "DISEASE", 112, 116], ["ADEM", "PROBLEM", 0, 4], ["vaccination", "TREATMENT", 33, 44], ["influenza", "PROBLEM", 53, 62], ["vaccination", "TREATMENT", 92, 103], ["H1N1", "PROBLEM", 112, 116]]], ["Also, four ADEM cases after vaccination against YF can be found in literature (74, 75) .", [["ADEM", "DISEASE", 11, 15], ["YF", "DISEASE", 48, 50], ["YF", "ORGANISM", 48, 50], ["YF", "SPECIES", 48, 50], ["vaccination", "TREATMENT", 28, 39], ["YF", "PROBLEM", 48, 50]]], ["Besides case reports, there have been some observational studies, albeit all having their limitations.", [["some observational studies", "TEST", 38, 64]]], ["In 26 out of 35 reported cases of ADEM, patients had infections or vaccinations prior to disease onset (76) .", [["ADEM", "DISEASE", 34, 38], ["infections", "DISEASE", 53, 63], ["patients", "ORGANISM", 40, 48], ["patients", "SPECIES", 40, 48], ["ADEM", "PROBLEM", 34, 38], ["infections", "PROBLEM", 53, 63], ["vaccinations", "TREATMENT", 67, 79], ["disease onset", "PROBLEM", 89, 102]]], ["Also, Pellegrino et al. concluded a possible relation between post-vaccination ADEM in children and adults.", [["ADEM", "DISEASE", 79, 83], ["children", "ORGANISM", 87, 95], ["children", "SPECIES", 87, 95]]], ["Four hundred four cases of ADEM were analyzed based on the data of the Vaccine Adverse Event Reporting System (VAERS) database and the EudraVigilance post-authorization module (EVPM) (77) .", [["ADEM", "DISEASE", 27, 31], ["EudraVigilance post-authorization module", "DNA", 135, 175], ["ADEM", "TREATMENT", 27, 31]]], ["About 60% of the cases occurred between 2 and 30 days after vaccination, most commonly against influenza and HPV.", [["influenza", "DISEASE", 95, 104], ["HPV", "ORGANISM", 109, 112], ["HPV", "SPECIES", 109, 112], ["vaccination", "TREATMENT", 60, 71], ["influenza", "PROBLEM", 95, 104], ["HPV", "PROBLEM", 109, 112]]], ["A case-control study on vaccination against hepatitis B, influenza, polio, diphtheria, pertussis, tetanus, measles, mumps, rubella, Japanese encephalitis, meningitis, hepatitis A, varicella and rabies did not reveal an increased risk for the onset of ADEM in the time spans of 0-30 days and 61-180 days after vaccination, but between 31 and 60 days (78) .", [["hepatitis B", "DISEASE", 44, 55], ["influenza", "DISEASE", 57, 66], ["polio", "DISEASE", 68, 73], ["diphtheria, pertussis, tetanus", "DISEASE", 75, 105], ["measles, mumps, rubella", "DISEASE", 107, 130], ["Japanese encephalitis", "DISEASE", 132, 153], ["meningitis", "DISEASE", 155, 165], ["hepatitis A", "DISEASE", 167, 178], ["varicella", "DISEASE", 180, 189], ["rabies", "DISEASE", 194, 200], ["ADEM", "DISEASE", 251, 255], ["hepatitis B", "ORGANISM", 44, 55], ["influenza", "ORGANISM", 57, 66], ["polio", "ORGANISM", 68, 73], ["diphtheria", "ORGANISM", 75, 85], ["varicella", "ORGANISM", 180, 189], ["hepatitis B", "SPECIES", 44, 55], ["hepatitis A", "SPECIES", 167, 178], ["rabies", "SPECIES", 194, 200], ["A case-control study", "TEST", 0, 20], ["vaccination", "TREATMENT", 24, 35], ["hepatitis B", "PROBLEM", 44, 55], ["influenza", "PROBLEM", 57, 66], ["polio", "PROBLEM", 68, 73], ["diphtheria", "PROBLEM", 75, 85], ["pertussis", "PROBLEM", 87, 96], ["tetanus", "PROBLEM", 98, 105], ["measles", "PROBLEM", 107, 114], ["mumps", "PROBLEM", 116, 121], ["rubella", "PROBLEM", 123, 130], ["Japanese encephalitis", "PROBLEM", 132, 153], ["meningitis", "PROBLEM", 155, 165], ["hepatitis A", "PROBLEM", 167, 178], ["varicella", "PROBLEM", 180, 189], ["rabies", "PROBLEM", 194, 200], ["ADEM", "PROBLEM", 251, 255], ["vaccination", "TREATMENT", 309, 320], ["meningitis", "OBSERVATION", 155, 165], ["hepatitis", "OBSERVATION", 167, 176], ["increased", "OBSERVATION_MODIFIER", 219, 228], ["ADEM", "OBSERVATION", 251, 255]]], ["Based on these reports, the risk for ADEM after vaccination cannot be completely ruled out.Effective Vaccination in MS TreatmentConsiderations on MS exacerbation and vaccination apply only for MS patients receiving no immunomodulatory/ immunosuppressive treatment.", [["ADEM", "DISEASE", 37, 41], ["MS", "DISEASE", 193, 195], ["patients", "ORGANISM", 196, 204], ["patients", "SPECIES", 196, 204], ["ADEM", "PROBLEM", 37, 41], ["vaccination", "TREATMENT", 48, 59], ["Effective Vaccination in MS Treatment", "TREATMENT", 91, 128], ["MS exacerbation", "PROBLEM", 146, 161], ["vaccination", "TREATMENT", 166, 177], ["immunomodulatory/ immunosuppressive treatment", "TREATMENT", 218, 263]]], ["If any kind of immunosuppression is used for MS therapy, this choice of treatment will dominate the decision whether to vaccinate or not (79) .", [["MS", "DISEASE", 45, 47], ["immunosuppression", "TREATMENT", 15, 32], ["MS therapy", "TREATMENT", 45, 55], ["treatment", "TREATMENT", 72, 81], ["immunosuppression", "OBSERVATION", 15, 32]]], ["In recent years, consensus statements on vaccinations during immunosuppressive treatments were published by various national and international societies and expert panels (80) (81) (82) (83) (84) .", [["vaccinations", "TREATMENT", 41, 53], ["immunosuppressive treatments", "TREATMENT", 61, 89], ["expert panels", "TEST", 157, 170]]], ["There is consensus that inactivated vaccines will do no harm (85) even in immunosuppressed patients.", [["patients", "ORGANISM", 91, 99], ["patients", "SPECIES", 91, 99], ["inactivated vaccines", "TREATMENT", 24, 44]]], ["However, data on the efficacy of vaccinations in combination with the various available MS medications are missing.", [["vaccinations", "TREATMENT", 33, 45], ["the various available MS medications", "TREATMENT", 66, 102]]], ["Thus, for patients either receiving more than one immunomodulatory treatment or having underlying immunomodulating condition, the outcome is difficult to predict (86).", [["patients", "ORGANISM", 10, 18], ["patients", "SPECIES", 10, 18], ["one immunomodulatory treatment", "TREATMENT", 46, 76], ["underlying immunomodulating condition", "PROBLEM", 87, 124]]], ["Therefore, the success of vaccination should be verified by antibody testing if a valid test is available.Effective Vaccination in MS TreatmentExcept for a few treatments, which only lead to mild immunosuppression, live vaccines are contraindicated under immunosuppressive treatment.", [["vaccination", "TREATMENT", 26, 37], ["antibody testing", "TEST", 60, 76], ["a valid test", "TEST", 80, 92], ["Effective Vaccination in MS Treatment", "TREATMENT", 106, 143], ["a few treatments", "TREATMENT", 154, 170], ["mild immunosuppression", "TREATMENT", 191, 213], ["live vaccines", "TREATMENT", 215, 228], ["immunosuppressive treatment", "TREATMENT", 255, 282], ["mild", "OBSERVATION_MODIFIER", 191, 195], ["immunosuppression", "OBSERVATION", 196, 213]]], ["In some situations, risks and benefits of a live vaccine have to be weighed against each other, e.g., in varicella zoster virus (VZV)-negative MS patients under fingolimod treatment, varicella vaccination may be considered, since severe complications from natural varicella infection may outweigh the risk from this live vaccine.", [["varicella zoster virus (VZV)-negative MS", "DISEASE", 105, 145], ["fingolimod", "CHEMICAL", 161, 171], ["varicella", "DISEASE", 183, 192], ["varicella infection", "DISEASE", 264, 283], ["fingolimod", "CHEMICAL", 161, 171], ["varicella zoster virus", "ORGANISM", 105, 127], ["VZV", "ORGANISM", 129, 132], ["patients", "ORGANISM", 146, 154], ["fingolimod", "SIMPLE_CHEMICAL", 161, 171], ["varicella zoster virus", "SPECIES", 105, 127], ["patients", "SPECIES", 146, 154], ["varicella zoster virus", "SPECIES", 105, 127], ["VZV", "SPECIES", 129, 132], ["a live vaccine", "TREATMENT", 42, 56], ["varicella zoster virus", "PROBLEM", 105, 127], ["VZV", "TEST", 129, 132], ["fingolimod treatment", "TREATMENT", 161, 181], ["varicella vaccination", "TREATMENT", 183, 204], ["severe complications", "PROBLEM", 230, 250], ["natural varicella infection", "PROBLEM", 256, 283], ["this live vaccine", "TREATMENT", 311, 328], ["varicella infection", "OBSERVATION", 264, 283]]], ["A recent case report on a lethal VZV infection in an immunocompromised patient after VZV live vaccination drives the discussion on this issue (87) .Effective Vaccination in MS TreatmentThere is consensus about the timing of vaccination in patients, who will undergo immunosuppressive treatment: Vaccinations should be given well in advance to the start of treatment (at least 2 weeks for inactivated and \u2265 4 weeks for live vaccines) and should be distinguished between primo-vaccinations and boosters.", [["VZV infection", "DISEASE", 33, 46], ["VZV", "ORGANISM", 33, 36], ["patient", "ORGANISM", 71, 78], ["VZV", "ORGANISM", 85, 88], ["patients", "ORGANISM", 239, 247], ["patient", "SPECIES", 71, 78], ["patients", "SPECIES", 239, 247], ["VZV", "SPECIES", 33, 36], ["VZV", "SPECIES", 85, 88], ["a lethal VZV infection", "PROBLEM", 24, 46], ["VZV live vaccination", "TREATMENT", 85, 105], ["Effective Vaccination in MS Treatment", "TREATMENT", 148, 185], ["vaccination", "TREATMENT", 224, 235], ["immunosuppressive treatment", "TREATMENT", 266, 293], ["Vaccinations", "TREATMENT", 295, 307], ["treatment", "TREATMENT", 356, 365], ["live vaccines", "TREATMENT", 418, 431], ["infection", "OBSERVATION", 37, 46]]], ["Importantly, the refractory period after immunosuppression has to be considered as well, which may be up to 1 year depending on the type of medication (e.g., rituximab or alemtuzumab) (81) .", [["rituximab", "CHEMICAL", 158, 167], ["alemtuzumab", "CHEMICAL", 171, 182], ["rituximab", "SIMPLE_CHEMICAL", 158, 167], ["alemtuzumab", "SIMPLE_CHEMICAL", 171, 182], ["immunosuppression", "TREATMENT", 41, 58], ["medication", "TREATMENT", 140, 150], ["rituximab", "TREATMENT", 158, 167], ["alemtuzumab", "TREATMENT", 171, 182], ["refractory", "OBSERVATION_MODIFIER", 17, 27]]], ["Vaccines will have various effects on the immune system, which greatly depend on the cell types typically engaged by the respective vaccines.", [["immune system", "ANATOMY", 42, 55], ["cell", "ANATOMY", 85, 89], ["immune system", "ANATOMICAL_SYSTEM", 42, 55], ["cell", "CELL", 85, 89], ["Vaccines", "TREATMENT", 0, 8], ["various effects on the immune system", "PROBLEM", 19, 55], ["the respective vaccines", "TREATMENT", 117, 140]]], ["The impact of immunosuppression on the various cell types (and possible mitigation of effects) should be taken into consideration.", [["cell", "ANATOMY", 47, 51], ["cell", "CELL", 47, 51], ["immunosuppression", "TREATMENT", 14, 31], ["the various cell types", "TREATMENT", 35, 57], ["immunosuppression", "OBSERVATION", 14, 31], ["various cell", "OBSERVATION_MODIFIER", 39, 51]]], ["Protective efficacy is mostly mediated by antibodies for the following vaccines: cholera, diphtheria toxoid, hepatitis A and B, haemophilus influenzae type b, influenza, Japanese encephalitis, meningococcal PS and conjugates, papillomavirus, pneumococcal PS and conjugates, polio (Sabin and Salk), rabies, rotavirus, rubella, tetanus toxoid, typhoid PS, and YF.", [["cholera", "DISEASE", 81, 88], ["diphtheria toxoid", "DISEASE", 90, 107], ["hepatitis A", "DISEASE", 109, 120], ["haemophilus influenzae type b", "DISEASE", 128, 157], ["influenza", "DISEASE", 159, 168], ["Japanese encephalitis", "DISEASE", 170, 191], ["meningococcal PS", "DISEASE", 193, 209], ["polio (Sabin and Salk), rabies, rotavirus, rubella, tetanus toxoid", "DISEASE", 274, 340], ["typhoid PS", "DISEASE", 342, 352], ["YF", "DISEASE", 358, 360], ["cholera", "ORGANISM", 81, 88], ["diphtheria toxoid", "ORGANISM", 90, 107], ["hepatitis A", "ORGANISM", 109, 120], ["B,", "ORGANISM", 125, 127], ["haemophilus influenzae type b", "ORGANISM", 128, 157], ["influenza", "ORGANISM", 159, 168], ["Japanese encephalitis", "ORGANISM", 170, 191], ["meningococcal PS", "ORGANISM", 193, 209], ["papillomavirus", "ORGANISM", 226, 240], ["pneumococcal PS", "ORGANISM", 242, 257], ["Sabin", "ORGANISM", 281, 286], ["Salk)", "ORGANISM", 291, 296], ["rabies", "ORGANISM", 298, 304], ["rotavirus", "ORGANISM", 306, 315], ["tetanus toxoid", "ORGANISM", 326, 340], ["antibodies", "PROTEIN", 42, 52], ["diphtheria toxoid", "SPECIES", 90, 107], ["haemophilus influenzae", "SPECIES", 128, 150], ["rotavirus", "SPECIES", 306, 315], ["tetanus toxoid", "SPECIES", 326, 340], ["diphtheria toxoid", "SPECIES", 90, 107], ["hepatitis A", "SPECIES", 109, 120], ["pneumococcal", "SPECIES", 242, 254], ["rotavirus", "SPECIES", 306, 315], ["YF", "SPECIES", 358, 360], ["the following vaccines", "TREATMENT", 57, 79], ["cholera", "PROBLEM", 81, 88], ["diphtheria toxoid", "TREATMENT", 90, 107], ["hepatitis A", "PROBLEM", 109, 120], ["haemophilus influenzae type b", "PROBLEM", 128, 157], ["influenza", "PROBLEM", 159, 168], ["Japanese encephalitis", "PROBLEM", 170, 191], ["meningococcal PS", "TREATMENT", 193, 209], ["conjugates", "TREATMENT", 214, 224], ["papillomavirus", "PROBLEM", 226, 240], ["pneumococcal PS and conjugates", "PROBLEM", 242, 272], ["polio (Sabin and Salk)", "PROBLEM", 274, 296], ["rabies", "PROBLEM", 298, 304], ["rotavirus", "PROBLEM", 306, 315], ["rubella", "PROBLEM", 317, 324], ["tetanus toxoid", "TREATMENT", 326, 340], ["typhoid PS", "PROBLEM", 342, 352], ["YF", "PROBLEM", 358, 360], ["pneumococcal PS", "OBSERVATION", 242, 257]]], ["Effects are solely born by T cells for tuberculosis (BCG), or by a combination of antibodies and T cells for measles and intranasal influenza vaccination.", [["T cells", "ANATOMY", 27, 34], ["T cells", "ANATOMY", 97, 104], ["tuberculosis", "DISEASE", 39, 51], ["measles", "DISEASE", 109, 116], ["influenza", "DISEASE", 132, 141], ["T cells", "CELL", 27, 34], ["T cells", "CELL", 97, 104], ["measles", "ORGANISM", 109, 116], ["T cells", "CELL_TYPE", 27, 34], ["antibodies", "PROTEIN", 82, 92], ["T cells", "CELL_TYPE", 97, 104], ["tuberculosis", "PROBLEM", 39, 51], ["BCG", "PROBLEM", 53, 56], ["antibodies", "PROBLEM", 82, 92], ["T cells", "PROBLEM", 97, 104], ["measles", "PROBLEM", 109, 116], ["intranasal influenza vaccination", "TREATMENT", 121, 153]]], ["Besides antibody-mediated protection, effects of T cells are discussed for pertussis (9) .Effective Vaccination in MS TreatmentFor patients receiving immunosuppressive treatment, vaccination control should be performed.", [["T cells", "ANATOMY", 49, 56], ["T cells", "CELL", 49, 56], ["patients", "ORGANISM", 131, 139], ["T cells", "CELL_TYPE", 49, 56], ["patients", "SPECIES", 131, 139], ["antibody-mediated protection", "TREATMENT", 8, 36], ["T cells", "PROBLEM", 49, 56], ["pertussis", "PROBLEM", 75, 84], ["Effective Vaccination in MS Treatment", "TREATMENT", 90, 127], ["immunosuppressive treatment", "TREATMENT", 150, 177], ["vaccination control", "TREATMENT", 179, 198]]], ["For diphtheria, TBE (with caution), hepatitis A, B, haemophilus influenzae type b, measles, mumps, pneumococcus, polio, rubella, tetanus, rabies and varicella, standards are available and recommended to be tested.", [["diphtheria", "DISEASE", 4, 14], ["hepatitis A", "DISEASE", 36, 47], ["haemophilus influenzae type b", "DISEASE", 52, 81], ["measles, mumps, pneumococcus, polio, rubella, tetanus", "DISEASE", 83, 136], ["rabies", "DISEASE", 138, 144], ["varicella", "DISEASE", 149, 158], ["hepatitis A", "ORGANISM", 36, 47], ["B", "GENE_OR_GENE_PRODUCT", 49, 50], ["haemophilus influenzae type b", "ORGANISM", 52, 81], ["measles", "ORGANISM", 83, 90], ["mumps", "ORGANISM", 92, 97], ["rabies", "ORGANISM", 138, 144], ["haemophilus influenzae", "SPECIES", 52, 74], ["TBE", "SPECIES", 16, 19], ["hepatitis A", "SPECIES", 36, 47], ["haemophilus influenzae", "SPECIES", 52, 74], ["rabies", "SPECIES", 138, 144], ["diphtheria", "PROBLEM", 4, 14], ["TBE", "PROBLEM", 16, 19], ["caution", "TEST", 26, 33], ["hepatitis A", "PROBLEM", 36, 47], ["haemophilus influenzae type b", "PROBLEM", 52, 81], ["measles", "PROBLEM", 83, 90], ["mumps", "PROBLEM", 92, 97], ["pneumococcus", "PROBLEM", 99, 111], ["polio", "PROBLEM", 113, 118], ["rubella", "PROBLEM", 120, 127], ["tetanus", "PROBLEM", 129, 136], ["rabies", "PROBLEM", 138, 144], ["varicella", "PROBLEM", 149, 158], ["hepatitis", "OBSERVATION", 36, 45], ["varicella", "OBSERVATION", 149, 158]]], ["In general, to increase the validity of vaccination control, titers should be assessed in paired samples (before and after immunization) via the same method and at highquality standards (81) .", [["samples", "ANATOMY", 97, 104], ["vaccination control", "TREATMENT", 40, 59], ["immunization", "TREATMENT", 123, 135]]], ["In general, patients should have received their recommended standard vaccines according to their region-specific vaccine guidelines.", [["patients", "ORGANISM", 12, 20], ["patients", "SPECIES", 12, 20], ["standard vaccines", "TREATMENT", 60, 77]]], ["Before certain immunosuppressive treatments are initiated, it is mandatory to exclude former infections and if necessary, vaccination should be considered according to the regulatory agencies.", [["infections", "DISEASE", 93, 103], ["certain immunosuppressive treatments", "TREATMENT", 7, 43], ["former infections", "PROBLEM", 86, 103], ["vaccination", "TREATMENT", 122, 133], ["infections", "OBSERVATION", 93, 103]]], ["Table 2 provides an overview on necessary vaccinations according to FDA/EMA guidelines (extended vaccination reflects the authors' suggestion).", [["necessary vaccinations", "TREATMENT", 32, 54]]], ["For many immunotherapies, a prior exclusion of an ongoing VZV infection is required and vaccination should be offered to those, who haven't gained any immunity yet.", [["VZV infection", "DISEASE", 58, 71], ["VZV", "ORGANISM", 58, 61], ["VZV", "SPECIES", 58, 61], ["many immunotherapies", "TREATMENT", 4, 24], ["an ongoing VZV infection", "PROBLEM", 47, 71], ["vaccination", "TREATMENT", 88, 99], ["ongoing", "OBSERVATION_MODIFIER", 50, 57], ["VZV", "OBSERVATION_MODIFIER", 58, 61], ["infection", "OBSERVATION", 62, 71]]], ["Additionally, VZV-seropositive patients undergoing immunotherapy should be offered vaccination as well to prevent zoster reactivation and late effects.", [["zoster", "DISEASE", 114, 120], ["VZV", "ORGANISM", 14, 17], ["patients", "ORGANISM", 31, 39], ["zoster", "ORGANISM", 114, 120], ["patients", "SPECIES", 31, 39], ["VZV", "SPECIES", 14, 17], ["VZV", "PROBLEM", 14, 17], ["immunotherapy", "TREATMENT", 51, 64], ["vaccination", "TREATMENT", 83, 94], ["zoster reactivation", "PROBLEM", 114, 133]]], ["Recently, a non-live subunit vaccine has been authorized for VZV-seropositive patients.", [["VZV-seropositive", "DISEASE", 61, 77], ["VZV", "ORGANISM", 61, 64], ["patients", "ORGANISM", 78, 86], ["patients", "SPECIES", 78, 86], ["VZV", "SPECIES", 61, 64], ["a non-live subunit vaccine", "TREATMENT", 10, 36], ["VZV", "PROBLEM", 61, 64]]], ["It possesses a better risk-benefit profile compared to the live vaccine and has already been approved by many countries (88) .", [["the live vaccine", "TREATMENT", 55, 71]]], ["Additionally, it should be considered to offer patients with upcoming fingolimod or alemtuzumab treatment the option of vaccination against HPV, as post-market surveillance showed increased reports of warts and cervical dysplasia due to these two MS therapies [EMA; (89) ].", [["warts", "ANATOMY", 201, 206], ["cervical dysplasia", "ANATOMY", 211, 229], ["fingolimod", "CHEMICAL", 70, 80], ["alemtuzumab", "CHEMICAL", 84, 95], ["warts", "DISEASE", 201, 206], ["cervical dysplasia", "DISEASE", 211, 229], ["MS", "DISEASE", 247, 249], ["fingolimod", "CHEMICAL", 70, 80], ["patients", "ORGANISM", 47, 55], ["fingolimod", "SIMPLE_CHEMICAL", 70, 80], ["alemtuzumab", "SIMPLE_CHEMICAL", 84, 95], ["HPV", "ORGANISM", 140, 143], ["warts", "PATHOLOGICAL_FORMATION", 201, 206], ["cervical dysplasia", "PATHOLOGICAL_FORMATION", 211, 229], ["patients", "SPECIES", 47, 55], ["HPV", "SPECIES", 140, 143], ["upcoming fingolimod", "TREATMENT", 61, 80], ["alemtuzumab treatment", "TREATMENT", 84, 105], ["vaccination", "TREATMENT", 120, 131], ["HPV", "PROBLEM", 140, 143], ["post-market surveillance", "TEST", 148, 172], ["warts", "PROBLEM", 201, 206], ["cervical dysplasia", "PROBLEM", 211, 229], ["these two MS therapies", "TREATMENT", 237, 259], ["warts", "OBSERVATION", 201, 206], ["cervical", "ANATOMY", 211, 219], ["dysplasia", "OBSERVATION", 220, 229]]], ["Furthermore, pneumococcal vaccine might be considered in patients receiving B cell-depleting therapies, as severe respiratory infections during Phase III studies were seen (90, 91) .DISCUSSIONVaccine hesitancy is a major problem nowadays.", [["B cell", "ANATOMY", 76, 82], ["respiratory", "ANATOMY", 114, 125], ["respiratory infections", "DISEASE", 114, 136], ["patients", "ORGANISM", 57, 65], ["B cell", "CELL", 76, 82], ["patients", "SPECIES", 57, 65], ["pneumococcal", "SPECIES", 13, 25], ["pneumococcal vaccine", "TREATMENT", 13, 33], ["B cell-depleting therapies", "TREATMENT", 76, 102], ["severe respiratory infections", "PROBLEM", 107, 136], ["Phase III studies", "TEST", 144, 161], ["severe", "OBSERVATION_MODIFIER", 107, 113], ["respiratory", "ANATOMY", 114, 125], ["infections", "OBSERVATION", 126, 136]]], ["The usefulness of active immunization is undisputed and has saved numerous lives.", [["active immunization", "TREATMENT", 18, 37]]], ["This has led to a recent outbreak of measles (2) and curiously some viruses and disorders, which have been assumed to be eradicated, seem to become a hot topic for Western health systems again.DISCUSSIONIndeed, side effects upon vaccination may occur in rare cases, however, the benefits for individual people as well as the whole population will generally outweigh adverse effects.", [["measles", "DISEASE", 37, 44], ["people", "ORGANISM", 303, 309], ["people", "SPECIES", 303, 309], ["measles", "PROBLEM", 37, 44], ["curiously some viruses and disorders", "PROBLEM", 53, 89], ["vaccination", "TREATMENT", 229, 240], ["adverse effects", "PROBLEM", 366, 381], ["viruses", "OBSERVATION", 68, 75]]], ["Vaccine hesitancy results in a twofold problem: (1) The missing protection for the unvaccinated people themselves but also (2) a risk for people, who are not able to get vaccinated.", [["people", "ORGANISM", 96, 102], ["people", "ORGANISM", 138, 144], ["people", "SPECIES", 96, 102], ["people", "SPECIES", 138, 144]]], ["The missing herd immunity poses a major problem for a group of patients with fragile health.", [["fragile health", "DISEASE", 77, 91], ["patients", "ORGANISM", 63, 71], ["patients", "SPECIES", 63, 71]]], ["For MS patients receiving immunosuppressive treatment, an acute infection can have dangerous sequelae.", [["MS", "DISEASE", 4, 6], ["infection", "DISEASE", 64, 73], ["patients", "ORGANISM", 7, 15], ["patients", "SPECIES", 7, 15], ["immunosuppressive treatment", "TREATMENT", 26, 53], ["an acute infection", "PROBLEM", 55, 73], ["dangerous sequelae", "PROBLEM", 83, 101], ["acute", "OBSERVATION_MODIFIER", 58, 63], ["infection", "OBSERVATION", 64, 73]]], ["Thus, if possible, MS patients should be vaccinated beforehand.", [["patients", "ORGANISM", 22, 30], ["patients", "SPECIES", 22, 30]]], ["The possible benefits outweighdependent on the individual case-the possible risks.DISCUSSIONAn additional perspective raises the possibility of vaccination against MS. Indeed, early approaches exploring vaccination with synthetic peptides in experimental animal models were successful, but translation into clinical treatment was so far unsatisfying (92) (93) (94) .DISCUSSIONInterestingly, it was recently shown that an anti-typhus vaccination (Typhim vaccine) might have the potential to ameliorate the disease course of MS by targeting prohibitins on TH17 cells.", [["TH17 cells", "ANATOMY", 554, 564], ["MS", "DISEASE", 164, 166], ["Typhim", "CHEMICAL", 446, 452], ["MS", "DISEASE", 523, 525], ["prohibitins", "GENE_OR_GENE_PRODUCT", 539, 550], ["TH17 cells", "CELL", 554, 564], ["prohibitins", "PROTEIN", 539, 550], ["TH17 cells", "CELL_TYPE", 554, 564], ["vaccination", "TREATMENT", 144, 155], ["MS", "PROBLEM", 164, 166], ["vaccination", "TREATMENT", 203, 214], ["synthetic peptides", "TREATMENT", 220, 238], ["clinical treatment", "TREATMENT", 307, 325], ["an anti-typhus vaccination (Typhim vaccine", "TREATMENT", 418, 460], ["the disease course of MS", "PROBLEM", 501, 525], ["TH17 cells", "TREATMENT", 554, 564], ["possible", "UNCERTAINTY", 4, 12], ["TH17 cells", "OBSERVATION", 554, 564]]], ["Tested in an experimental MS model it led to decreased levels of IL17 and increased numbers of FOXp3 + regulatory T cells (95) .", [["FOXp3 + regulatory T cells", "ANATOMY", 95, 121], ["IL17", "GENE_OR_GENE_PRODUCT", 65, 69], ["FOXp3", "GENE_OR_GENE_PRODUCT", 95, 100], ["IL17", "PROTEIN", 65, 69], ["FOXp3", "PROTEIN", 95, 100], ["regulatory T cells", "CELL_TYPE", 103, 121], ["an experimental MS model", "TEST", 10, 34], ["decreased levels of IL17", "PROBLEM", 45, 69], ["FOXp3", "TEST", 95, 100], ["decreased", "OBSERVATION_MODIFIER", 45, 54], ["increased", "OBSERVATION_MODIFIER", 74, 83], ["numbers", "OBSERVATION_MODIFIER", 84, 91]]], ["Further investigations are needed before studies should investigate treatment options for MS patients.", [["MS", "DISEASE", 90, 92], ["patients", "ORGANISM", 93, 101], ["patients", "SPECIES", 93, 101], ["Further investigations", "TEST", 0, 22], ["studies", "TEST", 41, 48], ["treatment options", "TREATMENT", 68, 85], ["MS patients", "PROBLEM", 90, 101]]], ["Still, it is a good example, how immunology of vaccination might overlap with and modulate the immunology of MS.CONCLUSIONTheoretically, an increased immune response against different types of vaccines, such as live attenuated viruses, inactive attenuated viruses, or portions of bacteria and viruses, could trigger increased immune response to self-antigens (45, 58, 96) , but an increased risk for MS itself or increased relapse rates after vaccination have not been show (with exception for YF) in case-control studies (7) .", [["MS", "DISEASE", 400, 402], ["vaccination", "TREATMENT", 47, 58], ["an increased immune response", "PROBLEM", 137, 165], ["vaccines", "TREATMENT", 193, 201], ["live attenuated viruses", "PROBLEM", 211, 234], ["inactive attenuated viruses", "PROBLEM", 236, 263], ["bacteria", "PROBLEM", 280, 288], ["viruses", "PROBLEM", 293, 300], ["increased immune response", "PROBLEM", 316, 341], ["self-antigens", "TEST", 345, 358], ["MS itself", "PROBLEM", 400, 409], ["increased relapse rates", "PROBLEM", 413, 436], ["vaccination", "TREATMENT", 443, 454], ["YF", "PROBLEM", 494, 496], ["increased", "OBSERVATION_MODIFIER", 140, 149], ["immune response", "OBSERVATION", 150, 165], ["bacteria", "OBSERVATION", 280, 288], ["increased", "OBSERVATION_MODIFIER", 381, 390]]], ["There is, however, evidence that infections can trigger relapses in MS (96) (97) (98) (99) (100) (101) (102) (103) (104) , which is why vaccination of MS patients should be pursued in order to reduce the risk of infections.", [["infections", "DISEASE", 33, 43], ["MS", "DISEASE", 68, 70], ["MS", "DISEASE", 151, 153], ["infections", "DISEASE", 212, 222], ["patients", "ORGANISM", 154, 162], ["patients", "SPECIES", 154, 162], ["infections", "PROBLEM", 33, 43], ["MS", "TEST", 68, 70], ["infections", "PROBLEM", 212, 222], ["infections", "OBSERVATION", 33, 43], ["infections", "OBSERVATION", 212, 222]]], ["To assure the best vaccination success, immunization and immunosuppressive treatments have to be well timed.", [["the best vaccination success", "TREATMENT", 10, 38], ["immunization", "TREATMENT", 40, 52], ["immunosuppressive treatments", "TREATMENT", 57, 85]]]], "PMC7486881": [["IntroductionFor a long time, a cell death inducing capacity of a virus was interpreted as the measure of its pathogenic potential.", [["cell", "ANATOMY", 31, 35], ["death", "DISEASE", 36, 41], ["cell", "CELL", 31, 35], ["a cell death", "PROBLEM", 29, 41], ["a virus", "PROBLEM", 63, 70]]], ["Nevertheless, viruses are obligatory intracellular pathogens, thus their propagation is entirely dependent on the intracellular environment of the host cells.", [["intracellular", "ANATOMY", 37, 50], ["intracellular", "ANATOMY", 114, 127], ["cells", "ANATOMY", 152, 157], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 37, 50], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 114, 127], ["cells", "CELL", 152, 157], ["host cells", "CELL_TYPE", 147, 157], ["viruses", "PROBLEM", 14, 21], ["obligatory intracellular pathogens", "PROBLEM", 26, 60], ["viruses", "OBSERVATION", 14, 21], ["intracellular", "OBSERVATION_MODIFIER", 37, 50], ["pathogens", "OBSERVATION", 51, 60], ["dependent", "OBSERVATION_MODIFIER", 97, 106], ["host cells", "OBSERVATION", 147, 157]]], ["Therefore, the question is legitimate: Can cell death paradoxically protect from virus infection?", [["cell", "ANATOMY", 43, 47], ["death", "DISEASE", 48, 53], ["infection", "DISEASE", 87, 96], ["Can cell", "CELL", 39, 47], ["Can cell death", "PROBLEM", 39, 53], ["virus infection", "PROBLEM", 81, 96]]], ["In a single cell level, the emergence of immediate cell death in response to infection ultimately blocks the way of virus propagation and therefore protects the rest of the cell population from an increasing viral burden.", [["cell", "ANATOMY", 12, 16], ["cell", "ANATOMY", 51, 55], ["cell", "ANATOMY", 173, 177], ["death", "DISEASE", 56, 61], ["infection", "DISEASE", 77, 86], ["cell", "CELL", 12, 16], ["cell", "CELL", 51, 55], ["cell", "CELL", 173, 177], ["immediate cell death", "PROBLEM", 41, 61], ["infection", "PROBLEM", 77, 86], ["virus propagation", "PROBLEM", 116, 133], ["the cell population", "PROBLEM", 169, 188], ["an increasing viral burden", "PROBLEM", 194, 220], ["immediate cell death", "OBSERVATION", 41, 61], ["infection", "OBSERVATION", 77, 86], ["virus", "OBSERVATION", 116, 121], ["cell population", "OBSERVATION", 173, 188], ["increasing", "OBSERVATION_MODIFIER", 197, 207], ["viral burden", "OBSERVATION", 208, 220]]], ["The strongest argument for this theory comes from experimental observations on viruses which, in fact, actively evade cell death pathways by encoding viral \u201canti-death\u201d proteins (in detail see Sections 2.4, 3.3 and Table 2.).", [["cell", "ANATOMY", 118, 122], ["death", "DISEASE", 123, 128], ["death", "DISEASE", 162, 167], ["cell", "CELL", 118, 122], ["viral \u201canti-death\u201d proteins", "PROTEIN", 150, 177], ["experimental observations on viruses", "PROBLEM", 50, 86]]], ["If, however, the relation of cell death and virus infection is scrutinized at organism level, the answer for the question is more complex, particularly, since viruses represent a broad group of pathogens with different tissue-tropisms and various strategies to infect and to replicate.", [["cell", "ANATOMY", 29, 33], ["tissue", "ANATOMY", 219, 225], ["death", "DISEASE", 34, 39], ["infection", "DISEASE", 50, 59], ["cell", "CELL", 29, 33], ["tissue", "TISSUE", 219, 225], ["cell death", "PROBLEM", 29, 39], ["virus infection", "PROBLEM", 44, 59], ["viruses", "PROBLEM", 159, 166], ["a broad group of pathogens", "PROBLEM", 177, 203], ["different tissue-tropisms", "PROBLEM", 209, 234], ["cell death", "OBSERVATION", 29, 39], ["more complex", "OBSERVATION_MODIFIER", 125, 137]]], ["In general, the interplay of three key factors can determine the final outcome of cell death in virus infection: timing, immunogenic capacity and tissue specificity of the cell destruction.", [["cell", "ANATOMY", 82, 86], ["tissue", "ANATOMY", 146, 152], ["cell", "ANATOMY", 172, 176], ["death", "DISEASE", 87, 92], ["infection", "DISEASE", 102, 111], ["cell", "CELL", 82, 86], ["tissue", "TISSUE", 146, 152], ["cell", "CELL", 172, 176], ["cell death", "PROBLEM", 82, 92], ["virus infection", "PROBLEM", 96, 111], ["immunogenic capacity", "PROBLEM", 121, 141], ["the cell destruction", "PROBLEM", 168, 188], ["cell destruction", "OBSERVATION", 172, 188]]], ["For instance, manifestation of a cell death with delayed kinetics can allow sufficient time for virus replication and therefore might not deliver any benefit for the host, or selective killing of immune cells results in attenuated immune-response, which is described in the course of human immunodeficiency virus (HIV) infection of T lymphocytes [1].", [["cell", "ANATOMY", 33, 37], ["immune cells", "ANATOMY", 196, 208], ["T lymphocytes", "ANATOMY", 332, 345], ["death", "DISEASE", 38, 43], ["human immunodeficiency virus (HIV) infection", "DISEASE", 284, 328], ["cell", "CELL", 33, 37], ["immune cells", "CELL", 196, 208], ["human immunodeficiency virus", "ORGANISM", 284, 312], ["HIV", "ORGANISM", 314, 317], ["T lymphocytes", "CELL", 332, 345], ["immune cells", "CELL_TYPE", 196, 208], ["T lymphocytes", "CELL_TYPE", 332, 345], ["human immunodeficiency virus (HIV", "SPECIES", 284, 317], ["human immunodeficiency virus", "SPECIES", 284, 312], ["HIV", "SPECIES", 314, 317], ["a cell death", "PROBLEM", 31, 43], ["delayed kinetics", "PROBLEM", 49, 65], ["virus replication", "TREATMENT", 96, 113], ["immune cells", "PROBLEM", 196, 208], ["human immunodeficiency virus", "PROBLEM", 284, 312], ["HIV) infection of T lymphocytes", "PROBLEM", 314, 345]]], ["Furthermore, even a virus propagation-limiting cell death is considered detrimental in tissues with limited renewing potential (e.g. central nervous system) or when the function of the tissue is compromised.IntroductionIf we assume that a given virus infection selectively triggers cell death pathways, then it is expected that the cells exhibit specific \u201csensors\u201d to recognize this particular event.", [["cell", "ANATOMY", 47, 51], ["tissues", "ANATOMY", 87, 94], ["central nervous system", "ANATOMY", 133, 155], ["tissue", "ANATOMY", 185, 191], ["cell", "ANATOMY", 282, 286], ["cells", "ANATOMY", 332, 337], ["death", "DISEASE", 52, 57], ["infection", "DISEASE", 251, 260], ["cell", "CELL", 47, 51], ["tissues", "TISSUE", 87, 94], ["central nervous system", "ANATOMICAL_SYSTEM", 133, 155], ["tissue", "TISSUE", 185, 191], ["cell", "CELL", 282, 286], ["cells", "CELL", 332, 337], ["a virus propagation", "PROBLEM", 18, 37], ["cell death", "PROBLEM", 47, 57], ["virus infection", "PROBLEM", 245, 260], ["the cells", "PROBLEM", 328, 337], ["compromised", "OBSERVATION", 195, 206]]], ["In fact, detection of viruses in mammalian cells is accomplished by the recognition of molecular elements which are decoded as foreign-to-the-organism, collectively termed as pathogen associated molecular patterns (PAMPs).", [["mammalian cells", "ANATOMY", 33, 48], ["mammalian cells", "CELL", 33, 48], ["pathogen associated molecular patterns", "GENE_OR_GENE_PRODUCT", 175, 213], ["mammalian cells", "CELL_TYPE", 33, 48], ["molecular elements", "DNA", 87, 105], ["pathogen associated molecular patterns", "PROTEIN", 175, 213], ["PAMPs", "PROTEIN", 215, 220], ["viruses in mammalian cells", "PROBLEM", 22, 48], ["viruses", "OBSERVATION", 22, 29], ["mammalian cells", "OBSERVATION", 33, 48], ["molecular elements", "OBSERVATION", 87, 105]]], ["Two distinct mechanisms can be identified in the context of PAMPs and cell death.", [["cell", "ANATOMY", 70, 74], ["death", "DISEASE", 75, 80], ["PAMPs", "GENE_OR_GENE_PRODUCT", 60, 65], ["cell", "CELL", 70, 74], ["PAMPs", "PROTEIN", 60, 65], ["PAMPs", "PROBLEM", 60, 65], ["cell death", "PROBLEM", 70, 80], ["distinct", "OBSERVATION_MODIFIER", 4, 12], ["mechanisms", "OBSERVATION", 13, 23], ["cell death", "OBSERVATION", 70, 80]]], ["First, PAMPs are recognized by so called pathogen recognition receptors (PRRs) [2], which in turn induce pathways leading to immune response and -in certain circumstances- indirectly to cell demise [1].", [["cell", "ANATOMY", 186, 190], ["PAMPs", "GENE_OR_GENE_PRODUCT", 7, 12], ["pathogen recognition receptors", "GENE_OR_GENE_PRODUCT", 41, 71], ["cell", "CELL", 186, 190], ["PAMPs", "PROTEIN", 7, 12], ["pathogen recognition receptors", "PROTEIN", 41, 71], ["PRRs", "PROTEIN", 73, 77], ["immune response", "PROBLEM", 125, 140]]], ["Second, PAMPs can also initiate cell-autonomous death signalling pathways.IntroductionIn this article, the machinery of pathogen recognition is reviewed in the aspect of cell death signalling and the major regulated cell death modalities, including apoptosis, necroptosis and pyroptosis are discussed in detail, which can emerge during a viral insult.", [["cell", "ANATOMY", 32, 36], ["cell", "ANATOMY", 170, 174], ["cell", "ANATOMY", 216, 220], ["death", "DISEASE", 48, 53], ["death", "DISEASE", 175, 180], ["death", "DISEASE", 221, 226], ["necroptosis", "DISEASE", 260, 271], ["pyroptosis", "DISEASE", 276, 286], ["viral insult", "DISEASE", 338, 350], ["PAMPs", "GENE_OR_GENE_PRODUCT", 8, 13], ["cell", "CELL", 32, 36], ["cell", "CELL", 170, 174], ["cell", "CELL", 216, 220], ["PAMPs", "PROTEIN", 8, 13], ["cell death signalling", "PROBLEM", 170, 191], ["the major regulated cell death modalities", "PROBLEM", 196, 237], ["apoptosis", "PROBLEM", 249, 258], ["necroptosis", "PROBLEM", 260, 271], ["pyroptosis", "PROBLEM", 276, 286], ["a viral insult", "PROBLEM", 336, 350], ["cell death", "OBSERVATION", 170, 180], ["cell death", "OBSERVATION", 216, 226], ["necroptosis", "OBSERVATION", 260, 271], ["pyroptosis", "OBSERVATION", 276, 286], ["viral insult", "OBSERVATION", 338, 350]]], ["Importantly, regulated cell death forms differ in their inflammatory potential, as apoptosis represent an anti-inflammatory cell death form, whereas necroptosis and pyroptosis may render immune stimulation more efficiently.Apoptotic core machinery ::: ApoptosisApoptosis is a widely studied regulated cell death form, which has been first described by Kerr and colleagues by the help of electron microscopic techniques in the 60\u00b4s of the last century [3].", [["cell", "ANATOMY", 23, 27], ["cell", "ANATOMY", 124, 128], ["cell", "ANATOMY", 301, 305], ["pyroptosis", "DISEASE", 165, 175], ["ApoptosisApoptosis", "DISEASE", 252, 270], ["cell", "CELL", 23, 27], ["cell", "CELL", 124, 128], ["cell", "CELL", 301, 305], ["regulated cell death forms", "PROBLEM", 13, 39], ["an anti-inflammatory cell death", "PROBLEM", 103, 134], ["necroptosis", "PROBLEM", 149, 160], ["pyroptosis", "PROBLEM", 165, 175], ["immune stimulation", "TREATMENT", 187, 205], ["electron microscopic techniques", "TEST", 387, 418], ["cell death", "OBSERVATION", 23, 33], ["inflammatory", "OBSERVATION_MODIFIER", 56, 68], ["anti-inflammatory cell death", "OBSERVATION", 106, 134], ["pyroptosis", "OBSERVATION", 165, 175], ["cell death", "OBSERVATION", 301, 311]]], ["Morphologically, apoptosis exhibits cell shrinkage, condensation and fragmentation of the nucleus.", [["cell", "ANATOMY", 36, 40], ["nucleus", "ANATOMY", 90, 97], ["cell", "CELL", 36, 40], ["nucleus", "CELLULAR_COMPONENT", 90, 97], ["apoptosis", "PROBLEM", 17, 26], ["cell shrinkage", "PROBLEM", 36, 50], ["condensation and fragmentation of the nucleus", "PROBLEM", 52, 97], ["apoptosis exhibits cell shrinkage", "OBSERVATION", 17, 50], ["condensation", "OBSERVATION_MODIFIER", 52, 64], ["fragmentation", "OBSERVATION_MODIFIER", 69, 82], ["nucleus", "ANATOMY", 90, 97]]], ["Immunologically important features of apoptosis include preserved membrane integrity of the apoptotic cells and engulfment of the dying cells by neighbouring phagocytes [4].", [["membrane", "ANATOMY", 66, 74], ["cells", "ANATOMY", 102, 107], ["cells", "ANATOMY", 136, 141], ["phagocytes", "ANATOMY", 158, 168], ["membrane", "CELLULAR_COMPONENT", 66, 74], ["cells", "CELL", 102, 107], ["cells", "CELL", 136, 141], ["phagocytes", "CELL", 158, 168], ["apoptotic cells", "CELL_TYPE", 92, 107], ["dying cells", "CELL_TYPE", 130, 141], ["phagocytes", "CELL_TYPE", 158, 168], ["apoptosis", "PROBLEM", 38, 47], ["apoptosis", "OBSERVATION", 38, 47], ["membrane integrity", "OBSERVATION", 66, 84], ["apoptotic cells", "OBSERVATION", 92, 107], ["engulfment", "OBSERVATION_MODIFIER", 112, 122]]], ["This special \u201cimmunologically silent\u201d characteristic enables apoptosis to play a central role in physiological processes such as development of organs and maturation of immune cells.", [["organs", "ANATOMY", 144, 150], ["immune cells", "ANATOMY", 169, 181], ["organs", "ORGAN", 144, 150], ["immune cells", "CELL", 169, 181], ["immune cells", "CELL_TYPE", 169, 181], ["immune cells", "PROBLEM", 169, 181], ["immune cells", "OBSERVATION", 169, 181]]], ["Caspases take a central stage in apoptosis regulation.", [["Caspases", "GENE_OR_GENE_PRODUCT", 0, 8], ["Caspases", "PROTEIN", 0, 8], ["Caspases", "TREATMENT", 0, 8], ["a central stage in apoptosis regulation", "TREATMENT", 14, 53], ["central stage", "OBSERVATION_MODIFIER", 16, 29], ["apoptosis regulation", "OBSERVATION", 33, 53]]], ["Functionally, caspases are divided into three subgroups: inflammatory, apoptotic-initiator and apoptotic-executioner caspases [5].", [["caspases", "GENE_OR_GENE_PRODUCT", 14, 22], ["caspases", "GENE_OR_GENE_PRODUCT", 117, 125], ["caspases", "PROTEIN", 14, 22], ["executioner caspases", "PROTEIN", 105, 125], ["inflammatory", "PROBLEM", 57, 69], ["apoptotic-executioner caspases", "TREATMENT", 95, 125], ["inflammatory", "OBSERVATION_MODIFIER", 57, 69]]], ["Initiator caspases are structurally distinguished by their large pro-domain, which enables them to be recruited into high-molecular-weight protein complexes in response to an apoptotic stimulus [6].", [["caspases", "GENE_OR_GENE_PRODUCT", 10, 18], ["Initiator caspases", "PROTEIN", 0, 18], ["pro-domain", "PROTEIN", 65, 75], ["high-molecular-weight protein complexes", "PROTEIN", 117, 156], ["an apoptotic stimulus", "TEST", 172, 193], ["large", "OBSERVATION_MODIFIER", 59, 64], ["pro-domain", "OBSERVATION", 65, 75]]], ["Intrinsic and extrinsic pathways represent the two main pathways of apoptosis initiation.", [["apoptosis initiation", "TREATMENT", 68, 88], ["extrinsic pathways", "OBSERVATION", 14, 32], ["two", "OBSERVATION_MODIFIER", 47, 50], ["main", "OBSERVATION_MODIFIER", 51, 55], ["apoptosis", "OBSERVATION", 68, 77]]], ["Intrinsic pathway is triggered by intracellular stress signals such as genotoxic stress, whereas extrinsic pathway is initiated by the ligation of transmembrane receptors of the tumor necrosis factor (TNF) superfamily, commonly termed death receptors (DR).", [["intracellular", "ANATOMY", 34, 47], ["transmembrane", "ANATOMY", 147, 160], ["tumor", "DISEASE", 178, 183], ["necrosis", "DISEASE", 184, 192], ["death", "DISEASE", 235, 240], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 34, 47], ["tumor necrosis factor", "GENE_OR_GENE_PRODUCT", 178, 199], ["TNF", "GENE_OR_GENE_PRODUCT", 201, 204], ["death receptors", "GENE_OR_GENE_PRODUCT", 235, 250], ["DR", "GENE_OR_GENE_PRODUCT", 252, 254], ["transmembrane receptors", "PROTEIN", 147, 170], ["tumor necrosis factor (TNF) superfamily", "PROTEIN", 178, 217], ["death receptors", "PROTEIN", 235, 250], ["DR", "PROTEIN", 252, 254], ["Intrinsic pathway", "PROBLEM", 0, 17], ["intracellular stress signals", "PROBLEM", 34, 62], ["genotoxic stress", "PROBLEM", 71, 87], ["the ligation of transmembrane receptors", "TREATMENT", 131, 170], ["the tumor necrosis factor", "PROBLEM", 174, 199], ["intracellular stress", "OBSERVATION", 34, 54], ["genotoxic stress", "OBSERVATION", 71, 87], ["tumor", "OBSERVATION_MODIFIER", 178, 183], ["necrosis", "OBSERVATION", 184, 192]]], ["Stimulation of the intrinsic pathway leads to conformational changes of pro-apoptotic members of the B cell lymphoma-2 (BCL-2) protein family: BCL-2-associated X protein (BAX) and BCL-2-antagonistic killer (BAK).", [["B cell lymphoma-2", "GENE_OR_GENE_PRODUCT", 101, 118], ["BCL-2", "GENE_OR_GENE_PRODUCT", 120, 125], ["BCL-2-associated X protein", "GENE_OR_GENE_PRODUCT", 143, 169], ["BAX", "GENE_OR_GENE_PRODUCT", 171, 174], ["BCL-2", "GENE_OR_GENE_PRODUCT", 180, 185], ["BAK", "GENE_OR_GENE_PRODUCT", 207, 210], ["pro-apoptotic members", "PROTEIN", 72, 93], ["B cell lymphoma-2 (BCL-2) protein family", "PROTEIN", 101, 141], ["BCL-2-associated X protein", "PROTEIN", 143, 169], ["BAX", "PROTEIN", 171, 174], ["BCL-2-antagonistic killer", "PROTEIN", 180, 205], ["BAK", "PROTEIN", 207, 210], ["the B cell lymphoma", "PROBLEM", 97, 116], ["BCL", "TEST", 120, 123], ["BCL", "TEST", 143, 146], ["protein", "TEST", 162, 169], ["BAX", "TEST", 171, 174], ["BCL", "TEST", 180, 183], ["B cell lymphoma", "OBSERVATION", 101, 116]]], ["Consequently, BAX and BAK translocate, oligomerize and form large pores throughout the mitochondrial membrane [7,8] leading to mitochondrial outer membrane permeabilization (MOMP) and resulting in the release of cytochrome-C [9].", [["mitochondrial membrane", "ANATOMY", 87, 109], ["mitochondrial outer membrane", "ANATOMY", 127, 155], ["BAX", "GENE_OR_GENE_PRODUCT", 14, 17], ["BAK", "GENE_OR_GENE_PRODUCT", 22, 25], ["mitochondrial membrane", "CELLULAR_COMPONENT", 87, 109], ["mitochondrial", "CELLULAR_COMPONENT", 127, 140], ["outer membrane", "CELLULAR_COMPONENT", 141, 155], ["MOMP", "CELLULAR_COMPONENT", 174, 178], ["cytochrome-C", "GENE_OR_GENE_PRODUCT", 212, 224], ["BAX", "PROTEIN", 14, 17], ["BAK", "PROTEIN", 22, 25], ["MOMP", "PROTEIN", 174, 178], ["cytochrome", "PROTEIN", 212, 222], ["BAX and BAK translocate", "TREATMENT", 14, 37], ["large pores throughout the mitochondrial membrane", "PROBLEM", 60, 109], ["mitochondrial outer membrane permeabilization", "TREATMENT", 127, 172], ["large", "OBSERVATION_MODIFIER", 60, 65], ["pores", "OBSERVATION_MODIFIER", 66, 71], ["mitochondrial membrane", "OBSERVATION", 87, 109], ["outer membrane", "ANATOMY", 141, 155]]], ["The assembly of apoptosome in the cytosol, a complex containing cytochrome C and apoptotic protease activating factor-1 (APAF-1), culminates in the recruitment of caspase-9 [9].", [["cytosol", "ANATOMY", 34, 41], ["apoptosome", "GENE_OR_GENE_PRODUCT", 16, 26], ["cytosol", "CELLULAR_COMPONENT", 34, 41], ["cytochrome C", "GENE_OR_GENE_PRODUCT", 64, 76], ["apoptotic protease activating factor-1", "GENE_OR_GENE_PRODUCT", 81, 119], ["APAF-1", "GENE_OR_GENE_PRODUCT", 121, 127], ["caspase-9", "GENE_OR_GENE_PRODUCT", 163, 172], ["apoptosome", "PROTEIN", 16, 26], ["cytochrome C", "PROTEIN", 64, 76], ["apoptotic protease activating factor-1 (APAF-1", "PROTEIN", 81, 127], ["caspase", "PROTEIN", 163, 170], ["a complex containing cytochrome C", "PROBLEM", 43, 76], ["apoptotic protease activating factor", "TEST", 81, 117], ["APAF", "TEST", 121, 125], ["caspase", "TEST", 163, 170]]], ["In the extrinsic pathway, the ligation of DRs leads to the recruitment of initiator caspases-8 and -10 in a high molecular weight complex termed death inducing signalling complex (DISC).", [["death", "DISEASE", 145, 150], ["DRs", "GENE_OR_GENE_PRODUCT", 42, 45], ["caspases-8", "GENE_OR_GENE_PRODUCT", 84, 94], ["-10", "GENE_OR_GENE_PRODUCT", 99, 102], ["high molecular weight complex termed death inducing signalling complex", "GENE_OR_GENE_PRODUCT", 108, 178], ["DISC", "GENE_OR_GENE_PRODUCT", 180, 184], ["DRs", "PROTEIN", 42, 45], ["initiator caspases-8 and -10", "PROTEIN", 74, 102], ["high molecular weight complex", "PROTEIN", 108, 137], ["death inducing signalling complex", "PROTEIN", 145, 178], ["DISC", "PROTEIN", 180, 184], ["the ligation of DRs", "TREATMENT", 26, 45], ["initiator caspases", "TEST", 74, 92], ["a high molecular weight complex termed death", "PROBLEM", 106, 150], ["signalling complex (DISC)", "PROBLEM", 160, 185], ["ligation", "OBSERVATION", 30, 38], ["signalling complex", "OBSERVATION", 160, 178], ["DISC", "ANATOMY", 180, 184]]], ["The recruitment and oligomerization of initiator caspases in both pathways enables proximity-driven self-cleavage and activation [10].", [["caspases", "GENE_OR_GENE_PRODUCT", 49, 57], ["initiator caspases", "PROTEIN", 39, 57], ["The recruitment and oligomerization of initiator caspases", "TREATMENT", 0, 57]]], ["As a consequence, the activation of initiator caspases results in the cleavage and activation of effector caspases (caspase-3, -6 and -7), and finally activated effector caspases selectively process their substrates.", [["caspases", "GENE_OR_GENE_PRODUCT", 46, 54], ["caspases", "GENE_OR_GENE_PRODUCT", 106, 114], ["caspase-3", "GENE_OR_GENE_PRODUCT", 116, 125], ["-6", "GENE_OR_GENE_PRODUCT", 127, 129], ["-7", "GENE_OR_GENE_PRODUCT", 134, 136], ["caspases", "GENE_OR_GENE_PRODUCT", 170, 178], ["initiator caspases", "PROTEIN", 36, 54], ["effector caspases", "PROTEIN", 97, 114], ["caspase-3, -6 and -7", "PROTEIN", 116, 136], ["effector caspases", "PROTEIN", 161, 178], ["initiator caspases", "TREATMENT", 36, 54], ["the cleavage", "PROBLEM", 66, 78], ["effector caspases", "TREATMENT", 97, 114], ["caspase", "TEST", 116, 123]]], ["The cleavage of them results in a series of events which finally leads to apoptosis [11].Immune response-driven cell-killing mechanisms ::: ApoptosisCytotoxic T cells (CTL) play crucial role in the adaptive immune response and natural killer (NK) cells exert similar functions in the innate immune response given to viral infection.", [["cell", "ANATOMY", 112, 116], ["ApoptosisCytotoxic T cells", "ANATOMY", 140, 166], ["CTL", "ANATOMY", 168, 171], ["natural killer (NK) cells", "ANATOMY", 227, 252], ["viral infection", "DISEASE", 316, 331], ["cell", "CELL", 112, 116], ["ApoptosisCytotoxic T cells", "CELL", 140, 166], ["CTL", "CELL", 168, 171], ["natural killer (NK) cells", "CELL", 227, 252], ["ApoptosisCytotoxic T cells", "CELL_TYPE", 140, 166], ["CTL", "CELL_TYPE", 168, 171], ["natural killer (NK) cells", "CELL_TYPE", 227, 252], ["ApoptosisCytotoxic T cells (CTL)", "TREATMENT", 140, 172], ["natural killer (NK) cells", "TREATMENT", 227, 252], ["viral infection", "PROBLEM", 316, 331], ["viral", "OBSERVATION_MODIFIER", 316, 321], ["infection", "OBSERVATION", 322, 331]]], ["In vivo studies by employing reporter viruses demonstrate that one single CTL is capable to kill up to 16 infected cells per day [12].", [["cells", "ANATOMY", 115, 120], ["cells", "CELL", 115, 120], ["CTL", "CELL_TYPE", 74, 77], ["vivo studies", "TEST", 3, 15]]], ["It is noteworthy that CTLs exhibit distinct cell killing capacity in different tissue types.", [["CTLs", "ANATOMY", 22, 26], ["cell", "ANATOMY", 44, 48], ["tissue", "ANATOMY", 79, 85], ["CTLs", "CELL", 22, 26], ["cell", "CELL", 44, 48], ["tissue", "TISSUE", 79, 85], ["CTLs", "CELL_TYPE", 22, 26], ["distinct cell killing capacity", "PROBLEM", 35, 65], ["distinct cell", "OBSERVATION", 35, 48], ["killing capacity", "OBSERVATION", 49, 65], ["different tissue", "OBSERVATION_MODIFIER", 69, 85], ["types", "OBSERVATION_MODIFIER", 86, 91]]], ["For instance, Herpes simplex and Vaccinia virus infected monocytes and macrophages are killed by CTLs, whereas epithelial cells are less susceptible to CTL mediated cell death mechanisms [13,14].", [["monocytes", "ANATOMY", 57, 66], ["macrophages", "ANATOMY", 71, 82], ["CTLs", "ANATOMY", 97, 101], ["epithelial cells", "ANATOMY", 111, 127], ["cell", "ANATOMY", 165, 169], ["Herpes simplex", "DISEASE", 14, 28], ["death", "DISEASE", 170, 175], ["Herpes simplex", "ORGANISM", 14, 28], ["Vaccinia virus", "ORGANISM", 33, 47], ["monocytes", "CELL", 57, 66], ["macrophages", "CELL", 71, 82], ["CTLs", "CELL", 97, 101], ["epithelial cells", "CELL", 111, 127], ["CTL", "CELL", 152, 155], ["cell", "CELL", 165, 169], ["monocytes", "CELL_TYPE", 57, 66], ["macrophages", "CELL_TYPE", 71, 82], ["CTLs", "CELL_TYPE", 97, 101], ["epithelial cells", "CELL_TYPE", 111, 127], ["Herpes simplex", "SPECIES", 14, 28], ["Vaccinia virus", "SPECIES", 33, 47], ["Vaccinia virus", "SPECIES", 33, 47], ["Herpes simplex", "PROBLEM", 14, 28], ["Vaccinia virus infected monocytes", "PROBLEM", 33, 66], ["macrophages", "PROBLEM", 71, 82], ["epithelial cells", "PROBLEM", 111, 127], ["CTL mediated cell death mechanisms", "PROBLEM", 152, 186], ["epithelial cells", "OBSERVATION", 111, 127]]], ["CTL and also NK cell driven cell killing is dependent on cell-cell contacts and involves the rapid secretion of cytotoxic perforin and granzymes [15] and the slower death receptor, Fas (also: CD95)-driven apoptotic pathway (Fig. 1.).", [["NK cell", "ANATOMY", 13, 20], ["cell", "ANATOMY", 28, 32], ["cell-cell contacts", "ANATOMY", 57, 75], ["death", "DISEASE", 165, 170], ["CTL", "CELL", 0, 3], ["NK cell", "CELL", 13, 20], ["cell", "CELL", 28, 32], ["cell", "CELL", 57, 61], ["cell", "CELL", 62, 66], ["perforin", "GENE_OR_GENE_PRODUCT", 122, 130], ["granzymes [15]", "GENE_OR_GENE_PRODUCT", 135, 149], ["Fas", "GENE_OR_GENE_PRODUCT", 181, 184], ["CD95", "GENE_OR_GENE_PRODUCT", 192, 196], ["CTL", "CELL_TYPE", 0, 3], ["cytotoxic perforin", "PROTEIN", 112, 130], ["granzymes", "PROTEIN", 135, 144], ["death receptor", "PROTEIN", 165, 179], ["Fas", "PROTEIN", 181, 184], ["CD95", "PROTEIN", 192, 196], ["CTL", "PROBLEM", 0, 3], ["cell killing", "PROBLEM", 28, 40], ["cytotoxic perforin", "TEST", 112, 130], ["granzymes", "TEST", 135, 144], ["the slower death receptor", "TEST", 154, 179], ["Fas", "TEST", 181, 184], ["CD95", "TEST", 192, 196], ["NK cell driven cell killing", "OBSERVATION", 13, 40]]], ["Granzymes are a family of serine proteases that are produced and stored in lytic granules inside the CTLs and NK cells.", [["granules", "ANATOMY", 81, 89], ["CTLs", "ANATOMY", 101, 105], ["NK cells", "ANATOMY", 110, 118], ["serine", "CHEMICAL", 26, 32], ["Granzymes", "GENE_OR_GENE_PRODUCT", 0, 9], ["serine", "AMINO_ACID", 26, 32], ["granules", "ORGANISM_SUBSTANCE", 81, 89], ["CTLs", "CELL", 101, 105], ["NK cells", "CELL", 110, 118], ["Granzymes", "PROTEIN", 0, 9], ["serine proteases", "PROTEIN", 26, 42], ["CTLs", "CELL_TYPE", 101, 105], ["NK cells", "CELL_TYPE", 110, 118], ["serine proteases", "PROBLEM", 26, 42], ["lytic", "OBSERVATION_MODIFIER", 75, 80], ["CTLs", "ANATOMY", 101, 105], ["NK cells", "OBSERVATION", 110, 118]]], ["A well-studied member of this family, Granzyme-B can enter the target cells either via newly formed trans-membrane perforin-pores [15] or by endocytosis.", [["cells", "ANATOMY", 70, 75], ["membrane", "ANATOMY", 106, 114], ["Granzyme-B", "GENE_OR_GENE_PRODUCT", 38, 48], ["cells", "CELL", 70, 75], ["perforin", "GENE_OR_GENE_PRODUCT", 115, 123], ["Granzyme-B", "PROTEIN", 38, 48], ["target cells", "CELL_TYPE", 63, 75], ["perforin", "PROTEIN", 115, 123]]], ["Subsequently, granzyme-B induces mitochondrial apoptosis by performing cleavage of the BCL-2 homology domain-3 (BH3)-only protein, BH3 interacting domain death agonist (BID), which then leads to BAX/BAK-mediated MOMP and the initiation of the caspase-9-driven apoptotic pathway [16].", [["mitochondrial", "ANATOMY", 33, 46], ["granzyme-B", "CHEMICAL", 14, 24], ["granzyme-B", "GENE_OR_GENE_PRODUCT", 14, 24], ["mitochondrial", "CELLULAR_COMPONENT", 33, 46], ["BCL-2 homology domain-3", "GENE_OR_GENE_PRODUCT", 87, 110], ["BH3", "GENE_OR_GENE_PRODUCT", 112, 115], ["BH3 interacting domain death agonist", "SIMPLE_CHEMICAL", 131, 167], ["BID", "SIMPLE_CHEMICAL", 169, 172], ["BAX", "GENE_OR_GENE_PRODUCT", 195, 198], ["BAK", "GENE_OR_GENE_PRODUCT", 199, 202], ["MOMP", "GENE_OR_GENE_PRODUCT", 212, 216], ["caspase-9", "GENE_OR_GENE_PRODUCT", 243, 252], ["granzyme-B", "PROTEIN", 14, 24], ["BCL-2 homology domain-3 (BH3)-only protein", "PROTEIN", 87, 129], ["BH3", "PROTEIN", 131, 134], ["BAX", "PROTEIN", 195, 198], ["BAK", "PROTEIN", 199, 202], ["MOMP", "PROTEIN", 212, 216], ["caspase-9", "PROTEIN", 243, 252], ["granzyme", "TEST", 14, 22], ["mitochondrial apoptosis", "PROBLEM", 33, 56], ["the BCL", "TEST", 83, 90], ["BAX/BAK", "TREATMENT", 195, 202], ["the caspase", "TREATMENT", 239, 250], ["mitochondrial apoptosis", "OBSERVATION", 33, 56]]], ["CTLs express Fas ligands (FasL) on their surface and the trimerized ligands are capable to bind the death receptor Fas, which is present on the cell surface of the target cells.", [["CTLs", "ANATOMY", 0, 4], ["surface", "ANATOMY", 41, 48], ["cell surface", "ANATOMY", 144, 156], ["cells", "ANATOMY", 171, 176], ["death", "DISEASE", 100, 105], ["CTLs", "CELL", 0, 4], ["Fas ligands", "GENE_OR_GENE_PRODUCT", 13, 24], ["FasL", "GENE_OR_GENE_PRODUCT", 26, 30], ["surface", "CELLULAR_COMPONENT", 41, 48], ["Fas", "GENE_OR_GENE_PRODUCT", 115, 118], ["cell surface", "CELLULAR_COMPONENT", 144, 156], ["cells", "CELL", 171, 176], ["CTLs", "CELL_TYPE", 0, 4], ["Fas ligands", "PROTEIN", 13, 24], ["FasL", "PROTEIN", 26, 30], ["trimerized ligands", "PROTEIN", 57, 75], ["death receptor Fas", "PROTEIN", 100, 118], ["target cells", "CELL_TYPE", 164, 176], ["Fas ligands", "TEST", 13, 24], ["target cells", "OBSERVATION", 164, 176]]], ["The ligation of the DRs results in the recruitment of the adaptor protein, Fas-associated protein with death domain (FADD), leading to recruitment of initiator caspases with a death domain (caspase-8/-10).", [["death", "DISEASE", 103, 108], ["death", "DISEASE", 176, 181], ["FADD", "GENE_OR_GENE_PRODUCT", 117, 121], ["caspases", "GENE_OR_GENE_PRODUCT", 160, 168], ["caspase-8", "GENE_OR_GENE_PRODUCT", 190, 199], ["-10", "GENE_OR_GENE_PRODUCT", 200, 203], ["DRs", "DNA", 20, 23], ["adaptor protein", "PROTEIN", 58, 73], ["Fas-associated protein", "PROTEIN", 75, 97], ["death domain", "PROTEIN", 103, 115], ["FADD", "PROTEIN", 117, 121], ["initiator caspases", "PROTEIN", 150, 168], ["death domain", "PROTEIN", 176, 188], ["caspase-8/-10", "PROTEIN", 190, 203], ["The ligation", "TREATMENT", 0, 12], ["death domain (FADD)", "PROBLEM", 103, 122], ["initiator caspases", "TREATMENT", 150, 168], ["a death domain", "PROBLEM", 174, 188], ["caspase", "TEST", 190, 197], ["ligation", "OBSERVATION", 4, 12]]], ["Interestingly the sensitivity towards DR-mediated cell killing is also selectively regulated on the host side, since in response to Influenza A virus (IAV) and Dengue virus infection, the upregulation of the elements of Fas pathway is observed.", [["cell", "ANATOMY", 50, 54], ["Influenza A virus", "DISEASE", 132, 149], ["Dengue virus infection", "DISEASE", 160, 182], ["DR", "GENE_OR_GENE_PRODUCT", 38, 40], ["cell", "CELL", 50, 54], ["Influenza A virus", "ORGANISM", 132, 149], ["IAV", "ORGANISM", 151, 154], ["Dengue virus", "ORGANISM", 160, 172], ["Fas", "GENE_OR_GENE_PRODUCT", 220, 223], ["DR", "PROTEIN", 38, 40], ["Fas", "PROTEIN", 220, 223], ["Influenza A virus", "SPECIES", 132, 149], ["Dengue virus", "SPECIES", 160, 172], ["Influenza A virus", "SPECIES", 132, 149], ["IAV", "SPECIES", 151, 154], ["Dengue virus", "SPECIES", 160, 172], ["the sensitivity", "TEST", 14, 29], ["mediated cell killing", "PROBLEM", 41, 62], ["Influenza A virus (IAV)", "PROBLEM", 132, 155], ["Dengue virus infection", "PROBLEM", 160, 182], ["Fas pathway", "TEST", 220, 231], ["cell killing", "OBSERVATION", 50, 62]]], ["Furthermore, IAV infection leads to downregulation of the anti-apoptotic cellular caspase-8 and FADD-like apoptosis regulator (cFLIP) [17], which if highly expressed can form inactive hetero-dimers with caspase-8.", [["cellular", "ANATOMY", 73, 81], ["infection", "DISEASE", 17, 26], ["IAV", "ORGANISM", 13, 16], ["cellular", "CELL", 73, 81], ["caspase-8", "GENE_OR_GENE_PRODUCT", 82, 91], ["FADD-like apoptosis regulator", "GENE_OR_GENE_PRODUCT", 96, 125], ["cFLIP", "GENE_OR_GENE_PRODUCT", 127, 132], ["caspase-8", "GENE_OR_GENE_PRODUCT", 203, 212], ["anti-apoptotic cellular caspase-8", "PROTEIN", 58, 91], ["FADD", "PROTEIN", 96, 100], ["apoptosis regulator", "PROTEIN", 106, 125], ["cFLIP", "PROTEIN", 127, 132], ["inactive hetero-dimers", "PROTEIN", 175, 197], ["caspase-8", "PROTEIN", 203, 212], ["IAV", "SPECIES", 13, 16], ["IAV infection", "PROBLEM", 13, 26], ["the anti-apoptotic cellular caspase", "TEST", 54, 89], ["FADD", "TEST", 96, 100], ["caspase", "TREATMENT", 203, 210], ["IAV", "OBSERVATION_MODIFIER", 13, 16], ["infection", "OBSERVATION", 17, 26], ["cellular caspase", "OBSERVATION", 73, 89], ["apoptosis", "OBSERVATION_MODIFIER", 106, 115]]], ["Surprisingly, the replication of IAV can be amplified by overexpression of pro-apoptotic genes and is blocked by the upregulation of anti-apoptotic genes in human lung epithelial cell line [18], which indicates a virus-promoting role for apoptosis in response to IAV in lung cells.", [["lung epithelial cell line", "ANATOMY", 163, 188], ["lung cells", "ANATOMY", 270, 280], ["IAV", "ORGANISM", 33, 36], ["human", "ORGANISM", 157, 162], ["lung epithelial cell line [18]", "CELL", 163, 193], ["IAV", "ORGANISM", 263, 266], ["lung cells", "CELL", 270, 280], ["pro-apoptotic genes", "DNA", 75, 94], ["anti-apoptotic genes", "DNA", 133, 153], ["human lung epithelial cell line [18", "CELL_LINE", 157, 192], ["lung cells", "CELL_TYPE", 270, 280], ["human", "SPECIES", 157, 162], ["IAV", "SPECIES", 33, 36], ["human", "SPECIES", 157, 162], ["IAV", "SPECIES", 263, 266], ["IAV", "PROBLEM", 33, 36], ["anti-apoptotic genes in human lung epithelial cell line", "TREATMENT", 133, 188], ["a virus", "PROBLEM", 211, 218], ["apoptosis", "PROBLEM", 238, 247], ["IAV in lung cells", "TREATMENT", 263, 280], ["IAV", "OBSERVATION", 33, 36], ["anti-apoptotic genes", "OBSERVATION", 133, 153], ["lung", "ANATOMY", 163, 167], ["epithelial cell line", "OBSERVATION", 168, 188], ["virus", "OBSERVATION", 213, 218], ["lung", "ANATOMY", 270, 274]]], ["Along these lines, the viral protein Hepatitis B virus x (HBx) sensitizes host cells towards TNF driven apoptosis by interfering the anti-apoptotic action of cFLIP [19].", [["cells", "ANATOMY", 79, 84], ["Hepatitis B virus x", "ORGANISM", 37, 56], ["HBx", "GENE_OR_GENE_PRODUCT", 58, 61], ["host cells", "CELL", 74, 84], ["TNF", "GENE_OR_GENE_PRODUCT", 93, 96], ["cFLIP", "GENE_OR_GENE_PRODUCT", 158, 163], ["HBx", "PROTEIN", 58, 61], ["host cells", "CELL_TYPE", 74, 84], ["TNF", "PROTEIN", 93, 96], ["cFLIP", "PROTEIN", 158, 163], ["Hepatitis B virus", "SPECIES", 37, 54], ["Hepatitis B virus", "SPECIES", 37, 54], ["the viral protein Hepatitis B virus x (HBx) sensitizes host cells", "TREATMENT", 19, 84], ["TNF", "TEST", 93, 96], ["lines", "OBSERVATION", 12, 17], ["viral protein Hepatitis", "OBSERVATION", 23, 46]]], ["Increasing body of literature supports the relevance of HIV induced apoptosis.", [["body", "ANATOMY", 11, 15], ["body", "ORGANISM_SUBDIVISION", 11, 15], ["HIV", "ORGANISM", 56, 59], ["HIV", "SPECIES", 56, 59], ["HIV induced apoptosis", "PROBLEM", 56, 77]]], ["In infected individuals, the progressive depletion of CD4 T lymphocytes is observed over the period of 5\u201310 years, which leads to opportunistic infections and malignancies.", [["CD4 T lymphocytes", "ANATOMY", 54, 71], ["malignancies", "ANATOMY", 159, 171], ["opportunistic infections", "DISEASE", 130, 154], ["malignancies", "DISEASE", 159, 171], ["CD4 T", "GENE_OR_GENE_PRODUCT", 54, 59], ["malignancies", "CANCER", 159, 171], ["CD4 T lymphocytes", "CELL_TYPE", 54, 71], ["the progressive depletion", "PROBLEM", 25, 50], ["CD4 T lymphocytes", "PROBLEM", 54, 71], ["opportunistic infections", "PROBLEM", 130, 154], ["malignancies", "PROBLEM", 159, 171], ["infected", "OBSERVATION_MODIFIER", 3, 11], ["progressive", "OBSERVATION_MODIFIER", 29, 40], ["depletion", "OBSERVATION_MODIFIER", 41, 50], ["CD4 T lymphocytes", "OBSERVATION", 54, 71], ["opportunistic", "OBSERVATION_MODIFIER", 130, 143], ["infections", "OBSERVATION", 144, 154], ["malignancies", "OBSERVATION", 159, 171]]], ["Several HIV viral proteins exert pro-apoptotic or apoptosis sensitizing properties by increasing the expression of death ligands and DRs, including the envelope protein glycoprotein 120 and the transactivator of transcription (Tat) (reviewed in details elsewhere: [20]).", [["death", "DISEASE", 115, 120], ["DRs", "GENE_OR_GENE_PRODUCT", 133, 136], ["envelope protein glycoprotein 120", "GENE_OR_GENE_PRODUCT", 152, 185], ["Tat", "GENE_OR_GENE_PRODUCT", 227, 230], ["HIV viral proteins", "PROTEIN", 8, 26], ["death ligands", "PROTEIN", 115, 128], ["DRs", "PROTEIN", 133, 136], ["envelope protein glycoprotein 120", "PROTEIN", 152, 185], ["transactivator of transcription", "PROTEIN", 194, 225], ["Tat", "PROTEIN", 227, 230], ["HIV", "SPECIES", 8, 11], ["Several HIV viral proteins", "PROBLEM", 0, 26], ["apoptosis sensitizing properties", "PROBLEM", 50, 82], ["death ligands", "PROBLEM", 115, 128], ["the envelope protein glycoprotein", "TEST", 148, 181], ["pro-apoptotic", "OBSERVATION_MODIFIER", 33, 46]]], ["Interestingly, the protease of HIV, encoded by the pol gene is capable to directly process caspase-8 in order to produce a catalytically active caspase leading to BAK activation and mitochondrial apoptosis [21,22].Virus infection-induced apoptosis by viral RNA and DNA fragments ::: ApoptosisApart from the significant role of immune response-driven cell death, it has been observed that activation of PRRs could lead to direct -cell autonomous- apoptosis initiation.", [["mitochondrial", "ANATOMY", 182, 195], ["cell", "ANATOMY", 350, 354], ["cell", "ANATOMY", 429, 433], ["Virus infection", "DISEASE", 214, 229], ["HIV", "ORGANISM", 31, 34], ["pol", "GENE_OR_GENE_PRODUCT", 51, 54], ["caspase-8", "GENE_OR_GENE_PRODUCT", 91, 100], ["caspase", "GENE_OR_GENE_PRODUCT", 144, 151], ["BAK", "GENE_OR_GENE_PRODUCT", 163, 166], ["mitochondrial", "CELLULAR_COMPONENT", 182, 195], ["Virus", "ORGANISM", 214, 219], ["DNA", "CELLULAR_COMPONENT", 265, 268], ["cell", "CELL", 350, 354], ["PRRs", "GENE_OR_GENE_PRODUCT", 402, 406], ["cell", "CELL", 429, 433], ["protease", "PROTEIN", 19, 27], ["pol gene", "DNA", 51, 59], ["caspase-8", "PROTEIN", 91, 100], ["catalytically active caspase", "PROTEIN", 123, 151], ["BAK", "PROTEIN", 163, 166], ["viral RNA", "RNA", 251, 260], ["DNA fragments", "DNA", 265, 278], ["PRRs", "PROTEIN", 402, 406], ["HIV", "SPECIES", 31, 34], ["HIV", "PROBLEM", 31, 34], ["caspase", "TEST", 91, 98], ["a catalytically active caspase", "TREATMENT", 121, 151], ["BAK activation", "PROBLEM", 163, 177], ["mitochondrial apoptosis", "PROBLEM", 182, 205], ["Virus infection", "PROBLEM", 214, 229], ["induced apoptosis", "PROBLEM", 230, 247], ["viral RNA", "PROBLEM", 251, 260], ["ApoptosisApart", "TREATMENT", 283, 297], ["immune response", "PROBLEM", 327, 342], ["driven cell death", "PROBLEM", 343, 360], ["PRRs", "PROBLEM", 402, 406], ["mitochondrial apoptosis", "OBSERVATION", 182, 205], ["infection", "OBSERVATION", 220, 229], ["viral RNA", "OBSERVATION", 251, 260]]], ["The group of RNA viruses (also termed: Riboviruses) comprises diverse pathogens that possess either double stranded RNA (dsRNA) (e.g.: Rotaviruses) or single stranded RNA (e.g.: Filoviruses) as genetic material.", [["Rotaviruses", "GENE_OR_GENE_PRODUCT", 135, 146], ["Filoviruses", "GENE_OR_GENE_PRODUCT", 178, 189], ["double stranded RNA", "RNA", 100, 119], ["dsRNA", "RNA", 121, 126], ["single stranded RNA", "RNA", 151, 170], ["RNA viruses", "PROBLEM", 13, 24], ["Riboviruses", "PROBLEM", 39, 50], ["diverse pathogens", "PROBLEM", 62, 79], ["double stranded RNA (dsRNA)", "PROBLEM", 100, 127], ["Rotaviruses", "PROBLEM", 135, 146], ["single stranded RNA", "PROBLEM", 151, 170], ["Filoviruses", "PROBLEM", 178, 189], ["RNA viruses", "OBSERVATION", 13, 24], ["double", "OBSERVATION_MODIFIER", 100, 106], ["stranded RNA", "OBSERVATION", 107, 119]]], ["Since the spatial distribution and also the structure of a viral RNA (vRNA) can be distinct from that of the host RNA, thus vRNAs fit well in the definition of PAMPs.", [["vRNAs", "GENE_OR_GENE_PRODUCT", 124, 129], ["PAMPs", "GENE_OR_GENE_PRODUCT", 160, 165], ["viral RNA", "RNA", 59, 68], ["vRNA", "RNA", 70, 74], ["host RNA", "RNA", 109, 117], ["vRNAs", "PROTEIN", 124, 129], ["PAMPs", "PROTEIN", 160, 165], ["a viral RNA (vRNA", "PROBLEM", 57, 74], ["spatial", "OBSERVATION_MODIFIER", 10, 17], ["distribution", "OBSERVATION_MODIFIER", 18, 30], ["viral RNA", "OBSERVATION", 59, 68], ["host RNA", "OBSERVATION", 109, 117]]], ["For instance, vRNAs are often di or tri-phosphorylated and they lack a 7-methylguanosine cap [23].", [["7-methylguanosine", "CHEMICAL", 71, 88], ["7-methylguanosine", "CHEMICAL", 71, 88], ["vRNAs", "GENE_OR_GENE_PRODUCT", 14, 19], ["vRNAs", "PROTEIN", 14, 19], ["a 7-methylguanosine cap", "TREATMENT", 69, 92]]], ["Detection of vRNAs takes place by different PRRs depending on the localization of the vRNA fragments.Virus infection-induced apoptosis by viral RNA and DNA fragments ::: ApoptosisIntracellular dsRNA fragments which are produced during virus replication are recognized in the cytosol by two caspase recruitment domain (CARD) containing RNA helicases: retinoic acid inducible gene-I (RIG-I) and melanoma differentiation-associated gene-5 (MDA-5) [24].", [["Intracellular", "ANATOMY", 179, 192], ["cytosol", "ANATOMY", 275, 282], ["melanoma", "ANATOMY", 393, 401], ["Virus infection", "DISEASE", 101, 116], ["retinoic acid", "CHEMICAL", 350, 363], ["retinoic acid", "CHEMICAL", 350, 363], ["vRNAs", "GENE_OR_GENE_PRODUCT", 13, 18], ["Virus", "ORGANISM", 101, 106], ["DNA", "CELLULAR_COMPONENT", 152, 155], ["cytosol", "CELLULAR_COMPONENT", 275, 282], ["caspase", "GENE_OR_GENE_PRODUCT", 290, 297], ["CARD", "GENE_OR_GENE_PRODUCT", 318, 322], ["retinoic acid inducible gene-I", "GENE_OR_GENE_PRODUCT", 350, 380], ["RIG-I", "GENE_OR_GENE_PRODUCT", 382, 387], ["melanoma differentiation-associated gene-5", "GENE_OR_GENE_PRODUCT", 393, 435], ["MDA-5", "GENE_OR_GENE_PRODUCT", 437, 442], ["vRNAs", "PROTEIN", 13, 18], ["PRRs", "PROTEIN", 44, 48], ["vRNA fragments", "DNA", 86, 100], ["viral RNA", "RNA", 138, 147], ["DNA fragments", "DNA", 152, 165], ["caspase recruitment domain", "PROTEIN", 290, 316], ["CARD", "PROTEIN", 318, 322], ["RNA helicases", "PROTEIN", 335, 348], ["retinoic acid inducible gene-I", "DNA", 350, 380], ["RIG-I", "DNA", 382, 387], ["melanoma differentiation-associated gene-5", "DNA", 393, 435], ["MDA", "DNA", 437, 440], ["vRNAs", "TEST", 13, 18], ["the vRNA fragments", "PROBLEM", 82, 100], ["Virus infection", "PROBLEM", 101, 116], ["induced apoptosis", "PROBLEM", 117, 134], ["viral RNA", "PROBLEM", 138, 147], ["ApoptosisIntracellular dsRNA fragments", "PROBLEM", 170, 208], ["virus replication", "TREATMENT", 235, 252], ["two caspase recruitment domain", "TREATMENT", 286, 316], ["RNA helicases", "TEST", 335, 348], ["retinoic acid inducible gene", "TEST", 350, 378], ["melanoma differentiation", "PROBLEM", 393, 417], ["MDA", "TEST", 437, 440], ["vRNA fragments", "OBSERVATION", 86, 100], ["infection", "OBSERVATION", 107, 116], ["viral RNA", "OBSERVATION", 138, 147], ["dsRNA fragments", "OBSERVATION", 193, 208], ["melanoma", "OBSERVATION", 393, 401]]], ["RIG-I activation by vRNAs leads to ATP-dependent conformational changes and enables tetramer formation [25], which via CARD-CARD homotypic interactions results in the recruitment of mitochondrial antiviral-signalling (MAVS), an adaptor protein associated with the mitochondrial membrane (Fig. 1.).", [["mitochondrial", "ANATOMY", 182, 195], ["mitochondrial membrane", "ANATOMY", 264, 286], ["ATP", "CHEMICAL", 35, 38], ["ATP", "CHEMICAL", 35, 38], ["RIG-I", "GENE_OR_GENE_PRODUCT", 0, 5], ["vRNAs", "GENE_OR_GENE_PRODUCT", 20, 25], ["ATP", "SIMPLE_CHEMICAL", 35, 38], ["CARD", "GENE_OR_GENE_PRODUCT", 119, 123], ["CARD", "GENE_OR_GENE_PRODUCT", 124, 128], ["mitochondrial", "CELLULAR_COMPONENT", 182, 195], ["MAVS", "GENE_OR_GENE_PRODUCT", 218, 222], ["mitochondrial membrane", "CELLULAR_COMPONENT", 264, 286], ["RIG", "PROTEIN", 0, 3], ["vRNAs", "PROTEIN", 20, 25], ["CARD", "PROTEIN", 119, 123], ["CARD", "PROTEIN", 124, 128], ["MAVS", "PROTEIN", 218, 222], ["adaptor protein", "PROTEIN", 228, 243], ["ATP", "TEST", 35, 38], ["dependent conformational changes", "PROBLEM", 39, 71], ["mitochondrial antiviral", "TREATMENT", 182, 205], ["signalling (MAVS", "PROBLEM", 206, 222], ["an adaptor protein", "PROBLEM", 225, 243], ["the mitochondrial membrane", "TREATMENT", 260, 286], ["mitochondrial antiviral", "OBSERVATION", 182, 205], ["mitochondrial membrane", "OBSERVATION", 264, 286]]], ["At this point MAVS forms aggregates providing scaffold for multiple binding partners [26] and can bifurcate into two main pathways leading to activation of transcription factors interferon regulatory factor-3 (IRF-3) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF\u1d0bB) [27].", [["B cells", "ANATOMY", 276, 283], ["MAVS", "GENE_OR_GENE_PRODUCT", 14, 18], ["interferon regulatory factor-3", "GENE_OR_GENE_PRODUCT", 178, 208], ["IRF-3", "GENE_OR_GENE_PRODUCT", 210, 215], ["kappa-light-chain-enhancer of activated B cells", "GENE_OR_GENE_PRODUCT", 236, 283], ["NF\u1d0bB", "GENE_OR_GENE_PRODUCT", 285, 289], ["MAVS", "PROTEIN", 14, 18], ["transcription factors", "PROTEIN", 156, 177], ["interferon regulatory factor-3 (IRF-3", "PROTEIN", 178, 215], ["nuclear factor kappa-light-chain-enhancer of activated B cells", "PROTEIN", 221, 283], ["NF\u1d0bB", "PROTEIN", 285, 289], ["transcription factors", "PROBLEM", 156, 177], ["interferon regulatory factor", "TEST", 178, 206], ["IRF", "TEST", 210, 213], ["nuclear factor kappa-light", "TEST", 221, 247], ["activated B cells", "PROBLEM", 266, 283]]], ["In the IRF-3 branch of the RIG-I pathway, TNFR associated factor-3 (TRAF-3) interacts with MAVS, which results in the recruitment of a protein complex comprising TRAF family member-associated NFkB activator (TANK), NFkB essential modulator (NEMO), inhibitor of kappa B kinase-\u03b5 (IKK\u025b) and TANK binding kinase-1 (TBK1) and subsequent phosphorylation, dimerization and translocation to the nucleus of both IRF-3 and IRF-7 [28] (Fig. 1).", [["nucleus", "ANATOMY", 388, 395], ["IRF-3", "GENE_OR_GENE_PRODUCT", 7, 12], ["RIG-I", "GENE_OR_GENE_PRODUCT", 27, 32], ["TNFR associated factor-3", "GENE_OR_GENE_PRODUCT", 42, 66], ["TRAF-3", "GENE_OR_GENE_PRODUCT", 68, 74], ["MAVS", "GENE_OR_GENE_PRODUCT", 91, 95], ["TRAF family member-associated NFkB activator", "GENE_OR_GENE_PRODUCT", 162, 206], ["TANK", "GENE_OR_GENE_PRODUCT", 208, 212], ["NFkB", "GENE_OR_GENE_PRODUCT", 215, 219], ["NEMO", "GENE_OR_GENE_PRODUCT", 241, 245], ["inhibitor of kappa B kinase-\u03b5", "GENE_OR_GENE_PRODUCT", 248, 277], ["IKK\u025b", "GENE_OR_GENE_PRODUCT", 279, 283], ["TANK binding kinase-1", "GENE_OR_GENE_PRODUCT", 289, 310], ["TBK1", "GENE_OR_GENE_PRODUCT", 312, 316], ["nucleus", "CELLULAR_COMPONENT", 388, 395], ["IRF-3", "GENE_OR_GENE_PRODUCT", 404, 409], ["IRF-7", "GENE_OR_GENE_PRODUCT", 414, 419], ["IRF", "PROTEIN", 7, 10], ["RIG", "PROTEIN", 27, 30], ["TNFR associated factor-3 (TRAF-3", "PROTEIN", 42, 74], ["MAVS", "PROTEIN", 91, 95], ["protein complex", "PROTEIN", 135, 150], ["TRAF family member", "PROTEIN", 162, 180], ["NFkB activator", "PROTEIN", 192, 206], ["TANK", "PROTEIN", 208, 212], ["NFkB essential modulator", "PROTEIN", 215, 239], ["NEMO", "PROTEIN", 241, 245], ["inhibitor of kappa B kinase", "PROTEIN", 248, 275], ["\u03b5", "PROTEIN", 276, 277], ["IKK\u025b", "PROTEIN", 279, 283], ["TANK binding kinase-1", "PROTEIN", 289, 310], ["TBK1", "PROTEIN", 312, 316], ["IRF", "PROTEIN", 404, 407], ["IRF", "PROTEIN", 414, 417], ["TNFR associated factor", "PROBLEM", 42, 64], ["MAVS", "PROBLEM", 91, 95], ["kappa B kinase", "TEST", 261, 275], ["IKK", "TEST", 279, 282], ["TANK binding kinase", "TEST", 289, 308], ["subsequent phosphorylation, dimerization", "PROBLEM", 322, 362], ["IRF", "TEST", 404, 407], ["IRF", "TEST", 414, 417], ["3 branch", "ANATOMY_MODIFIER", 11, 19], ["IRF", "OBSERVATION", 404, 407]]], ["Induction of IRF-3 primarily leads to the production of immunomodulatory molecules as Type I and III interferons (IFNs), which then renders the activation of CTLs, NK cells and initiates targeted cell-killing as discussed earlier (Section 2.2).", [["CTLs", "ANATOMY", 158, 162], ["NK cells", "ANATOMY", 164, 172], ["cell", "ANATOMY", 196, 200], ["IRF-3", "GENE_OR_GENE_PRODUCT", 13, 18], ["Type I and III interferons", "GENE_OR_GENE_PRODUCT", 86, 112], ["IFNs", "GENE_OR_GENE_PRODUCT", 114, 118], ["CTLs", "CELL", 158, 162], ["NK cells", "CELL", 164, 172], ["cell", "CELL", 196, 200], ["IRF-3", "PROTEIN", 13, 18], ["immunomodulatory molecules", "PROTEIN", 56, 82], ["Type I and III interferons", "PROTEIN", 86, 112], ["IFNs", "PROTEIN", 114, 118], ["CTLs", "CELL_TYPE", 158, 162], ["NK cells", "CELL_TYPE", 164, 172], ["IRF", "PROBLEM", 13, 16], ["immunomodulatory molecules", "PROBLEM", 56, 82], ["Type I and III interferons (IFNs)", "PROBLEM", 86, 119], ["IRF", "OBSERVATION", 13, 16]]], ["Nonetheless, this process requires the external intervention of immune cells.Virus infection-induced apoptosis by viral RNA and DNA fragments ::: ApoptosisIn contrast, studies on cell lines highlight the existence of direct death-inducing mechanisms.", [["immune cells", "ANATOMY", 64, 76], ["cell lines", "ANATOMY", 179, 189], ["Virus infection", "DISEASE", 77, 92], ["death", "DISEASE", 224, 229], ["immune cells", "CELL", 64, 76], ["Virus", "ORGANISM", 77, 82], ["DNA", "CELLULAR_COMPONENT", 128, 131], ["cell lines", "CELL", 179, 189], ["immune cells", "CELL_TYPE", 64, 76], ["viral RNA", "RNA", 114, 123], ["DNA fragments", "DNA", 128, 141], ["cell lines", "CELL_LINE", 179, 189], ["the external intervention", "TREATMENT", 35, 60], ["immune cells", "PROBLEM", 64, 76], ["Virus infection", "PROBLEM", 77, 92], ["induced apoptosis", "PROBLEM", 93, 110], ["viral RNA", "PROBLEM", 114, 123], ["cell lines", "TREATMENT", 179, 189], ["direct death", "PROBLEM", 217, 229], ["immune cells", "OBSERVATION", 64, 76], ["infection", "OBSERVATION", 83, 92], ["viral RNA", "OBSERVATION", 114, 123]]], ["As for instance, IAV infected human epithelial cell lines undergo caspase-dependent cell death, which is prevented by genetic depletion of RIG-I [29].", [["epithelial cell lines", "ANATOMY", 36, 57], ["cell", "ANATOMY", 84, 88], ["death", "DISEASE", 89, 94], ["IAV", "ORGANISM", 17, 20], ["human", "ORGANISM", 30, 35], ["epithelial cell lines", "CELL", 36, 57], ["caspase", "GENE_OR_GENE_PRODUCT", 66, 73], ["cell", "CELL", 84, 88], ["RIG-I", "GENE_OR_GENE_PRODUCT", 139, 144], ["IAV infected human epithelial cell lines", "CELL_LINE", 17, 57], ["caspase", "PROTEIN", 66, 73], ["RIG", "PROTEIN", 139, 142], ["human", "SPECIES", 30, 35], ["IAV", "SPECIES", 17, 20], ["human", "SPECIES", 30, 35], ["IAV infected human epithelial cell lines", "TREATMENT", 17, 57], ["caspase", "PROBLEM", 66, 73], ["dependent cell death", "PROBLEM", 74, 94], ["epithelial cell lines", "OBSERVATION", 36, 57], ["dependent", "OBSERVATION_MODIFIER", 74, 83], ["cell death", "OBSERVATION", 84, 94]]], ["In Sendai virus infection the lack of IRF-3 leads to the loss of virus induced apoptosis sensitivity of the cells [30].", [["cells", "ANATOMY", 108, 113], ["Sendai virus infection", "DISEASE", 3, 25], ["Sendai virus", "ORGANISM", 3, 15], ["IRF-3", "GENE_OR_GENE_PRODUCT", 38, 43], ["cells", "CELL", 108, 113], ["IRF-3", "PROTEIN", 38, 43], ["Sendai virus", "SPECIES", 3, 15], ["Sendai virus", "SPECIES", 3, 15], ["Sendai virus infection", "PROBLEM", 3, 25], ["IRF", "PROBLEM", 38, 41], ["the loss of virus induced apoptosis sensitivity of the cells", "PROBLEM", 53, 113], ["Sendai virus infection", "OBSERVATION", 3, 25]]], ["Analogously, Semliki forest virus infection leads to MAVS induction and caspase-8 activation [31].", [["infection", "DISEASE", 34, 43], ["Semliki forest virus", "ORGANISM", 13, 33], ["MAVS", "GENE_OR_GENE_PRODUCT", 53, 57], ["caspase-8", "GENE_OR_GENE_PRODUCT", 72, 81], ["MAVS", "PROTEIN", 53, 57], ["caspase-8", "PROTEIN", 72, 81], ["Semliki forest virus", "SPECIES", 13, 33], ["Semliki forest virus infection", "PROBLEM", 13, 43], ["MAVS induction", "TREATMENT", 53, 67], ["caspase", "TREATMENT", 72, 79], ["Semliki", "OBSERVATION", 13, 20], ["forest virus", "OBSERVATION", 21, 33]]], ["RIG-I signalling leads to the expression of IFN-stimulated genes (ISGs) and this induces the intrinsic apoptosis pathway [32].", [["RIG-I", "GENE_OR_GENE_PRODUCT", 0, 5], ["IFN-stimulated genes", "GENE_OR_GENE_PRODUCT", 44, 64], ["ISGs", "GENE_OR_GENE_PRODUCT", 66, 70], ["RIG", "PROTEIN", 0, 3], ["IFN-stimulated genes", "DNA", 44, 64], ["ISGs", "DNA", 66, 70], ["the intrinsic apoptosis pathway", "PROBLEM", 89, 120]]], ["How exactly this apoptotic process is mediated is still poorly understood, however some studies provide hints about the possible mechanisms concerned, as for example the upregulation or activation of certain pro-apoptotic elements in a RIG-I dependent manner.", [["RIG-I", "GENE_OR_GENE_PRODUCT", 236, 241], ["pro-apoptotic elements", "DNA", 208, 230], ["some studies", "TEST", 83, 95], ["pro-apoptotic elements", "OBSERVATION", 208, 230], ["RIG-I dependent", "OBSERVATION_MODIFIER", 236, 251]]], ["Naturally occurring Vaccinia virus expresses a BCL-2 analogue anti-apoptotic protein called F1L.", [["Vaccinia virus", "ORGANISM", 20, 34], ["BCL-2", "GENE_OR_GENE_PRODUCT", 47, 52], ["F1L", "GENE_OR_GENE_PRODUCT", 92, 95], ["BCL-2 analogue anti-apoptotic protein", "PROTEIN", 47, 84], ["F1L", "PROTEIN", 92, 95], ["Vaccinia virus", "SPECIES", 20, 34], ["Vaccinia virus", "SPECIES", 20, 34], ["Vaccinia virus", "PROBLEM", 20, 34], ["a BCL", "TEST", 45, 50], ["Vaccinia virus", "OBSERVATION", 20, 34]]], ["In contrast, infection with a genetically engineered Vaccinia virus strain lacking the F1L triggers IRF-3 activation and expression of the pro-apoptotic Noxa (from latin: danger) in monocytes and macrophages [33].", [["monocytes", "ANATOMY", 182, 191], ["macrophages", "ANATOMY", 196, 207], ["infection", "DISEASE", 13, 22], ["Vaccinia virus strain", "ORGANISM", 53, 74], ["F1L", "GENE_OR_GENE_PRODUCT", 87, 90], ["IRF-3", "GENE_OR_GENE_PRODUCT", 100, 105], ["Noxa", "GENE_OR_GENE_PRODUCT", 153, 157], ["latin", "GENE_OR_GENE_PRODUCT", 164, 169], ["monocytes", "CELL", 182, 191], ["macrophages", "CELL", 196, 207], ["F1L", "PROTEIN", 87, 90], ["IRF-3", "PROTEIN", 100, 105], ["pro-apoptotic Noxa", "PROTEIN", 139, 157], ["monocytes", "CELL_TYPE", 182, 191], ["macrophages", "CELL_TYPE", 196, 207], ["Vaccinia virus", "SPECIES", 53, 67], ["Vaccinia virus", "SPECIES", 53, 67], ["infection", "PROBLEM", 13, 22], ["a genetically engineered Vaccinia virus strain", "PROBLEM", 28, 74], ["the pro-apoptotic Noxa", "PROBLEM", 135, 157], ["infection", "OBSERVATION", 13, 22], ["pro-apoptotic Noxa", "OBSERVATION", 139, 157], ["monocytes", "ANATOMY", 182, 191]]], ["One work highlights the transcriptionally-independent function of IRF-3 in inducing the mitochondrial translocation of pro-apoptotic BAX and the initiation of intrinsic apoptosis [34], yet the transcriptional function of IRF-3 remains the predominant feature in majority of the studies.", [["mitochondrial", "ANATOMY", 88, 101], ["IRF-3", "GENE_OR_GENE_PRODUCT", 66, 71], ["mitochondrial", "CELLULAR_COMPONENT", 88, 101], ["BAX", "GENE_OR_GENE_PRODUCT", 133, 136], ["IRF-3", "GENE_OR_GENE_PRODUCT", 221, 226], ["IRF-3", "PROTEIN", 66, 71], ["pro-apoptotic BAX", "PROTEIN", 119, 136], ["IRF-3", "PROTEIN", 221, 226], ["pro-apoptotic BAX", "TREATMENT", 119, 136], ["intrinsic apoptosis", "PROBLEM", 159, 178], ["the studies", "TEST", 274, 285], ["pro-apoptotic BAX", "OBSERVATION", 119, 136], ["IRF", "OBSERVATION", 221, 224]]], ["Along with this, IRF-3 dependent degradation of X-linked inhibitor of apoptosis (XIAP) delivers a potential link to virus induced apoptosis.", [["IRF-3", "GENE_OR_GENE_PRODUCT", 17, 22], ["X-linked inhibitor of apoptosis", "GENE_OR_GENE_PRODUCT", 48, 79], ["XIAP", "GENE_OR_GENE_PRODUCT", 81, 85], ["IRF-3", "PROTEIN", 17, 22], ["XIAP", "PROTEIN", 81, 85], ["IRF", "TEST", 17, 20], ["X-linked inhibitor", "PROBLEM", 48, 66], ["apoptosis (XIAP)", "PROBLEM", 70, 86], ["a potential link to virus induced apoptosis", "PROBLEM", 96, 139]]], ["XIAP is a potent antagonist of caspase-3, -7 and -9 dependent apoptotic signalling.", [["XIAP", "GENE_OR_GENE_PRODUCT", 0, 4], ["caspase-3", "GENE_OR_GENE_PRODUCT", 31, 40], ["-7", "GENE_OR_GENE_PRODUCT", 42, 44], ["-9", "GENE_OR_GENE_PRODUCT", 49, 51], ["XIAP", "PROTEIN", 0, 4], ["XIAP", "TEST", 0, 4], ["a potent antagonist of caspase", "TREATMENT", 8, 38]]], ["Sendai and Vesicular stomatitis virus (VSV) infection results in TBK1/IKK\u03b5-mediated phosphorylation of XIAP in vivo at Ser430, leading to auto-ubiquitination and proteasomal degradation of XIAP.", [["proteasomal", "ANATOMY", 162, 173], ["Vesicular stomatitis", "DISEASE", 11, 31], ["infection", "DISEASE", 44, 53], ["Sendai", "ORGANISM", 0, 6], ["Vesicular stomatitis virus", "ORGANISM", 11, 37], ["VSV", "ORGANISM", 39, 42], ["TBK1", "GENE_OR_GENE_PRODUCT", 65, 69], ["IKK", "GENE_OR_GENE_PRODUCT", 70, 73], ["\u03b5", "GENE_OR_GENE_PRODUCT", 73, 74], ["XIAP", "GENE_OR_GENE_PRODUCT", 103, 107], ["Ser430", "AMINO_ACID", 119, 125], ["XIAP", "GENE_OR_GENE_PRODUCT", 189, 193], ["TBK1", "PROTEIN", 65, 69], ["IKK\u03b5", "PROTEIN", 70, 74], ["XIAP", "PROTEIN", 103, 107], ["XIAP", "PROTEIN", 189, 193], ["Vesicular stomatitis virus", "SPECIES", 11, 37], ["Vesicular stomatitis virus", "SPECIES", 11, 37], ["VSV", "SPECIES", 39, 42], ["Sendai", "PROBLEM", 0, 6], ["Vesicular stomatitis virus (VSV) infection", "PROBLEM", 11, 53], ["TBK1", "TEST", 65, 69], ["IKK", "TEST", 70, 73], ["XIAP", "TREATMENT", 103, 107], ["auto-ubiquitination", "PROBLEM", 138, 157], ["proteasomal degradation of XIAP", "PROBLEM", 162, 193], ["Vesicular stomatitis virus", "OBSERVATION", 11, 37], ["proteasomal degradation", "OBSERVATION", 162, 185]]], ["Given the multiple (~30) binding partners of aggregated MAVS [28] and a CARD domain structure highly similar to that of CARD of caspases it can be speculated that MAVS in certain conditions might recruit caspases with a CARD domain (e.g.: caspase-9 and -2), however this has not been investigated yet.Virus infection-induced apoptosis by viral RNA and DNA fragments ::: ApoptosisExtracellular vRNA detection is accomplished by toll-like receptor-3 (TLR3), located in cytoplasm membranes and endosomal compartments [35].", [["Extracellular", "ANATOMY", 379, 392], ["cytoplasm membranes", "ANATOMY", 467, 486], ["endosomal compartments", "ANATOMY", 491, 513], ["Virus infection", "DISEASE", 301, 316], ["MAVS", "GENE_OR_GENE_PRODUCT", 56, 60], ["CARD", "GENE_OR_GENE_PRODUCT", 120, 124], ["caspases", "GENE_OR_GENE_PRODUCT", 128, 136], ["MAVS", "GENE_OR_GENE_PRODUCT", 163, 167], ["caspases", "GENE_OR_GENE_PRODUCT", 204, 212], ["caspase-9", "GENE_OR_GENE_PRODUCT", 239, 248], ["-2", "GENE_OR_GENE_PRODUCT", 253, 255], ["Virus", "ORGANISM", 301, 306], ["DNA", "CELLULAR_COMPONENT", 352, 355], ["toll-like receptor-3", "GENE_OR_GENE_PRODUCT", 427, 447], ["TLR3", "GENE_OR_GENE_PRODUCT", 449, 453], ["cytoplasm membranes", "CELLULAR_COMPONENT", 467, 486], ["endosomal compartments", "CELLULAR_COMPONENT", 491, 513], ["MAVS", "PROTEIN", 56, 60], ["CARD domain structure", "PROTEIN", 72, 93], ["CARD", "PROTEIN", 120, 124], ["caspases", "PROTEIN", 128, 136], ["MAVS", "PROTEIN", 163, 167], ["caspases", "PROTEIN", 204, 212], ["CARD domain", "PROTEIN", 220, 231], ["caspase-9 and -2", "PROTEIN", 239, 255], ["viral RNA", "RNA", 338, 347], ["DNA fragments", "DNA", 352, 365], ["toll-like receptor-3", "PROTEIN", 427, 447], ["TLR3", "PROTEIN", 449, 453], ["aggregated MAVS", "PROBLEM", 45, 60], ["a CARD domain structure", "PROBLEM", 70, 93], ["caspases", "TREATMENT", 128, 136], ["MAVS", "PROBLEM", 163, 167], ["caspase", "TEST", 239, 246], ["Virus infection", "PROBLEM", 301, 316], ["induced apoptosis", "PROBLEM", 317, 334], ["viral RNA", "PROBLEM", 338, 347], ["Apoptosis", "PROBLEM", 370, 379], ["Extracellular vRNA detection", "TEST", 379, 407], ["infection", "OBSERVATION", 307, 316], ["viral RNA", "OBSERVATION", 338, 347], ["Extracellular vRNA", "OBSERVATION", 379, 397], ["cytoplasm membranes", "OBSERVATION", 467, 486], ["endosomal compartments", "OBSERVATION", 491, 513]]], ["TLR3 recruits IKK via the adaptor protein Toll/interleukin-1 receptor (TIR) and leads to the activation of transcription factor NFkB [36] and results in the induction of IRF-3.", [["TLR3", "GENE_OR_GENE_PRODUCT", 0, 4], ["IKK", "GENE_OR_GENE_PRODUCT", 14, 17], ["Toll/interleukin-1 receptor", "GENE_OR_GENE_PRODUCT", 42, 69], ["TIR", "GENE_OR_GENE_PRODUCT", 71, 74], ["NFkB [36]", "GENE_OR_GENE_PRODUCT", 128, 137], ["IRF-3", "GENE_OR_GENE_PRODUCT", 170, 175], ["TLR3", "PROTEIN", 0, 4], ["IKK", "PROTEIN", 14, 17], ["adaptor protein Toll/interleukin-1 receptor", "PROTEIN", 26, 69], ["TIR", "PROTEIN", 71, 74], ["transcription factor", "PROTEIN", 107, 127], ["NFkB [36]", "PROTEIN", 128, 137], ["IRF-3", "PROTEIN", 170, 175], ["the adaptor protein", "TREATMENT", 22, 41], ["interleukin-1 receptor (TIR", "TREATMENT", 47, 74], ["transcription factor NFkB", "TEST", 107, 132], ["IRF", "TEST", 170, 173]]], ["In addition, TLR3 stimulation by IAV can lead to the assembly of a DISC-like complex containing TRIF, RIPK1, FADD, cFLIP and caspase-8 (Fig. 1) [37,38].", [["TLR3", "GENE_OR_GENE_PRODUCT", 13, 17], ["IAV", "ORGANISM", 33, 36], ["DISC", "GENE_OR_GENE_PRODUCT", 67, 71], ["TRIF", "GENE_OR_GENE_PRODUCT", 96, 100], ["RIPK1", "GENE_OR_GENE_PRODUCT", 102, 107], ["FADD", "GENE_OR_GENE_PRODUCT", 109, 113], ["cFLIP", "GENE_OR_GENE_PRODUCT", 115, 120], ["caspase-8", "GENE_OR_GENE_PRODUCT", 125, 134], ["TLR3", "PROTEIN", 13, 17], ["DISC", "PROTEIN", 67, 71], ["TRIF", "PROTEIN", 96, 100], ["RIPK1", "PROTEIN", 102, 107], ["FADD", "PROTEIN", 109, 113], ["cFLIP", "PROTEIN", 115, 120], ["caspase-8", "PROTEIN", 125, 134], ["TLR3 stimulation", "TREATMENT", 13, 29], ["IAV", "PROBLEM", 33, 36], ["a DISC-like complex containing TRIF", "PROBLEM", 65, 100], ["RIPK1", "TEST", 102, 107], ["FADD", "TEST", 109, 113], ["cFLIP", "TEST", 115, 120], ["caspase", "TEST", 125, 132], ["DISC", "ANATOMY", 67, 71], ["cFLIP", "ANATOMY", 115, 120]]], ["In this setting the concentration of anti-apoptotic cFLIP isoforms determine, whether caspase-8 acts as an apoptotic initiator, since the formation of cFLIP/caspase-8 heterodimers works against the apoptotic homodimer formation of caspase-8.Virus infection-induced apoptosis by viral RNA and DNA fragments ::: ApoptosisViral DNA in the cytosol triggers also alarm signals, since the DNA in its normal condition resides exclusively in the cell nucleus.", [["cytosol", "ANATOMY", 336, 343], ["cell nucleus", "ANATOMY", 438, 450], ["Virus infection", "DISEASE", 241, 256], ["cFLIP", "GENE_OR_GENE_PRODUCT", 52, 57], ["caspase-8", "GENE_OR_GENE_PRODUCT", 86, 95], ["cFLIP", "GENE_OR_GENE_PRODUCT", 151, 156], ["caspase-8", "GENE_OR_GENE_PRODUCT", 157, 166], ["caspase-8", "GENE_OR_GENE_PRODUCT", 231, 240], ["Virus", "ORGANISM", 241, 246], ["DNA", "CELLULAR_COMPONENT", 292, 295], ["ApoptosisViral", "CELLULAR_COMPONENT", 310, 324], ["DNA", "CELLULAR_COMPONENT", 325, 328], ["cytosol", "CELLULAR_COMPONENT", 336, 343], ["DNA", "CELLULAR_COMPONENT", 383, 386], ["cell nucleus", "CELLULAR_COMPONENT", 438, 450], ["anti-apoptotic cFLIP isoforms", "PROTEIN", 37, 66], ["caspase-8", "PROTEIN", 86, 95], ["cFLIP", "PROTEIN", 151, 156], ["caspase-8 heterodimers", "PROTEIN", 157, 179], ["caspase-8", "PROTEIN", 231, 240], ["viral RNA", "RNA", 278, 287], ["DNA fragments", "DNA", 292, 305], ["ApoptosisViral DNA", "DNA", 310, 328], ["anti-apoptotic cFLIP isoforms", "TREATMENT", 37, 66], ["caspase", "TEST", 86, 93], ["an apoptotic initiator", "TREATMENT", 104, 126], ["cFLIP/caspase-8 heterodimers", "TREATMENT", 151, 179], ["caspase", "TEST", 231, 238], ["Virus infection", "PROBLEM", 241, 256], ["induced apoptosis", "PROBLEM", 257, 274], ["viral RNA", "PROBLEM", 278, 287], ["ApoptosisViral DNA", "PROBLEM", 310, 328], ["the cytosol triggers", "TEST", 332, 352], ["alarm signals", "TEST", 358, 371], ["the DNA", "TEST", 379, 386], ["infection", "OBSERVATION", 247, 256], ["viral RNA", "OBSERVATION", 278, 287], ["alarm signals", "OBSERVATION", 358, 371], ["normal condition", "OBSERVATION", 394, 410], ["cell nucleus", "OBSERVATION", 438, 450]]], ["The cyclic GMP-AMP (cGAMP) synthase (cGAS) exerts DNA binding activity, and upon binding produces cGAMP leading to the activation of protein stimulator of interferon gene (STING) (Fig. 1).", [["GMP", "CHEMICAL", 11, 14], ["AMP", "CHEMICAL", 15, 18], ["cGAMP", "CHEMICAL", 20, 25], ["cGAMP", "CHEMICAL", 98, 103], ["cyclic GMP-AMP", "CHEMICAL", 4, 18], ["cGAMP", "CHEMICAL", 20, 25], ["cyclic GMP-AMP (cGAMP) synthase", "GENE_OR_GENE_PRODUCT", 4, 35], ["cGAS", "SIMPLE_CHEMICAL", 37, 41], ["DNA", "CELLULAR_COMPONENT", 50, 53], ["cGAMP", "GENE_OR_GENE_PRODUCT", 98, 103], ["protein stimulator of interferon gene", "GENE_OR_GENE_PRODUCT", 133, 170], ["STING", "GENE_OR_GENE_PRODUCT", 172, 177], ["cyclic GMP-AMP (cGAMP) synthase", "PROTEIN", 4, 35], ["cGAS", "PROTEIN", 37, 41], ["cGAMP", "PROTEIN", 98, 103], ["interferon gene", "DNA", 155, 170], ["STING", "PROTEIN", 172, 177], ["The cyclic GMP", "TEST", 0, 14], ["AMP (cGAMP) synthase (cGAS", "TEST", 15, 41], ["DNA binding activity", "PROBLEM", 50, 70], ["cGAMP", "TREATMENT", 98, 103], ["protein stimulator of interferon gene", "TREATMENT", 133, 170]]], ["As a consequence, STING induces IRF-3 activation [39] [40] and intrinsic apoptosis [41].", [["STING", "GENE_OR_GENE_PRODUCT", 18, 23], ["IRF-3", "GENE_OR_GENE_PRODUCT", 32, 37], ["STING", "PROTEIN", 18, 23], ["IRF-3", "PROTEIN", 32, 37], ["IRF", "TEST", 32, 35], ["intrinsic apoptosis", "PROBLEM", 63, 82]]], ["It is expected that the release of mitochondrial DNA (mtDNA) into the cytosol have similar consequences and can unleash cGAS driven IRF-3 activation.", [["mitochondrial", "ANATOMY", 35, 48], ["cytosol", "ANATOMY", 70, 77], ["mitochondrial DNA", "CELLULAR_COMPONENT", 35, 52], ["mtDNA", "CELLULAR_COMPONENT", 54, 59], ["cytosol", "CELLULAR_COMPONENT", 70, 77], ["cGAS", "GENE_OR_GENE_PRODUCT", 120, 124], ["IRF-3", "GENE_OR_GENE_PRODUCT", 132, 137], ["mitochondrial DNA", "DNA", 35, 52], ["cGAS", "PROTEIN", 120, 124], ["IRF-3", "PROTEIN", 132, 137], ["mitochondrial DNA (mtDNA)", "TREATMENT", 35, 60]]], ["Intriguingly, apoptotic caspases suppress the STING mediated Interferon production [42] and studies on mice demonstrate that apoptotic caspases can cleave anti-viral sensors, including cGAS, MAVS and IRF-3 in order to reduce type I IFN production, indicating that caspase-dependent apoptosis might also contribute to virus propagation [43], but also suggests a negative feedback loop in controlling IFN production.Virus infection-induced apoptosis by viral RNA and DNA fragments ::: ApoptosisThe most of the PAMP detection mechanisms which lead to apoptosis culminate in IRF-3 activation highlighting the significance of IRF-3 in virus-induced apoptosis.", [["Virus infection", "DISEASE", 414, 429], ["caspases", "GENE_OR_GENE_PRODUCT", 24, 32], ["STING", "GENE_OR_GENE_PRODUCT", 46, 51], ["Interferon", "GENE_OR_GENE_PRODUCT", 61, 71], ["mice", "ORGANISM", 103, 107], ["caspases", "GENE_OR_GENE_PRODUCT", 135, 143], ["cGAS", "GENE_OR_GENE_PRODUCT", 185, 189], ["MAVS", "GENE_OR_GENE_PRODUCT", 191, 195], ["IRF-3", "GENE_OR_GENE_PRODUCT", 200, 205], ["type I IFN", "GENE_OR_GENE_PRODUCT", 225, 235], ["caspase", "GENE_OR_GENE_PRODUCT", 264, 271], ["IFN", "GENE_OR_GENE_PRODUCT", 399, 402], ["Virus", "ORGANISM", 414, 419], ["DNA", "CELLULAR_COMPONENT", 465, 468], ["PAMP", "GENE_OR_GENE_PRODUCT", 508, 512], ["IRF-3", "GENE_OR_GENE_PRODUCT", 571, 576], ["IRF-3", "GENE_OR_GENE_PRODUCT", 621, 626], ["apoptotic caspases", "PROTEIN", 14, 32], ["STING", "PROTEIN", 46, 51], ["Interferon", "PROTEIN", 61, 71], ["apoptotic caspases", "PROTEIN", 125, 143], ["cGAS", "PROTEIN", 185, 189], ["MAVS", "PROTEIN", 191, 195], ["IRF-3", "PROTEIN", 200, 205], ["IFN", "PROTEIN", 232, 235], ["caspase", "PROTEIN", 264, 271], ["IFN", "PROTEIN", 399, 402], ["viral RNA", "RNA", 451, 460], ["DNA fragments", "DNA", 465, 478], ["IRF-3", "PROTEIN", 571, 576], ["IRF-3", "PROTEIN", 621, 626], ["mice", "SPECIES", 103, 107], ["mice", "SPECIES", 103, 107], ["apoptotic caspases", "TREATMENT", 14, 32], ["the STING mediated Interferon production", "TREATMENT", 42, 82], ["apoptotic caspases", "TREATMENT", 125, 143], ["anti-viral sensors", "TREATMENT", 155, 173], ["cGAS", "TEST", 185, 189], ["MAVS", "PROBLEM", 191, 195], ["IRF", "TEST", 200, 203], ["type I IFN production", "PROBLEM", 225, 246], ["caspase-dependent apoptosis", "PROBLEM", 264, 291], ["virus propagation", "PROBLEM", 317, 334], ["a negative feedback loop in controlling IFN production", "PROBLEM", 359, 413], ["Virus infection", "PROBLEM", 414, 429], ["induced apoptosis", "PROBLEM", 430, 447], ["viral RNA", "PROBLEM", 451, 460], ["Apoptosis", "PROBLEM", 483, 492], ["the PAMP detection mechanisms", "PROBLEM", 504, 533], ["apoptosis", "PROBLEM", 548, 557], ["IRF", "TEST", 571, 574], ["IRF", "PROBLEM", 621, 624], ["apoptosis", "PROBLEM", 644, 653], ["apoptotic caspases", "OBSERVATION", 14, 32], ["negative", "OBSERVATION", 361, 369], ["feedback loop", "OBSERVATION", 370, 383], ["infection", "OBSERVATION", 420, 429], ["viral RNA", "OBSERVATION", 451, 460], ["IRF", "OBSERVATION", 621, 624], ["apoptosis", "OBSERVATION", 644, 653]]], ["Still, the mechanism, by which IRF-3 triggers cell death signalling pathways is only partially understood and the studies indicate a strong cell type specificity in the apoptosis sensitivity in response to viral PAMPs.Virus infection-induced apoptosis by viral RNA and DNA fragments ::: Apoptosis", [["cell", "ANATOMY", 46, 50], ["cell", "ANATOMY", 140, 144], ["death", "DISEASE", 51, 56], ["Virus infection", "DISEASE", 218, 233], ["IRF-3", "GENE_OR_GENE_PRODUCT", 31, 36], ["cell", "CELL", 46, 50], ["cell", "CELL", 140, 144], ["Virus", "ORGANISM", 218, 223], ["DNA", "CELLULAR_COMPONENT", 269, 272], ["IRF-3", "PROTEIN", 31, 36], ["viral PAMPs", "PROTEIN", 206, 217], ["viral RNA", "RNA", 255, 264], ["DNA fragments", "DNA", 269, 282], ["cell death signalling pathways", "PROBLEM", 46, 76], ["the studies", "TEST", 110, 121], ["the apoptosis sensitivity", "PROBLEM", 165, 190], ["viral PAMPs", "PROBLEM", 206, 217], ["Virus infection", "PROBLEM", 218, 233], ["induced apoptosis", "PROBLEM", 234, 251], ["viral RNA", "PROBLEM", 255, 264], ["Apoptosis", "PROBLEM", 287, 296], ["viral PAMPs", "OBSERVATION", 206, 217], ["infection", "OBSERVATION", 224, 233], ["viral RNA", "OBSERVATION", 255, 264]]]], "a07d068eba6119be003af526a8a0d6e246a92148": [["Aus allen cytologischen Beobachtungen schlie\u00dfen wir, dass die Chromosomen, und damit die Gene, in Mitose und Meiose gleichm\u00e4\u00dfig auf die Tochterzellen verteilt werden.", [["Aus allen cytologischen Beobachtungen schlie\u00dfen wir, dass die Chromosomen, und damit die Gene, in Mitose und Meiose gleichm\u00e4\u00dfig auf die Tochterzellen verteilt werden", "SPECIES", 0, 165]]], ["Dazu werden die Centromerenbereiche der Chromosomen benutzt, die als Ansatzpunkte f\u00fcr die Mikrotubuli des Spindelapparates dienen.", [["Dazu werden die Centromerenbereiche der Chromosomen benutzt, die als Ansatzpunkte f\u00fcr die Mikrotubuli des Spindelapparates dienen", "SPECIES", 0, 129]]], ["Der normale Replikationsmechanismus linearer DNA-Molek\u00fcle f\u00fchrt in jedem Replikationszyklus zu einer Verk\u00fcrzung der DNA-Doppelhelix von den Enden her, da die RNA-Primer am Ende der DNA zwar entfernt, aber nicht durch DNA-Sequenzen ersetzt werden k\u00f6nnen.", [["Replikationszyklus zu einer Verk\u00fcrzung der DNA-Doppelhelix von den Enden her, da die RNA-Primer am Ende der DNA zwar entfernt", "SPECIES", 73, 198]]], ["Au\u00dferdem muss eine spezielle Struktur sicherstellen, dass die freien Enden der DNA im Chromosom nicht von Exonukleasen abgebaut werden oder durch Reparaturenzyme mit den freien Enden der DNA eines anderen Chromosoms verschmelzen.", [["Au\u00dferdem muss eine spezielle Struktur sicherstellen, dass die freien Enden der DNA im Chromosom nicht von Exonukleasen abgebaut werden oder durch Reparaturenzyme mit den freien Enden der DNA eines anderen Chromosoms verschmelzen", "SPECIES", 0, 228]]], ["Das wird durch besondere terminale Dom\u00e4nen, die Telomere, gew\u00e4hrleistet.\u00dcberblickBei der weiteren Untersuchung der molekularen Struktur des Genoms machte man die unerwartete Entdeckung, dass das eukaryotische Genom zum gr\u00f6\u00dften Teil nicht aus Protein-kodierenden DNA-Sequenzen besteht.", [["\u00dcberblickBei der weiteren Untersuchung der molekularen Struktur des Genoms machte man die unerwartete Entdeckung, dass das eukaryotische Genom zum gr\u00f6\u00dften Teil nicht aus Protein-kodierenden DNA-Sequenzen besteht", "SPECIES", 72, 283], ["Genom", "TEST", 209, 214], ["zum", "TEST", 215, 218], ["aus Protein", "TEST", 238, 249]]], ["Die erstaunlich gro\u00dfen Unterschiede im DNA-Gehalt der Genome h\u00f6herer Organismen m\u00fcssen haupts\u00e4chlich Unterschieden in der Menge repetitiver DNA zugeschrieben werden.", [["Die", "PROBLEM", 0, 3]]], ["Sie beruhen also nicht auf wesentlichen Unterschieden in der Zahl Protein-kodierender Gene.\u00dcberblickChromosomen sind dynamische Strukturen, die strukturell und funktionell eng mit dem Stoffwechsel und dem Differenzierungsgrad der jeweiligen Zelle verbunden sind.", [["\u00dcberblickChromosomen sind dynamische Strukturen, die strukturell und funktionell eng mit dem Stoffwechsel und dem Differenzierungsgrad der jeweiligen Zelle verbunden sind", "SPECIES", 91, 261]]], ["Ihre Bedeutung geht weit \u00fcber das hinaus, was man von einem reinen \"Gen-Depot\" erwarten w\u00fcrde.", [["man", "SPECIES", 46, 49]]], ["Solche quantitativ unbalancierten Genkonstitutionen werden in der Regel vom Organismus nicht toleriert.", [["Solche", "TREATMENT", 0, 6]]], ["Verschiedene Organismengruppen haben daher spezifische Mechanismen entwickelt, um f\u00fcr einen funktionellen Ausgleich (Dosiskompensation) der verschiedenen Genkopienzahlen zu sorgen.", [["Verschiedene", "PROBLEM", 0, 12]]], ["In Drosophila erfolgt der Ausgleich in der Genaktivit\u00e4t durch erh\u00f6hte Aktivit\u00e4t der X-chromosomalen Gene im M\u00e4nnchen.\u00dcberblickDie Inaktivierung des S\u00e4uger-X-Chromosoms l\u00e4sst verschiedene wesentliche biologische Mechanismen erkennen.", [["Drosophila", "SPECIES", 3, 13], ["\u00dcberblickDie Inaktivierung des S\u00e4uger-X-Chromosoms l\u00e4sst verschiedene wesentliche biologische Mechanismen erkennen", "SPECIES", 117, 231], ["\u00dcberblickDie", "TEST", 117, 129], ["Chromosoms", "TEST", 157, 167]]], ["Man bezeichnet eine solche Information als chromosomale Pr\u00e4gung (Imprinting).", [["Man", "SPECIES", 0, 3], ["Man bezeichnet eine solche", "TREATMENT", 0, 26]]], ["Eine weitere Konsequenz der X-Chromosomeninaktivierung ist, dass verschiedene Zellen von S\u00e4ugerweibchen eine unterschiedliche Konstitution hinsichtlich der aktiven X-chromosomalen Gene besitzen k\u00f6nnen.", [["Eine weitere Konsequenz der X-Chromosomeninaktivierung ist, dass verschiedene Zellen von S\u00e4ugerweibchen eine unterschiedliche Konstitution hinsichtlich der aktiven X-chromosomalen Gene besitzen k\u00f6nnen", "SPECIES", 0, 200]]], ["Eine Kette derartiger DNA-Histonpartikel formt eine Chromatinfibrille von 10 nm Durchmesser.", [["Eine Kette derartiger DNA-Histonpartikel formt eine Chromatinfibrille von 10 nm Durchmesser", "SPECIES", 0, 91]]], ["Aktives und inaktives Chromatin unterscheiden sich dabei in dem Ausma\u00df der Kondensation; Insulator-Elemente sind an der Ausbildung offener Chromatinstrukturen und an der Anheftung der Chromatiden an der Kernmembran beteiligt.", [["dem Ausma\u00df der Kondensation; Insulator-Elemente sind an der Ausbildung offener Chromatinstrukturen und an der Anheftung der Chromatiden an der Kernmembran beteiligt", "SPECIES", 60, 224], ["an der Ausbildung offener", "TREATMENT", 113, 138], ["an der Kernmembran beteiligt", "TREATMENT", 196, 224]]], ["Die Kompartimentierung des Zellkerns in chromosomale Territorien und Interchromatindom\u00e4nen erlaubt die r\u00e4umliche Trennung verschiedener funktioneller Abl\u00e4ufe im Zellkern, wie Transkription und Reifung der RNA.", [["Die Kompartimentierung des Zellkerns in chromosomale Territorien und Interchromatindom\u00e4nen erlaubt die r\u00e4umliche Trennung verschiedener funktioneller Abl\u00e4ufe im Zellkern, wie Transkription und Reifung der", "SPECIES", 0, 204], ["Die Kompartimentierung des Zellkerns", "TREATMENT", 0, 36], ["chromosomale Territorien", "TREATMENT", 40, 64]]], ["7.1 Das eukaryotische Chromosom 7.1 Das eukaryotische ChromosomChromosomen als Tr\u00e4ger der ErbanlagenDie Chromosomentheorie der Vererbung besagt, dass die Erbeigenschaften eines Organismus in seinen Chromosomen niedergelegt sind.", [["Das eukaryotische", "TEST", 4, 21], ["Chromosom", "TEST", 22, 31], ["Das eukaryotische ChromosomChromosomen als Tr\u00e4ger der Erbanlagen", "TREATMENT", 36, 100]]], ["Sie wurde kurz nach der Wiederentdeckung der Mendel'schen Regeln von Sutton und Boveri formuliert und sehr bald durch mehrere Forscher best\u00e4tigt.", [["Sie wurde kurz nach der Wiederentdeckung der Mendel'schen Regeln von Sutton und Boveri formuliert und sehr bald durch mehrere Forscher best\u00e4tigt", "SPECIES", 0, 144]]], ["Jahrhunderts eine wichtige Rolle f\u00fcr die Genetik gespielt und eine gro\u00dfe Zahl von Beobachtungen zur Verf\u00fcgung gestellt, die wir erst heute anhand molekularer Forschungsergebnisse allm\u00e4hlich verstehen lernen.", [["Jahrhunderts eine wichtige Rolle f\u00fcr die Genetik gespielt und eine gro\u00dfe Zahl von Beobachtungen zur Verf\u00fcgung gestellt, die wir erst heute anhand molekularer Forschungsergebnisse allm\u00e4hlich verstehen lernen", "SPECIES", 0, 206]]], ["Ein Widerspruch zwischen den Mendel'schen Regeln und cytologischen Beobachtungen scheint in der Feststellung zu liegen, dass die Anzahl der Chromosomen bei den meisten Organismen relativ niedrig ist (Tabelle 7.1), jedenfalls zu gering, um mit der Vorstellung vereinbar zu sein, dass jedes Chromosom einer Erbeigenschaft zuzuordnen ist.", [["Widerspruch zwischen den Mendel'schen Regeln und cytologischen Beobachtungen scheint in der Feststellung zu liegen, dass die Anzahl der Chromosomen bei den meisten Organismen relativ niedrig ist (Tabelle 7.1), jedenfalls zu gering, um mit der Vorstellung vereinbar zu sein", "SPECIES", 4, 276], ["Ein Widerspruch zwischen den Mendel'schen Regeln", "TREATMENT", 0, 48]]], ["Obwohl \u00fcber die tats\u00e4chliche Anzahl der Erbeigenschaften (Gene) verschiedener Organismen noch bis in j\u00fcngste Zeit sehr widerstreitende Ansichten vertreten wurden, wurde doch sehr bald erkannt, dass jedes Chromosom Hunderte oder sogar Tausende von Erbeigenschaften tragen muss.", [["Obwohl \u00fcber die", "TREATMENT", 0, 15], ["Anzahl der Erbeigenschaften (Gene)", "TREATMENT", 29, 63], ["bis", "TEST", 94, 97]]], ["Dieser Schluss steht nunmehr aber in eindeutigem Widerspruch zu der Regel Mendels, dass sich Merkmale unabh\u00e4ngig voneinander auf die Nachkommen verteilen, da alle in einem Chromosom gelegenen Gene gekoppelt bleiben, also nicht unabh\u00e4ngig voneinander verteilt werden (s.", [["Dieser Schluss", "TREATMENT", 0, 14]]], ["Tab.", [["Tab", "GENE_OR_GENE_PRODUCT", 0, 3]]], ["In der klassischen Cytologie hatte man sich die Frage gestellt, ob Chromosomen auch w\u00e4hrend der Interphase in ihrer Individualit\u00e4t erhalten bleiben, oder ob sie sich w\u00e4hrend der Telophase aufl\u00f6sen und erst w\u00e4hrend der folgenden Prophase neu ausbilden.", [["man", "SPECIES", 35, 38], ["ob", "ANATOMY", 64, 66]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["7 .20) definitiv beantwortet werden k\u00f6nnen, nachdem auch Carl Rabl (1853 Rabl ( -1917 sich aufgrund cytologischer Untersuchungen an Amphibienzellkernen bereits im Sinne einer chromosomalen Kontinuit\u00e4t durch den gesamten Zellzyklus hindurch ausgesprochen hatte.", [["nachdem auch Carl Rabl (1853 Rabl ( -1917 sich aufgrund cytologischer Untersuchungen an Amphibienzellkernen bereits im Sinne einer chromosomalen Kontinuit\u00e4t durch den gesamten Zellzyklus hindurch ausgesprochen", "SPECIES", 44, 253], ["an Amphibienzellkernen bereits", "TREATMENT", 129, 159]]], ["Dennoch wurde die Tatsache der Konstanz der Chromosomenindividualit\u00e4t erst auf der Grundlage der Beobachtungen von Cytologen in den 1930er Jahren endg\u00fcltig akzeptiert.", [["Dennoch wurde die Tatsache der Konstanz der Chromosomenindividualit\u00e4t erst auf der Grundlage der Beobachtungen von Cytologen in den 1930er Jahren endg\u00fcltig akzeptiert", "SPECIES", 0, 166]]], ["Es waren gleichzeitig Emil Heitz , Hans Bauer und Theophilus Shickel Painter (1889 -1969 , die diesen wichtigen Schluss zogen.", [["Es waren gleichzeitig Emil Heitz , Hans Bauer und Theophilus Shickel Painter (1889 -1969 , die diesen wichtigen Schluss zogen", "SPECIES", 0, 125]]], ["Es sollen hier nur einige Beispiele genannt werden:Morphologie der Chromosomen\u2022 die h\u00e4ufige Verschmelzung von Nukleolen (s. auch S. 228),Morphologie der Chromosomen\u2022 die Tendenz von Heterochromatinbereichen, miteinander zu verschmelzen (s.", [["sollen hier nur einige Beispiele genannt werden:Morphologie der Chromosomen\u2022 die h\u00e4ufige Verschmelzung von Nukleolen (s. auch S. 228),Morphologie der Chromosomen\u2022 die Tendenz von Heterochromatinbereichen, miteinander zu verschmelzen (s.", "SPECIES", 3, 239]]], ["Bei den V-f\u00f6rmigen Chromosomen gibt es solche, bei denen die beiden Chromosomenarme ann\u00e4hernd gleich lang sind und solche, bei denen ein Arm deutlich k\u00fcrzer ist als der andere.", [["Bei den V-f\u00f6rmigen Chromosomen gibt es solche, bei denen die beiden Chromosomenarme ann\u00e4hernd gleich lang sind und solche, bei denen ein Arm deutlich k\u00fcrzer ist als der andere", "SPECIES", 0, 175], ["Arm", "ANATOMY", 137, 140]]], ["Sehen wir uns diese Chromosomen w\u00e4hrend ihrer Anaphasebewegungen an, so erkennen wir, dass bei den st\u00e4bchenf\u00f6rmigen Chromosomen stets ein Ende des Chromosoms in Richtung auf den Spindelpol orientiert ist, bei den V-f\u00f6rmigen aber der Bereich des Chromosoms, an dem sich beide Arme treffen.", [["dass bei den st\u00e4bchenf\u00f6rmigen Chromosomen stets ein Ende des Chromosoms in Richtung auf den Spindelpol orientiert ist, bei den V-f\u00f6rmigen aber der Bereich des Chromosoms, an dem sich beide Arme treffen", "SPECIES", 86, 287]]], ["Auf Grund dieses Verhaltens nennt man die betreffenden Chromosomen auch akrozentrisch (= telozentrisch) oder metazentrisch (Abb.", [["man", "SPECIES", 34, 37]]], ["Zwischen beiden Extremformen der Chromosomenmorphologie gibt es ein Kontinuum von Varianten, das von geringf\u00fcgig ungleichen Chromosomenarml\u00e4ngen bis zu einer Morphologie reicht, bei der ein zweiter Chromosomenarm kaum erkennbar ist.", [["Zwischen beiden Extremformen der Chromosomenmorphologie gibt es ein Kontinuum von Varianten, das von geringf\u00fcgig ungleichen Chromosomenarml\u00e4ngen bis zu einer Morphologie reicht, bei der ein zweiter Chromosomenarm kaum erkennbar", "SPECIES", 0, 227]]], ["Man spricht demgem\u00e4\u00df von submetazentrischen oder subtelozentrischen Chromosomen, ohne dass diese Bezeichnungen mehr als rein deskriptiven Wert haben.", [["Man", "SPECIES", 0, 3]]], ["Die Verschmelzung akrozentrischer Chromosomen wird auch Robertson'sche Fusion (zentrische Fusion) (engl.", [["Die Verschmelzung akrozentrischer Chromosomen", "TREATMENT", 0, 45], ["Robertson'sche Fusion (zentrische Fusion", "TREATMENT", 56, 96]]], ["Robertsonian fusion) genannt und ist ein f\u00fcr die Evolution von S\u00e4ugerchromosomen charakteristisches Ph\u00e4nomen.", [["Robertsonian fusion", "TREATMENT", 0, 19], ["von S\u00e4ugerchromosomen charakteristisches Ph\u00e4nomen", "PROBLEM", 59, 108]]], ["Erscheinungen dieser Art sind insbesondere f\u00fcr die Ermittlung populationsgenetischer und evolution\u00e4rer Zusammenh\u00e4nge von Bedeutung.Gestalt!", [["Erscheinungen dieser", "SPECIES", 0, 20]]], ["Chromosomen sind normalerweise nur in der Mitose und Meiose, also in der kondensierten Form der Pro-, Meta-und Anaphase, sichtbar.", [["Meta-und Anaphase", "TREATMENT", 102, 119]]], ["Ihre Gr\u00f6\u00dfe und Form variiert stark und ist jeweils charakteristisch f\u00fcr eine Spezies.CentromerenDie Bezeichnungen metazentrisch oder telozentrisch (sprachlich ein Widerspruch in sich selbst) sollen nicht auf die Lage der Mitte des Chromosoms hinweisen, sondern kennzeichnen die Lage des Centromers.", [["CentromerenDie Bezeichnungen metazentrisch", "TREATMENT", 85, 127], ["telozentrisch (sprachlich ein Widerspruch in sich selbst", "TREATMENT", 133, 189]]], ["So nennt man den Bereich der Chromosomen, in dem die Spindel ansetzt, um die Bewegung des Chromosoms w\u00e4hrend der Mitose und Meiose zu den Spindelpolen zu steuern (s.", [["man", "SPECIES", 9, 12], ["dem die Spindel ansetzt, um die Bewegung des Chromosoms w\u00e4hrend der Mitose und Meiose zu den Spindelpolen zu steuern (s.", "SPECIES", 45, 165]]], ["In Chromosomen, deren Kinetochor nicht terminal liegt, erkennt man den betreffenden Chromosomenabschnitt bereits im Verlauf der zunehmenden Chromosomenkondensation w\u00e4hrend der Prophase als Einschn\u00fcrung.", [["man", "SPECIES", 63, 66]]], ["Man bezeichnet diesen Bereich in der cytologischen Terminologie daher auch als prim\u00e4re Konstriktion.", [["Man", "SPECIES", 0, 3]]], ["Diese Morphologie steht mit einer besonderen molekularen Struktur des Centromerenbereiches in Zusammenhang.Centromeren!", [["Diese", "TEST", 0, 5]]], ["Die Form der Chromosomen wird durch das Centromer bestimmt.", [["Die Form der Chromosomen wird durch das Centromer bestimmt", "SPECIES", 0, 58]]], ["Die Region des Centromers bildet in der Metaphase die prim\u00e4re Konstriktion.", [["Die Region des Centromers bildet", "TREATMENT", 0, 32]]], ["Sie dient dem Ansatz der Spindelfasern, die f\u00fcr die Verteilung der Chromatiden w\u00e4hrend der Zellteilung sorgen.ChromatidenDie zweite auffallende Eigenschaft eines Prophaseoder Metaphasechromosoms ist dessen deutliche L\u00e4ngsteilung: Es besteht aus zwei L\u00e4ngsuntereinheiten, die wir Chromatiden nennen.", [["Chromatiden", "TEST", 110, 121]]], ["Sie sind das Produkt des Verdoppelungsmechanismus der Chromosomen, der w\u00e4hrend der S-Phase abl\u00e4uft (Replikation).", [["Sie sind das Produkt des Verdoppelungsmechanismus der Chromosomen, der w\u00e4hrend der S-Phase abl\u00e4uft", "SPECIES", 0, 98]]], ["Es entstehen dabei in allen Chromosomen aus einer Chromatide zwei Schwesterchromatiden.ChromatidenDie Chromatiden sind zun\u00e4chst bis in die fr\u00fche Prophase eng gepaart, trennen sich aber mit der fortschreitenden Kondensation der Chromosomen und h\u00e4ngen schlie\u00dflich nur noch in ihren Centromerenbereichen zusammen.", [["Chromatiden", "TREATMENT", 87, 98]]], ["Durch diesen Mechanismus ist gew\u00e4hrleistet, dass beide Tochterzellkerne eine Chromatide eines jeden Chromosoms erhalten.", [["dass beide Tochterzellkerne eine Chromatide", "TREATMENT", 44, 87]]], ["Chromatiden sind somit die Grundelemente eines Chromosoms und stellen von der Anaphase bis zur S-Phase gleichzeitig auch ein Chromosom dar.", [["Grundelemente eines Chromosoms und stellen von der Anaphase bis zur S-Phase gleichzeitig auch ein Chromosom dar", "SPECIES", 27, 138], ["Chromatiden sind somit die", "PROBLEM", 0, 26], ["Chromosoms", "TEST", 47, 57]]], ["Wenn man von einem Chromosom spricht, wird man daher -je nach dem Zusammenhang -zuvor kl\u00e4ren m\u00fcssen, ob man ein Chromosom vor oder nach der S-Phase meint.", [["man", "SPECIES", 5, 8], ["man", "SPECIES", 43, 46], ["man", "SPECIES", 104, 107], ["Wenn man von einem Chromosom spricht, wird man daher -je nach dem Zusammenhang -zuvor kl\u00e4ren m\u00fcssen, ob man ein Chromosom vor oder nach der S-Phase meint", "SPECIES", 0, 153], ["ob", "ANATOMY", 101, 103]]], ["Den Status des Zellkernes kennzeichnet man daher auch sinnvollerweise durch Angabe der Anzahl Chromatiden (C-Wert) eines Chromosomenpaares (2C oder 4C w\u00e4hrend des mitotischen Zellzyklus oder C, 2C oder 4C w\u00e4hrend der Meiose, s.", [["man", "SPECIES", 39, 42], ["Chromatiden (C-Wert) eines Chromosomenpaares", "TREATMENT", 94, 138]]], ["S. 186).Chromatiden!", [["Chromatiden", "TREATMENT", 8, 19]]], ["Grundeinheit eines Chromosoms ist die Chromatide.", [["Chromatide", "CHEMICAL", 38, 48]]], ["Ein Chromosom besteht vor der Replikation aus einer einzigen Chromatide, nach der Replikation in der S-Phase aus zwei identischen Schwesterchromatiden.NukleolenbildungsorteBetrachtet man Chromosomen genauer, so erkennt man in einzelnen Chromosomen eines Chromosomensatzes neben der prim\u00e4ren Konstriktion eine weitere Einschn\u00fcrung.", [["Ein Chromosom", "TREATMENT", 0, 13], ["aus einer einzigen Chromatide", "TREATMENT", 42, 71]]], ["Man bezeichnet sie als sekund\u00e4re Konstriktion.", [["Man", "SPECIES", 0, 3]]], ["In cytologisch g\u00fcnstigen F\u00e4llen kann man erkennen, dass an dieser Stelle des betreffenden Chromosoms w\u00e4hrend der Interphase und der fr\u00fchen Prophase der Nukleolus mit dem Chromosom verbunden ist.", [["man", "SPECIES", 37, 40], ["an dieser Stelle des", "TREATMENT", 56, 76]]], ["Er wird daher auch Nukleolenbildungsort oder Nukleolusorganisator [engl. nucleolus organizer region (NOR)] genannt.", [["nucleolus", "ANATOMY", 73, 82], ["nucleolus", "CELLULAR_COMPONENT", 73, 82]]], ["Der Nukleolus ist ein Organell, dessen Bildung den funktionellen Zustand der betreffenden Gene anzeigt (s.", [["Der Nukleolus ist ein Organell, dessen Bildung den funktionellen Zustand der betreffenden Gene anzeigt (s.", "SPECIES", 0, 106], ["Der Nukleolus ist ein Organell", "TREATMENT", 0, 30]]], ["Zweitens hat man beobachtet, dass in manchen Zellen nicht alle NORs aktiv werden und einen Nukleolus formen (s.", [["man", "SPECIES", 13, 16]]], ["S. 290).Nukleolenbildungsorte!", [["Nukleolenbildungsorte", "CHEMICAL", 8, 29]]], ["Sie wird daher auch Nukleolenbildungsort oder Nukleolusorganizerregion (NOR) genannt.SatellitenEs soll noch erw\u00e4hnt werden, dass sekund\u00e4re Konstriktionen bisweilen weit terminal im Chromosom auftreten und dann einen kurzen Chromosomenbereich abtrennen, den man als Satelliten bezeichnet.", [["dass sekund\u00e4re Konstriktionen bisweilen weit terminal im Chromosom auftreten und dann einen kurzen Chromosomenbereich abtrennen, den man als Satelliten bezeichnet", "SPECIES", 124, 286]]], ["E. Heitz hat f\u00fcr solche Chromosomen auch den Namen SAT-Chromosomen eingef\u00fchrt.", [["SAT-Chromosomen eingef\u00fchrt", "CELL", 51, 77], ["E. Heitz hat f\u00fcr solche Chromosomen auch den Namen SAT-Chromosomen eingef\u00fchrt", "SPECIES", 0, 77], ["solche", "TEST", 17, 23], ["Chromosomen", "TEST", 24, 35], ["SAT", "TEST", 51, 54]]], ["Warum es im letzten Fall zur Ausbildung einer Konstriktion kommt, ist unklar.HeterochromatinBereits an ungef\u00e4rbten Metaphasechromosomen, deutlicher aber in gef\u00e4rbten Chromosomenpr\u00e4paraten, kann man erkennen, dass Chromosomen nicht gleichf\u00f6rmig strukturiert sind, wenn man einmal von den bereits besprochenen Strukturelementen absieht.", [["man", "SPECIES", 194, 197], ["Warum es im letzten Fall zur Ausbildung einer Konstriktion kommt, ist unklar", "SPECIES", 0, 76], ["ungef\u00e4rbten Metaphasechromosomen", "OBSERVATION", 103, 135]]], ["Kompakte Chromosomenregionen findet man regelm\u00e4\u00dfig um die Centromerenbereiche herum, manchmal auch terminal, oder sie umfassen ganze Chromosomenarme oder sogar ein ganzes Chromosom (Abb.", [["man", "SPECIES", 36, 39], ["Kompakte", "TEST", 0, 8]]], ["Andererseits scheint die generelle Centromerenstruktur auch w\u00e4hrend der Interphase erhalten zu bleiben, da sich die sogenannten CREST-Proteine (engl. calcinosis, Raynaud's phenomenon, esophageal dismotility, sclerodactyly, and telangiectasia) auch in Interphasekernen in punktf\u00f6rmigen Bereichen des Kerns nachweisen lassen, die wohl den Centromerenbereichen der Chromosomen entsprechen.", [["esophageal", "ANATOMY", 184, 194], ["calcinosis", "DISEASE", 150, 160], ["Raynaud's phenomenon", "DISEASE", 162, 182], ["esophageal dismotility", "DISEASE", 184, 206], ["sclerodactyly", "DISEASE", 208, 221], ["telangiectasia", "DISEASE", 227, 241], ["esophageal", "ORGAN", 184, 194], ["calcinosis", "PROBLEM", 150, 160], ["Raynaud's phenomenon", "PROBLEM", 162, 182], ["esophageal dismotility", "PROBLEM", 184, 206], ["sclerodactyly", "PROBLEM", 208, 221], ["telangiectasia", "PROBLEM", 227, 241], ["auch", "TREATMENT", 243, 247], ["Raynaud", "ANATOMY", 162, 169], ["esophageal", "ANATOMY", 184, 194], ["dismotility", "OBSERVATION", 195, 206], ["telangiectasia", "OBSERVATION", 227, 241]]], ["Zu den bisher identifizierten S\u00e4uger-Centromerenproteinen geh\u00f6ren:Heterochromatin\u2022 CENP-A.", [["Heterochromatin\u2022 CENP-A.", "CELL", 66, 90], ["Zu den bisher identifizierten S\u00e4uger-Centromerenproteinen geh\u00f6ren:Heterochromatin\u2022 CENP-A.", "SPECIES", 0, 90]]], ["Es ist nur in aktiven Centromeren vorhanden und zeigt \u00c4hnlichkeit zu Histon H3.Heterochromatin\u2022 CENP-B.", [["CENP-B.", "GENE_OR_GENE_PRODUCT", 96, 103], ["CENP", "PROTEIN", 96, 100]]], ["Es bindet an die DNA in der CENP-Box, die man in menschlicher \u03b1-Satelliten-DNA (centromerassoziiert) und in der minor-satellite-DNA (s.", [["DNA", "CELLULAR_COMPONENT", 17, 20], ["DNA", "CELLULAR_COMPONENT", 75, 78], ["DNA", "CELLULAR_COMPONENT", 128, 131], ["die DNA", "DNA", 13, 20], ["menschlicher \u03b1-Satelliten-DNA", "DNA", 49, 78], ["centromerassoziiert", "DNA", 80, 99], ["der minor-satellite-DNA", "DNA", 108, 131], ["man", "SPECIES", 42, 45]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["Deletion des Gens f\u00fcr CENP-B in M\u00e4usen zeigt keine ph\u00e4notypischen Effekte.Heterochromatin\u2022 CENP-C.", [["CENP", "PROTEIN", 91, 95], ["Deletion des", "PROBLEM", 0, 12], ["CENP", "TEST", 22, 26]]], ["Im Gegensatz zu CENP-B ist es f\u00fcr die Centromerenfunktion erforderlich.Heterochromatin\u2022 CENP-E.", [["CENP", "PROTEIN", 88, 92], ["Im Gegensatz zu CENP-B ist es f\u00fcr die Centromerenfunktion erforderlich", "SPECIES", 0, 70]]], ["M\u00f6glicherweise ein Motorprotein f\u00fcr die Bewegung der Chromosomen in der Spindel.HeterochromatinAu\u00dferdem ist im Centromerenbereich Topoisomerase IIa vertreten, die f\u00fcr Chromosomenkondensation und die Trennung von Schwesterchromatiden erforderlich ist.", [["HeterochromatinAu\u00dferdem ist im Centromerenbereich Topoisomerase IIa vertreten", "TREATMENT", 80, 157], ["Topoisomerase IIa", "OBSERVATION", 130, 147]]], ["Weiterhin sind Proteinkinasen (Mas und Bub) gefunden worden, deren Funktion wahrscheinlich mit der Anheftung der Chromosomen an die Spindel zusammenh\u00e4ngt.DNA-Struktur des CentromerenbereichesAuch auf der DNA-Ebene weist der Centromerenbereich Besonderheiten auf.", [["DNA", "CELLULAR_COMPONENT", 154, 157], ["Weiterhin sind Proteinkinasen (Mas und Bub) gefunden worden, deren Funktion wahrscheinlich mit der Anheftung der Chromosomen an die Spindel zusammenh\u00e4ngt", "SPECIES", 0, 153], ["DNA", "PROBLEM", 154, 157]]], ["Durch in-situ-Hybridisierung hat sich zeigen lassen, dass im centromerassoziierten Heterochromatin stets gr\u00f6\u00dfere Bl\u00f6cke von hochrepetitiven DNA-Sequenzen liegen (Abb.", [["dass im centromerassoziierten Heterochromatin stets gr\u00f6\u00dfere Bl\u00f6cke von hochrepetitiven DNA-Sequenzen liegen", "SPECIES", 53, 160], ["Durch", "TREATMENT", 0, 5], ["Hybridisierung hat sich zeigen lassen", "TREATMENT", 14, 51], ["dass im centromerassoziierten", "TREATMENT", 53, 82]]], ["Am bekanntesten ist die Satelliten-DNA, die in den Centromerenregionen der M\u00e4usechromosomen zu finden ist (s. auch S. 237).", [["den Centromerenregionen der M\u00e4usechromosomen zu finden ist (s. auch S. 237", "SPECIES", 47, 121], ["DNA", "PROBLEM", 35, 38]]], ["Die Centromerenbereiche der M\u00e4usechromosomen sind aus (mindestens) zwei Klassen hochrepetitiver DNA aufgebaut, die als minor und major satellite, also als kleine und gro\u00dfe Satelli-ten-DNA, bezeichnet werden.", [["Die Centromerenbereiche der M\u00e4usechromosomen sind aus (mindestens) zwei Klassen hochrepetitiver DNA aufgebaut, die als minor und major satellite, also als kleine und gro\u00dfe Satelli-ten-DNA, bezeichnet werden", "SPECIES", 0, 206], ["aus (mindestens)", "TREATMENT", 50, 66], ["als kleine", "TEST", 151, 161], ["Satelli", "TEST", 172, 179]]], ["Die genauere Untersuchung dieser DNA-Bereiche enth\u00fcllt eine klare Untergliederung in mehrere Teilbereiche.DNA-Struktur des CentromerenbereichesMan findet die gleichen Satelliten-DNA-Fraktionen auch in einer der Hausmaus Mus musculus verwandten Art, M. spretus, und auch hier sind sie in einem charakteristischen, aber von der Hausmaus verschiedenen Muster organisiert (Abb.", [["DNA", "CELLULAR_COMPONENT", 106, 109], ["Mus musculus", "ORGANISM", 220, 232], ["Man", "SPECIES", 143, 146], ["Mus musculus", "SPECIES", 220, 232], ["Mus musculus", "SPECIES", 220, 232], ["M. spretus", "SPECIES", 249, 259], ["DNA", "TEST", 106, 109], ["DNA", "PROBLEM", 178, 181], ["Fraktionen", "PROBLEM", 182, 192]]], ["Auch in anderen Organismen hat man Hinweise auf eine z.", [["man", "SPECIES", 31, 34]]], ["T. chromosomenspezifische Organisation dieser hochrepetitiven DNA-Bl\u00f6cke erhalten, und in Hefechromosomen wurde eine spezielle Struktur der Centromerenregionen unter Beteiligung repetitiver Elemente nachgewiesen (Abb.", [["T. chromosomenspezifische Organisation dieser hochrepetitiven DNA-Bl\u00f6cke erhalten", "SPECIES", 0, 81], ["T. chromosomenspezifische", "TEST", 0, 25], ["DNA", "TEST", 62, 65]]], ["7.6 Die Funktion der hochrepetitiven DNA-Bl\u00f6cke in den Centromerenbereichen ist noch ungekl\u00e4rt.", [["der hochrepetitiven DNA", "TEST", 17, 40], ["Bl\u00f6cke", "PROBLEM", 41, 47]]], ["Hierf\u00fcr geben die Analysen von Centromerenregionen in Drosophila-Chromosomen Hinweise.", [["Drosophila", "SPECIES", 54, 64]]], ["Bei Drosophila bestehen Centromeren aus Bl\u00f6cken von repetitiven Sequenzen, in die einzelne (teilweise defekte) Transposons eingelagert sind.", [["Drosophila", "SPECIES", 4, 14], ["Bei Drosophila", "SPECIES", 0, 14], ["Bei Drosophila", "TREATMENT", 0, 14]]], ["Es ist daher anzunehmen, dass in h\u00f6heren Eukaryotenim Gegensatz zur B\u00e4ckerhefe -Centromerenfunktionen durch die Komplexbildung von Satelliten-DNA mit chromosomalen Proteinen erzielt werden.", [["h\u00f6heren Eukaryotenim Gegensatz zur B\u00e4ckerhefe -Centromerenfunktionen durch die Komplexbildung von Satelliten-DNA mit chromosomalen Proteinen erzielt werden", "SPECIES", 33, 188]]], ["Solche \"Neocentromere\" sind nach Deletionen funktioneller Centromere in menschlichen Chromosomen wiederholt beobachtet worden und haben zu dem Verdacht gef\u00fchrt, dass eine Centromerenfunktion auch epigenetisch programmiert werden kann.DNA-Struktur des CentromerenbereichesMan k\u00f6nnte auch annehmen, dass die Bl\u00f6cke repetitiver DNA im Centromerenbereich f\u00fcr die Homologenerkennung in der Meiose eine Bedeutung haben, da sie eine eindeutige Kennzeichnung eines bestimmten Chromosoms durch ein besonderes DNA-Muster erm\u00f6glichen.", [["DNA", "CELLULAR_COMPONENT", 234, 237], ["Man", "SPECIES", 271, 274], ["Solche", "TREATMENT", 0, 6], ["DNA", "PROBLEM", 234, 237]]], ["Auf ultrastrukturellem Niveau erkennt man jedoch \u00e4hnliche strukturelle Unterschiede zum \u00fcbrigen Chromosom wie im Centromerenbereich (s.", [["man", "SPECIES", 38, 41]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["Cytologisch erscheinen sie heterochromatisch, wenn sie \u00fcberhaupt als besonderer Chromosomenabschnitt erkennbar sind.", [["Cytologisch", "TEST", 0, 11]]], ["Auf ultrastrukturellem Niveau lassen sie im Zygot\u00e4n eine Verdickung erkennen, die zun\u00e4chst von der Bildung des synaptonemalen Komplexes ausgeschlossen ist: Die Paarung der Homologen beginnt meist in einem Chromosomenbereich der etwas proximal des Telomers liegt.", [["Auf ultrastrukturellem Niveau lassen sie im Zygot\u00e4n eine Verdickung erkennen, die zun\u00e4chst von der Bildung des synaptonemalen Komplexes ausgeschlossen ist: Die Paarung der Homologen beginnt meist in einem Chromosomenbereich der etwas proximal des Telomers liegt", "SPECIES", 0, 261]]], ["Nach Abschluss der Homologenpaarung im Pachyt\u00e4n sind jedoch auch die Telomeren vollst\u00e4ndig an der Bildung des synaptonemalen Komplexes beteiligt.Das Telomer FunktionFunktionell sind den Telomeren besondere Aufgaben zuzuweisen:Das Telomer Funktion\u2022 Sie m\u00fcssen gegen Fusionen mit anderen Chromosomen gesch\u00fctzt sein und die Enden der DNA-Doppelhelix gegen exonukleolytische Angriffe sch\u00fctzen.Das Telomer Funktion\u2022 Sie m\u00fcssen besondere Eigenschaften besitzen, um die vollst\u00e4ndige Replikation der Doppelhelix zu erm\u00f6glichen.Das Telomer Funktion\u2022 Sie tragen zur spezifischen Lokalisation der Chromosomen im Kern bei.", [["Das Telomer FunktionFunktionell sind den Telomeren besondere Aufgaben zuzuweisen:Das Telomer Funktion", "SPECIES", 145, 246], ["Sie m\u00fcssen gegen Fusionen mit anderen Chromosomen gesch\u00fctzt sein und die Enden der DNA-Doppelhelix gegen exonukleolytische Angriffe sch\u00fctzen", "SPECIES", 248, 388], ["Sie m\u00fcssen besondere Eigenschaften besitzen, um die vollst\u00e4ndige Replikation der Doppelhelix zu erm\u00f6glichen", "SPECIES", 411, 518], ["Nach Abschluss", "TREATMENT", 0, 14], ["an der Bildung des", "TREATMENT", 91, 109]]], ["In der meiotischen Prophase sind sie oft mit der Kernmembran assoziiert.Das Telomer FunktionDiese unterschiedlichen Aspekte der Telomerenfunktion m\u00fcssen sich in einer dementsprechenden molekularen Struktur widerspiegeln.Molekulare StrukturEine besondere molekulare Struktur der Telomeren-DNA ist auch zu erwarten, wenn man sich den Mechanismus der DNA-Replikation vergegenw\u00e4rtigt (s.", [["man", "SPECIES", 319, 322], ["Molekulare StrukturEine besondere molekulare Struktur der Telomeren-DNA ist auch zu erwarten, wenn man sich den Mechanismus der DNA-Replikation vergegenw\u00e4rtigt (s.", "SPECIES", 220, 383], ["sich", "PROBLEM", 153, 157], ["Molekulare", "TEST", 220, 230]]], ["Im Gegensatz zur Synthese des leading strand, die bis zum Ende der chromosomalen DNA durchl\u00e4uft, kann der komplement\u00e4re Strang (lagging strand) nicht bis zum Ende repliziert werden, da die DNA-Polymerase nicht im Stande ist, Nukleotide an 5\u2032-Enden anzuf\u00fcgen.", [["bis zum Ende repliziert werden, da die DNA-Polymerase nicht im Stande ist, Nukleotide an 5\u2032-Enden anzuf\u00fcgen", "SPECIES", 150, 257], ["Im Gegensatz zur Synthese des", "TREATMENT", 0, 29], ["Nukleotide", "TREATMENT", 225, 235], ["an 5\u2032-Enden anzuf\u00fcgen", "TREATMENT", 236, 257]]], ["Die Synthese dieses Stranges muss daher \u00fcber RNA-Primersequenzen und Okazaki-Fragmente erfolgen.", [["Stranges muss daher \u00fcber RNA-Primersequenzen und Okazaki-Fragmente erfolgen", "SPECIES", 20, 95], ["Stranges", "TEST", 20, 28], ["RNA", "TEST", 45, 48]]], ["Diese Probleme wurden ausf\u00fchrlich in Kapitel 2 er\u00f6rtert.Molekulare Telomerenstruktur von HefechromosomenDie Struktur der Chromosomenenden von Hefe ist komplexer als die der makronukle\u00e4ren Ciliatenchromosomen.", [["Molekulare Telomerenstruktur von HefechromosomenDie Struktur der Chromosomenenden von Hefe ist komplexer als die der makronukle\u00e4ren", "SPECIES", 56, 187]]], ["Sie erstreckt sich \u00fcber mehr als 100 Basenpaare, enth\u00e4lt aber ebenfalls GC-reiche DNA-Repeats (Abb.", [["Abb", "DNA", 95, 98], ["GC", "TEST", 72, 74]]], ["W\u00e4hrend der Replikation werden enzymatisch einzelne oder mehrere 3\u2032-G 1-3 T-5\u2032-Gruppen an das 3\u2032-Ende der replizierenden DNA angeh\u00e4ngt.", [["mehrere", "TEST", 57, 64]]], ["Diese Verl\u00e4ngerung gestattet es den Replikationsenzymen, den Telomerenbereich in einen 5\u2032-C 1-3 A-3\u2032-RNA-Primer zu kopieren, mit dessen Hilfe der unvollst\u00e4ndige Strang dann aufgef\u00fcllt werden kann.", [["Diese", "TEST", 0, 5]]], ["Wie bei Ciliaten wird also auch in Hefen eine GC-reiche Sequenz zur Erhaltung des Telomerenbereiches verwendet.Molekulare Telomerenstruktur von Drosophila-ChromosomenDer GC-Reichtum der Telomerenenden scheint jedoch kein generelles Kriterium zu sein.", [["Drosophila", "SPECIES", 144, 154], ["Molekulare Telomerenstruktur von Drosophila-ChromosomenDer GC-Reichtum der Telomerenenden scheint jedoch kein generelles Kriterium zu sein", "SPECIES", 111, 249], ["Molekulare", "TEST", 111, 121], ["von Drosophila", "TEST", 140, 154], ["ChromosomenDer", "TEST", 155, 169], ["GC", "TEST", 170, 172], ["Reichtum der Telomerenenden scheint jedoch", "TREATMENT", 173, 215], ["von Drosophila", "OBSERVATION", 140, 154]]], ["Die Struktur der Chromosomenenden, die man bei Drosophila gefunden hat, ist komplexer, \u00e4hnelt im Prinzip aber der der Hefen.", [["Drosophila", "SPECIES", 47, 57]]], ["Bei D. melanogaster ist es Mary Lou Pardue und Harald Biessmann (1992) gelungen, eine solche telomerenassoziierte DNA-Sequenz zu identifizieren.", [["D. melanogaster", "SPECIES", 4, 19], ["Bei D. melanogaster ist es Mary Lou Pardue und Harald Biessmann (1992) gelungen", "SPECIES", 0, 79]]], ["Es handelt sich um die HeT-A-und TART-Sequenzen, Mitglieder von Familien repetitiver DNA-Sequenzen, die in Telomeren und im centromerenassoziierten 235 7.1 Das eukaryotische Chromosom Abb.", [["HeT", "TEST", 23, 26]]], ["Wesentliche DNA-Elemente sind auch hier GC-reiche Repeats (C 1-3 A), die durch die Telomerase erg\u00e4nzt werden k\u00f6nnen.", [["Wesentliche DNA", "TEST", 0, 15], ["Elemente", "TEST", 16, 24]]], ["Die Bedeutung der X-Y\u2032-Elemente ist noch ungekl\u00e4rt, sie scheinen jedoch den Charakter von Transposons zu besitzen.", [["Die Bedeutung der X-Y\u2032-Elemente ist noch ungekl\u00e4rt, sie scheinen jedoch den Charakter von Transposons zu besitzen", "SPECIES", 0, 113]]], ["Ob auch bei Drosophila einfache GC-reiche Tandem-Repeats an den \u00e4u\u00dfersten Chromatidenenden vorhanden sind, wie bei Ciliaten und Hefen,ist bisher ungekl\u00e4rt,aber es gibt keine Hinweise darauf.", [["Drosophila", "SPECIES", 12, 22], ["Ob auch bei Drosophila einfache GC-reiche Tandem-Repeats an den \u00e4u\u00dfersten Chromatidenenden vorhanden sind, wie bei Ciliaten und Hefen,ist bisher ungekl\u00e4rt,aber es gibt keine Hinweise darauf", "SPECIES", 0, 189], ["GC", "TEST", 32, 34]]], ["HeT-A-und TART-Sequenzen bei Drosophila hinsichtlich der Telomerenstruktur sind unverstanden.", [["Drosophila", "SPECIES", 29, 39], ["HeT", "TEST", 0, 3], ["TART", "TEST", 10, 14]]], ["Sie k\u00f6nnten beispielsweise der Telomerase als Erkennungssequenzen dienen oder auch Funktionen in der Interaktion der Telomeren mit der Kernmembran aus\u00fcben.Molekulare Telomerenstruktur von Drosophila-ChromosomenMittels k\u00fcnstlicher Hefeminichromosomen, sogenannter YACs (engl. yeast artificial chromosomes) l\u00e4sst sich,wie schon die Centromerenfunktion,so auch die Telomerenfunktion isolierter DNA-Sequenzen testen.", [["chromosomes", "ANATOMY", 292, 303], ["sogenannter YACs", "DNA", 251, 267], ["engl", "DNA", 269, 273], ["Drosophila", "SPECIES", 188, 198], ["yeast", "SPECIES", 275, 280], ["yeast", "SPECIES", 275, 280], ["Molekulare", "TEST", 155, 165], ["von Drosophila", "TEST", 184, 198], ["von Drosophila", "OBSERVATION", 184, 198], ["artificial chromosomes", "OBSERVATION", 281, 303]]], ["Kombiniert man beispielsweise Telomerensequenzen von Tetrahymena, eine Hefe-CEN3-Sequenz (s.", [["man", "SPECIES", 11, 14]]], ["S. 46) mit beliebigen anderen DNA-Sequenzen einer L\u00e4nge von 50 kb bis weit \u00fcber 1000 kb und transformiert diese linearen Molek\u00fcle dann in eine Hefezelle, so werden sie wie normale Hefechromosomen repliziert und in Mitose und Meiose korrekt auf die Tochterzellen verteilt.", [["bis", "TEST", 66, 69]]], ["Sie verhalten sich mithin wie \"echte\" Chromosomen.TelomerenproteineDie Besonderheiten der DNA-Struktur in den Telomeren lassen die Frage aufkommen, ob sie sich auch durch besondere Proteine auszeichnen, wie wir es bereits f\u00fcr die Centromerenregionen gesehen haben.", [["Telomerenproteine", "TREATMENT", 50, 67]]], ["Man hat nicht nur spezifische Telomerenproteine gefunden, sondern alles deutet daraufhin, dass die Proteinzusammensetzung von Telomeren sehr komplex ist.", [["Man", "SPECIES", 0, 3]]], ["Eine wesentliche Funktion solcher Proteine besteht neben der Kontrolle der Telomerenl\u00e4nge darin, die Fusion mit anderen Telomeren zu verhindern.", [["Eine wesentliche Funktion solcher Proteine besteht neben der Kontrolle der Telomerenl\u00e4nge darin, die Fusion mit anderen Telomeren zu verhindern", "SPECIES", 0, 143], ["Eine wesentliche Funktion solcher", "TREATMENT", 0, 33], ["Proteine", "TREATMENT", 34, 42]]], ["Andere Proteine m\u00fcssen spezifische Interaktionen mit der Kernmembran eingehen, wie sie in der meiotischen Prophase in manchen Organismen erfolgt und sich in der Ausbildung von Bukett-Stadien anzeigt.TelomerenproteineEs sind mehrere Telomerenproteine bekannt, deren Funktionen jedoch nur unvollst\u00e4ndig aufgekl\u00e4rt sind.", [["Proteine", "TREATMENT", 7, 15], ["TelomerenproteineEs", "TREATMENT", 199, 218]]], ["Bei Hefe kennt man das Telomerenprotein TAZ1, bei S\u00e4ugern die Proteine TRF1 und TRF2.", [["TRF1", "GENE_OR_GENE_PRODUCT", 71, 75], ["TRF2", "GENE_OR_GENE_PRODUCT", 80, 84], ["TRF1", "PROTEIN", 71, 75], ["TRF2", "PROTEIN", 80, 84], ["man", "SPECIES", 15, 18], ["Bei Hefe kennt man das Telomerenprotein TAZ1, bei S\u00e4ugern die Proteine", "SPECIES", 0, 70]]], ["F\u00fcr das Telomerenprotein TAZ1 konnte gezeigt werden, dass seine \u00dcberexpression zu einer Verk\u00fcrzung der Telomeren, eine St\u00f6rung seiner Funktion zu einer Verl\u00e4ngerung der Telomeren f\u00fchrt.", [["F\u00fcr das Telomerenprotein TAZ1 konnte gezeigt werden, dass seine \u00dcberexpression zu einer Verk\u00fcrzung der Telomeren, eine St\u00f6rung seiner Funktion zu einer Verl\u00e4ngerung der Telomeren f\u00fchrt", "SPECIES", 0, 184]]], ["In Schistosaccharomyces pombe f\u00fchrt eine Deletion von TAZ1-Protein zu einer Blockierung der Meiose.", [["Schistosaccharomyces pombe", "SPECIES", 3, 29], ["Schistosaccharomyces pombe f\u00fchrt eine Deletion von TAZ1-Protein zu einer Blockierung der Meiose", "SPECIES", 3, 98]]], ["Es erfolgt keine Rekombination, und das Chromosomen-Clustering unterbleibt, Telomere werden nicht verl\u00e4ngert, und es kommt zu keinem Silencing.", [["Telomere werden nicht verl\u00e4ngert, und es kommt zu keinem", "SPECIES", 76, 132], ["Chromosomen", "TEST", 40, 51]]], ["In diesem Zusammenhang ist es auch von Interesse, dass zellzyklusrelevante Proteine wie Cdc13 in Telomeren von S. cerevisiae zu finden sind.", [["S. cerevisiae", "SPECIES", 111, 124]]], ["Mutationen zeigen eine schnelle Verk\u00fcrzung der Telomeren.", [["Mutationen zeigen", "TREATMENT", 0, 17]]], ["So zeigt es sich erneut, dass Zellzyklusregulation und Chromosomenstruktur eng miteinander verwoben sind.TelomerenproteineEs w\u00e4re jedoch falsch anzunehmen, dass mit dem Vorhandensein von Telomerase die Fragen bez\u00fcglich der Instandhaltung von Telomeren gel\u00f6st sind.", [["dass mit dem Vorhandensein von Telomerase die Fragen bez\u00fcglich der Instandhaltung von Telomeren gel\u00f6st sind", "SPECIES", 156, 263], ["TelomerenproteineEs", "TREATMENT", 105, 124], ["jedoch falsch anzunehmen", "TREATMENT", 130, 154], ["dass mit dem Vorhandensein von Telomerase die", "TREATMENT", 156, 201]]], ["Untersuchungen in Hefe und an menschlichen Tumorzelllinien ohne Telomeraseaktivit\u00e4t zeigen, dass Telomeren auch ohne Telomerase instand gehalten werden k\u00f6nnen.", [["Untersuchungen", "TREATMENT", 0, 14], ["an menschlichen Tumorzelllinien", "TREATMENT", 27, 58]]], ["H\u00f6chstwahrscheinlich spielen hierbei Rekombinationsmechanismen eine Rolle.", [["eine Rolle", "OBSERVATION", 63, 73]]], ["Es ist verst\u00e4ndlich, dass in einem so kritischen Bereich des Genoms alternative Mechanismen verf\u00fcgbar bleiben, wenn der prim\u00e4re Korrekturmechanismus ausf\u00e4llt.TelomerenproteineAuch unsere Kenntnis der Telomerenstruktur und -funktion steht noch in den Anf\u00e4ngen.", [["kritischen Bereich des", "TREATMENT", 38, 60], ["TelomerenproteineAuch", "TEST", 158, 179]]], ["Viele diesbez\u00fcgliche Fragen werden sich erst mit unserer zunehmenden Kenntnis molekularer Interaktionen zwischen Nukleins\u00e4ure und Proteinen stellen und l\u00f6sen lassen.", [["Viele diesbez\u00fcgliche Fragen werden sich erst mit unserer zunehmenden Kenntnis molekularer Interaktionen zwischen Nukleins\u00e4ure und Proteinen stellen und l\u00f6sen lassen", "SPECIES", 0, 164], ["Viele", "TEST", 0, 5], ["sich", "PROBLEM", 35, 39], ["Kenntnis", "TEST", 69, 77]]], ["Dass die Kenntnis der biologischen Funktionen im Telomerenbereich der Chromosomen von gro\u00dfer Bedeutung ist, deutet sich in der M\u00f6glichkeit an, dass Telomeren und Telomerasefunktionen eng mit der Regulation des Zellzyklus verkn\u00fcpft sind und dass die Kontrolle der Telomerenl\u00e4nge eine wichtige Rolle im Proliferationsverhalten der Zelle, z.", [["Dass die Kenntnis der biologischen Funktionen im Telomerenbereich der Chromosomen von gro\u00dfer Bedeutung ist, deutet sich in der M\u00f6glichkeit an, dass Telomeren und Telomerasefunktionen eng mit der Regulation des Zellzyklus verkn\u00fcpft sind und dass die Kontrolle der Telomerenl\u00e4nge eine wichtige Rolle im Proliferationsverhalten der Zelle, z.", "SPECIES", 0, 338], ["dass Telomeren und Telomerasefunktionen eng mit der Regulation des", "TREATMENT", 143, 209]]], ["B. als Tumorsuppressormechanismus, und f\u00fcr Fragen der Alterung von Zellen spielt.", [["B. als Tumorsuppressormechanismus, und f\u00fcr Fragen der Alterung von Zellen spielt", "SPECIES", 0, 80]]], ["Generell findet man hohe Telomeraseaktivit\u00e4t in Keimbahnzellen und wenig oder keine Telomerase in somatischen Zellen.Repetitive DNADie Untersuchung von Reaktionskinetiken von eukaryotischer DNA lie\u00df bereits fr\u00fchzeitig erkennen, dass aufgrund unterschiedlicher Sequenzh\u00e4ufigkeiten mehrere DNA-Sequenzfraktionen unterschieden werden m\u00fcssen.", [["man", "SPECIES", 16, 19], ["Keimbahnzellen", "TREATMENT", 48, 62], ["Repetitive DNADie", "PROBLEM", 117, 134], ["DNA", "TEST", 190, 193], ["lie\u00df", "TEST", 194, 198], ["bereits", "TEST", 199, 206], ["erkennen", "PROBLEM", 218, 226]]], ["Am auff\u00e4lligsten in einigen Organismen waren DNA-Anteile, die besonders schnell renaturierten und einen relativ gro\u00dfen Anteil an der Gesamt-DNA umfassen k\u00f6nnen.", [["besonders schnell renaturierten und einen relativ gro\u00dfen Anteil an der Gesamt-DNA umfassen k\u00f6nnen", "SPECIES", 62, 159]]], ["Man bezeichnete diese repetitiven DNA-Fraktionen daher als hochrepetitive DNA (engl. highly repetitive DNA).", [["DNA", "CELLULAR_COMPONENT", 74, 77], ["DNA", "CELLULAR_COMPONENT", 103, 106], ["hochrepetitive DNA", "DNA", 59, 77], ["Man", "SPECIES", 0, 3], ["als hochrepetitive DNA", "PROBLEM", 55, 77], ["highly repetitive DNA", "PROBLEM", 85, 106], ["DNA", "OBSERVATION", 103, 106]]], ["Zuerst ausf\u00fchrlich untersucht wurde eine hochrepetitive DNA-Fraktion der Hausmaus, Mus musculus, die bereits zuvor als Satelliten-DNA (engl. satellite DNA) bekannt gewesen war.Repetitive DNADie Bezeichnung Satelliten-DNA ist durch die analytische Methodik bedingt, die zur Entdeckung dieser DNA-Fraktion gef\u00fchrt hat.", [["Mus musculus", "ORGANISM", 83, 95], ["DNA", "CELLULAR_COMPONENT", 130, 133], ["DNA", "CELLULAR_COMPONENT", 151, 154], ["Mus musculus", "SPECIES", 83, 95], ["Mus musculus", "SPECIES", 83, 95], ["Repetitive DNADie", "PROBLEM", 176, 193], ["musculus", "ANATOMY", 87, 95]]], ["Grundlage der Fraktionierung ist in solchen Experimenten die mittlere Basenzusammensetzung der DNA, da das Kriterium der Trennung die Schwimmdichte (engl. buoyant density) ist.", [["density", "OBSERVATION", 163, 170]]], ["W\u00e4hrend der Zentrifugation stellt sich im Zentrifugenr\u00f6hrchen ein Gradient aus Cs + -Ionen ein, der schlie\u00dflich ein Gleichgewicht erreicht, bei unver\u00e4nderten Zentrifugationsbedingungen unver\u00e4ndert bleibt und unbegrenzt stabil ist.", [["W\u00e4hrend der Zentrifugation stellt sich im Zentrifugenr\u00f6hrchen ein Gradient aus Cs + -Ionen ein, der schlie\u00dflich ein Gleichgewicht erreicht, bei unver\u00e4nderten Zentrifugationsbedingungen unver\u00e4ndert bleibt und unbegrenzt stabil", "SPECIES", 0, 225]]], ["Es zeigt sich, dass bei praktisch allen Eukaryoten der Hauptanteil der DNA-Molek\u00fcle einen mittleren GC-Gehalt von etwa 40% hat.", [["dass bei praktisch allen Eukaryoten der Hauptanteil der DNA-Molek\u00fcle einen mittleren GC-Gehalt von etwa 40", "SPECIES", 15, 121]]], ["In CsCl-Gradienten bedingt das bei 20\u00b0C eine Schwimmdichte von 1,701 g \u00d7 cm -3 .", [["CsCl", "CHEMICAL", 3, 7]]], ["Neben dieser Hauptfraktion, der sogenannten Hauptbande (engl. main band), findet man beinahe immer zus\u00e4tzliche kleinere Fraktionen, die sich in ihrem jeweiligen GC-Gehalt deutlich von dem der Hauptbande unterscheiden und dadurch eine andere Schwimmdichte besitzen.", [["man", "SPECIES", 81, 84]]], ["Man spricht demgem\u00e4\u00df auch von leichten (niedriger GC-Gehalt) oder schweren (hoher GC-Gehalt) Satelliten-DNAs.Repetitive DNADie Beobachtung, dass Satelliten-DNA-Fraktionen selbst zwischen nahe verwandten Organismengruppen in v\u00f6llig verschiedenen Anzahlen, relativen Mengen der Gesamt-DNA des Genoms und unterschiedlichen mittlerer Basenzusammensetzung auftreten, hatte zun\u00e4chst zu dem Verdacht gef\u00fchrt, dass es sich hierbei um Viren handelt.", [["hoher GC-Gehalt", "CELL", 76, 91], ["Satelliten-DNAs", "CELL", 93, 108], ["Man", "SPECIES", 0, 3], ["relativen Mengen der Gesamt-DNA des Genoms und unterschiedlichen mittlerer Basenzusammensetzung auftreten, hatte zun\u00e4chst zu dem Verdacht gef\u00fchrt, dass es sich hierbei um Viren handelt", "SPECIES", 255, 439], ["DNA", "PROBLEM", 156, 159], ["Fraktionen", "PROBLEM", 160, 170], ["Anzahlen", "TREATMENT", 245, 253]]], ["Die Lokalisierung von Satelliten-DNAs im Genom durch in-situ-Hybridisierung (Technik-Box 13) r\u00e4umte die letzten Zweifel dar\u00fcber aus, dass es sich bei Satelliten-DNA um integrale Teile des Eukaryotengenoms handelt.Repetitive DNA!", [["DNA", "CELLULAR_COMPONENT", 224, 227], ["Die Lokalisierung von Satelliten-DNAs im Genom durch in-situ-Hybridisierung (Technik-Box 13) r\u00e4umte die letzten Zweifel dar\u00fcber aus, dass es sich bei Satelliten-DNA um integrale Teile des Eukaryotengenoms handelt", "SPECIES", 0, 212], ["Die", "PROBLEM", 0, 3], ["DNAs im Genom durch", "TREATMENT", 33, 52], ["Hybridisierung (Technik-Box", "TREATMENT", 61, 88], ["dass es sich bei Satelliten", "TREATMENT", 133, 160], ["Repetitive DNA", "PROBLEM", 213, 227]]], ["Hochrepetitive DNA zeichnet sich meist durch eine besondere, von der Hauptmenge der DNA abweichende Basenzusammensetzung aus.", [["Hochrepetitive DNA zeichnet sich", "TREATMENT", 0, 32]]], ["Sie erscheint dann in Gleichgewichtszentrifugationsexperimenten aufgrund ihrer abweichenden Schwimmdichte als Satellitenbande.Repetitive DNADie Gleichgewichtszentrifugationstechnik gestattete es, Satelliten-DNAs relativ einfach zu isolieren.", [["zu isolieren", "OBSERVATION", 228, 240]]], ["Die Analyse solcher DNA-Fraktionen hat gezeigt, dass es sich meist um hochrepetitive DNA-Sequenzen handelt, so dass der Begriff Satelliten-DNA heute \u00fcblicherweise alternativ zum Begriff hochrepetitive DNA-Fraktion gebraucht wird, obwohl auch andere DNA-Sequenzen als Satellitenfraktion sichtbar werden k\u00f6nnen.", [["Die Analyse solcher DNA-Fraktionen hat gezeigt, dass es sich meist um hochrepetitive DNA-Sequenzen handelt, so dass der Begriff Satelliten-DNA heute \u00fcblicherweise alternativ zum Begriff hochrepetitive DNA-Fraktion gebraucht wird, obwohl auch andere DNA-Sequenzen als Satellitenfraktion sichtbar werden k\u00f6nnen", "SPECIES", 0, 308], ["Satelliten", "TEST", 128, 138]]], ["Ein weiterer Begriff, der ebenfalls oft auf hochrepetitive DNA-Fraktionen angewendet wird, ist der von Peter Walker gepr\u00e4gte Begriff simple sequence DNA.", [["DNA", "CELLULAR_COMPONENT", 149, 152], ["Ein weiterer Begriff, der ebenfalls oft auf hochrepetitive DNA-Fraktionen angewendet wird, ist der von Peter Walker gepr\u00e4gte Begriff", "SPECIES", 0, 132]]], ["Er beruht auf dem Befund, dass hoch-repetitive DNA-Sequenzen meist aus sehr einfachen, tandemartig wiederholt angeordneten DNA-Sequenzen bestehen.", [["repetitive DNA", "PROBLEM", 36, 50], ["auf dem", "OBSERVATION", 10, 17]]], ["Die L\u00e4nge einer dieser wiederholten Sequenzen ist bisweilen \u00e4u\u00dferst kurz und kann, beispielsweise bei Satelliten-DNA der Hausmaus, nur f\u00fcnf Basenpaare umfassen, wie Edwin Southern gezeigt hat.", [["Die L\u00e4nge einer dieser wiederholten Sequenzen ist bisweilen \u00e4u\u00dferst kurz und kann, beispielsweise bei Satelliten-DNA der Hausmaus, nur f\u00fcnf Basenpaare umfassen", "SPECIES", 0, 159]]], ["Die tandemartig angeordneten DNA-Sequenzen sind in den meisten F\u00e4llen nicht identisch, sondern ihre Nukleotidsequenzen weichen im Allgemeinen erheblich von der als Consensussequenz ermittelten Grundsequenz ab, sie divergieren (engl. diverged nucleotide sequences) (Abb.", [["nucleotide", "CHEMICAL", 242, 252], ["nucleotide", "CHEMICAL", 242, 252], ["diverged nucleotide sequences", "DNA", 233, 262], ["Abb", "DNA", 265, 268], ["diverged nucleotide sequences", "TEST", 233, 262]]], ["Da die H\u00e4ufigkeit solcher DNA-Sequenzen im Allgemeinen sehr viel niedriger ist als die der hochrepetitiven Sequenzfraktionen, unterscheidet man etwas willk\u00fcrlich \"mittelrepetitive\" (engl. middle repetitive) und \"niedrigrepetitive\" (engl. low repetitive) Anteile.", [["man", "SPECIES", 140, 143]]], ["Beide DNA-Fraktionen geh\u00f6ren Sequenzen an, die man unterschiedlichen Familien repetitiver DNA-Sequenzen zuweisen muss.", [["DNA", "CELLULAR_COMPONENT", 6, 9], ["man", "SPECIES", 47, 50]]], ["\u00c4hnlich wie hochrepetitive DNA besteht innerhalb jeder dieser Sequenzfamilien gro\u00dfe Sequenz\u00e4hnlichkeit der verschiedenen Familienangeh\u00f6rigen.", [["\u00c4hnlich", "PROBLEM", 0, 7]]], ["Im Gegensatz zu hochrepetitiver DNA sind die Kopien dieser Familien jedoch im Genom verstreut (engl. interspersed repetitive sequences).Repetitive DNAWir unterscheiden aufgrund der Gr\u00f6\u00dfe zwei Klassen von mittelrepetitiven Sequenzen: Kurze Sequenzen von 200 bis 400 bp L\u00e4nge werden als SINEs (engl. short interspersed element) bezeichnet.", [["SINEs", "DNA", 285, 290], ["interspersed repetitive sequences", "TEST", 101, 134], ["bp L\u00e4nge werden als SINEs", "TREATMENT", 265, 290], ["short interspersed element) bezeichnet", "PROBLEM", 298, 336]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["Modellvorstellung der Evolution von Satelliten-DNA.", [["DNA", "CELLULAR_COMPONENT", 47, 50], ["Modellvorstellung der Evolution von Satelliten-DNA", "DNA", 0, 50], ["DNA", "PROBLEM", 47, 50]]], ["Dieses Modell versucht, die Verteilungs-und Evolutionsmuster von Satelliten-DNA zu erkl\u00e4ren.", [["Verteilungs-und Evolutionsmuster von Satelliten-DNA zu erkl\u00e4ren", "SPECIES", 28, 91], ["Verteilungs", "TEST", 28, 39]]], ["Nach einer lokalen Amplifikation einer Grundsequenz werden Kopien allm\u00e4hlich durch das Genom verstreut.", [["Nach einer lokalen", "TREATMENT", 0, 18]]], ["Die verstreuten Kopien degenerieren und sind nicht mehr als Elemente der zuvor amplifizierten DNA-Sequenzfamilie erkennbar.", [["Die verstreuten Kopien degenerieren und sind nicht mehr als Elemente der zuvor amplifizierten DNA-Sequenzfamilie erkennbar", "SPECIES", 0, 122]]], ["Die urspr\u00fcnglich amplifizierten Satelliten-DNA-Sequenzen werden im Laufe der Evolution relativ h\u00e4ufig durch neu amplifizierte Sequenzen ersetzt wie die gro\u00dfen Unterschiede in der Ausstattung mit Satelliten-DNA zwischen nahe verwandten Organismen beweisen.", [["Die urspr\u00fcnglich amplifizierten Satelliten-DNA-Sequenzen werden im Laufe der Evolution relativ h\u00e4ufig durch neu amplifizierte Sequenzen ersetzt wie die gro\u00dfen Unterschiede in der Ausstattung mit Satelliten-DNA zwischen nahe verwandten Organismen beweisen", "SPECIES", 0, 254], ["Die urspr\u00fcnglich amplifizierten Satelliten", "TREATMENT", 0, 42], ["Sequenzen werden im Laufe der Evolution relativ h\u00e4ufig durch neu amplifizierte", "TREATMENT", 47, 125]]], ["(Aus Walker 1971) 300 bp und kommen etwa 700 000 bis 1 000 000-mal im menschlichen Genom vor.Repetitive DNADie zweite Klasse mittelrepetitiver Sequenzen hat eine L\u00e4nge von mehreren kb (1,4 bis 6 kb) und wird daher als LINEs (engl. long interspersed element) bezeichnet; sie kommen in geringerer Kopienzahl im Genom vor (60 000 bis 100 000).", [["wird daher", "DNA", 203, 213], ["LINEs", "DNA", 218, 223], ["engl", "DNA", 225, 229], ["bis", "TEST", 49, 52]]], ["Aufgrund ihrer Eigenschaft, von bestimmten Restriktionsenzymen geschnitten zu werden, werden sie verschiedenen Familien zugeordnet; die bekannteste ist die Kpn-Familie (wird mit dem Restriktionsenzym KpnI geschnitten).", [["von bestimmten Restriktionsenzymen geschnitten zu werden, werden sie verschiedenen Familien zugeordnet; die bekannteste ist die Kpn-Familie (wird mit dem Restriktionsenzym KpnI geschnitten", "SPECIES", 28, 216]]], ["9).Repetitive DNADie Anzahl der Mitglieder einer Sequenzfamilie mittelrepetitiver DNA kann in einem weiten Bereich variieren.", [["Repetitive DNADie Anzahl der Mitglieder einer", "TREATMENT", 3, 48]]], ["Im \u00dcbrigen ist es schwierig, eine Abgrenzung zwischen mittelrepetitiver und hochrepetitiver DNA auf der Grundlage der Kopienanzahl zu treffen.", [["Im \u00dcbrigen ist es schwierig, eine Abgrenzung zwischen mittelrepetitiver und hochrepetitiver DNA auf der Grundlage der Kopienanzahl zu treffen", "SPECIES", 0, 141], ["Im \u00dcbrigen ist es schwierig", "TREATMENT", 0, 27], ["eine Abgrenzung zwischen mittelrepetitiver", "TREATMENT", 29, 71]]], ["Die Unterscheidung von hoch-und mittelrepetitiver DNA ist daher bisweilen mehr als eine operationelle Unterscheidung anzusehen.Repetitive DNAWie schon bei hochrepetitiver DNA sind auch bei niedrigerrepetitiven DNA-Familien die einzelnen Kopien im Genom nicht notwendigerweise identisch, sondern k\u00f6nnen in der Sequenz betr\u00e4chtlich voneinander abweichen.", [["Die Unterscheidung von hoch-und mittelrepetitiver DNA ist daher bisweilen mehr als eine operationelle Unterscheidung anzusehen", "SPECIES", 0, 126]]], ["Daf\u00fcr ist teilweise nat\u00fcrlich die verstreute Anordnung im Genom mit verantwortlich.", [["Daf\u00fcr ist teilweise nat\u00fcrlich die", "TREATMENT", 0, 33]]], ["B. in der rDNA erfolgt, gegen\u00fcber einer Anordnung in Gruppen generell erschwert.", [["Gruppen generell erschwert", "SPECIES", 53, 79]]], ["Hauptgrund f\u00fcr die gr\u00f6\u00dfere Sequenzerhaltung aber ist, dass zu dieser DNA-Fraktion auch Gene geh\u00f6ren.", [["Hauptgrund f\u00fcr die gr\u00f6\u00dfere Sequenzerhaltung aber ist, dass zu dieser DNA-Fraktion auch Gene geh\u00f6ren", "SPECIES", 0, 99]]], ["Man kann davon ausgehen, dass Gene im Allgemeinen zumindest in Teilbereichen weniger Ver\u00e4nderun-gen durch Mutationen im Laufe der Evolution zulassen als DNA-Bereiche, die nicht f\u00fcr Proteine kodieren.Repetitive DNAEs hat relativ vieler Experimente und letztlich der Anwendung gentechnologischer Methoden bedurft, um zu einem genaueren Verst\u00e4ndnis der Zusammensetzung repetitiver DNA-Fraktionen niedriger Repetitionsh\u00e4ufigkeiten zu gelangen.", [["Man", "SPECIES", 0, 3], ["Teilbereichen weniger Ver\u00e4nderun-gen durch Mutationen im Laufe der Evolution zulassen als DNA-Bereiche, die nicht f\u00fcr Proteine kodieren", "SPECIES", 63, 198], ["Anwendung gentechnologischer Methoden bedurft, um zu einem genaueren Verst\u00e4ndnis der Zusammensetzung repetitiver DNA-Fraktionen niedriger Repetitionsh\u00e4ufigkeiten zu gelangen", "SPECIES", 265, 438], ["dass Gene im Allgemeinen zumindest", "TREATMENT", 25, 59], ["Proteine kodieren", "TREATMENT", 181, 198]]], ["Zusammenfassend l\u00e4sst sich heute sagen, dass der Hauptanteil an der mittelrepetitiven DNA aus transponierbaren DNA-Sequenzen (Transposons) besteht, also DNA-Sequenzen, die ihre Position im Genom ver\u00e4ndern k\u00f6nnen (s.", [["an der mittelrepetitiven DNA aus transponierbaren DNA", "TREATMENT", 61, 114]]], ["Diese DNA-Sequenzfamilien k\u00f6nnen in der Anzahl vorhandener Kopien \u00e4u\u00dferst variabel sein.", [["Diese DNA", "PROBLEM", 0, 9], ["Sequenzfamilien k\u00f6nnen", "TREATMENT", 10, 32]]], ["So gibt es im menschlichen Genom transponierbare Elemente mit 300 000 bis 500 000 Kopien im haploiden Genom (z.", [["Kopien", "TREATMENT", 82, 88]]], ["In Drosophila hingegen hat sich die mittlere Gr\u00f6\u00dfe einer Familie transponierbarer Elemente bei 30 bis 60 Kopien stabilisiert.", [["Drosophila", "SPECIES", 3, 13]]], ["Insbesondere sind hier die Gene f\u00fcr strukturelle RNA-Molek\u00fcle zu nennen (ribosomale RNA, S. 295), aber auch Proteinkodierende Gene k\u00f6nnen in gr\u00f6\u00dferen Kopienzahlen vorkommen.", [["Insbesondere sind hier die Gene f\u00fcr strukturelle RNA-Molek\u00fcle zu nennen (ribosomale RNA, S. 295", "SPECIES", 0, 95]]], ["S. 309), die, je nach Organismus, mit 50 bis zu mehreren hundert Kopien im haploiden Genom vertreten sind.Repetitive DNA!", [["DNA", "CELLULAR_COMPONENT", 117, 120], ["Kopien", "TREATMENT", 65, 71], ["Repetitive DNA", "PROBLEM", 106, 120]]], ["Diese sind im Genom verstreut und bestehen aus l\u00e4ngeren DNA-Sequenzen als hochrepetitive DNA.", [["DNA", "CELLULAR_COMPONENT", 89, 92], ["hochrepetitive DNA", "DNA", 74, 92], ["als hochrepetitive DNA", "PROBLEM", 70, 92]]], ["Unter solchen DNA-Sequenzen befinden sich auch Gene.", [["DNA", "CELLULAR_COMPONENT", 14, 17], ["Sequenzen befinden sich auch Gene", "DNA", 18, 51]]], ["Ein anderer Teil mittelrepetitiver DNA-Sequenzen geh\u00f6rt zur Klasse der \"mobilen genetischen Elemente\" (Transposons).Repetitive DNAAbschlie\u00dfend soll hier noch eine Fraktion repetitiver DNA-Sequenzen erw\u00e4hnt werden, die sich von den bisher besprochenen repetitiven DNA-Sequenzen grunds\u00e4tzlich dadurch unterscheidet, dass sie nicht mit einer Reaktionskinetik 2.", [["Ein anderer Teil mittelrepetitiver DNA-Sequenzen geh\u00f6rt zur Klasse der \"mobilen genetischen Elemente", "SPECIES", 0, 100], ["Repetitive DNAAbschlie\u00dfend soll hier noch", "TREATMENT", 116, 157]]], ["Die Renaturierungsgeschwindigkeit dieser DNA-Fraktionen ist so hoch, dass man sie mit der normalen Messung einer Renaturierungskinetik praktisch nicht erfasst, da die Renaturierung bereits beendet ist, wenn man mit der Messung beginnt.", [["Die Renaturierungsgeschwindigkeit dieser DNA-Fraktionen ist so hoch, dass man sie mit der normalen Messung einer Renaturierungskinetik praktisch nicht erfasst, da die Renaturierung bereits beendet ist, wenn man mit der Messung beginnt", "SPECIES", 0, 234]]], ["Elektronenmikroskopische Untersuchungen, und sp\u00e4tere DNA-Sequenzanalysen zeigten, dass es sich hierbei um denaturierte DNA-Molek\u00fcle handelt, die aufgrund interner gegenl\u00e4ufiger (d. h. invertierter) komplement\u00e4rer Nukleotidsequenzen einen (partiellen) Doppelstrang formen (Abb.", [["Elektronenmikroskopische", "TEST", 0, 24]]], ["Das ist auch mit dem Befund, dass im Allgemeinen keine Transkripte solcher DNA-Sequenzen beobachtet werden, vereinbar.Repetitive DNAEin wichtiger Gesichtspunkt bei der Betrachtung hochrepetitiver DNA ist, dass Satelliten-DNA-Fraktionen evolution\u00e4r schnellen Ver\u00e4nderungen unterworfen sind.", [["Das ist auch mit dem Befund, dass im Allgemeinen keine Transkripte solcher DNA-Sequenzen beobachtet werden", "SPECIES", 0, 106], ["Gesichtspunkt bei der Betrachtung hochrepetitiver DNA ist, dass Satelliten-DNA-Fraktionen evolution\u00e4r schnellen Ver\u00e4nderungen unterworfen", "SPECIES", 146, 283], ["Fraktionen", "PROBLEM", 225, 235]]], ["Das kann nur bedeuten, dass das Genom \u00fcber Eliminations-und Amplifikationsmechanismen verf\u00fcgt, die gemeinsam in der Lage sind, eine vorhandene hochrepetitive DNA-Fraktion kurzfristig und relativ vollst\u00e4ndig durch eine neue zu ersetzen.", [["Das kann nur bedeuten, dass das Genom \u00fcber Eliminations-und Amplifikationsmechanismen verf\u00fcgt, die gemeinsam in der Lage sind, eine vorhandene hochrepetitive DNA-Fraktion kurzfristig und relativ vollst\u00e4ndig durch eine neue zu ersetzen", "SPECIES", 0, 234]]], ["Geht man von der Lokalisation von hochrepetitiver DNA im Heterochromatin aus, so dr\u00e4ngt sich die Vermutung auf, dass sie mit dem besonderen Verpackungsmodus der DNA in diesen Genombereichen, zumindest aber mit der Bindung spezieller chromosomaler Proteine in Verbindung gebracht werden m\u00fcssen.", [["man", "SPECIES", 5, 8], ["Heterochromatin aus", "PROBLEM", 57, 76]]], ["Ausnahmen findet man lediglich in den Keimzellen einiger Organismen, die eine abweichende Chromosomenanzahl besitzen.", [["man", "SPECIES", 17, 20]]], ["S. 258).Die Variabilit\u00e4t der ChromosomenIm Gegensatz zu dieser Uniformit\u00e4t der Chromosomen innerhalb eines Organismus und zwischen Organismen einer Art steht die gro\u00dfe Variabilit\u00e4t der Chromosomenanzahlen und -morphologie, die man beim Vergleich verschiedener Arten und vor allem h\u00f6herer Gruppen des Tier-und Pflanzenreiches findet (Tabelle 7.1).", [["Die Variabilit\u00e4t der ChromosomenIm Gegensatz zu dieser Uniformit\u00e4t der Chromosomen innerhalb eines Organismus und zwischen Organismen einer Art steht die gro\u00dfe Variabilit\u00e4t der Chromosomenanzahlen und -morphologie, die man beim Vergleich verschiedener Arten und vor allem h\u00f6herer Gruppen des Tier-und Pflanzenreiches findet", "SPECIES", 8, 331], ["Die", "PROBLEM", 8, 11]]], ["Hinzu kommen neue Techniken der in-situ-Hybridisierung (Chromosomenpainting), die den Anwendungsbereich der B\u00e4nderungstechniken noch erweitern (s.", [["Hinzu kommen neue Techniken der in-situ-Hybridisierung (Chromosomenpainting), die den Anwendungsbereich der B\u00e4nderungstechniken noch erweitern (s.", "SPECIES", 0, 146]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["G-Banden erh\u00e4lt man nach einer Vorbehandlung in warmer Salzl\u00f6sung oder mit proteolytischen Enzymen (Proteinase K oder Pronase E) und anschlie\u00dfender Giemsaf\u00e4rbung oder durch die Verwendung AT-spezifischer Fluoreszenzfarbstoffe (z.", [["man", "SPECIES", 16, 19], ["G", "TEST", 0, 1], ["Enzymen", "TEST", 91, 98], ["Proteinase K oder Pronase E)", "TREATMENT", 100, 128]]], ["B. DAPI, DIPI).", [["DAPI", "CHEMICAL", 3, 7], ["DAPI", "SIMPLE_CHEMICAL", 3, 7], ["DIPI", "SIMPLE_CHEMICAL", 9, 13], ["DAPI", "OBSERVATION", 3, 7]]], ["Q-Banden sieht man als fluoreszierende Chromosomenabschnitte nach Quinacrinf\u00e4rbung.", [["man", "SPECIES", 15, 18]]], ["R-Banden (engl. reversed bands) erkennt man nach einer Behandlung mit Fluoreszenzfarbstoffen, die bevorzugt GC-reiche DNA anf\u00e4rben (z.", [["R-Banden", "GENE_OR_GENE_PRODUCT", 0, 8], ["man", "SPECIES", 40, 43], ["reversed bands", "PROBLEM", 16, 30], ["GC", "TEST", 108, 110], ["Banden", "OBSERVATION", 2, 8]]], ["B. Mithramycin, Acridinorange).", [["Mithramycin", "TREATMENT", 3, 14]]], ["Zum einen findet man, dass bestimmte B\u00e4nderungsmuster im Laufe der Evolution, zwar in ver\u00e4nderten chromosomalen Positionen, aber im \u00dcbrigen doch strikt konserviert erhalten bleiben.", [["man", "SPECIES", 17, 20]]], ["Solche Befunde wurden vor allem bei der vergleichenden Untersuchung von Primatenkaryotypen gemacht.", [["Solche Befunde wurden vor allem bei der vergleichenden Untersuchung von Primatenkaryotypen gemacht", "SPECIES", 0, 98], ["Solche", "TREATMENT", 0, 6]]], ["Offenbar bleiben bestimmte Genkombinationen in der gleichen Gruppierung von Banden erhalten, durchlaufen aber chromosomale Verschiebungen ganzer Gruppen von Banden.", [["von Banden", "OBSERVATION", 153, 163]]], ["Zum anderen weisen bestimmte Bandenmuster wie das G-und das R-Bandenmuster eine enge Korrelation zur DNA-Synthese der betreffenden Chromosomenabschnitte auf.", [["Zum anderen weisen bestimmte Bandenmuster wie das G-und das R-Bandenmuster eine enge Korrelation zur DNA-Synthese der betreffenden Chromosomenabschnitte auf", "SPECIES", 0, 156]]], ["Einer der Bandentypen, die C-Banden, l\u00e4sst sich spezifisch bestimmten heterochromatischen Chromosomenbereichen zuordnen. sifizieren lassen (Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 140, 143]]], ["Ganz offensichtlich besteht also ein Zusammenhang des Vorhandenseins dieses morphologisch abweichenden Chromosoms mit dem Geschlecht des Organismus.", [["Ganz", "TREATMENT", 0, 4]]], ["Derartige Chromosomen werden daher als Geschlechtschromosomen bezeichnet -im Gegensatz zu allen \u00fcbrigen Chromosomen, die man Autosomen nennt.Die Variabilit\u00e4t der ChromosomenDie wichtigste Konsequenz des Besitzes von unterschiedlichen Geschlechtschromosomen wird uns bei der Betrachtung der Meiose deutlich: Die Gameten besitzen zur H\u00e4lfte jeweils das eine oder das andere Geschlechtschromosom.", [["man", "SPECIES", 121, 124], ["Derartige Chromosomen werden daher als Geschlechtschromosomen bezeichnet -im Gegensatz zu allen \u00fcbrigen Chromosomen, die man Autosomen nennt", "SPECIES", 0, 140], ["Die Variabilit\u00e4t der ChromosomenDie wichtigste Konsequenz des Besitzes von unterschiedlichen Geschlechtschromosomen wird uns bei der Betrachtung der Meiose deutlich: Die Gameten besitzen zur H\u00e4lfte jeweils das eine oder das andere", "SPECIES", 141, 371], ["Derartige", "TEST", 0, 9]]], ["Bei S\u00e4ugern beispielsweise ist das M\u00e4nnchen das heterogametische Geschlecht, w\u00e4hrend bei V\u00f6geln oder bei Schmetterlingen (Lepidopteren) das Weibchen heterogametisch ist.", [["Bei S\u00e4ugern beispielsweise ist das M\u00e4nnchen das heterogametische Geschlecht, w\u00e4hrend bei V\u00f6geln oder bei Schmetterlingen (Lepidopteren) das Weibchen heterogametisch", "SPECIES", 0, 164]]], ["Zur nomenklatorischen Kennzeichnung von Geschlechtschromosomen verwendet man generell die Namen Xund Y-Chromosom, wenn das M\u00e4nnchen heterogametisch ist, oder W-(\u2248Y) und Z-Chromosom (\u2248X), wenn das Weibchen heterogametisch ist.", [["Zur nomenklatorischen Kennzeichnung von Geschlechtschromosomen verwendet man generell die Namen Xund Y-Chromosom, wenn das M\u00e4nnchen heterogametisch ist, oder W-(\u2248Y) und Z-Chromosom (\u2248X)", "SPECIES", 0, 185]]], ["Bei manchen Tiergruppen besitzt das heterogametische Geschlecht lediglich ein Geschlechtschromosom im diploiden Satz, w\u00e4hrend dasselbe Chromosom im homogametischen Geschlecht doppelt vorhanden ist.", [["Bei manchen Tiergruppen besitzt das heterogametische Geschlecht lediglich ein Geschlechtschromosom im diploiden", "SPECIES", 0, 111], ["heterogametische", "TEST", 36, 52], ["Geschlecht", "TEST", 53, 63], ["Satz", "TEST", 112, 116], ["Chromosom", "TEST", 135, 144]]], ["In diesem Fall kennzeichnen wir die Geschlechtschromosomenkonstitutionen mit XX und X0.", [["diesem Fall kennzeichnen wir die Geschlechtschromosomenkonstitutionen mit XX und X0", "SPECIES", 3, 86]]], ["Wir k\u00f6nnen diese Beobachtung, mehr noch als die Strukturunterschiede in Organismen mit zwei verschiedenen Geschlechtschromosomen, als Hinweis darauf verstehen, dass Geschlechtschromosomen funktionell, also hinsichtlich ihrer genetischen Information, nicht identisch sind.Die Variabilit\u00e4t der ChromosomenIm Prinzip sind die Geschlechtschromosomen im heterogametischen Geschlecht stets haploid, ein Zustand den man auch als hemizygot bezeichnet.", [["man", "SPECIES", 409, 412], ["Die Variabilit\u00e4t der ChromosomenIm Prinzip sind die Geschlechtschromosomen im heterogametischen Geschlecht stets haploid, ein Zustand den man auch als hemizygot bezeichnet", "SPECIES", 271, 442], ["Die", "PROBLEM", 271, 274]]], ["F\u00fcr die Auspr\u00e4gung der auf hemizygoten Chromosomen lokalisierten Gene hat das schwerwiegende Konsequenzen, denn ein dort vorhandenes Allel wird stets voll ausgepr\u00e4gt, unabh\u00e4ngig davon, ob es im anderen (homogametischen) Geschlecht rezessiv oder dominant erscheint.Die Variabilit\u00e4t der ChromosomenCytologen bezeichnen Geschlechtschromosomen aufgrund der unterschiedlichen Morphologie auch als heteromorph und nennen sie dementsprechend Heterosomen.", [["dominant erscheint", "OBSERVATION", 245, 263]]], ["Obwohl weit weniger gebr\u00e4uchlich, ist diese Bezeichnung in mancher Hinsicht zweckm\u00e4\u00dfiger als der Begriff Geschlechtschromosomen, denn dieser suggeriert eine direkte Funktion des Chromosoms bei der Geschlechtsbestimmung des Organismus.", [["Obwohl weit weniger gebr\u00e4uchlich", "TREATMENT", 0, 32]]], ["Das Geschlechtschromosom des M\u00e4nnchens von Drosophila, das Y-Chromosom, hat zum Beispiel keinerlei geschlechtsbestimmende Funktionen, w\u00e4hrend beim Menschen wichtige m\u00e4nnliche geschlechtsbestimmende Gene auf dem Y-Chromosom liegen.", [["Drosophila", "SPECIES", 43, 53], ["auf dem", "OBSERVATION", 203, 210]]], ["In beiden F\u00e4llen ist das m\u00e4nnliche Geschlecht heterogametisch, wie uns die Bezeichnung der Geschlechtschromosomen verr\u00e4t.Die Variabilit\u00e4t der ChromosomenNicht n\u00e4her eingegangen wird hier auf F\u00e4lle multipler Geschlechtschromosomen, wie sie z.", [["Die Variabilit\u00e4t der ChromosomenNicht n\u00e4her eingegangen wird hier auf F\u00e4lle multipler Geschlechtschromosomen", "SPECIES", 121, 229]]], ["B. bei einigen Marsupialiern (Beuteltieren), Rodentiern (Nagern), anderen Vertebraten, aber auch bei Insekten oder Pflanzen gelegentlich beobachtet werden.", [["B. bei einigen", "SPECIES", 0, 14], ["Rodentiern (Nagern)", "TREATMENT", 45, 64], ["anderen Vertebraten", "TREATMENT", 66, 85]]], ["Es Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 3, 6], ["Abb", "PROTEIN", 3, 6], ["Abb", "OBSERVATION", 3, 6]]], ["Metaphasechromosomen von Drosophila melanogaster. a Weibchen mit zwei X-Chromosomen, b M\u00e4nnchen mit einem X-und einem Y-Chromosom.", [["Metaphasechromosomen von Drosophila melanogaster", "ORGANISM", 0, 48], ["Drosophila melanogaster", "SPECIES", 25, 48], ["Drosophila melanogaster", "SPECIES", 25, 48], ["a Weibchen mit zwei", "TEST", 50, 69], ["Drosophila melanogaster", "OBSERVATION", 25, 48]]], ["Zwei der Autosomenpaare sind metazentrisch, das dritte Paar ist punktf\u00f6rmig k\u00f6nnen in solchen F\u00e4llen mehrere X-oder Y-Chromosomen vorhanden sein.Die Variabilit\u00e4t der ChromosomenDer Erbgang von Geschlechtschromosomen ist nicht nur von gro\u00dfer praktischer Bedeutung, sondern seine Erforschung hat grundlegende Mechanismen der Chromosomenverteilung in Meiose und Mitose aufgedeckt (s.", [["Die Variabilit\u00e4t der ChromosomenDer Erbgang von Geschlechtschromosomen ist nicht nur von gro\u00dfer praktischer Bedeutung, sondern seine Erforschung hat grundlegende Mechanismen der Chromosomenverteilung in Meiose und Mitose aufgedeckt (s.", "SPECIES", 145, 380]]], ["Bei vielen Organismen findet man Geschlechtschromosomen (Heterosomen), die sich von den \u00fcbrigen Chromosomen (Autosomen) dadurch unterscheiden, dass sie sich trotz ihres homologen Charakters morphologisch unterscheiden.", [["man", "SPECIES", 29, 32]]], ["W\u00e4hrend das eine Geschlecht zwei identische Geschlechtschromosomen besitzt (es ist homogametisch), ist das andere durch zwei unterschiedliche Geschlechtschromosomen heterogametisch.", [["W\u00e4hrend das eine Geschlecht zwei identische Geschlechtschromosomen besitzt (es ist homogametisch), ist das andere durch zwei unterschiedliche Geschlechtschromosomen heterogametisch", "SPECIES", 0, 180]]], ["Heterogametie kann im m\u00e4nnlichen (X/ Y-Chromosomen) oder weiblichen Geschlecht (W / Z-Chromosomen) auftreten.", [["Heterogametie kann im m\u00e4nnlichen (X/ Y-Chromosomen) oder weiblichen Geschlecht (W / Z-Chromosomen) auftreten", "SPECIES", 0, 108], ["Heterogametie kann im m\u00e4nnlichen (X/ Y-Chromosomen)", "TREATMENT", 0, 51], ["weiblichen Geschlecht (W / Z-Chromosomen)", "TREATMENT", 57, 98]]], ["In manchen Organismen fehlt das zweite Geschlechtschromosom im heterogametischen Geschlecht ganz (X / O-Typ) oder es sind mehr als zwei Geschlechtschromosomen vorhanden.Lampenb\u00fcrstenchromosomenBisher haben wir eine Form von Variabilit\u00e4t der Chromosomenstruktur betrachtet, die den Organismus insgesamt betrifft, also mit seiner genetischen Ausstattung in Beziehung steht.", [["manchen Organismen fehlt das zweite Geschlechtschromosom im heterogametischen Geschlecht ganz (X / O-Typ)", "SPECIES", 3, 108], ["Geschlechtschromosom im heterogametischen Geschlecht ganz", "TREATMENT", 39, 96]]], ["Eine ungew\u00f6hnliche cytologische Struktur finden wir beispielsweise bei den Prophasechromosomen einiger Organismen w\u00e4hrend der ersten meiotischen Teilung.", [["Eine ungew\u00f6hnliche cytologische", "TREATMENT", 0, 31]]], ["Ganz allgemein sind meiotische Prophasechromosomen durch die vielen Chromomeren charakterisiert, die sich perlschnurartig auf den Chromosomenachsen zeigen.", [["Ganz", "TREATMENT", 0, 4]]], ["Wegen ihres Erschei-nungsbildes werden diese Chromosomen auch Lampenb\u00fcrstenchromosomen (engl. lamp-brush chromosomes) genannt, da sie im Extremfall den fr\u00fcher zur Reinigung von Petroleumlampen gebr\u00e4uchlichen B\u00fcrsten \u00e4hnlich sehen (Abb.", [["Wegen", "TEST", 0, 5], ["Erschei", "TEST", 12, 19]]], ["Solche Lampenb\u00fcrstenchromosomen sind vor allem in den prim\u00e4ren Oocyten vieler Organismen zu beobachten, treten jedoch bisweilen auch im prim\u00e4ren Spermatocytenstadium auf.", [["Solche", "TEST", 0, 6], ["Lampenb\u00fcrstenchromosomen", "TEST", 7, 31]]], ["H-markierter RNA wurden die wachsenden Transkripte an der Schleife radioaktiv markiert und anschlie\u00dfend autoradiographisch sichtbar gemacht.", [["an der Schleife radioaktiv markiert", "TREATMENT", 51, 86]]], ["Die markierte Probe ist komplement\u00e4r zu den neusynthetisierten RNA-Molek\u00fclen an der DNA-Achse.", [["Die markierte Probe ist komplement\u00e4r zu den neusynthetisierten RNA-Molek\u00fclen an der DNA-Achse", "SPECIES", 0, 93]]], ["(Aus Gall et al. 1981) markierter RNA-Vorstufen (z.", [["Gall", "ANATOMY", 5, 9]]], ["B. 3 H-Uridin) f\u00fcr kurze Zeit (wenige Stunden) RNA synthetisieren (eine sogenannte Pulsmarkierung), so sind sie nur in einem Teilbereich, beginnend an einem Ende, radioaktiv markiert, wie die anschlie\u00dfende Autoradiographie zeigt.", [["Uridin", "TREATMENT", 7, 13]]], ["Die L\u00e4nge des radioaktiven Teilbereiches nimmt mit der Inkubationszeit zu, bis nach etwa 24 Stunden die gesamte Lampenb\u00fcrstenschleife radioaktiv markiert ist.", [["Die L\u00e4nge des radioaktiven Teilbereiches nimmt mit der Inkubationszeit zu, bis nach etwa 24 Stunden die gesamte Lampenb\u00fcrstenschleife radioaktiv markiert", "SPECIES", 0, 153]]], ["Der molekulare Mechanismus, der diesem Markierungsmuster zugrunde liegt, ist bisher nicht verstanden.Lampenb\u00fcrstenchromosomenWir m\u00fcssen Lampenb\u00fcrstenschleifen jedenfalls als aktive Gene ansehen.So stellt sich die Frage,welche Beziehung zwischen Lampenb\u00fcrstenschleifen und Genen besteht.", [["Der molekulare Mechanismus", "PROBLEM", 0, 26], ["Lampenb\u00fcrstenchromosomenWir", "TREATMENT", 101, 128], ["Lampenb\u00fcrstenschleifen jedenfalls", "TREATMENT", 136, 169]]], ["Durch in-situ-Hybridisierungsexperimente konnten Joseph G. Gall und seine Mitarbeiter zeigen, dass zumindest ein Teil der Schleifen mehrere Transkriptionseinheiten beherbergt.", [["Durch", "TREATMENT", 0, 5], ["Gall und seine Mitarbeiter zeigen", "TREATMENT", 59, 92], ["dass zumindest ein Teil", "TREATMENT", 94, 117], ["Gall", "ANATOMY", 59, 63]]], ["In der klassischen Cytologie ist man hingegen davon ausgegangen, dass Chromomeren die cytologischen chromosomalen \u00c4quivalente einzelner Gene sind.", [["man", "SPECIES", 33, 36]]], ["Inwieweit Lampenb\u00fcrstenschleifen (und Querscheiben in Riesenchromosomen) tats\u00e4chlich ausschlie\u00dflich mit den Chromomeren meiotischer Prophasechromosomen zu korrelieren sind, ist jedoch nach wie vor eine offene Frage.", [["tats\u00e4chlich ausschlie\u00dflich mit den Chromomeren meiotischer Prophasechromosomen zu korrelieren sind, ist jedoch nach wie vor eine offene Frage", "SPECIES", 73, 214], ["Inwieweit Lampenb\u00fcrstenschleifen (und Querscheiben in Riesenchromosomen)", "TREATMENT", 0, 72], ["ist jedoch nach", "TREATMENT", 173, 188]]], ["Eine v\u00f6llige \u00dcbereinstimmung eines Lampenb\u00fcrstenschleifenbereiches mit dem Bereich eines einzelnen Gens kann heute ausgeschlossen werden, wenn man ein Gen als die DNA-kodierende Region f\u00fcr ein Protein ansieht (s. auch Diskussion des Genbegriffes, S. 8).Lampenb\u00fcrstenchromosomenEs w\u00e4re mit Sicherheit eine grobe Vereinfachung, Lampenb\u00fcrstenschleifen einfach als Orte erh\u00f6hter Transkription zu betrachten.", [["Eine v\u00f6llige \u00dcbereinstimmung eines Lampenb\u00fcrstenschleifenbereiches mit dem Bereich eines einzelnen Gens kann heute ausgeschlossen werden, wenn man ein Gen als die DNA-kodierende Region f\u00fcr ein Protein ansieht (s. auch Diskussion des Genbegriffes, S. 8", "SPECIES", 0, 251], ["Lampenb\u00fcrstenchromosomenEs w\u00e4re mit Sicherheit eine grobe Vereinfachung, Lampenb\u00fcrstenschleifen einfach als Orte erh\u00f6hter Transkription zu betrachten", "SPECIES", 253, 402], ["Eine v\u00f6llige \u00dcbereinstimmung", "TREATMENT", 0, 28], ["kodierende Region", "TREATMENT", 167, 184], ["Lampenb\u00fcrstenchromosomenEs", "TEST", 253, 279]]], ["Ganz offenbar erf\u00fcllen sie f\u00fcr die Keimzellentwicklung wichtige Stoffwechselfunktionen.Lampenb\u00fcrstenchromosomenBesonders deutlich wird das an Lampenb\u00fcrstenschleifen, die von Fertilit\u00e4tsgenen im Y-Chromosom von Drosophila w\u00e4hrend des prim\u00e4ren Spermatocytenstadiums ausgebildet werden, wie Meyer, Hess und Beermann zu Beginn der 1960er Jahre feststellten.", [["Drosophila", "SPECIES", 210, 220], ["Lampenb\u00fcrstenchromosomenBesonders deutlich wird das an Lampenb\u00fcrstenschleifen, die von Fertilit\u00e4tsgenen im Y-Chromosom von Drosophila w\u00e4hrend des prim\u00e4ren Spermatocytenstadiums ausgebildet werden, wie Meyer, Hess und Beermann zu Beginn der 1960er Jahre feststellten", "SPECIES", 87, 352], ["Lampenb\u00fcrstenchromosomenBesonders", "TREATMENT", 87, 120]]], ["Offenbar ist die Ausbildung solcher gro\u00dfer Lampenb\u00fcrstenschleifen, wie sie besonders gut ausgebildet bei D. hydei gefunden werden, eine Besonderheit einer begrenzten Anzahl von Drosophila-Arten, w\u00e4hrend kleinere Schleifen des Y-Chromosoms wohl bei den meisten, wenn nicht allen Drosophila-Arten, zu finden sind.", [["Drosophila", "SPECIES", 177, 187], ["Drosophila", "SPECIES", 278, 288], ["wie sie besonders gut ausgebildet bei D. hydei gefunden werden, eine Besonderheit einer begrenzten Anzahl von Drosophila-Arten, w\u00e4hrend kleinere Schleifen des Y-Chromosoms wohl bei den meisten, wenn nicht allen Drosophila-Arten, zu finden sind", "SPECIES", 67, 310]]], ["Gro\u00dfe Lampenb\u00fcrstenschleifen in D. melanogaster, D. hydei und einigen anderen Arten enthalten mehr als 250 000 Basenpaare (bisweilen weit \u00fcber 1 000 000 bp) DNA, wie die elektronenmikroskopische Darstellung transkriptionsaktiver Lampenb\u00fcrstenschleifen beweist.", [["D. melanogaster", "ORGANISM", 32, 47], ["D. melanogaster", "SPECIES", 32, 47], ["D. melanogaster", "SPECIES", 32, 47], ["Basenpaare (bisweilen weit \u00fcber", "TREATMENT", 111, 142], ["DNA", "PROBLEM", 157, 160]]], ["Die DNA dieser Y-chromosomalen Lampenb\u00fcrstenschleifen ist in sehr komplexer Weise aus repetitiven (wiederholten) DNA-Sequenzen aufgebaut.Lampenb\u00fcrstenchromosomenNeuerdings wurde ein Dynein-Gen im Y-Chromosom nachgewiesen.", [["DNA", "CELLULAR_COMPONENT", 113, 116], ["Lampenb\u00fcrstenchromosomen", "TEST", 137, 161]]], ["Es ist jedoch fraglich, ob dieses Gen einer Transkriptionseinheit innerhalb einer Lampenb\u00fcrstenschleife zugeordnet werden kann.", [["Es ist jedoch fraglich", "TREATMENT", 0, 22], ["ob", "ANATOMY", 24, 26]]], ["Vieles spricht daf\u00fcr, dass diese riesigen Transkriptionseinheiten, die die Lampenb\u00fcrstenschleifen bilden, in ihrer Hauptfunktion keine Protein-kodierenden Eigenschaften aufweisen.", [["Protein", "TEST", 135, 142]]], ["Sie tragen also zu einer Kompartimentierung des Kerns bei, wie sie in letzter Zeit f\u00fcr verschiedene Molek\u00fcle beobachtet wurde.Lampenb\u00fcrstenchromosomenMan kann daher diese Lampenb\u00fcrstenschleifen auch als ein weiteres Beispiel f\u00fcr \u00fcbergeordnete Funktionen von Chromosomen im Kernstoffwechsel ansehen, wie wir sie in der Bindung von Lamin an die Chromosomen \u00fcber die Mitose hinweg erw\u00e4hnen (s.", [["Man", "SPECIES", 150, 153], ["Lampenb\u00fcrstenchromosomenMan kann daher diese Lampenb\u00fcrstenschleifen auch als ein weiteres Beispiel f\u00fcr \u00fcbergeordnete Funktionen von Chromosomen im Kernstoffwechsel ansehen, wie wir sie in der Bindung von Lamin an die Chromosomen \u00fcber die Mitose hinweg erw\u00e4hnen (s.", "SPECIES", 126, 390], ["Lampenb\u00fcrstenchromosomen", "TREATMENT", 126, 150]]], ["Jede dieser Schleifen ist einer der Chromatiden zuzuordnen.Polyt\u00e4ne Chromosomen (Riesenchromosomen)Ein anderer Typ von cytologisch ungew\u00f6hnlichen Chromosomen l\u00e4sst sich in manchen Geweben, vor allem von Insekten, beobachten.", [["Jede dieser Schleifen ist einer der Chromatiden zuzuordnen", "TREATMENT", 0, 58], ["Polyt\u00e4ne", "TEST", 59, 67], ["Chromosomen", "TEST", 68, 79], ["beobachten", "TREATMENT", 213, 223]]], ["7.18 (Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 6, 9]]], ["Bei Einstellung der Transkription erfolgt eine Kondensation der chromosomalen DNA und damit eine R\u00fcckbildung in die st\u00e4rker lichtbrechenden Querscheiben.Polyt\u00e4ne Chromosomen (Riesenchromosomen)Die Tatsache, dass in Riesenchromosomen eine intensive RNA-Synthese zu beobachten ist, kennzeichnet diese Chromosomen als Interphasechromosomen.", [["Bei Einstellung der Transkription erfolgt eine Kondensation", "TREATMENT", 0, 59]]], ["Sie durchlaufen also gewisserma\u00dfen sich wiederholende S-Phasen, ohne zwischendurch einen vollen Zellzyklus, der eine Mitose beinhaltet, abzuschlie\u00dfen.", [["abzuschlie\u00dfen", "TREATMENT", 136, 149]]], ["Messungen des DNA-Gehaltes haben ergeben, dass die Vermehrung der DNA in den Riesenchromosomen mit dem Faktor 2 n erfolgt.", [["den Riesenchromosomen mit dem Faktor 2 n erfolgt", "SPECIES", 73, 121]]], ["Die Anzahl der Verdoppelungsschritte (n) kann mehr als 13 betragen, so dass der Polyt\u00e4niegrad in diesem Fall \u00fcber 8192 liegt.", [["Die Anzahl der Verdoppelungsschritte (n) kann mehr als 13 betragen", "SPECIES", 0, 66], ["Die Anzahl der Verdoppelungsschritte (n) kann mehr als", "TREATMENT", 0, 54]]], ["Solche Polyt\u00e4niegrade findet man in Speicheldr\u00fcsenchromosomen Vergleichen wir einen mitotischen Metaphasechromosomensatz mit einem Riesenchromosomensatz aus den Speicheldr\u00fcsen von Drosophila (Abb.", [["man", "SPECIES", 29, 32], ["Drosophila", "SPECIES", 180, 190], ["Solche", "TREATMENT", 0, 6], ["Speicheldr\u00fcsenchromosomen Vergleichen", "TREATMENT", 36, 73], ["Metaphasechromosomensatz mit einem Riesenchromosomensatz aus", "TREATMENT", 96, 156]]], ["Somatische Paarung ist eine Besonderheit von Drosophila und anderen Insekten.", [["Drosophila", "SPECIES", 45, 55], ["Somatische", "TREATMENT", 0, 10]]], ["7.23), vergleichbar der Struktur, die beim Vorliegen von Inver-sionsheterozygotie w\u00e4hrend der Homologenpaarung in der meiotischen Prophase I auftritt (s.", [["vergleichbar der Struktur", "PROBLEM", 7, 32], ["die", "PROBLEM", 34, 37]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["Liegt eine Deletion in einem der Homologen vor, bildet sich eine Paarungsl\u00fccke.Polyt\u00e4ne Chromosomen (Riesenchromosomen)Solche Heterozygotien waren von gro\u00dfer Bedeutung f\u00fcr die praktische genetische Arbeit, da sie die cytologische Kartierung von Genen sehr erleichterten (Abb.", [["Polyt\u00e4ne Chromosomen (Riesenchromosomen)", "TREATMENT", 79, 119]]], ["7.24 Df(1)w rJ1Polyt\u00e4ne Chromosomen (Riesenchromosomen)Df (1)62g18 Df (1) kation oder Inversion) in eine neue chromosomale Position verlagert wird.Dieser inaktivierende Einfluss der Umgebung ist jedoch oft nicht vollst\u00e4ndig, so dass in einigen Zellen noch Genexpression beobachtet wird, w\u00e4hrend sie in andern unterdr\u00fcckt ist.", [["Df", "TEST", 5, 7], ["w rJ1Polyt\u00e4ne Chromosomen (Riesenchromosomen", "TREATMENT", 10, 54], ["kation oder Inversion", "TREATMENT", 74, 95]]], ["Die Querscheibenstruktur wird in einem Teil der Kerne in solchen Chromosomenabschnitten aufgegeben und ist der Struktur von \u03b2-Heterochromatin vergleichbar.", [["solchen Chromosomenabschnitten aufgegeben und ist der Struktur von \u03b2-Heterochromatin vergleichbar", "SPECIES", 57, 154], ["Heterochromatin vergleichbar", "OBSERVATION", 126, 154]]], ["Im Riesenchromosom werden solche strukturellen Chromosomenver\u00e4nderungen, die normalerweise allenfalls aufgrund ph\u00e4notypischer Effekte erkennbar sind, direkt sichtbar.Polyt\u00e4ne Chromosomen (Riesenchromosomen)Eine zus\u00e4tzliche Einschr\u00e4nkung erf\u00e4hrt die Annahme, dass alle Chromosomenbereiche w\u00e4hrend der Polyt\u00e4nisierung gleichm\u00e4\u00dfig replizieren, durch Beobachtungen,nach denen einzelne Querscheiben oder kleine Bereiche mit mehreren Querscheiben nur teilweise an der Polyt\u00e4nisierung teilnehmen.", [["Polyt\u00e4ne Chromosomen (Riesenchromosomen)", "TREATMENT", 166, 206], ["durch Beobachtungen", "TREATMENT", 341, 360], ["an der Polyt\u00e4nisierung teilnehmen", "TREATMENT", 455, 488]]], ["Kann man f\u00fcr heterochromatische Chromosomenabschnitte den Ausschluss von der Replikation vom funktionellen Standpunkt her noch verstehen, da solche Bereiche im Allgemeinen keine,oder in den polyt\u00e4nen Zellen nicht relevante Gene enthalten, so ist die Ursache und der Mechanismus f\u00fcr die partielle Unterreplikation euchromatischer Chromosomenbereiche ebenso unverstanden wie deren strukturelle Grundlage.", [["man", "SPECIES", 5, 8]]], ["Man ist bisher davon ausgegangen, dass in solchen Regionen die Kontinuit\u00e4t der chromosomalen DNA in einem Teil der Chromatiden unterbrochen ist.", [["Man", "SPECIES", 0, 3]]], ["Es kann jedoch auch zum Ausschluss von DNA-Abschnitten von der Replikation kommen,wobei die flankierenden DNA-Abschnitte anschlie\u00dfend wieder kovalent miteinander verbunden werden, so dass die Kontinuit\u00e4t der chromosomalen DNA wiederhergestellt wird.Polyt\u00e4ne Chromosomen (Riesenchromosomen)In anderen F\u00e4llen hat man \u00fcbrigens eine entgegengesetzte Situation gefunden: die \u00dcberreplikation von Chromosomenbereichen mit der Folge einer Erh\u00f6hung der Kopienzahl bestimmter Gene, beispielsweise der Choriongene in den Follikelzellen des Drosophila-Ovars (s.", [["man", "SPECIES", 311, 314], ["Drosophila", "SPECIES", 529, 539], ["Es kann jedoch", "TREATMENT", 0, 14], ["von Chromosomenbereichen mit der Folge einer Erh\u00f6hung der Kopienzahl bestimmter Gene", "TREATMENT", 386, 470]]], ["Wir werden sp\u00e4ter noch weitere Gesichtspunkte solch einer Flexibilit\u00e4t des Genoms auf dem DNA-Niveau besprechen.Polyt\u00e4ne Chromosomen (Riesenchromosomen)Fragt man nach dem funktionellen Hintergrund der partiellen Unterreplikation, so wird man wohl davon ausgehen m\u00fcssen, dass hierbei quantitative Fragen der Genexpression eine Rolle spielen.", [["man", "SPECIES", 158, 161], ["Gesichtspunkte solch einer Flexibilit\u00e4t des Genoms auf dem DNA-Niveau besprechen", "SPECIES", 31, 111]]], ["Vielleicht sind die normalen Regulationsmechanismen dieser Gene nicht in der Lage, die zellspezifisch erforderliche Aktivit\u00e4t dieser Gene mit der erh\u00f6hten Gendosis nach der Polyt\u00e4nisierung regulativ in Einklang zu bringen.", [["Einklang zu bringen", "SPECIES", 202, 221], ["Vielleicht sind die", "TREATMENT", 0, 19], ["Gene mit der erh\u00f6hten Gendosis nach der Polyt\u00e4nisierung regulativ", "TREATMENT", 133, 198]]], ["Die Folge k\u00f6nnte sein, dass eine Regulation der Anzahl verf\u00fcgbarer Genkopien durch Regulation des Polyt\u00e4niegrades stattfindet, \u00e4hnlich wie der hohe Bedarf an Chorionproteinen in Drosophila-Ovarien durch eine intrachromosomale \u00dcberreplikation der erforderlichen Gene erzielt wird.Polyt\u00e4ne Chromosomen (Riesenchromosomen)Angesichts dieser Beobachtungen lokaler Unterschiede der DNA-Replikation selbst in mitotischen Chromosomen ist es wichtig festzustellen, dass alle experimentellen Daten daf\u00fcr sprechen, dass eine Chromatide im Normalfall aus einer einzigen kovalent hindurchlaufenden DNA-Doppelhelix besteht.Polyt\u00e4ne Chromosomen (Riesenchromosomen)In unserer bisherigen Besprechung von Riesenchromosomen haben wir Puffs als Orte intensiver RNA-Synthese kennengelernt.", [["Drosophila", "SPECIES", 178, 188], ["Besprechung von Riesenchromosomen haben wir Puffs als Orte intensiver RNA-Synthese kennengelernt", "SPECIES", 671, 767], ["dass eine Regulation", "TREATMENT", 23, 43], ["Genkopien durch Regulation des", "TREATMENT", 67, 97], ["an Chorionproteinen in Drosophila", "TREATMENT", 155, 188], ["Ovarien durch eine intrachromosomale \u00dcberreplikation", "TREATMENT", 189, 241], ["Polyt\u00e4ne", "TEST", 279, 287], ["Chromosomen", "TEST", 288, 299], ["Riesenchromosomen", "TEST", 301, 318], ["Angesichts", "TEST", 319, 329], ["Polyt\u00e4ne Chromosomen (Riesenchromosomen)", "TREATMENT", 609, 649]]], ["Klassische Cytologen wie Breuer und Pavan,sp\u00e4ter auch Swift,Gabrusewicz-Garcia,Crouse und Keyl,haben jedoch bereits fr\u00fchzeitig erkannt, dass es in Insektenpolyt\u00e4nchromosomen auch Puffs gibt, in denen eine \u00dcberreplikation der DNA (DNA-Puffs) stattfindet, die vergleichbar ist mit der \u00dcberreplikation der Choriongene in ovarialen Follikelzellen von Drosophila.", [["Drosophila", "SPECIES", 347, 357], ["Klassische", "TEST", 0, 10], ["Cytologen", "TEST", 11, 20]]], ["7.2 Variabilit\u00e4t der Chromosomen und Dosiskompensation Besonders auffallend und daher besonders ausgiebig untersucht sind diese DNA-Puffs in Larven von Sciara-und Rhynchosciara-Arten (Trauerm\u00fccken der Familie Sciaridae).", [["Variabilit\u00e4t der Chromosomen", "TEST", 4, 32], ["Dosiskompensation", "TEST", 37, 54], ["ausgiebig", "TEST", 96, 105], ["DNA", "TEST", 128, 131], ["von Sciara", "TEST", 148, 158]]], ["Larvenstadiums (Tag 62 der larvalen Entwicklung) gleichzeitig mehrere gro\u00dfe Puffs gebildet, die sich w\u00e4hrend der Pr\u00e4puppenperiode allm\u00e4hlich wieder zur\u00fcckbilden (Abb.", [["Larvenstadiums (Tag 62 der larvalen Entwicklung)", "TREATMENT", 0, 48]]], ["Gleichzeitig erfolgt eine intensive Transkription, die mRNA f\u00fcr Sekretproteine liefert.", [["Gleichzeitig erfolgt eine", "CHEMICAL", 0, 25], ["Gleichzeitig", "TREATMENT", 0, 12]]], ["Diese fibrill\u00e4ren Sekretproteine sind in gro\u00dfen Mengen zur Bildung des Kokons erforderlich (s. auch S. 314f).", [["gro\u00dfen Mengen zur Bildung des Kokons erforderlich (s. auch S. 314f", "SPECIES", 41, 107], ["Diese fibrill\u00e4ren Sekretproteine", "TREATMENT", 0, 32]]], ["Andere Mechanismen neben der hier erw\u00e4hnten intrachromosomalen \u00dcberreplikation, auch Amplifikation genannt, zur Erh\u00f6hung der Stoffwechselleistung eines bestimmten Gens sind neben der Polyt\u00e4nisierung von Chromosomen die Polyploidisierung und die extrachromosomale Amplifikation.", [["Andere Mechanismen neben der hier erw\u00e4hnten intrachromosomalen \u00dcberreplikation, auch Amplifikation genannt, zur Erh\u00f6hung der Stoffwechselleistung eines bestimmten Gens sind neben der Polyt\u00e4nisierung von Chromosomen die Polyploidisierung und die extrachromosomale Amplifikation", "SPECIES", 0, 276]]], ["F\u00fcr diese alternativen Wege der Erh\u00f6hung der Anzahl der DNA-Templates f\u00fcr mRNA-Synthese werden wir an anderen Stellen noch Beispiele besprechen (Kap.", [["mRNA", "TEST", 74, 78], ["Synthese", "TREATMENT", 79, 87]]], ["Eine andere M\u00f6glichkeit zur Deckung eines hohen Bedarfs an bestimmten Molek\u00fclen ist der Import dieser Molek\u00fcle aus Hilfszellen.", [["Eine andere M\u00f6glichkeit zur Deckung eines", "TREATMENT", 0, 41], ["an bestimmten Molek\u00fclen ist", "TREATMENT", 56, 83]]], ["Ein Beispiel f\u00fcr einen solchen Fall ist die Funktion der N\u00e4hr-und Follikelzellen w\u00e4hrend der Oogenese von Drosophila (Kap.", [["Drosophila", "SPECIES", 106, 116], ["Beispiel f\u00fcr einen solchen Fall ist die Funktion der N\u00e4hr-und Follikelzellen w\u00e4hrend der Oogenese von Drosophila", "SPECIES", 4, 116]]], ["Man unterscheidet aufgrund des unterschiedlichen Unterreplikationsverhaltens zwischen \u03b1und \u03b2-Heterochromatin. \u03b1-Heterochromatin nimmt an der Polyt\u00e4nisierung nicht teil.Keimbahn-limitierte ChromosomenWie so oft in der Biologie, gilt auch hier die Regel, dass alle Zellen eines mehrzelligen Organismus \u00fcber einen vollst\u00e4ndigen Chromosomensatz verf\u00fcgen, nur mit Einschr\u00e4nkungen.", [["Man", "SPECIES", 0, 3], ["Heterochromatin", "PROBLEM", 93, 108], ["Heterochromatin", "PROBLEM", 112, 127], ["an der Polyt\u00e4nisierung nicht teil", "TREATMENT", 134, 167], ["Heterochromatin", "OBSERVATION", 93, 108], ["Heterochromatin", "OBSERVATION", 112, 127]]], ["Die auff\u00e4lligsten Abweichungen von dieser Regel beobachtet man in Keimzellen mancher Organismen.", [["man", "SPECIES", 59, 62]]], ["In den einfachsten F\u00e4llen findet man hier zus\u00e4tzliche Chromosomen, deren Anzahl und Gr\u00f6\u00dfe mehr oder weniger variieren kann.", [["man", "SPECIES", 33, 36]]], ["Man spricht auch von \u00fcberz\u00e4hligen Chromosomen, Extrachromosomen (E-Chromosomen) oder, wenn sie in somatischen Zellen nicht zu finden sind, von Keimbahn-limitierten Chromosomen.", [["von Keimbahn-limitierten Chromosomen", "CELL", 139, 175], ["Man", "SPECIES", 0, 3]]], ["In der cytologischen Nomenklatur werden sie auch h\u00e4ufig als B-Chromosomen bezeichnet.", [["B-Chromosomen bezeichnet", "CELL", 60, 84]]], ["Prinzipielle Unterschiede zwischen diesen Chromosomen betreffen wahrscheinlich ausschlie\u00dflich den Verteilungsmechanismus, der f\u00fcr ihre Elimination aus somatischen Zellen verantwortlich ist.", [["Prinzipielle", "TREATMENT", 0, 12]]], ["Sie werden daher im Fol-Abb.", [["Fol-Abb", "GENE_OR_GENE_PRODUCT", 20, 27], ["Abb", "PROTEIN", 24, 27]]], ["DNA-Puffs in Rhynchosciara.", [["DNA", "CELLULAR_COMPONENT", 0, 3], ["DNA", "PROBLEM", 0, 3]]], ["Die Folge von Riesenchromosomen aus Speicheldr\u00fcsen von Rhynchosciara angelae zeigt die allm\u00e4hliche Ausbildung eines DNA-Puffs im Laufe der Entwicklung der Larve.", [["Die Folge von Riesenchromosomen aus Speicheldr\u00fcsen von Rhynchosciara angelae zeigt die allm\u00e4hliche Ausbildung eines DNA-Puffs im Laufe der Entwicklung der Larve", "SPECIES", 0, 160]]], ["Die Puffs bilden sich nach ihrer Aktivit\u00e4tsphase zu normalen Querscheiben zur\u00fcck, die aber nun durch einen erh\u00f6hten DNA-Gehalt gekennzeichnet sind.", [["Aktivit\u00e4tsphase", "TREATMENT", 33, 48]]], ["Pavan 1955) genden als biologisch prinzipiell gleichwertig betrachtet.Keimbahn-limitierte ChromosomenBesonders gut untersucht sind die B-Chromosomen von Zuckm\u00fccken der Familie Orthocladiinae (Dipteren), deren Anzahl sich mit einer gewissen Variationsbreite bei etwa 100 je Keimzelle stabilisiert.", [["Anzahl sich mit einer gewissen Variationsbreite bei etwa 100 je Keimzelle stabilisiert", "SPECIES", 209, 295], ["Pavan", "TREATMENT", 0, 5], ["Keimbahn", "TEST", 70, 78]]], ["Hans Bauer hat in genetischen Experimenten gezeigt, dass diese Chromosomen f\u00fcr die Fertilit\u00e4t der Individuen unentbehrlich sind.Keimbahn-limitierte ChromosomenB-Chromosomen kommen besonders h\u00e4ufig bei Pflanzen vor.", [["Keimbahn", "SIMPLE_CHEMICAL", 128, 136], ["Keimbahn", "TEST", 128, 136], ["ChromosomenB", "TEST", 148, 160]]], ["Vielleicht sind sie in ihrer Funktion intrachromosomalen heterochromatischen Chromosomenbereichen anderer Organismen vergleichbar, die anscheinend eine keimbahnspezifische Funktion haben.", [["Vielleicht", "TEST", 0, 10]]], ["Hinweise auf die Existenz solcher Bereiche geben Organismen, bei denen heterochromatische Chromosomenabschnitte bei der Entstehung somatischer Zellen w\u00e4hrend der Fr\u00fchentwicklung aus dem Genom eliminiert werden.Keimbahn-limitierte ChromosomenDie bisher erw\u00e4hnten Keimbahnchromosomen kommen h\u00e4ufig in nicht genau festgelegter Anzahl im Genom der Keimbahn vor, und sie gehen bei der Bildung somatischer Zellen im fr\u00fchen Embryo offenbar nicht durch gerichtete Eliminationsmechanismen, sondern einfach durch das Fehlen eines geregelten Verteilungsmechanismus verloren.", [["Hinweise auf die Existenz solcher Bereiche geben Organismen, bei denen heterochromatische Chromosomenabschnitte bei der Entstehung somatischer Zellen w\u00e4hrend der Fr\u00fchentwicklung aus dem Genom eliminiert werden", "SPECIES", 0, 209], ["Keimbahn", "TEST", 210, 218]]], ["S. 179).Keimbahn-limitierte ChromosomenEs gibt jedoch auch keimbahnspezifische Chromosomen, sogenannte limitierte Chromosomen (L-Chromosomen), die in den Keimzellen durch besondere Mechanismen verteilt werden.", [["Keimbahn", "TEST", 8, 16], ["ChromosomenEs", "TEST", 28, 41]]], ["Somatisch besteht das Genom von Sciara coprophila aus drei Autosomenpaaren und einem X-Chromosom im m\u00e4nnlichen Soma oder zwei X-Chromoso-men in weiblichen Somazellen.", [["men", "SPECIES", 137, 140], ["Sciara coprophila aus drei Autosomenpaaren und einem X-Chromosom im m\u00e4nnlichen Soma oder zwei X-Chromoso-men in weiblichen", "SPECIES", 32, 154], ["Somatisch", "TEST", 0, 9], ["Sciara", "TEST", 32, 38], ["coprophila", "TEST", 39, 49], ["aus", "TEST", 50, 53], ["Autosomenpaaren", "TEST", 59, 74], ["einem", "TEST", 79, 84], ["Chromosom", "TEST", 87, 96]]], ["Ungew\u00f6hnlich ist nun bereits, dass in (haploiden) Spermatozoen neben je einem Autosom zwei X-Chromosomen (m\u00fctterlichen Ursprungs) vorhanden sind, w\u00e4hrend ein (haploides) Ei einen Autosomensatz, jedoch nur ein X-Chromosom besitzt.", [["Ei einen Autosomensatz, jedoch nur ein X-Chromosom besitzt", "SPECIES", 170, 228], ["dass in (haploiden", "TREATMENT", 30, 48], ["Spermatozoen", "TREATMENT", 50, 62], ["Chromosomen (m\u00fctterlichen Ursprungs", "TREATMENT", 93, 128]]], ["Als Folge dieser Geschlechtschromosomenkonstitution erh\u00e4lt die Zygote drei X-Chromosomen.", [["Als Folge dieser Geschlechtschromosomenkonstitution", "PROBLEM", 0, 51]]], ["Je nach Geschlecht werden ein oder zwei der X-Chromosomen w\u00e4hrend der fr\u00fchen Furchungsteilungen bei der Bildung somatischer Zellen eliminiert.", [["Je nach Geschlecht werden ein oder zwei der X-Chromosomen w\u00e4hrend der fr\u00fchen Furchungsteilungen bei der Bildung somatischer Zellen eliminiert", "SPECIES", 0, 141]]], ["Der zur Elimination erforderliche Mechanismus kann zwischen den X-Chromosomen m\u00e4nnlichen und weiblichen Ursprungs unterscheiden, denn im M\u00e4nnchen bleibt stets das m\u00fctterliche X-Chromosom somatisch erhalten, w\u00e4hrend im weiblichen Soma stets ein X-Chromosom m\u00fctterlichen und eines v\u00e4terlichen Ursprungs zu finden ist.", [["Der zur Elimination erforderliche Mechanismus kann zwischen den X-Chromosomen m\u00e4nnlichen und weiblichen Ursprungs unterscheiden, denn im M\u00e4nnchen bleibt stets das m\u00fctterliche X-Chromosom somatisch erhalten, w\u00e4hrend im weiblichen Soma stets ein X-Chromosom m\u00fctterlichen und eines v\u00e4terlichen Ursprungs zu finden", "SPECIES", 0, 310]]], ["Die X-Chromosomen m\u00fcssen also in ihrem Ursprung gekennzeichnet sein, ein Zustand, den man mit dem Begriff Imprinting charakterisiert (s.", [["ihrem Ursprung gekennzeichnet sein, ein Zustand, den man mit dem Begriff Imprinting charakterisiert (s.", "SPECIES", 33, 136]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["Ein solches chromosomales Imprinting scheint auch bei den Autosomen vorzuliegen, denn die Autosomen in den Spermatozoen sind stets m\u00fctterlichen Ursprungs.Keimbahn-limitierte ChromosomenDiese bereits hochgradig spezialisierte Chromosomenkonstitution wird noch zus\u00e4tzlich durch die Anwesenheit keimbahnlimitierter Chromosomen (limitierter Chromosomen) kompliziert.", [["Keimbahn-limitierte ChromosomenDiese bereits hochgradig spezialisierte Chromosomenkonstitution wird noch zus\u00e4tzlich durch die Anwesenheit keimbahnlimitierter Chromosomen (limitierter Chromosomen) kompliziert", "SPECIES", 154, 361], ["Ein solches chromosomales", "TREATMENT", 0, 25], ["Keimbahn", "TEST", 154, 162]]], ["Zellteilung, noch vor der Elimination der X-Chromosomen, aus den somatischen Zellen entfernt.", [["noch vor der Elimination der X-Chromosomen, aus den somatischen Zellen entfernt", "SPECIES", 13, 92], ["Zellteilung", "TREATMENT", 0, 11], ["aus", "PROBLEM", 57, 60]]], ["Im Gegensatz zu den fr\u00fcher beschriebenen B-Chromosomen werden die limitierten Chromosomen gezielt eliminiert.", [["Im Gegensatz zu den fr\u00fcher beschriebenen B-Chromosomen werden die limitierten Chromosomen gezielt eliminiert", "SPECIES", 0, 108]]], ["Sie durchlaufen einen normalen Zellzyklus bis zur Metaphase, bleiben dann aber zwischen den Tochterzellkernen liegen, da die Chromosomenenden sich offenbar nicht in zwei Chromatiden spalten und dadurch voneinander trennen k\u00f6nnen.", [["Sie durchlaufen einen", "TREATMENT", 0, 21]]], ["Der zugrundeliegende molekulare Mechanismus ist unbekannt.Keimbahn-limitierte ChromosomenAuch in der m\u00e4nnlichen Keimbahn erfolgen mehrere komplexe Eliminationsschritte.", [["Keimbahn", "TEST", 58, 66]]], ["Zun\u00e4chst wird eines der L-Chromosomen entfernt, in einem n\u00e4chsten Schritt verliert die Zelle eines der v\u00e4terlichen X-Chromosomen.", [["Zun\u00e4chst wird eines der L-Chromosomen entfernt", "TREATMENT", 0, 46]]], ["Diese ersten Eliminationsschritte erfolgen w\u00e4hrend der Spermatogonienmitosen.", [["Spermatogonienmitosen", "CHEMICAL", 55, 76]]], ["Die \u00fcbrigen Eliminationsereignisse fallen ins Spermato-7. und Weibchen unterscheiden sich lediglich in der Elimination der X-Chromosomen: Im M\u00e4nnchen werden beide paternalen X-Chromosomen eliminiert und nur das maternale X-Chro-mosom bleibt erhalten, w\u00e4hrend im Weibchen eines der paternalen X-Chromosomen im Genom verbleibt.", [["und Weibchen unterscheiden sich lediglich in der Elimination der X-Chromosomen: Im M\u00e4nnchen werden beide paternalen X-Chromosomen eliminiert und nur das maternale X-Chro-mosom bleibt erhalten, w\u00e4hrend im Weibchen eines der paternalen X-Chromosomen im Genom verbleibt", "SPECIES", 58, 324]]], ["In einer ersten meiotischen Teilung (Abb.", [["einer ersten meiotischen Teilung", "CELL", 3, 35], ["Abb", "GENE_OR_GENE_PRODUCT", 37, 40]]], ["7.29) , die als monozentrische Mitose verl\u00e4uft, werden die v\u00e4terlichen Chromosomen von den Homologen m\u00fctterlicher Herkunft getrennt, wobei alle verbliebenen L-Chromosomen unabh\u00e4ngig von ihrem Ursprung mit den m\u00fctterlichen Chromosomen segregieren.", [["von den Homologen m\u00fctterlicher Herkunft getrennt, wobei alle verbliebenen L-Chromosomen unabh\u00e4ngig von ihrem Ursprung mit den m\u00fctterlichen Chromosomen segregieren", "SPECIES", 83, 245]]], ["Die v\u00e4terlichen Chromosomen sammeln sich in einem kleinen Eliminationsvesikel und degenerieren.", [["sich", "PROBLEM", 36, 40]]], ["Aus dieser Teilung entsteht demnach eine einzige sekund\u00e4re Spermatocyte.", [["Aus", "TEST", 0, 3]]], ["Diese teilt sich mittels einer normalen bipolaren Spindel (Abb.", [["Abb", "PROTEIN", 59, 62]]], ["Hierbei erf\u00e4hrt jedoch das X-Chromosom, das den \u00fcbrigen Chromosomen in der Verteilung vorausl\u00e4uft, keine Chromatidenverteilung, wie sie f\u00fcr die \u00fcbrigen Chromosomen stattfindet, sondern beide Chromatiden werden zusammen an einen Pol verlagert.", [["Hierbei erf\u00e4hrt jedoch das X-Chromosom, das den \u00fcbrigen Chromosomen in der Verteilung vorausl\u00e4uft, keine Chromatidenverteilung, wie sie f\u00fcr die \u00fcbrigen Chromosomen stattfindet, sondern beide Chromatiden werden zusammen an einen Pol verlagert", "SPECIES", 0, 241]]], ["Die Zelle, die diesen Zellkern erh\u00e4lt, wird zum Spermatozoon, w\u00e4hrend die andere Zelle degeneriert.Keimbahn-limitierte ChromosomenDer komplizierte Eliminationsmechanismus hat sich offenbar in einer Reihe verwandter Nematoce-ren-Arten erhalten.", [["Keimbahn", "TEST", 99, 107]]], ["Wie schon im Falle der B-Chromosomen m\u00fcssen wir davon ausgehen, dass die heterochromatischen L-Chromosomen in der Keimbahn eine biologische Funktion haben.Keimbahn-limitierte ChromosomenVon der ungew\u00f6hnlichen Chromosomenkonstitution von Sciara ist der Schritt zu den vielerlei Anomalien, die wir bei verwandten Dipterengruppen antreffen, nicht weit.", [["Keimbahn-limitierte ChromosomenVon der ungew\u00f6hnlichen Chromosomenkonstitution von Sciara ist der Schritt zu den vielerlei Anomalien, die wir bei verwandten Dipterengruppen antreffen", "SPECIES", 155, 336], ["Keimbahn", "TEST", 155, 163]]], ["Es sollen an dieser Stelle jedoch nur noch die Chromosomenverh\u00e4ltnisse von Schildl\u00e4usen (Sternorrhynchi: Coccidina) dargestellt werden, da sie ein klassisches Beispiel f\u00fcr chromosomales Imprinting sind.Keimbahn-limitierte ChromosomenIn beiden Geschlechtern findet man in somatischen Zellen 2n = 10 Chromosomen.", [["man", "SPECIES", 264, 267], ["Keimbahn", "TEST", 202, 210]]], ["W\u00e4hrend diese im Weibchen ein normales Verhalten im Zellzyklus aufweisen, bleibt im m\u00e4nnlichen Soma die H\u00e4lfte der Chromosomen heterochromatisch und verschmilzt in einem Chromozentrum des Interphasekerns (Abb.", [["diese", "TEST", 8, 13], ["der Chromosomen heterochromatisch", "PROBLEM", 111, 144]]], ["Auch die zweite meiotische Teilung ist nicht nur dadurch abnormal, dass hier nun die Homologen getrennt werden, sondern deren Verteilung auf die Tochterzellen ist nicht zufallsgem\u00e4\u00df.", [["dadurch abnormal", "DISEASE", 49, 65], ["zweite meiotische Teilung ist nicht nur dadurch abnormal, dass hier nun die Homologen getrennt werden, sondern deren Verteilung auf die Tochterzellen ist nicht zufallsgem\u00e4\u00df", "SPECIES", 9, 181]]], ["Nur die Tochterzelle mit den euchromatischen Chromosomen ist in der Lage, ein funktionelles Spermatozoon zu bilden, w\u00e4hrend die andere Zelle degeneriert.Keimbahn-limitierte ChromosomenWas unterscheidet nun die beiden Chromosomens\u00e4tze und was ist die Ursache f\u00fcr die Heterochromatisierung eines der haploiden Komplemente im M\u00e4nnchen?", [["Keimbahn-limitierte ChromosomenWas unterscheidet nun die beiden Chromosomens\u00e4tze und was ist die Ursache f\u00fcr die Heterochromatisierung eines der haploiden Komplemente im M\u00e4nnchen", "SPECIES", 153, 331], ["Keimbahn", "TEST", 153, 161]]], ["Bestrahlt man elterliche Tiere und untersucht die Nachkommen cytologisch, findet man, je nach Dosis der R\u00f6ntgenbestrahlung (s.", [["man", "SPECIES", 10, 13]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["10 .28), Chromosomenaberrationen.", [["Chromosomenaberrationen", "CHEMICAL", 9, 32], ["Chromosomenaberrationen", "PROBLEM", 9, 32]]], ["Bestrahlt man M\u00e4nnchen mit erh\u00f6hten Dosen, beobachtet man eine zunehmende Letalit\u00e4t weiblicher Nachkommen, w\u00e4hrend die \u00dcberlebensrate m\u00e4nnlicher Nachkommen nicht beeinflusst wird.", [["man", "SPECIES", 10, 13]]], ["Das bedeutet, dass der Chromosomensatz v\u00e4terlicher Herkunft im M\u00e4nnchen heterochromatisch wird und offenbar, zumindest in somatischen Zellen, nicht funktionell ist.Keimbahn-limitierte ChromosomenEs liegt hier, wie schon bei Sciara, ein chromosomales Imprinting vor, das den Nachkommen gestattet, zwischen Chromosomen v\u00e4terlicher (paternaler) und m\u00fctterlicher (maternaler) Herkunft zu unterscheiden.", [["Keimbahn", "TEST", 164, 172]]], ["Fr\u00fchere Annahmen, dass Methylierung der DNA f\u00fcr das Imprinting in Coccidenchromosomen verantwortlich ist, scheinen sich nicht zu best\u00e4tigen.Keimbahn-limitierte ChromosomenDie Tatsache, dass Mutationen im heterochromatischen Zustand der Chromosomen nicht zur Auspr\u00e4gung kommen, ist ein weiterer Beweis f\u00fcr funktionelle Inaktivit\u00e4t heterochromatisierter Chromosomen.", [["Keimbahn", "TEST", 140, 148]]], ["Die inaktivierten (v\u00e4terlichen) Chromosomen der Coccidenm\u00e4nnchen sind zudem ein weiteres Beispiel f\u00fcr fakultatives Heterochromatin.", [["Heterochromatin", "PROBLEM", 115, 130]]], ["Meiose IMeiose IIAbb.", [["IIAbb", "PROTEIN", 15, 20]]], ["Schematische Darstellung der ersten und zweiten meiotischen Teilung in der m\u00e4nnlichen Keimbahn von Sciara coprophila (vgl.", [["Sciara coprophila", "SPECIES", 99, 116], ["Sciara coprophila", "SPECIES", 99, 116], ["Schematische", "TEST", 0, 12]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["Oben: In der ersten meiotischen Teilung bildet sich eine monopolare Spindel, die die noch vorhandenen L-Chromosomen, das m\u00fctterliche X-Chromosom und ein Homologes jedes der zwei Autosomenpaare zum Pol wandern l\u00e4sst, w\u00e4hrend die \u00fcbrigen vier Chromosomen aus der Zelle eliminiert werden.", [["noch vorhandenen L-Chromosomen, das m\u00fctterliche X-Chromosom und ein Homologes jedes der zwei Autosomenpaare zum Pol wandern l\u00e4sst, w\u00e4hrend die \u00fcbrigen vier Chromosomen aus der Zelle eliminiert werden", "SPECIES", 85, 284]]], ["Unten: In der zweiten meiotischen Teilung wandert das X-Chromosom mit beiden Chromatiden vorab zum Spindelpol.", [["Spindelpol", "CHEMICAL", 99, 109], ["der zweiten meiotischen Teilung wandert das X-Chromosom mit beiden Chromatiden vorab zum", "SPECIES", 10, 98]]], ["Die Abbildung l\u00e4sst noch die klumpenf\u00f6rmigen Reste des Eliminationschromatins aus der ersten Teilung erkennen.", [["Die", "PROBLEM", 0, 3]]], ["In einigen F\u00e4llen ist die Verteilung von limitierten Chromosomen mit chromosomalem Imprinting verbunden, das in den Nachkommen diese Chromosomen nach v\u00e4terlicher oder m\u00fctterlicher Herkunft unterscheiden l\u00e4sst.Dosiskompensation bei DrosophilaDas Genom eines Organismus ist genetisch sehr genau balanciert.", [["Dosiskompensation", "TEST", 209, 226]]], ["Umso erstaunlicher ist es, dass bei einem einzigen Chromosomenpaar Abweichungen offenbar nicht zu vergleichbar schwerwiegenden Defekten f\u00fchren: bei Ver\u00e4nderungen der Geschlechtschromosomenzahlen durch Nondisjunktion.", [["Umso erstaunlicher ist es, dass bei einem einzigen Chromosomenpaar Abweichungen offenbar nicht zu vergleichbar schwerwiegenden Defekten f\u00fchren: bei Ver\u00e4nderungen der Geschlechtschromosomenzahlen durch Nondisjunktion", "SPECIES", 0, 215]]], ["W\u00e4hrend eines der Geschlechtschromosomen im einen Geschlecht in diploider Anzahl vorhanden ist, liegt es im anderen Geschlecht nur haploid (hemizygot) vor.", [["Anzahl vorhanden ist", "TREATMENT", 74, 94]]], ["Ist \u00fcberhaupt ein zweites Geschlechtschromosom vorhanden, wie in allen X / Y-oder W/Z-Geschlechtsbestimmungsmechanismen oder in davon abgeleiteten Geschlechtschromosomenkonstitutionen, so ist dieses in einem Geschlecht haploid vorhanden, fehlt aber im anderen Geschlecht vollst\u00e4ndig.", [["Ist \u00fcberhaupt ein zweites Geschlechtschromosom vorhanden, wie in allen X / Y-oder W/Z-Geschlechtsbestimmungsmechanismen oder", "SPECIES", 0, 124]]], ["Diese genetische Situation kann nicht einfach durch eine (partielle) genetische Identit\u00e4t der Geschlechtschromosomen erkl\u00e4rt werden.", [["Diese genetische Situation kann nicht einfach durch eine (partielle)", "TREATMENT", 0, 68]]], ["Untersucht man seine Funktionen, wird deutlich, dass bei der Aktivierung der ersten zygyotisch aktiven Gene im syncytialen Blastoderm (fr\u00fches Entwicklungsstadium bei Drosophila; vgl.", [["man", "SPECIES", 11, 14], ["Drosophila", "SPECIES", 166, 176], ["Gene im syncytialen Blastoderm", "TREATMENT", 103, 133]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["13.17) eine Dosiskompensation X-chromosomaler Gene im M\u00e4nnchen noch nicht erfolgt sein kann.", [["eine Dosiskompensation", "TREATMENT", 7, 29]]], ["Dosiskompensation w\u00fcrde den Z\u00e4hlmechanismus, der das X:A-Verh\u00e4ltnis im Embryo ermittelt und damit das Geschlecht bestimmt, au\u00dfer Kraft setzen.", [["Dosiskompensation w\u00fcrde den Z\u00e4hlmechanismus, der das X:A-Verh\u00e4ltnis im Embryo ermittelt und damit das Geschlecht bestimmt, au\u00dfer Kraft setzen", "SPECIES", 0, 141], ["Kraft setzen", "OBSERVATION", 129, 141]]], ["Dosiskompensation kann daher erst in sp\u00e4teren Entwicklungsphasen voll wirksam werden.Dosiskompensation bei DrosophilaF\u00fcr das Verst\u00e4ndnis der Dosiskompensationsmechanismen spielen einige autosomale Gene eine wichtige Rolle, die im Falle einer Loss-of-function-Mutation zu m\u00e4nnlicher Letalit\u00e4t f\u00fchren.", [["Dosiskompensation bei DrosophilaF\u00fcr das Verst\u00e4ndnis der Dosiskompensationsmechanismen spielen einige autosomale", "SPECIES", 85, 196], ["Dosiskompensation", "TREATMENT", 0, 17], ["Dosiskompensation", "TEST", 85, 102]]], ["Homozygot mutante M\u00e4nnchen aller dieser f\u00fcnf Gene sterben im Laufe der Larvalentwicklung ab, w\u00e4hrend Weibchen lebensf\u00e4hig sind.", [["Homozygot", "TREATMENT", 0, 9]]], ["Die Vermutung, dass die Genprodukte des mle-Gens und der msl-und mof-Gene die Hyperaktivit\u00e4t des X-Chromosoms im M\u00e4nnchen kontrollieren, lie\u00df sich durch Untersuchungen der zellul\u00e4ren Lokalisation der f\u00fcnf genannten Proteine beweisen.", [["Die Vermutung, dass die Genprodukte des mle-Gens und der msl-und mof-Gene die Hyperaktivit\u00e4t des X-Chromosoms im M\u00e4nnchen kontrollieren, lie\u00df sich durch Untersuchungen der zellul\u00e4ren Lokalisation der f\u00fcnf genannten Proteine beweisen", "SPECIES", 0, 232], ["Gene die Hyperaktivit\u00e4t des", "TREATMENT", 69, 96], ["Chromosoms im M\u00e4nnchen kontrollieren", "TREATMENT", 99, 135], ["lie\u00df sich durch", "TREATMENT", 137, 152]]], ["Diese Proteine binden in M\u00e4nnchen spezifisch an das X-Chromosom, w\u00e4hrend sie in Weibchen am X-Chromosom nicht nachweisbar sind (Abb.", [["Abb", "DNA", 128, 131]]], ["Das MLE-Protein ist eine ATP-abh\u00e4ngige RNA-Helikase.", [["ATP", "CHEMICAL", 25, 28], ["ATP", "CHEMICAL", 25, 28], ["Das MLE", "TEST", 0, 7], ["Protein ist eine ATP", "TEST", 8, 28]]], ["MOF hat Histon-Acetyltransferase-(HAT-)Aktivit\u00e4t.", [["Histon-Acetyltransferase", "SIMPLE_CHEMICAL", 8, 32], ["Histon-Acetyltransferase-(HAT-)Aktivit\u00e4t", "PROTEIN", 8, 48], ["MOF hat Histon-Acetyltransferase", "TREATMENT", 0, 32], ["Aktivit\u00e4t", "TREATMENT", 39, 48]]], ["Es bindet an das N-terminale Ende von Histon H4.", [["H4", "PROTEIN", 45, 47]]], ["Zus\u00e4tzlich sind f\u00fcr die Bindung des Multiproteinkomplexes zwei RNA-Molek\u00fcle, roX1 und roX2, erforderlich, die beide im X-Chromosom kodiert werden.", [["Zus\u00e4tzlich sind f\u00fcr die Bindung des Multiproteinkomplexes zwei RNA-Molek\u00fcle, roX1 und roX2, erforderlich, die beide im X-Chromosom kodiert werden", "SPECIES", 0, 145], ["Zus\u00e4tzlich", "TREATMENT", 0, 10]]], ["Nach gegenw\u00e4rtigen Vorstellungen \u00fcber die molekularen Prozesse, die zur Aktivit\u00e4tserh\u00f6hung im X-Chromosom f\u00fchren, werden zun\u00e4chst die MSL-Proteine an spezifischen Stellen des X-Chromosoms gebunden, die die roX-Gene einschlie\u00dfen.", [["Nach gegenw\u00e4rtigen Vorstellungen \u00fcber die molekularen Prozesse, die zur Aktivit\u00e4tserh\u00f6hung im X-Chromosom f\u00fchren, werden zun\u00e4chst die MSL-Proteine an spezifischen Stellen des X-Chromosoms gebunden, die die roX-Gene einschlie\u00dfen", "SPECIES", 0, 227], ["Proteine an spezifischen Stellen des", "TREATMENT", 138, 174]]], ["Sie bilden Komplexe mit den roX-RNAs, die dann in der Lage sind, an weitere X-chromosomale Loci zu binden.", [["zu binden", "OBSERVATION", 96, 105]]], ["Die Bindung dieser RNP-Komplexe bewirkt Ver\u00e4nderungen in der Chromatinstruktur, die zur Erh\u00f6hung der Transkriptionsrate im m\u00e4nnlichen X-Chromosom f\u00fchren.", [["Die Bindung dieser RNP-Komplexe bewirkt Ver\u00e4nderungen in der Chromatinstruktur, die zur Erh\u00f6hung der Transkriptionsrate im m\u00e4nnlichen X-Chromosom f\u00fchren", "SPECIES", 0, 152]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["Dosiskompensation bei Drosophila.", [["Drosophila", "SPECIES", 22, 32], ["Dosiskompensation bei Drosophila", "SPECIES", 0, 32]]], ["Das nur im M\u00e4nnchen gebildete MSL-1-Protein bindet spezifisch an das m\u00e4nnliche X-Chromosom.", [["MSL", "TEST", 30, 33]]], ["Es spielt eine noch ungekl\u00e4rte Rolle bei der Regulation der aufgrund der Dosiskompensation erh\u00f6hten Transkriptionsrate dieses Chromosoms. a Riesenchromosomensatz aus Larven von D. melanogaster, Stamm Samarkand, nach DNA-F\u00e4rbung. b Der gleiche Chromosomensatz nach Immunreaktion mit Anti-MSL-1-Antiserum und anschlie\u00dfender Immunreaktion mit Texas-Rot-konjugiertem sekund\u00e4rem Antiserum.", [["Antiserum", "ORGANISM_SUBSTANCE", 374, 383], ["D. melanogaster", "SPECIES", 177, 192], ["Antiserum", "SPECIES", 293, 302], ["Riesenchromosomensatz aus Larven von D. melanogaster", "SPECIES", 140, 192], ["Der gleiche Chromosomensatz nach Immunreaktion mit Anti-MSL-1-Antiserum und anschlie\u00dfender Immunreaktion mit Texas-Rot-konjugiertem sekund\u00e4rem", "SPECIES", 231, 373], ["Der gleiche", "TEST", 231, 242], ["Antiserum", "TEST", 293, 302], ["mit Texas", "TEST", 336, 345]]], ["Die Hyperaktivit\u00e4t des X-Chromosoms im M\u00e4nnchen wird durch f\u00fcnf chromosomale Proteine induziert, die durch Kombination mit strukturellen RNA-Molek\u00fclen (roX1 und roX2) durch Ver\u00e4nderungen der Chromatinstruktur eine erh\u00f6hte Transkriptionsaktivit\u00e4t erm\u00f6glichen.", [["Die Hyperaktivit\u00e4t des X-Chromosoms im M\u00e4nnchen wird durch f\u00fcnf chromosomale Proteine induziert, die durch Kombination mit strukturellen RNA-Molek\u00fclen (roX1 und roX2) durch Ver\u00e4nderungen der Chromatinstruktur eine erh\u00f6hte Transkriptionsaktivit\u00e4t erm\u00f6glichen", "SPECIES", 0, 257], ["Proteine induziert", "TREATMENT", 77, 95], ["Molek\u00fclen (roX1 und roX2)", "TREATMENT", 141, 166]]], ["Die Expression solcher Proteine im Weibchen wirkt sich ebenso letal aus wie das Fehlen dieser Proteine im M\u00e4nnchen.", [["Proteine", "TREATMENT", 23, 31], ["Proteine im M\u00e4nnchen", "TREATMENT", 94, 114]]], ["In beiden F\u00e4llen ist die fehlerhafte Dosiskompensation f\u00fcr die Letalit\u00e4t verantwortlich.Dosiskompensation bei S\u00e4ugernAuf einem ganz anderen Weg wird die Dosiskompensation in S\u00e4ugern erreicht.", [["Dosiskompensation bei S\u00e4ugernAuf einem ganz", "TREATMENT", 88, 131]]], ["Auf der Grundlage cytologischer Studien und genetischer Daten wurde von Mary Lyon 1961 die Hypothese (Lyon-Hypothese) formuliert, dass im weiblichen Geschlecht von S\u00e4ugern eines der X-Chromosomen inaktiv ist.", [["Auf der Grundlage cytologischer Studien und genetischer Daten wurde von Mary Lyon 1961 die Hypothese (Lyon-Hypothese) formuliert, dass im weiblichen Geschlecht von S\u00e4ugern eines der X-Chromosomen inaktiv", "SPECIES", 0, 203]]], ["Auf der cytologischen Seite war ein zentraler Befund f\u00fcr das Verst\u00e4ndnis der Dosiskompensation die Beobachtung von M.L.Barr,dass in Interphasezellen von weiblichen S\u00e4ugern ein stark anf\u00e4rbbarer Chromatink\u00f6rper, auch Geschlechtschromatin (engl. sex chromatin) genannt, zu beobachten ist, der in m\u00e4nnlichen Zellen fehlt.", [["chromatin", "ANATOMY", 248, 257], ["chromatin", "CELLULAR_COMPONENT", 248, 257], ["Auf der cytologischen Seite war ein zentraler Befund f\u00fcr das Verst\u00e4ndnis der Dosiskompensation die Beobachtung von M.L.Barr,dass in Interphasezellen von weiblichen S\u00e4ugern ein stark anf\u00e4rbbarer", "SPECIES", 0, 193]]], ["Die Korrelation dieses Geschlechtschromatins mit dem nach Lyon inaktiven X-Chromosom w\u00fcrde somit die Lyon-Hypothese unterst\u00fctzen.", [["Die Korrelation dieses Geschlechtschromatins mit dem nach Lyon inaktiven X-Chromosom w\u00fcrde somit die Lyon-Hypothese unterst\u00fctzen", "SPECIES", 0, 128]]], ["Diese Korrelation l\u00e4sst sich tats\u00e4chlich durch einfache cytologische Methoden beweisen.Dosiskompensation bei S\u00e4ugernNach seinem Entdecker (Barr u.", [["Dosiskompensation", "TEST", 87, 104]]], ["Barr body) genannt.", [["body", "ANATOMY", 5, 9]]], ["Dieser Barr-K\u00f6rper entsteht durch eine ringf\u00f6rmige Struktur des inaktiven X-Chromosoms.", [["Dieser Barr-K\u00f6rper entsteht durch", "TREATMENT", 0, 33]]], ["Die Anzahl vorhandener Barr-K\u00f6rper ist jeweils um eins geringer als die Gesamtzahl der vorhandenen X-Chromosomen (Abb.", [["Die Anzahl vorhandener Barr-K\u00f6rper ist jeweils um eins geringer als die Gesamtzahl der vorhandenen X-Chromosomen", "SPECIES", 0, 112], ["Die Anzahl", "TREATMENT", 0, 10], ["Barr-K\u00f6rper ist jeweils um eins geringer", "TREATMENT", 23, 63]]], ["7.32) .Dosiskompensation bei S\u00e4ugernDas bedeutet, dass Klinefelter-M\u00e4nner (XXY) einen Barr-K\u00f6rper besitzen, Turner-Frauen (X0) keinen, w\u00e4hrend XXX-, XXXX-oder XXXXX-Individuen zwei, drei oder vier Barr-K\u00f6rper aufweisen.Das ist ein sehr eindeutiger Hinweis darauf, dass alle gegen\u00fcber der m\u00e4nnlichen Normalkonstitution (mit einem X-Chromosom) \u00fcberz\u00e4hligen X-Chromosomen inaktiviert werden, und zwar unabh\u00e4ngig vom Geschlecht des Individiums.", [["Klinefelter-M\u00e4nner", "DISEASE", 55, 73], ["Dosiskompensation bei S\u00e4ugernDas bedeutet, dass Klinefelter-M\u00e4nner (XXY) einen Barr-K\u00f6rper besitzen, Turner-Frauen (X0) keinen, w\u00e4hrend XXX-, XXXX-oder XXXXX-Individuen zwei, drei oder vier Barr-K\u00f6rper aufweisen", "SPECIES", 7, 218], ["Das ist ein sehr eindeutiger Hinweis darauf, dass alle gegen\u00fcber der m\u00e4nnlichen Normalkonstitution (mit einem X-Chromosom) \u00fcberz\u00e4hligen X-Chromosomen inaktiviert werden, und zwar unabh\u00e4ngig vom Geschlecht des Individiums", "SPECIES", 219, 439]]], ["Sie bleiben auch in der Interphase kondensiert und liegen als sp\u00e4treplizierendes Heterochromatin vor.", [["Heterochromatin vor", "OBSERVATION", 81, 100]]], ["Die ma\u00dfgeblichen Experimente sind leicht zu verstehen, wenn man die Folge einer Abb.", [["man", "SPECIES", 60, 63]]], ["Barr-Bodies in Interphase-Zellkernen von S\u00e4ugern mit unterschiedlichen Anzahlen von X-Chromosomen.", [["Bodies", "ANATOMY_MODIFIER", 5, 11]]], ["Es bleibt jeweils nur ein X-Chromosom aktiv, w\u00e4hrend die \u00fcbrigen als inaktives (\"fakultatives\") Heterochromatin (= Barr-Body) erscheinen.", [["Heterochromatin", "CHEMICAL", 96, 111], ["Es bleibt jeweils nur ein X-Chromosom aktiv, w\u00e4hrend die \u00fcbrigen als inaktives (\"fakultatives\") Heterochromatin (= Barr-Body) erscheinen", "SPECIES", 0, 136], ["Heterochromatin (= Barr-Body) erscheinen", "TREATMENT", 96, 136]]], ["Allerdings kann eine bestimmte Anzahl von Barr-Bodies durch unterschiedliche Konstitutionen der Geschlechtschromosomen verursacht werden wie die obere Zeile anzeigt (a).", [["Allerdings", "TREATMENT", 0, 10]]], ["Menschliche XXX-Zellen, gef\u00e4rbt mit fluoreszierenden Antik\u00f6rpern gegen Histon H1.", [["Menschliche XXX-Zellen, gef\u00e4rbt mit fluoreszierenden Antik\u00f6rpern gegen Histon H1", "SPECIES", 0, 80], ["Zellen", "PROBLEM", 16, 22]]], ["Zwei der X-Chromosomen formen Barr-Bodies.", [["Bodies", "ANATOMY_MODIFIER", 35, 41]]], ["Photo: T. Yang Inaktivierung eines der X-Chromosomen in Individuen bedenkt, die f\u00fcr ein Markergen heterozygot sind.", [["T. Yang Inaktivierung eines der X-Chromosomen in Individuen bedenkt, die f\u00fcr ein Markergen heterozygot sind", "SPECIES", 7, 114]]], ["Wichtig ist hierbei, dass man ein Markergen ausw\u00e4hlt, das zellautonom zur Auspr\u00e4gung kommt, dessen Genprodukte also auf die Zelle beschr\u00e4nkt bleiben, in der das Gen stoffwechselaktiv ist.", [["man", "SPECIES", 26, 29]]], ["Es stellt sich dann die Frage, ob in allen Zellen dasselbe X-Chromosom inaktiv ist, oder ob verschiedene Zellen unterschiedliche X-Chromosomen inaktivieren und wenn ja, wie diese Zellen zueinander angeordnet sind.Dosiskompensation bei S\u00e4ugernDie Antwort l\u00e4sst sich sehr einfach an Markergenen ablesen, die die Fellfarbe von M\u00e4usen bestimmen.", [["Zellen dasselbe X-Chromosom inaktiv ist, oder ob verschiedene Zellen unterschiedliche X-Chromosomen inaktivieren und wenn ja, wie diese Zellen zueinander angeordnet sind", "SPECIES", 43, 212], ["ob", "ANATOMY", 31, 33]]], ["Sieht man sich ein f\u00fcr ein solches Gen heterozygotes M\u00e4useweibchen an, so erkennen wir eine gefleckte F\u00e4rbung des Fells (Abb.", [["man", "SPECIES", 6, 9]]], ["Dieses Muster beantwortet zwei unserer Fragen: Erstens kann offenbar jedes der beiden X-Chromosomen inaktiv werden.", [["Erstens kann offenbar jedes der beiden X-Chromosomen inaktiv werden", "SPECIES", 47, 114], ["Dieses", "TEST", 0, 6]]], ["Zweitens betrifft die Inaktivierung jeweils Gruppen benachbarter Zellen, bei denen dasselbe X-Chromosom inaktiv ist, wie die fleckenf\u00f6rmige Verteilung des Auspr\u00e4gungsmusters beider Allele belegt.Dosiskompensation bei S\u00e4ugernDass das bei M\u00e4usen beobachtete Verteilungsmuster keine Ausnahme, sondern die Regel ist, beweisen \u00e4hnliche Untersuchungen am Menschen (Abb.", [["Zweitens betrifft die Inaktivierung jeweils Gruppen benachbarter Zellen, bei denen dasselbe X-Chromosom inaktiv ist, wie die fleckenf\u00f6rmige Verteilung des Auspr\u00e4gungsmusters beider Allele belegt", "SPECIES", 0, 194], ["Dosiskompensation", "TREATMENT", 195, 212]]], ["Aus der vergleichenden Untersuchung von weiblichen Individuen aufeinanderfolgender Generationen l\u00e4sst sich leicht erkennen, dass die Auspr\u00e4gung des Allels nicht an bestimmte K\u00f6rperregionen gebunden ist, sondern sich zufallsgem\u00e4\u00df im K\u00f6rper verteilt.", [["Aus der vergleichenden Untersuchung von weiblichen Individuen aufeinanderfolgender Generationen l\u00e4sst sich leicht erkennen, dass die Auspr\u00e4gung des Allels nicht an bestimmte K\u00f6rperregionen gebunden ist, sondern sich zufallsgem\u00e4\u00df im K\u00f6rper verteilt", "SPECIES", 0, 247]]], ["Wir k\u00f6nnen also davon ausgehen, dass das Auspr\u00e4gungsmuster des einen X-Chromosoms gegen\u00fcber dem des anderen nicht genetisch fixiert ist.Dosiskompensation bei S\u00e4ugernWie erkl\u00e4rt sich dann die Bildung von homogenen Bereichen, die sich mit Bereichen der Auspr\u00e4gung des alternativen Allels abwechseln?", [["Dosiskompensation bei S\u00e4ugernWie erkl\u00e4rt sich dann die Bildung von homogenen Bereichen, die sich mit Bereichen der Auspr\u00e4gung des alternativen Allels abwechseln", "SPECIES", 136, 296], ["Dosiskompensation", "TREATMENT", 136, 153]]], ["(In der englischsprachigen Literatur wird der Begriff cell lineage gebraucht.)", [["der englischsprachigen Literatur wird", "TREATMENT", 4, 41]]], ["\u00dcbertragen wir dieses Schema einer klonalen Zelldifferenzierung auf die Inaktivierung des X-Chromosoms, so gelangen wir zu der Erkenntnis, dass Gruppen benachbarter Zellen, die eine einheitliche Genexpression des einen Allels zeigen, in der Entwicklung (Ontogenese) des Organismus aus einer gemeinsamen Urprungszelle herstammen m\u00fcssen, in der die Entscheidung \u00fcber die Aktivit\u00e4t oder Inaktivit\u00e4t eines bestimmten Allels erfolgt ist.", [["Schema einer klonalen Zelldifferenzierung auf die Inaktivierung des X-Chromosoms, so gelangen wir zu der Erkenntnis, dass Gruppen benachbarter Zellen, die eine einheitliche Genexpression des einen Allels zeigen", "SPECIES", 22, 232], ["\u00dcbertragen wir", "TREATMENT", 0, 14], ["Schema einer klonalen", "TREATMENT", 22, 43]]], ["Diese Entscheidung muss, wenn man das Fleckenmuster betrachtet, irreversibel sein, da offensichtlich innerhalb eines Farbbereiches kein Umschlag zur Expression des anderen Allels erfolgt.", [["man", "SPECIES", 30, 33]]], ["Fleckenhafte Auspr\u00e4gung von heterozygoten Markergenen als Folge der Inaktivierung eines X-Chromosoms in S\u00e4ugern.", [["Fleckenhafte Auspr\u00e4gung von heterozygoten", "TREATMENT", 0, 41]]], ["Bei Anwesenheit geeigneter heterozygoter Zellmarker in den X-Chromosomen ist die Inaktivierung bzw.", [["Bei Anwesenheit geeigneter heterozygoter Zellmarker in den X-Chromosomen ist die Inaktivierung bzw", "SPECIES", 0, 98]]], ["Aktivierung eines bestimmten Allels leicht zu erkennen, da bei Zellautonomie der Genexpression ph\u00e4notypische Mosaike gebildet werden.", [["Aktivierung eines", "TREATMENT", 0, 17], ["da bei Zellautonomie", "TREATMENT", 56, 76]]], ["Die Gr\u00f6\u00dfe der Farbflecken im Fell wird durch die Anzahl der gleichartigen Zellen, d.h. durch den Zeitpunkt der Inaktivierung des einen X-Chromosoms in der Embryonalentwicklung bestimmt (vgl.", [["Die Gr\u00f6\u00dfe der Farbflecken im Fell wird durch die Anzahl der gleichartigen Zellen, d.h. durch den Zeitpunkt der Inaktivierung des einen X-Chromosoms in der Embryonalentwicklung bestimmt", "SPECIES", 0, 184]]], ["Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 0, 3], ["Abb", "PROTEIN", 0, 3]]], ["(Nach Lyon 1963 und Thompson 1965 mationen \u00fcber den Zeitpunkt der Inaktivierung des anderen X-Chromosoms vermittelt: Ist der Fleck gro\u00df, so sind viele Mitosen nach dieser Entscheidung erfolgt.", [["Nach Lyon 1963 und Thompson 1965 mationen \u00fcber den Zeitpunkt der Inaktivierung des anderen X-Chromosoms vermittelt: Ist der Fleck gro\u00df, so sind viele Mitosen nach dieser Entscheidung erfolgt", "SPECIES", 1, 191]]], ["Diese Situation ist in Abb.", [["Abb", "PROTEIN", 23, 26]]], ["Aus dem Schema k\u00f6nnen wir hinsichtlich der Entscheidung \u00fcber die Aktivit\u00e4t eines X-Chromosoms als wichtigste Schl\u00fcsse das Folgende zusammenfassen:Dosiskompensation bei S\u00e4ugern\u2022 Die Entscheidung \u00fcber die Aktivit\u00e4t eines X-Chromosoms erfolgt in der fr\u00fchen Embryonalentwicklung.Dosiskompensation bei S\u00e4ugern\u2022 Die Entscheidung erfolgt nicht zu einem bestimmten Zeitpunkt innerhalb der Entwicklung, sondern kann zeitlich f\u00fcr verschiedene Zellen variieren.Dosiskompensation bei S\u00e4ugern\u2022 Die Entscheidung ist irreversibel, d. h. ein einmal inaktiviertes X-Chromosom bleibt in allen folgenden Zellgenerationen inaktiv.Dosiskompensation bei S\u00e4ugern\u00dcber die molekularen Ursachen der Inaktivierung der X-Chromosomen bei S\u00e4ugern gibt es heute schon recht pr\u00e4zise Vorstellungen.", [["Aus dem Schema k\u00f6nnen wir hinsichtlich der Entscheidung \u00fcber die Aktivit\u00e4t eines X-Chromosoms als wichtigste Schl\u00fcsse das Folgende zusammenfassen:Dosiskompensation bei S\u00e4ugern\u2022 Die Entscheidung \u00fcber die Aktivit\u00e4t eines X-Chromosoms erfolgt", "SPECIES", 0, 239], ["Dosiskompensation bei S\u00e4ugern\u2022 Die Entscheidung ist irreversibel, d. h. ein einmal inaktiviertes X-Chromosom bleibt", "SPECIES", 450, 565], ["Dosiskompensation bei S\u00e4ugern\u00dcber die molekularen Ursachen der Inaktivierung der X-Chromosomen bei S\u00e4ugern gibt es heute schon recht pr\u00e4zise", "SPECIES", 610, 750], ["Dosiskompensation bei S\u00e4ugern\u2022 Die", "TREATMENT", 146, 180], ["Dosiskompensation", "TREATMENT", 275, 292], ["Dosiskompensation", "TREATMENT", 450, 467], ["Dosiskompensation", "TREATMENT", 610, 627]]], ["X-chromosome-inactivation centre, Xic) kontrolliert.", [["X-chromosome", "DNA", 0, 12], ["chromosome-inactivation centre", "TREATMENT", 2, 32]]], ["Aufgrund cytogenetischer Daten wird die Gr\u00f6\u00dfe des Xic-Genorts mit etwa 1 Mb angegeben.", [["Aufgrund cytogenetischer Daten wird die Gr\u00f6\u00dfe des Xic-Genorts mit etwa 1 Mb angegeben", "SPECIES", 0, 85]]], ["Diese Region enth\u00e4lt mindestens vier Gene, die an der X-Inaktivierung beteiligt sind: Xist kodiert f\u00fcr ein spezifisches Transkript des inaktiven X-Chromosomes (engl.", [["Xist kodiert", "TREATMENT", 86, 98]]], ["X inactive-specific transcript), das allerdings nicht f\u00fcr ein Protein kodiert.", [["X inactive", "DNA", 0, 10], ["Protein kodiert", "PROTEIN", 62, 77]]], ["Die anderen Elemente innerhalb der Xic-Region sind verantwortlich f\u00fcr die Xist-Expression.", [["Xist", "DNA", 74, 78]]], ["Eines davon ist DXPas34, das urspr\u00fcnglich aufgrund seines Methylierungsprofils auf dem aktiven X-Chromosom definiert wurde.", [["Eines davon ist DXPas34, das urspr\u00fcnglich aufgrund seines Methylierungsprofils auf dem aktiven X-Chromosom definiert wurde", "SPECIES", 0, 122]]], ["Das andere ist das TsiX-Transkript, ein nicht-kodierendes Transkript, das vom Gegenstrang zu Xist abgelesen wird und das die Aktivit\u00e4t von Xist zu Beginn der Inaktivierung reguliert (Abb.", [["Das andere ist das TsiX-Transkript, ein nicht-kodierendes Transkript, das vom Gegenstrang zu Xist abgelesen wird und das die Aktivit\u00e4t von Xist zu Beginn der Inaktivierung reguliert", "SPECIES", 0, 181]]], ["7.36) .Dosiskompensation bei S\u00e4ugernEin hervorragendes Modell, um die fr\u00fchen Vorg\u00e4nge bei der X-Inaktivierung zu untersuchen, sind embryonale Stammzellen (ES) der Maus.", [["Dosiskompensation bei S\u00e4ugernEin hervorragendes Modell, um die fr\u00fchen Vorg\u00e4nge bei der X-Inaktivierung zu untersuchen", "SPECIES", 7, 124], ["Dosiskompensation", "TREATMENT", 7, 24]]], ["Durch insitu-Hybridisierung mit Fluoreszenzmarkern (engl. fluorescence in situ hybridization, FISH) kann die Xist-RNA erkannt werden: In weiblichen ES-Zellen erscheinen zwei punktf\u00f6rmige Signale, wohingegen bei m\u00e4nnlichen ES-Zellen nur ein derartiges Signal erscheint (Abb.", [["Xist", "DNA", 109, 113], ["wohingegen bei m\u00e4nnlichen ES-Zellen nur ein derartiges Signal erscheint", "SPECIES", 196, 267], ["fluorescence", "TEST", 58, 70], ["Zellen", "TEST", 151, 157], ["Signale", "TEST", 187, 194]]], ["Werden die weiblichen ES-Zellen zur Differenzierung angeregt, h\u00e4ufen sich Xist-Transkripte an dem sp\u00e4ter inaktiven X-Chromosom an, wohingegen die Expression von Xist an den aktiven m\u00e4nnlichen und weiblichen X-Chromosomen abgeschaltet wird.", [["Werden die weiblichen ES-Zellen zur Differenzierung angeregt, h\u00e4ufen sich Xist-Transkripte an dem sp\u00e4ter inaktiven X-Chromosom an, wohingegen die Expression von Xist an den aktiven m\u00e4nnlichen und weiblichen X-Chromosomen abgeschaltet wird", "SPECIES", 0, 238]]], ["Der Beginn der X-Inaktivierung erscheint daher unmittelbar mit der Anh\u00e4ufung von Xist-Transkripten gekoppelt zu sein.", [["Xist", "DNA", 81, 85], ["Der Beginn der X-Inaktivierung erscheint daher unmittelbar mit der Anh\u00e4ufung von Xist-Transkripten gekoppelt zu sein", "SPECIES", 0, 116]]], ["Dabei ist die Hochregulierung der Xist-Expression offensichtlich auch mit einer Verl\u00e4ngerung der Lebenszeit der Xist-Dosiskompensation bei S\u00e4ugernAbb.", [["Dabei ist die Hochregulierung der Xist-Expression offensichtlich auch mit einer Verl\u00e4ngerung der Lebenszeit der Xist-Dosiskompensation bei S\u00e4ugernAbb", "SPECIES", 0, 149]]], ["Zufallsgem\u00e4\u00dfe Inaktivierung eines der weiblichen X-Chromosomen beim Menschen.", [["Zufallsgem\u00e4\u00dfe", "TREATMENT", 0, 13]]], ["Eine X-chromosomale rezessive Mutation (Anhidrotische ektodermale Dysplasie) f\u00fchrt zu Ver\u00e4nderungen in den Sekreten der Haut, die durch geeignete F\u00e4rbungen sichtbar gemacht werden k\u00f6nnen.", [["Eine X-chromosomale rezessive Mutation (Anhidrotische ektodermale Dysplasie)", "TREATMENT", 0, 76]]], ["Bei einem Vergleich der Sekretmuster, die durch die Heterozygotie der Mutation und die Inaktivierung des X-Chromosoms entstehen, \u00fcber mehrere Generationen zeigt sich, dass die Muster nicht erblich festgelegt sind, sondern individuell variieren.", [["Bei einem Vergleich der Sekretmuster, die durch die Heterozygotie der Mutation und die Inaktivierung des X-Chromosoms entstehen", "SPECIES", 0, 127]]], ["Zwei Promotoren (P1, P2; Abb.", [["Abb", "GENE_OR_GENE_PRODUCT", 25, 28], ["P1", "DNA", 17, 19], ["P2", "DNA", 21, 23], ["Abb", "DNA", 25, 28]]], ["7.36) sind f\u00fcr die stabile Xist-Transkription verantwortlich; es wird diskutiert, ob der weiter oberhalb liegende Promotor P0 oder weitere regulatorische Elemente f\u00fcr die fr\u00fchere Expression der instabilen Xist-Transkripte verantwortlich sind.Dosiskompensation bei S\u00e4ugernWichtige Hinweise auf die Funktion von Xist kamen von verschiedenen k\u00fcnstlichen Maus-Mutanten.", [["Dosiskompensation bei S\u00e4ugernWichtige Hinweise auf die Funktion von Xist kamen von verschiedenen k\u00fcnstlichen Maus-Mutanten", "SPECIES", 242, 364], ["Dosiskompensation bei S\u00e4ugernWichtige", "TREATMENT", 242, 279]]], ["Diese Hemmung ist zun\u00e4chst abh\u00e4ngig von der kontinuierlichen Xist-Expression und zun\u00e4chst noch umkehrbar.", [["Diese Hemmung ist zun\u00e4chst abh\u00e4ngig von der kontinuierlichen Xist-Expression und zun\u00e4chst noch umkehrbar", "SPECIES", 0, 104]]], ["(Die noch undifferenzierten Zellen sind hyperacetyliert, wohingegen die Zellen, die schon festgelegt sind, hypoacetyliert sind.)", [["hyperacetyliert", "TREATMENT", 40, 55]]], ["Deletionsexperimente in der Xic-Region machen deutlich, welche Abschnitte f\u00fcr die Auswahl des zu inaktivierenden X-Chromosoms verantwortlich sind.", [["Region machen deutlich, welche Abschnitte f\u00fcr die Auswahl des zu inaktivierenden X-Chromosoms verantwortlich sind", "SPECIES", 32, 145]]], ["Die Deletion des DxPas34-Locus, der in der Initiationsregion des TsiX-antisense-Transkripts liegt, beseitigt sowohl die antisense-Aktivit\u00e4t von TsiX als auch die Xist-Transkription (oder vermindert sie zumindest stark).Dosiskompensation bei S\u00e4ugernEin weiterer wichtiger Hinweis \u00fcber die Auswahl des zu inaktivierenden Chromosoms kommt aus Untersuchungen \u00fcber die X-Inaktivierung in extraembryonalem Gewebe wie dem Trophektoderm.", [["Die Deletion des DxPas34-Locus, der in der Initiationsregion des TsiX-antisense-Transkripts liegt, beseitigt sowohl die antisense-Aktivit\u00e4t von TsiX als auch die Xist-Transkription", "SPECIES", 0, 180], ["Dosiskompensation bei S\u00e4ugernEin weiterer wichtiger Hinweis \u00fcber die Auswahl des zu inaktivierenden Chromosoms kommt aus Untersuchungen \u00fcber die X-Inaktivierung", "SPECIES", 219, 379], ["Dosiskompensation bei S\u00e4ugernEin weiterer", "TREATMENT", 219, 260]]], ["Die Inaktivierung des pater-Zygote X-Inaktivierung X-Inaktivierung X-Inaktivierung Zellgenerationen Abb.", [["Die Inaktivierung des pater-Zygote X-Inaktivierung X-Inaktivierung X-Inaktivierung Zellgenerationen Abb", "SPECIES", 0, 103]]], ["Die Inaktivierung eines der beiden X-Chromosomen erfolgt zufallsgem\u00e4\u00df, ist jedoch hinsichtlich des Zeitpunktes nicht genau festgelegt.", [["ist jedoch hinsichtlich des", "TREATMENT", 71, 98]]], ["Eine einmal erfolgte Inaktivierung ist im Allgemeinen irreversibel und f\u00fchrt daher zu ph\u00e4notypischen Mosaiken, falls zellautonom ausgepr\u00e4gte unterschiedliche Allele geeigneter Markergene in beiden X-Chromosomen vorhanden sind (siehe Abb.", [["beiden X", "DNA", 190, 198], ["siehe Abb", "DNA", 227, 236], ["Eine einmal erfolgte Inaktivierung ist im Allgemeinen irreversibel und f\u00fchrt daher zu ph\u00e4notypischen Mosaiken, falls zellautonom ausgepr\u00e4gte unterschiedliche", "SPECIES", 0, 157], ["Mosaiken", "PROBLEM", 101, 109]]], ["Im inaktiven Zustand ist das X-Chromosom als dargestellt.", [["Im inaktiven Zustand ist das X-Chromosom als dargestellt", "SPECIES", 0, 56], ["Chromosom als dargestellt", "PROBLEM", 31, 56]]], ["Die dargestellten bekannten Elemente und Regionen im X-Inaktivierungszentrum (Xic) beeinflussen die Auswahl und die cis-Inaktivierung w\u00e4hrend des Beginns der X-Inaktivierung.", [["Die dargestellten bekannten Elemente und Regionen im X-Inaktivierungszentrum (Xic) beeinflussen die Auswahl und die cis-Inaktivierung w\u00e4hrend des Beginns der X-Inaktivierung", "SPECIES", 0, 173], ["Die", "PROBLEM", 0, 3]]], ["Gene sind fett dargestellt, und die Pfeilrichtungen geben die jeweilige Richtung der Transkription an.", [["Gene sind fett dargestellt", "PROBLEM", 0, 26]]], ["Brx (brain X-linked), Tsx (testis X-linked) und Cdx4 (caudal-4) sind Gene, die zwar im Xic liegen, aber wohl keine definierte Funktion im Zusammenhang mit der X-Inaktivierung haben.", [["brain", "ANATOMY", 5, 10], ["Brx", "GENE_OR_GENE_PRODUCT", 0, 3], ["brain", "ORGAN", 5, 10], ["testis", "ORGAN", 27, 33], ["Brx", "PROTEIN", 0, 3], ["Tsx", "DNA", 22, 25], ["wohl keine definierte Funktion im Zusammenhang mit der X-Inaktivierung haben", "SPECIES", 104, 180], ["Brx", "TEST", 0, 3], ["Tsx (testis X", "TEST", 22, 35], ["brain", "ANATOMY", 5, 10], ["testis", "ANATOMY", 27, 33]]], ["Die 2.1(2)P-Region zeigt unterschiedliche Histon-H4-Hyperacetylierung in undifferenzierten weiblichen und m\u00e4nnlichen embryonalen Stammzellen (ES) und ist m\u00f6glicherweise ein regulatorisches Element in der X-Inaktivierung.", [["P", "TEST", 10, 11], ["Region zeigt", "TEST", 12, 24], ["Histon", "TEST", 42, 48], ["H4", "PROBLEM", 49, 51], ["Hyperacetylierung", "TREATMENT", 52, 69], ["undifferenzierten weiblichen", "TREATMENT", 73, 101], ["embryonalen Stammzellen (ES) und ist m\u00f6glicherweise ein regulatorisches Element", "TREATMENT", 117, 196]]], ["P1 und P2 sind somatische Promotoren von Xist, und von P0 wird vermutet, dass es in undifferenzierten ES-Zellen und in fr\u00fchen Embryonen als Promotor von Xist wirkt.", [["Promotoren von Xist, und von P0 wird vermutet, dass es in undifferenzierten ES-Zellen und in fr\u00fchen Embryonen als Promotor von Xist wirkt", "SPECIES", 26, 163]]], ["S12 und S19 sind Pseudogene ribosomaler Gene, die im 5'-Bereich des Xist-Gens der Maus liegen.", [["Xist", "DNA", 68, 72], ["S12 und S19 sind Pseudogene ribosomaler Gene", "TREATMENT", 0, 44]]], ["Die blauen Balken zeigen Regionen, denen bestimmte Funktionen (Wahl, Z\u00e4hlen, Inaktivierung) zugeordnet werden konnten.", [["Die", "PROBLEM", 0, 3]]], ["Heard 2001) nalen X-Chromosoms wird au\u00dferdem in allen Geweben der Beuteltiere gefunden; es wird daher auch die Hypothese vertreten, dass dies die urspr\u00fcngliche Form der X-Inaktivierung sei, und dass die zuf\u00e4llige X-Inaktivierung erst sp\u00e4ter bei der Evolution der Eutheria (Plazenta-Tiere) \"erfunden\" wurde.Dosiskompensation bei S\u00e4ugernDie Inaktivierung des X-Chromosoms beginnt am Xic und breitet sich von dort \u00fcber das gesamte X-Chromosom aus.", [["Geweben der Beuteltiere gefunden; es wird daher auch die Hypothese vertreten, dass dies die urspr\u00fcngliche Form der X-Inaktivierung sei, und dass die zuf\u00e4llige X-Inaktivierung erst sp\u00e4ter bei der Evolution der Eutheria (Plazenta-Tiere) \"erfunden\" wurde", "SPECIES", 54, 305], ["Dosiskompensation bei S\u00e4ugernDie Inaktivierung des X-Chromosoms beginnt am Xic und breitet sich von dort \u00fcber das gesamte X-Chromosom aus", "SPECIES", 306, 443], ["Dosiskompensation", "TREATMENT", 306, 323], ["Chromosoms", "TEST", 359, 369]]], ["Die Inaktivierung dieses autosomalen Materials unterscheidet sich nicht von dem des X-Chromosoms -h\u00f6chstens in seinem Ausma\u00df: Es ist gew\u00f6hnlich nicht so effektiv und nicht so ausgepr\u00e4gt, und es ist mit einer begrenzten Ausdehnung der Xist-RNA in dem autosomalen Bereich assoziiert.", [["Die Inaktivierung dieses autosomalen Materials unterscheidet sich nicht von dem des X-Chromosoms -h\u00f6chstens in seinem Ausma\u00df: Es ist gew\u00f6hnlich nicht so effektiv und nicht so ausgepr\u00e4gt, und es ist mit einer begrenzten Ausdehnung der Xist-RNA in dem autosomalen Bereich assoziiert", "SPECIES", 0, 280], ["von dem des", "PROBLEM", 72, 83], ["Chromosoms", "TEST", 86, 96], ["h\u00f6chstens", "PROBLEM", 98, 107]]], ["Sowohl im menschli-chen X-Chromosom als auch im X-Chromosom der Maus wurden doppelt so viele LINE-Elemente gefunden wie in den Autosomen,und es scheint,dass sowohl die Zahl der LINE-Elemente als auch ihre Verteilung innerhalb des X-Chromosoms mit der Effizienz der X-Inaktivierung korrelieren.Dosiskompensation bei S\u00e4ugernEine Analyse von mehr als 600 Genen des X-Chromosoms des Menschen zeigte allerdings, dass ca.", [["Sowohl im menschli-chen X-Chromosom als auch im X-Chromosom der Maus wurden doppelt so viele LINE-Elemente gefunden wie in den Autosomen,und es scheint,dass sowohl die Zahl der LINE-Elemente als auch ihre Verteilung innerhalb des X-Chromosoms mit der Effizienz der X-Inaktivierung korrelieren", "SPECIES", 0, 292], ["Dosiskompensation bei S\u00e4ugernEine Analyse von mehr als 600 Genen des X-Chromosoms des Menschen zeigte", "SPECIES", 293, 394], ["Sowohl", "TEST", 0, 6], ["Chromosom als auch", "PROBLEM", 26, 44], ["Elemente als", "PROBLEM", 182, 194], ["Dosiskompensation bei S\u00e4ugernEine", "TREATMENT", 293, 326], ["dass ca", "OBSERVATION", 407, 414]]], ["Die meisten davon liegen auf dem kurzen Arm des X-Chromsoms (Xp).", [["Die meisten davon liegen auf dem kurzen Arm des X-Chromsoms", "SPECIES", 0, 59], ["Die meisten davon liegen auf dem kurzen Arm des", "TREATMENT", 0, 47]]], ["Die H\u00e4ufigkeit, mit der Gene auf dem kurzen Arm von der Inaktivierung verschont bleiben, entspricht der H\u00e4ufigkeit autosomaler Gene bei X:autosomalen Translokationen und ist ein Zeichen daf\u00fcr, dass der kurze Arm des menschlichen X-Chromosoms unter evolution\u00e4ren Gesichtspunkten erst \"k\u00fcrzlich\" zum X-Chromosom hinzugekommen ist.", [["Die H\u00e4ufigkeit, mit der Gene auf dem kurzen Arm von der Inaktivierung verschont bleiben, entspricht der H\u00e4ufigkeit autosomaler Gene bei X:autosomalen Translokationen und ist ein Zeichen daf\u00fcr, dass der kurze Arm des menschlichen X-Chromosoms unter evolution\u00e4ren Gesichtspunkten erst \"k\u00fcrzlich\" zum X-Chromosom hinzugekommen", "SPECIES", 0, 323], ["Chromosoms", "TEST", 231, 241], ["evolution\u00e4ren", "TEST", 248, 261]]], ["Dieser Abschnitt enth\u00e4lt auch deutlich weniger LINE-Elemente -umgekehrt ist deren Dichte am h\u00f6chsten in der Region Xq13-Xq21, die das menschliche XIC enth\u00e4lt.", [["Dieser Abschnitt enth\u00e4lt auch deutlich weniger LINE-Elemente -umgekehrt ist deren Dichte am h\u00f6chsten in der Region Xq13-Xq21, die das menschliche XIC enth\u00e4lt", "SPECIES", 0, 157], ["Dieser", "TEST", 0, 6]]], ["Weiterhin sind etwa 10% der X-gekoppelten Gene in unterschiedlichem Ausma\u00df inaktiviert, was zu einer beachtlichen seitlich daran anliegenden Dimeren aus H2A/H2B.", [["H2A/H2B", "GENE_OR_GENE_PRODUCT", 153, 160], ["H2A", "PROTEIN", 153, 156], ["H2B", "PROTEIN", 157, 160], ["zu einer beachtlichen seitlich daran anliegenden Dimeren aus H2A/H2B", "SPECIES", 92, 160], ["Weiterhin sind etwa", "TREATMENT", 0, 19], ["H2B", "ANATOMY", 157, 160]]], ["Durch Vertiefungen an der Oberfl\u00e4che dieses Histoncores windet sich die DNA.", [["DNA", "CELLULAR_COMPONENT", 72, 75]]], ["Positiv geladene Aminos\u00e4uren an den sogenannten \u03b2-Br\u00fccken zwischen den Histonen treten in Kontakt mit der negativ geladenen DNA.", [["DNA", "CELLULAR_COMPONENT", 124, 127], ["Kontakt mit der negativ geladenen", "SPECIES", 90, 123]]], ["Diese relativ einfache Konstruktion der Histon-DNA-Interaktion erlaubt eine leichte Dissoziation, wie sie wahrscheinlich f\u00fcr Replikation und Transkription unabdingbar ist.Dosiskompensation bei S\u00e4ugernDie R\u00f6ntgenstrukturanalyse des Nukleosoms (Abb.", [["Diese relativ einfache Konstruktion der Histon-DNA-Interaktion erlaubt eine leichte Dissoziation, wie sie wahrscheinlich f\u00fcr Replikation und Transkription unabdingbar", "SPECIES", 0, 166], ["Dosiskompensation", "TREATMENT", 171, 188]]], ["7.41) hat wichtige Einzelheiten der Organisation der Histone aufgezeigt.", [["hat wichtige Einzelheiten der Organisation der Histone aufgezeigt", "TREATMENT", 6, 71]]], ["Die C-terminalen Regionen der Histone sind einander sehr \u00e4hnlich und bestehen aus zentralen \u03b1-Helices, die \u00fcber \u03b2-Schleifen auf jeder Seite mit zwei k\u00fcrzeren seitlichen \u03b1-Helices verbunden sind.", [["Die C-terminalen Regionen der Histone sind einander sehr \u00e4hnlich", "TREATMENT", 0, 64]]], ["Die 16 \u03b2-Schleifen ergeben somit 8 Br\u00fccken, deren jede einen Kontaktpunkt mit der DNA schafft.", [["Schleifen ergeben somit", "TREATMENT", 9, 32]]], ["Die zentralen Helices dienen der Dimerisierung der Histone, die sich in diesem Bereich ber\u00fchren (man spricht von einer Handshake-Region).", [["man", "SPECIES", 97, 100]]], ["Die N-terminalen Enden der Nterminalen \u03b1-Helices ber\u00fchren sich ebenfalls und formen vier weitere Kontaktstellen mit der DNA in deren minor groove.Chromosomale Territorien und Architektur des ZellkernsNachdem wir nun die grundlegende Organisation der DNA in Form von Nukleosomen kennen gelernt haben, wollen wir uns der Architektur des Zellkerns insgesamt zuwenden.", [["DNA", "CELLULAR_COMPONENT", 120, 123], ["Chromosomale Territorien und Architektur des ZellkernsNachdem wir nun die grundlegende Organisation der DNA in Form von Nukleosomen kennen gelernt haben, wollen wir uns der Architektur des Zellkerns insgesamt zuwenden", "SPECIES", 146, 363], ["Chromosomale Territorien und Architektur des", "TREATMENT", 146, 190], ["groove", "ANATOMY_MODIFIER", 139, 145]]], ["Diese Architektur ist gekennzeichnet durch dreidimensionale Netzwerke h\u00f6herer Chromatinstrukturen einerseits und Kompartimentierung andererseits.", [["Diese Architektur ist gekennzeichnet durch dreidimensionale", "TREATMENT", 0, 59]]], ["Beides ist essenziell f\u00fcr die Integration biologischer Prozesse wie DNA-Replikation, Transkription und Reifung der mRNA.", [["Replikation, Transkription und Reifung der mRNA", "RNA", 72, 119]]], ["Farblich kombinierte Fluoreszenz-in-situ-Hybridisierungen an einzelnen Zellen zeigten, dass einzelne Chromosomen an bestimmten Stellen (\"Territorien\") im Zellkern zu finden sind.", [["Farblich kombinierte Fluoreszenz-in-situ-Hybridisierungen an einzelnen Zellen zeigten, dass einzelne Chromosomen an bestimmten Stellen (\"Territorien\") im Zellkern zu finden sind", "SPECIES", 0, 177], ["Farblich kombinierte Fluoreszenz", "TREATMENT", 0, 32], ["Hybridisierungen", "TREATMENT", 41, 57], ["an einzelnen Zellen zeigten", "TREATMENT", 58, 85]]], ["Ein typisches Beispiel aus einer H\u00fchnerzelle zeigt Abb.", [["Ein typisches", "TREATMENT", 0, 13]]], ["Die Struktur von Metaphasechromosomen. a Submetazentrisches menschliches Chromosom aus einer Zellinie (COLO-320), bei dem die Windung der Chromatiden in der elektronenmikroskopischen Darstellung gut zu erkennen ist. b Submetazentrisches Chromosom aus einer M\u00e4usezellinien (L929), das durch besondere Vorbehandlung die Win-dung der Centromerenregion im Elektronenmikroskop besonders deutlich zeigt. c Die spiralige Struktur der Chromatiden menschlicher Metaphasechromosomen (COLO-320) ist auch im Lichtmikroskop zu erkennen. (a und c: aus Rattner u.", [["COLO-320", "CHEMICAL", 103, 111], ["COLO-320", "CHEMICAL", 474, 482], ["COLO-320", "CELL", 103, 111], ["c", "GENE_OR_GENE_PRODUCT", 398, 399], ["Submetazentrisches menschliches Chromosom aus einer Zellinie (COLO-320), bei dem die Windung der Chromatiden in der elektronenmikroskopischen Darstellung gut zu erkennen", "SPECIES", 41, 210], ["Win-dung der Centromerenregion im Elektronenmikroskop besonders deutlich zeigt", "SPECIES", 318, 396], ["Die spiralige Struktur der Chromatiden menschlicher Metaphasechromosomen (COLO-320) ist auch im Lichtmikroskop zu erkennen", "SPECIES", 400, 522], ["a Submetazentrisches", "TEST", 39, 59], ["b Submetazentrisches Chromosom aus einer M\u00e4usezellinien", "TREATMENT", 216, 271], ["das durch besondere Vorbehandlung die", "TREATMENT", 280, 317], ["Die", "PROBLEM", 400, 403], ["von Metaphasechromosomen", "OBSERVATION", 13, 37]]], ["Es verdichten sich aber zumindest bei menschlichen Chromosomen die Hinweise darauf, dass die kleineren Chromosomen \u00fcblicherweise innen und die gr\u00f6\u00dferen an der Peripherie des Zellkerns zu finden sind.", [["verdichten sich aber zumindest bei menschlichen Chromosomen die Hinweise darauf, dass die kleineren Chromosomen \u00fcblicherweise innen und die gr\u00f6\u00dferen an der Peripherie des Zellkerns zu finden sind", "SPECIES", 3, 198]]], ["67 Mb): Das gen\u00e4rmere Chromosom 18 befindet sich \u00fcblicherweise am Rande des Zellkerns, wohingegen das gendichtere Chromosom 19 im Innern des Zellkerns vorkommt (Abb.", [["Das gen\u00e4rmere Chromosom 18 befindet sich \u00fcblicherweise am Rande des Zellkerns, wohingegen das gendichtere Chromosom 19 im Innern des Zellkerns vorkommt", "SPECIES", 8, 159]]], ["7.45) .Chromosomale Territorien und Architektur des ZellkernsAuch das Bandenmuster der mitotischen Chromosomen ist ein Beispiel f\u00fcr Kompartimentierung.", [["Chromosomale Territorien und Architektur des ZellkernsAuch das Bandenmuster der mitotischen Chromosomen ist ein Beispiel f\u00fcr Kompartimentierung", "SPECIES", 7, 150], ["Chromosomale Territorien und Architektur des", "TREATMENT", 7, 51]]], ["Die Arme der mitotischen Chromosomen bestehen aus fr\u00fch-replizierenden Banden (den hellen Giemsa-Banden = R-Banden), die sich mit den mittel bis sp\u00e4t replizierenden, dunklen Giemsa-Banden (= G-Ban-den) abwechseln.", [["Die Arme der mitotischen Chromosomen bestehen aus fr\u00fch-replizierenden Banden (den hellen Giemsa-Banden = R-Banden), die sich mit den mittel bis sp\u00e4t replizierenden, dunklen Giemsa-Banden (= G-Ban-den) abwechseln", "SPECIES", 0, 211]]], ["R-Banden haben eine h\u00f6here Gendichte und enthalten Haushaltsgene und gewebespezifische Gene, wohingegen G-Banden arm an Genen sind und nur gewebespezifische Gene enthalten.", [["R-Banden haben eine h\u00f6here Gendichte und enthalten Haushaltsgene und gewebespezifische Gene, wohingegen G-Banden arm an Genen sind und nur gewebespezifische Gene enthalten", "SPECIES", 0, 171], ["R", "TEST", 0, 1]]], ["Die h\u00f6chste Gendichte ist in einer Unterfraktion der R-Banden, den T-Banden, enthalten.", [["Die h\u00f6chste Gendichte ist in einer Unterfraktion der R-Banden, den T-Banden", "SPECIES", 0, 75]]], ["Das in der mittleren Phase der Replikation replizierende Chromatin der G-Banden wird \u00fcberwiegend in der Mitte des Zellkerns und der Gegend des Nukleolus gefunden, aber auch an Ein-Abb.", [["Phase der Replikation replizierende Chromatin der G-Banden wird \u00fcberwiegend", "TREATMENT", 21, 96]]], ["Chromosomen-Territorien in einer H\u00fchnerzelle. a DAPI-gef\u00e4rbte, diploide Metaphase einer H\u00fchnerzelle. b Dieselbe Metaphase nach in-situ-Hybridisierung mit verschiedenen Fluoreszenzfarbstoffen.", [["Fluoreszenzfarbstoffen", "CHEMICAL", 168, 190], ["einer H\u00fchnerzelle", "CELL", 27, 44], ["DAPI", "SIMPLE_CHEMICAL", 48, 52], ["Chromosomen", "TEST", 0, 11], ["a DAPI", "TREATMENT", 46, 52], ["gef\u00e4rbte", "TREATMENT", 53, 61], ["diploide Metaphase einer H\u00fchnerzelle", "TREATMENT", 63, 99], ["Hybridisierung mit verschiedenen Fluoreszenzfarbstoffen", "TREATMENT", 135, 190]]], ["Die Proben zur Anf\u00e4rbung der H\u00fchnerchromosomen wurden mit einem kombinatorischen Schema mit \u00d6stradiol (1, 4, 5, 6), Digoxigenin (2, 4, 6, Z) und Biotin (3, 5, 6, Z) markiert. c \u00d6stradiol-und Digoxigeninmarkierte Proben werden \u00fcber Sekund\u00e4rantik\u00f6rper nachge-wiesen, die mit Cy3 und FITC markiert sind; biotinylierte Proben werden \u00fcber Cy5-gekoppeltes Streptavidin nachgewiesen. d Der optische Schnitt in der Mitte eines Fibroblasten-Zellkerns des Huhns zeigt wechselseitig ausschlie\u00dfliche Chromosomen-Territorien, wobei homologe Chromosomen an unterschiedlichen Stellen lokalisiert sind (beachte, dass in diesem Schnitt jeweils nur eines der beiden Chromosomen-Territorien f\u00fcr die Chromosomen 4 und 6 sichtbar ist).", [["\u00d6stradiol", "CHEMICAL", 92, 101], ["Digoxigenin", "CHEMICAL", 116, 127], ["\u00d6stradiol", "CHEMICAL", 92, 101], ["Digoxigenin", "CHEMICAL", 116, 127], ["Biotin", "CHEMICAL", 145, 151], ["Biotin", "SIMPLE_CHEMICAL", 145, 151], ["Die Proben zur Anf\u00e4rbung der H\u00fchnerchromosomen wurden mit einem kombinatorischen Schema mit \u00d6stradiol", "SPECIES", 0, 101], ["Mitte eines Fibroblasten-Zellkerns des Huhns zeigt wechselseitig ausschlie\u00dfliche Chromosomen-Territorien, wobei homologe Chromosomen an unterschiedlichen Stellen lokalisiert sind (beachte, dass in diesem Schnitt jeweils nur eines der beiden Chromosomen-Territorien f\u00fcr die Chromosomen 4 und 6 sichtbar", "SPECIES", 407, 708], ["Schema mit \u00d6stradiol", "TREATMENT", 81, 101], ["Digoxigenin", "TREATMENT", 116, 127], ["Z) und Biotin", "TREATMENT", 138, 151], ["\u00d6stradiol", "TEST", 177, 186], ["Digoxigeninmarkierte", "TREATMENT", 191, 211], ["markiert", "TEST", 286, 294], ["biotinylierte Proben", "TREATMENT", 301, 321], ["Fibroblasten", "TEST", 419, 431]]], ["Sp\u00e4t replizierendes Chromatin enth\u00e4lt die heterochromatische Region und ist sowohl an der Peripherie als auch im Innern des Zellkerns enthalten.Chromosomale Territorien und Architektur des ZellkernsDie Markierung der DNA mit Thymidin-Analoga ergab Hinweise darauf, dass in verschiedenen lebenden S\u00e4ugerzellen bei der DNA-Synthese Chromatinaggregate entstehen.", [["Chromatin enth\u00e4lt die heterochromatische Region und ist sowohl an der Peripherie als auch im Innern des Zellkerns enthalten", "SPECIES", 20, 143], ["Chromosomale Territorien und Architektur des ZellkernsDie Markierung der DNA mit Thymidin-Analoga ergab Hinweise darauf, dass in verschiedenen lebenden S\u00e4ugerzellen bei der DNA-Synthese Chromatinaggregate entstehen", "SPECIES", 144, 358], ["Sp\u00e4t replizierendes Chromatin enth\u00e4lt die heterochromatische Region", "TREATMENT", 0, 67], ["an der Peripherie als auch", "TREATMENT", 83, 109], ["Chromosomale Territorien und Architektur des", "TREATMENT", 144, 188]]], ["Diese \"Replikations-Foci\" bestehen aus Clustern aktiver Replikons zusammen mit den Replikationsfaktoren; sie haben einen DNA-Gehalt von ca.", [["Foci", "PROBLEM", 20, 24]]], ["W\u00e4hrend der S-Phase ist die Replikationsmaschinerie mit einem Replikations-Focus f\u00fcr die Zeit verbunden, die notwendig ist, um dessen Replikation zu beenden (ca.", [["W\u00e4hrend der S-Phase ist die Replikationsmaschinerie mit einem Replikations-Focus f\u00fcr die Zeit verbunden, die notwendig ist, um dessen Replikation zu beenden", "SPECIES", 0, 156], ["der S-Phase ist die Replikationsmaschinerie mit einem Replikations", "TREATMENT", 8, 74]]], ["Erstaunlicherweise bleiben die Replikations-Foci aber auch nach der Replikation sichtbar und k\u00f6nnen unabh\u00e4ngig vom aktuellen Zustand des Zellzyklus durch mehrere Zellzyklen beobachtet werden.Chromosomale Territorien und Architektur des ZellkernsNeben den bisher besprochenen Kompartimenten des Zellkerns, die von Chromosomen angef\u00fcllt werden, gibt es auch definierte Bereiche, die offensichtlich frei von Chromatin sind.", [["Zustand des", "TREATMENT", 125, 136], ["Chromosomale Territorien und Architektur des", "TREATMENT", 191, 235], ["besprochenen Kompartimenten des", "TREATMENT", 262, 293]]], ["Dieser Interchromatinbereich ist mit einem Netz von Ribonukleoproteinen angef\u00fcllt.", [["Dieser Interchromatinbereich ist mit einem Netz von Ribonukleoproteinen angef\u00fcllt", "SPECIES", 0, 81], ["Dieser", "TEST", 0, 6]]], ["Es ist vorstellbar, dass hier gesplei\u00dfte RNA mit Proteinen komplexiert und zu den Kernporen transportiert wird, um so ein Verwir-ren der RNA im Inneren der kompakten Chromatindom\u00e4nen zu verhindern.", [["dass hier gesplei\u00dfte RNA mit Proteinen komplexiert und zu den Kernporen transportiert wird, um so ein Verwir-ren der RNA im Inneren der kompakten Chromatindom\u00e4nen zu verhindern", "SPECIES", 20, 196], ["dass hier gesplei\u00dfte RNA mit Proteinen komplexiert", "TREATMENT", 20, 70], ["ein Verwir-ren der RNA", "TREATMENT", 118, 140]]], ["Weiterhin gibt es deutlich Hinweise darauf, dass transkriptionell stille Gene in der N\u00e4he des centromeren Heterochromatinclusters lokalisiert sind; aktive Gene sind dagegen an anderen Stellen positioniert.", [["dass transkriptionell stille Gene in der N\u00e4he des", "TREATMENT", 44, 93]]], ["Die Position einzelner Gene erscheint dynamisch und abh\u00e4ngig vom Zustand der Transkription.", [["Gene erscheint dynamisch", "TEST", 23, 47]]], ["7.46.Chromosomale Territorien und Architektur des Zellkerns!", [["Chromosomale Territorien", "TREATMENT", 5, 29]]], ["Untersuchungen der h\u00f6heren Ordnung des Chromatins zeigten, dass Chromosomen in bestimmtem Kompartimenten des Zellkerns (Territorien) zu finden sind.", [["Untersuchungen der h\u00f6heren Ordnung des", "TREATMENT", 0, 38], ["dass Chromosomen", "TREATMENT", 59, 75]]], ["Diese Betrachtungsweise l\u00e4sst sich mit einem topologischen Modell der Genregulation verbinden.Chromosomale Territorien und Architektur des ZellkernsAn dieser Stelle kommen m\u00f6gliche neuartige Strukturen ins Spiel, die als Insulatoren von Chromatinregionen bezeichnet werden.", [["Diese Betrachtungsweise l\u00e4sst sich mit einem topologischen Modell der Genregulation verbinden", "SPECIES", 0, 93], ["Chromosomale Territorien und Architektur des ZellkernsAn dieser Stelle kommen m\u00f6gliche neuartige Strukturen ins Spiel, die als Insulatoren von Chromatinregionen bezeichnet werden", "SPECIES", 94, 272], ["Chromosomale", "TEST", 94, 106], ["Territorien", "TEST", 107, 118]]], ["Insulatoren werden in vielen Organismen (von Hefen bis zu Menschen) gefunden.", [["Insulatoren", "TREATMENT", 0, 11]]], ["Es sind Sequenzelemente, die die Wechselwirkungen zwischen Enhancern und Promotoren (vgl.", [["Promotoren", "CHEMICAL", 73, 83]]], ["8) verhindern, wenn sie zwischen diesen lokalisiert sind.", [["verhindern", "PROBLEM", 3, 13]]], ["Sie markieren offensichtlich Grenzen zwischen gr\u00f6\u00dferen Transkriptionseinheiten als dies einzelne Gene alleine darstellen.", [["Sie markieren offensichtlich Grenzen zwischen", "TREATMENT", 0, 45]]], ["Daher sind sie Schl\u00fcsselelemente in dem Prozess, voneinander unabh\u00e4ngige Dom\u00e4nen der Genexpression zu etablieren.Chromosomale Territorien und Architektur des ZellkernsErste Hinweise auf diese Rolle der Insulatoren beim Aufbau von Chromatindom\u00e4nen erhielt man bei der Analyse des gypsy-Insulators von Drosophila.", [["Drosophila", "SPECIES", 300, 310], ["Chromosomale Territorien und Architektur des ZellkernsErste Hinweise auf diese Rolle der Insulatoren beim Aufbau von Chromatindom\u00e4nen erhielt man bei der Analyse des gypsy-Insulators von Drosophila", "SPECIES", 113, 310], ["Chromosomale Territorien und Architektur des", "TREATMENT", 113, 157]]], ["Proteinkomponenten dieses Insulators kommen an ca.", [["ca", "OBSERVATION", 47, 49]]], ["500 Stellen im Drosophila-Genom vor.", [["Drosophila", "SPECIES", 15, 25]]], ["Diese Stellen sind jeweils an den Grenzen der Banden zu den Interbanden der polyt\u00e4nen Chromosomen vorhanden, was eine Funktion bei der Trennung von kondensiertem (= stillem) und nicht-kondensiertem (= aktivem) Chromatin nahe legt.", [["Diese Stellen sind jeweils an den Grenzen der Banden zu den Interbanden der polyt\u00e4nen Chromosomen vorhanden, was eine Funktion bei der Trennung von kondensiertem (= stillem) und nicht-kondensiertem (= aktivem", "SPECIES", 0, 208]]], ["Diese 500 Insulatoren verschmelzen aufgrund von Wechselwirkung mit daran gebundenen Proteinen zu ca.", [["Diese", "TREATMENT", 0, 5], ["Insulatoren verschmelzen", "TREATMENT", 10, 34]]], ["25 gr\u00f6\u00dferen Strukturen, die als \"Insulator-K\u00f6rperchen\" bezeichnet werden und \u00fcberwiegend in der Peripherie diploider Zellen Abb.", [["K\u00f6rperchen", "TREATMENT", 43, 53]]], ["Chromosomen-Territorien genreicher und genarmer Chromosomen.", [["Chromosomen", "TEST", 0, 11]]], ["Im Zellkern einer nicht-stimulierten menschlichen Lymphocyte sind 3-dimensionale Rekonstruktionen der Territorien der Chromosomen 18 (rot: genarm) und 19 (gr\u00fcn: genreich) gezeichnet.", [["Rekonstruktionen der Territorien der Chromosomen 18 (rot: genarm) und 19 (gr\u00fcn: genreich) gezeichnet", "SPECIES", 81, 181], ["Im", "TEST", 0, 2], ["Zellkern", "TEST", 3, 11], ["nicht", "TEST", 18, 23], ["Lymphocyte", "TEST", 50, 60]]], ["Die Territorien des Chromosoms 18 werden \u00fcblicherweise an der Peripherie des Zellkerns gefunden, wohingegen die Territorien des Chromosoms 19 im Innern des Zellkerns gefunden werden. a X, Y-Ansicht: Der Schnitt durch die Mitte des Nukleus ist als grauer Schatten gezeigt.", [["Die Territorien des Chromosoms 18 werden \u00fcblicherweise an der Peripherie des Zellkerns gefunden, wohingegen die Territorien des Chromosoms 19 im Innern des Zellkerns gefunden werden", "SPECIES", 0, 181], ["Der Schnitt durch die Mitte des Nukleus ist als grauer Schatten gezeigt", "SPECIES", 199, 270], ["Die Territorien des Chromosoms", "TREATMENT", 0, 30], ["an der Peripherie des Zellkerns gefunden", "TREATMENT", 55, 95], ["Der Schnitt durch die Mitte des", "TREATMENT", 199, 230]]], ["Es k\u00f6nnen nur die Territorien unterhalb der Schnittebene gesehen werden. b X, Z-Ansicht: Der Pfeil markiert die Seite, von der der Schnitt in a betrachtet wurde. ( rakterisiert, die die Anheftung individueller Chromatinschleifen an eine proteinhaltige Matrix bzw. an ein Kernskelett sowohl in Interphase-Kernen als auch im mitotischen Chromosom bewirken.", [["an eine proteinhaltige Matrix bzw", "TREATMENT", 229, 262], ["an ein Kernskelett sowohl", "TREATMENT", 264, 289], ["ein Kernskelett", "OBSERVATION", 267, 282]]], ["Eine m\u00f6gliche Funktion der MAR/SAR-Elemente ist aber auch die Wirkung als Insulatoren.", [["Eine m\u00f6gliche Funktion der MAR/SAR-Elemente ist aber auch die Wirkung als Insulatoren", "SPECIES", 0, 85]]], ["Eine derartige Identit\u00e4t von struktureller und funktioneller Wirkung wurde f\u00fcr die MAR-Elemente der apoB-, b-Interferonund \u03b11-Antitrypsin-Gene des Menschen und f\u00fcr das Lysozymgen des Huhns gezeigt.", [["Eine derartige Identit\u00e4t von struktureller und funktioneller Wirkung wurde f\u00fcr die MAR-Elemente der apoB-, b-Interferonund \u03b11-Antitrypsin-Gene des Menschen und f\u00fcr das Lysozymgen des Huhns gezeigt", "SPECIES", 0, 196], ["apoB", "TEST", 100, 104], ["Antitrypsin-Gene des", "TREATMENT", 126, 146]]], ["Ein weiteres Beispiel ist der gypsy-Insulator von Drosophila.", [["Drosophila", "SPECIES", 50, 60], ["Beispiel ist der gypsy-Insulator von Drosophila", "SPECIES", 13, 60]]], ["Hier wurden Wechselwirkungen nicht nur mit der Kernmatrix gezeigt, sondern auch mit Topoisomerase II und Histon H1 (als \u00dcbersicht dazu siehe Zhan et al. 2001 im Literaturverzeichnis) .Chromosomale Territorien und Architektur des ZellkernsDas Konzept der Insulatoren wird erg\u00e4nzt durch unterschiedliche Modifikationen der Histone (Methylierung des Histon H3 an Lys9 korrespondiert mit Heterochromatin und inaktivem Zustand und Methy-lierung an Lys4 sowie Acetylierung der Histone H3 und H4 korrespondiert dagegen mit dem aktiven Zustand).", [["Hier wurden Wechselwirkungen nicht nur mit der Kernmatrix gezeigt, sondern auch mit Topoisomerase II und Histon H1 (als \u00dcbersicht dazu siehe Zhan et al. 2001 im Literaturverzeichnis", "SPECIES", 0, 181], ["Chromosomale Territorien und Architektur des ZellkernsDas Konzept der Insulatoren wird erg\u00e4nzt durch unterschiedliche Modifikationen der Histone (Methylierung des Histon H3 an Lys9 korrespondiert mit Heterochromatin und inaktivem Zustand und Methy-lierung an Lys4 sowie Acetylierung der Histone H3 und H4 korrespondiert dagegen mit dem aktiven Zustand", "SPECIES", 184, 535], ["sondern auch mit Topoisomerase II und Histon H1 (als \u00dcbersicht dazu", "TREATMENT", 67, 134], ["Chromosomale Territorien und Architektur des", "TREATMENT", 184, 228], ["Konzept der Insulatoren wird erg\u00e4nzt durch unterschiedliche Modifikationen der Histone (Methylierung des", "TREATMENT", 242, 346], ["an Lys9 korrespondiert mit Heterochromatin", "TREATMENT", 357, 399], ["an Lys4 sowie Acetylierung der Histone H3", "TREATMENT", 440, 481]]], ["Zus\u00e4tzlich sind weitere Proteine in der inaktiven Region mit dem Chromatin assoziiert (z.", [["Zus\u00e4tzlich sind weitere Proteine", "TREATMENT", 0, 32]]], ["B. bei Hefe Swi6 Drosophila HP1).", [["HP1", "GENE_OR_GENE_PRODUCT", 28, 31], ["HP1", "PROTEIN", 28, 31], ["Drosophila", "SPECIES", 17, 27], ["B. bei Hefe Swi6 Drosophila", "SPECIES", 0, 27]]], ["F\u00fcr das \u03b2-Globincluster wurde gezeigt, dass die flankierenden Insulator-Sequenzen Bindestellen f\u00fcr das CTCF (engl.", [["CTCF", "PROTEIN", 103, 107]]], ["CCCTC-binding factor) Protein enthalten.", [["CCCTC-binding factor", "GENE_OR_GENE_PRODUCT", 0, 20], ["CCCTC-binding factor", "PROTEIN", 0, 20], ["Protein enthalten", "PROTEIN", 22, 39], ["Protein enthalten", "TREATMENT", 22, 39]]], ["Gerade das Beispiel der Insulatoren des \u03b2-Globingenclusters zeigt aber auch, dass das Insulator-Konzept dynamisch sein muss, um die unterschiedliche Aktivierung der individuellen \u03b2-Globingene w\u00e4hrend der Embryonalentwicklung zu erkl\u00e4ren.", [["Gerade das Beispiel der Insulatoren des \u03b2-Globingenclusters zeigt aber auch, dass das Insulator-Konzept dynamisch sein muss, um die unterschiedliche Aktivierung der individuellen \u03b2-Globingene w\u00e4hrend der Embryonalentwicklung zu erkl\u00e4ren", "SPECIES", 0, 236], ["der Insulatoren des", "TREATMENT", 20, 39], ["Globingene", "TREATMENT", 181, 191]]], ["Ein m\u00f6gliches Modell dazu ist in Abb.", [["Abb", "PROTEIN", 33, 36]]], ["7Autoradiographie an Geweben, Zellen und ChromosomenExponieren Entwickeln Pr\u00e4parat CytologischesPhotographischer FilmAutoradiographie.", [["7Autoradiographie", "TREATMENT", 0, 17], ["an Geweben", "TREATMENT", 18, 28]]], ["Radioaktiv markiertes Gewebe wird auf einen Objekttr\u00e4ger gebracht und mit lichtempfindlicher Emulsion bedeckt.", [["Radioaktiv markiertes Gewebe wird auf einen Objekttr\u00e4ger gebracht und mit lichtempfindlicher Emulsion bedeckt", "SPECIES", 0, 109], ["Radioaktiv markiertes", "TREATMENT", 0, 21]]], ["Die durch Silberk\u00f6rnchen gekennzeichneten Regionen des Pr\u00e4parates lassen die Lokalisation radioaktiven Materials im Gewebe erkennen.", [["Die durch Silberk\u00f6rnchen gekennzeichneten Regionen des Pr\u00e4parates lassen die Lokalisation radioaktiven Materials im Gewebe erkennen", "SPECIES", 0, 131], ["Die durch Silberk\u00f6rnchen gekennzeichneten Regionen des", "TREATMENT", 0, 54]]], ["Falls erforderlich, lassen sie sich nachtr\u00e4glich auch wieder durch Behandlung mit Abschw\u00e4cherl\u00f6sung entfernen, um die darunterliegenden Gewebeteile genauer erkennen zu k\u00f6nnen.", [["lassen sie sich nachtr\u00e4glich auch wieder durch Behandlung mit Abschw\u00e4cherl\u00f6sung entfernen, um die darunterliegenden Gewebeteile genauer erkennen zu k\u00f6nnen", "SPECIES", 20, 174], ["Falls erforderlich", "PROBLEM", 0, 18]]]], "PMC7166904": [["INTRODUCTIONAcute gastroenteritis in children, particularly under the age of five, remains a major cause of morbidity and mortality worldwide, with an estimated incidence of 2.5 billion cases annually [Unicef WHO, 2009; Gautam et al., 2013].", [["gastroenteritis", "DISEASE", 18, 33], ["children", "ORGANISM", 37, 45], ["children", "SPECIES", 37, 45], ["INTRODUCTIONAcute gastroenteritis", "PROBLEM", 0, 33], ["gastroenteritis", "OBSERVATION", 18, 33], ["morbidity", "OBSERVATION", 108, 117]]], ["Acute gastroenteritis is the second leading cause of mortality in study patients outside the neonatal period and accounts for an estimated 1.5 million deaths each year.", [["gastroenteritis", "DISEASE", 6, 21], ["deaths", "DISEASE", 151, 157], ["patients", "ORGANISM", 72, 80], ["patients", "SPECIES", 72, 80], ["Acute gastroenteritis", "PROBLEM", 0, 21], ["gastroenteritis", "OBSERVATION", 6, 21], ["mortality", "OBSERVATION", 53, 62]]], ["In the United States, acute gastroenteritis in children under five is responsible for approximately 300 deaths, 200,000 hospitalizations, and 1.5 million outpatient visits, an estimated $250 million in direct medical costs, and $1 billion in indirect medical costs [de Bruin et al., 2006; Churgay and Aftab, 2012].INTRODUCTIONIn children, viruses are the major causes of acute gastroenteritis [Parashar et al., 2003; Terletskaia\u2010Ladwig et al., 2007].", [["gastroenteritis", "DISEASE", 28, 43], ["deaths", "DISEASE", 104, 110], ["gastroenteritis", "DISEASE", 377, 392], ["children", "ORGANISM", 47, 55], ["children", "ORGANISM", 329, 337], ["children", "SPECIES", 47, 55], ["children", "SPECIES", 329, 337], ["acute gastroenteritis", "PROBLEM", 22, 43], ["acute gastroenteritis", "PROBLEM", 371, 392], ["acute", "OBSERVATION_MODIFIER", 22, 27], ["gastroenteritis", "OBSERVATION", 28, 43], ["acute", "OBSERVATION_MODIFIER", 371, 376], ["gastroenteritis", "OBSERVATION", 377, 392]]], ["Rotavirus, adenovirus, astrovirus, norovirus, and sapovirus, have all been established as etiological agents of acute gastroenteritis in children [Hammond et al., 1981; Wilhelmi et al., 2003; Claas et al., 2005; Colomba et al., 2006; Unicef WHO, 2009; Churgay and Aftab, 2012; Chhabra et al., 2013; Payne et al., 2013].", [["Rotavirus, adenovirus, astrovirus, norovirus", "DISEASE", 0, 44], ["gastroenteritis", "DISEASE", 118, 133], ["Rotavirus", "ORGANISM", 0, 9], ["adenovirus", "ORGANISM", 11, 21], ["astrovirus, norovirus", "ORGANISM", 23, 44], ["children", "ORGANISM", 137, 145], ["children", "SPECIES", 137, 145], ["Rotavirus", "PROBLEM", 0, 9], ["adenovirus", "PROBLEM", 11, 21], ["astrovirus", "PROBLEM", 23, 33], ["norovirus", "PROBLEM", 35, 44], ["sapovirus", "PROBLEM", 50, 59], ["acute gastroenteritis", "PROBLEM", 112, 133], ["acute", "OBSERVATION_MODIFIER", 112, 117], ["gastroenteritis", "OBSERVATION", 118, 133]]], ["Additionally, some clinical studies have suggested that coronaviruses may be a cause of acute gastroenteritis [Payne et al., 1986; van Maarseveen et al., 2010; Jev\u0161nik et al., 2013].", [["gastroenteritis", "DISEASE", 94, 109], ["coronaviruses", "ORGANISM", 56, 69], ["some clinical studies", "TEST", 14, 35], ["coronaviruses", "PROBLEM", 56, 69], ["acute gastroenteritis", "PROBLEM", 88, 109], ["acute", "OBSERVATION_MODIFIER", 88, 93], ["gastroenteritis", "OBSERVATION", 94, 109]]], ["Clinical data indicates that severe acute respiratory syndrome coronavirus (SARS\u2010CoV) caused significant diarrhea [Booth et al., 2003; Choi et al., 2003; Hsu et al., 2003; Peiris et al., 2003; Hsueh et al., 2004; Grant et al., 2012].", [["acute respiratory syndrome coronavirus", "DISEASE", 36, 74], ["SARS\u2010CoV)", "DISEASE", 76, 85], ["diarrhea", "DISEASE", 105, 113], ["SARS\u2010CoV", "ORGANISM", 76, 84], ["severe acute respiratory syndrome coronavirus", "SPECIES", 29, 74], ["SARS\u2010CoV", "SPECIES", 76, 84], ["Clinical data", "TEST", 0, 13], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 29, 74], ["significant diarrhea", "PROBLEM", 93, 113], ["severe", "OBSERVATION_MODIFIER", 29, 35], ["acute", "OBSERVATION_MODIFIER", 36, 41], ["respiratory syndrome coronavirus", "OBSERVATION", 42, 74], ["significant", "OBSERVATION_MODIFIER", 93, 104], ["diarrhea", "OBSERVATION", 105, 113]]], ["However, the true significance of endemic coronaviruses as gastrointestinal pathogens has not been fully elucidated [Trujillo et al., 2006; Dominguez et al., 2009; Esper et al., 2010; Jev\u0161nik et al., 2013].INTRODUCTIONElectron microscopy (EM) has been the gold standard diagnostic method for acute gastroenteritis, but this method requires a high concentration of viral particles per gram of stool, is labor\u2010intensive, [Kuypers et al., 2007; Wei et al., 2013] and is now infrequently used.", [["gastrointestinal", "ANATOMY", 59, 75], ["stool", "ANATOMY", 392, 397], ["coronaviruses", "DISEASE", 42, 55], ["gastrointestinal pathogens", "DISEASE", 59, 85], ["gastroenteritis", "DISEASE", 298, 313], ["coronaviruses", "ORGANISM", 42, 55], ["gastrointestinal", "ORGAN", 59, 75], ["stool", "ORGANISM_SUBSTANCE", 392, 397], ["endemic coronaviruses", "PROBLEM", 34, 55], ["gastrointestinal pathogens", "PROBLEM", 59, 85], ["acute gastroenteritis", "PROBLEM", 292, 313], ["a high concentration of viral particles", "TREATMENT", 340, 379], ["endemic coronaviruses", "OBSERVATION", 34, 55], ["acute", "OBSERVATION_MODIFIER", 292, 297], ["gastroenteritis", "OBSERVATION", 298, 313]]], ["Many laboratories use commercially available immunoassays for the diagnosis of rotavirus, norovirus, and adenovirus diseases; however, these tests are limited by their ability to detect a single viral pathogen at a time, poor sensitivity and specificity, and limited availability outside suspected outbreaks [de Bruin et al., 2006; Terletskaia\u2010Ladwig et al., 2007; Harris et al., 2009; Mans et al., 2010; Chhabra et al., 2013; Gautam et al., 2013].", [["rotavirus, norovirus", "DISEASE", 79, 99], ["adenovirus diseases", "DISEASE", 105, 124], ["rotavirus", "ORGANISM", 79, 88], ["norovirus", "ORGANISM", 90, 99], ["adenovirus", "ORGANISM", 105, 115], ["rotavirus", "SPECIES", 79, 88], ["norovirus", "SPECIES", 90, 99], ["adenovirus", "SPECIES", 105, 115], ["immunoassays", "TEST", 45, 57], ["rotavirus", "PROBLEM", 79, 88], ["norovirus", "PROBLEM", 90, 99], ["adenovirus diseases", "PROBLEM", 105, 124], ["these tests", "TEST", 135, 146], ["a single viral pathogen", "PROBLEM", 186, 209], ["rotavirus", "OBSERVATION", 79, 88], ["norovirus", "OBSERVATION", 90, 99]]], ["Laboratories have been transitioning toward molecular\u2010based techniques like RT\u2010PCR for detection of etiologic viruses in patients with diarrheal illness.INTRODUCTIONThe primary objective of this study was to determine the epidemiology of six common known enteric viruses (adenovirus, astrovirus, norovirus GI and GII, rotavirus, and sapovirus) as well as assess the role of the known endemic human coronaviruses in acute gastroenteritis in children.", [["etiologic viruses", "DISEASE", 100, 117], ["diarrheal illness", "DISEASE", 135, 152], ["enteric viruses", "DISEASE", 255, 270], ["norovirus GI and GII, rotavirus, and sapovirus", "DISEASE", 296, 342], ["acute gastroenteritis", "DISEASE", 415, 436], ["patients", "ORGANISM", 121, 129], ["adenovirus", "ORGANISM", 272, 282], ["astrovirus", "ORGANISM", 284, 294], ["norovirus GI", "ORGANISM", 296, 308], ["human", "ORGANISM", 392, 397], ["children", "ORGANISM", 440, 448], ["patients", "SPECIES", 121, 129], ["human", "SPECIES", 392, 397], ["children", "SPECIES", 440, 448], ["adenovirus", "SPECIES", 272, 282], ["rotavirus", "SPECIES", 318, 327], ["human coronaviruses", "SPECIES", 392, 411], ["molecular\u2010based techniques", "TEST", 44, 70], ["RT\u2010PCR", "TEST", 76, 82], ["etiologic viruses", "PROBLEM", 100, 117], ["diarrheal illness", "PROBLEM", 135, 152], ["this study", "TEST", 190, 200], ["six common known enteric viruses", "PROBLEM", 238, 270], ["adenovirus", "PROBLEM", 272, 282], ["astrovirus", "PROBLEM", 284, 294], ["norovirus", "PROBLEM", 296, 305], ["GII", "PROBLEM", 313, 316], ["rotavirus", "PROBLEM", 318, 327], ["sapovirus", "PROBLEM", 333, 342], ["acute gastroenteritis", "PROBLEM", 415, 436], ["viruses", "OBSERVATION", 110, 117], ["enteric viruses", "ANATOMY", 255, 270], ["endemic human coronaviruses", "OBSERVATION", 384, 411], ["acute", "OBSERVATION_MODIFIER", 415, 420], ["gastroenteritis", "OBSERVATION", 421, 436]]], ["The secondary objective of this study was to compare the sensitivities of electron microscopy and RT\u2010PCR for the diagnosis of viral acute gastroenteritis.", [["viral acute gastroenteritis", "DISEASE", 126, 153], ["this study", "TEST", 27, 37], ["electron microscopy", "TEST", 74, 93], ["RT\u2010PCR", "TEST", 98, 104], ["viral acute gastroenteritis", "PROBLEM", 126, 153], ["viral", "OBSERVATION_MODIFIER", 126, 131], ["acute", "OBSERVATION_MODIFIER", 132, 137], ["gastroenteritis", "OBSERVATION", 138, 153]]], ["This is the first hospital\u2010based, multi\u2010year, longitudinal study evaluating multiple viral etiologies of acute gastroenteritis in pediatric patients in the United States.Study Patients ::: MATERIALS AND METHODSAll stool samples from September 2006 to June 2009 submitted for viral diagnostic testing by electron microscopy (EM) at Children's Hospital Colorado (CHCO) in Aurora, CO were diluted in sterile deionized water, vortexed, centrifuged, further diluted to 2.5% v/v of original specimen, and archived at \u221270 \u00b0C. For EM, samples were concentrated by ultracentrifugation for 30 min at 22 psi, using an Airfuge and EM90 rotor (Beckman Coulter, Fullerton CA) [Hammond et al., 1981; Payne et al., 2013] negatively stained and scanned at 25,000 \u00d7 magnification for virus particles.", [["stool samples", "ANATOMY", 214, 227], ["specimen", "ANATOMY", 485, 493], ["samples", "ANATOMY", 527, 534], ["acute gastroenteritis", "DISEASE", 105, 126], ["patients", "ORGANISM", 140, 148], ["Patients", "ORGANISM", 176, 184], ["CO", "SIMPLE_CHEMICAL", 378, 380], ["patients", "SPECIES", 140, 148], ["Patients", "SPECIES", 176, 184], ["Children", "SPECIES", 331, 339], ["longitudinal study", "TEST", 46, 64], ["acute gastroenteritis", "PROBLEM", 105, 126], ["viral diagnostic testing", "TEST", 275, 299], ["original specimen", "TEST", 476, 493], ["virus particles", "PROBLEM", 766, 781], ["multiple", "OBSERVATION_MODIFIER", 76, 84], ["viral", "OBSERVATION_MODIFIER", 85, 90], ["acute", "OBSERVATION_MODIFIER", 105, 110], ["gastroenteritis", "OBSERVATION", 111, 126]]], ["Use of the banked specimens and clinical data was approved by the Colorado Multiple Institutional Review Board.DNA/RNA Extraction From Fecal Specimens ::: MATERIALS AND METHODSNucleic acids from each sample were extracted on a Qiagen Biorobot EZ1 using the EZ1 viral RNA mini kit (Qiagen, Valencia, CA) according to the manufacturer's instructions, was eluted in RNase\u2010free water, and stored at \u221280 \u00b0C. Samples were divided into groups of 6 samples, and 10 microliters of each sample was combined.", [["specimens", "ANATOMY", 18, 27], ["sample", "ANATOMY", 200, 206], ["Samples", "ANATOMY", 403, 410], ["samples", "ANATOMY", 441, 448], ["sample", "ANATOMY", 477, 483], ["METHODSNucleic acids", "CHEMICAL", 169, 189], ["DNA", "CELLULAR_COMPONENT", 111, 114], ["METHODSNucleic acids", "SIMPLE_CHEMICAL", 169, 189], ["the banked specimens", "TEST", 7, 27], ["DNA", "PROBLEM", 111, 114], ["RNA Extraction", "TEST", 115, 129], ["Fecal Specimens", "TEST", 135, 150], ["METHODSNucleic acids", "TREATMENT", 169, 189], ["a Qiagen Biorobot EZ1", "TREATMENT", 225, 246], ["the EZ1", "TREATMENT", 253, 260], ["Qiagen, Valencia, CA)", "TREATMENT", 281, 302], ["Samples", "TEST", 403, 410], ["each sample", "TEST", 472, 483], ["RNA Extraction", "OBSERVATION", 115, 129], ["Fecal", "ANATOMY", 135, 140]]], ["Each 60 microliter pool was stored at \u221280 \u00b0C.PCR and Sequencing ::: MATERIALS AND METHODSFour separate multiplex RT\u2010PCR assays, based on modifications of previously published assays, were used to screen for the following viruses: adenovirus (family: Adenoviridae, genus: Mastadenovirus, species: Human adenovirus A\u2010F) [Claas et al., 2005; Payne et al., 2013] and rotavirus (family: Reoviridae, subfamily: Sedoreovirinae, genus: Rotavirus, species: rotavirus A) [van Maarseveen et al., 2010; S\u00e1nchez\u2010Fauquier et al., 2011], astrovirus (family: Astroviridae, genus: Mamastrovirus) and sapovirus (family: Caliciviridae, genus: Sapovirus, species: Sapporo virus) [Hsueh et al., 2004; De Benedictis et al., 2011; Grant et al., 2012], norovirus groups I and II (family: Caliciviridae, genus: Norovirus, species: Norwalk virus, genogroups GI and GII) [Trujillo et al., 2006; Finkbeiner et al., 2008], and the four known endemic humans coronavirus (order: Nidovirales, family: Coronaviridae, genus: Alphacoronavirus species: human coronavirus 229E and NL63; genus: Betacoronavirus, species: human coronavirus HKU1 and OC43) [Kuypers et al., 2007; Dominguez et al., 2009; Finkbeiner et al., 2009a, 2009b].", [["Norovirus", "DISEASE", 786, 795], ["humans coronavirus", "DISEASE", 921, 939], ["adenovirus", "ORGANISM", 230, 240], ["Human", "ORGANISM", 296, 301], ["adenovirus A\u2010F", "ORGANISM", 302, 316], ["rotavirus", "ORGANISM", 363, 372], ["Rotavirus", "ORGANISM", 428, 437], ["rotavirus A", "ORGANISM", 448, 459], ["astrovirus", "ORGANISM", 523, 533], ["Sapporo virus", "ORGANISM", 644, 657], ["norovirus", "ORGANISM", 729, 738], ["Norovirus", "ORGANISM", 786, 795], ["Norwalk virus", "ORGANISM", 806, 819], ["humans", "ORGANISM", 921, 927], ["coronavirus", "ORGANISM", 928, 939], ["Alphacoronavirus species", "ORGANISM", 991, 1015], ["human", "ORGANISM", 1017, 1022], ["coronavirus 229E", "ORGANISM", 1023, 1039], ["NL63", "ORGANISM", 1044, 1048], ["Betacoronavirus", "GENE_OR_GENE_PRODUCT", 1057, 1072], ["human", "ORGANISM", 1083, 1088], ["coronavirus HKU1", "ORGANISM", 1089, 1105], ["Human", "SPECIES", 296, 301], ["Sapporo virus", "SPECIES", 644, 657], ["humans", "SPECIES", 921, 927], ["coronavirus", "SPECIES", 928, 939], ["human", "SPECIES", 1017, 1022], ["coronavirus", "SPECIES", 1023, 1034], ["human", "SPECIES", 1083, 1088], ["coronavirus", "SPECIES", 1089, 1100], ["Human adenovirus A\u2010F", "SPECIES", 296, 316], ["Sapporo virus", "SPECIES", 644, 657], ["humans coronavirus", "SPECIES", 921, 939], ["human coronavirus 229E", "SPECIES", 1017, 1039], ["human coronavirus", "SPECIES", 1083, 1100], ["PCR", "TEST", 45, 48], ["METHODSFour separate multiplex RT\u2010PCR assays", "TEST", 82, 126], ["previously published assays", "TEST", 154, 181], ["Rotavirus", "PROBLEM", 428, 437], ["Sapovirus", "PROBLEM", 624, 633], ["Norovirus", "PROBLEM", 786, 795], ["Alphacoronavirus species", "PROBLEM", 991, 1015], ["human coronavirus", "TEST", 1017, 1034], ["NL63", "TEST", 1044, 1048], ["Betacoronavirus", "TEST", 1057, 1072], ["human coronavirus", "TEST", 1083, 1100]]], ["Each pool containing RNA from six samples was run on each protocol.", [["samples", "ANATOMY", 34, 41], ["Each pool containing RNA", "PROBLEM", 0, 24], ["six samples", "TEST", 30, 41], ["each protocol", "TREATMENT", 53, 66]]], ["If a pool was positive for a given assay, RNA from each of the six samples was run individually to determine which of the samples were positive.", [["samples", "ANATOMY", 67, 74], ["samples", "ANATOMY", 122, 129], ["a pool", "TEST", 3, 9], ["assay", "TEST", 35, 40], ["RNA", "TEST", 42, 45], ["the six samples", "TEST", 59, 74], ["the samples", "TEST", 118, 129]]], ["Negative and positive controls were included in each run for all protocols.", [["all protocols", "TREATMENT", 61, 74], ["positive controls", "OBSERVATION_MODIFIER", 13, 30]]], ["Due to concern for PCR inhibitors in stool, samples were spiked with 10 \u00b5L of extracted RNA from each pool with a known quantity of pandemic 2009 H1N1 influenza A RNA, and then assessed for influenza RNA by RT\u2010PCR (Supplemental Table).PCR and Sequencing ::: MATERIALS AND METHODSNorovirus\u2010positive samples were randomly selected for sequencing during the peak of activity, and conventional PCR targeting a 343\u2010nucleotide region of the capsid gene was performed using a previously published assay [Mans et al., 2010; De Benedictis et al., 2011].", [["stool", "ANATOMY", 37, 42], ["samples", "ANATOMY", 44, 51], ["METHODSNorovirus\u2010positive samples", "ANATOMY", 272, 305], ["stool", "ORGANISM_SUBSTANCE", 37, 42], ["METHODSNorovirus\u2010positive samples", "CANCER", 272, 305], ["pandemic 2009 H1N1 influenza A RNA", "RNA", 132, 166], ["influenza RNA", "RNA", 190, 203], ["343\u2010nucleotide region", "DNA", 406, 427], ["capsid gene", "DNA", 435, 446], ["H1N1 influenza", "SPECIES", 146, 160], ["pandemic 2009 H1N1 influenza A", "SPECIES", 132, 162], ["PCR inhibitors in stool", "PROBLEM", 19, 42], ["samples", "TEST", 44, 51], ["extracted RNA", "PROBLEM", 78, 91], ["pandemic 2009 H1N1 influenza A RNA", "PROBLEM", 132, 166], ["influenza RNA", "PROBLEM", 190, 203], ["PCR", "TEST", 235, 238], ["METHODSNorovirus\u2010positive samples", "TEST", 272, 305], ["conventional PCR", "TEST", 377, 393]]], ["Amplicons were analyzed by agarose gel electrophoresis and sequenced on an ABI 3730 DNA sequencer (Applied Biosystems Technologies, Carlsbad, CA) at the University of Colorado School of Medicine Cancer Center DNA Sequencing and Analysis Core.Data Analysis ::: MATERIALS AND METHODSSpecimens were decoded, and medical chart review was performed on virus\u2010positive subjects using a standardized form.", [["Cancer", "DISEASE", 195, 201], ["agarose", "SIMPLE_CHEMICAL", 27, 34], ["DNA", "CELLULAR_COMPONENT", 84, 87], ["DNA", "CELLULAR_COMPONENT", 209, 212], ["Amplicons", "TREATMENT", 0, 9], ["agarose gel electrophoresis", "TREATMENT", 27, 54], ["an ABI", "TEST", 72, 78], ["DNA sequencer", "TEST", 84, 97], ["Data Analysis", "TEST", 242, 255], ["medical chart review", "TEST", 309, 329]]], ["In order to assess typical clinical features of the viruses, clinical data comparisons were limited to patients who were not immunocompromised and who were positive for only one virus.", [["patients", "ORGANISM", 103, 111], ["patients", "SPECIES", 103, 111], ["the viruses", "PROBLEM", 48, 59], ["clinical data comparisons", "TEST", 61, 86], ["immunocompromised", "PROBLEM", 125, 142], ["one virus", "PROBLEM", 174, 183], ["viruses", "OBSERVATION", 52, 59]]], ["Study data were collected and managed using REDCap electronic data capture tools hosted at the UCSOM [Harris et al., 2009; Chhabra et al., 2013].", [["Study data", "TEST", 0, 10]]], ["Statistical computations were conducted with SAS software, version 9.1.3.", [["SAS software", "TEST", 45, 57], ["version", "TEST", 59, 66]]], ["Significance was determined using the Wilcoxon Signed Rank test or Chi Square.Patients ::: RESULTSFrom September 2006 to June 2009, 1777 stool samples were submitted for viral diagnostic testing.", [["stool samples", "ANATOMY", 137, 150], ["Patients", "ORGANISM", 78, 86], ["stool samples", "CANCER", 137, 150], ["Patients", "SPECIES", 78, 86], ["stool samples", "TEST", 137, 150], ["viral diagnostic testing", "TEST", 170, 194]]], ["Of these, 1105 (62%) had enough residual sample to permit inclusion in the study.", [["enough residual sample", "PROBLEM", 25, 47], ["the study", "TEST", 71, 80]]], ["There were no differences in the age, gender, or order location of patients with samples included in or excluded from the study.", [["samples", "ANATOMY", 81, 88], ["patients", "ORGANISM", 67, 75], ["patients", "SPECIES", 67, 75], ["the study", "TEST", 118, 127], ["no", "UNCERTAINTY", 11, 13], ["differences", "OBSERVATION_MODIFIER", 14, 25]]], ["The majority (941, 85%) of samples were from pediatric patients (median age = 2.97 years, 54% male) (Table I).", [["samples", "ANATOMY", 27, 34], ["samples", "CANCER", 27, 34], ["patients", "ORGANISM", 55, 63], ["patients", "SPECIES", 55, 63]]], ["The remaining 164 samples were referral specimens submitted from adults seen at the University of Colorado Hospital (UCH) from September 2006 to December 2008, of which 141 (86%) were submitted between September 2006 and January 2007.Virus Detection ::: RESULTSAll pools were positive for influenza, indicating the absence of PCR inhibitors.", [["samples", "ANATOMY", 18, 25], ["specimens", "ANATOMY", 40, 49], ["influenza", "DISEASE", 289, 298], ["Virus", "ORGANISM", 234, 239], ["referral specimens", "TEST", 31, 49], ["RESULTSAll pools", "TEST", 254, 270], ["influenza", "PROBLEM", 289, 298], ["PCR inhibitors", "TREATMENT", 326, 340]]], ["Viral RNA/DNA was detected in 247 (26.2%) of the 941 pediatric samples.", [["samples", "ANATOMY", 63, 70], ["Viral", "ORGANISM", 0, 5], ["DNA", "CELLULAR_COMPONENT", 10, 13], ["samples", "CANCER", 63, 70], ["Viral RNA", "RNA", 0, 9], ["Viral RNA/DNA", "TEST", 0, 13], ["pediatric samples", "TEST", 53, 70]]], ["Of these, 95 (10.0%) were positive for adenovirus, 33 (3.5%) for astrovirus, 8 (0.9%) for norovirus GI, 90 (9.6%) for norovirus GII, 49 (5.2%) for rotavirus, and 2 (0.2%) for sapovirus.", [["astrovirus", "DISEASE", 65, 75], ["norovirus GI", "DISEASE", 90, 102], ["norovirus GII", "DISEASE", 118, 131], ["rotavirus", "DISEASE", 147, 156], ["adenovirus", "ORGANISM", 39, 49], ["astrovirus", "ORGANISM", 65, 75], ["norovirus GII", "ORGANISM", 118, 131], ["rotavirus", "ORGANISM", 147, 156], ["adenovirus", "SPECIES", 39, 49], ["norovirus GII", "SPECIES", 118, 131], ["rotavirus", "SPECIES", 147, 156], ["adenovirus", "TEST", 39, 49], ["astrovirus", "TEST", 65, 75], ["norovirus GI", "TEST", 90, 102], ["norovirus GII", "TEST", 118, 131], ["rotavirus", "PROBLEM", 147, 156], ["sapovirus", "PROBLEM", 175, 184]]], ["Coronavirus RNA was not detected in any sample (Table II).", [["sample", "ANATOMY", 40, 46], ["Coronavirus RNA", "RNA", 0, 15], ["Coronavirus", "SPECIES", 0, 11], ["Coronavirus RNA", "PROBLEM", 0, 15]]], ["Overall, 100 (27.3%) outpatient samples, 80 (32.4%) inpatient samples, and 67 (27.1%) samples from immunocompromised patients were positive for at least one virus (Table II).", [["samples", "ANATOMY", 32, 39], ["samples", "ANATOMY", 62, 69], ["samples", "ANATOMY", 86, 93], ["samples", "CANCER", 62, 69], ["samples", "CANCER", 86, 93], ["patients", "ORGANISM", 117, 125], ["patients", "SPECIES", 117, 125], ["outpatient samples", "TEST", 21, 39], ["inpatient samples", "TEST", 52, 69], ["samples", "TEST", 86, 93], ["immunocompromised patients", "TEST", 99, 125]]], ["Evidence of co\u2010infection was present in 28 (3.0%) of pediatric samples (Table III).Virus Detection ::: RESULTSEach virus demonstrated seasonal and variable changes from year to year (Fig. 1).", [["samples", "ANATOMY", 63, 70], ["co\u2010infection", "DISEASE", 12, 24], ["Virus", "ORGANISM", 83, 88], ["co\u2010infection", "PROBLEM", 12, 24], ["pediatric samples", "TEST", 53, 70], ["Virus Detection", "TEST", 83, 98], ["RESULTSEach virus", "PROBLEM", 103, 120], ["co\u2010infection", "OBSERVATION", 12, 24]]], ["Adenovirus was detected throughout the year in children with acute gastroenteritis, with highest prevalence (44.5%) in April 2009.", [["acute gastroenteritis", "DISEASE", 61, 82], ["Adenovirus", "ORGANISM", 0, 10], ["children", "ORGANISM", 47, 55], ["children", "SPECIES", 47, 55], ["Adenovirus", "SPECIES", 0, 10], ["Adenovirus", "PROBLEM", 0, 10], ["acute gastroenteritis", "PROBLEM", 61, 82], ["acute", "OBSERVATION_MODIFIER", 61, 66], ["gastroenteritis", "OBSERVATION", 67, 82]]], ["Astrovirus was detected from January to August 2007, with highest prevalence (15%) in April 2007; however, in 2008 and 2009 was only detected January to March.", [["Astrovirus", "SPECIES", 0, 10], ["Astrovirus", "PROBLEM", 0, 10]]], ["Norovirus GII was most prevalent from October 2006 to April 2007, and then was not detected until April 2008 with an increase in prevalence in December 2008.", [["Norovirus", "DISEASE", 0, 9], ["Norovirus GII", "ORGANISM", 0, 13], ["Norovirus GII", "PROBLEM", 0, 13]]], ["Rotavirus was highly prevalent from October 2006 to April 2007 with decreasing prevalence thereafter.Virus Detection ::: RESULTSOf the 164 adult samples tested, 64 (39%) were positive, of which 51 (80%) contained norovirus GII nucleic acid, 4 (2.4%) adenovirus, 2 (1.2%) astrovirus, 6 (3.6%) norovirus GI, and 1 (0.6%) rotavirus as shown in Table II.", [["samples", "ANATOMY", 145, 152], ["Rotavirus", "DISEASE", 0, 9], ["nucleic acid", "CHEMICAL", 227, 239], ["astrovirus", "DISEASE", 271, 281], ["norovirus GI", "DISEASE", 292, 304], ["rotavirus", "DISEASE", 319, 328], ["Rotavirus", "ORGANISM", 0, 9], ["Virus", "ORGANISM", 101, 106], ["samples", "CANCER", 145, 152], ["adenovirus", "ORGANISM", 250, 260], ["astrovirus", "ORGANISM", 271, 281], ["norovirus", "ORGANISM", 292, 301], ["GI", "CANCER", 302, 304], ["rotavirus", "ORGANISM", 319, 328], ["rotavirus", "SPECIES", 319, 328], ["Rotavirus", "PROBLEM", 0, 9], ["Virus Detection", "TEST", 101, 116], ["adult samples", "TEST", 139, 152], ["norovirus", "TEST", 213, 222], ["nucleic acid", "TEST", 227, 239], ["adenovirus", "TEST", 250, 260], ["astrovirus", "TEST", 271, 281], ["norovirus GI", "TEST", 292, 304], ["rotavirus", "PROBLEM", 319, 328]]], ["All 51 samples positive for norovirus GII were collected between October 2006 and January 2007, and 8 of 14 (57%) samples were positive in October, 11 of 27 (41%) in November, 22 of 58 (38%) in December, and 10 of 41 (24%) in January.", [["samples", "ANATOMY", 7, 14], ["samples", "ANATOMY", 114, 121], ["samples", "CANCER", 7, 14], ["norovirus GII", "ORGANISM", 28, 41], ["samples", "CANCER", 114, 121], ["norovirus", "SPECIES", 28, 37], ["All 51 samples", "TEST", 0, 14], ["norovirus GII", "PROBLEM", 28, 41]]], ["During this timeframe, 12 adult and 7 pediatric, norovirus positive samples were sequenced: 16 (84%) were norovirus GII.4. and 3 (16%), all from pediatric patients, were norovirus GII.14.Persistent Infection ::: RESULTS329 samples were collected from 112 patients.", [["samples", "ANATOMY", 68, 75], ["samples", "ANATOMY", 223, 230], ["norovirus", "DISEASE", 106, 115], ["norovirus", "DISEASE", 170, 179], ["norovirus", "ORGANISM", 49, 58], ["samples", "CANCER", 68, 75], ["patients", "ORGANISM", 155, 163], ["RESULTS329 samples", "CANCER", 212, 230], ["patients", "ORGANISM", 255, 263], ["patients", "SPECIES", 155, 163], ["patients", "SPECIES", 255, 263], ["norovirus positive samples", "PROBLEM", 49, 75], ["norovirus GII", "PROBLEM", 106, 119], ["norovirus GII", "PROBLEM", 170, 183], ["Persistent Infection", "PROBLEM", 187, 207], ["RESULTS329 samples", "TEST", 212, 230], ["norovirus", "OBSERVATION", 170, 179], ["Infection", "OBSERVATION", 198, 207]]], ["Of these, 18 patients had multiple samples positive for at least one virus.", [["samples", "ANATOMY", 35, 42], ["patients", "ORGANISM", 13, 21], ["patients", "SPECIES", 13, 21], ["multiple samples positive", "PROBLEM", 26, 51], ["virus", "OBSERVATION", 69, 74]]], ["Five immunocompromised patients in this study had multiple, serial stool samples positive for the same virus.", [["stool samples", "ANATOMY", 67, 80], ["patients", "ORGANISM", 23, 31], ["patients", "SPECIES", 23, 31], ["this study", "TEST", 35, 45], ["serial stool samples", "TEST", 60, 80], ["the same virus", "PROBLEM", 94, 108], ["immunocompromised", "OBSERVATION", 5, 22]]], ["Details of these clinical cases are outlined in Table V.Clinical Data ::: RESULTSThe demographic and clinical characteristics of the 135 non\u2010immunocompromised patients with singly positive samples and clinical data available are shown in Table IV.", [["samples", "ANATOMY", 189, 196], ["patients", "ORGANISM", 159, 167], ["patients", "SPECIES", 159, 167], ["singly positive samples", "PROBLEM", 173, 196], ["clinical data", "TEST", 201, 214]]], ["The median duration of diarrhea was 6 days (IQR 3\u201014), with a median of 6 stools per day (IQR 4\u201010) per patient.", [["diarrhea", "DISEASE", 23, 31], ["patient", "ORGANISM", 104, 111], ["patient", "SPECIES", 104, 111], ["diarrhea", "PROBLEM", 23, 31]]], ["In total, 56% of patients had emesis and 41.6% had fever.", [["emesis", "DISEASE", 30, 36], ["fever", "DISEASE", 51, 56], ["patients", "ORGANISM", 17, 25], ["patients", "SPECIES", 17, 25], ["emesis", "PROBLEM", 30, 36], ["fever", "PROBLEM", 51, 56]]], ["Approximately one\u2010quarter of the patients had fecal leukocytes and erythrocytes present.", [["fecal leukocytes", "ANATOMY", 46, 62], ["erythrocytes", "ANATOMY", 67, 79], ["patients", "ORGANISM", 33, 41], ["fecal leukocytes", "CELL", 46, 62], ["erythrocytes", "CELL", 67, 79], ["fecal leukocytes", "CELL_TYPE", 46, 62], ["erythrocytes", "CELL_TYPE", 67, 79], ["patients", "SPECIES", 33, 41], ["fecal leukocytes", "PROBLEM", 46, 62], ["erythrocytes", "PROBLEM", 67, 79], ["fecal leukocytes", "ANATOMY", 46, 62], ["erythrocytes", "OBSERVATION", 67, 79]]], ["Patients with adenovirus were more likely to have decreased urine output (28.6%).", [["urine", "ANATOMY", 60, 65], ["decreased urine output", "DISEASE", 50, 72], ["Patients", "ORGANISM", 0, 8], ["adenovirus", "ORGANISM", 14, 24], ["urine", "ORGANISM_SUBSTANCE", 60, 65], ["Patients", "SPECIES", 0, 8], ["adenovirus", "PROBLEM", 14, 24], ["decreased urine output", "PROBLEM", 50, 72], ["adenovirus", "OBSERVATION", 14, 24], ["output", "OBSERVATION_MODIFIER", 66, 72]]], ["There were no other statistically significant differences in symptoms or laboratory values among the different enteric viruses.Performance Characteristics: RT\u2010PCR versus EM ::: RESULTSSamples positive by RT\u2010PCR for adenovirus, rotavirus, and caliciviruses or astroviruses were compared with those positive by EM (Table VI).", [["adenovirus", "ORGANISM", 215, 225], ["rotavirus", "ORGANISM", 227, 236], ["astroviruses", "CANCER", 259, 271], ["adenovirus", "SPECIES", 215, 225], ["rotavirus", "SPECIES", 227, 236], ["other statistically significant differences in symptoms", "PROBLEM", 14, 69], ["laboratory values", "TEST", 73, 90], ["the different enteric viruses", "PROBLEM", 97, 126], ["RT\u2010PCR", "TEST", 156, 162], ["RESULTSSamples", "TEST", 177, 191], ["RT\u2010PCR", "TEST", 204, 210], ["adenovirus", "PROBLEM", 215, 225], ["rotavirus", "PROBLEM", 227, 236], ["caliciviruses", "PROBLEM", 242, 255], ["astroviruses", "PROBLEM", 259, 271], ["no other", "UNCERTAINTY", 11, 19], ["enteric viruses", "OBSERVATION", 111, 126]]], ["Of 111 samples positive for adenovirus by EM or PCR, 99 (89%) were positive by PCR and 12 (11%) were positive by EM.", [["samples", "ANATOMY", 7, 14], ["samples", "CANCER", 7, 14], ["adenovirus", "ORGANISM", 28, 38], ["adenovirus", "SPECIES", 28, 38], ["111 samples", "TEST", 3, 14], ["adenovirus", "PROBLEM", 28, 38], ["PCR", "TEST", 48, 51], ["PCR", "TEST", 79, 82]]], ["Of 192 samples positive for astrovirus, sapovirus, or norovirus by EM (designated collectively as \u201csmall round viruses\u201d) or RT\u2010PCR, 186 (97%) were positive by RT\u2010PCR and 21 (11%) were positive by EM.", [["samples", "ANATOMY", 7, 14], ["samples", "CANCER", 7, 14], ["astrovirus", "ORGANISM", 28, 38], ["sapovirus", "GENE_OR_GENE_PRODUCT", 40, 49], ["norovirus", "ORGANISM", 54, 63], ["sapovirus", "SPECIES", 40, 49], ["192 samples", "TEST", 3, 14], ["astrovirus", "PROBLEM", 28, 38], ["sapovirus", "PROBLEM", 40, 49], ["norovirus", "PROBLEM", 54, 63], ["small round viruses", "PROBLEM", 99, 118], ["RT\u2010PCR", "TEST", 124, 130], ["RT\u2010PCR", "TEST", 159, 165]]], ["For rotavirus, 50 (60%) were positive by RT\u2010PCR and 56 (67%) were positive by EM.DISCUSSIONThis is the first hospital\u2010based, 3\u2010year, longitudinal study evaluating multiple viral etiologies of acute gastroenteritis in pediatric patients in the United States.", [["acute gastroenteritis", "DISEASE", 192, 213], ["rotavirus", "ORGANISM", 4, 13], ["patients", "ORGANISM", 227, 235], ["patients", "SPECIES", 227, 235], ["rotavirus", "SPECIES", 4, 13], ["rotavirus", "PROBLEM", 4, 13], ["RT\u2010PCR", "TEST", 41, 47], ["longitudinal study", "TEST", 133, 151], ["acute gastroenteritis", "PROBLEM", 192, 213], ["acute", "OBSERVATION_MODIFIER", 192, 197], ["gastroenteritis", "OBSERVATION", 198, 213]]], ["Overall, 26% of all samples from children with gastrointestinal symptoms showed evidence of viral infection by RT\u2010PCR, similar to what has been reported in most studies using molecular techniques [Esper et al., 2010; Chhabra et al., 2013; Jev\u0161nik et al., 2013; Payne et al., 2013].", [["samples", "ANATOMY", 20, 27], ["gastrointestinal", "ANATOMY", 47, 63], ["gastrointestinal symptoms", "DISEASE", 47, 72], ["viral infection", "DISEASE", 92, 107], ["samples", "CANCER", 20, 27], ["children", "ORGANISM", 33, 41], ["gastrointestinal", "ORGAN", 47, 63], ["children", "SPECIES", 33, 41], ["gastrointestinal symptoms", "PROBLEM", 47, 72], ["viral infection", "PROBLEM", 92, 107], ["RT\u2010PCR", "PROBLEM", 111, 117], ["gastrointestinal", "ANATOMY", 47, 63], ["evidence of", "UNCERTAINTY", 80, 91], ["viral", "OBSERVATION_MODIFIER", 92, 97], ["infection", "OBSERVATION", 98, 107]]], ["Of note, viral agents were not detected in 74% of samples, and few samples had bacterial agents identified, suggesting that diarrhea had a non\u2010infectious cause or was due to a pathogen not assessed in this study.", [["samples", "ANATOMY", 50, 57], ["samples", "ANATOMY", 67, 74], ["diarrhea", "DISEASE", 124, 132], ["samples", "CANCER", 50, 57], ["viral agents", "TREATMENT", 9, 21], ["bacterial agents", "TREATMENT", 79, 95], ["diarrhea", "PROBLEM", 124, 132], ["a pathogen", "PROBLEM", 174, 184], ["this study", "TEST", 201, 211], ["pathogen", "OBSERVATION", 176, 184]]], ["Recently, Payne et al. prospectively evaluated the etiology of acute gastroenteritis in children less than 5 years of age for 12 months in three counties in the United States and found that 21% of cases were attributed to norovirus and 12% to rotavirus.", [["gastroenteritis", "DISEASE", 69, 84], ["norovirus", "DISEASE", 222, 231], ["rotavirus", "DISEASE", 243, 252], ["children", "ORGANISM", 88, 96], ["rotavirus", "ORGANISM", 243, 252], ["children", "SPECIES", 88, 96], ["norovirus", "SPECIES", 222, 231], ["rotavirus", "SPECIES", 243, 252], ["acute gastroenteritis", "PROBLEM", 63, 84], ["norovirus", "PROBLEM", 222, 231], ["rotavirus", "PROBLEM", 243, 252], ["acute", "OBSERVATION_MODIFIER", 63, 68], ["gastroenteritis", "OBSERVATION", 69, 84]]], ["When Chhabra et al. expanded this study to evaluate the roles of bocavirus, parechovirus, and aichivirus in acute gastroenteritis in addition to the viruses studied here, viruses were identified in two\u2010thirds of their patients.", [["gastroenteritis", "DISEASE", 114, 129], ["bocavirus", "GENE_OR_GENE_PRODUCT", 65, 74], ["parechovirus", "GENE_OR_GENE_PRODUCT", 76, 88], ["patients", "ORGANISM", 218, 226], ["patients", "SPECIES", 218, 226], ["this study", "TEST", 29, 39], ["bocavirus", "PROBLEM", 65, 74], ["parechovirus", "PROBLEM", 76, 88], ["aichivirus", "PROBLEM", 94, 104], ["acute gastroenteritis", "PROBLEM", 108, 129], ["the viruses", "PROBLEM", 145, 156], ["viruses", "PROBLEM", 171, 178], ["bocavirus", "OBSERVATION", 65, 74], ["acute", "OBSERVATION_MODIFIER", 108, 113], ["gastroenteritis", "OBSERVATION", 114, 129], ["viruses", "OBSERVATION", 149, 156]]], ["This increased identification of an etiological agent is likely due to their active surveillance and more comprehensive survey.", [["likely due to", "UNCERTAINTY", 57, 70]]], ["Additionally, there are reports of diarrhea associated with rotavirus groups B in children in Asia [Sanekata et al., 2003] and group C worldwide [Jiang et al., 1995; Kumazaki and Usuku, 2013], as well as toroviruses [Koopmans et al., 1997; Jamieson et al., 1998] in children with gastroenteritis, which were not included in the RT\u2010PCR assay in this study.", [["diarrhea", "DISEASE", 35, 43], ["rotavirus groups B", "DISEASE", 60, 78], ["gastroenteritis", "DISEASE", 280, 295], ["rotavirus groups B", "ORGANISM", 60, 78], ["children", "ORGANISM", 82, 90], ["children", "ORGANISM", 266, 274], ["children", "SPECIES", 82, 90], ["children", "SPECIES", 266, 274], ["diarrhea", "PROBLEM", 35, 43], ["gastroenteritis", "PROBLEM", 280, 295], ["the RT\u2010PCR assay", "TEST", 324, 340], ["this study", "TEST", 344, 354], ["diarrhea", "OBSERVATION", 35, 43], ["gastroenteritis", "OBSERVATION", 280, 295]]], ["Nevertheless, these studies suggest that there are likely other, yet to be discovered, viruses that cause acute gastroenteritis in children.DISCUSSIONAs expected, the incidence of rotaviruses decreased over the course of this study, which corresponded with the implementation of the rotavirus vaccine, RotaTeq (Merck, USA) in 2006 and Rotarix (GlaxoSmithKline, Belgium) in 2008.", [["gastroenteritis", "DISEASE", 112, 127], ["rotaviruses", "DISEASE", 180, 191], ["children", "ORGANISM", 131, 139], ["rotaviruses", "ORGANISM", 180, 191], ["rotavirus", "ORGANISM", 283, 292], ["children", "SPECIES", 131, 139], ["rotavirus", "SPECIES", 283, 292], ["these studies", "TEST", 14, 27], ["viruses", "PROBLEM", 87, 94], ["acute gastroenteritis", "PROBLEM", 106, 127], ["rotaviruses", "PROBLEM", 180, 191], ["this study", "TEST", 221, 231], ["the rotavirus vaccine", "TREATMENT", 279, 300], ["acute", "OBSERVATION_MODIFIER", 106, 111], ["gastroenteritis", "OBSERVATION", 112, 127], ["rotaviruses", "OBSERVATION", 180, 191]]], ["Interestingly, norovirus GII was detected more frequently than rotavirus both prior to and following vaccine implementation, which indicates a significant, continuous burden of disease due to norovirus infections.", [["norovirus infections", "DISEASE", 192, 212], ["norovirus GII", "ORGANISM", 15, 28], ["norovirus", "ORGANISM", 192, 201], ["norovirus GII", "SPECIES", 15, 28], ["rotavirus", "SPECIES", 63, 72], ["norovirus GII", "PROBLEM", 15, 28], ["rotavirus", "PROBLEM", 63, 72], ["vaccine implementation", "TREATMENT", 101, 123], ["a significant, continuous burden of disease", "PROBLEM", 141, 184], ["norovirus infections", "PROBLEM", 192, 212], ["norovirus", "OBSERVATION", 15, 24], ["significant", "OBSERVATION_MODIFIER", 143, 154], ["disease", "OBSERVATION", 177, 184], ["norovirus", "OBSERVATION", 192, 201]]], ["A significant amount of adenovirus DNA was detected in children with gastrointestinal symptoms, and while other studies have shown variable detection rates of adenovirus 40 and 41 [Colomba et al., 2006; Chhabra et al., 2013] the assay in this study was able to detect multiple serotypes in addition to 40 and 41.", [["gastrointestinal", "ANATOMY", 69, 85], ["gastrointestinal symptoms", "DISEASE", 69, 94], ["adenovirus", "ORGANISM", 24, 34], ["DNA", "CELLULAR_COMPONENT", 35, 38], ["children", "ORGANISM", 55, 63], ["gastrointestinal", "ORGAN", 69, 85], ["adenovirus 40", "ORGANISM", 159, 172], ["adenovirus DNA", "DNA", 24, 38], ["children", "SPECIES", 55, 63], ["adenovirus", "SPECIES", 24, 34], ["adenovirus DNA", "PROBLEM", 24, 38], ["gastrointestinal symptoms", "PROBLEM", 69, 94], ["other studies", "TEST", 106, 119], ["variable detection rates of adenovirus", "PROBLEM", 131, 169], ["the assay", "TEST", 225, 234], ["this study", "TEST", 238, 248], ["multiple serotypes", "PROBLEM", 268, 286], ["significant", "OBSERVATION_MODIFIER", 2, 13], ["amount", "OBSERVATION_MODIFIER", 14, 20], ["adenovirus DNA", "OBSERVATION", 24, 38], ["gastrointestinal", "ANATOMY", 69, 85]]], ["Only serotypes 40 and 41, and occasionally 18 and 31 have been associated with gastroenteritis.", [["gastroenteritis", "DISEASE", 79, 94], ["serotypes", "TEST", 5, 14], ["gastroenteritis", "PROBLEM", 79, 94], ["gastroenteritis", "OBSERVATION", 79, 94]]], ["Despite the fact that providers at this institution are discouraged from sending samples for EM unless the patient is symptomatic, the numbers in this study may overestimate the burden of gastroenteritis in children attributed to adenoviruses and could represent asymptomatic shedding of non\u2010enteric adenoviruses with other pathogens responsible for symptoms.DISCUSSIONAstroviruses have long been known to cause gastroenteritis in humans [De Benedictis et al., 2011; Chhabra et al., 2013].", [["gastroenteritis", "DISEASE", 188, 203], ["gastroenteritis", "DISEASE", 412, 427], ["patient", "ORGANISM", 107, 114], ["children", "ORGANISM", 207, 215], ["adenoviruses", "ORGANISM", 230, 242], ["adenoviruses", "ORGANISM", 300, 312], ["humans", "ORGANISM", 431, 437], ["patient", "SPECIES", 107, 114], ["children", "SPECIES", 207, 215], ["humans", "SPECIES", 431, 437], ["humans", "SPECIES", 431, 437], ["symptomatic", "PROBLEM", 118, 129], ["this study", "TEST", 146, 156], ["gastroenteritis", "PROBLEM", 188, 203], ["adenoviruses", "PROBLEM", 230, 242], ["asymptomatic shedding of non\u2010enteric adenoviruses", "PROBLEM", 263, 312], ["other pathogens", "PROBLEM", 318, 333], ["symptoms.DISCUSSIONAstroviruses", "PROBLEM", 350, 381], ["gastroenteritis", "PROBLEM", 412, 427], ["symptomatic", "OBSERVATION_MODIFIER", 118, 129], ["gastroenteritis", "OBSERVATION", 188, 203]]], ["Recently, however, new astrovirus strains have been discovered and been associated with disease in humans [Zimmerman et al., 2001; Finkbeiner et al., 2008, 2009a, 2009b; Hall, 2011; Lindesmith et al., 2011].", [["astrovirus", "ORGANISM", 23, 33], ["humans", "ORGANISM", 99, 105], ["humans", "SPECIES", 99, 105], ["humans", "SPECIES", 99, 105], ["new astrovirus strains", "PROBLEM", 19, 41], ["disease in humans", "PROBLEM", 88, 105]]], ["The astrovirus protocol used in this study was not designed to detect these novel strains and likely underestimates the true burden of astrovirus disease in these study patients [Phan et al., 2007; De Benedictis et al., 2011].", [["astrovirus disease", "DISEASE", 135, 153], ["astrovirus", "ORGANISM", 4, 14], ["astrovirus", "ORGANISM", 135, 145], ["patients", "ORGANISM", 169, 177], ["patients", "SPECIES", 169, 177], ["The astrovirus protocol", "TREATMENT", 0, 23], ["this study", "TEST", 32, 42], ["these novel strains", "PROBLEM", 70, 89], ["astrovirus disease", "PROBLEM", 135, 153], ["these study", "TEST", 157, 168], ["astrovirus disease", "OBSERVATION", 135, 153]]], ["Surprisingly, in contrast to other studies, very few cases of sapovirus were detected.", [["sapovirus", "DISEASE", 62, 71], ["sapovirus", "CANCER", 62, 71], ["other studies", "TEST", 29, 42], ["sapovirus", "PROBLEM", 62, 71], ["sapovirus", "OBSERVATION", 62, 71]]], ["In other studies, sapoviruses have been reported to cause more vomiting than diarrhea in children, and this study only evaluated stool samples [Chhabra et al., 2013].", [["stool samples", "ANATOMY", 129, 142], ["vomiting", "DISEASE", 63, 71], ["diarrhea", "DISEASE", 77, 85], ["sapoviruses", "GENE_OR_GENE_PRODUCT", 18, 29], ["children", "ORGANISM", 89, 97], ["children", "SPECIES", 89, 97], ["other studies", "TEST", 3, 16], ["sapoviruses", "PROBLEM", 18, 29], ["vomiting than diarrhea in children", "PROBLEM", 63, 97], ["this study", "TEST", 103, 113], ["stool samples", "TEST", 129, 142]]], ["Additionally, no cases were associated with the known endemic human coronaviruses.", [["human", "ORGANISM", 62, 67], ["human", "SPECIES", 62, 67], ["human coronaviruses", "SPECIES", 62, 81], ["the known endemic human coronaviruses", "PROBLEM", 44, 81], ["endemic human coronaviruses", "OBSERVATION", 54, 81]]], ["While similar results have been documented in the literature [Esper et al., 2010; Jev\u0161nik et al., 2013], other studies have found endemic coronaviruses and coronavirus\u2010like particles in stool in patients with gastroenteritis [Payne et al., 1986; Risku et al., 2010].", [["stool", "ANATOMY", 186, 191], ["gastroenteritis", "DISEASE", 209, 224], ["coronaviruses", "ORGANISM", 138, 151], ["stool", "ORGANISM_SUBSTANCE", 186, 191], ["patients", "ORGANISM", 195, 203], ["patients", "SPECIES", 195, 203], ["other studies", "TEST", 105, 118], ["endemic coronaviruses", "PROBLEM", 130, 151], ["coronavirus\u2010like particles in stool", "PROBLEM", 156, 191], ["gastroenteritis", "PROBLEM", 209, 224], ["endemic coronaviruses", "OBSERVATION", 130, 151], ["gastroenteritis", "OBSERVATION", 209, 224]]], ["The data from this study supports the hypothesis that known endemic coronaviruses do not cause clinically significant gastroenteritis in children.DISCUSSIONAll viruses demonstrated seasonal as well as annual variation throughout the study period.", [["gastroenteritis", "DISEASE", 118, 133], ["coronaviruses", "ORGANISM", 68, 81], ["children", "ORGANISM", 137, 145], ["children", "SPECIES", 137, 145], ["The data", "TEST", 0, 8], ["this study", "TEST", 14, 24], ["endemic coronaviruses", "PROBLEM", 60, 81], ["clinically significant gastroenteritis in children", "PROBLEM", 95, 145], ["the study", "TEST", 229, 238], ["significant", "OBSERVATION_MODIFIER", 106, 117], ["gastroenteritis", "OBSERVATION", 118, 133]]], ["Adenovirus was present throughout the year, while astrovirus, rotavirus, and norovirus GII were present most frequently in the fall and winter months, similar to previously reported data [Zimmerman et al., 2001; Hall, 2011; Chhabra et al., 2013].", [["Adenovirus", "ORGANISM", 0, 10], ["astrovirus", "ORGANISM", 50, 60], ["rotavirus", "ORGANISM", 62, 71], ["norovirus GII", "ORGANISM", 77, 90], ["Adenovirus", "SPECIES", 0, 10], ["rotavirus", "SPECIES", 62, 71], ["Adenovirus", "PROBLEM", 0, 10], ["astrovirus", "PROBLEM", 50, 60], ["rotavirus", "PROBLEM", 62, 71], ["norovirus GII", "PROBLEM", 77, 90]]], ["The data in this study indicate that there was an outbreak of norovirus GII.4 in this community during the winter of 2006\u20132007.", [["norovirus", "DISEASE", 62, 71], ["norovirus GII.4", "ORGANISM", 62, 77], ["The data", "TEST", 0, 8], ["this study", "TEST", 12, 22], ["norovirus GII.4", "PROBLEM", 62, 77], ["norovirus", "OBSERVATION", 62, 71]]], ["This observation supports other data which suggests norovirus GII.4 strain is the leading cause of norovirus outbreaks due to its ability to rapidly evolve through antigenic variation, possibly driven by herd immunity [Lindesmith et al., 2011] as well as recombination [Bull et al., 2007; Phan et al., 2007; Unicef WHO, 2009].", [["norovirus outbreaks", "DISEASE", 99, 118], ["norovirus GII", "ORGANISM", 52, 65], ["norovirus", "ORGANISM", 99, 108], ["This observation", "TEST", 0, 16], ["other data", "TEST", 26, 36], ["norovirus GII", "PROBLEM", 52, 65], ["norovirus outbreaks", "PROBLEM", 99, 118], ["norovirus", "OBSERVATION", 52, 61], ["norovirus", "OBSERVATION", 99, 108]]], ["These data also support the observation that multiple different strains of norovirus can circulate in the community at one time, which could facilitate evolution of new strains.DISCUSSIONIt is unclear how long virus shedding can occur in the intestinal tract following natural infection.", [["intestinal tract", "ANATOMY", 242, 258], ["norovirus", "DISEASE", 75, 84], ["infection", "DISEASE", 277, 286], ["norovirus", "ORGANISM", 75, 84], ["long virus", "ORGANISM", 205, 215], ["intestinal tract", "ORGAN", 242, 258], ["norovirus", "SPECIES", 75, 84], ["norovirus", "PROBLEM", 75, 84], ["new strains", "PROBLEM", 165, 176], ["long virus shedding", "PROBLEM", 205, 224], ["natural infection", "PROBLEM", 269, 286], ["norovirus", "OBSERVATION", 75, 84], ["new", "OBSERVATION_MODIFIER", 165, 168], ["strains", "OBSERVATION", 169, 176], ["intestinal tract", "ANATOMY", 242, 258], ["infection", "OBSERVATION", 277, 286]]], ["Several publications have shown variable duration of shedding in pediatric patients both with and without symptoms [Payne et al., 1986, 2013; Wilde et al., 1991; Mitchell et al., 1995; Richardson et al., 1998; Parashar et al., 2003; Wilhelmi et al., 2003; Colomba et al., 2006; Unicef WHO, 2009; Graham et al., 2010; Churgay and Aftab, 2012; Chhabra et al., 2013; Jev\u0161nik et al., 2013].", [["patients", "ORGANISM", 75, 83], ["patients", "SPECIES", 75, 83], ["symptoms", "PROBLEM", 106, 114], ["variable", "OBSERVATION_MODIFIER", 32, 40], ["duration", "OBSERVATION_MODIFIER", 41, 49]]], ["Data from this study indicate that immunocompromised children, in particular those who have received HSCTs, may be infected and shed enteric viruses for up to 8 months and are at risk for persistent symptomatic infection.", [["infection", "DISEASE", 211, 220], ["children", "ORGANISM", 53, 61], ["children", "SPECIES", 53, 61], ["this study", "TEST", 10, 20], ["immunocompromised", "PROBLEM", 35, 52], ["HSCTs", "TREATMENT", 101, 106], ["infected", "PROBLEM", 115, 123], ["shed enteric viruses", "PROBLEM", 128, 148], ["persistent symptomatic infection", "PROBLEM", 188, 220], ["immunocompromised", "OBSERVATION", 35, 52], ["infected", "OBSERVATION", 115, 123], ["persistent", "OBSERVATION_MODIFIER", 188, 198], ["symptomatic", "OBSERVATION_MODIFIER", 199, 210], ["infection", "OBSERVATION", 211, 220]]], ["These findings have significant clinical and infection control implications and complicate the diagnosis of diarrhea in these study patients.", [["infection", "DISEASE", 45, 54], ["diarrhea", "DISEASE", 108, 116], ["patients", "ORGANISM", 132, 140], ["patients", "SPECIES", 132, 140], ["significant clinical and infection control implications", "PROBLEM", 20, 75], ["diarrhea", "PROBLEM", 108, 116], ["these study", "TEST", 120, 131], ["significant", "OBSERVATION_MODIFIER", 20, 31], ["infection", "OBSERVATION", 45, 54], ["diarrhea", "OBSERVATION", 108, 116]]], ["Immunocompromised patients might also provide a reservoir for these viruses and a potential environment for recombination events and generation of novel viral strains [Booth et al., 2003; Choi et al., 2003; Hsu et al., 2003; Peiris et al., 2003; Hsueh et al., 2004; Schorn et al., 2010].", [["patients", "ORGANISM", 18, 26], ["patients", "SPECIES", 18, 26], ["a reservoir", "TREATMENT", 46, 57], ["these viruses", "PROBLEM", 62, 75], ["recombination events", "PROBLEM", 108, 128], ["novel viral strains", "PROBLEM", 147, 166]]], ["Furthermore, prolonged infection with enteric pathogens has been shown to put patients at risk for significant sequelae including severe weight loss, malnutrition, dehydration, and altered intestinal mucosa [Roddie et al., 2009; Schwartz et al., 2011; Jev\u0161nik et al., 2013].DISCUSSIONThis study did not demonstrate statistically significant differences in history, physical examination, laboratory studies, or patient management among illnesses caused by different enteric viruses.", [["intestinal mucosa", "ANATOMY", 189, 206], ["infection", "DISEASE", 23, 32], ["enteric pathogens", "DISEASE", 38, 55], ["weight loss", "DISEASE", 137, 148], ["malnutrition", "DISEASE", 150, 162], ["dehydration", "DISEASE", 164, 175], ["patients", "ORGANISM", 78, 86], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 189, 206], ["patient", "ORGANISM", 410, 417], ["patients", "SPECIES", 78, 86], ["patient", "SPECIES", 410, 417], ["prolonged infection", "PROBLEM", 13, 32], ["enteric pathogens", "PROBLEM", 38, 55], ["significant sequelae", "PROBLEM", 99, 119], ["severe weight loss", "PROBLEM", 130, 148], ["malnutrition", "PROBLEM", 150, 162], ["dehydration", "PROBLEM", 164, 175], ["altered intestinal mucosa", "PROBLEM", 181, 206], ["DISCUSSIONThis study", "TEST", 274, 294], ["physical examination", "TEST", 365, 385], ["laboratory studies", "TEST", 387, 405], ["illnesses", "PROBLEM", 435, 444], ["different enteric viruses", "PROBLEM", 455, 480], ["prolonged", "OBSERVATION_MODIFIER", 13, 22], ["infection", "OBSERVATION", 23, 32], ["significant", "OBSERVATION_MODIFIER", 99, 110], ["sequelae", "OBSERVATION", 111, 119], ["severe", "OBSERVATION_MODIFIER", 130, 136], ["weight loss", "OBSERVATION", 137, 148], ["malnutrition", "OBSERVATION", 150, 162], ["dehydration", "OBSERVATION", 164, 175], ["intestinal mucosa", "ANATOMY", 189, 206], ["enteric viruses", "OBSERVATION", 465, 480]]], ["However, while enteric viruses are generally thought not to elicit severe inflammatory gastroenteritis, nearly one quarter of patients with viral acute gastroenteritis in this study had erythrocytes and leukocytes present in their stool.", [["erythrocytes", "ANATOMY", 186, 198], ["leukocytes", "ANATOMY", 203, 213], ["stool", "ANATOMY", 231, 236], ["gastroenteritis", "DISEASE", 87, 102], ["viral acute gastroenteritis", "DISEASE", 140, 167], ["enteric viruses", "ORGANISM", 15, 30], ["patients", "ORGANISM", 126, 134], ["erythrocytes", "CELL", 186, 198], ["leukocytes", "CELL", 203, 213], ["stool", "ORGANISM_SUBSTANCE", 231, 236], ["erythrocytes", "CELL_TYPE", 186, 198], ["leukocytes", "CELL_TYPE", 203, 213], ["patients", "SPECIES", 126, 134], ["enteric viruses", "PROBLEM", 15, 30], ["severe inflammatory gastroenteritis", "PROBLEM", 67, 102], ["viral acute gastroenteritis", "PROBLEM", 140, 167], ["this study", "TEST", 171, 181], ["erythrocytes", "PROBLEM", 186, 198], ["leukocytes", "TEST", 203, 213], ["viruses", "OBSERVATION", 23, 30], ["severe", "OBSERVATION_MODIFIER", 67, 73], ["inflammatory", "OBSERVATION_MODIFIER", 74, 86], ["gastroenteritis", "OBSERVATION", 87, 102], ["one quarter", "OBSERVATION_MODIFIER", 111, 122], ["viral", "OBSERVATION_MODIFIER", 140, 145], ["acute", "OBSERVATION_MODIFIER", 146, 151], ["gastroenteritis", "OBSERVATION", 152, 167]]], ["Additionally, a significant number of pediatric patients with viral acute gastroenteritis were hospitalized due to gastrointestinal symptoms, and a small number were admitted to the intensive care unit, which indicates these infections can have significant financial impacts.DISCUSSIONIn the past decade, many clinical laboratories have been moving toward RT\u2010PCR multiplex assays to assess the etiology of multiple infectious diseases.", [["gastrointestinal", "ANATOMY", 115, 131], ["viral acute gastroenteritis", "DISEASE", 62, 89], ["gastrointestinal symptoms", "DISEASE", 115, 140], ["infections", "DISEASE", 225, 235], ["infectious diseases", "DISEASE", 415, 434], ["patients", "ORGANISM", 48, 56], ["gastrointestinal", "ORGAN", 115, 131], ["patients", "SPECIES", 48, 56], ["viral acute gastroenteritis", "PROBLEM", 62, 89], ["gastrointestinal symptoms", "PROBLEM", 115, 140], ["these infections", "PROBLEM", 219, 235], ["RT\u2010PCR multiplex assays", "TEST", 356, 379], ["multiple infectious diseases", "PROBLEM", 406, 434], ["significant", "OBSERVATION_MODIFIER", 16, 27], ["number", "OBSERVATION_MODIFIER", 28, 34], ["viral", "OBSERVATION_MODIFIER", 62, 67], ["acute", "OBSERVATION_MODIFIER", 68, 73], ["gastroenteritis", "OBSERVATION", 74, 89], ["gastrointestinal", "ANATOMY", 115, 131], ["small", "OBSERVATION_MODIFIER", 148, 153], ["infections", "OBSERVATION", 225, 235], ["multiple", "OBSERVATION_MODIFIER", 406, 414], ["infectious", "OBSERVATION", 415, 425]]], ["At the time these samples were collected and submitted for diagnostic testing, this institution only employed EM for viral testing of stool samples.", [["samples", "ANATOMY", 18, 25], ["stool samples", "ANATOMY", 134, 147], ["samples", "CANCER", 18, 25], ["stool samples", "ORGANISM_SUBSTANCE", 134, 147], ["these samples", "TEST", 12, 25], ["diagnostic testing", "TEST", 59, 77], ["viral testing of stool samples", "TEST", 117, 147]]], ["These results clearly demonstrate that RT\u2010PCR is superior in the detection of noroviruses, astroviruses, and adenoviruses in stool than EM.", [["noroviruses", "DISEASE", 78, 89], ["astroviruses", "DISEASE", 91, 103], ["noroviruses", "ORGANISM", 78, 89], ["adenoviruses", "ORGANISM", 109, 121], ["stool", "ORGANISM_SUBSTANCE", 125, 130], ["RT\u2010PCR", "TEST", 39, 45], ["noroviruses", "PROBLEM", 78, 89], ["astroviruses", "PROBLEM", 91, 103], ["adenoviruses", "PROBLEM", 109, 121], ["superior", "OBSERVATION_MODIFIER", 49, 57], ["noroviruses", "OBSERVATION", 78, 89]]], ["RT\u2010PCR did not perform significantly better than EM in the diagnosis of rotavirus, but this may have been due to the fact that the RT\u2010PCR assay in use detected only group A rotaviruses, while EM was able to detect groups A\u2010C. Additionally, the assays used in this study were designed for laboratory research and have not been fully vetted for clinical samples.DISCUSSIONThis study has several limitations.", [["samples", "ANATOMY", 352, 359], ["rotavirus", "DISEASE", 72, 81], ["rotavirus", "ORGANISM", 72, 81], ["rotaviruses", "ORGANISM", 173, 184], ["rotavirus", "SPECIES", 72, 81], ["A rotaviruses", "SPECIES", 171, 184], ["RT\u2010PCR", "TEST", 0, 6], ["rotavirus", "PROBLEM", 72, 81], ["the RT\u2010PCR assay", "TEST", 127, 143], ["A rotaviruses", "PROBLEM", 171, 184], ["the assays", "TEST", 240, 250], ["this study", "TEST", 259, 269], ["laboratory research", "TEST", 288, 307], ["clinical samples", "TEST", 343, 359], ["rotavirus", "OBSERVATION", 72, 81]]], ["It was retrospective and conducted at a large tertiary care children's hospital, which likely biased sample collection toward more seriously ill patients and those with underlying medical conditions and therefore may not reflect the burden of disease in the wider pediatric population.", [["ill", "DISEASE", 141, 144], ["children", "ORGANISM", 60, 68], ["patients", "ORGANISM", 145, 153], ["children", "SPECIES", 60, 68], ["patients", "SPECIES", 145, 153], ["biased sample collection", "PROBLEM", 94, 118], ["underlying medical conditions", "PROBLEM", 169, 198], ["disease", "PROBLEM", 243, 250], ["may not reflect", "UNCERTAINTY", 213, 228], ["disease", "OBSERVATION", 243, 250], ["wider", "OBSERVATION_MODIFIER", 258, 263]]], ["Providers at the institution in this study are discouraged from routinely sending stool samples in patients with acute gastroenteritis unless it will impact clinical care, and this may have caused selection bias toward children with severe symptoms.", [["samples", "ANATOMY", 88, 95], ["gastroenteritis", "DISEASE", 119, 134], ["stool samples", "ORGANISM_SUBSTANCE", 82, 95], ["patients", "ORGANISM", 99, 107], ["children", "ORGANISM", 219, 227], ["patients", "SPECIES", 99, 107], ["children", "SPECIES", 219, 227], ["this study", "TEST", 32, 42], ["routinely sending stool samples", "TEST", 64, 95], ["acute gastroenteritis", "PROBLEM", 113, 134], ["severe symptoms", "PROBLEM", 233, 248], ["acute", "OBSERVATION_MODIFIER", 113, 118], ["gastroenteritis", "OBSERVATION", 119, 134]]], ["Diluted stool samples were used, which might have reduced the ability to detect viral nucleic acid present in small amounts.", [["stool samples", "ANATOMY", 8, 21], ["nucleic acid", "CHEMICAL", 86, 98], ["stool samples", "ORGANISM_SUBSTANCE", 8, 21], ["Diluted stool samples", "TEST", 0, 21], ["viral nucleic acid", "TEST", 80, 98], ["nucleic acid", "OBSERVATION", 86, 98], ["small amounts", "OBSERVATION_MODIFIER", 110, 123]]], ["Additionally, the presence of viral nucleic acid in stool may not reflect the cause of current symptoms but could instead reflect prolonged shedding from a previous infection or asymptomatic carriage [Kapusinszky et al., 2012].DISCUSSIONIn summary, a viral cause was identified in 26% of children with diarrheal disease, with the largest burdens of disease attributed to adenoviruses and noroviruses in children.", [["stool", "ANATOMY", 52, 57], ["nucleic acid", "CHEMICAL", 36, 48], ["infection", "DISEASE", 165, 174], ["diarrheal disease", "DISEASE", 302, 319], ["adenoviruses and noroviruses", "DISEASE", 371, 399], ["stool", "ORGANISM_SUBSTANCE", 52, 57], ["children", "ORGANISM", 288, 296], ["adenoviruses", "ORGANISM", 371, 383], ["children", "ORGANISM", 403, 411], ["children", "SPECIES", 288, 296], ["children", "SPECIES", 403, 411], ["viral nucleic acid in stool", "PROBLEM", 30, 57], ["current symptoms", "PROBLEM", 87, 103], ["prolonged shedding", "PROBLEM", 130, 148], ["a previous infection", "PROBLEM", 154, 174], ["asymptomatic carriage", "PROBLEM", 178, 199], ["a viral cause", "PROBLEM", 249, 262], ["diarrheal disease", "PROBLEM", 302, 319], ["disease", "PROBLEM", 349, 356], ["adenoviruses", "PROBLEM", 371, 383], ["noroviruses", "PROBLEM", 388, 399], ["viral", "OBSERVATION_MODIFIER", 30, 35], ["nucleic acid", "OBSERVATION", 36, 48], ["infection", "OBSERVATION", 165, 174], ["diarrheal disease", "OBSERVATION", 302, 319], ["largest", "OBSERVATION_MODIFIER", 330, 337], ["disease", "OBSERVATION", 349, 356], ["adenoviruses", "OBSERVATION", 371, 383], ["noroviruses", "OBSERVATION", 388, 399]]], ["This study indicates that immunocompromised patients can experience prolonged symptomatic infection and shedding of enteric virus.", [["infection", "DISEASE", 90, 99], ["patients", "ORGANISM", 44, 52], ["enteric virus", "ORGANISM", 116, 129], ["patients", "SPECIES", 44, 52], ["This study", "TEST", 0, 10], ["immunocompromised", "PROBLEM", 26, 43], ["prolonged symptomatic infection", "PROBLEM", 68, 99], ["enteric virus", "PROBLEM", 116, 129], ["immunocompromised", "OBSERVATION", 26, 43], ["symptomatic", "OBSERVATION_MODIFIER", 78, 89], ["infection", "OBSERVATION", 90, 99], ["enteric virus", "OBSERVATION", 116, 129]]], ["The data in this study also support the use of improved rapid, well\u2010standardized RT\u2010PCR diagnostic methods to establish the etiology of diarrhea.", [["diarrhea", "DISEASE", 136, 144], ["The data", "TEST", 0, 8], ["this study", "TEST", 12, 22], ["diagnostic methods", "TEST", 88, 106], ["diarrhea", "PROBLEM", 136, 144], ["diarrhea", "OBSERVATION", 136, 144]]], ["In addition to the advances made in the prevention of rotavirus disease, development of targeted therapies and vaccines towards other enteric viruses are needed to alleviate the significant burden of disease associated with diarrheal illness in children.", [["rotavirus disease", "DISEASE", 54, 71], ["enteric viruses", "DISEASE", 134, 149], ["diarrheal illness", "DISEASE", 224, 241], ["rotavirus", "ORGANISM", 54, 63], ["children", "ORGANISM", 245, 253], ["children", "SPECIES", 245, 253], ["rotavirus", "SPECIES", 54, 63], ["rotavirus disease", "PROBLEM", 54, 71], ["targeted therapies", "TREATMENT", 88, 106], ["vaccines", "TREATMENT", 111, 119], ["other enteric viruses", "PROBLEM", 128, 149], ["the significant burden of disease", "PROBLEM", 174, 207], ["diarrheal illness", "PROBLEM", 224, 241], ["rotavirus disease", "OBSERVATION", 54, 71], ["significant", "OBSERVATION_MODIFIER", 178, 189], ["burden", "OBSERVATION_MODIFIER", 190, 196], ["disease", "OBSERVATION", 200, 207]]]], "29adb820da11c75265a497f9bd610a4dc6f81466": [["Abnormal respiratory signs, including tachypnea and dyspnea, are common in sick or stressed camelids.", [["respiratory", "ANATOMY", 9, 20], ["camelids", "ANATOMY", 92, 100], ["respiratory signs", "DISEASE", 9, 26], ["tachypnea", "DISEASE", 38, 47], ["dyspnea", "DISEASE", 52, 59], ["camelids", "CANCER", 92, 100], ["Abnormal respiratory signs", "PROBLEM", 0, 26], ["tachypnea", "PROBLEM", 38, 47], ["dyspnea", "PROBLEM", 52, 59], ["stressed camelids", "PROBLEM", 83, 100], ["respiratory signs", "OBSERVATION", 9, 26], ["tachypnea", "OBSERVATION", 38, 47]]], ["Compared with other species of domestic hoofstock, these signs in camelids commonly arise from upper respiratory tract dysfunction or from multisystemic diseases, rather than from pneumonia.", [["upper respiratory tract", "ANATOMY", 95, 118], ["respiratory tract dysfunction", "DISEASE", 101, 130], ["multisystemic diseases", "DISEASE", 139, 161], ["pneumonia", "DISEASE", 180, 189], ["upper", "ORGANISM_SUBDIVISION", 95, 100], ["respiratory tract", "ORGANISM_SUBDIVISION", 101, 118], ["these signs in camelids", "PROBLEM", 51, 74], ["upper respiratory tract dysfunction", "PROBLEM", 95, 130], ["multisystemic diseases", "PROBLEM", 139, 161], ["pneumonia", "PROBLEM", 180, 189], ["upper", "ANATOMY_MODIFIER", 95, 100], ["respiratory tract", "ANATOMY", 101, 118], ["multisystemic", "OBSERVATION_MODIFIER", 139, 152], ["diseases", "OBSERVATION", 153, 161], ["pneumonia", "OBSERVATION", 180, 189]]], ["Thus, the veterinarian should be prepared to explore beyond thoracic auscultation and beyond the respiratory tract altogether, even if the camelid is demonstrating overt signs of respiratory tract dysfunction.AnatomyThe alae of the nose are soft and fleshy, and the external termination of each nostril is slitlike.", [["thoracic", "ANATOMY", 60, 68], ["respiratory tract", "ANATOMY", 97, 114], ["respiratory tract", "ANATOMY", 179, 196], ["nose", "ANATOMY", 232, 236], ["nostril", "ANATOMY", 295, 302], ["respiratory tract dysfunction", "DISEASE", 179, 208], ["thoracic", "ORGAN", 60, 68], ["respiratory tract", "ORGANISM_SUBDIVISION", 97, 114], ["respiratory tract", "ORGANISM_SUBDIVISION", 179, 196], ["nose", "ORGAN", 232, 236], ["nostril", "ORGAN", 295, 302], ["thoracic auscultation", "TEST", 60, 81], ["respiratory tract dysfunction", "PROBLEM", 179, 208], ["thoracic", "ANATOMY", 60, 68], ["respiratory tract", "ANATOMY", 97, 114], ["respiratory tract dysfunction", "OBSERVATION", 179, 208], ["alae", "ANATOMY_MODIFIER", 220, 224], ["nose", "ANATOMY", 232, 236], ["soft", "OBSERVATION", 241, 245], ["fleshy", "OBSERVATION", 250, 256], ["external", "OBSERVATION_MODIFIER", 266, 274], ["nostril", "ANATOMY", 295, 302], ["slitlike", "OBSERVATION", 306, 314]]], ["Camels can completely occlude their nostrils by depressing these alae, presumably as protection against blowing sand, whereas New World camelids cannot.", [["nostrils", "ANATOMY", 36, 44], ["nostrils", "ORGAN", 36, 44], ["depressing these alae", "PROBLEM", 48, 69], ["blowing sand", "PROBLEM", 104, 116]]], ["However, the external nasal structures of all camelids are vulnerable to injury or external compression such as from snake bite, manual compression, or a too-narrow halter and may occlude the airway anyway.C H A P T E R 37Diseases of the Respiratory TractChristopher CebraThe nasal passages and larynx are also relatively narrow.", [["nasal structures", "ANATOMY", 22, 38], ["camelids", "ANATOMY", 46, 54], ["airway", "ANATOMY", 192, 198], ["larynx", "ANATOMY", 295, 301], ["injury", "DISEASE", 73, 79], ["snake bite", "DISEASE", 117, 127], ["nasal structures", "MULTI-TISSUE_STRUCTURE", 22, 38], ["airway", "ORGAN", 192, 198], ["larynx", "ORGAN", 295, 301], ["injury", "PROBLEM", 73, 79], ["external compression", "TREATMENT", 83, 103], ["snake bite", "PROBLEM", 117, 127], ["manual compression", "TREATMENT", 129, 147], ["a too-narrow halter", "TREATMENT", 152, 171], ["external", "ANATOMY_MODIFIER", 13, 21], ["nasal", "ANATOMY", 22, 27], ["structures", "ANATOMY_MODIFIER", 28, 38], ["all", "OBSERVATION_MODIFIER", 42, 45], ["camelids", "OBSERVATION", 46, 54], ["injury", "OBSERVATION", 73, 79], ["external compression", "OBSERVATION", 83, 103], ["compression", "OBSERVATION", 136, 147], ["airway", "ANATOMY", 192, 198], ["Respiratory Tract", "ANATOMY", 238, 255], ["nasal passages", "OBSERVATION", 276, 290], ["larynx", "ANATOMY", 295, 301], ["relatively", "OBSERVATION_MODIFIER", 311, 321], ["narrow", "OBSERVATION", 322, 328]]], ["The nasolacrimal orifice is positioned on the medial aspect of the lateral cartilaginous wall of the nasal cavity and is usually just beyond what may be seen without an endoscope.", [["nasolacrimal orifice", "ANATOMY", 4, 24], ["medial aspect", "ANATOMY", 46, 59], ["lateral cartilaginous wall", "ANATOMY", 67, 93], ["nasal cavity", "ANATOMY", 101, 113], ["nasolacrimal orifice", "MULTI-TISSUE_STRUCTURE", 4, 24], ["lateral cartilaginous wall", "TISSUE", 67, 93], ["nasal cavity", "ORGAN", 101, 113], ["an endoscope", "TREATMENT", 166, 178], ["nasolacrimal orifice", "OBSERVATION", 4, 24], ["medial", "ANATOMY_MODIFIER", 46, 52], ["lateral", "ANATOMY_MODIFIER", 67, 74], ["cartilaginous", "ANATOMY_MODIFIER", 75, 88], ["wall", "ANATOMY_MODIFIER", 89, 93], ["nasal cavity", "ANATOMY", 101, 113], ["endoscope", "OBSERVATION", 169, 178]]], ["This narrowness may be an adaptation to moisten and warm inspired air in the dry, hot, or cold native environments.", [["warm", "OBSERVATION_MODIFIER", 52, 56], ["inspired air", "OBSERVATION", 57, 69], ["dry", "OBSERVATION", 77, 80]]], ["Regardless of the cause, the narrowness of the airway allows small amounts of compromise to severely restrict air flow and also means that many diagnostic or therapeutic modalities such as paranasal endoscopy and nasogastric or nasotracheal intubation are more difficult to perform on camelids than on some other species.", [["airway", "ANATOMY", 47, 53], ["paranasal", "ANATOMY", 189, 198], ["airway", "MULTI-TISSUE_STRUCTURE", 47, 53], ["paranasal", "ORGAN", 189, 198], ["the narrowness of the airway", "PROBLEM", 25, 53], ["small amounts of compromise", "PROBLEM", 61, 88], ["severely restrict air flow", "PROBLEM", 92, 118], ["therapeutic modalities", "TREATMENT", 158, 180], ["paranasal endoscopy", "TEST", 189, 208], ["nasogastric", "TREATMENT", 213, 224], ["nasotracheal intubation", "TREATMENT", 228, 251], ["airway", "ANATOMY", 47, 53], ["small", "OBSERVATION_MODIFIER", 61, 66], ["amounts", "OBSERVATION_MODIFIER", 67, 74], ["compromise", "OBSERVATION", 78, 88], ["severely", "OBSERVATION_MODIFIER", 92, 100], ["restrict", "OBSERVATION_MODIFIER", 101, 109], ["air flow", "OBSERVATION", 110, 118], ["nasogastric", "ANATOMY", 213, 224], ["nasotracheal intubation", "OBSERVATION", 228, 251]]], ["Of the passages, the ventral meatus is the largest, and its ventromedial component represents the widest, straightest path to the larynx.", [["ventral meatus", "ANATOMY", 21, 35], ["ventromedial component", "ANATOMY", 60, 82], ["larynx", "ANATOMY", 130, 136], ["ventral meatus", "ORGAN", 21, 35], ["larynx", "ORGAN", 130, 136], ["passages", "OBSERVATION_MODIFIER", 7, 15], ["ventral", "ANATOMY_MODIFIER", 21, 28], ["meatus", "ANATOMY", 29, 35], ["largest", "OBSERVATION_MODIFIER", 43, 50], ["ventromedial", "OBSERVATION_MODIFIER", 60, 72], ["widest", "OBSERVATION_MODIFIER", 98, 104], ["larynx", "ANATOMY", 130, 136]]], ["Its dorsal component is approximately half the diameter and often too narrow to allow passage of a tube or endoscope.", [["dorsal component", "ANATOMY", 4, 20], ["tube", "ANATOMY", 99, 103], ["tube", "TISSUE", 99, 103], ["a tube or endoscope", "TREATMENT", 97, 116], ["dorsal", "OBSERVATION_MODIFIER", 4, 10], ["component", "OBSERVATION_MODIFIER", 11, 20], ["approximately", "OBSERVATION_MODIFIER", 24, 37], ["half", "OBSERVATION_MODIFIER", 38, 42], ["diameter", "OBSERVATION_MODIFIER", 47, 55], ["too narrow", "OBSERVATION_MODIFIER", 66, 76], ["tube", "OBSERVATION", 99, 103]]], ["Therefore, it is helpful to manually press either of those items as ventromedially as possible during entry in to the nose.Christopher CebraCamelids have a relatively long palate, with the soft palate component accentuated in camelids.", [["nose", "ANATOMY", 118, 122], ["long palate", "ANATOMY", 167, 178], ["soft palate", "ANATOMY", 189, 200], ["nose", "ORGAN", 118, 122], ["Christopher CebraCamelids", "ORGANISM", 123, 148], ["palate", "ORGAN", 172, 178], ["palate", "ORGAN", 194, 200], ["a relatively long palate", "PROBLEM", 154, 178], ["the soft palate component", "PROBLEM", 185, 210], ["nose", "ANATOMY", 118, 122], ["relatively", "OBSERVATION_MODIFIER", 156, 166], ["long", "OBSERVATION_MODIFIER", 167, 171], ["palate", "OBSERVATION", 172, 178], ["soft palate", "ANATOMY", 189, 200], ["component", "OBSERVATION_MODIFIER", 201, 210], ["accentuated", "OBSERVATION", 211, 222]]], ["Laryngeal and tracheal anatomy are relatively conventional; the caveat, however, is that the length and narrowness of the nose and mouth make direct visualization of the larynx, and hence tracheal intubation, a challenge.Christopher CebraThe anatomy of the camelid lung is also relatively conventional except that the small accessory lobe in the right side represents the only example of separation into lobes.", [["Laryngeal", "ANATOMY", 0, 9], ["tracheal", "ANATOMY", 14, 22], ["nose", "ANATOMY", 122, 126], ["mouth", "ANATOMY", 131, 136], ["larynx", "ANATOMY", 170, 176], ["tracheal", "ANATOMY", 188, 196], ["camelid lung", "ANATOMY", 257, 269], ["accessory lobe", "ANATOMY", 324, 338], ["right side", "ANATOMY", 346, 356], ["lobes", "ANATOMY", 404, 409], ["Laryngeal", "MULTI-TISSUE_STRUCTURE", 0, 9], ["tracheal", "ORGAN", 14, 22], ["nose", "ORGAN", 122, 126], ["mouth", "ORGANISM_SUBDIVISION", 131, 136], ["larynx", "ORGAN", 170, 176], ["tracheal", "ORGAN", 188, 196], ["lung", "ORGAN", 265, 269], ["accessory lobe", "MULTI-TISSUE_STRUCTURE", 324, 338], ["lobes", "CANCER", 404, 409], ["the length and narrowness of the nose", "PROBLEM", 89, 126], ["tracheal intubation", "TREATMENT", 188, 207], ["separation into lobes", "PROBLEM", 388, 409], ["tracheal", "ANATOMY", 14, 22], ["anatomy", "OBSERVATION", 23, 30], ["length", "OBSERVATION_MODIFIER", 93, 99], ["nose", "ANATOMY", 122, 126], ["mouth", "ANATOMY", 131, 136], ["larynx", "ANATOMY", 170, 176], ["tracheal", "ANATOMY", 188, 196], ["intubation", "OBSERVATION", 197, 207], ["camelid", "ANATOMY_MODIFIER", 257, 264], ["lung", "ANATOMY", 265, 269], ["small", "OBSERVATION_MODIFIER", 318, 323], ["accessory", "OBSERVATION_MODIFIER", 324, 333], ["lobe", "ANATOMY_MODIFIER", 334, 338], ["right", "ANATOMY_MODIFIER", 346, 351], ["separation", "OBSERVATION", 388, 398], ["lobes", "ANATOMY_MODIFIER", 404, 409]]], ["Similar to ruminants, the forestomach pushes close to the caudal border of the heart ventrally, making the dorsal lung field much more expansive for auscultation.", [["forestomach", "ANATOMY", 26, 37], ["caudal border", "ANATOMY", 58, 71], ["heart", "ANATOMY", 79, 84], ["dorsal lung", "ANATOMY", 107, 118], ["forestomach", "ORGAN", 26, 37], ["caudal border", "MULTI-TISSUE_STRUCTURE", 58, 71], ["heart", "ORGAN", 79, 84], ["ventrally", "MULTI-TISSUE_STRUCTURE", 85, 94], ["lung", "ORGAN", 114, 118], ["ruminants", "SPECIES", 11, 20], ["auscultation", "TEST", 149, 161], ["ruminants", "OBSERVATION_MODIFIER", 11, 20], ["forestomach", "ANATOMY", 26, 37], ["caudal", "ANATOMY_MODIFIER", 58, 64], ["border", "ANATOMY_MODIFIER", 65, 71], ["heart", "ANATOMY", 79, 84], ["ventrally", "ANATOMY_MODIFIER", 85, 94], ["dorsal", "ANATOMY_MODIFIER", 107, 113], ["lung", "ANATOMY", 114, 118], ["expansive", "OBSERVATION_MODIFIER", 135, 144]]], ["The mediastinum is reported to be complete.ExaminationThe alae of the nostrils should be thin and mobile.", [["mediastinum", "ANATOMY", 4, 15], ["nostrils", "ANATOMY", 70, 78], ["mediastinum", "ORGAN", 4, 15], ["nostrils", "ORGAN", 70, 78], ["Examination", "TEST", 43, 54], ["mediastinum", "ANATOMY", 4, 15], ["alae", "ANATOMY_MODIFIER", 58, 62], ["nostrils", "ANATOMY", 70, 78]]], ["With each breath, whether the airway is patent or not, the alae should be pulled back to open the nostril.", [["airway", "ANATOMY", 30, 36], ["nostril", "ANATOMY", 98, 105], ["airway", "MULTI-TISSUE_STRUCTURE", 30, 36], ["nostril", "ORGAN", 98, 105], ["airway", "ANATOMY", 30, 36], ["patent", "OBSERVATION", 40, 46], ["nostril", "ANATOMY", 98, 105]]], ["Collapse of one or both alae may represent a neuromuscular defect; decreased function may also come from edema or inflammation.", [["neuromuscular", "ANATOMY", 45, 58], ["edema", "ANATOMY", 105, 110], ["neuromuscular defect", "DISEASE", 45, 65], ["edema", "DISEASE", 105, 110], ["inflammation", "DISEASE", 114, 126], ["edema", "PATHOLOGICAL_FORMATION", 105, 110], ["Collapse of one or both alae", "PROBLEM", 0, 28], ["a neuromuscular defect", "PROBLEM", 43, 65], ["decreased function", "PROBLEM", 67, 85], ["edema", "PROBLEM", 105, 110], ["inflammation", "PROBLEM", 114, 126], ["one", "ANATOMY_MODIFIER", 12, 15], ["both", "ANATOMY_MODIFIER", 19, 23], ["alae", "ANATOMY_MODIFIER", 24, 28], ["may represent", "UNCERTAINTY", 29, 42], ["neuromuscular defect", "OBSERVATION", 45, 65], ["decreased", "OBSERVATION_MODIFIER", 67, 76], ["edema", "OBSERVATION", 105, 110], ["inflammation", "OBSERVATION", 114, 126]]], ["The internal mucosa should be assessed for evidence of edema or discoloration.", [["internal mucosa", "ANATOMY", 4, 19], ["edema", "ANATOMY", 55, 60], ["edema", "DISEASE", 55, 60], ["mucosa", "MULTI-TISSUE_STRUCTURE", 13, 19], ["edema", "PATHOLOGICAL_FORMATION", 55, 60], ["edema", "PROBLEM", 55, 60], ["discoloration", "PROBLEM", 64, 77], ["internal mucosa", "ANATOMY", 4, 19], ["edema", "OBSERVATION", 55, 60], ["discoloration", "OBSERVATION", 64, 77]]], ["Airflow should be felt from each nostril.", [["nostril", "ORGANISM_SUBDIVISION", 33, 40], ["Airflow", "TREATMENT", 0, 7]]], ["Air passage within the nostril may be assessed by placing a stethoscope on each side of the nose.", [["nostril", "ANATOMY", 23, 30], ["nose", "ANATOMY", 92, 96], ["nostril", "ORGAN", 23, 30], ["nose", "ORGANISM_SUBDIVISION", 92, 96], ["Air passage within the nostril", "PROBLEM", 0, 30], ["a stethoscope on each side of the nose", "TREATMENT", 58, 96], ["passage", "OBSERVATION_MODIFIER", 4, 11], ["nostril", "ANATOMY", 23, 30], ["stethoscope", "OBSERVATION", 60, 71], ["nose", "ANATOMY", 92, 96]]], ["The laryngeal region should be palpated for obvious swelling or mass lesions.ExaminationNasal discharge from camelids is usually clear and noncopious.", [["laryngeal region", "ANATOMY", 4, 20], ["mass lesions", "ANATOMY", 64, 76], ["Nasal", "ANATOMY", 88, 93], ["swelling", "DISEASE", 52, 60], ["laryngeal", "ORGAN", 4, 13], ["mass lesions", "CANCER", 64, 76], ["obvious swelling", "PROBLEM", 44, 60], ["mass lesions", "PROBLEM", 64, 76], ["Examination", "TEST", 77, 88], ["noncopious", "PROBLEM", 139, 149], ["laryngeal", "ANATOMY", 4, 13], ["swelling", "OBSERVATION", 52, 60], ["mass", "OBSERVATION", 64, 68], ["Nasal", "ANATOMY", 88, 93]]], ["Thicker discharge may reflect increased mucus content or white blood cells (WBCs).", [["mucus", "ANATOMY", 40, 45], ["white blood cells", "ANATOMY", 57, 74], ["WBCs", "ANATOMY", 76, 80], ["mucus", "ORGANISM_SUBSTANCE", 40, 45], ["white blood cells", "CELL", 57, 74], ["WBCs", "CELL", 76, 80], ["white blood cells", "CELL_TYPE", 57, 74], ["WBCs", "CELL_TYPE", 76, 80], ["Thicker discharge", "PROBLEM", 0, 17], ["increased mucus content", "PROBLEM", 30, 53], ["white blood cells", "TEST", 57, 74], ["WBCs", "TEST", 76, 80], ["may reflect", "UNCERTAINTY", 18, 29], ["increased", "OBSERVATION_MODIFIER", 30, 39], ["mucus content", "OBSERVATION", 40, 53]]], ["These rarely reach sufficient quantity to restrict air flow.", [["air flow", "OBSERVATION", 51, 59]]], ["Hemorrhagic discharge typically reflects inflammation at some point in the airway or a bleeding disorder.", [["airway", "ANATOMY", 75, 81], ["Hemorrhagic", "DISEASE", 0, 11], ["inflammation", "DISEASE", 41, 53], ["bleeding disorder", "DISEASE", 87, 104], ["airway", "MULTI-TISSUE_STRUCTURE", 75, 81], ["Hemorrhagic discharge", "PROBLEM", 0, 21], ["inflammation", "PROBLEM", 41, 53], ["a bleeding disorder", "PROBLEM", 85, 104], ["inflammation", "OBSERVATION", 41, 53], ["airway", "ANATOMY", 75, 81], ["bleeding", "OBSERVATION", 87, 95]]], ["Green-tinged or feed-containing discharge reflects difficulty swallowing or regurgitation.", [["Green-tinged", "CHEMICAL", 0, 12], ["difficulty swallowing", "PROBLEM", 51, 72], ["regurgitation", "PROBLEM", 76, 89], ["tinged", "OBSERVATION", 6, 12], ["regurgitation", "OBSERVATION", 76, 89]]], ["With cleft palate or abnormal regurgitation, the camelid may asphyxiate because of occlusion of the upper airway.ExaminationThe most common serious upper airway sign is dyspnea.", [["cleft palate", "ANATOMY", 5, 17], ["camelid", "ANATOMY", 49, 56], ["upper airway", "ANATOMY", 100, 112], ["upper airway", "ANATOMY", 148, 160], ["cleft palate", "DISEASE", 5, 17], ["abnormal regurgitation", "DISEASE", 21, 43], ["dyspnea", "DISEASE", 169, 176], ["palate", "ORGAN", 11, 17], ["upper airway", "ORGANISM_SUBDIVISION", 100, 112], ["upper airway", "MULTI-TISSUE_STRUCTURE", 148, 160], ["cleft palate", "PROBLEM", 5, 17], ["abnormal regurgitation", "PROBLEM", 21, 43], ["occlusion of the upper airway", "PROBLEM", 83, 112], ["Examination", "TEST", 113, 124], ["dyspnea", "PROBLEM", 169, 176], ["cleft palate", "ANATOMY", 5, 17], ["abnormal", "OBSERVATION_MODIFIER", 21, 29], ["regurgitation", "OBSERVATION", 30, 43], ["occlusion", "OBSERVATION", 83, 92], ["upper", "ANATOMY_MODIFIER", 100, 105], ["airway", "ANATOMY", 106, 112], ["airway", "ANATOMY", 154, 160], ["dyspnea", "OBSERVATION", 169, 176]]], ["Affected camelids have increased nostril flaring, are exercise or stress intolerant, frequently mouth-breathe with the lips pulled away from teeth, and often have inspiratory or expiratory stridor.", [["camelids", "ANATOMY", 9, 17], ["nostril", "ANATOMY", 33, 40], ["lips", "ANATOMY", 119, 123], ["teeth", "ANATOMY", 141, 146], ["stridor", "DISEASE", 189, 196], ["nostril", "ORGANISM_SUBDIVISION", 33, 40], ["mouth", "ORGANISM_SUBDIVISION", 96, 101], ["lips", "ORGANISM_SUBDIVISION", 119, 123], ["teeth", "ORGAN", 141, 146], ["Affected camelids", "PROBLEM", 0, 17], ["increased nostril flaring", "PROBLEM", 23, 48], ["stress intolerant", "PROBLEM", 66, 83], ["inspiratory or expiratory stridor", "PROBLEM", 163, 196], ["increased", "OBSERVATION_MODIFIER", 23, 32], ["nostril", "OBSERVATION_MODIFIER", 33, 40], ["flaring", "OBSERVATION", 41, 48], ["lips", "ANATOMY", 119, 123], ["teeth", "ANATOMY", 141, 146], ["expiratory", "ANATOMY", 178, 188], ["stridor", "OBSERVATION", 189, 196]]], ["Whereas in other species with laryngeal dysfunction inspiratory stridor is more common, the sail-like nature of the camelid soft palate makes expiratory stridor common as well.ExaminationWith added stress, the respiratory distress may worsen, with the head flopping to one side or over the dorsum.", [["laryngeal", "ANATOMY", 30, 39], ["camelid soft palate", "ANATOMY", 116, 135], ["respiratory", "ANATOMY", 210, 221], ["head", "ANATOMY", 252, 256], ["dorsum", "ANATOMY", 290, 296], ["laryngeal dysfunction", "DISEASE", 30, 51], ["stridor", "DISEASE", 64, 71], ["expiratory stridor", "DISEASE", 142, 160], ["respiratory distress", "DISEASE", 210, 230], ["laryngeal", "ORGAN", 30, 39], ["palate", "ORGAN", 129, 135], ["head", "ORGANISM_SUBDIVISION", 252, 256], ["dorsum", "ORGANISM_SUBDIVISION", 290, 296], ["laryngeal dysfunction inspiratory stridor", "PROBLEM", 30, 71], ["the camelid soft palate", "PROBLEM", 112, 135], ["expiratory stridor", "PROBLEM", 142, 160], ["the respiratory distress", "PROBLEM", 206, 230], ["laryngeal", "ANATOMY", 30, 39], ["dysfunction", "OBSERVATION", 40, 51], ["inspiratory stridor", "OBSERVATION", 52, 71], ["more common", "OBSERVATION_MODIFIER", 75, 86], ["soft palate", "ANATOMY", 124, 135], ["respiratory", "ANATOMY", 210, 221], ["distress", "OBSERVATION", 222, 230], ["head", "ANATOMY", 252, 256], ["dorsum", "ANATOMY", 290, 296]]], ["In such cases, the veterinarian should halt the stressful interventions and try to promote the camelid's breathing by delaying nonlife-saving procedures, allowing the animal some space, keeping the animal's head and neck in an extended position, administering oxygen by oral or nasal insufflation, or, in extreme cases, performing a tracheostomy.ExaminationWith lower respiratory tract disease, a variety of signs, including tachypnea, dyspnea, inspiratory or expiratory grunts, obtundation, weight loss, and lethargy, may be seen.", [["head", "ANATOMY", 207, 211], ["neck", "ANATOMY", 216, 220], ["oral", "ANATOMY", 270, 274], ["nasal", "ANATOMY", 278, 283], ["lower respiratory tract", "ANATOMY", 362, 385], ["oxygen", "CHEMICAL", 260, 266], ["respiratory tract disease", "DISEASE", 368, 393], ["tachypnea", "DISEASE", 425, 434], ["dyspnea", "DISEASE", 436, 443], ["inspiratory or expiratory grunts", "DISEASE", 445, 477], ["obtundation", "DISEASE", 479, 490], ["weight loss", "DISEASE", 492, 503], ["lethargy", "DISEASE", 509, 517], ["oxygen", "CHEMICAL", 260, 266], ["head", "ORGANISM_SUBDIVISION", 207, 211], ["neck", "ORGANISM_SUBDIVISION", 216, 220], ["oxygen", "SIMPLE_CHEMICAL", 260, 266], ["oral", "ORGANISM_SUBDIVISION", 270, 274], ["nasal", "ORGANISM_SUBDIVISION", 278, 283], ["lower", "ORGANISM_SUBDIVISION", 362, 367], ["respiratory tract", "ORGANISM_SUBDIVISION", 368, 385], ["the stressful interventions", "TREATMENT", 44, 71], ["saving procedures", "TREATMENT", 135, 152], ["oxygen", "TREATMENT", 260, 266], ["nasal insufflation", "TREATMENT", 278, 296], ["a tracheostomy", "TREATMENT", 331, 345], ["lower respiratory tract disease", "PROBLEM", 362, 393], ["signs", "PROBLEM", 408, 413], ["tachypnea", "PROBLEM", 425, 434], ["dyspnea", "PROBLEM", 436, 443], ["inspiratory or expiratory grunts", "PROBLEM", 445, 477], ["obtundation", "PROBLEM", 479, 490], ["weight loss", "PROBLEM", 492, 503], ["lethargy", "PROBLEM", 509, 517], ["head", "ANATOMY", 207, 211], ["neck", "ANATOMY", 216, 220], ["tracheostomy", "OBSERVATION", 333, 345], ["respiratory tract", "ANATOMY", 368, 385], ["inspiratory", "ANATOMY", 445, 456], ["expiratory grunts", "OBSERVATION", 460, 477], ["obtundation", "OBSERVATION", 479, 490], ["weight loss", "OBSERVATION", 492, 503], ["may be seen", "UNCERTAINTY", 519, 530]]], ["The trachea may be auscultated along the neck, and the lungs are best assessed by auscultating from within the short-haired axillary window.", [["trachea", "ANATOMY", 4, 11], ["neck", "ANATOMY", 41, 45], ["lungs", "ANATOMY", 55, 60], ["trachea", "MULTI-TISSUE_STRUCTURE", 4, 11], ["neck", "ORGAN", 41, 45], ["lungs", "ORGAN", 55, 60], ["trachea", "ANATOMY", 4, 11], ["may be", "UNCERTAINTY", 12, 18], ["auscultated", "OBSERVATION", 19, 30], ["neck", "ANATOMY", 41, 45], ["lungs", "ANATOMY", 55, 60], ["short", "OBSERVATION_MODIFIER", 111, 116], ["axillary", "ANATOMY", 124, 132], ["window", "ANATOMY_MODIFIER", 133, 139]]], ["Although this does not allow auscultation of the most dorsocaudal lung, moving the stethoscope around the dorsal extent of that window and stretching the skin more dorsally usually allows adequate assessment.ExaminationWhenever lower respiratory disease is suspected, information of lung function may be obtained from arterial blood gas (ABG) analysis.", [["dorsocaudal lung", "ANATOMY", 54, 70], ["dorsal", "ANATOMY", 106, 112], ["skin", "ANATOMY", 154, 158], ["respiratory", "ANATOMY", 234, 245], ["lung", "ANATOMY", 283, 287], ["arterial blood", "ANATOMY", 318, 332], ["respiratory disease", "DISEASE", 234, 253], ["lung", "ORGAN", 66, 70], ["skin", "ORGAN", 154, 158], ["lung", "ORGAN", 283, 287], ["arterial blood", "MULTI-TISSUE_STRUCTURE", 318, 332], ["auscultation", "TEST", 29, 41], ["the stethoscope", "TREATMENT", 79, 94], ["adequate assessment", "TEST", 188, 207], ["Examination", "TEST", 208, 219], ["lower respiratory disease", "PROBLEM", 228, 253], ["lung function", "TEST", 283, 296], ["arterial blood gas", "TEST", 318, 336], ["ABG) analysis", "TEST", 338, 351], ["most", "ANATOMY_MODIFIER", 49, 53], ["dorsocaudal", "ANATOMY_MODIFIER", 54, 65], ["lung", "ANATOMY", 66, 70], ["dorsal", "ANATOMY_MODIFIER", 106, 112], ["window", "OBSERVATION", 128, 134], ["skin", "ANATOMY", 154, 158], ["respiratory disease", "OBSERVATION", 234, 253], ["lung", "ANATOMY", 283, 287]]], ["Camelids have a number of superficial arteries, but the most commonly used are found on the medial aspects of the limbs and are thus more accessible in neonates and debilitated older animals in lateral recumbency than in more vigorous individuals.", [["superficial arteries", "ANATOMY", 26, 46], ["limbs", "ANATOMY", 114, 119], ["superficial arteries", "MULTI-TISSUE_STRUCTURE", 26, 46], ["limbs", "ORGANISM_SUBDIVISION", 114, 119], ["neonates", "ORGANISM", 152, 160], ["superficial arteries", "ANATOMY", 26, 46], ["medial", "ANATOMY_MODIFIER", 92, 98], ["limbs", "ANATOMY", 114, 119], ["debilitated", "OBSERVATION_MODIFIER", 165, 176], ["lateral recumbency", "OBSERVATION_MODIFIER", 194, 212]]], ["The median artery is found between the shoulder and the elbow, running along the craniomedial aspect of the humerus.", [["artery", "ANATOMY", 11, 17], ["shoulder", "ANATOMY", 39, 47], ["elbow", "ANATOMY", 56, 61], ["craniomedial aspect", "ANATOMY", 81, 100], ["humerus", "ANATOMY", 108, 115], ["artery", "MULTI-TISSUE_STRUCTURE", 11, 17], ["shoulder", "ORGANISM_SUBDIVISION", 39, 47], ["elbow", "ORGANISM_SUBDIVISION", 56, 61], ["humerus", "ORGAN", 108, 115], ["median artery", "ANATOMY", 4, 17], ["shoulder", "ANATOMY", 39, 47], ["elbow", "ANATOMY", 56, 61], ["craniomedial", "ANATOMY_MODIFIER", 81, 93], ["humerus", "ANATOMY", 108, 115]]], ["Its pulse is usually palpable, although the structure of the artery itself usually is not.", [["artery", "ANATOMY", 61, 67], ["artery", "MULTI-TISSUE_STRUCTURE", 61, 67], ["palpable", "OBSERVATION", 21, 29], ["artery", "ANATOMY", 61, 67]]], ["The saphenous artery is often both visible and palpable from medial midthigh to below the stifle.", [["saphenous artery", "ANATOMY", 4, 20], ["medial midthigh", "ANATOMY", 61, 76], ["saphenous artery", "MULTI-TISSUE_STRUCTURE", 4, 20], ["stifle", "ORGANISM_SUBDIVISION", 90, 96], ["saphenous artery", "ANATOMY", 4, 20], ["palpable", "OBSERVATION", 47, 55], ["medial", "OBSERVATION_MODIFIER", 61, 67], ["stifle", "OBSERVATION", 90, 96]]], ["It is usually approached in a near-parallel fashion, often from its dorsal aspect to avoid puncturing the accompanying vein ( Figure 37 -2).", [["dorsal aspect", "ANATOMY", 68, 81], ["vein", "ANATOMY", 119, 123], ["vein", "MULTI-TISSUE_STRUCTURE", 119, 123], ["dorsal", "OBSERVATION_MODIFIER", 68, 74], ["vein", "ANATOMY", 119, 123]]], ["Both arteries are useful in neonates; the saphenous vein is also used extensively in adults.ExaminationEndoscopy and bronchoscopy allow direct visualization of the mucosa and discharges and are especially useful for diagnosing obstructions, aspiration, inflammatory conditions, or lungworms.", [["arteries", "ANATOMY", 5, 13], ["saphenous vein", "ANATOMY", 42, 56], ["mucosa", "ANATOMY", 164, 170], ["obstructions", "DISEASE", 227, 239], ["lungworms", "DISEASE", 281, 290], ["arteries", "MULTI-TISSUE_STRUCTURE", 5, 13], ["neonates", "ORGANISM", 28, 36], ["saphenous vein", "MULTI-TISSUE_STRUCTURE", 42, 56], ["mucosa", "MULTI-TISSUE_STRUCTURE", 164, 170], ["obstructions", "PATHOLOGICAL_FORMATION", 227, 239], ["Examination", "TEST", 92, 103], ["Endoscopy", "TEST", 103, 112], ["bronchoscopy", "TEST", 117, 129], ["direct visualization", "TEST", 136, 156], ["diagnosing obstructions", "PROBLEM", 216, 239], ["aspiration", "PROBLEM", 241, 251], ["inflammatory conditions", "PROBLEM", 253, 276], ["lungworms", "PROBLEM", 281, 290], ["arteries", "ANATOMY", 5, 13], ["neonates", "OBSERVATION", 28, 36], ["saphenous vein", "ANATOMY", 42, 56], ["mucosa", "ANATOMY", 164, 170], ["aspiration", "OBSERVATION", 241, 251], ["inflammatory", "OBSERVATION_MODIFIER", 253, 265]]], ["The ventromedial aspect of the ventral meatus is most useful.", [["ventromedial aspect", "ANATOMY", 4, 23], ["ventral meatus", "ANATOMY", 31, 45], ["ventromedial aspect", "MULTI-TISSUE_STRUCTURE", 4, 23], ["ventral meatus", "ORGAN", 31, 45], ["ventromedial", "ANATOMY_MODIFIER", 4, 16], ["ventral meatus", "ANATOMY", 31, 45], ["most useful", "UNCERTAINTY", 49, 60]]], ["Although externally narrow, it widens considerably at the level of the molars; with a small enough endoscope and sufficient lubrication, valuable information can be obtained.", [["molars", "ANATOMY", 71, 77], ["molars", "ORGAN", 71, 77], ["externally narrow", "PROBLEM", 9, 26], ["a small enough endoscope", "TREATMENT", 84, 108], ["sufficient lubrication", "TREATMENT", 113, 135], ["externally", "OBSERVATION_MODIFIER", 9, 19], ["narrow", "OBSERVATION", 20, 26], ["widens", "OBSERVATION_MODIFIER", 31, 37], ["considerably", "OBSERVATION_MODIFIER", 38, 50], ["molars", "ANATOMY", 71, 77], ["small", "OBSERVATION_MODIFIER", 86, 91]]], ["With persistence, a 6-millimeter (mm) external diameter scope will pass on most crias and adult alpacas, and adult llamas may accommodate 9-mm scopes fairly easily. being more useful than radiography for finding small focal lesions such as tumors, abscesses, or granulomas.", [["focal lesions", "ANATOMY", 218, 231], ["tumors", "ANATOMY", 240, 246], ["abscesses", "ANATOMY", 248, 257], ["granulomas", "ANATOMY", 262, 272], ["tumors", "DISEASE", 240, 246], ["abscesses", "DISEASE", 248, 257], ["granulomas", "DISEASE", 262, 272], ["alpacas", "ORGANISM", 96, 103], ["llamas", "ORGANISM", 115, 121], ["focal lesions", "PATHOLOGICAL_FORMATION", 218, 231], ["tumors", "CANCER", 240, 246], ["abscesses", "PATHOLOGICAL_FORMATION", 248, 257], ["granulomas", "PATHOLOGICAL_FORMATION", 262, 272], ["a 6-millimeter (mm) external diameter scope", "TREATMENT", 18, 61], ["radiography", "TEST", 188, 199], ["small focal lesions", "PROBLEM", 212, 231], ["tumors", "PROBLEM", 240, 246], ["abscesses", "PROBLEM", 248, 257], ["granulomas", "PROBLEM", 262, 272], ["persistence", "OBSERVATION_MODIFIER", 5, 16], ["6-millimeter", "OBSERVATION_MODIFIER", 20, 32], ["alpacas", "OBSERVATION", 96, 103], ["small", "OBSERVATION_MODIFIER", 212, 217], ["focal", "OBSERVATION_MODIFIER", 218, 223], ["lesions", "OBSERVATION", 224, 231], ["tumors", "OBSERVATION", 240, 246], ["abscesses", "OBSERVATION", 248, 257], ["granulomas", "OBSERVATION", 262, 272]]], ["Transthoracic ultrasonography is most useful for identifying pleural fluid or when parenchymal disease is extensive or against the body wall.Supplemental Oxygen and VentilationAlthough camelids often appear relatively vigorous in spite of hypoxemia, it is generally accepted that they are healthier and have more efficient body functions when oxygenation is closer to normal.", [["pleural fluid", "ANATOMY", 61, 74], ["parenchymal", "ANATOMY", 83, 94], ["body wall", "ANATOMY", 131, 140], ["body", "ANATOMY", 323, 327], ["parenchymal disease", "DISEASE", 83, 102], ["Oxygen", "CHEMICAL", 154, 160], ["hypoxemia", "DISEASE", 239, 248], ["Oxygen", "CHEMICAL", 154, 160], ["pleural fluid", "ORGANISM_SUBSTANCE", 61, 74], ["body wall", "MULTI-TISSUE_STRUCTURE", 131, 140], ["Oxygen", "SIMPLE_CHEMICAL", 154, 160], ["body", "ORGANISM_SUBDIVISION", 323, 327], ["Transthoracic ultrasonography", "TEST", 0, 29], ["pleural fluid", "PROBLEM", 61, 74], ["parenchymal disease", "PROBLEM", 83, 102], ["Supplemental Oxygen", "TREATMENT", 141, 160], ["VentilationAlthough camelids", "TREATMENT", 165, 193], ["hypoxemia", "PROBLEM", 239, 248], ["pleural", "ANATOMY", 61, 68], ["fluid", "OBSERVATION", 69, 74], ["parenchymal", "ANATOMY_MODIFIER", 83, 94], ["disease", "OBSERVATION", 95, 102], ["body", "ANATOMY_MODIFIER", 131, 135], ["wall", "ANATOMY_MODIFIER", 136, 140], ["Oxygen", "OBSERVATION_MODIFIER", 154, 160], ["relatively", "OBSERVATION_MODIFIER", 207, 217], ["vigorous", "OBSERVATION", 218, 226], ["hypoxemia", "OBSERVATION", 239, 248], ["normal", "OBSERVATION", 368, 374]]], ["Thus, similar rules apply as in other species: camelids with an arterial partial pressure of oxygen (PaO 2 ) less than 60 millimeters of mercury (mm Hg) are candidates for supplemental oxygen, and camelids with PaCO 2 greater than 60 mm Hg are candidates for mechanical ventilation.", [["arterial", "ANATOMY", 64, 72], ["oxygen", "CHEMICAL", 93, 99], ["mercury", "CHEMICAL", 137, 144], ["oxygen", "CHEMICAL", 185, 191], ["oxygen", "CHEMICAL", 93, 99], ["PaO 2", "CHEMICAL", 101, 106], ["mercury", "CHEMICAL", 137, 144], ["Hg", "CHEMICAL", 149, 151], ["oxygen", "CHEMICAL", 185, 191], ["PaCO 2", "CHEMICAL", 211, 217], ["Hg", "CHEMICAL", 237, 239], ["arterial", "MULTI-TISSUE_STRUCTURE", 64, 72], ["oxygen", "SIMPLE_CHEMICAL", 93, 99], ["mercury", "SIMPLE_CHEMICAL", 137, 144], ["oxygen", "SIMPLE_CHEMICAL", 185, 191], ["an arterial partial pressure of oxygen (PaO", "TREATMENT", 61, 104], ["supplemental oxygen", "TREATMENT", 172, 191], ["PaCO", "TEST", 211, 215], ["mechanical ventilation", "TREATMENT", 259, 281], ["arterial", "ANATOMY", 64, 72], ["partial", "OBSERVATION_MODIFIER", 73, 80], ["pressure", "OBSERVATION_MODIFIER", 81, 89], ["oxygen", "OBSERVATION_MODIFIER", 93, 99], ["mechanical ventilation", "OBSERVATION", 259, 281]]], ["In neonates or other small camelids, oxygen cages may be used.", [["oxygen", "CHEMICAL", 37, 43], ["oxygen", "CHEMICAL", 37, 43], ["oxygen", "SIMPLE_CHEMICAL", 37, 43], ["other small camelids", "TREATMENT", 15, 35], ["oxygen cages", "TREATMENT", 37, 49], ["small", "OBSERVATION_MODIFIER", 21, 26], ["camelids", "OBSERVATION", 27, 35], ["oxygen cages", "OBSERVATION", 37, 49]]], ["For larger camelids or for crias kept near their mothers, intranasal oxygen is often effective and well tolerated.", [["oxygen", "CHEMICAL", 69, 75], ["oxygen", "CHEMICAL", 69, 75], ["oxygen", "SIMPLE_CHEMICAL", 69, 75], ["larger camelids", "PROBLEM", 4, 19], ["crias", "PROBLEM", 27, 32], ["intranasal oxygen", "TREATMENT", 58, 75]]], ["Soft rubber catheters or specialized breathing tubes may be tabbed into one nostril so that the distal end in the nostril is approximately at the level of the medial canthus of the eye.", [["nostril", "ANATOMY", 76, 83], ["nostril", "ANATOMY", 114, 121], ["medial canthus", "ANATOMY", 159, 173], ["eye", "ANATOMY", 181, 184], ["nostril", "ORGAN", 76, 83], ["distal end", "MULTI-TISSUE_STRUCTURE", 96, 106], ["nostril", "ORGAN", 114, 121], ["medial canthus", "MULTI-TISSUE_STRUCTURE", 159, 173], ["eye", "ORGAN", 181, 184], ["Soft rubber catheters", "TREATMENT", 0, 21], ["specialized breathing tubes", "TREATMENT", 25, 52], ["rubber catheters", "OBSERVATION", 5, 21], ["breathing tubes", "OBSERVATION", 37, 52], ["distal", "OBSERVATION_MODIFIER", 96, 102], ["end", "OBSERVATION_MODIFIER", 103, 106], ["nostril", "ANATOMY", 114, 121], ["approximately", "OBSERVATION_MODIFIER", 125, 138], ["medial", "ANATOMY_MODIFIER", 159, 165], ["canthus", "ANATOMY_MODIFIER", 166, 173], ["eye", "ANATOMY", 181, 184]]], ["Pure oxygen may be delivered at approximately 0.75 to 1.5 liters per hour L/hr per 9 kilograms kg (20 lb), with the higher volumes used in acute or severe cases.", [["oxygen", "CHEMICAL", 5, 11], ["oxygen", "CHEMICAL", 5, 11], ["oxygen", "SIMPLE_CHEMICAL", 5, 11], ["Pure oxygen", "TREATMENT", 0, 11], ["acute or severe cases", "PROBLEM", 139, 160], ["acute", "OBSERVATION_MODIFIER", 139, 144], ["severe", "OBSERVATION_MODIFIER", 148, 154]]], ["Delivered oxygen may be gradually decreased over 1 to 5 days as the clinical condition or blood gas values improve.Supplemental Oxygen and VentilationMechanical ventilation also follows the principles used in other species.", [["blood", "ANATOMY", 90, 95], ["oxygen", "CHEMICAL", 10, 16], ["Oxygen", "CHEMICAL", 128, 134], ["oxygen", "CHEMICAL", 10, 16], ["Oxygen", "CHEMICAL", 128, 134], ["oxygen", "SIMPLE_CHEMICAL", 10, 16], ["blood", "ORGANISM_SUBSTANCE", 90, 95], ["Oxygen", "SIMPLE_CHEMICAL", 128, 134], ["Delivered oxygen", "TREATMENT", 0, 16], ["blood gas values", "TEST", 90, 106], ["Supplemental Oxygen", "TREATMENT", 115, 134], ["VentilationMechanical ventilation", "TREATMENT", 139, 172], ["Oxygen", "OBSERVATION_MODIFIER", 128, 134]]], ["The ventilator or breathing bag may be hooked to an endotracheal tube or tracheostomy tube, with the latter necessary for animals with an intact gag or chew reflex or a collapsed upper airway.Diseases of the Respiratory Tract Dorsal Displacement of the Soft Palate (Pharyngeal Collapse)The most common cause of dyspnea is dorsal displacement of the soft palate, possibly compounded by dorsal pharyngeal collapse or epiglottic entrapment.", [["endotracheal tube", "ANATOMY", 52, 69], ["upper airway", "ANATOMY", 179, 191], ["Soft Palate", "ANATOMY", 253, 264], ["Pharyngeal", "ANATOMY", 266, 276], ["dorsal", "ANATOMY", 322, 328], ["soft palate", "ANATOMY", 349, 360], ["dorsal pharyngeal", "ANATOMY", 385, 402], ["dyspnea", "DISEASE", 311, 318], ["endotracheal tube", "TISSUE", 52, 69], ["tube", "TISSUE", 86, 90], ["upper airway", "ORGANISM_SUBDIVISION", 179, 191], ["Pharyngeal", "ORGAN", 266, 276], ["dorsal", "ORGANISM_SUBDIVISION", 322, 328], ["palate", "ORGAN", 354, 360], ["pharyngeal", "ORGAN", 392, 402], ["The ventilator", "TREATMENT", 0, 14], ["breathing bag", "TREATMENT", 18, 31], ["an endotracheal tube", "TREATMENT", 49, 69], ["tracheostomy tube", "TREATMENT", 73, 90], ["a collapsed upper airway", "PROBLEM", 167, 191], ["Diseases of the Respiratory Tract", "PROBLEM", 192, 225], ["the Soft Palate (Pharyngeal Collapse", "PROBLEM", 249, 285], ["dyspnea", "PROBLEM", 311, 318], ["dorsal displacement of the soft palate", "PROBLEM", 322, 360], ["dorsal pharyngeal collapse", "PROBLEM", 385, 411], ["epiglottic entrapment", "PROBLEM", 415, 436], ["breathing bag", "OBSERVATION", 18, 31], ["endotracheal tube", "OBSERVATION", 52, 69], ["tracheostomy tube", "OBSERVATION", 73, 90], ["gag", "OBSERVATION", 145, 148], ["collapsed", "OBSERVATION", 169, 178], ["upper", "ANATOMY_MODIFIER", 179, 184], ["airway", "ANATOMY", 185, 191], ["Respiratory Tract", "ANATOMY", 208, 225], ["Dorsal", "ANATOMY_MODIFIER", 226, 232], ["Displacement", "OBSERVATION_MODIFIER", 233, 245], ["Soft Palate", "ANATOMY", 253, 264], ["Pharyngeal", "ANATOMY", 266, 276], ["Collapse", "OBSERVATION", 277, 285], ["most common", "OBSERVATION_MODIFIER", 290, 301], ["dyspnea", "OBSERVATION", 311, 318], ["dorsal", "OBSERVATION_MODIFIER", 322, 328], ["displacement", "OBSERVATION_MODIFIER", 329, 341], ["soft palate", "ANATOMY", 349, 360], ["possibly compounded", "UNCERTAINTY", 362, 381], ["dorsal", "ANATOMY_MODIFIER", 385, 391], ["pharyngeal", "ANATOMY", 392, 402], ["collapse", "OBSERVATION", 403, 411], ["epiglottic", "ANATOMY", 415, 425], ["entrapment", "OBSERVATION", 426, 436]]], ["In most cases, the underlying cause is unknown, but it is postulated that this is part of the stress response, especially in weakened or sedated camelids.", [["the stress response", "PROBLEM", 90, 109]]], ["In some cases, fatigue of the airway musculature caused by chronic high airway resistance or a neuromuscular defect may play a role.", [["airway", "ANATOMY", 30, 36], ["airway", "ANATOMY", 72, 78], ["neuromuscular", "ANATOMY", 95, 108], ["fatigue", "DISEASE", 15, 22], ["neuromuscular defect", "DISEASE", 95, 115], ["airway musculature", "ORGANISM_SUBDIVISION", 30, 48], ["airway", "MULTI-TISSUE_STRUCTURE", 72, 78], ["fatigue of the airway musculature", "PROBLEM", 15, 48], ["chronic high airway resistance", "PROBLEM", 59, 89], ["a neuromuscular defect", "PROBLEM", 93, 115], ["fatigue", "OBSERVATION", 15, 22], ["airway musculature", "ANATOMY", 30, 48], ["chronic", "OBSERVATION_MODIFIER", 59, 66], ["high airway resistance", "OBSERVATION", 67, 89], ["neuromuscular defect", "OBSERVATION", 95, 115]]], ["Clinical signs include dyspnea, stridor, openmouthed breathing, dorsiflexion of the head and neck, regurgitation, nystagmus, and death.", [["head", "ANATOMY", 84, 88], ["neck", "ANATOMY", 93, 97], ["dyspnea", "DISEASE", 23, 30], ["stridor", "DISEASE", 32, 39], ["nystagmus", "DISEASE", 114, 123], ["death", "DISEASE", 129, 134], ["head", "ORGANISM_SUBDIVISION", 84, 88], ["neck", "ORGANISM_SUBDIVISION", 93, 97], ["Clinical signs", "TEST", 0, 14], ["dyspnea", "PROBLEM", 23, 30], ["stridor", "PROBLEM", 32, 39], ["openmouthed breathing", "PROBLEM", 41, 62], ["dorsiflexion of the head and neck", "PROBLEM", 64, 97], ["regurgitation", "PROBLEM", 99, 112], ["nystagmus", "PROBLEM", 114, 123], ["death", "PROBLEM", 129, 134], ["stridor", "OBSERVATION", 32, 39], ["head", "ANATOMY", 84, 88], ["neck", "ANATOMY", 93, 97], ["regurgitation", "OBSERVATION", 99, 112], ["nystagmus", "OBSERVATION", 114, 123]]], ["Definitive diagnosis requires upper airway endoscopy ( Figure 37-3) , but the diagnosis can often be inferred, as endoscopy of patients in respiratory distress may be unnecessarily life threatening.", [["upper airway", "ANATOMY", 30, 42], ["respiratory", "ANATOMY", 139, 150], ["respiratory distress", "DISEASE", 139, 159], ["upper airway", "MULTI-TISSUE_STRUCTURE", 30, 42], ["patients", "ORGANISM", 127, 135], ["patients", "SPECIES", 127, 135], ["upper airway endoscopy", "TREATMENT", 30, 52], ["endoscopy", "TEST", 114, 123], ["respiratory distress", "PROBLEM", 139, 159], ["upper", "ANATOMY_MODIFIER", 30, 35], ["airway", "ANATOMY", 36, 42]]], ["Possible treatments include administration of nasal oxygen, maintaining the head and neck in extension, placing a towel over the eyes to reduce sensory input, reversal of sedative medications, and tracheostomy.", [["nasal", "ANATOMY", 46, 51], ["head", "ANATOMY", 76, 80], ["neck", "ANATOMY", 85, 89], ["eyes", "ANATOMY", 129, 133], ["oxygen", "CHEMICAL", 52, 58], ["oxygen", "CHEMICAL", 52, 58], ["nasal", "ORGANISM_SUBDIVISION", 46, 51], ["oxygen", "SIMPLE_CHEMICAL", 52, 58], ["head", "ORGANISM_SUBDIVISION", 76, 80], ["neck", "ORGANISM_SUBDIVISION", 85, 89], ["eyes", "ORGAN", 129, 133], ["treatments", "TREATMENT", 9, 19], ["nasal oxygen", "TREATMENT", 46, 58], ["a towel over the eyes", "TREATMENT", 112, 133], ["sensory input", "TREATMENT", 144, 157], ["sedative medications", "TREATMENT", 171, 191], ["tracheostomy", "TREATMENT", 197, 209], ["head", "ANATOMY", 76, 80], ["neck", "ANATOMY", 85, 89], ["tracheostomy", "OBSERVATION", 197, 209]]], ["When stress is the causative factor, handling to administer medications, draw blood samples, maintain the neck in a certain position, or perform other diagnostic or therapeutic procedures may worsen the condition.", [["blood samples", "ANATOMY", 78, 91], ["neck", "ANATOMY", 106, 110], ["blood", "ORGANISM_SUBSTANCE", 78, 83], ["neck", "ORGANISM_SUBDIVISION", 106, 110], ["medications", "TREATMENT", 60, 71], ["blood samples", "TEST", 78, 91], ["therapeutic procedures", "TREATMENT", 165, 187], ["neck", "ANATOMY", 106, 110]]], ["However, camelids with spontaneous dorsiflexion rarely improve without some degree of intervention.", [["intervention", "TREATMENT", 86, 98], ["dorsiflexion", "OBSERVATION", 35, 47]]], ["When this appears to be In dyspneic camelids, endoscopy does reduce available airway and may lead to distress of the patient, so procedures should be completed as quickly as possible.", [["airway", "ANATOMY", 78, 84], ["airway", "MULTI-TISSUE_STRUCTURE", 78, 84], ["patient", "ORGANISM", 117, 124], ["patient", "SPECIES", 117, 124], ["dyspneic camelids", "PROBLEM", 27, 44], ["endoscopy", "TEST", 46, 55], ["distress", "PROBLEM", 101, 109], ["procedures", "TREATMENT", 129, 139], ["appears to be", "UNCERTAINTY", 10, 23]]], ["Dorsal displacement of the soft palate may exacerbate respiratory compromise.Diseases of the Respiratory Tract Dorsal Displacement of the Soft Palate (Pharyngeal Collapse)Transtracheal or transendoscopic wash or bronchoalveolar lavage (BAL) may be used to collect information on infections, parasitic infestations, and cytologic abnormalities.", [["Dorsal", "ANATOMY", 0, 6], ["soft palate", "ANATOMY", 27, 38], ["respiratory", "ANATOMY", 54, 65], ["Pharyngeal", "ANATOMY", 151, 161], ["bronchoalveolar lavage", "ANATOMY", 212, 234], ["BAL", "ANATOMY", 236, 239], ["respiratory compromise", "DISEASE", 54, 76], ["infections", "DISEASE", 279, 289], ["parasitic infestations", "DISEASE", 291, 313], ["palate", "ORGAN", 32, 38], ["Pharyngeal", "ORGAN", 151, 161], ["Dorsal displacement of the soft palate", "PROBLEM", 0, 38], ["respiratory compromise", "PROBLEM", 54, 76], ["Diseases of the Respiratory Tract", "PROBLEM", 77, 110], ["the Soft Palate (Pharyngeal Collapse", "PROBLEM", 134, 170], ["Transtracheal or transendoscopic wash", "TREATMENT", 171, 208], ["bronchoalveolar lavage", "TREATMENT", 212, 234], ["infections", "PROBLEM", 279, 289], ["parasitic infestations", "PROBLEM", 291, 313], ["cytologic abnormalities", "PROBLEM", 319, 342], ["displacement", "OBSERVATION_MODIFIER", 7, 19], ["soft palate", "ANATOMY", 27, 38], ["may exacerbate", "UNCERTAINTY", 39, 53], ["respiratory compromise", "OBSERVATION", 54, 76], ["Respiratory Tract", "ANATOMY", 93, 110], ["Dorsal", "ANATOMY_MODIFIER", 111, 117], ["Displacement", "OBSERVATION_MODIFIER", 118, 130], ["Soft Palate", "ANATOMY", 138, 149], ["Pharyngeal", "ANATOMY", 151, 161], ["Collapse", "OBSERVATION", 162, 170], ["Transtracheal", "ANATOMY", 171, 184], ["bronchoalveolar lavage", "OBSERVATION", 212, 234]]], ["Transtracheal wash using catheters or commercial kits for foals may be performed after clipping and surgically preparing the ventral midline of the neck a few centimeters beyond halfway down the trachea and infiltrating the site with a local anesthetic.", [["Transtracheal", "ANATOMY", 0, 13], ["ventral midline", "ANATOMY", 125, 140], ["neck", "ANATOMY", 148, 152], ["trachea", "ANATOMY", 195, 202], ["site", "ANATOMY", 224, 228], ["foals", "ORGANISM", 58, 63], ["neck", "ORGAN", 148, 152], ["trachea", "ORGAN", 195, 202], ["Transtracheal wash using catheters", "TREATMENT", 0, 34], ["commercial kits", "TREATMENT", 38, 53], ["clipping", "TREATMENT", 87, 95], ["a local anesthetic", "TREATMENT", 234, 252], ["catheters", "OBSERVATION", 25, 34], ["ventral", "ANATOMY_MODIFIER", 125, 132], ["midline", "ANATOMY_MODIFIER", 133, 140], ["neck", "ANATOMY", 148, 152], ["trachea", "ANATOMY", 195, 202], ["infiltrating", "OBSERVATION", 207, 219]]], ["1 Transendoscopic tracheal washes yield similar results, except possibly on bacteriologic culture, and the endoscope may be wedged in a bronchus for a BAL.Diseases of the Respiratory Tract Dorsal Displacement of the Soft Palate (Pharyngeal Collapse)Pleural fluid may be obtained from healthy camelids or more readily from those with subacute to chronic hypoproteinemia.", [["tracheal", "ANATOMY", 18, 26], ["bronchus", "ANATOMY", 136, 144], ["BAL", "ANATOMY", 151, 154], ["Soft Palate", "ANATOMY", 216, 227], ["Pharyngeal", "ANATOMY", 229, 239], ["Pleural fluid", "ANATOMY", 249, 262], ["camelids", "ANATOMY", 292, 300], ["hypoproteinemia", "DISEASE", 353, 368], ["tracheal", "MULTI-TISSUE_STRUCTURE", 18, 26], ["bronchus", "ORGAN", 136, 144], ["Pharyngeal", "ORGAN", 229, 239], ["Transendoscopic tracheal washes", "TREATMENT", 2, 33], ["bacteriologic culture", "TEST", 76, 97], ["the endoscope", "TREATMENT", 103, 116], ["a BAL", "TEST", 149, 154], ["Diseases of the Respiratory Tract", "PROBLEM", 155, 188], ["the Soft Palate (Pharyngeal Collapse)Pleural fluid", "PROBLEM", 212, 262], ["chronic hypoproteinemia", "PROBLEM", 345, 368], ["tracheal", "ANATOMY", 18, 26], ["washes", "OBSERVATION", 27, 33], ["bronchus", "ANATOMY", 136, 144], ["Respiratory Tract", "ANATOMY", 171, 188], ["Dorsal", "ANATOMY_MODIFIER", 189, 195], ["Displacement", "OBSERVATION_MODIFIER", 196, 208], ["Soft Palate", "ANATOMY", 216, 227], ["Pharyngeal", "ANATOMY", 229, 239], ["Collapse", "OBSERVATION", 240, 248], ["Pleural", "ANATOMY", 249, 256], ["fluid", "OBSERVATION", 257, 262], ["subacute", "OBSERVATION_MODIFIER", 333, 341], ["chronic", "OBSERVATION_MODIFIER", 345, 352], ["hypoproteinemia", "OBSERVATION", 353, 368]]], ["1 Fluid is best obtained approximately one third to half way up the thorax, at the sixth or seventh intercostal space.", [["thorax", "ANATOMY", 68, 74], ["intercostal space", "ANATOMY", 100, 117], ["thorax", "ORGAN", 68, 74], ["intercostal space", "MULTI-TISSUE_STRUCTURE", 100, 117], ["Fluid", "OBSERVATION", 2, 7], ["thorax", "ANATOMY", 68, 74], ["sixth", "ANATOMY_MODIFIER", 83, 88], ["seventh intercostal space", "ANATOMY", 92, 117]]], ["The area should be clipped, aseptically prepared, and infused with local anesthetic.", [["local anesthetic", "TREATMENT", 67, 83], ["clipped", "OBSERVATION", 19, 26]]], ["A needle, cannula, or chest tube may be used, depending on how much fluid is expected, and how flocculent it is likely to be.", [["chest tube", "ANATOMY", 22, 32], ["chest tube", "MULTI-TISSUE_STRUCTURE", 22, 32], ["A needle, cannula", "TREATMENT", 0, 17], ["chest tube", "TREATMENT", 22, 32], ["cannula", "OBSERVATION_MODIFIER", 10, 17], ["chest", "ANATOMY", 22, 27], ["tube", "OBSERVATION", 28, 32], ["likely to be", "UNCERTAINTY", 112, 124]]], ["Normal pleural fluid contains less than 1500 nucleated cells per microliter (cells/\u00b5L), with lymphocytes making up at least 80% of these cells.", [["pleural fluid", "ANATOMY", 7, 20], ["nucleated cells", "ANATOMY", 45, 60], ["cells", "ANATOMY", 77, 82], ["lymphocytes", "ANATOMY", 93, 104], ["cells", "ANATOMY", 137, 142], ["pleural fluid", "ORGANISM_SUBSTANCE", 7, 20], ["cells", "CELL", 55, 60], ["cells", "CELL", 77, 82], ["lymphocytes", "CELL", 93, 104], ["cells", "CELL", 137, 142], ["lymphocytes", "CELL_TYPE", 93, 104], ["microliter (cells", "TEST", 65, 82], ["lymphocytes", "TEST", 93, 104], ["pleural", "ANATOMY", 7, 14], ["fluid", "OBSERVATION", 15, 20], ["less", "OBSERVATION_MODIFIER", 30, 34], ["lymphocytes", "ANATOMY", 93, 104]]], ["1 Pleural fluid usually has protein concentrations less than 2.7 grams per deciliter (g/dL), but as with abdominal fluid, outliers are possible.Diseases of the Respiratory Tract Dorsal Displacement of the Soft Palate (Pharyngeal Collapse)Imaging studies are useful for assessing the upper airway and lung.", [["Pleural fluid", "ANATOMY", 2, 15], ["abdominal fluid", "ANATOMY", 105, 120], ["Pharyngeal", "ANATOMY", 218, 228], ["upper airway", "ANATOMY", 283, 295], ["lung", "ANATOMY", 300, 304], ["Pleural fluid", "ORGANISM_SUBSTANCE", 2, 15], ["Pharyngeal", "ORGAN", 218, 228], ["upper airway", "MULTI-TISSUE_STRUCTURE", 283, 295], ["lung", "ORGAN", 300, 304], ["Pleural fluid", "TEST", 2, 15], ["protein concentrations", "TEST", 28, 50], ["abdominal fluid", "PROBLEM", 105, 120], ["Diseases of the Respiratory Tract Dorsal Displacement of the Soft Palate (Pharyngeal Collapse", "PROBLEM", 144, 237], ["Imaging studies", "TEST", 238, 253], ["Pleural", "ANATOMY", 2, 9], ["fluid", "OBSERVATION", 10, 15], ["abdominal", "ANATOMY", 105, 114], ["fluid", "OBSERVATION", 115, 120], ["Respiratory Tract", "ANATOMY", 160, 177], ["Dorsal", "ANATOMY_MODIFIER", 178, 184], ["Displacement", "OBSERVATION_MODIFIER", 185, 197], ["Soft Palate", "ANATOMY", 205, 216], ["Pharyngeal", "ANATOMY", 218, 228], ["Collapse", "OBSERVATION", 229, 237], ["upper", "ANATOMY_MODIFIER", 283, 288], ["airway", "ANATOMY", 289, 295], ["lung", "ANATOMY", 300, 304]]], ["Conventional radiography or cross-sectional techniques are useful for the bony and cartilaginous structures of the head.", [["bony", "ANATOMY", 74, 78], ["cartilaginous structures", "ANATOMY", 83, 107], ["head", "ANATOMY", 115, 119], ["bony", "TISSUE", 74, 78], ["cartilaginous structures", "MULTI-TISSUE_STRUCTURE", 83, 107], ["head", "ORGANISM_SUBDIVISION", 115, 119], ["Conventional radiography", "TEST", 0, 24], ["cross-sectional techniques", "TEST", 28, 54], ["the bony and cartilaginous structures of the head", "TEST", 70, 119], ["bony", "ANATOMY", 74, 78], ["cartilaginous", "OBSERVATION", 83, 96], ["head", "ANATOMY", 115, 119]]], ["Intranasal contrast material may be used, if occlusion is suspected.", [["Intranasal contrast material", "TREATMENT", 0, 28], ["occlusion", "PROBLEM", 45, 54], ["occlusion", "OBSERVATION", 45, 54]]], ["Radiography and cross-sectional studies may be used to assess the lung, with the cross-sectional studies of passive transfer.", [["lung", "ANATOMY", 66, 70], ["lung", "ORGAN", 66, 70], ["Radiography", "TEST", 0, 11], ["cross-sectional studies", "TEST", 16, 39], ["the cross-sectional studies", "TEST", 77, 104], ["lung", "ANATOMY", 66, 70]]], ["2 No respiratory signs were noted, but it is likely that they would have developed had the cria lived longer.", [["respiratory", "ANATOMY", 5, 16], ["respiratory signs", "PROBLEM", 5, 22], ["respiratory", "ANATOMY", 5, 16], ["signs", "OBSERVATION", 17, 22]]], ["Mannheimia hemolytica was isolated.Retropharyngeal LymphadenopathyEnlargement of the retropharyngeal lymph nodes may lead to occlusion of the upper airway and dysphagia.", [["retropharyngeal lymph nodes", "ANATOMY", 85, 112], ["upper airway", "ANATOMY", 142, 154], ["occlusion of the upper airway", "DISEASE", 125, 154], ["dysphagia", "DISEASE", 159, 168], ["Mannheimia hemolytica", "ORGANISM", 0, 21], ["retropharyngeal lymph nodes", "MULTI-TISSUE_STRUCTURE", 85, 112], ["upper airway", "ORGANISM_SUBDIVISION", 142, 154], ["Mannheimia hemolytica", "SPECIES", 0, 21], ["Mannheimia hemolytica", "SPECIES", 0, 21], ["Mannheimia hemolytica", "PROBLEM", 0, 21], ["Retropharyngeal Lymphadenopathy", "PROBLEM", 35, 66], ["the retropharyngeal lymph nodes", "PROBLEM", 81, 112], ["occlusion of the upper airway", "PROBLEM", 125, 154], ["dysphagia", "PROBLEM", 159, 168], ["Lymphadenopathy", "OBSERVATION", 51, 66], ["retropharyngeal", "ANATOMY", 85, 100], ["lymph nodes", "OBSERVATION", 101, 112], ["may lead to", "UNCERTAINTY", 113, 124], ["occlusion", "OBSERVATION", 125, 134], ["upper", "ANATOMY_MODIFIER", 142, 147], ["airway", "ANATOMY", 148, 154], ["dysphagia", "OBSERVATION", 159, 168]]], ["This finding is relatively rare in camelids and may be the result of neoplastic change or infection.", [["neoplastic", "ANATOMY", 69, 79], ["infection", "DISEASE", 90, 99], ["camelids", "CANCER", 35, 43], ["neoplastic change", "PROBLEM", 69, 86], ["infection", "PROBLEM", 90, 99], ["relatively", "OBSERVATION_MODIFIER", 16, 26], ["rare", "OBSERVATION_MODIFIER", 27, 31], ["may be the result of", "UNCERTAINTY", 48, 68], ["neoplastic", "OBSERVATION", 69, 79], ["infection", "OBSERVATION", 90, 99]]], ["The most common neoplasm of the area is lymphoma.", [["neoplasm", "ANATOMY", 16, 24], ["area", "ANATOMY", 32, 36], ["lymphoma", "ANATOMY", 40, 48], ["lymphoma", "DISEASE", 40, 48], ["neoplasm", "CANCER", 16, 24], ["lymphoma", "CANCER", 40, 48], ["lymphoma", "PROBLEM", 40, 48], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["neoplasm", "OBSERVATION", 16, 24], ["area", "ANATOMY", 32, 36], ["lymphoma", "OBSERVATION", 40, 48]]], ["3 The most common infection is likely to be Corynebacterium pseudotuberculosis, although this is more likely to affect the submandibular lymph nodes, rather than the retropharyngeal nodes.", [["submandibular lymph nodes", "ANATOMY", 123, 148], ["retropharyngeal nodes", "ANATOMY", 166, 187], ["infection", "DISEASE", 18, 27], ["Corynebacterium pseudotuberculosis", "DISEASE", 44, 78], ["Corynebacterium pseudotuberculosis", "ORGANISM", 44, 78], ["submandibular lymph nodes", "MULTI-TISSUE_STRUCTURE", 123, 148], ["retropharyngeal nodes", "MULTI-TISSUE_STRUCTURE", 166, 187], ["Corynebacterium pseudotuberculosis", "SPECIES", 44, 78], ["Corynebacterium pseudotuberculosis", "SPECIES", 44, 78], ["The most common infection", "PROBLEM", 2, 27], ["Corynebacterium pseudotuberculosis", "PROBLEM", 44, 78], ["the submandibular lymph nodes", "PROBLEM", 119, 148], ["the retropharyngeal nodes", "PROBLEM", 162, 187], ["most common", "OBSERVATION_MODIFIER", 6, 17], ["infection", "OBSERVATION", 18, 27], ["likely to be", "UNCERTAINTY", 31, 43], ["Corynebacterium", "OBSERVATION_MODIFIER", 44, 59], ["pseudotuberculosis", "OBSERVATION", 60, 78], ["more likely", "UNCERTAINTY", 97, 108], ["submandibular", "ANATOMY", 123, 136], ["lymph nodes", "OBSERVATION", 137, 148], ["retropharyngeal", "ANATOMY", 166, 181], ["nodes", "OBSERVATION", 182, 187]]], ["4, 5 Penetrating foreign bodies may also lead to infection in that area with a variety of bacteria introduced.Retropharyngeal LymphadenopathyMasses may become large enough to be appreciated from the outside or may require deep palpation of the upper neck.", [["upper neck", "ANATOMY", 244, 254], ["infection", "DISEASE", 49, 58], ["upper neck", "ORGANISM_SUBDIVISION", 244, 254], ["Penetrating foreign bodies", "PROBLEM", 5, 31], ["infection in that area", "PROBLEM", 49, 71], ["bacteria", "PROBLEM", 90, 98], ["Retropharyngeal LymphadenopathyMasses", "PROBLEM", 110, 147], ["deep palpation", "TEST", 222, 236], ["Penetrating", "OBSERVATION_MODIFIER", 5, 16], ["foreign bodies", "OBSERVATION", 17, 31], ["may also lead to", "UNCERTAINTY", 32, 48], ["infection", "OBSERVATION", 49, 58], ["variety", "OBSERVATION_MODIFIER", 79, 86], ["bacteria", "OBSERVATION", 90, 98], ["Lymphadenopathy", "OBSERVATION", 126, 141], ["large", "OBSERVATION_MODIFIER", 159, 164], ["deep", "ANATOMY_MODIFIER", 222, 226], ["palpation", "OBSERVATION", 227, 236], ["upper", "ANATOMY_MODIFIER", 244, 249], ["neck", "ANATOMY", 250, 254]]], ["A small amount of external pressure may cause an exacerbation of stridor or dyspnea.", [["stridor", "DISEASE", 65, 72], ["dyspnea", "DISEASE", 76, 83], ["external pressure", "TREATMENT", 18, 35], ["stridor", "PROBLEM", 65, 72], ["dyspnea", "PROBLEM", 76, 83], ["small", "OBSERVATION_MODIFIER", 2, 7], ["amount", "OBSERVATION_MODIFIER", 8, 14], ["external pressure", "OBSERVATION", 18, 35], ["may cause", "UNCERTAINTY", 36, 45], ["exacerbation", "OBSERVATION_MODIFIER", 49, 61], ["stridor", "OBSERVATION", 65, 72], ["dyspnea", "OBSERVATION", 76, 83]]], ["Endoscopy, ultrasonography, or imaging studies may also reveal the mass lesion, and facilitate aspiration or biopsy.", [["mass lesion", "ANATOMY", 67, 78], ["Endoscopy", "TEST", 0, 9], ["ultrasonography", "TEST", 11, 26], ["imaging studies", "TEST", 31, 46], ["the mass lesion", "PROBLEM", 63, 78], ["aspiration", "TEST", 95, 105], ["biopsy", "TEST", 109, 115], ["mass", "OBSERVATION", 67, 71], ["aspiration", "OBSERVATION", 95, 105]]], ["Treatment for the primary disease may be all that is necessary, but if the camelid has dyspnea or dysphagia, lancing of the abscesses or tracheostomy may provide relief.Nasal BotsInfestations of the caudal nasal passages and dorsal pharyngeal region by nasal bots larvae from sheep (Oestrus ovis) or deer (Cephenemyia sp.) have been reported.", [["abscesses", "ANATOMY", 124, 133], ["Nasal", "ANATOMY", 169, 174], ["caudal nasal passages", "ANATOMY", 199, 220], ["dorsal pharyngeal region", "ANATOMY", 225, 249], ["dyspnea", "DISEASE", 87, 94], ["dysphagia", "DISEASE", 98, 107], ["abscesses", "DISEASE", 124, 133], ["abscesses", "PATHOLOGICAL_FORMATION", 124, 133], ["caudal nasal", "ORGANISM_SUBDIVISION", 199, 211], ["dorsal pharyngeal", "ORGAN", 225, 242], ["sheep", "ORGANISM", 276, 281], ["Oestrus ovis", "ORGANISM", 283, 295], ["deer", "ORGANISM_SUBDIVISION", 300, 304], ["Cephenemyia sp.", "ORGANISM", 306, 321], ["sheep", "SPECIES", 276, 281], ["Oestrus ovis", "SPECIES", 283, 295], ["deer", "SPECIES", 300, 304], ["Cephenemyia sp.", "SPECIES", 306, 321], ["sheep", "SPECIES", 276, 281], ["Oestrus ovis", "SPECIES", 283, 295], ["Cephenemyia sp.", "SPECIES", 306, 321], ["Treatment", "TREATMENT", 0, 9], ["the primary disease", "PROBLEM", 14, 33], ["dyspnea", "PROBLEM", 87, 94], ["dysphagia", "PROBLEM", 98, 107], ["the abscesses", "PROBLEM", 120, 133], ["tracheostomy", "TREATMENT", 137, 149], ["Nasal BotsInfestations", "TREATMENT", 169, 191], ["the caudal nasal passages", "TREATMENT", 195, 220], ["dorsal pharyngeal region", "PROBLEM", 225, 249], ["nasal bots larvae", "PROBLEM", 253, 270], ["abscesses", "OBSERVATION", 124, 133], ["caudal", "ANATOMY_MODIFIER", 199, 205], ["nasal", "ANATOMY", 206, 211], ["passages", "OBSERVATION", 212, 220], ["dorsal", "ANATOMY_MODIFIER", 225, 231], ["pharyngeal", "ANATOMY", 232, 242], ["region", "ANATOMY_MODIFIER", 243, 249], ["nasal bots", "ANATOMY", 253, 263]]], ["6Laryngeal EdemaLaryngeal edema has a similar clinical appearance to dorsal displacement of the soft palate.", [["dorsal", "ANATOMY", 69, 75], ["soft palate", "ANATOMY", 96, 107], ["edema", "DISEASE", 26, 31], ["palate", "ORGAN", 101, 107], ["6Laryngeal EdemaLaryngeal edema", "PROBLEM", 0, 31], ["dorsal displacement of the soft palate", "PROBLEM", 69, 107], ["EdemaLaryngeal", "OBSERVATION_MODIFIER", 11, 25], ["edema", "OBSERVATION", 26, 31], ["dorsal", "ANATOMY_MODIFIER", 69, 75], ["displacement", "OBSERVATION_MODIFIER", 76, 88], ["soft palate", "ANATOMY", 96, 107]]], ["Causes include insect or snake bites, tracheal intubation, tight cervical wraps or collars, entrapment of the neck in gates or fences, hypoproteinemia, overhydration, jugular thrombosis, cervical hematoma or trauma, heat stress, ingestion of caustic plants or medications, or right heart failure.", [["tracheal", "ANATOMY", 38, 46], ["cervical", "ANATOMY", 65, 73], ["neck", "ANATOMY", 110, 114], ["jugular", "ANATOMY", 167, 174], ["cervical", "ANATOMY", 187, 195], ["right heart", "ANATOMY", 276, 287], ["insect or snake bites", "DISEASE", 15, 36], ["entrapment of the neck", "DISEASE", 92, 114], ["hypoproteinemia", "DISEASE", 135, 150], ["overhydration", "DISEASE", 152, 165], ["jugular thrombosis", "DISEASE", 167, 185], ["hematoma", "DISEASE", 196, 204], ["trauma", "DISEASE", 208, 214], ["heart failure", "DISEASE", 282, 295], ["tracheal", "ORGAN", 38, 46], ["cervical", "ORGANISM_SUBDIVISION", 65, 73], ["neck", "ORGAN", 110, 114], ["jugular", "MULTI-TISSUE_STRUCTURE", 167, 174], ["cervical", "ORGANISM_SUBDIVISION", 187, 195], ["heart", "ORGAN", 282, 287], ["snake bites", "PROBLEM", 25, 36], ["tracheal intubation", "TREATMENT", 38, 57], ["tight cervical wraps", "TREATMENT", 59, 79], ["collars", "TREATMENT", 83, 90], ["entrapment of the neck in gates", "PROBLEM", 92, 123], ["hypoproteinemia", "PROBLEM", 135, 150], ["overhydration", "PROBLEM", 152, 165], ["jugular thrombosis", "PROBLEM", 167, 185], ["cervical hematoma", "PROBLEM", 187, 204], ["trauma", "PROBLEM", 208, 214], ["heat stress", "PROBLEM", 216, 227], ["caustic plants", "PROBLEM", 242, 256], ["medications", "TREATMENT", 260, 271], ["right heart failure", "PROBLEM", 276, 295], ["tracheal", "ANATOMY", 38, 46], ["intubation", "OBSERVATION", 47, 57], ["cervical", "ANATOMY", 65, 73], ["entrapment", "OBSERVATION", 92, 102], ["neck", "ANATOMY", 110, 114], ["hypoproteinemia", "OBSERVATION", 135, 150], ["overhydration", "OBSERVATION", 152, 165], ["jugular", "ANATOMY", 167, 174], ["thrombosis", "OBSERVATION", 175, 185], ["cervical", "ANATOMY", 187, 195], ["hematoma", "OBSERVATION", 196, 204], ["right", "ANATOMY_MODIFIER", 276, 281], ["heart", "ANATOMY", 282, 287], ["failure", "OBSERVATION", 288, 295]]], ["Clinical pathology data may reveal evidence of an underlying inflammatory disease or hypoproteinemia.", [["hypoproteinemia", "DISEASE", 85, 100], ["Clinical pathology data", "TEST", 0, 23], ["an underlying inflammatory disease", "PROBLEM", 47, 81], ["hypoproteinemia", "PROBLEM", 85, 100], ["evidence of", "UNCERTAINTY", 35, 46], ["underlying", "OBSERVATION_MODIFIER", 50, 60], ["inflammatory", "OBSERVATION", 61, 73], ["hypoproteinemia", "OBSERVATION", 85, 100]]], ["Radiographic or ultrasonographic examination of the region reveals thickening of the soft tissue structures and separation of other tissue layers.", [["soft tissue structures", "ANATOMY", 85, 107], ["tissue layers", "ANATOMY", 132, 145], ["soft tissue structures", "TISSUE", 85, 107], ["tissue layers", "TISSUE", 132, 145], ["Radiographic or ultrasonographic examination of the region", "TEST", 0, 58], ["thickening of the soft tissue structures", "PROBLEM", 67, 107], ["other tissue layers", "PROBLEM", 126, 145], ["thickening", "OBSERVATION", 67, 77], ["soft tissue", "ANATOMY", 85, 96], ["separation", "OBSERVATION_MODIFIER", 112, 122], ["other tissue", "OBSERVATION_MODIFIER", 126, 138], ["layers", "OBSERVATION_MODIFIER", 139, 145]]], ["If the camelid is stable, treatment should be directed at resolving the underlying condition.", [["treatment", "TREATMENT", 26, 35], ["the underlying condition", "PROBLEM", 68, 92], ["stable", "OBSERVATION_MODIFIER", 18, 24]]], ["Antiinflammatory drugs or diuretics may aid in reducing swelling.", [["swelling", "DISEASE", 56, 64], ["diuretics", "SIMPLE_CHEMICAL", 26, 35], ["Antiinflammatory drugs", "TREATMENT", 0, 22], ["diuretics", "TREATMENT", 26, 35], ["reducing swelling", "PROBLEM", 47, 64], ["reducing", "OBSERVATION_MODIFIER", 47, 55], ["swelling", "OBSERVATION", 56, 64]]], ["If dyspnea is severe, intranasal oxygen or tracheostomy may be necessary.Arytenoid Chondritis and Laryngeal AbscessationInflammation or infection of the laryngeal cartilages is much rarer and much more serious than simple edema of the region.", [["Laryngeal", "ANATOMY", 98, 107], ["laryngeal cartilages", "ANATOMY", 153, 173], ["edema", "ANATOMY", 222, 227], ["dyspnea", "DISEASE", 3, 10], ["oxygen", "CHEMICAL", 33, 39], ["Chondritis", "DISEASE", 83, 93], ["Inflammation", "DISEASE", 120, 132], ["infection", "DISEASE", 136, 145], ["edema", "DISEASE", 222, 227], ["oxygen", "CHEMICAL", 33, 39], ["oxygen", "SIMPLE_CHEMICAL", 33, 39], ["laryngeal cartilages", "MULTI-TISSUE_STRUCTURE", 153, 173], ["edema", "PATHOLOGICAL_FORMATION", 222, 227], ["dyspnea", "PROBLEM", 3, 10], ["severe", "PROBLEM", 14, 20], ["intranasal oxygen", "TREATMENT", 22, 39], ["tracheostomy", "TREATMENT", 43, 55], ["Arytenoid Chondritis", "PROBLEM", 73, 93], ["Laryngeal AbscessationInflammation", "PROBLEM", 98, 132], ["infection of the laryngeal cartilages", "PROBLEM", 136, 173], ["simple edema of the region", "PROBLEM", 215, 241], ["severe", "OBSERVATION_MODIFIER", 14, 20], ["Chondritis", "OBSERVATION", 83, 93], ["Laryngeal", "ANATOMY", 98, 107], ["Abscessation", "OBSERVATION", 108, 120], ["infection", "OBSERVATION", 136, 145], ["laryngeal cartilages", "ANATOMY", 153, 173], ["more serious", "OBSERVATION_MODIFIER", 197, 209], ["simple", "OBSERVATION_MODIFIER", 215, 221], ["edema", "OBSERVATION", 222, 227], ["region", "ANATOMY_MODIFIER", 235, 241]]], ["Affected camelids usually have severe dyspnea with exercise intolerance and stertorous breathing.", [["camelids", "ANATOMY", 9, 17], ["dyspnea", "DISEASE", 38, 45], ["exercise intolerance", "DISEASE", 51, 71], ["Affected camelids", "PROBLEM", 0, 17], ["severe dyspnea", "PROBLEM", 31, 45], ["exercise intolerance", "PROBLEM", 51, 71], ["stertorous breathing", "PROBLEM", 76, 96], ["severe", "OBSERVATION_MODIFIER", 31, 37], ["dyspnea", "OBSERVATION", 38, 45]]], ["Increased recumbency and collapsing with exercise are seen.", [["Increased recumbency", "PROBLEM", 0, 20], ["recumbency", "OBSERVATION_MODIFIER", 10, 20], ["collapsing", "OBSERVATION_MODIFIER", 25, 35]]], ["The application of mild external pressure to the laryngeal region exacerbates the signs.", [["laryngeal region", "ANATOMY", 49, 65], ["laryngeal", "ORGAN", 49, 58], ["mild external pressure", "TREATMENT", 19, 41], ["mild", "OBSERVATION_MODIFIER", 19, 23], ["external", "OBSERVATION_MODIFIER", 24, 32], ["pressure", "OBSERVATION_MODIFIER", 33, 41], ["laryngeal", "ANATOMY", 49, 58], ["region", "ANATOMY_MODIFIER", 59, 65], ["signs", "OBSERVATION", 82, 87]]], ["Endoscopic examination is usually necessary to confirm the diagnosis.", [["Endoscopic examination", "TEST", 0, 22]]], ["Radiography of the region may reveal soft tissue thickening or mineralization.", [["soft tissue", "ANATOMY", 37, 48], ["soft tissue", "TISSUE", 37, 48], ["Radiography of the region", "TEST", 0, 25], ["soft tissue thickening", "PROBLEM", 37, 59], ["mineralization", "PROBLEM", 63, 77], ["soft tissue", "ANATOMY", 37, 48], ["thickening", "OBSERVATION", 49, 59], ["mineralization", "OBSERVATION", 63, 77]]], ["Antibiotics (for 2 or more weeks) and antiinflammatory medications (for a few days) usually reduce the regional swelling.", [["swelling", "DISEASE", 112, 120], ["Antibiotics", "TREATMENT", 0, 11], ["antiinflammatory medications", "TREATMENT", 38, 66], ["the regional swelling", "PROBLEM", 99, 120], ["regional", "OBSERVATION_MODIFIER", 103, 111], ["swelling", "OBSERVATION", 112, 120]]], ["Surgical resection or tracheostomy may be necessary in extreme cases.Arytenoid Chondritis and Laryngeal AbscessationLaryngitis with abscessation not involving the cartilage was identified in one 10-day-old cria with possible partial failure ( Figure 37-7) , or more advanced imaging techniques that allow the nasal passages to be displayed in slices.", [["Laryngeal", "ANATOMY", 94, 103], ["cartilage", "ANATOMY", 163, 172], ["nasal", "ANATOMY", 309, 314], ["slices", "ANATOMY", 343, 349], ["Arytenoid Chondritis", "DISEASE", 69, 89], ["Laryngeal AbscessationLaryngitis", "DISEASE", 94, 126], ["abscessation", "DISEASE", 132, 144], ["Laryngeal AbscessationLaryngitis", "CANCER", 94, 126], ["cartilage", "TISSUE", 163, 172], ["Surgical resection", "TREATMENT", 0, 18], ["tracheostomy", "TREATMENT", 22, 34], ["Arytenoid Chondritis", "PROBLEM", 69, 89], ["Laryngeal AbscessationLaryngitis", "PROBLEM", 94, 126], ["abscessation", "PROBLEM", 132, 144], ["partial failure", "PROBLEM", 225, 240], ["advanced imaging techniques", "TEST", 266, 293], ["the nasal passages", "TREATMENT", 305, 323], ["resection", "OBSERVATION", 9, 18], ["tracheostomy", "OBSERVATION", 22, 34], ["Chondritis", "OBSERVATION", 79, 89], ["Laryngeal", "ANATOMY", 94, 103], ["AbscessationLaryngitis", "OBSERVATION", 104, 126], ["cartilage", "ANATOMY", 163, 172], ["one 10-", "OBSERVATION_MODIFIER", 191, 198], ["possible", "UNCERTAINTY", 216, 224], ["partial", "OBSERVATION_MODIFIER", 225, 232], ["failure", "OBSERVATION", 233, 240], ["nasal", "ANATOMY", 309, 314]]], ["Aerophagia and hyperinflated lungs may also be seen.", [["lungs", "ANATOMY", 29, 34], ["Aerophagia", "DISEASE", 0, 10], ["lungs", "ORGAN", 29, 34], ["Aerophagia and hyperinflated lungs", "PROBLEM", 0, 34], ["hyperinflated", "OBSERVATION", 15, 28], ["lungs", "ANATOMY", 29, 34], ["may also be seen", "UNCERTAINTY", 35, 51]]], ["Endoscopy or contrast radiography reveals imperforate membranes or bony obstruction.", [["imperforate membranes", "ANATOMY", 42, 63], ["bony", "ANATOMY", 67, 71], ["bony obstruction", "DISEASE", 67, 83], ["bony obstruction", "PATHOLOGICAL_FORMATION", 67, 83], ["Endoscopy or contrast radiography", "TEST", 0, 33], ["imperforate membranes", "PROBLEM", 42, 63], ["bony obstruction", "PROBLEM", 67, 83], ["imperforate membranes", "OBSERVATION", 42, 63], ["bony", "ANATOMY", 67, 71], ["obstruction", "OBSERVATION", 72, 83]]], ["Mucoid fluid may obscure the actual obstruction.", [["Mucoid fluid", "ANATOMY", 0, 12], ["obstruction", "DISEASE", 36, 47], ["Mucoid fluid", "PROBLEM", 0, 12], ["the actual obstruction", "PROBLEM", 25, 47], ["fluid", "OBSERVATION", 7, 12], ["actual", "OBSERVATION_MODIFIER", 29, 35], ["obstruction", "OBSERVATION", 36, 47]]], ["Plain radiography reveals bony obstruction only and may be difficult to interpret.", [["bony", "ANATOMY", 26, 30], ["bony obstruction", "DISEASE", 26, 42], ["Plain radiography", "TEST", 0, 17], ["bony obstruction", "PROBLEM", 26, 42], ["bony", "ANATOMY", 26, 30], ["obstruction", "OBSERVATION", 31, 42]]], ["Clinical pathology data reflect stress or secondary aspiration pneumonia.", [["pneumonia", "DISEASE", 63, 72], ["Clinical pathology data", "TEST", 0, 23], ["stress", "PROBLEM", 32, 38], ["secondary aspiration pneumonia", "PROBLEM", 42, 72], ["secondary", "OBSERVATION_MODIFIER", 42, 51], ["aspiration", "OBSERVATION_MODIFIER", 52, 62], ["pneumonia", "OBSERVATION", 63, 72]]], ["Blood oxygenation is usually poor.", [["Blood", "ANATOMY", 0, 5], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["Blood oxygenation", "TEST", 0, 17], ["oxygenation", "OBSERVATION_MODIFIER", 6, 17]]], ["Tracheostomy or surgical repair are possible and provide immediate relief, but camelids frequently outgrow these stomata and repeated procedures may be necessary.", [["stomata", "ANATOMY", 113, 120], ["Tracheostomy", "TREATMENT", 0, 12], ["surgical repair", "TREATMENT", 16, 31], ["camelids", "TREATMENT", 79, 87], ["repeated procedures", "TREATMENT", 125, 144], ["surgical repair", "OBSERVATION", 16, 31]]], ["10 Much of the controversy surrounding choanal atresia involves questions of heritability.", [["choanal", "ANATOMY", 39, 46], ["choanal atresia", "DISEASE", 39, 54], ["choanal atresia", "PATHOLOGICAL_FORMATION", 39, 54], ["choanal atresia", "PROBLEM", 39, 54], ["heritability", "PROBLEM", 77, 89], ["choanal", "ANATOMY", 39, 46], ["atresia", "OBSERVATION", 47, 54]]], ["Camelids that have given rise to previous offspring with choanal atresia appear to be more likely to have subsequent affected offspring compared with camelids that never have had affected offspring.", [["choanal", "ANATOMY", 57, 64], ["choanal atresia", "DISEASE", 57, 72], ["choanal atresia", "PROBLEM", 57, 72], ["atresia", "OBSERVATION", 65, 72]]], ["In contrast, breeding affected camelids rarely leads to the birth of affected offspring.Arytenoid Chondritis and Laryngeal AbscessationSimilar problems are seen in camelids with severe facial distortion.", [["camelids", "ANATOMY", 31, 39], ["Laryngeal", "ANATOMY", 113, 122], ["facial", "ANATOMY", 185, 191], ["camelids", "DISEASE", 31, 39], ["Chondritis", "DISEASE", 98, 108], ["facial", "ORGAN", 185, 191], ["breeding affected camelids", "PROBLEM", 13, 39], ["Arytenoid Chondritis", "PROBLEM", 88, 108], ["Laryngeal AbscessationSimilar problems", "PROBLEM", 113, 151], ["severe facial distortion", "PROBLEM", 178, 202], ["Chondritis", "OBSERVATION", 98, 108], ["Laryngeal", "ANATOMY", 113, 122], ["AbscessationSimilar", "OBSERVATION", 123, 142], ["severe", "OBSERVATION_MODIFIER", 178, 184], ["facial", "ANATOMY", 185, 191], ["distortion", "OBSERVATION", 192, 202]]], ["They usually have a patent airway, although reduced Most reports involve individual camelids, but herd outbreaks have occurred.", [["airway", "ANATOMY", 27, 33], ["airway", "MULTI-TISSUE_STRUCTURE", 27, 33], ["herd outbreaks", "PROBLEM", 98, 112], ["patent", "OBSERVATION", 20, 26], ["airway", "ANATOMY", 27, 33]]], ["Clinical signs are mainly from the physical narrowing of the upper airway.", [["upper airway", "ANATOMY", 61, 73], ["upper airway", "ORGANISM_SUBDIVISION", 61, 73], ["Clinical signs", "PROBLEM", 0, 14], ["the physical narrowing of the upper airway", "PROBLEM", 31, 73], ["physical", "OBSERVATION_MODIFIER", 35, 43], ["narrowing", "OBSERVATION", 44, 53], ["upper", "ANATOMY_MODIFIER", 61, 66], ["airway", "ANATOMY", 67, 73]]], ["These include sneezing, coughing, respiratory stridor mainly on inspiration, nasal discharge possibly with mild epistaxis, exercise intolerance, and open mouth breathing.", [["respiratory", "ANATOMY", 34, 45], ["nasal", "ANATOMY", 77, 82], ["mouth", "ANATOMY", 154, 159], ["sneezing", "DISEASE", 14, 22], ["coughing", "DISEASE", 24, 32], ["respiratory stridor", "DISEASE", 34, 53], ["epistaxis", "DISEASE", 112, 121], ["exercise intolerance", "DISEASE", 123, 143], ["nasal", "ORGANISM_SUBDIVISION", 77, 82], ["mouth", "ORGANISM_SUBDIVISION", 154, 159], ["sneezing", "PROBLEM", 14, 22], ["coughing", "PROBLEM", 24, 32], ["respiratory stridor", "PROBLEM", 34, 53], ["nasal discharge", "PROBLEM", 77, 92], ["mild epistaxis", "PROBLEM", 107, 121], ["exercise intolerance", "PROBLEM", 123, 143], ["open mouth breathing", "PROBLEM", 149, 169], ["sneezing", "OBSERVATION", 14, 22], ["respiratory", "ANATOMY", 34, 45], ["stridor", "OBSERVATION", 46, 53], ["nasal", "ANATOMY", 77, 82], ["mild", "OBSERVATION_MODIFIER", 107, 111], ["epistaxis", "OBSERVATION", 112, 121], ["exercise intolerance", "OBSERVATION", 123, 143]]], ["Pulmonary auscultation is usually normal but is complicated by sounds referred from the upper airway.", [["Pulmonary", "ANATOMY", 0, 9], ["upper airway", "ANATOMY", 88, 100], ["Pulmonary", "ORGAN", 0, 9], ["upper airway", "ORGANISM_SUBDIVISION", 88, 100], ["Pulmonary auscultation", "TEST", 0, 22], ["auscultation", "OBSERVATION", 10, 22], ["normal", "OBSERVATION", 34, 40], ["sounds", "OBSERVATION", 63, 69], ["upper", "ANATOMY_MODIFIER", 88, 93], ["airway", "ANATOMY", 94, 100]]], ["Affected camelids are afebrile and have normal clinical pathology data except for the changes caused by stress.", [["camelids", "ANATOMY", 9, 17], ["camelids", "CANCER", 9, 17], ["Affected camelids", "PROBLEM", 0, 17], ["afebrile", "PROBLEM", 22, 30], ["stress", "PROBLEM", 104, 110]]], ["Most cases occur in adults, but one case of a 9-month-old llama has been reported.", [["llama", "ORGANISM", 58, 63]]], ["Many also have a history of treatment failure with antibiotics.Arytenoid Chondritis and Laryngeal AbscessationDefinitive diagnosis of Cephenemyia infestation is by endoscopic examination.", [["Laryngeal", "ANATOMY", 88, 97], ["Chondritis", "DISEASE", 73, 83], ["Cephenemyia infestation", "DISEASE", 134, 157], ["Laryngeal", "ORGAN", 88, 97], ["Cephenemyia", "ORGANISM", 134, 145], ["treatment failure", "PROBLEM", 28, 45], ["antibiotics", "TREATMENT", 51, 62], ["Arytenoid Chondritis", "PROBLEM", 63, 83], ["Cephenemyia infestation", "PROBLEM", 134, 157], ["endoscopic examination", "TEST", 164, 186], ["failure", "OBSERVATION", 38, 45], ["Chondritis", "OBSERVATION", 73, 83], ["Laryngeal", "ANATOMY", 88, 97], ["Cephenemyia infestation", "OBSERVATION", 134, 157]]], ["They are often found within a pouch of soft tissue on the dorsal nasopharyngeal wall.", [["pouch", "ANATOMY", 30, 35], ["soft tissue", "ANATOMY", 39, 50], ["dorsal nasopharyngeal wall", "ANATOMY", 58, 84], ["pouch", "TISSUE", 30, 35], ["soft tissue", "TISSUE", 39, 50], ["dorsal nasopharyngeal wall", "MULTI-TISSUE_STRUCTURE", 58, 84], ["pouch", "OBSERVATION", 30, 35], ["soft tissue", "ANATOMY_MODIFIER", 39, 50], ["dorsal", "ANATOMY_MODIFIER", 58, 64], ["nasopharyngeal wall", "ANATOMY", 65, 84]]], ["This pouch may also be seen radiographically.", [["pouch", "ANATOMY", 5, 10], ["pouch", "ORGAN", 5, 10], ["This pouch", "TREATMENT", 0, 10], ["pouch", "OBSERVATION", 5, 10], ["may also be seen", "UNCERTAINTY", 11, 27], ["radiographically", "OBSERVATION", 28, 44]]], ["Oestrus ovis are less commonly reported but have a predilection for the dorsal nasal turbinates and sinuses in sheep.", [["dorsal nasal turbinates", "ANATOMY", 72, 95], ["sinuses", "ANATOMY", 100, 107], ["Oestrus ovis", "ORGANISM", 0, 12], ["dorsal nasal turbinates", "MULTI-TISSUE_STRUCTURE", 72, 95], ["sinuses", "MULTI-TISSUE_STRUCTURE", 100, 107], ["sheep", "ORGANISM", 111, 116], ["Oestrus ovis", "SPECIES", 0, 12], ["sheep", "SPECIES", 111, 116], ["Oestrus ovis", "SPECIES", 0, 12], ["sheep", "SPECIES", 111, 116], ["Oestrus ovis", "PROBLEM", 0, 12], ["the dorsal nasal turbinates and sinuses in sheep", "PROBLEM", 68, 116], ["dorsal", "ANATOMY_MODIFIER", 72, 78], ["nasal turbinates", "ANATOMY", 79, 95], ["sinuses", "ANATOMY", 100, 107]]], ["These areas are inaccessible to endoscopy.", [["endoscopy", "TEST", 32, 41]]], ["Oestrus ovis larvae may be distinguished from Cephenemyia sp. by examining the two dark peritremes at the posterior (exposed) end.", [["Oestrus ovis larvae", "ORGANISM", 0, 19], ["Cephenemyia sp", "ORGANISM", 46, 60], ["posterior (exposed) end", "DNA", 106, 129], ["Oestrus ovis", "SPECIES", 0, 12], ["Oestrus ovis", "SPECIES", 0, 12], ["Oestrus ovis larvae", "PROBLEM", 0, 19], ["dark", "OBSERVATION_MODIFIER", 83, 87], ["peritremes", "OBSERVATION", 88, 98], ["posterior", "ANATOMY_MODIFIER", 106, 115]]], ["Peritremes are circular in Oestrus with a central button and kidney-shaped in Cephenemyia with buttons aligned with the medially oriented lesser curvature.Arytenoid Chondritis and Laryngeal AbscessationTreatment depends on the severity of signs.", [["kidney", "ANATOMY", 61, 67], ["Laryngeal", "ANATOMY", 180, 189], ["Chondritis", "DISEASE", 165, 175], ["kidney", "ORGAN", 61, 67], ["Laryngeal", "ORGAN", 180, 189], ["circular in Oestrus", "PROBLEM", 15, 34], ["Arytenoid Chondritis", "PROBLEM", 155, 175], ["Laryngeal AbscessationTreatment", "TREATMENT", 180, 211], ["signs", "PROBLEM", 239, 244], ["circular", "OBSERVATION_MODIFIER", 15, 23], ["Oestrus", "OBSERVATION", 27, 34], ["central button", "OBSERVATION", 42, 56], ["kidney", "ANATOMY", 61, 67], ["shaped", "OBSERVATION_MODIFIER", 68, 74], ["Cephenemyia", "ANATOMY_MODIFIER", 78, 89], ["buttons aligned", "OBSERVATION", 95, 110], ["medially", "ANATOMY_MODIFIER", 120, 128], ["lesser", "OBSERVATION_MODIFIER", 138, 144], ["curvature", "OBSERVATION_MODIFIER", 145, 154], ["Chondritis", "OBSERVATION", 165, 175], ["Laryngeal", "ANATOMY", 180, 189], ["Abscessation", "OBSERVATION", 190, 202]]], ["Mildly affected camelids may be treated with ivermectin, which often resolves the infestation within 2 weeks.", [["camelids", "ANATOMY", 16, 24], ["ivermectin", "CHEMICAL", 45, 55], ["ivermectin", "CHEMICAL", 45, 55], ["camelids", "CANCER", 16, 24], ["ivermectin", "SIMPLE_CHEMICAL", 45, 55], ["Mildly affected camelids", "PROBLEM", 0, 24], ["ivermectin", "TREATMENT", 45, 55], ["affected", "OBSERVATION", 7, 15]]], ["More compromised camelids may require more aggressive intervention.", [["camelids", "ANATOMY", 17, 25], ["camelids", "CANCER", 17, 25], ["aggressive intervention", "TREATMENT", 43, 66]]], ["Removal of larvae one at a time using the endoscope's biopsy instrument is time consuming but effective.Upper Airway MalformationsCongenital upper airway malformations are relatively common in New World camelids.", [["upper airway", "ANATOMY", 141, 153], ["Malformations", "DISEASE", 117, 130], ["Congenital upper airway malformations", "DISEASE", 130, 167], ["upper airway malformations", "PATHOLOGICAL_FORMATION", 141, 167], ["Removal of larvae", "TREATMENT", 0, 17], ["the endoscope's biopsy instrument", "TREATMENT", 38, 71], ["Upper Airway Malformations", "PROBLEM", 104, 130], ["Congenital upper airway malformations", "PROBLEM", 130, 167], ["Airway", "ANATOMY", 110, 116], ["Malformations", "OBSERVATION", 117, 130], ["upper", "ANATOMY_MODIFIER", 141, 146], ["airway", "ANATOMY", 147, 153], ["malformations", "OBSERVATION", 154, 167]]], ["Among the more common are choanal atresia (10.4% of reported congenital defects in one study), wry face (7%), and cleft palate (3%).", [["choanal atresia", "ANATOMY", 26, 41], ["wry face", "ANATOMY", 95, 103], ["cleft palate", "ANATOMY", 114, 126], ["choanal atresia", "DISEASE", 26, 41], ["congenital defects", "DISEASE", 61, 79], ["cleft palate", "DISEASE", 114, 126], ["palate", "ORGAN", 120, 126], ["choanal atresia", "PROBLEM", 26, 41], ["congenital defects", "PROBLEM", 61, 79], ["one study", "TEST", 83, 92], ["cleft palate", "PROBLEM", 114, 126], ["choanal", "ANATOMY", 26, 33], ["atresia", "OBSERVATION", 34, 41], ["congenital", "OBSERVATION_MODIFIER", 61, 71], ["defects", "OBSERVATION", 72, 79], ["cleft palate", "ANATOMY", 114, 126]]], ["9 Subepiglottic cysts and hypoplastic trachea are less common.", [["Subepiglottic cysts", "ANATOMY", 2, 21], ["hypoplastic trachea", "ANATOMY", 26, 45], ["Subepiglottic cysts", "DISEASE", 2, 21], ["hypoplastic trachea", "DISEASE", 26, 45], ["Subepiglottic cysts", "CANCER", 2, 21], ["trachea", "ORGAN", 38, 45], ["Subepiglottic cysts", "PROBLEM", 2, 21], ["hypoplastic trachea", "PROBLEM", 26, 45], ["Subepiglottic", "OBSERVATION_MODIFIER", 2, 15], ["cysts", "OBSERVATION", 16, 21], ["hypoplastic", "OBSERVATION", 26, 37], ["trachea", "ANATOMY", 38, 45], ["less", "OBSERVATION_MODIFIER", 50, 54], ["common", "OBSERVATION_MODIFIER", 55, 61]]], ["All of these impede air flow or heighten risk of aspiration.Upper Airway MalformationsChoanal atresia is anatomically well described.", [["Malformations", "DISEASE", 73, 86], ["Choanal atresia", "DISEASE", 86, 101], ["aspiration", "PROBLEM", 49, 59], ["Upper Airway Malformations", "PROBLEM", 60, 86], ["Choanal atresia", "PROBLEM", 86, 101], ["air flow", "OBSERVATION", 20, 28], ["aspiration", "OBSERVATION", 49, 59], ["Airway", "ANATOMY", 66, 72], ["Malformations", "OBSERVATION", 73, 86], ["atresia", "OBSERVATION", 94, 101], ["anatomically", "OBSERVATION_MODIFIER", 105, 117]]], ["It results from failure of the buccopharyngeal membranes to completely rupture during the early second trimester of fetal development, leaving membranous or bony obstructions over one or both nasal passages ( Figure 37 -5) .", [["buccopharyngeal membranes", "ANATOMY", 31, 56], ["fetal", "ANATOMY", 116, 121], ["membranous", "ANATOMY", 143, 153], ["bony obstructions", "ANATOMY", 157, 174], ["nasal", "ANATOMY", 192, 197], ["buccopharyngeal membranes", "CELLULAR_COMPONENT", 31, 56], ["fetal", "ORGAN", 116, 121], ["bony obstructions", "PATHOLOGICAL_FORMATION", 157, 174], ["failure of the buccopharyngeal membranes", "PROBLEM", 16, 56], ["rupture", "PROBLEM", 71, 78], ["fetal development", "PROBLEM", 116, 133], ["membranous or bony obstructions", "PROBLEM", 143, 174], ["failure", "OBSERVATION", 16, 23], ["buccopharyngeal membranes", "ANATOMY", 31, 56], ["rupture", "OBSERVATION", 71, 78], ["membranous", "OBSERVATION_MODIFIER", 143, 153], ["bony", "ANATOMY", 157, 161], ["obstructions", "OBSERVATION", 162, 174], ["nasal passages", "ANATOMY", 192, 206]]], ["Camelids with unilateral lesions may thrive into adulthood, showing little more than a heightened respiratory rate, open-mouthed breathing, or dyspnea when stressed.", [["lesions", "ANATOMY", 25, 32], ["respiratory", "ANATOMY", 98, 109], ["dyspnea", "DISEASE", 143, 150], ["lesions", "PATHOLOGICAL_FORMATION", 25, 32], ["unilateral lesions", "PROBLEM", 14, 32], ["a heightened respiratory rate", "PROBLEM", 85, 114], ["mouthed breathing", "PROBLEM", 121, 138], ["dyspnea", "PROBLEM", 143, 150], ["unilateral", "OBSERVATION_MODIFIER", 14, 24], ["lesions", "OBSERVATION", 25, 32]]], ["Bilaterally affected neonates are born with little or no ability to breathe nasally.", [["neonates", "ORGANISM", 21, 29], ["Bilaterally affected neonates", "PROBLEM", 0, 29], ["affected", "OBSERVATION_MODIFIER", 12, 20], ["neonates", "OBSERVATION", 21, 29]]], ["Affected crias typically display open-mouthed breathing, with the lips pulled away from the mouth, stertor (inspiratory or expiratory), and pronounced nostril flaring (Figure 37-6).", [["lips", "ANATOMY", 66, 70], ["mouth", "ANATOMY", 92, 97], ["nostril", "ANATOMY", 151, 158], ["lips", "ORGANISM_SUBDIVISION", 66, 70], ["mouth", "ORGANISM_SUBDIVISION", 92, 97], ["nostril", "ORGANISM_SUBDIVISION", 151, 158], ["Affected crias", "PROBLEM", 0, 14], ["mouthed breathing", "PROBLEM", 38, 55], ["the lips", "PROBLEM", 62, 70], ["pronounced nostril flaring", "PROBLEM", 140, 166], ["Figure", "TEST", 168, 174], ["mouthed breathing", "OBSERVATION", 38, 55], ["lips", "ANATOMY", 66, 70], ["mouth", "ANATOMY", 92, 97], ["inspiratory", "ANATOMY", 108, 119], ["nostril", "ANATOMY", 151, 158], ["flaring", "OBSERVATION", 159, 166]]], ["They often have difficulty eating and are at high risk for aspiration.", [["difficulty eating", "PROBLEM", 16, 33], ["aspiration", "PROBLEM", 59, 69], ["aspiration", "OBSERVATION", 59, 69]]], ["Air flow at the nostrils is absent or reduced, and soft rubber tubes cannot be passed nasally beyond the level of the eye.", [["nostrils", "ANATOMY", 16, 24], ["eye", "ANATOMY", 118, 121], ["nostrils", "ORGAN", 16, 24], ["eye", "ORGAN", 118, 121], ["Air flow at the nostrils", "PROBLEM", 0, 24], ["soft rubber tubes", "TREATMENT", 51, 68], ["flow", "OBSERVATION", 4, 8], ["nostrils", "ANATOMY", 16, 24], ["absent", "OBSERVATION", 28, 34], ["reduced", "OBSERVATION_MODIFIER", 38, 45], ["soft", "OBSERVATION_MODIFIER", 51, 55], ["rubber tubes", "OBSERVATION", 56, 68], ["eye", "ANATOMY", 118, 121]]], ["Definitive diagnosis may be achieved by endoscopic examination with a pediatric endoscope (up to approximately 6 mm diameter), plain radiography, contrast radiology, in which approximately 5 to 10 milliliters (mL) of contrast (preferably an organic iodide to reduce risk of aspiration complications) is instilled into each nasal passage and the nose held in dorsal extension Infection on the skin of the nares by Conidiobolus coronatus in two llamas led to proliferation of tissue, chronic nasal discharge, and eventual occlusion of the nasal passages.", [["nasal", "ANATOMY", 323, 328], ["nose", "ANATOMY", 345, 349], ["dorsal", "ANATOMY", 358, 364], ["skin", "ANATOMY", 392, 396], ["nares", "ANATOMY", 404, 409], ["tissue", "ANATOMY", 474, 480], ["nasal", "ANATOMY", 490, 495], ["nasal", "ANATOMY", 537, 542], ["organic iodide", "CHEMICAL", 241, 255], ["iodide", "CHEMICAL", 249, 255], ["iodide", "SIMPLE_CHEMICAL", 249, 255], ["nose", "ORGANISM_SUBDIVISION", 345, 349], ["skin", "ORGAN", 392, 396], ["nares", "ORGANISM_SUBDIVISION", 404, 409], ["Conidiobolus coronatus", "ORGANISM", 413, 435], ["llamas", "ORGANISM", 443, 449], ["tissue", "TISSUE", 474, 480], ["nasal", "ORGANISM_SUBDIVISION", 490, 495], ["Conidiobolus coronatus", "SPECIES", 413, 435], ["Conidiobolus coronatus", "SPECIES", 413, 435], ["endoscopic examination", "TEST", 40, 62], ["a pediatric endoscope", "TREATMENT", 68, 89], ["plain radiography", "TEST", 127, 144], ["contrast", "TREATMENT", 217, 225], ["an organic iodide", "TREATMENT", 238, 255], ["aspiration complications", "PROBLEM", 274, 298], ["each nasal passage", "TREATMENT", 318, 336], ["the nose", "TREATMENT", 341, 349], ["dorsal extension Infection", "PROBLEM", 358, 384], ["Conidiobolus coronatus in two llamas", "PROBLEM", 413, 449], ["proliferation of tissue", "PROBLEM", 457, 480], ["chronic nasal discharge", "PROBLEM", 482, 505], ["eventual occlusion of the nasal passages", "PROBLEM", 511, 551], ["aspiration", "OBSERVATION", 274, 284], ["nose", "ANATOMY", 345, 349], ["dorsal", "OBSERVATION_MODIFIER", 358, 364], ["extension", "OBSERVATION_MODIFIER", 365, 374], ["Infection", "OBSERVATION", 375, 384], ["skin", "ANATOMY", 392, 396], ["nares", "ANATOMY", 404, 409], ["proliferation", "OBSERVATION_MODIFIER", 457, 470], ["tissue", "ANATOMY", 474, 480], ["chronic", "OBSERVATION_MODIFIER", 482, 489], ["nasal", "ANATOMY", 490, 495], ["discharge", "OBSERVATION", 496, 505], ["eventual", "OBSERVATION_MODIFIER", 511, 519], ["occlusion", "OBSERVATION", 520, 529], ["nasal", "ANATOMY", 537, 542], ["passages", "OBSERVATION", 543, 551]]], ["14, 15 Conidiobolus is a tropical fungus and most common in the Gulf Coast region in the United States, but one infected llama was a lifelong resident of Illinois.", [["llama", "ORGANISM", 121, 126], ["llama", "SPECIES", 121, 126], ["a tropical fungus", "PROBLEM", 23, 40], ["tropical", "OBSERVATION_MODIFIER", 25, 33], ["fungus", "OBSERVATION", 34, 40], ["most common", "OBSERVATION_MODIFIER", 45, 56], ["Gulf", "ANATOMY_MODIFIER", 64, 68], ["Coast", "ANATOMY_MODIFIER", 69, 74], ["one", "OBSERVATION_MODIFIER", 108, 111], ["infected", "OBSERVATION", 112, 120]]], ["Diagnosis was achieved by histopathologic examination of tissue sections and fungal culture.", [["tissue sections", "ANATOMY", 57, 72], ["tissue sections", "MULTI-TISSUE_STRUCTURE", 57, 72], ["histopathologic examination", "TEST", 26, 53], ["tissue sections", "TEST", 57, 72], ["fungal culture", "TEST", 77, 91]]], ["Systemic antifungal medications have been used successfully in other species, but in the single treated llama case report, infected tissue was surgically removed after iodides and topical fungicides failed to resolve the lesion.Snake BiteAlthough snake envenomation affects several organ systems, the propensity for camelids to be bit on the lips or nose warrants the discussion here.", [["tissue", "ANATOMY", 132, 138], ["lesion", "ANATOMY", 221, 227], ["organ", "ANATOMY", 282, 287], ["lips", "ANATOMY", 342, 346], ["nose", "ANATOMY", 350, 354], ["snake envenomation", "DISEASE", 247, 265], ["iodides", "CHEMICAL", 168, 175], ["tissue", "TISSUE", 132, 138], ["iodides", "SIMPLE_CHEMICAL", 168, 175], ["organ", "ORGAN", 282, 287], ["lips", "ORGANISM_SUBDIVISION", 342, 346], ["nose", "ORGAN", 350, 354], ["Systemic antifungal medications", "TREATMENT", 0, 31], ["infected tissue", "PROBLEM", 123, 138], ["iodides", "TREATMENT", 168, 175], ["topical fungicides", "TREATMENT", 180, 198], ["the lesion", "PROBLEM", 217, 227], ["camelids", "PROBLEM", 316, 324], ["bit on the lips or nose", "PROBLEM", 331, 354], ["antifungal", "OBSERVATION", 9, 19], ["lesion", "OBSERVATION", 221, 227], ["lips", "ANATOMY", 342, 346], ["nose", "ANATOMY", 350, 354]]], ["Bites occur during seasons of snake activity, usually late spring and the summer.", [["snake", "ORGANISM_SUBDIVISION", 30, 35]]], ["Most reports involve the Western diamondback in California or the smaller prairie rattlesnake in Colorado.", [["smaller", "OBSERVATION_MODIFIER", 66, 73], ["prairie", "OBSERVATION_MODIFIER", 74, 81], ["rattlesnake", "OBSERVATION_MODIFIER", 82, 93]]], ["16, 17 The venom of these snakes contains a combination of enzymatic and nonenzymatic toxins.", [["venom", "ANATOMY", 11, 16], ["venom", "ORGANISM_SUBSTANCE", 11, 16], ["enzymatic and nonenzymatic toxins", "PROBLEM", 59, 92], ["nonenzymatic toxins", "OBSERVATION", 73, 92]]], ["The overall effects are local tissue digestion, anticoagulation, hemolysis, vasculopathy, and hypotension.", [["tissue", "ANATOMY", 30, 36], ["hemolysis", "DISEASE", 65, 74], ["vasculopathy", "DISEASE", 76, 88], ["hypotension", "DISEASE", 94, 105], ["tissue", "TISSUE", 30, 36], ["local tissue digestion", "PROBLEM", 24, 46], ["anticoagulation", "TREATMENT", 48, 63], ["hemolysis", "PROBLEM", 65, 74], ["vasculopathy", "PROBLEM", 76, 88], ["hypotension", "PROBLEM", 94, 105], ["local tissue digestion", "OBSERVATION", 24, 46], ["hemolysis", "OBSERVATION", 65, 74], ["vasculopathy", "OBSERVATION", 76, 88], ["hypotension", "OBSERVATION", 94, 105]]], ["Eastern diamondbacks have a more hemolytic effect, and the Mojave rattlesnake has a presynaptic paralytic neurotoxin.", [["hemolytic", "DISEASE", 33, 42], ["paralytic", "DISEASE", 96, 105], ["Mojave rattlesnake", "SPECIES", 59, 77], ["a more hemolytic effect", "PROBLEM", 26, 49], ["a presynaptic paralytic neurotoxin", "TREATMENT", 82, 116], ["more hemolytic", "OBSERVATION_MODIFIER", 28, 42]]], ["Neurotoxin also is present sporadically in other species of pit vipers.", [["pit vipers", "ANATOMY", 60, 70], ["Neurotoxin", "CHEMICAL", 0, 10], ["Neurotoxin", "GENE_OR_GENE_PRODUCT", 0, 10], ["pit vipers", "MULTI-TISSUE_STRUCTURE", 60, 70], ["Neurotoxin", "PROBLEM", 0, 10], ["pit vipers", "OBSERVATION", 60, 70]]], ["In addition to the venom, bites are also often contaminated with a variety of microorganisms, including Pseudomonas aerugi nosa, Clostridium, and Bacteroides fragilis.Snake BiteAffected camelids generally have severe local swelling, which, in the case of bites on the face, may cause severe lip, nose, and eyelid edema and occasionally tracks to the laryngeal region and neck.", [["venom", "ANATOMY", 19, 24], ["face", "ANATOMY", 268, 272], ["lip", "ANATOMY", 291, 294], ["nose", "ANATOMY", 296, 300], ["eyelid edema", "ANATOMY", 306, 318], ["laryngeal region", "ANATOMY", 350, 366], ["neck", "ANATOMY", 371, 375], ["swelling", "DISEASE", 223, 231], ["eyelid edema", "DISEASE", 306, 318], ["venom", "ORGANISM_SUBSTANCE", 19, 24], ["Pseudomonas aerugi nosa", "ORGANISM", 104, 127], ["Clostridium", "ORGANISM", 129, 140], ["Bacteroides fragilis", "ORGANISM", 146, 166], ["lip", "ORGAN", 291, 294], ["nose", "ORGANISM_SUBDIVISION", 296, 300], ["eyelid edema", "PATHOLOGICAL_FORMATION", 306, 318], ["laryngeal region", "MULTI-TISSUE_STRUCTURE", 350, 366], ["neck", "ORGAN", 371, 375], ["Pseudomonas aerugi nosa", "SPECIES", 104, 127], ["Bacteroides fragilis", "SPECIES", 146, 166], ["Pseudomonas aerugi nosa", "SPECIES", 104, 127], ["Bacteroides fragilis", "SPECIES", 146, 166], ["the venom", "PROBLEM", 15, 24], ["bites", "PROBLEM", 26, 31], ["a variety of microorganisms", "PROBLEM", 65, 92], ["Pseudomonas aerugi nosa", "PROBLEM", 104, 127], ["Clostridium", "PROBLEM", 129, 140], ["Bacteroides fragilis", "PROBLEM", 146, 166], ["severe local swelling", "PROBLEM", 210, 231], ["severe lip, nose", "PROBLEM", 284, 300], ["eyelid edema", "PROBLEM", 306, 318], ["venom", "ANATOMY", 19, 24], ["Bacteroides fragilis", "OBSERVATION", 146, 166], ["severe", "OBSERVATION_MODIFIER", 210, 216], ["local", "OBSERVATION_MODIFIER", 217, 222], ["swelling", "OBSERVATION", 223, 231], ["face", "ANATOMY", 268, 272], ["may cause", "UNCERTAINTY", 274, 283], ["severe", "OBSERVATION_MODIFIER", 284, 290], ["lip", "ANATOMY", 291, 294], ["nose", "ANATOMY", 296, 300], ["eyelid", "ANATOMY", 306, 312], ["edema", "OBSERVATION", 313, 318], ["laryngeal", "ANATOMY", 350, 359], ["region", "ANATOMY_MODIFIER", 360, 366], ["neck", "ANATOMY", 371, 375]]], ["Swollen areas often exude sanguinous fluid, and close inspection may reveal paired fang marks.Snake Bitein size.", [["sanguinous fluid", "ANATOMY", 26, 42], ["Swollen areas", "PROBLEM", 0, 13], ["sanguinous fluid", "PROBLEM", 26, 42], ["close inspection", "TEST", 48, 64], ["sanguinous fluid", "OBSERVATION", 26, 42], ["fang marks", "OBSERVATION", 83, 93], ["size", "OBSERVATION_MODIFIER", 107, 111]]], ["Diagnosis of the disorder is suggested by physical examination with possible endoscopic or radiographic confirmation.", [["the disorder", "PROBLEM", 13, 25], ["physical examination", "TEST", 42, 62], ["endoscopic or radiographic confirmation", "TEST", 77, 116]]], ["Surgical repair or tracheostomy may be necessary.", [["Surgical repair", "TREATMENT", 0, 15], ["tracheostomy", "TREATMENT", 19, 31], ["repair", "OBSERVATION", 9, 15], ["tracheostomy", "OBSERVATION", 19, 31]]], ["Less is known about the heritability of this disorder, although a genetic basis is suspected.Snake BiteCleft palate is relatively common in camelids, some of which also have other congenital malformations.", [["camelids", "ANATOMY", 140, 148], ["BiteCleft palate", "DISEASE", 99, 115], ["congenital malformations", "DISEASE", 180, 204], ["palate", "ORGAN", 109, 115], ["malformations", "PATHOLOGICAL_FORMATION", 191, 204], ["this disorder", "PROBLEM", 40, 53], ["other congenital malformations", "PROBLEM", 174, 204], ["palate", "ANATOMY", 109, 115], ["relatively", "OBSERVATION_MODIFIER", 119, 129], ["common", "OBSERVATION", 130, 136], ["congenital", "OBSERVATION_MODIFIER", 180, 190], ["malformations", "OBSERVATION", 191, 204]]], ["9 The airway is not specifically narrowed with this disorder.", [["airway", "ANATOMY", 6, 12], ["airway", "MULTI-TISSUE_STRUCTURE", 6, 12], ["this disorder", "PROBLEM", 47, 60], ["airway", "ANATOMY", 6, 12], ["not specifically", "UNCERTAINTY", 16, 32], ["narrowed", "OBSERVATION", 33, 41]]], ["Aspiration is the greatest danger.", [["Aspiration", "PROBLEM", 0, 10], ["greatest", "OBSERVATION_MODIFIER", 18, 26]]], ["Affected camelids frequently cough after eating and may have milk come out the nose.", [["nose", "ANATOMY", 79, 83], ["milk", "ORGANISM_SUBSTANCE", 61, 65], ["nose", "ORGANISM_SUBDIVISION", 79, 83], ["Affected camelids", "PROBLEM", 0, 17], ["cough", "PROBLEM", 29, 34], ["cough", "OBSERVATION", 29, 34], ["nose", "ANATOMY", 79, 83]]], ["Some clefts are large enough to be seen on oral examination, although many affect only the caudal palate and require endoscopy to diagnose.", [["oral", "ANATOMY", 43, 47], ["caudal palate", "ANATOMY", 91, 104], ["clefts", "DISEASE", 5, 11], ["clefts", "PATHOLOGICAL_FORMATION", 5, 11], ["oral", "ORGANISM_SUBDIVISION", 43, 47], ["caudal", "ORGAN", 91, 97], ["palate", "ORGAN", 98, 104], ["Some clefts", "PROBLEM", 0, 11], ["oral examination", "TEST", 43, 59], ["endoscopy", "TEST", 117, 126], ["clefts", "OBSERVATION", 5, 11], ["large", "OBSERVATION_MODIFIER", 16, 21], ["caudal palate", "ANATOMY", 91, 104]]], ["Surgical repair is uncommon but may be successful with the smaller clefts.", [["clefts", "DISEASE", 67, 73], ["clefts", "PATHOLOGICAL_FORMATION", 67, 73], ["Surgical repair", "TREATMENT", 0, 15], ["the smaller clefts", "PROBLEM", 55, 73], ["repair", "OBSERVATION", 9, 15], ["smaller", "OBSERVATION_MODIFIER", 59, 66], ["clefts", "OBSERVATION", 67, 73]]], ["11 Camelids with large defects tend to aspirate at a very young age, whereas those with smaller defects may thrive for a longer period.", [["large defects", "PROBLEM", 17, 30], ["smaller defects", "PROBLEM", 88, 103], ["large", "OBSERVATION_MODIFIER", 17, 22], ["defects", "OBSERVATION", 23, 30], ["aspirate", "OBSERVATION", 39, 47], ["smaller", "OBSERVATION_MODIFIER", 88, 95], ["defects", "OBSERVATION", 96, 103]]], ["No information is available concerning heritability in camelids.Fungal Rhinitis and SinusitisTrue fungal infections of the nasal passages are rare in New World camelids.", [["nasal", "ANATOMY", 123, 128], ["Rhinitis", "DISEASE", 71, 79], ["fungal infections", "DISEASE", 98, 115], ["nasal", "ORGAN", 123, 128], ["heritability in camelids", "PROBLEM", 39, 63], ["Fungal Rhinitis", "PROBLEM", 64, 79], ["Sinusitis", "PROBLEM", 84, 93], ["True fungal infections of the nasal passages", "PROBLEM", 93, 137], ["Rhinitis", "OBSERVATION", 71, 79], ["Sinusitis", "OBSERVATION", 84, 93], ["fungal", "OBSERVATION_MODIFIER", 98, 104], ["infections", "OBSERVATION", 105, 115], ["nasal", "ANATOMY", 123, 128], ["passages", "OBSERVATION", 129, 137], ["New", "OBSERVATION_MODIFIER", 150, 153]]], ["Turbinate infection by Rhizopus spp., together with nodular pneumonia and meningoencephalitis, was identified in a single llama with various cranial nerve deficits and eventually weight loss.", [["cranial nerve", "ANATOMY", 141, 154], ["infection", "DISEASE", 10, 19], ["Rhizopus spp.", "DISEASE", 23, 36], ["pneumonia", "DISEASE", 60, 69], ["meningoencephalitis", "DISEASE", 74, 93], ["cranial nerve deficits", "DISEASE", 141, 163], ["weight loss", "DISEASE", 179, 190], ["Rhizopus spp.", "ORGANISM", 23, 36], ["cranial nerve", "MULTI-TISSUE_STRUCTURE", 141, 154], ["Rhizopus spp.", "SPECIES", 23, 36], ["Rhizopus spp.", "SPECIES", 23, 36], ["Turbinate infection", "PROBLEM", 0, 19], ["Rhizopus spp.", "PROBLEM", 23, 36], ["nodular pneumonia", "PROBLEM", 52, 69], ["meningoencephalitis", "PROBLEM", 74, 93], ["various cranial nerve deficits", "PROBLEM", 133, 163], ["weight loss", "PROBLEM", 179, 190], ["infection", "OBSERVATION", 10, 19], ["nodular", "OBSERVATION_MODIFIER", 52, 59], ["pneumonia", "OBSERVATION", 60, 69], ["meningoencephalitis", "OBSERVATION", 74, 93], ["cranial nerve", "ANATOMY", 141, 154], ["deficits", "OBSERVATION", 155, 163], ["weight loss", "OBSERVATION", 179, 190]]], ["12 Sinus infection with osseous proliferation and facial deformation was associated with an Aspergillus-like organism in a llama.", [["osseous", "ANATOMY", 24, 31], ["facial", "ANATOMY", 50, 56], ["Sinus infection", "DISEASE", 3, 18], ["osseous", "TISSUE", 24, 31], ["facial", "ORGAN", 50, 56], ["12 Sinus infection", "PROBLEM", 0, 18], ["osseous proliferation", "PROBLEM", 24, 45], ["facial deformation", "PROBLEM", 50, 68], ["an Aspergillus", "PROBLEM", 89, 103], ["Sinus", "ANATOMY", 3, 8], ["infection", "OBSERVATION", 9, 18], ["osseous", "ANATOMY", 24, 31], ["proliferation", "OBSERVATION", 32, 45], ["facial", "ANATOMY", 50, 56], ["deformation", "OBSERVATION", 57, 68], ["Aspergillus", "OBSERVATION", 92, 103], ["organism", "OBSERVATION", 109, 117], ["llama", "ANATOMY", 123, 128]]], ["13 Infections of the sinus or nasal passages may be difficult to diagnose.", [["sinus", "ANATOMY", 21, 26], ["nasal", "ANATOMY", 30, 35], ["sinus", "MULTI-TISSUE_STRUCTURE", 21, 26], ["the sinus or nasal passages", "PROBLEM", 17, 44], ["Infections", "OBSERVATION", 3, 13], ["sinus", "ANATOMY", 21, 26], ["nasal", "ANATOMY", 30, 35], ["passages", "OBSERVATION", 36, 44]]], ["Most lead to bone deformation, bone lysis and proliferation, and soft tissue densities that may be seen on radiographs or cross-sectional imaging studies.", [["bone", "ANATOMY", 13, 17], ["bone", "ANATOMY", 31, 35], ["soft tissue", "ANATOMY", 65, 76], ["bone", "TISSUE", 13, 17], ["bone", "TISSUE", 31, 35], ["soft tissue", "TISSUE", 65, 76], ["bone deformation", "PROBLEM", 13, 29], ["bone lysis", "PROBLEM", 31, 41], ["proliferation", "PROBLEM", 46, 59], ["soft tissue densities", "PROBLEM", 65, 86], ["radiographs", "TEST", 107, 118], ["cross-sectional imaging studies", "TEST", 122, 153], ["bone", "ANATOMY", 13, 17], ["deformation", "OBSERVATION", 18, 29], ["bone", "ANATOMY", 31, 35], ["lysis", "OBSERVATION", 36, 41], ["proliferation", "OBSERVATION_MODIFIER", 46, 59], ["soft tissue", "OBSERVATION_MODIFIER", 65, 76], ["densities", "OBSERVATION", 77, 86], ["may be seen", "UNCERTAINTY", 92, 103]]], ["Smaller masses or those involving the airway may be identified by endoscopy.", [["masses", "ANATOMY", 8, 14], ["airway", "ANATOMY", 38, 44], ["masses", "CANCER", 8, 14], ["airway", "MULTI-TISSUE_STRUCTURE", 38, 44], ["Smaller masses", "PROBLEM", 0, 14], ["endoscopy", "TEST", 66, 75], ["masses", "OBSERVATION", 8, 14], ["airway", "ANATOMY", 38, 44], ["may be", "UNCERTAINTY", 45, 51]]], ["Biopsy with or without fungal culture is necessary to distinguish these masses from tumors. not been explored extensively.", [["masses", "ANATOMY", 72, 78], ["tumors", "ANATOMY", 84, 90], ["tumors", "DISEASE", 84, 90], ["masses", "CANCER", 72, 78], ["tumors", "CANCER", 84, 90], ["Biopsy", "TEST", 0, 6], ["fungal culture", "TEST", 23, 37], ["these masses", "PROBLEM", 66, 78], ["tumors", "PROBLEM", 84, 90], ["masses", "OBSERVATION", 72, 78], ["tumors", "OBSERVATION", 84, 90]]], ["It appears to improve survival in most species but usually must be given within hours of envenomation.", [["envenomation", "DISEASE", 89, 101], ["envenomation", "PROBLEM", 89, 101], ["most species", "OBSERVATION_MODIFIER", 34, 46], ["envenomation", "OBSERVATION", 89, 101]]], ["In one report, a camelid appeared to have an anaphylactic reaction to equine-derived antivenin.", [["anaphylactic reaction", "DISEASE", 45, 66], ["antivenin", "CHEMICAL", 85, 94], ["equine", "ORGANISM", 70, 76], ["antivenin", "SIMPLE_CHEMICAL", 85, 94], ["an anaphylactic reaction", "PROBLEM", 42, 66], ["antivenin", "TREATMENT", 85, 94], ["anaphylactic", "OBSERVATION", 45, 57]]], ["16 Use of ovine-derived antivenin has not been reported.Fungal Rhinitis and SinusitisReported survival of moderate to severely affected camelids is about 50%.", [["antivenin", "CHEMICAL", 24, 33], ["Rhinitis", "DISEASE", 63, 71], ["camelids", "DISEASE", 136, 144], ["antivenin", "CHEMICAL", 24, 33], ["ovine", "ORGANISM", 10, 15], ["antivenin", "GENE_OR_GENE_PRODUCT", 24, 33], ["antivenin", "PROTEIN", 24, 33], ["ovine-derived antivenin", "TREATMENT", 10, 33], ["Fungal Rhinitis", "PROBLEM", 56, 71], ["moderate to severely affected camelids", "PROBLEM", 106, 144], ["Rhinitis", "OBSERVATION", 63, 71], ["moderate", "OBSERVATION_MODIFIER", 106, 114], ["severely", "OBSERVATION_MODIFIER", 118, 126], ["affected", "OBSERVATION_MODIFIER", 127, 135], ["camelids", "OBSERVATION", 136, 144]]], ["Death occurs secondary to cardiopulmonary failure, asphyxiation, or septic shock.", [["cardiopulmonary", "ANATOMY", 26, 41], ["Death", "DISEASE", 0, 5], ["cardiopulmonary failure", "DISEASE", 26, 49], ["asphyxiation", "DISEASE", 51, 63], ["septic shock", "DISEASE", 68, 80], ["Death", "PROBLEM", 0, 5], ["cardiopulmonary failure", "PROBLEM", 26, 49], ["asphyxiation", "PROBLEM", 51, 63], ["septic shock", "PROBLEM", 68, 80], ["cardiopulmonary", "ANATOMY", 26, 41], ["failure", "OBSERVATION", 42, 49], ["asphyxiation", "OBSERVATION", 51, 63], ["septic shock", "OBSERVATION", 68, 80]]], ["Necropsies have revealed extensive local necrosis, hemorrhage, edema, and congestion, laryngeal edema, third-compartment ulceration with possible perforation, intestinal thrombosis, multifocal ecchymoses, pneumonia, endocarditis, pericarditis, myocarditis, peritonitis, hepatic lipidosis, and hemorrhage, edema, or congestion of a variety of internal organs.Fungal Rhinitis and SinusitisThe possibility of survival is higher in less severely affected camelids.", [["edema", "ANATOMY", 63, 68], ["laryngeal", "ANATOMY", 86, 95], ["intestinal", "ANATOMY", 159, 169], ["hepatic", "ANATOMY", 270, 277], ["edema", "ANATOMY", 305, 310], ["organs", "ANATOMY", 351, 357], ["camelids", "ANATOMY", 451, 459], ["necrosis", "DISEASE", 41, 49], ["hemorrhage", "DISEASE", 51, 61], ["edema", "DISEASE", 63, 68], ["congestion", "DISEASE", 74, 84], ["laryngeal edema", "DISEASE", 86, 101], ["perforation", "DISEASE", 146, 157], ["intestinal thrombosis", "DISEASE", 159, 180], ["ecchymoses", "DISEASE", 193, 203], ["pneumonia", "DISEASE", 205, 214], ["endocarditis", "DISEASE", 216, 228], ["pericarditis", "DISEASE", 230, 242], ["myocarditis", "DISEASE", 244, 255], ["peritonitis", "DISEASE", 257, 268], ["hepatic lipidosis", "DISEASE", 270, 287], ["hemorrhage", "DISEASE", 293, 303], ["edema", "DISEASE", 305, 310], ["Rhinitis", "DISEASE", 365, 373], ["edema", "PATHOLOGICAL_FORMATION", 63, 68], ["laryngeal edema", "PATHOLOGICAL_FORMATION", 86, 101], ["intestinal", "ORGAN", 159, 169], ["hepatic", "ORGAN", 270, 277], ["edema", "PATHOLOGICAL_FORMATION", 305, 310], ["organs", "ORGAN", 351, 357], ["camelids", "CANCER", 451, 459], ["Necropsies", "TEST", 0, 10], ["extensive local necrosis", "PROBLEM", 25, 49], ["hemorrhage", "PROBLEM", 51, 61], ["edema", "PROBLEM", 63, 68], ["congestion", "PROBLEM", 74, 84], ["laryngeal edema", "PROBLEM", 86, 101], ["third-compartment ulceration", "PROBLEM", 103, 131], ["perforation", "PROBLEM", 146, 157], ["intestinal thrombosis", "PROBLEM", 159, 180], ["multifocal ecchymoses", "PROBLEM", 182, 203], ["pneumonia", "PROBLEM", 205, 214], ["endocarditis", "PROBLEM", 216, 228], ["pericarditis", "PROBLEM", 230, 242], ["myocarditis", "PROBLEM", 244, 255], ["peritonitis", "PROBLEM", 257, 268], ["hepatic lipidosis", "PROBLEM", 270, 287], ["hemorrhage", "PROBLEM", 293, 303], ["edema", "PROBLEM", 305, 310], ["congestion", "PROBLEM", 315, 325], ["a variety of internal organs", "PROBLEM", 329, 357], ["Fungal Rhinitis", "PROBLEM", 358, 373], ["Sinusitis", "PROBLEM", 378, 387], ["survival", "PROBLEM", 406, 414], ["extensive", "OBSERVATION_MODIFIER", 25, 34], ["local", "OBSERVATION_MODIFIER", 35, 40], ["necrosis", "OBSERVATION", 41, 49], ["hemorrhage", "OBSERVATION", 51, 61], ["edema", "OBSERVATION", 63, 68], ["congestion", "OBSERVATION", 74, 84], ["laryngeal", "ANATOMY", 86, 95], ["edema", "OBSERVATION", 96, 101], ["compartment", "ANATOMY", 109, 120], ["ulceration", "OBSERVATION", 121, 131], ["possible", "UNCERTAINTY", 137, 145], ["perforation", "OBSERVATION", 146, 157], ["intestinal", "ANATOMY", 159, 169], ["thrombosis", "OBSERVATION", 170, 180], ["multifocal", "OBSERVATION_MODIFIER", 182, 192], ["ecchymoses", "OBSERVATION", 193, 203], ["pneumonia", "OBSERVATION", 205, 214], ["endocarditis", "OBSERVATION", 216, 228], ["pericarditis", "OBSERVATION", 230, 242], ["myocarditis", "OBSERVATION", 244, 255], ["peritonitis", "OBSERVATION", 257, 268], ["hepatic", "ANATOMY", 270, 277], ["lipidosis", "OBSERVATION", 278, 287], ["hemorrhage", "OBSERVATION", 293, 303], ["edema", "OBSERVATION", 305, 310], ["congestion", "OBSERVATION", 315, 325], ["variety", "OBSERVATION_MODIFIER", 331, 338], ["internal", "ANATOMY_MODIFIER", 342, 350], ["organs", "ANATOMY", 351, 357], ["Rhinitis", "OBSERVATION", 365, 373], ["Sinusitis", "OBSERVATION", 378, 387], ["possibility of", "UNCERTAINTY", 391, 405], ["survival", "OBSERVATION", 406, 414], ["higher", "OBSERVATION_MODIFIER", 418, 424], ["less severely", "OBSERVATION_MODIFIER", 428, 441]]], ["A proportion of snakebites results in little to no venom injection and hence may result in minor clinical signs or may never be noticed.", [["venom", "ANATOMY", 51, 56], ["snakebites", "DISEASE", 16, 26], ["venom", "ORGANISM_SUBSTANCE", 51, 56], ["snakebites", "PROBLEM", 16, 26], ["venom injection", "TREATMENT", 51, 66], ["minor clinical signs", "PROBLEM", 91, 111], ["snakebites", "OBSERVATION", 16, 26]]], ["Prevention revolves around avoiding contact between camelids and venomous snakes.", [["venomous snakes", "PROBLEM", 65, 80]]], ["One report infers that bites occur overnight or in the morning, which suggests a preventative role to housing camelids overnight.SinusitisNonfungal sinusitis in New World camelids usually occurs secondary to a maxillary tooth root abscess.", [["maxillary tooth root abscess", "ANATOMY", 210, 238], ["Sinusitis", "DISEASE", 129, 138], ["sinusitis", "DISEASE", 148, 157], ["maxillary tooth root abscess", "DISEASE", 210, 238], ["Sinusitis", "PROBLEM", 129, 138], ["Nonfungal sinusitis", "PROBLEM", 138, 157], ["a maxillary tooth root abscess", "PROBLEM", 208, 238], ["sinusitis", "OBSERVATION", 148, 157], ["maxillary", "ANATOMY_MODIFIER", 210, 219], ["tooth", "ANATOMY", 220, 225], ["root", "ANATOMY_MODIFIER", 226, 230], ["abscess", "OBSERVATION", 231, 238]]], ["Oestrus ovis infestation is another possibility.", [["Oestrus ovis infestation", "DISEASE", 0, 24], ["Oestrus ovis", "ORGANISM", 0, 12], ["Oestrus ovis", "SPECIES", 0, 12], ["Oestrus ovis", "SPECIES", 0, 12], ["Oestrus ovis infestation", "PROBLEM", 0, 24], ["another possibility", "UNCERTAINTY", 28, 47]]], ["The airway is affected by discharge from the primary lesion and by remodeling of bone that encroaches on the airway.", [["airway", "ANATOMY", 4, 10], ["primary lesion", "ANATOMY", 45, 59], ["bone", "ANATOMY", 81, 85], ["airway", "ANATOMY", 109, 115], ["airway", "MULTI-TISSUE_STRUCTURE", 4, 10], ["lesion", "CANCER", 53, 59], ["bone", "TISSUE", 81, 85], ["airway", "MULTI-TISSUE_STRUCTURE", 109, 115], ["the primary lesion", "PROBLEM", 41, 59], ["remodeling of bone", "PROBLEM", 67, 85], ["airway", "ANATOMY", 4, 10], ["primary", "OBSERVATION_MODIFIER", 45, 52], ["lesion", "OBSERVATION", 53, 59], ["bone", "ANATOMY", 81, 85], ["airway", "ANATOMY", 109, 115]]], ["Characteristically, mucopurulent nasal discharge is unilateral, and nasal air flow is reduced on the affected side.", [["nasal", "ANATOMY", 33, 38], ["nasal", "ANATOMY", 68, 73], ["nasal", "ORGAN", 33, 38], ["mucopurulent nasal discharge", "PROBLEM", 20, 48], ["nasal air flow", "PROBLEM", 68, 82], ["mucopurulent", "OBSERVATION_MODIFIER", 20, 32], ["nasal", "ANATOMY", 33, 38], ["discharge", "OBSERVATION", 39, 48], ["unilateral", "OBSERVATION_MODIFIER", 52, 62], ["nasal", "ANATOMY", 68, 73], ["air flow", "OBSERVATION", 74, 82], ["reduced", "OBSERVATION_MODIFIER", 86, 93]]], ["Distortion of facial symmetry and draining tracts on the side of the face may develop.", [["facial", "ANATOMY", 14, 20], ["draining tracts", "ANATOMY", 34, 49], ["face", "ANATOMY", 69, 73], ["draining tracts", "MULTI-TISSUE_STRUCTURE", 34, 49], ["Distortion of facial symmetry", "PROBLEM", 0, 29], ["draining tracts", "PROBLEM", 34, 49], ["facial", "ANATOMY", 14, 20], ["symmetry", "OBSERVATION", 21, 29], ["draining", "OBSERVATION", 34, 42], ["tracts", "OBSERVATION_MODIFIER", 43, 49], ["face", "ANATOMY", 69, 73]]], ["Other findings are reviewed in the section on tooth root abscesses.", [["tooth root abscesses", "ANATOMY", 46, 66], ["tooth root abscesses", "DISEASE", 46, 66], ["tooth root", "MULTI-TISSUE_STRUCTURE", 46, 56], ["abscesses", "PATHOLOGICAL_FORMATION", 57, 66], ["tooth root abscesses", "PROBLEM", 46, 66], ["root", "ANATOMY", 52, 56], ["abscesses", "OBSERVATION", 57, 66]]], ["Radiography is the best way to diagnose the disorder and confirm the infected tooth.", [["tooth", "ANATOMY", 78, 83], ["infected tooth", "DISEASE", 69, 83], ["tooth", "ORGAN", 78, 83], ["Radiography", "TEST", 0, 11], ["the disorder", "PROBLEM", 40, 52], ["the infected tooth", "PROBLEM", 65, 83], ["infected tooth", "OBSERVATION", 69, 83]]], ["Removal of the infected tooth and establishment of drainage usually lead to resolution of the sinus lesions.NeoplasiaAirway tumors are rare in camelids.", [["tooth", "ANATOMY", 24, 29], ["sinus lesions", "ANATOMY", 94, 107], ["NeoplasiaAirway tumors", "ANATOMY", 108, 130], ["camelids", "ANATOMY", 143, 151], ["sinus lesions", "DISEASE", 94, 107], ["NeoplasiaAirway tumors", "DISEASE", 108, 130], ["tooth", "ORGAN", 24, 29], ["sinus lesions", "PATHOLOGICAL_FORMATION", 94, 107], ["NeoplasiaAirway tumors", "CANCER", 108, 130], ["camelids", "CANCER", 143, 151], ["Removal", "TREATMENT", 0, 7], ["the infected tooth", "PROBLEM", 11, 29], ["drainage", "TREATMENT", 51, 59], ["the sinus lesions", "PROBLEM", 90, 107], ["NeoplasiaAirway tumors", "PROBLEM", 108, 130], ["infected tooth", "OBSERVATION", 15, 29], ["drainage", "OBSERVATION", 51, 59], ["resolution", "OBSERVATION_MODIFIER", 76, 86], ["sinus", "ANATOMY", 94, 99], ["lesions", "OBSERVATION", 100, 107], ["tumors", "OBSERVATION", 124, 130]]], ["Fibrosarcoma was identified in one elderly alpaca, in which the tumor arose from the anterior aspect of the nasal septum and led to near-occlusion of one nostril.", [["Fibrosarcoma", "ANATOMY", 0, 12], ["tumor", "ANATOMY", 64, 69], ["anterior aspect", "ANATOMY", 85, 100], ["nasal septum", "ANATOMY", 108, 120], ["nostril", "ANATOMY", 154, 161], ["Fibrosarcoma", "DISEASE", 0, 12], ["tumor", "DISEASE", 64, 69], ["Fibrosarcoma", "CANCER", 0, 12], ["alpaca", "ORGANISM", 43, 49], ["tumor", "CANCER", 64, 69], ["anterior aspect", "MULTI-TISSUE_STRUCTURE", 85, 100], ["nasal septum", "MULTI-TISSUE_STRUCTURE", 108, 120], ["nostril", "ORGAN", 154, 161], ["Fibrosarcoma", "PROBLEM", 0, 12], ["the tumor", "PROBLEM", 60, 69], ["tumor", "OBSERVATION", 64, 69], ["anterior", "ANATOMY_MODIFIER", 85, 93], ["nasal septum", "ANATOMY", 108, 120], ["occlusion", "OBSERVATION", 137, 146], ["one nostril", "ANATOMY_MODIFIER", 150, 161]]], ["Additionally, a variety of tumors arising from the digestive structures of the mouth may affect the airway by their presence.", [["tumors", "ANATOMY", 27, 33], ["digestive structures", "ANATOMY", 51, 71], ["mouth", "ANATOMY", 79, 84], ["airway", "ANATOMY", 100, 106], ["tumors", "DISEASE", 27, 33], ["tumors", "CANCER", 27, 33], ["digestive structures", "MULTI-TISSUE_STRUCTURE", 51, 71], ["mouth", "ORGAN", 79, 84], ["airway", "MULTI-TISSUE_STRUCTURE", 100, 106], ["tumors", "PROBLEM", 27, 33], ["variety", "OBSERVATION_MODIFIER", 16, 23], ["tumors", "OBSERVATION", 27, 33], ["digestive", "ANATOMY_MODIFIER", 51, 60], ["mouth", "ANATOMY", 79, 84], ["airway", "ANATOMY", 100, 106]]], ["These include squamous cell carcinomas, odontogenic neoplasms, and ossifying fibromas that appear to arise from a tooth.", [["squamous cell carcinomas", "ANATOMY", 14, 38], ["odontogenic neoplasms", "ANATOMY", 40, 61], ["ossifying fibromas", "ANATOMY", 67, 85], ["tooth", "ANATOMY", 114, 119], ["squamous cell carcinomas", "DISEASE", 14, 38], ["odontogenic neoplasms", "DISEASE", 40, 61], ["ossifying fibromas", "DISEASE", 67, 85], ["squamous cell carcinomas", "CANCER", 14, 38], ["odontogenic neoplasms", "CANCER", 40, 61], ["ossifying fibromas", "CANCER", 67, 85], ["tooth", "ORGAN", 114, 119], ["squamous cell carcinomas", "PROBLEM", 14, 38], ["odontogenic neoplasms", "PROBLEM", 40, 61], ["ossifying fibromas", "PROBLEM", 67, 85], ["a tooth", "PROBLEM", 112, 119], ["squamous cell carcinomas", "OBSERVATION", 14, 38], ["odontogenic neoplasms", "OBSERVATION", 40, 61], ["ossifying", "OBSERVATION_MODIFIER", 67, 76], ["fibromas", "OBSERVATION", 77, 85], ["tooth", "ANATOMY", 114, 119]]], ["18, 19 If masses encroach on the airway, unilateral mucopurulent nasal discharge, reduced nasal airflow, and gross distortion of the face or nasal passages may be present.", [["masses", "ANATOMY", 10, 16], ["airway", "ANATOMY", 33, 39], ["nasal", "ANATOMY", 65, 70], ["nasal", "ANATOMY", 90, 95], ["face", "ANATOMY", 133, 137], ["nasal", "ANATOMY", 141, 146], ["airway", "MULTI-TISSUE_STRUCTURE", 33, 39], ["nasal", "ORGANISM_SUBDIVISION", 65, 70], ["nasal", "ORGANISM_SUBDIVISION", 90, 95], ["masses encroach on the airway", "PROBLEM", 10, 39], ["unilateral mucopurulent nasal discharge", "PROBLEM", 41, 80], ["reduced nasal airflow", "PROBLEM", 82, 103], ["gross distortion of the face or nasal passages", "PROBLEM", 109, 155], ["masses", "OBSERVATION", 10, 16], ["airway", "ANATOMY", 33, 39], ["unilateral", "OBSERVATION_MODIFIER", 41, 51], ["mucopurulent", "OBSERVATION_MODIFIER", 52, 64], ["nasal", "ANATOMY", 65, 70], ["discharge", "OBSERVATION", 71, 80], ["reduced", "OBSERVATION_MODIFIER", 82, 89], ["nasal airflow", "OBSERVATION", 90, 103], ["gross", "OBSERVATION_MODIFIER", 109, 114], ["distortion", "OBSERVATION_MODIFIER", 115, 125], ["face", "ANATOMY", 133, 137], ["nasal", "ANATOMY", 141, 146], ["passages", "OBSERVATION", 147, 155]]], ["Radiography, endoscopy, or advanced imaging techniques may be used to diagnose and observe the extent of the mass.", [["Radiography", "TEST", 0, 11], ["endoscopy", "TEST", 13, 22], ["advanced imaging techniques", "TEST", 27, 54], ["the mass", "PROBLEM", 105, 113], ["mass", "OBSERVATION", 109, 113]]], ["Biopsy is necessary to confirm the tissue type.", [["tissue", "ANATOMY", 35, 41], ["tissue", "TISSUE", 35, 41], ["Biopsy", "TEST", 0, 6]]], ["Treatment usually involves resection, with or without postoperative chemotherapy.NeoplasiaLymphoma or malignant round cell tumor compressing the trachea has been described in a llama and an alpaca.", [["NeoplasiaLymphoma", "ANATOMY", 81, 98], ["malignant round cell tumor", "ANATOMY", 102, 128], ["trachea", "ANATOMY", 145, 152], ["NeoplasiaLymphoma", "DISEASE", 81, 98], ["malignant round cell tumor", "DISEASE", 102, 128], ["NeoplasiaLymphoma", "CANCER", 81, 98], ["malignant round cell tumor", "CANCER", 102, 128], ["trachea", "ORGAN", 145, 152], ["llama", "ORGANISM", 177, 182], ["alpaca", "ORGANISM", 190, 196], ["Treatment", "TREATMENT", 0, 9], ["resection", "TREATMENT", 27, 36], ["postoperative chemotherapy", "TREATMENT", 54, 80], ["NeoplasiaLymphoma", "PROBLEM", 81, 98], ["malignant round cell tumor", "PROBLEM", 102, 128], ["resection", "OBSERVATION", 27, 36], ["malignant", "OBSERVATION_MODIFIER", 102, 111], ["round cell tumor", "OBSERVATION", 112, 128], ["trachea", "ANATOMY", 145, 152], ["alpaca", "OBSERVATION", 190, 196]]], ["3, 20 Both were 7 to 8 years old, older than the median age for camelids with lymphoma.", [["lymphoma", "ANATOMY", 78, 86], ["lymphoma", "DISEASE", 78, 86], ["lymphoma", "CANCER", 78, 86], ["lymphoma", "PROBLEM", 78, 86], ["lymphoma", "OBSERVATION", 78, 86]]], ["In the llama, a cervical node was palpably enlarged, but the mass was entirely intrathoracic in the alpaca.", [["cervical node", "ANATOMY", 16, 29], ["mass", "ANATOMY", 61, 65], ["llama", "ORGANISM", 7, 12], ["cervical node", "MULTI-TISSUE_STRUCTURE", 16, 29], ["alpaca", "ORGANISM", 100, 106], ["the mass", "PROBLEM", 57, 65], ["intrathoracic in the alpaca", "PROBLEM", 79, 106], ["llama", "ANATOMY_MODIFIER", 7, 12], ["cervical", "ANATOMY", 16, 24], ["node", "OBSERVATION", 25, 29], ["enlarged", "OBSERVATION_MODIFIER", 43, 51], ["mass", "OBSERVATION", 61, 65], ["intrathoracic", "OBSERVATION", 79, 92], ["alpaca", "OBSERVATION", 100, 106]]], ["In addition to the typical signs of emaciation and Hemorrhagic diathesis appears to be more common in camelids bit in Colorado than in California.", [["emaciation", "DISEASE", 36, 46], ["Hemorrhagic diathesis", "DISEASE", 51, 72], ["emaciation", "PROBLEM", 36, 46], ["Hemorrhagic diathesis", "PROBLEM", 51, 72], ["emaciation", "OBSERVATION", 36, 46], ["Hemorrhagic", "OBSERVATION_MODIFIER", 51, 62], ["diathesis", "OBSERVATION", 63, 72], ["appears to be", "UNCERTAINTY", 73, 86], ["more common", "OBSERVATION_MODIFIER", 87, 98]]], ["Swelling may also occlude air flow, leading to dyspnea, nostril flare, stridor, and tachypnea and cause dysphagia.", [["nostril", "ANATOMY", 56, 63], ["Swelling", "DISEASE", 0, 8], ["dyspnea", "DISEASE", 47, 54], ["stridor", "DISEASE", 71, 78], ["tachypnea", "DISEASE", 84, 93], ["dysphagia", "DISEASE", 104, 113], ["nostril", "ORGANISM_SUBDIVISION", 56, 63], ["Swelling", "PROBLEM", 0, 8], ["air flow", "PROBLEM", 26, 34], ["dyspnea", "PROBLEM", 47, 54], ["nostril flare", "PROBLEM", 56, 69], ["stridor", "PROBLEM", 71, 78], ["tachypnea", "PROBLEM", 84, 93], ["dysphagia", "PROBLEM", 104, 113], ["air flow", "OBSERVATION", 26, 34], ["dyspnea", "OBSERVATION", 47, 54], ["nostril", "ANATOMY", 56, 63], ["flare", "OBSERVATION", 64, 69], ["stridor", "OBSERVATION", 71, 78]]], ["Systemic signs of envenomation include bruxism, signs of shock, hyperthermia, tachycardia, cardiac arrhythmias, recumbency, lethargy, ileus, and anorexia.", [["cardiac", "ANATOMY", 91, 98], ["envenomation", "DISEASE", 18, 30], ["bruxism", "DISEASE", 39, 46], ["shock", "DISEASE", 57, 62], ["hyperthermia", "DISEASE", 64, 76], ["tachycardia", "DISEASE", 78, 89], ["cardiac arrhythmias", "DISEASE", 91, 110], ["lethargy", "DISEASE", 124, 132], ["ileus", "DISEASE", 134, 139], ["anorexia", "DISEASE", 145, 153], ["envenomation", "PROBLEM", 18, 30], ["bruxism", "PROBLEM", 39, 46], ["shock", "PROBLEM", 57, 62], ["hyperthermia", "PROBLEM", 64, 76], ["tachycardia", "PROBLEM", 78, 89], ["cardiac arrhythmias", "PROBLEM", 91, 110], ["recumbency", "PROBLEM", 112, 122], ["lethargy", "PROBLEM", 124, 132], ["ileus", "PROBLEM", 134, 139], ["anorexia", "PROBLEM", 145, 153], ["envenomation", "OBSERVATION", 18, 30], ["bruxism", "OBSERVATION", 39, 46], ["shock", "OBSERVATION", 57, 62], ["hyperthermia", "OBSERVATION", 64, 76], ["tachycardia", "OBSERVATION", 78, 89], ["cardiac", "ANATOMY", 91, 98], ["arrhythmias", "OBSERVATION", 99, 110], ["recumbency", "OBSERVATION_MODIFIER", 112, 122], ["lethargy", "OBSERVATION", 124, 132], ["ileus", "OBSERVATION", 134, 139], ["anorexia", "OBSERVATION", 145, 153]]], ["Further obtundation and other neurologic signs, respiratory signs, and colic may occur with progression of envenomation.", [["neurologic", "ANATOMY", 30, 40], ["respiratory", "ANATOMY", 48, 59], ["respiratory signs", "DISEASE", 48, 65], ["colic", "DISEASE", 71, 76], ["envenomation", "DISEASE", 107, 119], ["Further obtundation", "PROBLEM", 0, 19], ["other neurologic signs", "TEST", 24, 46], ["respiratory signs", "PROBLEM", 48, 65], ["colic", "PROBLEM", 71, 76], ["envenomation", "PROBLEM", 107, 119], ["obtundation", "OBSERVATION", 8, 19], ["respiratory", "ANATOMY", 48, 59], ["signs", "OBSERVATION", 60, 65], ["colic", "OBSERVATION", 71, 76], ["envenomation", "OBSERVATION", 107, 119]]], ["Obviously, if the bite is on another part of the body such as a leg, signs referable to that body part will be present, possibly in the absence of respiratory signs.", [["body", "ANATOMY", 49, 53], ["leg", "ANATOMY", 64, 67], ["body", "ANATOMY", 93, 97], ["respiratory", "ANATOMY", 147, 158], ["respiratory signs", "DISEASE", 147, 164], ["body", "ORGANISM_SUBDIVISION", 49, 53], ["leg", "ORGANISM_SUBDIVISION", 64, 67], ["body", "ORGANISM_SUBDIVISION", 93, 97], ["the bite", "PROBLEM", 14, 22], ["respiratory signs", "PROBLEM", 147, 164], ["leg", "ANATOMY", 64, 67]]], ["Local signs often worsen over the first 48 to 96 hours.NeoplasiaAlthough not yet described, Mojave rattlesnake bites would be likely to cause much less severe local inflammation, but they cause progressive neuromuscular weakness and respiratory paralysis.NeoplasiaBlood examination reveals evidence of stress, inflammation, muscle damage, and possibly cardiopulmonary or renal failure.", [["neuromuscular", "ANATOMY", 206, 219], ["respiratory", "ANATOMY", 233, 244], ["muscle", "ANATOMY", 324, 330], ["renal", "ANATOMY", 371, 376], ["rattlesnake bites", "DISEASE", 99, 116], ["inflammation", "DISEASE", 165, 177], ["neuromuscular weakness", "DISEASE", 206, 228], ["respiratory paralysis", "DISEASE", 233, 254], ["inflammation", "DISEASE", 310, 322], ["muscle damage", "DISEASE", 324, 337], ["cardiopulmonary or renal failure", "DISEASE", 352, 384], ["muscle", "ORGAN", 324, 330], ["renal", "ORGAN", 371, 376], ["Mojave rattlesnake bites", "SPECIES", 92, 116], ["Local signs", "PROBLEM", 0, 11], ["Mojave rattlesnake bites", "PROBLEM", 92, 116], ["much less severe local inflammation", "PROBLEM", 142, 177], ["progressive neuromuscular weakness", "PROBLEM", 194, 228], ["respiratory paralysis", "PROBLEM", 233, 254], ["NeoplasiaBlood examination", "TEST", 255, 281], ["stress", "PROBLEM", 302, 308], ["inflammation", "PROBLEM", 310, 322], ["muscle damage", "PROBLEM", 324, 337], ["cardiopulmonary or renal failure", "PROBLEM", 352, 384], ["worsen", "OBSERVATION_MODIFIER", 18, 24], ["severe", "OBSERVATION_MODIFIER", 152, 158], ["local", "OBSERVATION_MODIFIER", 159, 164], ["inflammation", "OBSERVATION", 165, 177], ["progressive", "OBSERVATION_MODIFIER", 194, 205], ["neuromuscular", "ANATOMY", 206, 219], ["weakness", "OBSERVATION", 220, 228], ["respiratory paralysis", "OBSERVATION", 233, 254], ["evidence of", "UNCERTAINTY", 290, 301], ["stress", "OBSERVATION", 302, 308], ["inflammation", "OBSERVATION", 310, 322], ["muscle", "ANATOMY", 324, 330], ["damage", "OBSERVATION", 331, 337], ["possibly", "UNCERTAINTY", 343, 351], ["cardiopulmonary", "ANATOMY", 352, 367], ["renal", "ANATOMY", 371, 376], ["failure", "OBSERVATION", 377, 384]]], ["Neutrophilia and neutropenia are both possible, usually with concurrent left shift and lymphopenia.", [["Neutrophilia", "DISEASE", 0, 12], ["neutropenia", "DISEASE", 17, 28], ["lymphopenia", "DISEASE", 87, 98], ["Neutrophilia", "PROBLEM", 0, 12], ["neutropenia", "PROBLEM", 17, 28], ["concurrent left shift", "PROBLEM", 61, 82], ["lymphopenia", "PROBLEM", 87, 98], ["neutropenia", "OBSERVATION", 17, 28], ["left", "ANATOMY_MODIFIER", 72, 76], ["shift", "OBSERVATION", 77, 82], ["lymphopenia", "OBSERVATION", 87, 98]]], ["Anemia, thrombocytopenia, and hypofibrinogenemia may also be seen.", [["Anemia", "DISEASE", 0, 6], ["thrombocytopenia", "DISEASE", 8, 24], ["hypofibrinogenemia", "DISEASE", 30, 48], ["Anemia", "PROBLEM", 0, 6], ["thrombocytopenia", "PROBLEM", 8, 24], ["hypofibrinogenemia", "PROBLEM", 30, 48], ["thrombocytopenia", "OBSERVATION", 8, 24], ["hypofibrinogenemia", "OBSERVATION", 30, 48], ["may also be seen", "UNCERTAINTY", 49, 65]]], ["As with other camelid diseases, hypoalbuminemia, hyperglycemia, and hypokalemia are common.", [["camelid diseases", "DISEASE", 14, 30], ["hypoalbuminemia", "DISEASE", 32, 47], ["hyperglycemia", "DISEASE", 49, 62], ["hypokalemia", "DISEASE", 68, 79], ["other camelid diseases", "PROBLEM", 8, 30], ["hypoalbuminemia", "PROBLEM", 32, 47], ["hyperglycemia", "PROBLEM", 49, 62], ["hypokalemia", "PROBLEM", 68, 79], ["hypoalbuminemia", "OBSERVATION", 32, 47], ["hyperglycemia", "OBSERVATION", 49, 62], ["hypokalemia", "OBSERVATION", 68, 79]]], ["Increases in muscle enzymes are often dramatic and may be accompanied by increases in liver enzymes.", [["muscle", "ANATOMY", 13, 19], ["liver", "ANATOMY", 86, 91], ["muscle", "ORGAN", 13, 19], ["liver", "ORGAN", 86, 91], ["muscle enzymes", "PROTEIN", 13, 27], ["liver enzymes", "PROTEIN", 86, 99], ["Increases in muscle enzymes", "PROBLEM", 0, 27], ["increases in liver enzymes", "PROBLEM", 73, 99], ["muscle", "ANATOMY", 13, 19], ["may be", "UNCERTAINTY", 51, 57], ["increases", "OBSERVATION_MODIFIER", 73, 82], ["liver", "ANATOMY", 86, 91]]], ["Azotemia and acidosis are common in more severely affected camelids.", [["camelids", "ANATOMY", 59, 67], ["Azotemia", "DISEASE", 0, 8], ["acidosis", "DISEASE", 13, 21], ["camelids", "CANCER", 59, 67], ["Azotemia", "PROBLEM", 0, 8], ["acidosis", "PROBLEM", 13, 21], ["severely affected camelids", "PROBLEM", 41, 67], ["acidosis", "OBSERVATION", 13, 21], ["more severely", "OBSERVATION_MODIFIER", 36, 49], ["affected", "OBSERVATION_MODIFIER", 50, 58], ["camelids", "OBSERVATION", 59, 67]]], ["Coagulation profiles may reveal the hypocoagulable state.NeoplasiaTreatment may be multimodal and extensive.", [["NeoplasiaTreatment", "DISEASE", 57, 75], ["Coagulation profiles", "TEST", 0, 20], ["the hypocoagulable state", "PROBLEM", 32, 56], ["NeoplasiaTreatment", "TREATMENT", 57, 75], ["hypocoagulable state", "OBSERVATION", 36, 56], ["may be", "UNCERTAINTY", 76, 82], ["multimodal", "OBSERVATION_MODIFIER", 83, 93], ["extensive", "OBSERVATION_MODIFIER", 98, 107]]], ["Airway preservation is often the primary goal and may be achieved through nasotracheal intubation or tracheostomy in severely affected camelids.", [["Airway", "ANATOMY", 0, 6], ["nasotracheal", "ANATOMY", 74, 86], ["camelids", "ANATOMY", 135, 143], ["Airway", "MULTI-TISSUE_STRUCTURE", 0, 6], ["Airway preservation", "TREATMENT", 0, 19], ["nasotracheal intubation", "TREATMENT", 74, 97], ["tracheostomy", "TREATMENT", 101, 113], ["severely affected camelids", "PROBLEM", 117, 143], ["tracheostomy", "OBSERVATION", 101, 113]]], ["Characteristically, tracheostomy sites or other skin breaks bleed persistently.", [["tracheostomy sites", "ANATOMY", 20, 38], ["skin", "ANATOMY", 48, 52], ["skin", "ORGAN", 48, 52], ["tracheostomy sites", "TREATMENT", 20, 38], ["other skin breaks bleed", "PROBLEM", 42, 65], ["tracheostomy sites", "OBSERVATION", 20, 38], ["skin", "ANATOMY", 48, 52], ["breaks", "OBSERVATION_MODIFIER", 53, 59], ["bleed", "OBSERVATION", 60, 65]]], ["Because of the progression of lesions, camelids not requiring immediate airway intervention should still be kept under observation, in case some future intervention is necessary.", [["lesions", "ANATOMY", 30, 37], ["camelids", "ANATOMY", 39, 47], ["airway", "ANATOMY", 72, 78], ["lesions", "PATHOLOGICAL_FORMATION", 30, 37], ["airway", "MULTI-TISSUE_STRUCTURE", 72, 78], ["lesions", "PROBLEM", 30, 37], ["immediate airway intervention", "TREATMENT", 62, 91], ["some future intervention", "TREATMENT", 140, 164], ["progression", "OBSERVATION_MODIFIER", 15, 26], ["lesions", "OBSERVATION", 30, 37]]], ["Even in apparently hydrated camelids, some form of fluid therapy is helpful in preventing thrombotic complications.", [["fluid", "ANATOMY", 51, 56], ["thrombotic complications", "DISEASE", 90, 114], ["fluid", "ORGANISM_SUBSTANCE", 51, 56], ["fluid therapy", "TREATMENT", 51, 64], ["thrombotic complications", "PROBLEM", 90, 114], ["fluid therapy", "OBSERVATION", 51, 64], ["thrombotic", "OBSERVATION_MODIFIER", 90, 100], ["complications", "OBSERVATION", 101, 114]]], ["The finding of hepatic lipidosis in one affected camelid suggests some may benefit from specific treatments against this condition.", [["hepatic", "ANATOMY", 15, 22], ["hepatic lipidosis", "DISEASE", 15, 32], ["hepatic", "ORGAN", 15, 22], ["hepatic lipidosis", "PROBLEM", 15, 32], ["specific treatments", "TREATMENT", 88, 107], ["this condition", "PROBLEM", 116, 130], ["hepatic", "ANATOMY", 15, 22], ["lipidosis", "OBSERVATION", 23, 32]]], ["However, the risk of edema is even higher in camelids with snake bite than in the general population, so any fluids must be given at a judicious rate and sometimes accompanied with a colloid, blood, or blood products.", [["edema", "ANATOMY", 21, 26], ["colloid", "ANATOMY", 183, 190], ["blood", "ANATOMY", 192, 197], ["blood", "ANATOMY", 202, 207], ["edema", "DISEASE", 21, 26], ["snake bite", "DISEASE", 59, 69], ["edema", "PATHOLOGICAL_FORMATION", 21, 26], ["blood", "ORGANISM_SUBSTANCE", 192, 197], ["blood", "ORGANISM_SUBSTANCE", 202, 207], ["edema", "PROBLEM", 21, 26], ["snake bite", "PROBLEM", 59, 69], ["any fluids", "TREATMENT", 105, 115], ["a colloid, blood, or blood products", "PROBLEM", 181, 216], ["edema", "OBSERVATION", 21, 26], ["higher", "OBSERVATION_MODIFIER", 35, 41]]], ["Given the tendency toward tissue swelling, any neck wrap must be loose and assessed frequently, lest it should become constricting.NeoplasiaBroad-spectrum antibiotics with good anaerobic coverage are recommended because of the contaminated nature of the bites and the risk of translocation across a compromised bowel.", [["tissue", "ANATOMY", 26, 32], ["neck", "ANATOMY", 47, 51], ["bowel", "ANATOMY", 311, 316], ["swelling", "DISEASE", 33, 41], ["tissue", "TISSUE", 26, 32], ["neck", "ORGANISM_SUBDIVISION", 47, 51], ["bowel", "ORGAN", 311, 316], ["the tendency toward tissue swelling", "PROBLEM", 6, 41], ["any neck wrap", "TREATMENT", 43, 56], ["NeoplasiaBroad-spectrum antibiotics", "TREATMENT", 131, 166], ["good anaerobic coverage", "TREATMENT", 172, 195], ["the bites", "PROBLEM", 250, 259], ["translocation across a compromised bowel", "PROBLEM", 276, 316], ["tissue", "ANATOMY", 26, 32], ["swelling", "OBSERVATION", 33, 41], ["neck", "ANATOMY", 47, 51], ["wrap", "OBSERVATION", 52, 56], ["loose", "OBSERVATION", 65, 70], ["constricting", "OBSERVATION", 118, 130], ["compromised", "OBSERVATION", 299, 310], ["bowel", "ANATOMY", 311, 316]]], ["A tetanus toxoid is also recommended.NeoplasiaAntiinflammatory medications may aid in reducing the swelling and some of the effects of the toxins.", [["tetanus", "DISEASE", 2, 9], ["swelling", "DISEASE", 99, 107], ["tetanus toxoid", "ORGANISM", 2, 16], ["A tetanus toxoid", "TREATMENT", 0, 16], ["NeoplasiaAntiinflammatory medications", "TREATMENT", 37, 74], ["the swelling", "PROBLEM", 95, 107], ["the toxins", "PROBLEM", 135, 145], ["swelling", "OBSERVATION", 99, 107]]], ["Generally, when veterinary treatment is initiated, nonsteroidal medications are preferable to corticosteroids or antihistamines.", [["nonsteroidal", "ANATOMY", 51, 63], ["corticosteroids", "CHEMICAL", 94, 109], ["antihistamines", "SIMPLE_CHEMICAL", 113, 127], ["veterinary treatment", "TREATMENT", 16, 36], ["nonsteroidal medications", "TREATMENT", 51, 75], ["corticosteroids", "TREATMENT", 94, 109], ["antihistamines", "TREATMENT", 113, 127]]], ["Corticosteroids are often used in a last-ditch effort and may be indicated in some forms of shock; especially when repeated, they also suppress the immune system during a period of possible sepsis.", [["immune system", "ANATOMY", 148, 161], ["shock", "DISEASE", 92, 97], ["sepsis", "DISEASE", 190, 196], ["Corticosteroids", "TREATMENT", 0, 15], ["shock", "PROBLEM", 92, 97], ["sepsis", "PROBLEM", 190, 196], ["shock", "OBSERVATION", 92, 97], ["possible", "UNCERTAINTY", 181, 189], ["sepsis", "OBSERVATION", 190, 196]]], ["Antihistamines are unlikely to be of value beyond the peracute stage and may worsen hypotension.NeoplasiaLocal wound care should be performed on weeping or necrotizing lesions.", [["wound", "ANATOMY", 111, 116], ["necrotizing lesions", "ANATOMY", 156, 175], ["hypotension", "DISEASE", 84, 95], ["Antihistamines", "CHEMICAL", 0, 14], ["Antihistamines", "SIMPLE_CHEMICAL", 0, 14], ["wound", "PATHOLOGICAL_FORMATION", 111, 116], ["necrotizing lesions", "PATHOLOGICAL_FORMATION", 156, 175], ["Antihistamines", "TREATMENT", 0, 14], ["hypotension", "PROBLEM", 84, 95], ["NeoplasiaLocal wound care", "TREATMENT", 96, 121], ["necrotizing lesions", "PROBLEM", 156, 175], ["unlikely to be", "UNCERTAINTY", 19, 33], ["necrotizing", "OBSERVATION_MODIFIER", 156, 167], ["lesions", "OBSERVATION", 168, 175]]], ["Fasciotomy may also release internal pressure and prevent secondary lesions.", [["lesions", "ANATOMY", 68, 75], ["lesions", "PATHOLOGICAL_FORMATION", 68, 75], ["Fasciotomy", "TREATMENT", 0, 10], ["internal pressure", "TEST", 28, 45], ["secondary lesions", "PROBLEM", 58, 75], ["pressure", "OBSERVATION_MODIFIER", 37, 45], ["prevent", "UNCERTAINTY", 50, 57], ["secondary", "OBSERVATION_MODIFIER", 58, 67], ["lesions", "OBSERVATION", 68, 75]]], ["The use of antivenin has camelids based on serologic studies, may be found by observing intranuclear inclusion bodies on light microscopic examination or finding evidence of virus by PCR reaction on tissues.", [["tissues", "ANATOMY", 199, 206], ["antivenin", "CHEMICAL", 11, 20], ["antivenin", "CHEMICAL", 11, 20], ["antivenin", "GENE_OR_GENE_PRODUCT", 11, 20], ["tissues", "TISSUE", 199, 206], ["antivenin", "TREATMENT", 11, 20], ["camelids", "TREATMENT", 25, 33], ["serologic studies", "TEST", 43, 60], ["light microscopic examination", "TEST", 121, 150], ["virus", "PROBLEM", 174, 179], ["PCR reaction on tissues", "PROBLEM", 183, 206], ["evidence of", "UNCERTAINTY", 162, 173], ["virus", "OBSERVATION", 174, 179]]], ["Cross-reactivity to antiporcine adenovirus antibodies allows immunofluorescent detection as well.NeoplasiaMost camelids affected by adenovirus are juveniles with progressive dyspnea or tachypnea that does not respond to antibiotic treatment.", [["dyspnea", "DISEASE", 174, 181], ["tachypnea", "DISEASE", 185, 194], ["adenovirus", "ORGANISM", 32, 42], ["NeoplasiaMost camelids", "ORGANISM", 97, 119], ["adenovirus", "ORGANISM", 132, 142], ["antiporcine adenovirus antibodies", "PROTEIN", 20, 53], ["adenovirus", "SPECIES", 32, 42], ["Cross-reactivity", "TEST", 0, 16], ["antiporcine adenovirus antibodies", "TEST", 20, 53], ["immunofluorescent detection", "TEST", 61, 88], ["NeoplasiaMost camelids", "PROBLEM", 97, 119], ["adenovirus", "PROBLEM", 132, 142], ["progressive dyspnea", "PROBLEM", 162, 181], ["tachypnea", "PROBLEM", 185, 194], ["antibiotic treatment", "TREATMENT", 220, 240], ["adenovirus", "OBSERVATION", 132, 142], ["progressive", "OBSERVATION_MODIFIER", 162, 173], ["dyspnea", "OBSERVATION", 174, 181], ["tachypnea", "OBSERVATION", 185, 194]]], ["Unless secondary bacterial infection occurs, fever is uncommon and pulmonary auscultation reveals few abnormalities.", [["pulmonary", "ANATOMY", 67, 76], ["bacterial infection", "DISEASE", 17, 36], ["fever", "DISEASE", 45, 50], ["pulmonary", "ORGAN", 67, 76], ["bacterial infection", "PROBLEM", 17, 36], ["fever", "PROBLEM", 45, 50], ["pulmonary auscultation", "TEST", 67, 89], ["few abnormalities", "PROBLEM", 98, 115], ["bacterial", "OBSERVATION_MODIFIER", 17, 26], ["infection", "OBSERVATION", 27, 36], ["pulmonary", "ANATOMY", 67, 76], ["few", "OBSERVATION_MODIFIER", 98, 101], ["abnormalities", "OBSERVATION", 102, 115]]], ["Radiographic changes are subtle, with some increase in interstitial density.", [["interstitial", "ANATOMY", 55, 67], ["interstitial", "TISSUE", 55, 67], ["some increase in interstitial density", "PROBLEM", 38, 75], ["subtle", "OBSERVATION_MODIFIER", 25, 31], ["some", "OBSERVATION_MODIFIER", 38, 42], ["increase", "OBSERVATION_MODIFIER", 43, 51], ["interstitial", "ANATOMY_MODIFIER", 55, 67], ["density", "OBSERVATION", 68, 75]]], ["Clinical pathology data are likewise unremarkable, although one report suggests concurrent adenoviral hepatitis may lead to inflammatory and enzymatic changes.", [["adenoviral hepatitis", "DISEASE", 91, 111], ["adenoviral", "ORGANISM", 91, 101], ["Clinical pathology data", "TEST", 0, 23], ["concurrent adenoviral hepatitis", "PROBLEM", 80, 111], ["inflammatory and enzymatic changes", "PROBLEM", 124, 158], ["unremarkable", "OBSERVATION", 37, 49], ["adenoviral hepatitis", "OBSERVATION", 91, 111], ["may lead to", "UNCERTAINTY", 112, 123], ["inflammatory", "OBSERVATION_MODIFIER", 124, 136]]], ["30 ABG analysis reveals marginal to poor arterial oxygenation and progressive inability to exhale carbon dioxide, in spite of tachypnea and the outward appearance of adequate ventilatory effort.", [["arterial", "ANATOMY", 41, 49], ["carbon dioxide", "CHEMICAL", 98, 112], ["tachypnea", "DISEASE", 126, 135], ["carbon dioxide", "CHEMICAL", 98, 112], ["arterial", "MULTI-TISSUE_STRUCTURE", 41, 49], ["carbon dioxide", "SIMPLE_CHEMICAL", 98, 112], ["ABG analysis", "TEST", 3, 15], ["poor arterial oxygenation", "PROBLEM", 36, 61], ["progressive inability to exhale carbon dioxide", "PROBLEM", 66, 112], ["tachypnea", "PROBLEM", 126, 135], ["the outward appearance", "PROBLEM", 140, 162], ["marginal", "OBSERVATION_MODIFIER", 24, 32], ["arterial oxygenation", "OBSERVATION", 41, 61], ["progressive", "OBSERVATION_MODIFIER", 66, 77], ["tachypnea", "OBSERVATION", 126, 135], ["outward", "OBSERVATION_MODIFIER", 144, 151], ["adequate", "OBSERVATION_MODIFIER", 166, 174], ["ventilatory effort", "OBSERVATION", 175, 193]]], ["Gross necropsy frequently reveals little more than pulmonary edema.", [["pulmonary", "ANATOMY", 51, 60], ["pulmonary edema", "DISEASE", 51, 66], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 51, 66], ["Gross necropsy", "TEST", 0, 14], ["pulmonary edema", "PROBLEM", 51, 66], ["necropsy", "OBSERVATION", 6, 14], ["little", "OBSERVATION_MODIFIER", 34, 40], ["pulmonary", "ANATOMY", 51, 60], ["edema", "OBSERVATION", 61, 66]]], ["Further investigation using one of the aforementioned methods may reveal evidence of adenoviral infection.NeoplasiaThe clinical course is relatively short (1 week) and difficult to reverse.", [["adenoviral infection", "DISEASE", 85, 105], ["adenoviral", "ORGANISM", 85, 95], ["Further investigation", "TEST", 0, 21], ["the aforementioned methods", "TEST", 35, 61], ["adenoviral infection", "PROBLEM", 85, 105], ["may reveal evidence of", "UNCERTAINTY", 62, 84], ["adenoviral", "OBSERVATION_MODIFIER", 85, 95], ["infection", "OBSERVATION", 96, 105]]], ["Older camelids may be better suited to surviving the initial infection and may also have a more chronic course.", [["infection", "DISEASE", 61, 70], ["the initial infection", "PROBLEM", 49, 70], ["infection", "OBSERVATION", 61, 70], ["more chronic", "OBSERVATION_MODIFIER", 91, 103]]], ["Antibiotics, antiinflammatories, and medications to decrease pulmonary edema may all play some role in treatment.", [["pulmonary", "ANATOMY", 61, 70], ["pulmonary edema", "DISEASE", 61, 76], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 61, 76], ["Antibiotics", "TREATMENT", 0, 11], ["antiinflammatories", "TREATMENT", 13, 31], ["medications", "TREATMENT", 37, 48], ["pulmonary edema", "PROBLEM", 61, 76], ["treatment", "TREATMENT", 103, 112], ["pulmonary", "ANATOMY", 61, 70], ["edema", "OBSERVATION", 71, 76]]], ["Intranasal oxygen treatment and ultimately mechanical ventilation may be necessary for advanced disease.NeoplasiaBluetongue.", [["oxygen", "CHEMICAL", 11, 17], ["NeoplasiaBluetongue", "CHEMICAL", 104, 123], ["oxygen", "CHEMICAL", 11, 17], ["oxygen", "SIMPLE_CHEMICAL", 11, 17], ["Intranasal oxygen treatment", "TREATMENT", 0, 27], ["ultimately mechanical ventilation", "TREATMENT", 32, 65], ["advanced disease", "PROBLEM", 87, 103], ["NeoplasiaBluetongue", "PROBLEM", 104, 123], ["oxygen treatment", "OBSERVATION", 11, 27]]], ["For many years, it has been known that camelids seroconvert to bluetongue, but reports of clinical disease have been rare.", [["bluetongue", "DISEASE", 63, 73], ["bluetongue", "ORGANISM", 63, 73], ["clinical disease", "PROBLEM", 90, 106]]], ["21 Single affected camelids have been reported in Colorado, California, and Germany, and a group of affected llamas were seen in France in 2007.", [["camelids", "CANCER", 19, 27], ["llamas", "ORGANISM", 109, 115], ["Single affected camelids", "PROBLEM", 3, 27], ["affected llamas", "PROBLEM", 100, 115]]], ["[31] [32] [33] The European cases occurred during multispecies outbreaks.", [["[31] [32] [33]", "SIMPLE_CHEMICAL", 0, 14]]], ["Bluetongue is caused by an orbivirus in the reovirus family.", [["Bluetongue", "DISEASE", 0, 10], ["orbivirus", "CANCER", 27, 36], ["reovirus", "ORGANISM", 44, 52], ["Bluetongue", "PROBLEM", 0, 10]]], ["There are at least 24 serotypes.", [["serotypes", "OBSERVATION", 22, 31]]], ["Cattle are the usual reservoir species because they often suffer prolonged viremia after infection and rarely show signs of acute clinical disease.", [["viremia", "DISEASE", 75, 82], ["infection", "DISEASE", 89, 98], ["Cattle", "ORGANISM", 0, 6], ["Cattle", "SPECIES", 0, 6], ["Cattle", "TREATMENT", 0, 6], ["the usual reservoir species", "TREATMENT", 11, 38], ["prolonged viremia", "PROBLEM", 65, 82], ["infection", "PROBLEM", 89, 98], ["acute clinical disease", "PROBLEM", 124, 146], ["viremia", "OBSERVATION", 75, 82], ["acute", "OBSERVATION_MODIFIER", 124, 129]]], ["The disease is spread by biting Culicoides flies (midges), occasionally through semen, and occasionally transplacentally.", [["semen", "ANATOMY", 80, 85], ["Culicoides flies", "ORGANISM", 32, 48], ["midges", "ORGANISM_SUBDIVISION", 50, 56], ["semen", "ORGANISM_SUBSTANCE", 80, 85], ["Culicoides flies", "SPECIES", 32, 48], ["The disease", "PROBLEM", 0, 11], ["biting Culicoides flies", "PROBLEM", 25, 48], ["disease", "OBSERVATION", 4, 11], ["spread", "OBSERVATION_MODIFIER", 15, 21]]], ["Although cattle rarely show more than occasional reproductive problems, including abortion and birth defects, some other species, particular sheep and some wild cervids and ruminants, often suffer severe, often lethal disease.", [["abortion", "DISEASE", 82, 90], ["birth defects", "DISEASE", 95, 108], ["cattle", "ORGANISM", 9, 15], ["sheep", "ORGANISM", 141, 146], ["cattle", "SPECIES", 9, 15], ["sheep", "SPECIES", 141, 146], ["cattle", "SPECIES", 9, 15], ["sheep", "SPECIES", 141, 146], ["occasional reproductive problems", "PROBLEM", 38, 70], ["abortion", "PROBLEM", 82, 90], ["birth defects", "PROBLEM", 95, 108], ["some other species", "PROBLEM", 110, 128], ["often lethal disease", "PROBLEM", 205, 225], ["reproductive", "OBSERVATION_MODIFIER", 49, 61], ["problems", "OBSERVATION", 62, 70], ["defects", "OBSERVATION", 101, 108]]], ["The underlying lesion is vasculitis.", [["lesion", "ANATOMY", 15, 21], ["vasculitis", "DISEASE", 25, 35], ["lesion", "CANCER", 15, 21], ["The underlying lesion", "PROBLEM", 0, 21], ["vasculitis", "PROBLEM", 25, 35], ["lesion", "OBSERVATION", 15, 21], ["vasculitis", "OBSERVATION", 25, 35]]], ["Common clinical signs include fever, anorexia, facial and lingual edema, oral ulceration, cyanosis, lameness, and dyspnea.", [["facial", "ANATOMY", 47, 53], ["lingual edema", "ANATOMY", 58, 71], ["oral", "ANATOMY", 73, 77], ["fever", "DISEASE", 30, 35], ["anorexia", "DISEASE", 37, 45], ["facial and lingual edema", "DISEASE", 47, 71], ["oral ulceration", "DISEASE", 73, 88], ["cyanosis", "DISEASE", 90, 98], ["lameness", "DISEASE", 100, 108], ["dyspnea", "DISEASE", 114, 121], ["lingual edema", "PATHOLOGICAL_FORMATION", 58, 71], ["oral", "ORGANISM_SUBDIVISION", 73, 77], ["Common clinical signs", "PROBLEM", 0, 21], ["fever", "PROBLEM", 30, 35], ["anorexia", "PROBLEM", 37, 45], ["facial and lingual edema", "PROBLEM", 47, 71], ["oral ulceration", "PROBLEM", 73, 88], ["cyanosis", "PROBLEM", 90, 98], ["lameness", "PROBLEM", 100, 108], ["dyspnea", "PROBLEM", 114, 121], ["fever", "OBSERVATION", 30, 35], ["anorexia", "OBSERVATION", 37, 45], ["facial", "ANATOMY", 47, 53], ["lingual", "ANATOMY", 58, 65], ["edema", "OBSERVATION", 66, 71], ["oral", "ANATOMY", 73, 77], ["ulceration", "OBSERVATION", 78, 88], ["cyanosis", "OBSERVATION", 90, 98], ["lameness", "OBSERVATION", 100, 108], ["dyspnea", "OBSERVATION", 114, 121]]], ["Death is usually the result of pulmonary edema or secondary bacterial infections.NeoplasiaSigns reported in camelids include hiccup-like breathing, anorexia, weakness, recumbency, and respiratory stertor.", [["pulmonary", "ANATOMY", 31, 40], ["respiratory", "ANATOMY", 184, 195], ["Death", "DISEASE", 0, 5], ["pulmonary edema", "DISEASE", 31, 46], ["bacterial infections", "DISEASE", 60, 80], ["NeoplasiaSigns", "DISEASE", 81, 95], ["hiccup-like breathing", "DISEASE", 125, 146], ["anorexia", "DISEASE", 148, 156], ["weakness", "DISEASE", 158, 166], ["respiratory stertor", "DISEASE", 184, 203], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 31, 46], ["Death", "PROBLEM", 0, 5], ["pulmonary edema", "PROBLEM", 31, 46], ["secondary bacterial infections", "PROBLEM", 50, 80], ["NeoplasiaSigns", "PROBLEM", 81, 95], ["hiccup", "PROBLEM", 125, 131], ["like breathing", "PROBLEM", 132, 146], ["anorexia", "PROBLEM", 148, 156], ["weakness", "PROBLEM", 158, 166], ["recumbency", "PROBLEM", 168, 178], ["respiratory stertor", "PROBLEM", 184, 203], ["usually the result of", "UNCERTAINTY", 9, 30], ["pulmonary", "ANATOMY", 31, 40], ["edema", "OBSERVATION", 41, 46], ["secondary", "OBSERVATION_MODIFIER", 50, 59], ["bacterial", "OBSERVATION_MODIFIER", 60, 69], ["infections", "OBSERVATION", 70, 80], ["hiccup", "OBSERVATION", 125, 131], ["anorexia", "OBSERVATION", 148, 156], ["weakness", "OBSERVATION", 158, 166], ["recumbency", "OBSERVATION_MODIFIER", 168, 178], ["respiratory stertor", "OBSERVATION", 184, 203]]], ["Viremia and seroconversion without clinical signs have been reported as well.", [["Viremia", "DISEASE", 0, 7], ["Viremia", "PROBLEM", 0, 7], ["seroconversion", "PROBLEM", 12, 26], ["clinical signs", "TEST", 35, 49]]], ["Postmortem revealed small ulcers throughout the mouth, severe diffuse pulmonary edema, hydrothorax, and fibrinous pericarditis.", [["mouth", "ANATOMY", 48, 53], ["pulmonary", "ANATOMY", 70, 79], ["ulcers", "DISEASE", 26, 32], ["pulmonary edema", "DISEASE", 70, 85], ["hydrothorax", "DISEASE", 87, 98], ["fibrinous pericarditis", "DISEASE", 104, 126], ["ulcers", "PATHOLOGICAL_FORMATION", 26, 32], ["mouth", "ORGANISM_SUBDIVISION", 48, 53], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 70, 85], ["small ulcers throughout the mouth", "PROBLEM", 20, 53], ["severe diffuse pulmonary edema", "PROBLEM", 55, 85], ["hydrothorax", "PROBLEM", 87, 98], ["fibrinous pericarditis", "PROBLEM", 104, 126], ["small", "OBSERVATION_MODIFIER", 20, 25], ["ulcers", "OBSERVATION", 26, 32], ["mouth", "ANATOMY", 48, 53], ["severe", "OBSERVATION_MODIFIER", 55, 61], ["diffuse", "OBSERVATION_MODIFIER", 62, 69], ["pulmonary", "ANATOMY", 70, 79], ["edema", "OBSERVATION", 80, 85], ["hydrothorax", "OBSERVATION", 87, 98], ["fibrinous", "OBSERVATION_MODIFIER", 104, 113], ["pericarditis", "OBSERVATION", 114, 126]]], ["Bluetongue virus was identified by PCR in blood, lungs, the heart, lymph nodes, and the spleen.", [["blood", "ANATOMY", 42, 47], ["lungs", "ANATOMY", 49, 54], ["heart", "ANATOMY", 60, 65], ["lymph nodes", "ANATOMY", 67, 78], ["spleen", "ANATOMY", 88, 94], ["Bluetongue virus", "ORGANISM", 0, 16], ["blood", "ORGANISM_SUBSTANCE", 42, 47], ["lungs", "ORGAN", 49, 54], ["heart", "ORGAN", 60, 65], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 67, 78], ["spleen", "ORGAN", 88, 94], ["Bluetongue virus", "SPECIES", 0, 16], ["Bluetongue virus", "PROBLEM", 0, 16], ["PCR in blood, lungs, the heart, lymph nodes, and the spleen", "PROBLEM", 35, 94], ["virus", "OBSERVATION", 11, 16], ["lungs", "ANATOMY", 49, 54], ["heart", "ANATOMY", 60, 65], ["lymph nodes", "OBSERVATION", 67, 78], ["spleen", "ANATOMY", 88, 94]]], ["It is still not known whether the affected camelids had some cause for particular susceptibility, their immune system was overwhelmed by the amount of viral challenge during the outbreak, or these represent the innate susceptibility of camelids to bluetongue.", [["bluetongue", "DISEASE", 248, 258], ["camelids", "CANCER", 43, 51], ["bluetongue", "ORGANISM", 248, 258], ["bluetongue", "SPECIES", 248, 258], ["the affected camelids", "PROBLEM", 30, 51], ["particular susceptibility", "PROBLEM", 71, 96], ["viral challenge", "PROBLEM", 151, 166], ["viral", "OBSERVATION", 151, 156]]], ["Lack of partial inappetence, affected camelids have tachypnea or dyspnea.", [["camelids", "ANATOMY", 38, 46], ["inappetence", "DISEASE", 16, 27], ["camelids", "DISEASE", 38, 46], ["tachypnea", "DISEASE", 52, 61], ["dyspnea", "DISEASE", 65, 72], ["camelids", "CANCER", 38, 46], ["partial inappetence", "PROBLEM", 8, 27], ["affected camelids", "PROBLEM", 29, 46], ["tachypnea", "PROBLEM", 52, 61], ["dyspnea", "PROBLEM", 65, 72], ["partial", "OBSERVATION_MODIFIER", 8, 15], ["inappetence", "OBSERVATION", 16, 27], ["dyspnea", "OBSERVATION", 65, 72]]], ["If the mass is palpable, diagnosis may be achieved by aspirate or biopsy.", [["mass", "ANATOMY", 7, 11], ["the mass", "PROBLEM", 3, 11], ["biopsy", "TEST", 66, 72], ["mass", "OBSERVATION", 7, 11], ["palpable", "OBSERVATION", 15, 23]]], ["If it is intrathoracic, imaging studies are likely to reveal its presence.", [["imaging studies", "TEST", 24, 39], ["intrathoracic", "ANATOMY", 9, 22]]], ["Local resection and chemotherapy may lead to some resolution of signs and period of remission.Lower Respiratory tractPrimary diseases confined to the lower respiratory tract are uncommon in New World camelids.", [["lower respiratory tract", "ANATOMY", 150, 173], ["Primary diseases confined to the lower respiratory tract", "DISEASE", 117, 173], ["tract", "ORGANISM_SUBDIVISION", 112, 117], ["lower", "ORGANISM_SUBDIVISION", 150, 155], ["respiratory tract", "ORGANISM_SUBDIVISION", 156, 173], ["Local resection", "TREATMENT", 0, 15], ["chemotherapy", "TREATMENT", 20, 32], ["signs", "PROBLEM", 64, 69], ["remission", "PROBLEM", 84, 93], ["Lower Respiratory tract", "PROBLEM", 94, 117], ["Primary diseases", "PROBLEM", 117, 133], ["resection", "OBSERVATION", 6, 15], ["remission", "OBSERVATION", 84, 93], ["Respiratory tract", "ANATOMY", 100, 117], ["diseases", "OBSERVATION", 125, 133], ["lower", "ANATOMY_MODIFIER", 150, 155], ["respiratory tract", "ANATOMY", 156, 173]]], ["Viral, bacterial, fungal, and parasitic pneumonias are rare, and if present, may arise from or lead to systemic infection.", [["Viral, bacterial, fungal, and parasitic pneumonias", "DISEASE", 0, 50], ["infection", "DISEASE", 112, 121], ["Viral", "PROBLEM", 0, 5], ["bacterial", "PROBLEM", 7, 16], ["fungal", "PROBLEM", 18, 24], ["parasitic pneumonias", "PROBLEM", 30, 50], ["systemic infection", "PROBLEM", 103, 121], ["bacterial", "OBSERVATION_MODIFIER", 7, 16], ["fungal", "OBSERVATION_MODIFIER", 18, 24], ["parasitic", "OBSERVATION_MODIFIER", 30, 39], ["pneumonias", "OBSERVATION", 40, 50], ["systemic", "OBSERVATION_MODIFIER", 103, 111], ["infection", "OBSERVATION", 112, 121]]], ["Tumors may be found in the lung, heart, or chest cavity but are also usually part of a multifocal process.", [["Tumors", "ANATOMY", 0, 6], ["lung", "ANATOMY", 27, 31], ["heart", "ANATOMY", 33, 38], ["chest cavity", "ANATOMY", 43, 55], ["Tumors", "DISEASE", 0, 6], ["Tumors", "CANCER", 0, 6], ["lung", "ORGAN", 27, 31], ["heart", "ORGAN", 33, 38], ["chest cavity", "ORGANISM_SUBDIVISION", 43, 55], ["Tumors", "PROBLEM", 0, 6], ["the lung, heart, or chest cavity", "PROBLEM", 23, 55], ["a multifocal process", "PROBLEM", 85, 105], ["lung", "ANATOMY", 27, 31], ["heart", "ANATOMY", 33, 38], ["chest", "ANATOMY", 43, 48], ["cavity", "ANATOMY_MODIFIER", 49, 55], ["multifocal", "OBSERVATION_MODIFIER", 87, 97], ["process", "OBSERVATION", 98, 105]]], ["Aspiration is relatively common, but usually arises from sedation, neuromuscular disorders, and gastroesophageal disorders.", [["neuromuscular", "ANATOMY", 67, 80], ["gastroesophageal", "ANATOMY", 96, 112], ["neuromuscular disorders", "DISEASE", 67, 90], ["gastroesophageal disorders", "DISEASE", 96, 122], ["gastroesophageal", "ORGAN", 96, 112], ["Aspiration", "PROBLEM", 0, 10], ["sedation", "TREATMENT", 57, 65], ["neuromuscular disorders", "PROBLEM", 67, 90], ["gastroesophageal disorders", "PROBLEM", 96, 122], ["gastroesophageal", "ANATOMY", 96, 112]]], ["Congenital lesions of the lung are less common or less commonly reported than malformations of other organ systems and usually involve vascular structures (see Chapter 36) .Lower Respiratory tractMore commonly, lower respiratory signs occur secondary to another disease process.", [["lesions", "ANATOMY", 11, 18], ["lung", "ANATOMY", 26, 30], ["organ", "ANATOMY", 101, 106], ["vascular structures", "ANATOMY", 135, 154], ["respiratory", "ANATOMY", 217, 228], ["Congenital lesions of the lung", "DISEASE", 0, 30], ["malformations", "DISEASE", 78, 91], ["respiratory signs", "DISEASE", 217, 234], ["lesions", "PATHOLOGICAL_FORMATION", 11, 18], ["lung", "ORGAN", 26, 30], ["organ", "ORGAN", 101, 106], ["vascular structures", "MULTI-TISSUE_STRUCTURE", 135, 154], ["Lower", "ORGANISM_SUBDIVISION", 173, 178], ["Respiratory tract", "ORGANISM_SUBDIVISION", 179, 196], ["Congenital lesions of the lung", "PROBLEM", 0, 30], ["malformations of other organ systems", "PROBLEM", 78, 114], ["Lower Respiratory tract", "PROBLEM", 173, 196], ["lower respiratory signs", "PROBLEM", 211, 234], ["another disease process", "PROBLEM", 254, 277], ["lesions", "OBSERVATION", 11, 18], ["lung", "ANATOMY", 26, 30], ["less common", "OBSERVATION_MODIFIER", 35, 46], ["vascular", "ANATOMY", 135, 143], ["Respiratory tract", "ANATOMY", 179, 196], ["disease", "OBSERVATION", 262, 269]]], ["The most common causes of tachypnea or dyspnea at our clinic are cardiac disease, anemia, hypoproteinemia and edema, overhydration, stress, hyperthermia, intracarotid injection, metabolic acidosis, abdominal enlargement, pain, and thrombosis.", [["cardiac", "ANATOMY", 65, 72], ["edema", "ANATOMY", 110, 115], ["abdominal", "ANATOMY", 198, 207], ["tachypnea", "DISEASE", 26, 35], ["dyspnea", "DISEASE", 39, 46], ["cardiac disease", "DISEASE", 65, 80], ["anemia", "DISEASE", 82, 88], ["hypoproteinemia", "DISEASE", 90, 105], ["edema", "DISEASE", 110, 115], ["overhydration", "DISEASE", 117, 130], ["hyperthermia", "DISEASE", 140, 152], ["metabolic acidosis", "DISEASE", 178, 196], ["abdominal enlargement", "DISEASE", 198, 219], ["pain", "DISEASE", 221, 225], ["thrombosis", "DISEASE", 231, 241], ["cardiac", "ORGAN", 65, 72], ["edema", "PATHOLOGICAL_FORMATION", 110, 115], ["abdominal", "ORGANISM_SUBDIVISION", 198, 207], ["tachypnea", "PROBLEM", 26, 35], ["dyspnea", "PROBLEM", 39, 46], ["cardiac disease", "PROBLEM", 65, 80], ["anemia", "PROBLEM", 82, 88], ["hypoproteinemia", "PROBLEM", 90, 105], ["edema", "PROBLEM", 110, 115], ["overhydration", "PROBLEM", 117, 130], ["stress", "PROBLEM", 132, 138], ["hyperthermia", "PROBLEM", 140, 152], ["intracarotid injection", "TREATMENT", 154, 176], ["metabolic acidosis", "PROBLEM", 178, 196], ["abdominal enlargement", "PROBLEM", 198, 219], ["pain", "PROBLEM", 221, 225], ["thrombosis", "PROBLEM", 231, 241], ["tachypnea", "OBSERVATION", 26, 35], ["cardiac", "ANATOMY", 65, 72], ["disease", "OBSERVATION", 73, 80], ["anemia", "OBSERVATION", 82, 88], ["hypoproteinemia", "OBSERVATION", 90, 105], ["edema", "OBSERVATION", 110, 115], ["overhydration", "OBSERVATION", 117, 130], ["metabolic acidosis", "OBSERVATION", 178, 196], ["abdominal", "ANATOMY", 198, 207], ["enlargement", "OBSERVATION", 208, 219], ["pain", "OBSERVATION", 221, 225], ["thrombosis", "OBSERVATION", 231, 241]]], ["Therefore, even when examining a camelid with overt signs of lower respiratory tract disease, a comprehensive physical and diagnostic evaluation is warranted.Acute PneumoniaViral Pneumonia.", [["lower respiratory tract", "ANATOMY", 61, 84], ["lower respiratory tract disease", "DISEASE", 61, 92], ["Pneumonia", "DISEASE", 179, 188], ["lower", "ORGANISM_SUBDIVISION", 61, 66], ["respiratory tract", "ORGANISM_SUBDIVISION", 67, 84], ["lower respiratory tract disease", "PROBLEM", 61, 92], ["diagnostic evaluation", "TEST", 123, 144], ["Acute PneumoniaViral Pneumonia", "PROBLEM", 158, 188], ["lower", "ANATOMY_MODIFIER", 61, 66], ["respiratory tract", "ANATOMY", 67, 84], ["PneumoniaViral", "OBSERVATION_MODIFIER", 164, 178], ["Pneumonia", "OBSERVATION", 179, 188]]], ["Viral lower respiratory disease appears to be less common in camelids than in horses or cattle, and reports of outbreaks are rare.", [["respiratory", "ANATOMY", 12, 23], ["Viral lower respiratory disease", "DISEASE", 0, 31], ["cattle", "SPECIES", 88, 94], ["horses", "SPECIES", 78, 84], ["cattle", "SPECIES", 88, 94], ["Viral lower respiratory disease", "PROBLEM", 0, 31], ["outbreaks", "PROBLEM", 111, 120], ["lower", "ANATOMY_MODIFIER", 6, 11], ["respiratory disease", "OBSERVATION", 12, 31], ["appears to be", "UNCERTAINTY", 32, 45], ["less common", "OBSERVATION_MODIFIER", 46, 57], ["outbreaks", "OBSERVATION", 111, 120]]], ["However, seroconversion to most bovine respiratory viruses does occur in camelids under a variety of management circumstances, and disease is occasionally, albeit rarely, attributed to these infections.", [["respiratory viruses", "DISEASE", 39, 58], ["infections", "DISEASE", 191, 201], ["bovine", "ORGANISM", 32, 38], ["bovine", "SPECIES", 32, 38], ["seroconversion", "TREATMENT", 9, 23], ["most bovine respiratory viruses", "PROBLEM", 27, 58], ["disease", "PROBLEM", 131, 138], ["these infections", "PROBLEM", 185, 201], ["respiratory viruses", "OBSERVATION", 39, 58], ["infections", "OBSERVATION", 191, 201]]], ["[21] [22] [23] [24] [25] Bovine herpesvirus 1 was isolated from a small number of llamas with coughs of several months duration that eventually led to bacterial bronchopneumonia.", [["[21] [22] [23] [24", "CHEMICAL", 0, 18], ["bronchopneumonia", "DISEASE", 161, 177], ["[21] [22] [23] [24", "SIMPLE_CHEMICAL", 0, 18], ["Bovine herpesvirus 1", "ORGANISM", 25, 45], ["llamas", "ORGANISM", 82, 88], ["Bovine", "SPECIES", 25, 31], ["Bovine herpesvirus 1", "SPECIES", 25, 45], ["Bovine herpesvirus 1", "TEST", 25, 45], ["coughs", "PROBLEM", 94, 100], ["bacterial bronchopneumonia", "PROBLEM", 151, 177], ["small", "OBSERVATION_MODIFIER", 66, 71], ["llamas", "OBSERVATION", 82, 88], ["bacterial", "OBSERVATION_MODIFIER", 151, 160], ["bronchopneumonia", "OBSERVATION", 161, 177]]], ["26, 27 Bovine viral diarrhea virus (BVDV) has been linked occasionally to acute and shortlived oculonasal discharge in camelids.", [["oculonasal", "ANATOMY", 95, 105], ["Bovine viral diarrhea", "DISEASE", 7, 28], ["Bovine viral diarrhea virus", "ORGANISM", 7, 34], ["BVDV", "ORGANISM", 36, 40], ["Bovine viral diarrhea virus", "SPECIES", 7, 34], ["Bovine viral diarrhea virus", "SPECIES", 7, 34], ["BVDV", "SPECIES", 36, 40], ["Bovine viral diarrhea virus (BVDV", "PROBLEM", 7, 40], ["acute and shortlived oculonasal discharge", "PROBLEM", 74, 115], ["viral diarrhea virus", "OBSERVATION", 14, 34], ["acute", "OBSERVATION_MODIFIER", 74, 79]]], ["Polymerase chain reaction (PCR) on whole blood is the most common diagnostic modality for BVDV.", [["whole blood", "ANATOMY", 35, 46], ["blood", "ORGANISM_SUBSTANCE", 41, 46], ["BVDV", "ORGANISM", 90, 94], ["BVDV", "SPECIES", 90, 94], ["Polymerase chain reaction", "PROBLEM", 0, 25], ["PCR", "TEST", 27, 30], ["whole blood", "TEST", 35, 46], ["BVDV", "PROBLEM", 90, 94], ["BVDV", "OBSERVATION", 90, 94]]], ["Virus isolation from blood or discharges and fluorescent antibody testing on lesions are less rewarding but may be used to detect either virus.", [["blood", "ANATOMY", 21, 26], ["lesions", "ANATOMY", 77, 84], ["Virus", "ORGANISM", 0, 5], ["blood", "ORGANISM_SUBSTANCE", 21, 26], ["lesions", "PATHOLOGICAL_FORMATION", 77, 84], ["Virus isolation", "PROBLEM", 0, 15], ["blood or discharges", "PROBLEM", 21, 40], ["fluorescent antibody testing", "TEST", 45, 73], ["lesions", "PROBLEM", 77, 84], ["virus", "PROBLEM", 137, 142], ["virus", "OBSERVATION", 137, 142]]], ["Coronavirus has been implicated as the possible cause of the recent outbreaks of nasal discharge and dyspnea in the United States, commonly referred to as the \"snots.\"", [["nasal", "ANATOMY", 81, 86], ["Coronavirus", "CHEMICAL", 0, 11], ["dyspnea", "DISEASE", 101, 108], ["nasal", "ORGANISM_SUBDIVISION", 81, 86], ["Coronavirus", "PROBLEM", 0, 11], ["nasal discharge", "PROBLEM", 81, 96], ["dyspnea", "PROBLEM", 101, 108], ["nasal", "ANATOMY", 81, 86], ["discharge", "OBSERVATION", 87, 96]]], ["This is a poorly described syndrome of upper or lower respiratory tract disease, often associated with outbreaks after shows.", [["lower respiratory tract", "ANATOMY", 48, 71], ["respiratory tract disease", "DISEASE", 54, 79], ["upper", "ORGANISM_SUBDIVISION", 39, 44], ["lower", "ORGANISM_SUBDIVISION", 48, 53], ["respiratory tract", "ORGANISM_SUBDIVISION", 54, 71], ["a poorly described syndrome", "PROBLEM", 8, 35], ["upper or lower respiratory tract disease", "PROBLEM", 39, 79], ["poorly described", "OBSERVATION_MODIFIER", 10, 26], ["syndrome", "OBSERVATION", 27, 35], ["upper", "ANATOMY_MODIFIER", 39, 44], ["lower", "ANATOMY_MODIFIER", 48, 53], ["respiratory tract", "ANATOMY", 54, 71]]], ["Affected camelids may have anything from mild serous discharge to thick, profuse nasal discharge or dyspnea.", [["camelids", "ANATOMY", 9, 17], ["serous", "ANATOMY", 46, 52], ["nasal", "ANATOMY", 81, 86], ["dyspnea", "DISEASE", 100, 107], ["serous", "ORGANISM_SUBSTANCE", 46, 52], ["nasal", "ORGAN", 81, 86], ["Affected camelids", "PROBLEM", 0, 17], ["mild serous discharge", "PROBLEM", 41, 62], ["thick, profuse nasal discharge", "PROBLEM", 66, 96], ["dyspnea", "PROBLEM", 100, 107], ["mild", "OBSERVATION_MODIFIER", 41, 45], ["serous", "OBSERVATION", 46, 52], ["profuse", "OBSERVATION_MODIFIER", 73, 80], ["nasal", "ANATOMY", 81, 86], ["discharge", "OBSERVATION", 87, 96], ["dyspnea", "OBSERVATION", 100, 107]]], ["Fever is uncommon and often associated with a poor prognosis.", [["Fever", "DISEASE", 0, 5], ["Fever", "PROBLEM", 0, 5], ["a poor prognosis", "PROBLEM", 44, 60]]], ["One investigation implicated a group 1 coronavirus, which was distinct from the group 2 coronavirus associated with enteritis.", [["coronavirus", "DISEASE", 88, 99], ["enteritis", "DISEASE", 116, 125], ["coronavirus", "ORGANISM", 39, 50], ["2 coronavirus", "ORGANISM", 86, 99], ["1 coronavirus", "SPECIES", 37, 50], ["a group 1 coronavirus", "PROBLEM", 29, 50], ["the group 2 coronavirus", "PROBLEM", 76, 99], ["enteritis", "PROBLEM", 116, 125], ["enteritis", "OBSERVATION", 116, 125]]], ["29 Electron microscopy or PCR on exudates and serologic tests may be used to detect infection.Acute PneumoniaAdenovirus has also been linked to lower respiratory disease.", [["respiratory", "ANATOMY", 150, 161], ["infection", "DISEASE", 84, 93], ["PneumoniaAdenovirus", "CHEMICAL", 100, 119], ["respiratory disease", "DISEASE", 150, 169], ["Electron microscopy", "TEST", 3, 22], ["PCR on exudates", "TEST", 26, 41], ["serologic tests", "TEST", 46, 61], ["infection", "PROBLEM", 84, 93], ["Acute PneumoniaAdenovirus", "PROBLEM", 94, 119], ["lower respiratory disease", "PROBLEM", 144, 169], ["infection", "OBSERVATION", 84, 93], ["PneumoniaAdenovirus", "OBSERVATION", 100, 119], ["lower", "OBSERVATION_MODIFIER", 144, 149], ["respiratory disease", "OBSERVATION", 150, 169]]], ["30 This virus, although relatively ubiquitous amongStreptococcal Infections (Alpaca Fever, Preston Disease)A growing body of evidence suggests that S. equi ssp. zooepi demicus is an important primary pathogen of camelids in North America.", [["amongStreptococcal Infections", "DISEASE", 46, 75], ["Alpaca Fever", "DISEASE", 77, 89], ["S. equi ssp", "ORGANISM", 148, 159], ["zooepi demicus", "ORGANISM", 161, 175], ["S. equi", "SPECIES", 148, 155], ["zooepi demicus", "SPECIES", 161, 175], ["S. equi ssp", "SPECIES", 148, 159], ["zooepi demicus", "SPECIES", 161, 175], ["This virus", "PROBLEM", 3, 13], ["relatively ubiquitous amongStreptococcal Infections (Alpaca Fever", "PROBLEM", 24, 89], ["Preston Disease)", "PROBLEM", 91, 107], ["S. equi ssp", "PROBLEM", 148, 159], ["relatively", "OBSERVATION_MODIFIER", 24, 34], ["ubiquitous", "OBSERVATION_MODIFIER", 35, 45], ["amongStreptococcal", "OBSERVATION_MODIFIER", 46, 64], ["Infections", "OBSERVATION", 65, 75], ["Alpaca", "OBSERVATION_MODIFIER", 77, 83], ["equi ssp", "OBSERVATION", 151, 159]]], ["36, 38, 39 This agent is known in South America as the cause of Alpaca fever but was not recognized on other continents for many years.", [["Alpaca fever", "DISEASE", 64, 76], ["Alpaca fever", "PROBLEM", 64, 76], ["Alpaca", "OBSERVATION_MODIFIER", 64, 70], ["fever", "OBSERVATION", 71, 76]]], ["With S. zooepidemicus very common in most places with sizeable equine populations, and llamas and alpacas becoming more common, transspecies transmission was just a matter of time.", [["S. zooepidemicus", "ORGANISM", 5, 21], ["llamas", "ORGANISM_SUBDIVISION", 87, 93], ["S. zooepidemicus", "SPECIES", 5, 21], ["llamas", "SPECIES", 87, 93], ["S. zooepidemicus", "SPECIES", 5, 21], ["llamas", "SPECIES", 87, 93], ["S. zooepidemicus", "PROBLEM", 5, 21], ["sizeable equine populations", "PROBLEM", 54, 81], ["zooepidemicus", "OBSERVATION", 8, 21], ["sizeable", "OBSERVATION_MODIFIER", 54, 62], ["equine populations", "OBSERVATION", 63, 81], ["llamas", "ANATOMY", 87, 93]]], ["Alpaca fever appears to start as a superficial infection of wounds, the prepuce, or the udder that causes local swelling and discomfort, or as a generalized internal infection.", [["wounds", "ANATOMY", 60, 66], ["prepuce", "ANATOMY", 72, 79], ["udder", "ANATOMY", 88, 93], ["Alpaca fever", "DISEASE", 0, 12], ["infection", "DISEASE", 47, 56], ["wounds", "DISEASE", 60, 66], ["swelling", "DISEASE", 112, 120], ["internal infection", "DISEASE", 157, 175], ["wounds", "PATHOLOGICAL_FORMATION", 60, 66], ["prepuce", "ORGAN", 72, 79], ["udder", "ORGANISM_SUBDIVISION", 88, 93], ["Alpaca fever", "PROBLEM", 0, 12], ["a superficial infection of wounds", "PROBLEM", 33, 66], ["local swelling", "PROBLEM", 106, 120], ["discomfort", "PROBLEM", 125, 135], ["a generalized internal infection", "PROBLEM", 143, 175], ["superficial", "OBSERVATION_MODIFIER", 35, 46], ["infection", "OBSERVATION", 47, 56], ["wounds", "OBSERVATION", 60, 66], ["local", "OBSERVATION_MODIFIER", 106, 111], ["swelling", "OBSERVATION", 112, 120], ["discomfort", "OBSERVATION", 125, 135], ["generalized", "OBSERVATION_MODIFIER", 145, 156], ["internal", "OBSERVATION_MODIFIER", 157, 165], ["infection", "OBSERVATION", 166, 175]]], ["Superficial infections may become generalized, and about half the affected camelids die.", [["infections", "DISEASE", 12, 22], ["Superficial infections", "PROBLEM", 0, 22], ["infections", "OBSERVATION", 12, 22], ["generalized", "OBSERVATION_MODIFIER", 34, 45]]], ["Generalized infections may be cleared, leaving abscesses, usually in the abdominal cavity or lungs.", [["abscesses", "ANATOMY", 47, 56], ["abdominal cavity", "ANATOMY", 73, 89], ["lungs", "ANATOMY", 93, 98], ["infections", "DISEASE", 12, 22], ["abscesses", "DISEASE", 47, 56], ["abscesses", "PATHOLOGICAL_FORMATION", 47, 56], ["abdominal cavity", "MULTI-TISSUE_STRUCTURE", 73, 89], ["lungs", "ORGAN", 93, 98], ["Generalized infections", "PROBLEM", 0, 22], ["abscesses", "PROBLEM", 47, 56], ["infections", "OBSERVATION", 12, 22], ["may be", "UNCERTAINTY", 23, 29], ["cleared", "OBSERVATION_MODIFIER", 30, 37], ["abscesses", "OBSERVATION", 47, 56], ["abdominal", "ANATOMY", 73, 82], ["cavity", "ANATOMY_MODIFIER", 83, 89], ["lungs", "ANATOMY", 93, 98]]], ["In North America, the organism has been isolated from blood, milk, uterine discharges, abscesses, wounds, and body cavity exudates (pleural or peritoneal fluid).", [["blood", "ANATOMY", 54, 59], ["milk", "ANATOMY", 61, 65], ["uterine", "ANATOMY", 67, 74], ["abscesses", "ANATOMY", 87, 96], ["wounds", "ANATOMY", 98, 104], ["body cavity", "ANATOMY", 110, 121], ["pleural", "ANATOMY", 132, 139], ["peritoneal fluid", "ANATOMY", 143, 159], ["abscesses", "DISEASE", 87, 96], ["wounds", "DISEASE", 98, 104], ["blood", "ORGANISM_SUBSTANCE", 54, 59], ["milk", "ORGANISM_SUBSTANCE", 61, 65], ["uterine", "ORGANISM_SUBDIVISION", 67, 74], ["abscesses", "PATHOLOGICAL_FORMATION", 87, 96], ["wounds", "PATHOLOGICAL_FORMATION", 98, 104], ["body cavity exudates", "ORGANISM_SUBSTANCE", 110, 130], ["pleural", "MULTI-TISSUE_STRUCTURE", 132, 139], ["peritoneal fluid", "MULTI-TISSUE_STRUCTURE", 143, 159], ["blood, milk, uterine discharges", "PROBLEM", 54, 85], ["abscesses", "PROBLEM", 87, 96], ["wounds", "PROBLEM", 98, 104], ["body cavity exudates", "PROBLEM", 110, 130], ["pleural or peritoneal fluid", "PROBLEM", 132, 159], ["North", "OBSERVATION_MODIFIER", 3, 8], ["America", "OBSERVATION_MODIFIER", 9, 16], ["uterine", "ANATOMY", 67, 74], ["abscesses", "OBSERVATION", 87, 96], ["wounds", "OBSERVATION", 98, 104], ["body", "ANATOMY_MODIFIER", 110, 114], ["cavity", "ANATOMY", 115, 121], ["exudates", "OBSERVATION", 122, 130], ["pleural", "ANATOMY", 132, 139], ["peritoneal", "ANATOMY", 143, 153], ["fluid", "OBSERVATION", 154, 159]]], ["Affected camelids have shown a broad spectrum of different clinical signs, ranging from infertility, uterine discharges, abnormal milk, and superficial swelling to tachypnea, dyspnea, cough, tenesmus, diarrhea, and colic.", [["uterine", "ANATOMY", 101, 108], ["milk", "ANATOMY", 130, 134], ["infertility", "DISEASE", 88, 99], ["uterine discharges", "DISEASE", 101, 119], ["abnormal milk", "DISEASE", 121, 134], ["swelling", "DISEASE", 152, 160], ["tachypnea", "DISEASE", 164, 173], ["dyspnea", "DISEASE", 175, 182], ["cough", "DISEASE", 184, 189], ["tenesmus", "DISEASE", 191, 199], ["diarrhea", "DISEASE", 201, 209], ["colic", "DISEASE", 215, 220], ["uterine", "ORGAN", 101, 108], ["milk", "ORGANISM_SUBSTANCE", 130, 134], ["Affected camelids", "PROBLEM", 0, 17], ["different clinical signs", "PROBLEM", 49, 73], ["infertility", "PROBLEM", 88, 99], ["uterine discharges", "PROBLEM", 101, 119], ["abnormal milk", "PROBLEM", 121, 134], ["superficial swelling", "PROBLEM", 140, 160], ["tachypnea", "PROBLEM", 164, 173], ["dyspnea", "PROBLEM", 175, 182], ["cough", "PROBLEM", 184, 189], ["tenesmus", "PROBLEM", 191, 199], ["diarrhea", "PROBLEM", 201, 209], ["colic", "PROBLEM", 215, 220], ["uterine", "ANATOMY", 101, 108], ["discharges", "OBSERVATION", 109, 119], ["abnormal milk", "OBSERVATION", 121, 134], ["superficial", "OBSERVATION_MODIFIER", 140, 151], ["swelling", "OBSERVATION", 152, 160], ["tachypnea", "OBSERVATION", 164, 173], ["cough", "OBSERVATION", 184, 189], ["tenesmus", "OBSERVATION", 191, 199], ["diarrhea", "OBSERVATION", 201, 209], ["colic", "ANATOMY", 215, 220]]], ["Signs of internal infection are accompanied by fever (102.5\u00b0F-106\u00b0F), depression, and anorexia, but these may not be present with focal disease.", [["internal infection", "DISEASE", 9, 27], ["fever", "DISEASE", 47, 52], ["depression", "DISEASE", 70, 80], ["anorexia", "DISEASE", 86, 94], ["internal infection", "PROBLEM", 9, 27], ["fever", "PROBLEM", 47, 52], ["depression", "PROBLEM", 70, 80], ["anorexia", "PROBLEM", 86, 94], ["focal disease", "PROBLEM", 130, 143], ["internal", "OBSERVATION_MODIFIER", 9, 17], ["infection", "OBSERVATION", 18, 27], ["fever", "OBSERVATION", 47, 52], ["depression", "OBSERVATION", 70, 80], ["anorexia", "OBSERVATION", 86, 94], ["may not be", "UNCERTAINTY", 106, 116], ["focal", "OBSERVATION_MODIFIER", 130, 135], ["disease", "OBSERVATION", 136, 143]]], ["Most camelids with the generalized form of this streptococcal disease show signs referable to the abdominal cavity, and a smaller number also or predominately show respiratory signs.", [["abdominal cavity", "ANATOMY", 98, 114], ["respiratory", "ANATOMY", 164, 175], ["streptococcal disease", "DISEASE", 48, 69], ["respiratory signs", "DISEASE", 164, 181], ["abdominal cavity", "MULTI-TISSUE_STRUCTURE", 98, 114], ["this streptococcal disease", "PROBLEM", 43, 69], ["respiratory signs", "PROBLEM", 164, 181], ["streptococcal", "OBSERVATION", 48, 61], ["abdominal cavity", "ANATOMY", 98, 114], ["smaller", "OBSERVATION_MODIFIER", 122, 129], ["respiratory signs", "OBSERVATION", 164, 181]]], ["38 This has given rise to the belief that the organism gains access to the body through the gastrointestinal (GI) tract and not the respiratory tract or lymphoreticular organs, as occurs with most other streptococcal infection (in horses, humans, etc.).", [["body", "ANATOMY", 75, 79], ["gastrointestinal (GI) tract", "ANATOMY", 92, 119], ["respiratory tract", "ANATOMY", 132, 149], ["lymphoreticular organs", "ANATOMY", 153, 175], ["gastrointestinal (GI) tract", "DISEASE", 92, 119], ["streptococcal infection", "DISEASE", 203, 226], ["body", "ORGANISM_SUBDIVISION", 75, 79], ["gastrointestinal", "ORGANISM_SUBDIVISION", 92, 108], ["GI) tract", "PATHOLOGICAL_FORMATION", 110, 119], ["respiratory tract", "ORGANISM_SUBDIVISION", 132, 149], ["lymphoreticular organs", "ORGAN", 153, 175], ["horses", "ORGANISM_SUBDIVISION", 231, 237], ["humans", "ORGANISM", 239, 245], ["humans", "SPECIES", 239, 245], ["humans", "SPECIES", 239, 245], ["the organism", "PROBLEM", 42, 54], ["the respiratory tract or lymphoreticular organs", "PROBLEM", 128, 175], ["most other streptococcal infection", "PROBLEM", 192, 226], ["gastrointestinal", "ANATOMY", 92, 108], ["GI", "ANATOMY", 110, 112], ["respiratory tract", "ANATOMY", 132, 149], ["lymphoreticular organs", "OBSERVATION", 153, 175], ["streptococcal", "OBSERVATION_MODIFIER", 203, 216], ["infection", "OBSERVATION", 217, 226]]], ["This is probably untrue.", [["probably", "UNCERTAINTY", 8, 16], ["untrue", "OBSERVATION_MODIFIER", 17, 23]]], ["Research has demonstrated the efficiency of respiratory infection, and greater use of ultrasonography in the diagnostic evaluation of sick camelids has identified pleuritis in a high percentage of cases.", [["respiratory", "ANATOMY", 44, 55], ["respiratory infection", "DISEASE", 44, 65], ["camelids", "DISEASE", 139, 147], ["pleuritis", "DISEASE", 163, 172], ["respiratory infection", "PROBLEM", 44, 65], ["ultrasonography", "TEST", 86, 101], ["the diagnostic evaluation", "TEST", 105, 130], ["sick camelids", "PROBLEM", 134, 147], ["pleuritis", "PROBLEM", 163, 172], ["efficiency", "OBSERVATION_MODIFIER", 30, 40], ["respiratory", "ANATOMY", 44, 55], ["infection", "OBSERVATION", 56, 65], ["pleuritis", "OBSERVATION", 163, 172]]], ["37 Alternative forms of transmission are also possible; anecdotally, this infection has been seen in camelids after orogastric intubation and reproductive examinations using equipment that may have been previously used on horses.Streptococcal Infections (Alpaca Fever, Preston Disease)Diagnosis of these infections requires a thorough evaluation.", [["orogastric", "ANATOMY", 116, 126], ["infection", "DISEASE", 74, 83], ["Streptococcal Infections", "DISEASE", 229, 253], ["Alpaca Fever", "DISEASE", 255, 267], ["infections", "DISEASE", 304, 314], ["this infection", "PROBLEM", 69, 83], ["orogastric intubation", "TREATMENT", 116, 137], ["reproductive examinations", "TEST", 142, 167], ["equipment", "TREATMENT", 174, 183], ["Streptococcal Infections", "PROBLEM", 229, 253], ["Alpaca Fever", "PROBLEM", 255, 267], ["Preston Disease)", "PROBLEM", 269, 285], ["these infections", "PROBLEM", 298, 314], ["a thorough evaluation", "TEST", 324, 345], ["infection", "OBSERVATION", 74, 83], ["Infections", "OBSERVATION", 243, 253], ["Alpaca", "OBSERVATION_MODIFIER", 255, 261], ["infections", "OBSERVATION", 304, 314]]], ["Clinical signs resemble those seen with other, more widely known diseases such as gastric ulcers, intestinal impaction, heat stress, acute eperythrozoonosis, and other infections.", [["gastric ulcers", "ANATOMY", 82, 96], ["intestinal", "ANATOMY", 98, 108], ["gastric ulcers", "DISEASE", 82, 96], ["intestinal impaction", "DISEASE", 98, 118], ["eperythrozoonosis", "DISEASE", 139, 156], ["infections", "DISEASE", 168, 178], ["gastric ulcers", "PATHOLOGICAL_FORMATION", 82, 96], ["intestinal", "ORGAN", 98, 108], ["known diseases", "PROBLEM", 59, 73], ["gastric ulcers", "PROBLEM", 82, 96], ["intestinal impaction", "PROBLEM", 98, 118], ["heat stress", "PROBLEM", 120, 131], ["acute eperythrozoonosis", "PROBLEM", 133, 156], ["other infections", "PROBLEM", 162, 178], ["diseases", "OBSERVATION", 65, 73], ["gastric", "ANATOMY", 82, 89], ["ulcers", "OBSERVATION", 90, 96], ["intestinal", "ANATOMY", 98, 108], ["impaction", "OBSERVATION", 109, 118], ["heat stress", "OBSERVATION", 120, 131], ["acute", "OBSERVATION_MODIFIER", 133, 138], ["eperythrozoonosis", "OBSERVATION", 139, 156], ["infections", "OBSERVATION", 168, 178]]], ["Streptococcal infections may also induce or promote some of these other diseases by altering thermoregulation and GI function, increasing stress, suppressing the immune system, and damaging the gut wall.Streptococcal Infections (Alpaca Fever, Preston Disease)Localized infections may be found by rectal palpation, thoracocentesis, abdominocentesis, exploratory surgery, or imaging studies (Figure 37-8) .", [["GI", "ANATOMY", 114, 116], ["immune system", "ANATOMY", 162, 175], ["gut wall", "ANATOMY", 194, 202], ["rectal", "ANATOMY", 296, 302], ["Streptococcal infections", "DISEASE", 0, 24], ["Streptococcal Infections", "DISEASE", 203, 227], ["Alpaca Fever", "DISEASE", 229, 241], ["infections", "DISEASE", 269, 279], ["abdominocentesis", "DISEASE", 331, 347], ["GI", "ORGANISM_SUBDIVISION", 114, 116], ["gut wall", "MULTI-TISSUE_STRUCTURE", 194, 202], ["rectal", "ORGAN", 296, 302], ["Streptococcal infections", "PROBLEM", 0, 24], ["these other diseases", "PROBLEM", 60, 80], ["altering thermoregulation", "PROBLEM", 84, 109], ["GI function", "TEST", 114, 125], ["increasing stress", "PROBLEM", 127, 144], ["Streptococcal Infections (Alpaca Fever", "PROBLEM", 203, 241], ["Preston Disease)", "PROBLEM", 243, 259], ["Localized infections", "PROBLEM", 259, 279], ["rectal palpation", "TEST", 296, 312], ["thoracocentesis", "TREATMENT", 314, 329], ["abdominocentesis", "TREATMENT", 331, 347], ["exploratory surgery", "TREATMENT", 349, 368], ["imaging studies", "TEST", 373, 388], ["Figure", "TEST", 390, 396], ["infections", "OBSERVATION", 14, 24], ["diseases", "OBSERVATION", 72, 80], ["gut", "ANATOMY", 194, 197], ["wall", "ANATOMY_MODIFIER", 198, 202], ["Infections", "OBSERVATION", 217, 227], ["Alpaca", "OBSERVATION_MODIFIER", 229, 235], ["infections", "OBSERVATION", 269, 279], ["rectal", "ANATOMY", 296, 302], ["palpation", "OBSERVATION", 303, 312], ["thoracocentesis", "OBSERVATION", 314, 329]]], ["Generalized infections may be identified through analysis of blood and other body fluids.", [["blood", "ANATOMY", 61, 66], ["body fluids", "ANATOMY", 77, 88], ["infections", "DISEASE", 12, 22], ["blood", "ORGANISM_SUBSTANCE", 61, 66], ["body", "ORGANISM_SUBDIVISION", 77, 81], ["fluids", "ORGANISM_SUBSTANCE", 82, 88], ["Generalized infections", "PROBLEM", 0, 22], ["blood and other body fluids", "PROBLEM", 61, 88], ["infections", "OBSERVATION", 12, 22]]], ["Complete blood cell count (CBC) typically shows nonspecific evidence of inflammation including neutrophilic leukocytosis, high band cell counts, and hyperfibrinogenemia.", [["blood cell", "ANATOMY", 9, 19], ["CBC", "ANATOMY", 27, 30], ["neutrophilic", "ANATOMY", 95, 107], ["high band cell", "ANATOMY", 122, 136], ["inflammation", "DISEASE", 72, 84], ["leukocytosis", "DISEASE", 108, 120], ["hyperfibrinogenemia", "DISEASE", 149, 168], ["blood cell", "CELL", 9, 19], ["CBC", "CELL", 27, 30], ["high band cell", "CELL", 122, 136], ["Complete blood cell count", "TEST", 0, 25], ["CBC", "TEST", 27, 30], ["inflammation", "PROBLEM", 72, 84], ["neutrophilic leukocytosis", "PROBLEM", 95, 120], ["high band cell counts", "PROBLEM", 122, 143], ["hyperfibrinogenemia", "PROBLEM", 149, 168], ["nonspecific evidence of", "UNCERTAINTY", 48, 71], ["inflammation", "OBSERVATION", 72, 84], ["neutrophilic", "OBSERVATION_MODIFIER", 95, 107], ["leukocytosis", "OBSERVATION", 108, 120], ["high band cell counts", "OBSERVATION", 122, 143], ["hyperfibrinogenemia", "OBSERVATION", 149, 168]]], ["Often, body cavity fluids (abdominal, thoracic) are abnormal, with very high nucleated cell counts (40,000 to 120,000 cells/\u00b5L), consisting predominately of nondegenerate neutrophils, and high protein concentrations (>4 g/dL).", [["body cavity fluids", "ANATOMY", 7, 25], ["abdominal", "ANATOMY", 27, 36], ["thoracic", "ANATOMY", 38, 46], ["nucleated cell", "ANATOMY", 77, 91], ["cells", "ANATOMY", 118, 123], ["neutrophils", "ANATOMY", 171, 182], ["body cavity fluids", "ORGANISM_SUBSTANCE", 7, 25], ["abdominal", "ORGANISM_SUBDIVISION", 27, 36], ["thoracic", "ORGAN", 38, 46], ["nucleated cell", "CELL", 77, 91], ["cells", "CELL", 118, 123], ["neutrophils", "CELL", 171, 182], ["nondegenerate neutrophils", "CELL_TYPE", 157, 182], ["abnormal", "PROBLEM", 52, 60], ["very high nucleated cell counts", "PROBLEM", 67, 98], ["cells/\u00b5L", "TEST", 118, 126], ["nondegenerate neutrophils", "PROBLEM", 157, 182], ["high protein concentrations", "PROBLEM", 188, 215], ["abdominal", "ANATOMY", 27, 36], ["thoracic", "ANATOMY", 38, 46], ["abnormal", "OBSERVATION", 52, 60], ["very", "OBSERVATION_MODIFIER", 67, 71], ["high nucleated", "OBSERVATION_MODIFIER", 72, 86], ["cell counts", "OBSERVATION", 87, 98], ["nondegenerate neutrophils", "OBSERVATION", 157, 182], ["high protein", "OBSERVATION_MODIFIER", 188, 200]]], ["Often, gram-positive cocci are visible free and within phagocytic cells.", [["cocci", "ANATOMY", 21, 26], ["phagocytic cells", "ANATOMY", 55, 71], ["phagocytic cells", "CELL", 55, 71], ["phagocytic cells", "CELL_TYPE", 55, 71], ["gram", "TEST", 7, 11], ["positive cocci", "PROBLEM", 12, 26], ["positive cocci", "OBSERVATION", 12, 26], ["phagocytic cells", "OBSERVATION", 55, 71]]], ["Definitive diagnosis requires bacteriologic culture of blood or body previous reports in spite of evidence of seroconversion makes the last possibility seem less likely.", [["blood", "ANATOMY", 55, 60], ["body", "ANATOMY", 64, 68], ["blood", "ORGANISM_SUBSTANCE", 55, 60], ["body", "ORGANISM_SUBDIVISION", 64, 68], ["bacteriologic culture", "TEST", 30, 51], ["blood", "PROBLEM", 55, 60], ["seroconversion", "PROBLEM", 110, 124], ["seroconversion", "OBSERVATION", 110, 124]]], ["Preventative measures include fly control, protection from flies, and possibly vaccination.", [["Preventative measures", "TREATMENT", 0, 21], ["fly control", "TREATMENT", 30, 41]]], ["Vaccines are available in endemic or threatened areas and should be given at least 3 weeks before the onset of the fly season.", [["Vaccines", "TREATMENT", 0, 8]]], ["The initial vaccination is a two-injection series at 3-week intervals, followed by an annual booster as long as the danger persists.", [["a two-injection series", "TREATMENT", 27, 49], ["an annual booster", "TREATMENT", 83, 100]]], ["34 Since Culicoides flies are most active after dusk, evening confinement in barns with fly screens may offer the most practical protection.Bacterial Pneumonia and Pleuropneumonia.Primary acute bacterial lower respiratory disease appears to be less common in camelids than in horses or cattle.", [["respiratory", "ANATOMY", 210, 221], ["Pneumonia", "DISEASE", 150, 159], ["bacterial lower respiratory disease", "DISEASE", 194, 229], ["Culicoides flies", "ORGANISM", 9, 25], ["horses", "ORGANISM_SUBDIVISION", 276, 282], ["cattle", "SPECIES", 286, 292], ["Culicoides flies", "SPECIES", 9, 25], ["horses", "SPECIES", 276, 282], ["cattle", "SPECIES", 286, 292], ["fly screens", "TEST", 88, 99], ["Bacterial Pneumonia", "PROBLEM", 140, 159], ["Pleuropneumonia", "PROBLEM", 164, 179], ["Primary acute bacterial lower respiratory disease", "PROBLEM", 180, 229], ["active", "OBSERVATION_MODIFIER", 35, 41], ["Pneumonia", "OBSERVATION", 150, 159], ["Pleuropneumonia", "OBSERVATION", 164, 179], ["acute", "OBSERVATION_MODIFIER", 188, 193], ["bacterial", "OBSERVATION_MODIFIER", 194, 203], ["lower", "ANATOMY_MODIFIER", 204, 209], ["respiratory disease", "OBSERVATION", 210, 229], ["appears to be", "UNCERTAINTY", 230, 243], ["less common", "OBSERVATION_MODIFIER", 244, 255]]], ["In most cases, bacterial pneumonia is just one component of a systemic bacterial infection.", [["pneumonia", "DISEASE", 25, 34], ["bacterial infection", "DISEASE", 71, 90], ["bacterial pneumonia", "PROBLEM", 15, 34], ["a systemic bacterial infection", "PROBLEM", 60, 90], ["bacterial", "OBSERVATION_MODIFIER", 15, 24], ["pneumonia", "OBSERVATION", 25, 34], ["one component", "OBSERVATION_MODIFIER", 43, 56], ["systemic", "OBSERVATION_MODIFIER", 62, 70], ["bacterial", "OBSERVATION_MODIFIER", 71, 80], ["infection", "OBSERVATION", 81, 90]]], ["In some of those cases, the lungs may by the first site and origin of the infection, but in others, another source is suspected.Bacterial Pneumonia and Pleuropneumonia.The paucity of reports on this condition may not be the result of any particular innate immunity in camelids or lack of suitable pathogens, but rather the infrequency of close confinement housing, crowded transport, or other practices which promote the spread of respiratory pathogens.", [["lungs", "ANATOMY", 28, 33], ["respiratory", "ANATOMY", 431, 442], ["infection", "DISEASE", 74, 83], ["Pneumonia", "DISEASE", 138, 147], ["respiratory pathogens", "DISEASE", 431, 452], ["lungs", "ORGAN", 28, 33], ["the infection", "PROBLEM", 70, 83], ["Bacterial Pneumonia", "PROBLEM", 128, 147], ["Pleuropneumonia", "PROBLEM", 152, 167], ["suitable pathogens", "PROBLEM", 288, 306], ["respiratory pathogens", "PROBLEM", 431, 452], ["lungs", "ANATOMY", 28, 33], ["origin", "OBSERVATION_MODIFIER", 60, 66], ["infection", "OBSERVATION", 74, 83], ["Pneumonia", "OBSERVATION", 138, 147], ["Pleuropneumonia", "OBSERVATION", 152, 167], ["respiratory pathogens", "OBSERVATION", 431, 452]]], ["Anecdotal reports are available describing bovine pathogens such as Pas teurella, Mannheimia, and Haemophilus spreading from cattle to camelids when the two species are kept close together.", [["bovine", "ORGANISM", 43, 49], ["Pas teurella", "ORGANISM", 68, 80], ["Haemophilus", "ORGANISM", 98, 109], ["cattle", "ORGANISM", 125, 131], ["bovine", "SPECIES", 43, 49], ["Pas teurella", "SPECIES", 68, 80], ["cattle", "SPECIES", 125, 131], ["bovine", "SPECIES", 43, 49], ["Pas teurella", "SPECIES", 68, 80], ["cattle", "SPECIES", 125, 131], ["bovine pathogens", "PROBLEM", 43, 59], ["Mannheimia", "PROBLEM", 82, 92], ["Haemophilus spreading", "PROBLEM", 98, 119], ["Mannheimia", "OBSERVATION", 82, 92], ["Haemophilus", "OBSERVATION_MODIFIER", 98, 109]]], ["Myco plasma has not been reported but seroconversion occurs, and thus infection remains a possibility.", [["Myco plasma", "ANATOMY", 0, 11], ["infection", "DISEASE", 70, 79], ["Myco", "ORGANISM_SUBSTANCE", 0, 4], ["plasma", "ORGANISM_SUBSTANCE", 5, 11], ["Myco plasma", "TEST", 0, 11], ["seroconversion", "PROBLEM", 38, 52], ["infection", "PROBLEM", 70, 79], ["infection", "OBSERVATION", 70, 79]]], ["35 Streptococcus equi ssp. zooepidemicus is the most frequent isolate from camelids with suspected primary acute bacterial pneumonia.", [["pneumonia", "DISEASE", 123, 132], ["Streptococcus equi", "ORGANISM", 3, 21], ["ssp", "ORGANISM", 22, 25], ["zooepidemicus", "ORGANISM", 27, 40], ["Streptococcus equi", "SPECIES", 3, 21], ["zooepidemicus", "SPECIES", 27, 40], ["Streptococcus equi ssp", "SPECIES", 3, 25], ["zooepidemicus", "SPECIES", 27, 40], ["Streptococcus equi ssp", "PROBLEM", 3, 25], ["zooepidemicus", "TREATMENT", 27, 40], ["primary acute bacterial pneumonia", "PROBLEM", 99, 132], ["primary", "OBSERVATION_MODIFIER", 99, 106], ["acute", "OBSERVATION_MODIFIER", 107, 112], ["bacterial", "OBSERVATION_MODIFIER", 113, 122], ["pneumonia", "OBSERVATION", 123, 132]]], ["Although the source is often unknown, many affected camelids have a history of close contact or shared equipment and housing with horses.", [["camelids", "CANCER", 52, 60]]], ["36 Bacteremia and the \"Alpaca fever\" syndrome are common sequelae to respiratory S. zooepidemicus infection.Bacterial Pneumonia and Pleuropneumonia.Camelids with acute bacterial pneumonia display fever, tachypnea, dyspnea, anorexia, and some degree of obtundation.", [["Bacteremia", "DISEASE", 3, 13], ["Alpaca fever", "DISEASE", 23, 35], ["respiratory S. zooepidemicus infection", "DISEASE", 69, 107], ["Pneumonia", "DISEASE", 118, 127], ["pneumonia", "DISEASE", 178, 187], ["fever", "DISEASE", 196, 201], ["tachypnea", "DISEASE", 203, 212], ["dyspnea", "DISEASE", 214, 221], ["anorexia", "DISEASE", 223, 231], ["S. zooepidemicus", "ORGANISM", 81, 97], ["S. zooepidemicus", "SPECIES", 81, 97], ["S. zooepidemicus", "SPECIES", 81, 97], ["Bacteremia", "PROBLEM", 3, 13], ["the \"Alpaca fever\" syndrome", "PROBLEM", 18, 45], ["respiratory S. zooepidemicus infection", "PROBLEM", 69, 107], ["Bacterial Pneumonia", "PROBLEM", 108, 127], ["Pleuropneumonia", "PROBLEM", 132, 147], ["acute bacterial pneumonia", "PROBLEM", 162, 187], ["fever", "PROBLEM", 196, 201], ["tachypnea", "PROBLEM", 203, 212], ["dyspnea", "PROBLEM", 214, 221], ["anorexia", "PROBLEM", 223, 231], ["obtundation", "PROBLEM", 252, 263], ["Bacteremia", "OBSERVATION", 3, 13], ["zooepidemicus infection", "OBSERVATION", 84, 107], ["Pneumonia", "OBSERVATION", 118, 127], ["Pleuropneumonia", "OBSERVATION", 132, 147], ["acute", "OBSERVATION_MODIFIER", 162, 167], ["bacterial", "OBSERVATION_MODIFIER", 168, 177], ["pneumonia", "OBSERVATION", 178, 187], ["fever", "OBSERVATION", 196, 201], ["tachypnea", "OBSERVATION", 203, 212], ["anorexia", "OBSERVATION", 223, 231], ["some degree", "OBSERVATION_MODIFIER", 237, 248], ["obtundation", "OBSERVATION", 252, 263]]], ["Abnormal nasal discharge, coughing, and abnormal pulmonary sounds on auscultation are less frequent or subtle findings.", [["nasal", "ANATOMY", 9, 14], ["pulmonary", "ANATOMY", 49, 58], ["coughing", "DISEASE", 26, 34], ["abnormal pulmonary sounds", "DISEASE", 40, 65], ["nasal", "ORGAN", 9, 14], ["pulmonary", "ORGAN", 49, 58], ["Abnormal nasal discharge", "PROBLEM", 0, 24], ["coughing", "PROBLEM", 26, 34], ["abnormal pulmonary sounds", "PROBLEM", 40, 65], ["auscultation", "TEST", 69, 81], ["nasal", "ANATOMY", 9, 14], ["discharge", "OBSERVATION", 15, 24], ["coughing", "OBSERVATION", 26, 34], ["abnormal", "OBSERVATION_MODIFIER", 40, 48], ["pulmonary", "ANATOMY", 49, 58], ["sounds", "OBSERVATION", 59, 65], ["less", "OBSERVATION_MODIFIER", 86, 90], ["frequent", "OBSERVATION_MODIFIER", 91, 99], ["subtle", "OBSERVATION_MODIFIER", 103, 109]]], ["Thoracic radiography and tracheal wash for cytologic examination and bacteriologic culture are useful to confirm the diagnosis and assist in choice of antibiotics.", [["Thoracic", "ANATOMY", 0, 8], ["tracheal", "ANATOMY", 25, 33], ["tracheal", "ORGAN", 25, 33], ["Thoracic radiography", "TEST", 0, 20], ["tracheal wash", "TEST", 25, 38], ["cytologic examination", "TEST", 43, 64], ["bacteriologic culture", "TEST", 69, 90], ["antibiotics", "TREATMENT", 151, 162], ["tracheal", "ANATOMY", 25, 33]]], ["Because of the frequency of concurrent bacteremia, culturing the blood or other body fluids may also be useful.", [["blood", "ANATOMY", 65, 70], ["body fluids", "ANATOMY", 80, 91], ["bacteremia", "DISEASE", 39, 49], ["blood", "ORGANISM_SUBSTANCE", 65, 70], ["body", "ORGANISM_SUBDIVISION", 80, 84], ["concurrent bacteremia", "PROBLEM", 28, 49], ["culturing the blood or other body fluids", "PROBLEM", 51, 91], ["bacteremia", "OBSERVATION", 39, 49]]], ["Hematologic analysis is frequently abnormal, with either neutropenia or neutrophilia possible.", [["neutropenia", "DISEASE", 57, 68], ["neutrophilia", "DISEASE", 72, 84], ["Hematologic analysis", "TEST", 0, 20], ["frequently abnormal", "PROBLEM", 24, 43], ["neutropenia", "PROBLEM", 57, 68], ["neutrophilia", "PROBLEM", 72, 84], ["neutrophilia", "OBSERVATION", 72, 84]]], ["Left shift, toxic changes in neutrophils, and hyperfibrinogenemia all support a diagnosis of an inflammatory response.", [["neutrophils", "ANATOMY", 29, 40], ["hyperfibrinogenemia", "DISEASE", 46, 65], ["neutrophils", "CELL", 29, 40], ["neutrophils", "CELL_TYPE", 29, 40], ["Left shift", "PROBLEM", 0, 10], ["toxic changes in neutrophils", "PROBLEM", 12, 40], ["hyperfibrinogenemia", "PROBLEM", 46, 65], ["an inflammatory response", "PROBLEM", 93, 117], ["shift", "OBSERVATION", 5, 10], ["toxic", "OBSERVATION_MODIFIER", 12, 17], ["neutrophils", "ANATOMY", 29, 40], ["hyperfibrinogenemia", "OBSERVATION", 46, 65], ["inflammatory", "OBSERVATION", 96, 108]]], ["37 Although Streptococcus is the most frequent isolate, the possibility of gram-negative pathogens suggests the need for broad-spectrum antibiotic treatment.", [["Streptococcus", "PROBLEM", 12, 25], ["gram-negative pathogens", "PROBLEM", 75, 98], ["broad-spectrum antibiotic treatment", "TREATMENT", 121, 156], ["Streptococcus", "OBSERVATION", 12, 25], ["negative pathogens", "OBSERVATION", 80, 98], ["antibiotic treatment", "OBSERVATION", 136, 156]]], ["Most of the agents approved for use against respiratory infections in cattle are suitable for camelids to some degree; however, the caveat is that long-acting, infrequently administered agents may be less desirable than more frequently administered ones in camelids likely to have bacteremia.", [["respiratory", "ANATOMY", 44, 55], ["respiratory infections", "DISEASE", 44, 66], ["bacteremia", "DISEASE", 281, 291], ["cattle", "ORGANISM", 70, 76], ["cattle", "SPECIES", 70, 76], ["cattle", "SPECIES", 70, 76], ["the agents", "TREATMENT", 8, 18], ["respiratory infections", "PROBLEM", 44, 66], ["camelids", "PROBLEM", 94, 102], ["agents", "TREATMENT", 186, 192], ["bacteremia", "PROBLEM", 281, 291], ["infections", "OBSERVATION", 56, 66], ["bacteremia", "OBSERVATION", 281, 291]]], ["Antiinflammatory drugs are also advisable, particularly in patients with high fever, obtundation, septic complications, or hyperfibrinogenemia.", [["fever", "DISEASE", 78, 83], ["septic complications", "DISEASE", 98, 118], ["hyperfibrinogenemia", "DISEASE", 123, 142], ["patients", "ORGANISM", 59, 67], ["patients", "SPECIES", 59, 67], ["Antiinflammatory drugs", "TREATMENT", 0, 22], ["high fever", "PROBLEM", 73, 83], ["obtundation", "PROBLEM", 85, 96], ["septic complications", "PROBLEM", 98, 118], ["hyperfibrinogenemia", "PROBLEM", 123, 142], ["septic complications", "OBSERVATION", 98, 118], ["hyperfibrinogenemia", "OBSERVATION", 123, 142]]], ["Camelids without systemic complications may recover uneventfully if caught early in the course of the disease. horses, occurs between horses (and humans), and infection is thought to occur through the respiratory tract.", [["respiratory tract", "ANATOMY", 201, 218], ["infection", "DISEASE", 159, 168], ["horses", "ORGANISM", 111, 117], ["horses", "ORGANISM_SUBDIVISION", 134, 140], ["humans", "ORGANISM", 146, 152], ["respiratory tract", "ORGANISM_SUBDIVISION", 201, 218], ["humans", "SPECIES", 146, 152], ["humans", "SPECIES", 146, 152], ["systemic complications", "PROBLEM", 17, 39], ["the disease", "PROBLEM", 98, 109], ["infection", "PROBLEM", 159, 168], ["without", "UNCERTAINTY", 9, 16], ["systemic", "OBSERVATION_MODIFIER", 17, 25], ["complications", "OBSERVATION", 26, 39], ["disease", "OBSERVATION", 102, 109], ["infection", "OBSERVATION", 159, 168], ["respiratory tract", "ANATOMY", 201, 218]]], ["It is likely that such transmission occurs to camelids and possibly between camelids and that measures used to prevent the transmission of other respiratory pathogens will limit the spread of this infection as well.Aspiration PneumoniaAspiration pneumonia is one of the most common and most life-threatening lower respiratory disorders in camelids.", [["respiratory", "ANATOMY", 314, 325], ["infection", "DISEASE", 197, 206], ["PneumoniaAspiration pneumonia", "DISEASE", 226, 255], ["respiratory disorders", "DISEASE", 314, 335], ["camelids", "TREATMENT", 76, 84], ["other respiratory pathogens", "PROBLEM", 139, 166], ["this infection", "PROBLEM", 192, 206], ["Aspiration PneumoniaAspiration pneumonia", "PROBLEM", 215, 255], ["threatening lower respiratory disorders in camelids", "PROBLEM", 296, 347], ["is likely", "UNCERTAINTY", 3, 12], ["infection", "OBSERVATION", 197, 206], ["pneumonia", "OBSERVATION", 246, 255], ["one of the most common", "OBSERVATION_MODIFIER", 259, 281], ["lower", "ANATOMY_MODIFIER", 308, 313], ["respiratory disorders", "OBSERVATION", 314, 335]]], ["It occurs following inhalation or administration of feed material into the lungs.", [["lungs", "ANATOMY", 75, 80], ["lungs", "ORGAN", 75, 80], ["administration of feed material", "TREATMENT", 34, 65], ["lungs", "ANATOMY", 75, 80]]], ["Common causes in neonates include tubing or feeding accidents, particularly in crias with generalized weakness or respiratory difficulty caused by choanal atresia, cleft palate, or pulmonary dysmaturity.", [["respiratory", "ANATOMY", 114, 125], ["choanal", "ANATOMY", 147, 154], ["cleft palate", "ANATOMY", 164, 176], ["pulmonary", "ANATOMY", 181, 190], ["accidents", "DISEASE", 52, 61], ["weakness", "DISEASE", 102, 110], ["respiratory difficulty", "DISEASE", 114, 136], ["choanal atresia", "DISEASE", 147, 162], ["cleft palate", "DISEASE", 164, 176], ["pulmonary dysmaturity", "DISEASE", 181, 202], ["neonates", "ORGANISM", 17, 25], ["palate", "ORGAN", 170, 176], ["pulmonary", "ORGAN", 181, 190], ["Common causes in neonates", "PROBLEM", 0, 25], ["tubing", "TREATMENT", 34, 40], ["feeding accidents", "PROBLEM", 44, 61], ["generalized weakness", "PROBLEM", 90, 110], ["respiratory difficulty", "PROBLEM", 114, 136], ["choanal atresia", "PROBLEM", 147, 162], ["cleft palate", "PROBLEM", 164, 176], ["pulmonary dysmaturity", "PROBLEM", 181, 202], ["tubing", "OBSERVATION", 34, 40], ["generalized", "OBSERVATION_MODIFIER", 90, 101], ["weakness", "OBSERVATION", 102, 110], ["respiratory difficulty", "OBSERVATION", 114, 136], ["choanal", "ANATOMY", 147, 154], ["atresia", "OBSERVATION", 155, 162], ["cleft palate", "ANATOMY", 164, 176], ["pulmonary", "ANATOMY", 181, 190], ["dysmaturity", "OBSERVATION", 191, 202]]], ["Common causes in juveniles and adults include esophageal obstruction or megaesophagus, sedation or anesthesia, particularly during recovery, and as part of the stress response to restraint or handling, particularly oral procedures and particularly when the head and neck are restrained in an upright position.Aspiration PneumoniaSigns of aspiration pneumonia include acute dyspnea, usually with a productive, retching cough, tachypnea, possible presence of green (plant material) or white (milk) feed material at the nares or coming out of the mouth, and the smell of forestomach contents around the nose and mouth.", [["esophageal", "ANATOMY", 46, 56], ["megaesophagus", "ANATOMY", 72, 85], ["oral", "ANATOMY", 215, 219], ["head", "ANATOMY", 257, 261], ["neck", "ANATOMY", 266, 270], ["milk", "ANATOMY", 490, 494], ["nares", "ANATOMY", 517, 522], ["mouth", "ANATOMY", 544, 549], ["forestomach", "ANATOMY", 568, 579], ["nose", "ANATOMY", 600, 604], ["mouth", "ANATOMY", 609, 614], ["esophageal obstruction", "DISEASE", 46, 68], ["megaesophagus", "DISEASE", 72, 85], ["aspiration pneumonia", "DISEASE", 338, 358], ["dyspnea", "DISEASE", 373, 380], ["cough", "DISEASE", 418, 423], ["tachypnea", "DISEASE", 425, 434], ["esophageal", "ORGAN", 46, 56], ["oral", "ORGANISM_SUBDIVISION", 215, 219], ["head", "ORGANISM_SUBDIVISION", 257, 261], ["neck", "ORGAN", 266, 270], ["milk", "ORGANISM_SUBDIVISION", 490, 494], ["nares", "ORGANISM_SUBDIVISION", 517, 522], ["mouth", "ORGANISM_SUBDIVISION", 544, 549], ["smell", "ORGANISM_SUBDIVISION", 559, 564], ["forestomach", "ORGAN", 568, 579], ["nose", "ORGANISM_SUBDIVISION", 600, 604], ["mouth", "ORGANISM_SUBDIVISION", 609, 614], ["esophageal obstruction", "PROBLEM", 46, 68], ["megaesophagus", "PROBLEM", 72, 85], ["sedation", "TREATMENT", 87, 95], ["anesthesia", "TREATMENT", 99, 109], ["restraint", "TREATMENT", 179, 188], ["handling", "TREATMENT", 192, 200], ["oral procedures", "TREATMENT", 215, 230], ["Aspiration", "PROBLEM", 309, 319], ["aspiration pneumonia", "PROBLEM", 338, 358], ["acute dyspnea", "PROBLEM", 367, 380], ["a productive, retching cough", "PROBLEM", 395, 423], ["tachypnea", "PROBLEM", 425, 434], ["green (plant material", "PROBLEM", 457, 478], ["white (milk) feed material at the nares", "PROBLEM", 483, 522], ["esophageal", "ANATOMY", 46, 56], ["obstruction", "OBSERVATION", 57, 68], ["megaesophagus", "OBSERVATION", 72, 85], ["head", "ANATOMY", 257, 261], ["neck", "ANATOMY", 266, 270], ["restrained", "OBSERVATION", 275, 285], ["aspiration", "OBSERVATION_MODIFIER", 338, 348], ["pneumonia", "OBSERVATION", 349, 358], ["acute", "OBSERVATION_MODIFIER", 367, 372], ["dyspnea", "OBSERVATION", 373, 380], ["productive", "OBSERVATION_MODIFIER", 397, 407], ["green", "OBSERVATION_MODIFIER", 457, 462], ["nares", "ANATOMY", 517, 522], ["mouth", "ANATOMY", 544, 549], ["forestomach", "ANATOMY", 568, 579], ["nose", "ANATOMY", 600, 604], ["mouth", "ANATOMY", 609, 614]]], ["Pulmonary auscultation may reveal areas of wheezes or dull areas with little evidence of air movement.", [["Pulmonary", "ANATOMY", 0, 9], ["wheezes", "DISEASE", 43, 50], ["Pulmonary", "ORGAN", 0, 9], ["Pulmonary auscultation", "TEST", 0, 22], ["wheezes", "PROBLEM", 43, 50], ["dull areas", "PROBLEM", 54, 64], ["air movement", "PROBLEM", 89, 101], ["auscultation", "OBSERVATION", 10, 22], ["wheezes", "OBSERVATION", 43, 50], ["dull", "OBSERVATION_MODIFIER", 54, 58], ["little evidence of", "UNCERTAINTY", 70, 88], ["air movement", "OBSERVATION", 89, 101]]], ["With chronicity, these dull or abnormal areas may grow, and fever, anorexia, and obtundation may develop in a progressive fashion.", [["fever", "DISEASE", 60, 65], ["anorexia", "DISEASE", 67, 75], ["obtundation", "DISEASE", 81, 92], ["chronicity", "PROBLEM", 5, 15], ["these dull", "PROBLEM", 17, 27], ["abnormal areas", "PROBLEM", 31, 45], ["fever", "PROBLEM", 60, 65], ["anorexia", "PROBLEM", 67, 75], ["obtundation", "PROBLEM", 81, 92], ["dull", "OBSERVATION_MODIFIER", 23, 27], ["abnormal", "OBSERVATION_MODIFIER", 31, 39], ["areas", "OBSERVATION_MODIFIER", 40, 45]]], ["The leukogram may show inflammatory changes, including either neutropenia or neutrophilia with a left shift.", [["neutropenia", "DISEASE", 62, 73], ["neutrophilia", "DISEASE", 77, 89], ["leukogram", "CANCER", 4, 13], ["The leukogram", "TEST", 0, 13], ["inflammatory changes", "PROBLEM", 23, 43], ["neutropenia", "PROBLEM", 62, 73], ["neutrophilia", "PROBLEM", 77, 89], ["a left shift", "PROBLEM", 95, 107], ["may show", "UNCERTAINTY", 14, 22], ["inflammatory", "OBSERVATION", 23, 35], ["neutropenia", "OBSERVATION", 62, 73], ["neutrophilia", "OBSERVATION", 77, 89], ["left", "ANATOMY_MODIFIER", 97, 101]]], ["Hyperfibrinogenemia may develop after 24 hours.", [["Hyperfibrinogenemia", "DISEASE", 0, 19], ["Hyperfibrinogenemia", "PROBLEM", 0, 19]]], ["ABG analysis may reveal hypoxemia.", [["hypoxemia", "DISEASE", 24, 33], ["ABG", "CHEMICAL", 0, 3], ["ABG analysis", "TEST", 0, 12], ["hypoxemia", "PROBLEM", 24, 33], ["hypoxemia", "OBSERVATION", 24, 33]]], ["Thoracic radiography may reveal areas of consolidation, particularly in the cranioventral or midventral lung.", [["cranioventral", "ANATOMY", 76, 89], ["midventral lung", "ANATOMY", 93, 108], ["cranioventral", "CANCER", 76, 89], ["lung", "ORGAN", 104, 108], ["Thoracic radiography", "TEST", 0, 20], ["consolidation", "PROBLEM", 41, 54], ["areas", "OBSERVATION_MODIFIER", 32, 37], ["consolidation", "OBSERVATION", 41, 54], ["cranioventral", "ANATOMY_MODIFIER", 76, 89], ["midventral", "ANATOMY_MODIFIER", 93, 103], ["lung", "ANATOMY", 104, 108]]], ["Tracheal wash or BAL reveals the presence of feed material and inflammatory cells and, if gastric contents are aspirated, also the presence of bacteria, fungi, and protozoa.Aspiration PneumoniaTreatment of aspiration pneumonia is difficult because of the mixed population of microbial contaminants and the possible presence of large fiber particles.", [["Tracheal", "ANATOMY", 0, 8], ["BAL", "ANATOMY", 17, 20], ["inflammatory cells", "ANATOMY", 63, 81], ["gastric", "ANATOMY", 90, 97], ["aspiration pneumonia", "DISEASE", 206, 226], ["BAL", "ORGANISM_SUBSTANCE", 17, 20], ["inflammatory cells", "CELL", 63, 81], ["gastric", "ORGAN", 90, 97], ["fiber particles", "CELLULAR_COMPONENT", 333, 348], ["inflammatory cells", "CELL_TYPE", 63, 81], ["Tracheal wash or BAL", "TEST", 0, 20], ["inflammatory cells", "PROBLEM", 63, 81], ["gastric contents", "PROBLEM", 90, 106], ["bacteria", "PROBLEM", 143, 151], ["fungi", "PROBLEM", 153, 158], ["protozoa", "PROBLEM", 164, 172], ["Aspiration", "PROBLEM", 173, 183], ["aspiration pneumonia", "PROBLEM", 206, 226], ["microbial contaminants", "PROBLEM", 275, 297], ["large fiber particles", "PROBLEM", 327, 348], ["wash", "OBSERVATION", 9, 13], ["feed material", "OBSERVATION", 45, 58], ["inflammatory cells", "OBSERVATION", 63, 81], ["gastric", "ANATOMY", 90, 97], ["bacteria", "OBSERVATION", 143, 151], ["aspiration", "OBSERVATION_MODIFIER", 206, 216], ["pneumonia", "OBSERVATION", 217, 226], ["mixed", "OBSERVATION_MODIFIER", 255, 260], ["population", "OBSERVATION_MODIFIER", 261, 271], ["microbial contaminants", "OBSERVATION", 275, 297], ["large", "OBSERVATION_MODIFIER", 327, 332], ["fiber particles", "OBSERVATION", 333, 348]]], ["On first occurrence, the camelid's head should be maintained lower than the heart base, and the camelid should be allowed to cough freely.", [["head", "ANATOMY", 35, 39], ["heart", "ANATOMY", 76, 81], ["cough", "DISEASE", 125, 130], ["head", "ORGAN", 35, 39], ["heart", "ORGAN", 76, 81], ["head", "ANATOMY", 35, 39], ["lower", "OBSERVATION", 61, 66], ["heart", "ANATOMY", 76, 81], ["base", "ANATOMY_MODIFIER", 82, 86]]], ["In many cases of acute abnormal regurgitation, the feed material does not reach the lung and may be expelled without causing pneumonia.", [["lung", "ANATOMY", 84, 88], ["abnormal regurgitation", "DISEASE", 23, 45], ["pneumonia", "DISEASE", 125, 134], ["lung", "ORGAN", 84, 88], ["acute abnormal regurgitation", "PROBLEM", 17, 45], ["the feed material", "TREATMENT", 47, 64], ["pneumonia", "PROBLEM", 125, 134], ["acute", "OBSERVATION_MODIFIER", 17, 22], ["abnormal", "OBSERVATION_MODIFIER", 23, 31], ["regurgitation", "OBSERVATION", 32, 45], ["lung", "ANATOMY", 84, 88], ["pneumonia", "OBSERVATION", 125, 134]]], ["If feed material has reached the lungs, the camelid should be treated aggressively with broad-spectrum antibiotics and antiinflammatory drugs.", [["lungs", "ANATOMY", 33, 38], ["lungs", "ORGAN", 33, 38], ["broad-spectrum antibiotics", "TREATMENT", 88, 114], ["antiinflammatory drugs", "TREATMENT", 119, 141], ["lungs", "ANATOMY", 33, 38]]], ["Many upper airway and forestomach bacteria are facultative anaerobes, so the chosen antimicrobial agents should cover that spectrum.", [["upper airway", "ANATOMY", 5, 17], ["forestomach", "ANATOMY", 22, 33], ["upper airway", "MULTI-TISSUE_STRUCTURE", 5, 17], ["forestomach", "ORGAN", 22, 33], ["Many upper airway and forestomach bacteria", "PROBLEM", 0, 42], ["facultative anaerobes", "PROBLEM", 47, 68], ["the chosen antimicrobial agents", "TREATMENT", 73, 104], ["upper", "ANATOMY_MODIFIER", 5, 10], ["airway", "ANATOMY", 11, 17], ["forestomach", "ANATOMY", 22, 33], ["facultative", "OBSERVATION_MODIFIER", 47, 58], ["anaerobes", "OBSERVATION", 59, 68]]], ["Combinations of an aminoglycoside with a \u03b2-lactam agent are common, potentially with the addition of metronidazole.", [["aminoglycoside", "CHEMICAL", 19, 33], ["\u03b2-lactam", "CHEMICAL", 41, 49], ["metronidazole", "CHEMICAL", 101, 114], ["aminoglycoside", "CHEMICAL", 19, 33], ["\u03b2-lactam", "CHEMICAL", 41, 49], ["metronidazole", "CHEMICAL", 101, 114], ["aminoglycoside", "SIMPLE_CHEMICAL", 19, 33], ["\u03b2-lactam", "SIMPLE_CHEMICAL", 41, 49], ["metronidazole", "SIMPLE_CHEMICAL", 101, 114], ["an aminoglycoside", "TREATMENT", 16, 33], ["a \u03b2-lactam agent", "TREATMENT", 39, 55], ["metronidazole", "TREATMENT", 101, 114]]], ["Other basic care, including fluid, oxygen, nutritional support, and environmental support, may be necessary in severe cases.", [["oxygen", "CHEMICAL", 35, 41], ["oxygen", "CHEMICAL", 35, 41], ["oxygen", "SIMPLE_CHEMICAL", 35, 41], ["fluid, oxygen", "TREATMENT", 28, 41], ["nutritional support", "TREATMENT", 43, 62], ["environmental support", "TREATMENT", 68, 89], ["fluid", "OBSERVATION", 28, 33]]], ["The prognosis relates chiefly to the amount of feed material aspirated and how long it is present in the lungs before initiation of treatment.Aspiration PneumoniaAll attempts should be made to avoid aspiration pneumonia.", [["lungs", "ANATOMY", 105, 110], ["pneumonia", "DISEASE", 210, 219], ["lungs", "ORGAN", 105, 110], ["treatment", "TREATMENT", 132, 141], ["Aspiration PneumoniaAll attempts", "TREATMENT", 142, 174], ["aspiration pneumonia", "PROBLEM", 199, 219], ["aspirated", "OBSERVATION", 61, 70], ["lungs", "ANATOMY", 105, 110], ["aspiration", "OBSERVATION", 199, 209]]], ["Stomach tubes should be checked for patency and cavity fluids with generalized infections or exudates with localized infections.Aspiration PneumoniaGeneralized infections often respond to treatment with antibiotics, including penicillin and ceftiofur (ceftiofur is superior when secondary gram-negative sepsis has occurred).", [["Stomach tubes", "ANATOMY", 0, 13], ["cavity fluids", "ANATOMY", 48, 61], ["exudates", "ANATOMY", 93, 101], ["infections", "DISEASE", 79, 89], ["infections", "DISEASE", 117, 127], ["PneumoniaGeneralized infections", "DISEASE", 139, 170], ["penicillin", "CHEMICAL", 226, 236], ["ceftiofur", "CHEMICAL", 241, 250], ["ceftiofur", "CHEMICAL", 252, 261], ["sepsis", "DISEASE", 303, 309], ["penicillin", "CHEMICAL", 226, 236], ["ceftiofur", "CHEMICAL", 241, 250], ["ceftiofur", "CHEMICAL", 252, 261], ["Stomach tubes", "MULTI-TISSUE_STRUCTURE", 0, 13], ["penicillin", "SIMPLE_CHEMICAL", 226, 236], ["ceftiofur", "SIMPLE_CHEMICAL", 241, 250], ["ceftiofur", "SIMPLE_CHEMICAL", 252, 261], ["Stomach tubes", "TREATMENT", 0, 13], ["patency and cavity fluids", "TREATMENT", 36, 61], ["generalized infections", "PROBLEM", 67, 89], ["exudates", "PROBLEM", 93, 101], ["localized infections", "PROBLEM", 107, 127], ["Aspiration PneumoniaGeneralized infections", "PROBLEM", 128, 170], ["treatment", "TREATMENT", 188, 197], ["antibiotics", "TREATMENT", 203, 214], ["penicillin", "TREATMENT", 226, 236], ["ceftiofur", "TREATMENT", 241, 250], ["ceftiofur", "TREATMENT", 252, 261], ["secondary gram-negative sepsis", "PROBLEM", 279, 309], ["tubes", "OBSERVATION", 8, 13], ["generalized", "OBSERVATION_MODIFIER", 67, 78], ["infections", "OBSERVATION", 79, 89], ["exudates", "OBSERVATION", 93, 101], ["localized", "OBSERVATION_MODIFIER", 107, 116], ["infections", "OBSERVATION", 117, 127], ["infections", "OBSERVATION", 160, 170], ["negative sepsis", "OBSERVATION", 294, 309]]], ["However, this treatment alone occasionally leaves abscesses that may cause problems later (including sudden death).", [["abscesses", "ANATOMY", 50, 59], ["abscesses", "DISEASE", 50, 59], ["death", "DISEASE", 108, 113], ["abscesses", "PATHOLOGICAL_FORMATION", 50, 59], ["this treatment", "TREATMENT", 9, 23], ["abscesses", "PROBLEM", 50, 59], ["sudden death", "PROBLEM", 101, 113], ["abscesses", "OBSERVATION", 50, 59]]], ["Peritoneal (and theoretically pleural) lavage may be attempted transcutaneously, but the best results are obtained with onetime, thorough surgical lavage of the abdomen in conjunction with medical treatments (antibiotics, fluids, nonsteroidal antiinflammatory drugs [NSAIDs], possibly plasma).", [["Peritoneal", "ANATOMY", 0, 10], ["pleural", "ANATOMY", 30, 37], ["abdomen", "ANATOMY", 161, 168], ["nonsteroidal", "ANATOMY", 230, 242], ["plasma", "ANATOMY", 285, 291], ["Peritoneal", "MULTI-TISSUE_STRUCTURE", 0, 10], ["abdomen", "ORGAN", 161, 168], ["nonsteroidal antiinflammatory drugs", "SIMPLE_CHEMICAL", 230, 265], ["NSAIDs", "SIMPLE_CHEMICAL", 267, 273], ["plasma", "ORGANISM_SUBSTANCE", 285, 291], ["Peritoneal (and theoretically pleural) lavage", "TREATMENT", 0, 45], ["thorough surgical lavage of the abdomen", "TEST", 129, 168], ["medical treatments", "TREATMENT", 189, 207], ["antibiotics", "TREATMENT", 209, 220], ["fluids", "TREATMENT", 222, 228], ["nonsteroidal antiinflammatory drugs", "TREATMENT", 230, 265], ["NSAIDs", "TREATMENT", 267, 273], ["pleural", "ANATOMY", 30, 37], ["lavage", "OBSERVATION", 39, 45], ["abdomen", "ANATOMY", 161, 168]]], ["The longterm survival rate without surgery is about 60%, whereas the survival rate after surgical lavage is about 80%.Aspiration PneumoniaLocal lesions appear to be best treated by drainage (if possible) and antibiotics.", [["PneumoniaLocal lesions", "ANATOMY", 129, 151], ["PneumoniaLocal lesions", "PATHOLOGICAL_FORMATION", 129, 151], ["The longterm survival rate", "TREATMENT", 0, 26], ["surgery", "TREATMENT", 35, 42], ["surgical lavage", "TEST", 89, 104], ["Aspiration PneumoniaLocal lesions", "PROBLEM", 118, 151], ["drainage", "TREATMENT", 181, 189], ["antibiotics", "TREATMENT", 208, 219], ["lavage", "OBSERVATION", 98, 104], ["lesions", "OBSERVATION", 144, 151], ["drainage", "OBSERVATION", 181, 189]]], ["Some break open spontaneously.", [["break", "OBSERVATION_MODIFIER", 5, 10], ["open", "OBSERVATION", 11, 15]]], ["Many abscesses recur after treatment.", [["abscesses", "ANATOMY", 5, 14], ["abscesses", "DISEASE", 5, 14], ["abscesses", "PATHOLOGICAL_FORMATION", 5, 14], ["Many abscesses", "PROBLEM", 0, 14], ["treatment", "TREATMENT", 27, 36], ["abscesses", "OBSERVATION", 5, 14]]], ["As long as drainage is not internal, and the abscesses are walled off well, camelids may live with them for years.Aspiration PneumoniaPrevention efforts are in their infancy and hampered by our limited understanding of the pathogenesis of this disease.", [["abscesses", "ANATOMY", 45, 54], ["abscesses", "DISEASE", 45, 54], ["abscesses", "PATHOLOGICAL_FORMATION", 45, 54], ["drainage", "TREATMENT", 11, 19], ["the abscesses", "PROBLEM", 41, 54], ["Aspiration", "PROBLEM", 114, 124], ["this disease", "PROBLEM", 239, 251], ["drainage", "OBSERVATION", 11, 19], ["abscesses", "OBSERVATION", 45, 54], ["disease", "OBSERVATION", 244, 251]]], ["Equine strangles vaccines should not be used; the older ones cause severe abscessation in llamas, and the newer ones have not been tested.", [["abscessation", "DISEASE", 74, 86], ["Equine", "ORGANISM", 0, 6], ["llamas", "ORGANISM", 90, 96], ["Equine strangles vaccines", "TREATMENT", 0, 25], ["severe abscessation in llamas", "PROBLEM", 67, 96], ["severe", "OBSERVATION_MODIFIER", 67, 73], ["abscessation", "OBSERVATION", 74, 86], ["llamas", "OBSERVATION", 90, 96]]], ["In South America, the organism is thought to be a widespread oral commensal, so no effort is made to prevent transmission from animal to animal.", [["oral", "ANATOMY", 61, 65], ["oral", "ORGANISM_SUBDIVISION", 61, 65], ["thought to be", "UNCERTAINTY", 34, 47], ["widespread", "OBSERVATION_MODIFIER", 50, 60]]], ["Instead, preventing stressful management practices and rough handling are emphasized.", [["stressful management practices", "TREATMENT", 20, 50]]], ["Several studies on camelids in North America have not supported the theory that the organism is an oral or respiratory tract commensal.", [["oral", "ANATOMY", 99, 103], ["respiratory tract", "ANATOMY", 107, 124], ["oral", "ORGANISM_SUBDIVISION", 99, 103], ["respiratory tract", "ORGANISM_SUBDIVISION", 107, 124], ["Several studies", "TEST", 0, 15], ["the organism", "PROBLEM", 80, 92], ["an oral or respiratory tract commensal", "PROBLEM", 96, 134], ["respiratory tract", "ANATOMY", 107, 124]]], ["This raises new issues on how transmission occurs.", [["new", "OBSERVATION_MODIFIER", 12, 15]]], ["Aerosol transmission of S. zooepidemicus, a common pharyngeal commensal of many other animals, they may appear better than their level of oxygenation warrants.", [["pharyngeal", "ANATOMY", 51, 61], ["S. zooepidemicus", "ORGANISM", 24, 40], ["pharyngeal", "ORGANISM_SUBDIVISION", 51, 61], ["S. zooepidemicus", "SPECIES", 24, 40], ["S. zooepidemicus", "SPECIES", 24, 40], ["S. zooepidemicus", "TREATMENT", 24, 40]]], ["However, that does not mean they thrive under hypoxemic conditions.Aspiration PneumoniaSigns of hypoxemia may range from mild decreases in activity to coma, cyanotic membranes, and death.", [["cyanotic membranes", "ANATOMY", 157, 175], ["hypoxemia", "DISEASE", 96, 105], ["coma", "DISEASE", 151, 155], ["cyanotic membranes", "DISEASE", 157, 175], ["death", "DISEASE", 181, 186], ["hypoxemic conditions", "PROBLEM", 46, 66], ["Aspiration PneumoniaSigns", "PROBLEM", 67, 92], ["hypoxemia", "PROBLEM", 96, 105], ["mild decreases in activity to coma", "PROBLEM", 121, 155], ["cyanotic membranes", "PROBLEM", 157, 175], ["death", "PROBLEM", 181, 186], ["hypoxemic", "OBSERVATION", 46, 55], ["hypoxemia", "OBSERVATION", 96, 105], ["mild", "OBSERVATION_MODIFIER", 121, 125], ["decreases", "OBSERVATION_MODIFIER", 126, 135], ["activity", "OBSERVATION_MODIFIER", 139, 147], ["cyanotic membranes", "OBSERVATION", 157, 175]]], ["Most camelids with pulmonary dysmaturity appear sluggish at birth.", [["camelids", "ANATOMY", 5, 13], ["pulmonary", "ANATOMY", 19, 28], ["pulmonary dysmaturity", "DISEASE", 19, 40], ["pulmonary", "ORGAN", 19, 28], ["pulmonary dysmaturity", "PROBLEM", 19, 40], ["sluggish at birth", "PROBLEM", 48, 65], ["pulmonary", "ANATOMY", 19, 28], ["dysmaturity", "OBSERVATION", 29, 40], ["sluggish", "OBSERVATION", 48, 56]]], ["They do not accomplish the tasks of standing, nursing, and passing meconium as quickly or as vigorously as healthy herdmates and may not accomplish them without assistance or at all in some cases.", [["meconium", "ORGANISM_SUBSTANCE", 67, 75]]], ["Poor appetite and the tendency to remain recumbent predispose them to neonatal sepsis or poor growth.", [["sepsis", "DISEASE", 79, 85], ["Poor appetite", "PROBLEM", 0, 13], ["neonatal sepsis", "PROBLEM", 70, 85], ["poor growth", "PROBLEM", 89, 100], ["sepsis", "OBSERVATION", 79, 85]]], ["Owners' attempts to support these crias through tube feeding and provision of warmth and shelter meet limited success.Aspiration PneumoniaWhenever a cria appears obtunded since birth or appears to be less vigorous or thrifty than other crias, hypoxemia should be suspected.", [["tube", "ANATOMY", 48, 52], ["hypoxemia", "DISEASE", 243, 252], ["tube", "TISSUE", 48, 52], ["these crias", "TREATMENT", 28, 39], ["tube feeding", "TREATMENT", 48, 60], ["Aspiration PneumoniaWhenever", "PROBLEM", 118, 146], ["obtunded", "PROBLEM", 162, 170], ["hypoxemia", "PROBLEM", 243, 252], ["obtunded", "OBSERVATION", 162, 170], ["appears to be", "UNCERTAINTY", 186, 199], ["less", "OBSERVATION_MODIFIER", 200, 204], ["vigorous", "OBSERVATION", 205, 213], ["hypoxemia", "OBSERVATION", 243, 252]]], ["Thoracic radiography and ABG analysis are the best ways to ascertain the presence of pulmonary dysmaturity.", [["pulmonary", "ANATOMY", 85, 94], ["pulmonary dysmaturity", "DISEASE", 85, 106], ["pulmonary", "ORGAN", 85, 94], ["Thoracic radiography", "TEST", 0, 20], ["ABG analysis", "TEST", 25, 37], ["pulmonary dysmaturity", "PROBLEM", 85, 106], ["pulmonary", "ANATOMY", 85, 94], ["dysmaturity", "OBSERVATION", 95, 106]]], ["ABG analysis might reveal hypoxemia but does not reveal the specific cause.", [["hypoxemia", "DISEASE", 26, 35], ["ABG", "CHEMICAL", 0, 3], ["ABG analysis", "TEST", 0, 12], ["hypoxemia", "PROBLEM", 26, 35], ["hypoxemia", "OBSERVATION", 26, 35]]], ["Dysmature lung appears more radiodense than normal lung and potentially resembles soft tissue in density.", [["lung", "ANATOMY", 10, 14], ["lung", "ANATOMY", 51, 55], ["soft tissue", "ANATOMY", 82, 93], ["lung", "ORGAN", 10, 14], ["lung", "ORGAN", 51, 55], ["soft tissue", "TISSUE", 82, 93], ["Dysmature lung", "PROBLEM", 0, 14], ["soft tissue in density", "PROBLEM", 82, 104], ["lung", "ANATOMY", 10, 14], ["more", "OBSERVATION_MODIFIER", 23, 27], ["radiodense", "OBSERVATION", 28, 38], ["lung", "ANATOMY", 51, 55], ["soft tissue", "OBSERVATION_MODIFIER", 82, 93], ["density", "OBSERVATION", 97, 104]]], ["Evidence of sepsis may be present or absent.Aspiration PneumoniaCrias identified as having pulmonary dysmaturity should immediately be placed on 1 to 3 L/hr supplemental oxygen.", [["pulmonary", "ANATOMY", 91, 100], ["sepsis", "DISEASE", 12, 18], ["pulmonary dysmaturity", "DISEASE", 91, 112], ["oxygen", "CHEMICAL", 170, 176], ["oxygen", "CHEMICAL", 170, 176], ["pulmonary", "ORGAN", 91, 100], ["oxygen", "SIMPLE_CHEMICAL", 170, 176], ["sepsis", "PROBLEM", 12, 18], ["Aspiration PneumoniaCrias", "PROBLEM", 44, 69], ["pulmonary dysmaturity", "PROBLEM", 91, 112], ["supplemental oxygen", "TREATMENT", 157, 176], ["sepsis", "OBSERVATION", 12, 18], ["pulmonary", "ANATOMY", 91, 100], ["dysmaturity", "OBSERVATION", 101, 112]]], ["With time, that may be enough support to resolve milder cases.", [["milder cases", "PROBLEM", 49, 61]]], ["Likelihood of success may be estimated by comparing pre-and post-oxygen arterial oxygen content.", [["arterial", "ANATOMY", 72, 80], ["oxygen", "CHEMICAL", 81, 87], ["oxygen", "CHEMICAL", 81, 87], ["arterial", "MULTI-TISSUE_STRUCTURE", 72, 80], ["oxygen", "SIMPLE_CHEMICAL", 81, 87], ["success", "OBSERVATION", 14, 21], ["arterial", "ANATOMY", 72, 80], ["oxygen content", "OBSERVATION", 81, 95]]], ["Crias in which this treatment is likely to work typically achieve PaO 2 of at least 60 mm Hg on oxygen and can usually be removed from supplemental oxygen within 48 hours.", [["oxygen", "CHEMICAL", 96, 102], ["oxygen", "CHEMICAL", 148, 154], ["PaO 2", "CHEMICAL", 66, 71], ["Hg", "CHEMICAL", 90, 92], ["oxygen", "CHEMICAL", 96, 102], ["oxygen", "CHEMICAL", 148, 154], ["oxygen", "SIMPLE_CHEMICAL", 96, 102], ["oxygen", "SIMPLE_CHEMICAL", 148, 154], ["oxygen", "TREATMENT", 96, 102], ["supplemental oxygen", "TREATMENT", 135, 154]]], ["Crias that are unable to oxygenate adequately on supplemental oxygen have a poor prognosis.Aspiration PneumoniaIn extreme cases, surfactant may be administered.", [["oxygen", "CHEMICAL", 62, 68], ["oxygen", "CHEMICAL", 62, 68], ["oxygen", "SIMPLE_CHEMICAL", 62, 68], ["supplemental oxygen", "TREATMENT", 49, 68], ["Aspiration PneumoniaIn extreme cases", "PROBLEM", 91, 127], ["surfactant", "TREATMENT", 129, 139]]], ["This is most successful if done immediately after birth, before tissues have suffered chronic hypoxia and opportunistic infection has set in.", [["tissues", "ANATOMY", 64, 71], ["hypoxia", "DISEASE", 94, 101], ["opportunistic infection", "DISEASE", 106, 129], ["tissues", "TISSUE", 64, 71], ["chronic hypoxia", "PROBLEM", 86, 101], ["opportunistic infection", "PROBLEM", 106, 129], ["chronic", "OBSERVATION_MODIFIER", 86, 93], ["hypoxia", "OBSERVATION", 94, 101], ["opportunistic", "OBSERVATION_MODIFIER", 106, 119], ["infection", "OBSERVATION", 120, 129]]], ["Clinical experiences are limited.Chronic PneumoniaChronic infections of the lung are much more frequent findings in camelids compared with acute ones, if one disregards neonatal sepsis.", [["lung", "ANATOMY", 76, 80], ["PneumoniaChronic infections of the lung", "DISEASE", 41, 80], ["camelids", "DISEASE", 116, 124], ["sepsis", "DISEASE", 178, 184], ["lung", "ORGAN", 76, 80], ["Chronic PneumoniaChronic infections of the lung", "PROBLEM", 33, 80], ["neonatal sepsis", "PROBLEM", 169, 184], ["PneumoniaChronic", "OBSERVATION_MODIFIER", 41, 57], ["infections", "OBSERVATION", 58, 68], ["lung", "ANATOMY", 76, 80], ["much", "OBSERVATION_MODIFIER", 85, 89], ["more frequent", "OBSERVATION_MODIFIER", 90, 103], ["sepsis", "OBSERVATION", 178, 184]]], ["However, the clinical course may be judged to be short because the camelid would have been first noticed to be abnormal only late in the course of the disease.", [["camelid", "CANCER", 67, 74], ["the disease", "PROBLEM", 147, 158], ["disease", "OBSERVATION", 151, 158]]], ["Careful examination and concurrent findings such as emaciation or hypoproteinemia may confirm the chronic nature of the infection.Chronic PneumoniaChronic infections and infestations may be caused by bacteria, fungi, or parasites.", [["emaciation", "DISEASE", 52, 62], ["hypoproteinemia", "DISEASE", 66, 81], ["infection", "DISEASE", 120, 129], ["PneumoniaChronic infections", "DISEASE", 138, 165], ["infestations", "DISEASE", 170, 182], ["Careful examination", "TEST", 0, 19], ["emaciation", "PROBLEM", 52, 62], ["hypoproteinemia", "PROBLEM", 66, 81], ["the infection", "PROBLEM", 116, 129], ["Chronic PneumoniaChronic infections", "PROBLEM", 130, 165], ["infestations", "PROBLEM", 170, 182], ["bacteria", "PROBLEM", 200, 208], ["fungi", "PROBLEM", 210, 215], ["parasites", "PROBLEM", 220, 229], ["hypoproteinemia", "OBSERVATION", 66, 81], ["chronic", "OBSERVATION_MODIFIER", 98, 105], ["infection", "OBSERVATION", 120, 129], ["PneumoniaChronic", "OBSERVATION_MODIFIER", 138, 154], ["infections", "OBSERVATION", 155, 165], ["infestations", "OBSERVATION", 170, 182], ["may be caused", "UNCERTAINTY", 183, 196], ["bacteria", "OBSERVATION", 200, 208], ["fungi", "OBSERVATION", 210, 215]]], ["The most common bacteria isolated form abscesses or granulomas.", [["abscesses", "ANATOMY", 39, 48], ["granulomas", "ANATOMY", 52, 62], ["abscesses", "DISEASE", 39, 48], ["granulomas", "DISEASE", 52, 62], ["abscesses", "PATHOLOGICAL_FORMATION", 39, 48], ["granulomas", "PATHOLOGICAL_FORMATION", 52, 62], ["The most common bacteria", "PROBLEM", 0, 24], ["abscesses", "PROBLEM", 39, 48], ["granulomas", "PROBLEM", 52, 62], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["abscesses", "OBSERVATION", 39, 48], ["granulomas", "OBSERVATION", 52, 62]]], ["Abscesses may be caused by Arcanobacter pyogenes, S. zooepidemicus, Fusobacterium necropho rum, C. pseudotuberculosis, Rhodococcus equi, Burkholderia pseu domallei, and other bacteria.", [["Abscesses", "ANATOMY", 0, 9], ["Abscesses", "DISEASE", 0, 9], ["C. pseudotuberculosis", "DISEASE", 96, 117], ["Rhodococcus equi", "DISEASE", 119, 135], ["Arcanobacter pyogenes", "ORGANISM", 27, 48], ["S. zooepidemicus", "ORGANISM", 50, 66], ["Fusobacterium necropho rum", "ORGANISM", 68, 94], ["C. pseudotuberculosis", "ORGANISM", 96, 117], ["Rhodococcus equi", "ORGANISM", 119, 135], ["Burkholderia pseu domallei", "ORGANISM", 137, 163], ["Arcanobacter pyogenes", "SPECIES", 27, 48], ["S. zooepidemicus", "SPECIES", 50, 66], ["Fusobacterium necropho", "SPECIES", 68, 90], ["C. pseudotuberculosis", "SPECIES", 96, 117], ["Rhodococcus equi", "SPECIES", 119, 135], ["Burkholderia pseu domallei", "SPECIES", 137, 163], ["Arcanobacter pyogenes", "SPECIES", 27, 48], ["S. zooepidemicus", "SPECIES", 50, 66], ["Fusobacterium necropho rum", "SPECIES", 68, 94], ["C. pseudotuberculosis", "SPECIES", 96, 117], ["Rhodococcus equi", "SPECIES", 119, 135], ["Burkholderia pseu domallei", "SPECIES", 137, 163], ["Abscesses", "PROBLEM", 0, 9], ["Arcanobacter pyogenes", "PROBLEM", 27, 48], ["S. zooepidemicus", "PROBLEM", 50, 66], ["Fusobacterium", "PROBLEM", 68, 81], ["C. pseudotuberculosis", "PROBLEM", 96, 117], ["Rhodococcus equi", "PROBLEM", 119, 135], ["Burkholderia pseu domallei", "PROBLEM", 137, 163], ["other bacteria", "PROBLEM", 169, 183], ["may be caused", "UNCERTAINTY", 10, 23], ["Arcanobacter pyogenes", "OBSERVATION", 27, 48], ["pseudotuberculosis", "OBSERVATION", 99, 117]]], ["In some cases, they may have been the original invader; in others, they are likely to be a secondary colonizer.", [["a secondary colonizer", "PROBLEM", 89, 110], ["likely to be", "UNCERTAINTY", 76, 88], ["secondary", "OBSERVATION_MODIFIER", 91, 100], ["colonizer", "OBSERVATION", 101, 110]]], ["Granulomas are frequently caused by Mycobacteria.", [["Granulomas", "ANATOMY", 0, 10], ["Granulomas", "DISEASE", 0, 10], ["Mycobacteria", "DISEASE", 36, 48], ["Granulomas", "PROBLEM", 0, 10], ["Mycobacteria", "PROBLEM", 36, 48], ["Mycobacteria", "OBSERVATION", 36, 48]]], ["Several different causes of fungal pneumonia have been identified, including Aspergillus, Histoplasma capsu latum, Coccidioides immitis, and Cryptococcus neoformans.", [["fungal pneumonia", "DISEASE", 28, 44], ["Histoplasma capsu latum", "DISEASE", 90, 113], ["Coccidioides immitis", "DISEASE", 115, 135], ["Cryptococcus neoformans", "DISEASE", 141, 164], ["Aspergillus", "ORGANISM", 77, 88], ["Histoplasma capsu latum", "ORGANISM", 90, 113], ["Coccidioides immitis", "ORGANISM", 115, 135], ["Cryptococcus neoformans", "ORGANISM", 141, 164], ["Histoplasma capsu latum", "SPECIES", 90, 113], ["Coccidioides immitis", "SPECIES", 115, 135], ["Cryptococcus neoformans", "SPECIES", 141, 164], ["Histoplasma capsu latum", "SPECIES", 90, 113], ["Coccidioides immitis", "SPECIES", 115, 135], ["Cryptococcus neoformans", "SPECIES", 141, 164], ["fungal pneumonia", "PROBLEM", 28, 44], ["Aspergillus", "PROBLEM", 77, 88], ["Histoplasma capsu latum", "PROBLEM", 90, 113], ["Coccidioides immitis", "PROBLEM", 115, 135], ["Cryptococcus neoformans", "PROBLEM", 141, 164], ["fungal", "OBSERVATION_MODIFIER", 28, 34], ["pneumonia", "OBSERVATION", 35, 44], ["Aspergillus", "OBSERVATION", 77, 88], ["Histoplasma capsu", "OBSERVATION", 90, 107], ["Coccidioides immitis", "OBSERVATION", 115, 135], ["Cryptococcus neoformans", "OBSERVATION", 141, 164]]], ["Disseminated infections are common with several of the fungi, and nonrespiratory signs may be dominant.", [["Disseminated infections", "DISEASE", 0, 23], ["Disseminated infections", "PROBLEM", 0, 23], ["the fungi", "TEST", 51, 60], ["nonrespiratory signs", "TEST", 66, 86], ["infections", "OBSERVATION", 13, 23], ["fungi", "OBSERVATION", 55, 60], ["nonrespiratory signs", "OBSERVATION", 66, 86], ["may be", "UNCERTAINTY", 87, 93], ["dominant", "OBSERVATION_MODIFIER", 94, 102]]], ["Although fungal infections should generally be considered rare, especially outside of the southwestern and northwestern United States, they are one of the more common causes for resting chronic negative pressure or by palpation to confirm that they are within the esophagus.", [["esophagus", "ANATOMY", 264, 273], ["fungal infections", "DISEASE", 9, 26], ["esophagus", "ORGAN", 264, 273], ["fungal infections", "PROBLEM", 9, 26], ["palpation", "TEST", 218, 227], ["fungal", "OBSERVATION_MODIFIER", 9, 15], ["infections", "OBSERVATION", 16, 26], ["esophagus", "ANATOMY", 264, 273]]], ["Weak neonates should not be fed by bottle from an elevated position but rather by orogastric intubation or from a pan.", [["orogastric", "ANATOMY", 82, 92], ["neonates", "ORGANISM", 5, 13], ["Weak neonates", "PROBLEM", 0, 13], ["an elevated position", "PROBLEM", 47, 67], ["orogastric intubation", "TREATMENT", 82, 103], ["neonates", "OBSERVATION", 5, 13], ["elevated", "OBSERVATION", 50, 58]]], ["Camelids with esophageal obstruction should not be restrained with the head upright.", [["esophageal", "ANATOMY", 14, 24], ["head", "ANATOMY", 71, 75], ["esophageal obstruction", "DISEASE", 14, 36], ["esophageal", "ORGAN", 14, 24], ["head", "ORGANISM_SUBDIVISION", 71, 75], ["esophageal obstruction", "PROBLEM", 14, 36], ["esophageal", "ANATOMY", 14, 24], ["obstruction", "OBSERVATION", 25, 36]]], ["Food and water access should be restricted for a minimum of 12 hours (up to 48 hours for feed, if necessary) before elective procedures that require heavy sedation or anesthesia.", [["water access", "TREATMENT", 9, 21], ["elective procedures", "TREATMENT", 116, 135], ["heavy sedation", "TREATMENT", 149, 163], ["anesthesia", "TREATMENT", 167, 177]]], ["Most importantly, if a camelid regurgitates during a procedure, it should be allowed or forced to lower its head until the mouth and upper airway are clear.Pulmonary Edema and Shock LungCamelids are prone to hypoproteinemia and hence are prone to develop edema.", [["head", "ANATOMY", 108, 112], ["mouth", "ANATOMY", 123, 128], ["upper airway", "ANATOMY", 133, 145], ["Pulmonary", "ANATOMY", 156, 165], ["edema", "ANATOMY", 255, 260], ["Pulmonary Edema", "DISEASE", 156, 171], ["hypoproteinemia", "DISEASE", 208, 223], ["edema", "DISEASE", 255, 260], ["head", "ORGANISM_SUBDIVISION", 108, 112], ["mouth", "ORGANISM_SUBDIVISION", 123, 128], ["upper airway", "ORGANISM_SUBDIVISION", 133, 145], ["edema", "PATHOLOGICAL_FORMATION", 255, 260], ["a camelid regurgitates", "PROBLEM", 21, 43], ["a procedure", "TREATMENT", 51, 62], ["Pulmonary Edema", "PROBLEM", 156, 171], ["Shock LungCamelids", "PROBLEM", 176, 194], ["hypoproteinemia", "PROBLEM", 208, 223], ["edema", "PROBLEM", 255, 260], ["head", "ANATOMY", 108, 112], ["mouth", "ANATOMY", 123, 128], ["upper", "ANATOMY_MODIFIER", 133, 138], ["airway", "ANATOMY", 139, 145], ["clear", "OBSERVATION", 150, 155], ["Edema", "OBSERVATION", 166, 171], ["Shock", "OBSERVATION", 176, 181], ["hypoproteinemia", "OBSERVATION", 208, 223], ["edema", "OBSERVATION", 255, 260]]], ["This may be worsened by IV fluid treatments.", [["IV fluid treatments", "TREATMENT", 24, 43], ["may be", "UNCERTAINTY", 5, 11], ["worsened", "OBSERVATION_MODIFIER", 12, 20], ["fluid treatments", "OBSERVATION", 27, 43]]], ["Spontaneous clinical edema appears to be rare.", [["edema", "DISEASE", 21, 26], ["edema", "PATHOLOGICAL_FORMATION", 21, 26], ["Spontaneous clinical edema", "PROBLEM", 0, 26], ["edema", "OBSERVATION", 21, 26], ["appears to be", "UNCERTAINTY", 27, 40], ["rare", "OBSERVATION_MODIFIER", 41, 45]]], ["Thus, this condition is most commonly encountered at intensive care facilities, but it may be one of the chief causes of death in camelids at those facilities.Pulmonary Edema and Shock LungCamelids affected by this condition are usually admitted and examined for another complaint, placed on IV fluids, and later develop dyspnea, tachypnea, and obtundation without fever, possibly losing the ability to remain in sternal recumbency or maintain the head in a normal position.", [["Pulmonary", "ANATOMY", 159, 168], ["sternal", "ANATOMY", 413, 420], ["head", "ANATOMY", 448, 452], ["death", "DISEASE", 121, 126], ["camelids", "DISEASE", 130, 138], ["Pulmonary Edema", "DISEASE", 159, 174], ["dyspnea", "DISEASE", 321, 328], ["tachypnea", "DISEASE", 330, 339], ["obtundation", "DISEASE", 345, 356], ["fever", "DISEASE", 365, 370], ["head", "ORGANISM_SUBDIVISION", 448, 452], ["death", "PROBLEM", 121, 126], ["Pulmonary Edema", "PROBLEM", 159, 174], ["Shock LungCamelids", "PROBLEM", 179, 197], ["IV fluids", "TREATMENT", 292, 301], ["dyspnea", "PROBLEM", 321, 328], ["tachypnea", "PROBLEM", 330, 339], ["obtundation", "PROBLEM", 345, 356], ["fever", "PROBLEM", 365, 370], ["Edema", "OBSERVATION", 169, 174], ["Shock", "OBSERVATION", 179, 184], ["dyspnea", "OBSERVATION", 321, 328], ["tachypnea", "OBSERVATION", 330, 339], ["sternal", "ANATOMY", 413, 420], ["head", "ANATOMY", 448, 452], ["normal", "OBSERVATION", 458, 464]]], ["Wheezes may be heard on thoracic auscultation, and pulmonary radiography may reveal a diffuse interstitial pattern or, in severe cases, perihilar consolidation.", [["thoracic", "ANATOMY", 24, 32], ["pulmonary", "ANATOMY", 51, 60], ["interstitial", "ANATOMY", 94, 106], ["perihilar", "ANATOMY", 136, 145], ["Wheezes", "DISEASE", 0, 7], ["thoracic", "ORGAN", 24, 32], ["pulmonary", "ORGAN", 51, 60], ["Wheezes", "PROBLEM", 0, 7], ["thoracic auscultation", "TEST", 24, 45], ["pulmonary radiography", "TEST", 51, 72], ["a diffuse interstitial pattern", "PROBLEM", 84, 114], ["perihilar consolidation", "PROBLEM", 136, 159], ["thoracic", "ANATOMY", 24, 32], ["pulmonary", "ANATOMY", 51, 60], ["diffuse", "OBSERVATION_MODIFIER", 86, 93], ["interstitial pattern", "OBSERVATION", 94, 114], ["severe", "OBSERVATION_MODIFIER", 122, 128], ["perihilar", "ANATOMY_MODIFIER", 136, 145], ["consolidation", "OBSERVATION", 146, 159]]], ["ABG analysis reveals hypoxemia.", [["hypoxemia", "DISEASE", 21, 30], ["ABG", "CHEMICAL", 0, 3], ["ABG analysis", "TEST", 0, 12], ["hypoxemia", "PROBLEM", 21, 30], ["hypoxemia", "OBSERVATION", 21, 30]]], ["Without treatment, the condition is often fatal.", [["treatment", "TREATMENT", 8, 17]]], ["Treatment consists of reducing the rate of fluid administration, administering colloids: Start with 8 to 10 mL/kg of 6% Hetastarch or plasma over 30 to 90 minutes, and then reassess; higher doses (up to 40 mL/kg) may be necessary with severe hypoproteinemia.", [["fluid", "ANATOMY", 43, 48], ["plasma", "ANATOMY", 134, 140], ["Hetastarch", "CHEMICAL", 120, 130], ["hypoproteinemia", "DISEASE", 242, 257], ["fluid", "ORGANISM_SUBSTANCE", 43, 48], ["Hetastarch", "SIMPLE_CHEMICAL", 120, 130], ["plasma", "ORGANISM_SUBSTANCE", 134, 140], ["fluid administration", "TREATMENT", 43, 63], ["plasma", "TREATMENT", 134, 140], ["severe hypoproteinemia", "PROBLEM", 235, 257], ["severe", "OBSERVATION_MODIFIER", 235, 241], ["hypoproteinemia", "OBSERVATION", 242, 257]]], ["This should be followed by administration of intranasal oxygen and possibly diuretics.", [["oxygen", "CHEMICAL", 56, 62], ["oxygen", "CHEMICAL", 56, 62], ["oxygen", "SIMPLE_CHEMICAL", 56, 62], ["intranasal oxygen", "TREATMENT", 45, 62], ["diuretics", "TREATMENT", 76, 85]]], ["Many affected camelids have concurrent upper airway problems such as pharyngeal collapse or dorsal displacement of the soft palate.", [["camelids", "ANATOMY", 14, 22], ["airway", "ANATOMY", 45, 51], ["pharyngeal", "ANATOMY", 69, 79], ["dorsal", "ANATOMY", 92, 98], ["soft palate", "ANATOMY", 119, 130], ["pharyngeal collapse", "DISEASE", 69, 88], ["camelids", "CANCER", 14, 22], ["upper airway", "ORGANISM_SUBDIVISION", 39, 51], ["pharyngeal", "ORGANISM_SUBDIVISION", 69, 79], ["palate", "ORGAN", 124, 130], ["Many affected camelids", "PROBLEM", 0, 22], ["concurrent upper airway problems", "PROBLEM", 28, 60], ["pharyngeal collapse", "PROBLEM", 69, 88], ["dorsal displacement of the soft palate", "PROBLEM", 92, 130], ["upper", "ANATOMY_MODIFIER", 39, 44], ["airway", "ANATOMY", 45, 51], ["problems", "OBSERVATION", 52, 60], ["pharyngeal", "ANATOMY", 69, 79], ["collapse", "OBSERVATION", 80, 88], ["dorsal", "OBSERVATION_MODIFIER", 92, 98], ["displacement", "OBSERVATION_MODIFIER", 99, 111], ["soft palate", "ANATOMY", 119, 130]]], ["These camelids have more stridor and often appear to be good candidates for tracheostomy; however, tracheostomy does not result in rapid improvement because of the lower airway disease.", [["lower airway", "ANATOMY", 164, 176], ["stridor", "DISEASE", 25, 32], ["airway disease", "DISEASE", 170, 184], ["airway", "MULTI-TISSUE_STRUCTURE", 170, 176], ["more stridor", "PROBLEM", 20, 32], ["tracheostomy", "TREATMENT", 76, 88], ["tracheostomy", "TREATMENT", 99, 111], ["the lower airway disease", "PROBLEM", 160, 184], ["stridor", "OBSERVATION", 25, 32], ["tracheostomy", "OBSERVATION", 76, 88], ["lower", "ANATOMY_MODIFIER", 164, 169], ["airway", "ANATOMY", 170, 176], ["disease", "OBSERVATION", 177, 184]]], ["As in camelids with upper airway problems, stress and manipulation may worsen the condition, so the clinician should limit treatments to those that are truly beneficial for the patient.Pulmonary Edema and Shock LungShock lung is similar except that the stimuli are different and the camelid is more likely to exude blood-tinged froth from the mouth.", [["airway", "ANATOMY", 26, 32], ["Pulmonary", "ANATOMY", 185, 194], ["lung", "ANATOMY", 221, 225], ["blood", "ANATOMY", 315, 320], ["froth", "ANATOMY", 328, 333], ["mouth", "ANATOMY", 343, 348], ["Edema", "DISEASE", 195, 200], ["upper airway", "MULTI-TISSUE_STRUCTURE", 20, 32], ["patient", "ORGANISM", 177, 184], ["Pulmonary", "ORGAN", 185, 194], ["lung", "ORGAN", 221, 225], ["blood", "ORGANISM_SUBSTANCE", 315, 320], ["froth", "ORGANISM_SUBDIVISION", 328, 333], ["mouth", "ORGANISM_SUBDIVISION", 343, 348], ["patient", "SPECIES", 177, 184], ["upper airway problems", "PROBLEM", 20, 41], ["stress", "PROBLEM", 43, 49], ["manipulation", "TREATMENT", 54, 66], ["treatments", "TREATMENT", 123, 133], ["Pulmonary Edema", "PROBLEM", 185, 200], ["Shock LungShock lung", "PROBLEM", 205, 225], ["the stimuli", "TEST", 249, 260], ["tinged froth from the mouth", "PROBLEM", 321, 348], ["upper", "ANATOMY_MODIFIER", 20, 25], ["airway", "ANATOMY", 26, 32], ["problems", "OBSERVATION", 33, 41], ["Edema", "OBSERVATION", 195, 200], ["Shock", "OBSERVATION", 205, 210], ["lung", "ANATOMY", 221, 225], ["similar", "OBSERVATION_MODIFIER", 229, 236], ["different", "OBSERVATION_MODIFIER", 265, 274], ["more likely", "UNCERTAINTY", 294, 305], ["tinged", "OBSERVATION", 321, 327], ["mouth", "ANATOMY", 343, 348]]], ["Many of the stimuli and the pathogenesis are not known.", [["the stimuli", "TEST", 8, 19]]], ["Camelids with septic, toxic, or traumatic conditions, with heat, exertional, or handling stress or other serious diseases frequently develop productive dyspnea and tachypnea.", [["septic, toxic, or traumatic", "DISEASE", 14, 41], ["exertional", "DISEASE", 65, 75], ["dyspnea", "DISEASE", 152, 159], ["tachypnea", "DISEASE", 164, 173], ["septic", "PROBLEM", 14, 20], ["toxic", "PROBLEM", 22, 27], ["traumatic conditions", "PROBLEM", 32, 52], ["heat, exertional", "PROBLEM", 59, 75], ["handling stress", "PROBLEM", 80, 95], ["other serious diseases", "PROBLEM", 99, 121], ["productive dyspnea", "PROBLEM", 141, 159], ["tachypnea", "PROBLEM", 164, 173], ["septic", "OBSERVATION", 14, 20], ["toxic", "OBSERVATION_MODIFIER", 22, 27], ["traumatic", "OBSERVATION_MODIFIER", 32, 41], ["productive", "OBSERVATION_MODIFIER", 141, 151], ["dyspnea", "OBSERVATION", 152, 159], ["tachypnea", "OBSERVATION", 164, 173]]], ["Treatment is the same as for pulmonary edema, with concurrent treatment for the primary condition.", [["pulmonary", "ANATOMY", 29, 38], ["pulmonary edema", "DISEASE", 29, 44], ["pulmonary", "ORGAN", 29, 38], ["Treatment", "TREATMENT", 0, 9], ["pulmonary edema", "PROBLEM", 29, 44], ["concurrent treatment", "TREATMENT", 51, 71], ["the primary condition", "PROBLEM", 76, 97], ["pulmonary", "ANATOMY", 29, 38], ["edema", "OBSERVATION", 39, 44]]], ["The prognosis is decidedly worse, and this condition often culminates in death in a matter of hours.Pulmonary DysmaturityBecause of their inconsistent gestation length, judging the maturity of neonatal crias is difficult.", [["Pulmonary", "ANATOMY", 100, 109], ["death", "DISEASE", 73, 78], ["Pulmonary", "ORGAN", 100, 109], ["their inconsistent gestation length", "PROBLEM", 132, 167], ["neonatal crias", "PROBLEM", 193, 207], ["inconsistent", "OBSERVATION_MODIFIER", 138, 150], ["gestation", "OBSERVATION", 151, 160], ["length", "OBSERVATION_MODIFIER", 161, 167]]], ["Although outward signs may be judged by appearance, lung function can only be judged by performance.", [["lung", "ANATOMY", 52, 56], ["lung", "ORGAN", 52, 56], ["outward signs", "PROBLEM", 9, 22], ["may be", "UNCERTAINTY", 23, 29], ["lung", "ANATOMY", 52, 56]]], ["Pulmonary dysmaturity results in hypoxemia and, in severe cases, hypercapnia.", [["Pulmonary", "ANATOMY", 0, 9], ["Pulmonary dysmaturity", "DISEASE", 0, 21], ["hypoxemia", "DISEASE", 33, 42], ["hypercapnia", "DISEASE", 65, 76], ["Pulmonary", "ORGAN", 0, 9], ["Pulmonary dysmaturity", "PROBLEM", 0, 21], ["hypoxemia", "PROBLEM", 33, 42], ["hypercapnia", "PROBLEM", 65, 76], ["dysmaturity", "OBSERVATION", 10, 21], ["hypoxemia", "OBSERVATION", 33, 42], ["severe", "OBSERVATION_MODIFIER", 51, 57], ["hypercapnia", "OBSERVATION", 65, 76]]], ["Because camelids appear to be better adapted to hypoxemia compared with treatment is rarely attempted or successful.", [["hypoxemia", "DISEASE", 48, 57], ["hypoxemia", "PROBLEM", 48, 57], ["treatment", "TREATMENT", 72, 81], ["hypoxemia", "OBSERVATION", 48, 57]]], ["Many camelids die shortly after signs are detected.", [["signs", "PROBLEM", 32, 37]]], ["Because of the nonspecific nature of the premortem signs, tuberculosis is not always suspected, and no diagnostic features may be suspected; therefore, it is generally believed that this disease is underreported.", [["tuberculosis", "DISEASE", 58, 70], ["the premortem signs", "PROBLEM", 37, 56], ["tuberculosis", "PROBLEM", 58, 70], ["this disease", "PROBLEM", 182, 194], ["nonspecific", "OBSERVATION_MODIFIER", 15, 26], ["tuberculosis", "OBSERVATION", 58, 70], ["not always", "UNCERTAINTY", 74, 84], ["disease", "OBSERVATION", 187, 194]]], ["Postmortem evaluation reveals the presence of thick-walled masses containing caseous material, particularly in the lung, liver, and regional lymph nodes.", [["caseous material", "ANATOMY", 77, 93], ["lung", "ANATOMY", 115, 119], ["liver", "ANATOMY", 121, 126], ["lymph nodes", "ANATOMY", 141, 152], ["caseous material", "TISSUE", 77, 93], ["lung", "ORGAN", 115, 119], ["liver", "ORGAN", 121, 126], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 141, 152], ["Postmortem evaluation", "TEST", 0, 21], ["thick-walled masses", "PROBLEM", 46, 65], ["caseous material", "PROBLEM", 77, 93], ["thick", "OBSERVATION_MODIFIER", 46, 51], ["walled", "OBSERVATION_MODIFIER", 52, 58], ["masses", "OBSERVATION", 59, 65], ["caseous", "OBSERVATION_MODIFIER", 77, 84], ["material", "OBSERVATION", 85, 93], ["lung", "ANATOMY", 115, 119], ["liver", "ANATOMY", 121, 126], ["regional", "ANATOMY_MODIFIER", 132, 140], ["lymph nodes", "OBSERVATION", 141, 152]]], ["Generalized infection is also possible.", [["infection", "DISEASE", 12, 21], ["Generalized infection", "PROBLEM", 0, 21], ["infection", "OBSERVATION", 12, 21]]], ["With M. microti an \"onion skin like\" capsule is frequently described.", [["skin", "ANATOMY", 26, 30], ["capsule", "ANATOMY", 37, 44], ["M. microti", "ORGANISM", 5, 15], ["skin", "ORGAN", 26, 30], ["capsule", "CANCER", 37, 44], ["M. microti", "SPECIES", 5, 15], ["onion", "SPECIES", 20, 25], ["M. microti", "SPECIES", 5, 15], ["M. microti an \"onion skin like\" capsule", "TREATMENT", 5, 44], ["microti", "OBSERVATION", 8, 15], ["skin", "ANATOMY", 26, 30]]], ["Some calcification may be evident.", [["calcification", "DISEASE", 5, 18], ["Some calcification", "PROBLEM", 0, 18], ["calcification", "OBSERVATION", 5, 18], ["may be", "UNCERTAINTY", 19, 25]]], ["Miliary tuberculosis, with widespread serosal nodules may also occur.", [["serosal nodules", "ANATOMY", 38, 53], ["tuberculosis", "DISEASE", 8, 20], ["serosal nodules", "PATHOLOGICAL_FORMATION", 38, 53], ["Miliary tuberculosis", "PROBLEM", 0, 20], ["widespread serosal nodules", "PROBLEM", 27, 53], ["tuberculosis", "OBSERVATION", 8, 20], ["widespread", "OBSERVATION_MODIFIER", 27, 37], ["serosal", "OBSERVATION_MODIFIER", 38, 45], ["nodules", "OBSERVATION", 46, 53]]], ["45 Histopathologic examination reveals the granulomatous nature of these masses and the presence of mycobacteria.", [["masses", "ANATOMY", 73, 79], ["masses", "CANCER", 73, 79], ["Histopathologic examination", "TEST", 3, 30], ["the granulomatous nature", "PROBLEM", 39, 63], ["these masses", "PROBLEM", 67, 79], ["mycobacteria", "PROBLEM", 100, 112], ["granulomatous", "OBSERVATION", 43, 56], ["masses", "OBSERVATION", 73, 79], ["mycobacteria", "OBSERVATION", 100, 112]]], ["Giant cells are not always evident.", [["Giant cells", "ANATOMY", 0, 11], ["Giant cells", "CELL", 0, 11], ["Giant cells", "CELL_TYPE", 0, 11], ["Giant cells", "PROBLEM", 0, 11], ["cells", "OBSERVATION", 6, 11], ["not always evident", "UNCERTAINTY", 16, 34]]], ["43, 52 Identification of infected camelids has been problematic.", [["camelids", "ANATOMY", 34, 42], ["infected camelids", "DISEASE", 25, 42], ["camelids", "CANCER", 34, 42], ["infected camelids", "PROBLEM", 25, 42], ["infected", "OBSERVATION", 25, 33]]], ["Intradermal tuberculin skin testing on the tail is often negative, both in the preclinical and clinical phases of infection, and has also yielded mixed results when done in the axillary region or other alternate sites.", [["skin", "ANATOMY", 23, 27], ["tail", "ANATOMY", 43, 47], ["axillary region", "ANATOMY", 177, 192], ["sites", "ANATOMY", 212, 217], ["infection", "DISEASE", 114, 123], ["skin", "ORGAN", 23, 27], ["tail", "ORGANISM_SUBDIVISION", 43, 47], ["axillary region", "MULTI-TISSUE_STRUCTURE", 177, 192], ["Intradermal tuberculin skin testing on the tail", "TEST", 0, 47], ["infection", "PROBLEM", 114, 123], ["tuberculin skin", "OBSERVATION", 12, 27], ["tail", "ANATOMY", 43, 47], ["negative", "OBSERVATION", 57, 65], ["infection", "OBSERVATION", 114, 123], ["axillary", "ANATOMY", 177, 185], ["region", "ANATOMY_MODIFIER", 186, 192]]], ["41, 43, [57] [58] [59] [60] [61] [62] False-positives are believed to be rare, but false-negatives are common.", [["[57] [58] [59] [60] [61] [62]", "SIMPLE_CHEMICAL", 8, 37], ["False-positives", "TEST", 38, 53], ["believed to be", "UNCERTAINTY", 58, 72]]], ["Serologic analysis may be complementary.", [["Serologic analysis", "TEST", 0, 18]]], ["48, 59, 63, 64 A number of newer, rapid tests, including lateral flow serology, \u03b3-interferon release assay, enzyme-linked immunosorbent assay (ELISA), and dual-path platform testing, are showing promise.", [["\u03b3-interferon", "SIMPLE_CHEMICAL", 80, 92], ["\u03b3-interferon", "PROTEIN", 80, 92], ["rapid tests", "TEST", 34, 45], ["lateral flow serology", "TEST", 57, 78], ["\u03b3-interferon release assay", "TEST", 80, 106], ["enzyme", "TEST", 108, 114], ["immunosorbent assay", "TEST", 122, 141], ["ELISA", "TEST", 143, 148], ["dual-path platform testing", "TEST", 155, 181]]], ["60,61 Skin testing 2 to 3 weeks previously may improve serologic results by evoking an amnestic antibody response.Pulmonary DysmaturityThe most effective means of prevention is decreasing exposure to the host animals.", [["Skin", "ANATOMY", 6, 10], ["Pulmonary", "ANATOMY", 114, 123], ["Skin", "ORGAN", 6, 10], ["Pulmonary", "ORGAN", 114, 123], ["Skin testing", "TEST", 6, 18], ["serologic results", "TEST", 55, 72], ["an amnestic antibody response", "PROBLEM", 84, 113], ["Pulmonary Dysmaturity", "PROBLEM", 114, 135], ["Dysmaturity", "OBSERVATION", 124, 135], ["most effective", "OBSERVATION_MODIFIER", 139, 153], ["decreasing", "OBSERVATION_MODIFIER", 177, 187]]], ["Raising feed and water off the ground (at least 3 feet for badgers) may decrease contamination and also help keep the camelids' heads away from soil-based organisms.Mycotic Pneumonia and Other DisordersC. immitis infection (coccidioidomycosis; San Joaquin Valley fever, desert fever) has been reported in California, Arizona, and Texas.", [["Mycotic Pneumonia", "DISEASE", 165, 182], ["immitis infection", "DISEASE", 205, 222], ["coccidioidomycosis", "DISEASE", 224, 242], ["San Joaquin Valley fever", "DISEASE", 244, 268], ["desert fever", "DISEASE", 270, 282], ["immitis", "ORGANISM", 205, 212], ["immitis", "SPECIES", 205, 212], ["decrease contamination", "PROBLEM", 72, 94], ["Mycotic Pneumonia", "PROBLEM", 165, 182], ["Other DisordersC", "PROBLEM", 187, 203], ["immitis infection", "PROBLEM", 205, 222], ["coccidioidomycosis", "PROBLEM", 224, 242], ["Joaquin Valley fever", "PROBLEM", 248, 268], ["desert fever", "PROBLEM", 270, 282], ["Pneumonia", "OBSERVATION", 173, 182], ["infection", "OBSERVATION", 213, 222], ["coccidioidomycosis", "OBSERVATION", 224, 242]]], ["65, 66 The causative fungus lives in dry soil, particularly in the Southwestern United States and adjacent regions in Mexico, with the San Joaquin Valley known for high concentrations.", [["The causative fungus", "PROBLEM", 7, 27], ["high concentrations", "PROBLEM", 164, 183], ["causative", "OBSERVATION_MODIFIER", 11, 20], ["fungus", "OBSERVATION", 21, 27], ["dry soil", "OBSERVATION_MODIFIER", 37, 45]]], ["Wind may spread the fungus beyond its normal range, but reports of disease far outside of this range are rare.", [["the fungus", "PROBLEM", 16, 26], ["disease", "PROBLEM", 67, 74], ["fungus", "OBSERVATION", 20, 26], ["normal range", "OBSERVATION_MODIFIER", 38, 50], ["disease", "OBSERVATION", 67, 74]]], ["It is postulated that camelids aerosolize and inspire infective arthroconidia during dust baths.", [["arthroconidia", "DISEASE", 64, 77], ["camelids aerosolize", "PROBLEM", 22, 41], ["inspire infective arthroconidia", "PROBLEM", 46, 77], ["infective", "OBSERVATION_MODIFIER", 54, 63]]], ["Once inspired, arthroconidia grow and mature, and release endospores, which cause local or, much more commonly, disseminated pyogranulomatous disease.", [["arthroconidia", "ANATOMY", 15, 28], ["pyogranulomatous", "ANATOMY", 125, 141], ["pyogranulomatous disease", "DISEASE", 125, 149], ["pyogranulomatous disease", "CANCER", 125, 149], ["disseminated pyogranulomatous disease", "PROBLEM", 112, 149], ["disseminated", "OBSERVATION_MODIFIER", 112, 124], ["pyogranulomatous disease", "OBSERVATION", 125, 149]]], ["Transplacental infection may occur.", [["infection", "DISEASE", 15, 24], ["Transplacental infection", "PROBLEM", 0, 24], ["infection", "OBSERVATION", 15, 24]]], ["Many mammalian species are susceptible, although most ruminants suffer only from local disease in the mediastinal lymph nodes.", [["mediastinal lymph nodes", "ANATOMY", 102, 125], ["ruminants", "ORGANISM", 54, 63], ["mediastinal lymph nodes", "MULTI-TISSUE_STRUCTURE", 102, 125], ["ruminants", "SPECIES", 54, 63], ["Many mammalian species", "PROBLEM", 0, 22], ["local disease in the mediastinal lymph nodes", "PROBLEM", 81, 125], ["mammalian species", "OBSERVATION", 5, 22], ["susceptible", "OBSERVATION_MODIFIER", 27, 38], ["local", "OBSERVATION_MODIFIER", 81, 86], ["disease", "OBSERVATION", 87, 94], ["mediastinal", "ANATOMY", 102, 113], ["lymph nodes", "OBSERVATION", 114, 125]]], ["All age groups are susceptible, and in utero transmission has been demonstrated.", [["susceptible", "OBSERVATION_MODIFIER", 19, 30]]], ["The most common sites of infection include the lungs, skin, the central nervous system (CNS), bones, and joints.Mycotic Pneumonia and Other DisordersC. neoformans or C. gatti infection has been reported in Oregon, California, British Columbia, and Australia.", [["sites", "ANATOMY", 16, 21], ["lungs", "ANATOMY", 47, 52], ["skin", "ANATOMY", 54, 58], ["central nervous system", "ANATOMY", 64, 86], ["CNS", "ANATOMY", 88, 91], ["bones", "ANATOMY", 94, 99], ["joints", "ANATOMY", 105, 111], ["infection", "DISEASE", 25, 34], ["Mycotic Pneumonia", "DISEASE", 112, 129], ["C. gatti infection", "DISEASE", 166, 184], ["lungs", "ORGAN", 47, 52], ["skin", "ORGAN", 54, 58], ["central nervous system", "ANATOMICAL_SYSTEM", 64, 86], ["CNS", "ANATOMICAL_SYSTEM", 88, 91], ["bones", "TISSUE", 94, 99], ["joints", "MULTI-TISSUE_STRUCTURE", 105, 111], ["C. gatti", "ORGANISM", 166, 174], ["C. gatti", "SPECIES", 166, 174], ["DisordersC. neoformans", "SPECIES", 140, 162], ["C. gatti", "SPECIES", 166, 174], ["infection", "PROBLEM", 25, 34], ["the central nervous system (CNS), bones, and joints", "PROBLEM", 60, 111], ["Mycotic Pneumonia", "PROBLEM", 112, 129], ["Other DisordersC", "PROBLEM", 134, 150], ["neoformans", "PROBLEM", 152, 162], ["C. gatti infection", "PROBLEM", 166, 184], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["infection", "OBSERVATION", 25, 34], ["lungs", "ANATOMY", 47, 52], ["skin", "ANATOMY", 54, 58], ["central", "ANATOMY_MODIFIER", 64, 71], ["nervous system", "ANATOMY", 72, 86], ["CNS", "ANATOMY", 88, 91], ["bones", "ANATOMY", 94, 99], ["joints", "ANATOMY", 105, 111], ["Pneumonia", "OBSERVATION", 120, 129], ["neoformans", "OBSERVATION", 152, 162], ["California", "OBSERVATION_MODIFIER", 214, 224], ["British Columbia", "OBSERVATION", 226, 242]]], ["[67] [68] [69] [70] [71] Inhalation of spores is the putative source of infection.", [["infection", "DISEASE", 72, 81], ["[67] [68] [69] [70] [71]", "CHEMICAL", 0, 24], ["[67] [68] [69] [70] [71]", "SIMPLE_CHEMICAL", 0, 24], ["spores", "PROBLEM", 39, 45], ["infection", "PROBLEM", 72, 81], ["infection", "OBSERVATION", 72, 81]]], ["The organism is relatively ubiquitous, with some strains associated with bird droppings and others with rotting vegetation; C. gatti is potentially associated with the Douglas-fir tree.", [["C. gatti", "ORGANISM", 124, 132], ["fir tree", "MULTI-TISSUE_STRUCTURE", 176, 184], ["C. gatti", "SPECIES", 124, 132], ["C. gatti", "SPECIES", 124, 132], ["some strains", "PROBLEM", 44, 56], ["bird droppings", "PROBLEM", 73, 87], ["rotting vegetation", "PROBLEM", 104, 122], ["C. gatti", "PROBLEM", 124, 132], ["bird droppings", "OBSERVATION", 73, 87], ["rotting vegetation", "OBSERVATION", 104, 122], ["Douglas", "OBSERVATION", 168, 175], ["fir tree", "OBSERVATION", 176, 184]]], ["The disease is usually sporadic in most species and was thought to relate to some degree of immunosuppression, but C. gatti appears to affect healthy animals as well.", [["immunosuppression", "DISEASE", 92, 109], ["C. gatti", "ORGANISM", 115, 123], ["C. gatti", "SPECIES", 115, 123], ["C. gatti", "SPECIES", 115, 123], ["The disease", "PROBLEM", 0, 11], ["sporadic", "PROBLEM", 23, 31], ["immunosuppression", "TREATMENT", 92, 109], ["disease", "OBSERVATION", 4, 11], ["most species", "OBSERVATION_MODIFIER", 35, 47], ["immunosuppression", "OBSERVATION", 92, 109]]], ["The most common site for infection is the CNS, followed by the lungs and the tachypnea in camelids at our clinic.", [["CNS", "ANATOMY", 42, 45], ["lungs", "ANATOMY", 63, 68], ["infection", "DISEASE", 25, 34], ["tachypnea", "DISEASE", 77, 86], ["CNS", "ANATOMICAL_SYSTEM", 42, 45], ["lungs", "ORGAN", 63, 68], ["infection", "PROBLEM", 25, 34], ["the tachypnea", "PROBLEM", 73, 86], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["infection", "OBSERVATION", 25, 34], ["lungs", "ANATOMY", 63, 68], ["tachypnea", "OBSERVATION", 77, 86]]], ["Parasitic pneumonia may be caused by lungworms or potentially protozoa.Tuberculosis and other Mycobacterial InfectionsBovine tuberculosis, caused by M. bovis, is becoming an increasingly important topic for the camelid industry, particularly in South America, Ireland, and the United Kingdom.", [["Parasitic pneumonia", "DISEASE", 0, 19], ["lungworms", "DISEASE", 37, 46], ["Tuberculosis", "DISEASE", 71, 83], ["Mycobacterial Infections", "DISEASE", 94, 118], ["Bovine tuberculosis", "DISEASE", 118, 137], ["Bovine", "ORGANISM", 118, 124], ["M. bovis", "ORGANISM", 149, 157], ["Bovine", "SPECIES", 118, 124], ["M. bovis", "SPECIES", 149, 157], ["Bovine tuberculosis", "SPECIES", 118, 137], ["M. bovis", "SPECIES", 149, 157], ["Parasitic pneumonia", "PROBLEM", 0, 19], ["lungworms", "PROBLEM", 37, 46], ["protozoa", "PROBLEM", 62, 70], ["Tuberculosis", "PROBLEM", 71, 83], ["other Mycobacterial InfectionsBovine tuberculosis", "PROBLEM", 88, 137], ["pneumonia", "OBSERVATION", 10, 19], ["may be caused", "UNCERTAINTY", 20, 33], ["protozoa", "OBSERVATION", 62, 70], ["Mycobacterial Infections", "OBSERVATION", 94, 118], ["tuberculosis", "OBSERVATION", 125, 137], ["M. bovis", "OBSERVATION", 149, 157]]], ["[40] [41] [42] [43] [44] Infections have been reported in Spain, and the Netherlands, and reactors are reported in New Zealand as well.", [["[40] [41] [42] [43]", "CHEMICAL", 0, 19], ["[40] [41] [42] [43] [44", "SIMPLE_CHEMICAL", 0, 23]]], ["45, 46 Countries with endemic problems have domestic ruminants or resident wildlife-badgers, bush-tailed possums, or ferrets-that harbor the organism and tend to share living, eating, or drinking spaces with domestic herd animals.", [["possums", "ORGANISM", 105, 112], ["ferrets", "ORGANISM", 117, 124], ["ferrets", "SPECIES", 117, 124], ["ferrets", "SPECIES", 117, 124], ["endemic problems", "PROBLEM", 22, 38]]], ["In areas without endemic tuberculosis, some outbreaks have been blamed on the importation of infected animals.Tuberculosis and other Mycobacterial InfectionsClinically similar disease can be caused by M. microti or M. kansasii.", [["tuberculosis", "DISEASE", 25, 37], ["Tuberculosis", "DISEASE", 110, 122], ["Mycobacterial Infections", "DISEASE", 133, 157], ["kansasii", "DISEASE", 218, 226], ["M. microti", "ORGANISM", 201, 211], ["M. kansasii", "ORGANISM", 215, 226], ["M. microti", "SPECIES", 201, 211], ["M. kansasii", "SPECIES", 215, 226], ["M. microti", "SPECIES", 201, 211], ["M. kansasii", "SPECIES", 215, 226], ["endemic tuberculosis", "PROBLEM", 17, 37], ["some outbreaks", "PROBLEM", 39, 53], ["Tuberculosis", "PROBLEM", 110, 122], ["other Mycobacterial Infections", "PROBLEM", 127, 157], ["similar disease", "PROBLEM", 168, 183], ["areas", "OBSERVATION_MODIFIER", 3, 8], ["without", "UNCERTAINTY", 9, 16], ["endemic", "OBSERVATION_MODIFIER", 17, 24], ["tuberculosis", "OBSERVATION", 25, 37], ["infected", "OBSERVATION", 93, 101], ["Mycobacterial", "OBSERVATION_MODIFIER", 133, 146], ["Infections", "OBSERVATION", 147, 157], ["kansasii", "OBSERVATION", 218, 226]]], ["[47] [48] [49] [50] [51] [52] [53] Both are reported most commonly in central and western Europe.", [["[47] [48] [49] [50] [51] [52] [53", "SIMPLE_CHEMICAL", 0, 33]]], ["M. microti is associated with voles; M. kansasii is also associated with animal hosts.Tuberculosis and other Mycobacterial InfectionsIf any of these mycobacterial infections are found in an area, local camelids will be at risk, facing the same challenges as other grazing livestock.", [["kansasii", "DISEASE", 40, 48], ["Tuberculosis", "DISEASE", 86, 98], ["Mycobacterial Infections", "DISEASE", 109, 133], ["mycobacterial infections", "DISEASE", 149, 173], ["M. microti", "ORGANISM", 0, 10], ["M. kansasii", "ORGANISM", 37, 48], ["M. microti", "SPECIES", 0, 10], ["M. kansasii", "SPECIES", 37, 48], ["M. microti", "SPECIES", 0, 10], ["voles", "SPECIES", 30, 35], ["M. kansasii", "SPECIES", 37, 48], ["M. kansasii", "PROBLEM", 37, 48], ["Tuberculosis", "PROBLEM", 86, 98], ["other Mycobacterial Infections", "PROBLEM", 103, 133], ["these mycobacterial infections", "PROBLEM", 143, 173], ["microti", "OBSERVATION", 3, 10], ["kansasii", "OBSERVATION", 40, 48], ["Mycobacterial Infections", "OBSERVATION", 109, 133], ["mycobacterial", "OBSERVATION_MODIFIER", 149, 162], ["infections", "OBSERVATION", 163, 173]]], ["Transmission is through inhalation or ingestion of materials contaminated by the wildlife or ruminant host.", [["ingestion of materials", "PROBLEM", 38, 60]]], ["Transmission among camelids and from camelids to humans is suspected as well.", [["humans", "ORGANISM", 49, 55], ["humans", "SPECIES", 49, 55], ["humans", "SPECIES", 49, 55]]], ["44, 54, 55 One owner in the United Kingdom was recently diagnosed with the same spoligotype of M. bovis that had previously been found in her herd; a common source of infection, rather than direct transmission from a camelid, is also possible.", [["infection", "DISEASE", 167, 176], ["camelid", "DISEASE", 217, 224], ["M. bovis", "ORGANISM", 95, 103], ["M. bovis", "SPECIES", 95, 103], ["M. bovis", "SPECIES", 95, 103], ["M. bovis", "PROBLEM", 95, 103], ["infection", "PROBLEM", 167, 176], ["M. bovis", "OBSERVATION", 95, 103], ["infection", "OBSERVATION", 167, 176]]], ["The potential for direct transmission is supported by the presence of oral granulomas and evidence of granulomas communicating with airways in some camelids and also the recent evidence of infection of the udder.", [["oral granulomas", "ANATOMY", 70, 85], ["granulomas", "ANATOMY", 102, 112], ["airways", "ANATOMY", 132, 139], ["udder", "ANATOMY", 206, 211], ["granulomas", "DISEASE", 75, 85], ["granulomas", "DISEASE", 102, 112], ["infection", "DISEASE", 189, 198], ["oral granulomas", "PATHOLOGICAL_FORMATION", 70, 85], ["granulomas", "PATHOLOGICAL_FORMATION", 102, 112], ["airways", "MULTI-TISSUE_STRUCTURE", 132, 139], ["udder", "ORGANISM_SUBDIVISION", 206, 211], ["oral granulomas", "PROBLEM", 70, 85], ["granulomas", "PROBLEM", 102, 112], ["infection of the udder", "PROBLEM", 189, 211], ["oral", "ANATOMY", 70, 74], ["granulomas", "OBSERVATION", 75, 85], ["evidence of", "UNCERTAINTY", 90, 101], ["granulomas", "OBSERVATION", 102, 112], ["airways", "ANATOMY", 132, 139], ["evidence of", "UNCERTAINTY", 177, 188], ["infection", "OBSERVATION", 189, 198]]], ["45, 56 Most mycobacteria affect several organ systems but primarily the lung.", [["organ systems", "ANATOMY", 40, 53], ["lung", "ANATOMY", 72, 76], ["organ", "ORGAN", 40, 45], ["lung", "ORGAN", 72, 76], ["Most mycobacteria affect several organ systems", "PROBLEM", 7, 53], ["mycobacteria", "OBSERVATION", 12, 24], ["lung", "ANATOMY", 72, 76]]], ["The basic lesion is the granuloma, and the usual course is slow progression.", [["lesion", "ANATOMY", 10, 16], ["granuloma", "ANATOMY", 24, 33], ["granuloma", "DISEASE", 24, 33], ["granuloma", "PATHOLOGICAL_FORMATION", 24, 33], ["The basic lesion", "PROBLEM", 0, 16], ["the granuloma", "PROBLEM", 20, 33], ["slow progression", "PROBLEM", 59, 75], ["basic", "OBSERVATION_MODIFIER", 4, 9], ["lesion", "OBSERVATION", 10, 16], ["granuloma", "OBSERVATION", 24, 33], ["slow", "OBSERVATION_MODIFIER", 59, 63], ["progression", "OBSERVATION_MODIFIER", 64, 75]]], ["Camelids covered with fleece and not monitored carefully may develop advanced disease before it is detected, and anecdotal evidence suggests that infection may take years to become apparent in some camelids.", [["infection", "DISEASE", 146, 155], ["fleece", "TREATMENT", 22, 28], ["advanced disease", "PROBLEM", 69, 85], ["infection", "PROBLEM", 146, 155], ["advanced", "OBSERVATION_MODIFIER", 69, 77], ["disease", "OBSERVATION", 78, 85], ["infection", "OBSERVATION", 146, 155]]], ["Premortem evaluations have been relatively limited.", [["Premortem evaluations", "TEST", 0, 21]]], ["The most common signs are weight loss, weakness, lethargy, recumbency, and anorexia.", [["weight loss", "DISEASE", 26, 37], ["weakness", "DISEASE", 39, 47], ["lethargy", "DISEASE", 49, 57], ["anorexia", "DISEASE", 75, 83], ["weight loss", "PROBLEM", 26, 37], ["weakness", "PROBLEM", 39, 47], ["lethargy", "PROBLEM", 49, 57], ["recumbency", "PROBLEM", 59, 69], ["anorexia", "PROBLEM", 75, 83], ["weight loss", "OBSERVATION", 26, 37], ["weakness", "OBSERVATION", 39, 47], ["lethargy", "OBSERVATION", 49, 57], ["anorexia", "OBSERVATION", 75, 83]]], ["External lymphadenopathy may be detectable in some animals; internal lymphadenopathy may also be detectable through rectal palpation or imaging studies.", [["rectal", "ANATOMY", 116, 122], ["lymphadenopathy", "DISEASE", 9, 24], ["lymphadenopathy", "DISEASE", 69, 84], ["rectal", "ORGAN", 116, 122], ["External lymphadenopathy", "PROBLEM", 0, 24], ["internal lymphadenopathy", "PROBLEM", 60, 84], ["rectal palpation", "TEST", 116, 132], ["imaging studies", "TEST", 136, 151], ["lymphadenopathy", "OBSERVATION", 9, 24], ["internal", "OBSERVATION_MODIFIER", 60, 68], ["lymphadenopathy", "OBSERVATION", 69, 84], ["may also be", "UNCERTAINTY", 85, 96], ["rectal", "ANATOMY", 116, 122], ["palpation", "OBSERVATION", 123, 132]]], ["The minority show respiratory signs, which may include a shallow breathing pattern with increased expiratory effort, and general harshness of lung sounds.", [["respiratory", "ANATOMY", 18, 29], ["lung", "ANATOMY", 142, 146], ["lung", "ORGAN", 142, 146], ["respiratory signs", "PROBLEM", 18, 35], ["a shallow breathing pattern", "PROBLEM", 55, 82], ["increased expiratory effort", "PROBLEM", 88, 115], ["general harshness of lung sounds", "PROBLEM", 121, 153], ["respiratory signs", "OBSERVATION", 18, 35], ["shallow breathing", "OBSERVATION", 57, 74], ["increased", "OBSERVATION_MODIFIER", 88, 97], ["expiratory effort", "OBSERVATION", 98, 115], ["lung", "ANATOMY", 142, 146], ["sounds", "OBSERVATION", 147, 153]]], ["Hematologic abnormalities may include anemia, neutrophilic leukocytosis, and lymphocytosis.", [["neutrophilic", "ANATOMY", 46, 58], ["Hematologic abnormalities", "DISEASE", 0, 25], ["anemia", "DISEASE", 38, 44], ["neutrophilic leukocytosis", "DISEASE", 46, 71], ["lymphocytosis", "DISEASE", 77, 90], ["Hematologic abnormalities", "PROBLEM", 0, 25], ["anemia", "PROBLEM", 38, 44], ["neutrophilic leukocytosis", "PROBLEM", 46, 71], ["lymphocytosis", "PROBLEM", 77, 90], ["may include", "UNCERTAINTY", 26, 37], ["anemia", "OBSERVATION", 38, 44], ["neutrophilic", "OBSERVATION_MODIFIER", 46, 58], ["leukocytosis", "OBSERVATION", 59, 71], ["lymphocytosis", "OBSERVATION", 77, 90]]], ["Often, marked hyperglobulinemia with concurrent hypoalbuminemia exists.", [["hyperglobulinemia", "DISEASE", 14, 31], ["hypoalbuminemia", "DISEASE", 48, 63], ["marked hyperglobulinemia", "PROBLEM", 7, 31], ["concurrent hypoalbuminemia", "PROBLEM", 37, 63], ["marked", "OBSERVATION_MODIFIER", 7, 13], ["hyperglobulinemia", "OBSERVATION", 14, 31], ["concurrent", "OBSERVATION_MODIFIER", 37, 47], ["hypoalbuminemia", "OBSERVATION", 48, 63]]], ["Thoracic radiography and ultrasonographic evaluation of the chest, liver, spleen, and regional lymph nodes may reveal multifocal radiodense or hyperechoic nodular lesions, possibly coalescing into diffuse areas of consolidation.", [["chest", "ANATOMY", 60, 65], ["liver", "ANATOMY", 67, 72], ["spleen", "ANATOMY", 74, 80], ["lymph nodes", "ANATOMY", 95, 106], ["hyperechoic nodular lesions", "ANATOMY", 143, 170], ["chest", "ORGAN", 60, 65], ["liver", "ORGAN", 67, 72], ["spleen", "ORGAN", 74, 80], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 95, 106], ["nodular lesions", "PATHOLOGICAL_FORMATION", 155, 170], ["Thoracic radiography", "TEST", 0, 20], ["ultrasonographic evaluation of the chest", "TEST", 25, 65], ["multifocal radiodense or hyperechoic nodular lesions", "PROBLEM", 118, 170], ["consolidation", "PROBLEM", 214, 227], ["chest", "ANATOMY", 60, 65], ["liver", "ANATOMY", 67, 72], ["spleen", "ANATOMY", 74, 80], ["regional", "ANATOMY_MODIFIER", 86, 94], ["lymph nodes", "OBSERVATION", 95, 106], ["multifocal", "OBSERVATION_MODIFIER", 118, 128], ["radiodense", "OBSERVATION_MODIFIER", 129, 139], ["hyperechoic", "OBSERVATION_MODIFIER", 143, 154], ["nodular", "OBSERVATION_MODIFIER", 155, 162], ["lesions", "OBSERVATION", 163, 170], ["possibly", "UNCERTAINTY", 172, 180], ["coalescing", "OBSERVATION_MODIFIER", 181, 191], ["diffuse", "OBSERVATION_MODIFIER", 197, 204], ["areas", "OBSERVATION_MODIFIER", 205, 210], ["consolidation", "OBSERVATION", 214, 227]]], ["Biopsies or aspirates of these or transtracheal wash samples may reveal acid-fast bacilli, which may be identified by mycobacterial culture and typed by PCR.", [["Biopsies", "ANATOMY", 0, 8], ["aspirates", "ANATOMY", 12, 21], ["samples", "ANATOMY", 53, 60], ["Biopsies", "CANCER", 0, 8], ["Biopsies", "TEST", 0, 8], ["aspirates", "TEST", 12, 21], ["transtracheal wash samples", "TEST", 34, 60], ["acid-fast bacilli", "PROBLEM", 72, 89], ["mycobacterial culture", "TEST", 118, 139], ["PCR", "TEST", 153, 156], ["aspirates", "OBSERVATION", 12, 21], ["transtracheal", "ANATOMY", 34, 47]]], ["Typing is important because the different pathogens have different legal aspects and zoonotic potential.", [["the different pathogens", "PROBLEM", 28, 51], ["zoonotic", "OBSERVATION_MODIFIER", 85, 93]]], ["Mycobacterial diseases are reportable in many areas.Tuberculosis and other Mycobacterial InfectionsBecause of the advanced nature of the disease upon identification and the zoonotic potential of these organisms, caused by Mycobacteria or may be confused with bacterial abscesses.", [["abscesses", "ANATOMY", 269, 278], ["Mycobacterial diseases", "DISEASE", 0, 22], ["Tuberculosis", "DISEASE", 52, 64], ["Mycobacterial Infections", "DISEASE", 75, 99], ["Mycobacteria", "DISEASE", 222, 234], ["bacterial abscesses", "DISEASE", 259, 278], ["abscesses", "PATHOLOGICAL_FORMATION", 269, 278], ["Mycobacterial diseases", "PROBLEM", 0, 22], ["Tuberculosis", "PROBLEM", 52, 64], ["other Mycobacterial Infections", "PROBLEM", 69, 99], ["the disease", "PROBLEM", 133, 144], ["these organisms", "PROBLEM", 195, 210], ["Mycobacteria", "PROBLEM", 222, 234], ["confused", "PROBLEM", 245, 253], ["bacterial abscesses", "PROBLEM", 259, 278], ["diseases", "OBSERVATION", 14, 22], ["Mycobacterial Infections", "OBSERVATION", 75, 99], ["disease", "OBSERVATION", 137, 144], ["Mycobacteria", "OBSERVATION", 222, 234], ["bacterial", "OBSERVATION_MODIFIER", 259, 268], ["abscesses", "OBSERVATION", 269, 278]]], ["Tracheal wash, BAL, cerebrospinal, peritoneal, pleural, or exudative fluid may contain thick-walled, endospore-containing sporangia (Coccidioides; 5-50 micrometers [\u00b5m]) or \"ghost\" spherules if the sporangia has burst, or yeast cells (Histoplasma, Cryptococcus, Aspergillus; 3-5 \u00b5m) either free or within macrophages, or septate hyphae (Asper gillus or other, rare fungi).", [["Tracheal", "ANATOMY", 0, 8], ["BAL", "ANATOMY", 15, 18], ["cerebrospinal", "ANATOMY", 20, 33], ["peritoneal", "ANATOMY", 35, 45], ["pleural", "ANATOMY", 47, 54], ["exudative fluid", "ANATOMY", 59, 74], ["spherules", "ANATOMY", 181, 190], ["sporangia", "ANATOMY", 198, 207], ["cells", "ANATOMY", 228, 233], ["macrophages", "ANATOMY", 305, 316], ["septate hyphae", "ANATOMY", 321, 335], ["BAL", "ORGANISM_SUBSTANCE", 15, 18], ["cerebrospinal", "ORGANISM_SUBSTANCE", 20, 33], ["peritoneal", "MULTI-TISSUE_STRUCTURE", 35, 45], ["pleural", "MULTI-TISSUE_STRUCTURE", 47, 54], ["yeast cells", "CELL", 222, 233], ["Histoplasma, Cryptococcus", "ORGANISM", 235, 260], ["macrophages", "CELL", 305, 316], ["Asper gillus", "ORGANISM", 337, 349], ["yeast cells", "CELL_TYPE", 222, 233], ["macrophages", "CELL_TYPE", 305, 316], ["yeast", "SPECIES", 222, 227], ["yeast", "SPECIES", 222, 227], ["Asper gillus", "SPECIES", 337, 349], ["Tracheal wash, BAL, cerebrospinal, peritoneal, pleural, or exudative fluid", "TEST", 0, 74], ["thick-walled, endospore-containing sporangia (Coccidioides", "PROBLEM", 87, 145], ["\"ghost\" spherules", "PROBLEM", 173, 190], ["the sporangia", "PROBLEM", 194, 207], ["burst", "PROBLEM", 212, 217], ["yeast cells", "PROBLEM", 222, 233], ["Histoplasma", "TEST", 235, 246], ["Cryptococcus", "PROBLEM", 248, 260], ["Aspergillus", "TEST", 262, 273], ["septate hyphae (Asper gillus", "PROBLEM", 321, 349], ["wash", "OBSERVATION", 9, 13], ["BAL", "OBSERVATION", 15, 18], ["cerebrospinal", "ANATOMY", 20, 33], ["peritoneal", "ANATOMY", 35, 45], ["pleural", "ANATOMY", 47, 54], ["exudative", "OBSERVATION_MODIFIER", 59, 68], ["fluid", "OBSERVATION", 69, 74], ["burst", "OBSERVATION_MODIFIER", 212, 217], ["yeast cells", "OBSERVATION", 222, 233], ["Cryptococcus", "OBSERVATION_MODIFIER", 248, 260], ["septate hyphae", "OBSERVATION", 321, 335]]], ["Cryptococcus yeast forms are round and surrounded by a mucopolysaccharide capsule, which may increase the diameter to up to 10 \u00b5m.", [["mucopolysaccharide capsule", "ANATOMY", 55, 81], ["Cryptococcus yeast", "ORGANISM", 0, 18], ["Cryptococcus", "SPECIES", 0, 12], ["yeast", "SPECIES", 13, 18], ["Cryptococcus yeast", "SPECIES", 0, 18], ["Cryptococcus yeast forms", "TEST", 0, 24], ["a mucopolysaccharide capsule", "PROBLEM", 53, 81], ["yeast forms", "OBSERVATION", 13, 24], ["round", "OBSERVATION_MODIFIER", 29, 34], ["mucopolysaccharide capsule", "OBSERVATION", 55, 81], ["increase", "OBSERVATION_MODIFIER", 93, 101], ["diameter", "OBSERVATION_MODIFIER", 106, 114], ["up to 10 \u00b5m", "OBSERVATION_MODIFIER", 118, 129]]], ["Mixing a drop of tracheal wash or cerebrospinal fluid (CSF) with filtered India ink highlights this capsule as a clear halo around the yeast cell.", [["tracheal", "ANATOMY", 17, 25], ["cerebrospinal fluid", "ANATOMY", 34, 53], ["capsule", "ANATOMY", 100, 107], ["yeast cell", "ANATOMY", 135, 145], ["cerebrospinal fluid", "ORGANISM_SUBSTANCE", 34, 53], ["CSF", "ORGANISM_SUBSTANCE", 55, 58], ["capsule", "CANCER", 100, 107], ["yeast cell", "CELL", 135, 145], ["yeast cell", "CELL_TYPE", 135, 145], ["yeast", "SPECIES", 135, 140], ["yeast", "SPECIES", 135, 140], ["tracheal wash", "TREATMENT", 17, 30], ["cerebrospinal fluid (CSF", "TEST", 34, 58], ["filtered India ink", "TREATMENT", 65, 83], ["this capsule", "TREATMENT", 95, 107], ["drop", "OBSERVATION_MODIFIER", 9, 13], ["tracheal", "ANATOMY", 17, 25], ["wash", "OBSERVATION", 26, 30], ["cerebrospinal", "ANATOMY", 34, 47], ["fluid", "OBSERVATION", 48, 53], ["clear", "OBSERVATION_MODIFIER", 113, 118], ["halo", "OBSERVATION", 119, 123], ["yeast cell", "OBSERVATION", 135, 145]]], ["Aggregates of Pneumocystis cysts also may be fluid in tracheal wash or BAL fluid; Pneumocystis cysts are more likely to appear in aggregates compared with Cryptococcus or other fungi affecting the lungs.", [["cysts", "ANATOMY", 27, 32], ["fluid", "ANATOMY", 45, 50], ["tracheal", "ANATOMY", 54, 62], ["BAL fluid", "ANATOMY", 71, 80], ["cysts", "ANATOMY", 95, 100], ["lungs", "ANATOMY", 197, 202], ["Pneumocystis cysts", "DISEASE", 14, 32], ["Pneumocystis cysts", "DISEASE", 82, 100], ["Pneumocystis", "ORGANISM", 14, 26], ["cysts", "PATHOLOGICAL_FORMATION", 27, 32], ["tracheal", "ORGAN", 54, 62], ["BAL fluid", "ORGANISM_SUBSTANCE", 71, 80], ["Pneumocystis cysts", "PATHOLOGICAL_FORMATION", 82, 100], ["lungs", "ORGAN", 197, 202], ["Pneumocystis cysts", "PROBLEM", 14, 32], ["fluid in tracheal wash", "PROBLEM", 45, 67], ["BAL fluid", "PROBLEM", 71, 80], ["Pneumocystis cysts", "PROBLEM", 82, 100], ["Cryptococcus", "PROBLEM", 155, 167], ["other fungi affecting the lungs", "PROBLEM", 171, 202], ["Pneumocystis cysts", "OBSERVATION", 14, 32], ["may be", "UNCERTAINTY", 38, 44], ["fluid", "OBSERVATION_MODIFIER", 45, 50], ["tracheal", "ANATOMY", 54, 62], ["wash", "OBSERVATION", 63, 67], ["BAL fluid", "OBSERVATION", 71, 80], ["Pneumocystis cysts", "OBSERVATION", 82, 100], ["more likely", "UNCERTAINTY", 105, 116], ["Cryptococcus", "OBSERVATION", 155, 167], ["fungi", "OBSERVATION", 177, 182], ["lungs", "ANATOMY", 197, 202]]], ["Cysts also may be identified histopathologically.", [["Cysts", "ANATOMY", 0, 5], ["Cysts", "PROBLEM", 0, 5], ["may be", "UNCERTAINTY", 11, 17]]], ["Samples of most fungi may be left at room temperature for several hours to promote fungal growth of development of hyphae.", [["Samples", "ANATOMY", 0, 7], ["hyphae", "ANATOMY", 115, 121], ["hyphae", "CELL", 115, 121], ["most fungi", "PROBLEM", 11, 21], ["hyphae", "PROBLEM", 115, 121], ["fungal growth", "OBSERVATION", 83, 96], ["hyphae", "OBSERVATION", 115, 121]]], ["Caution must be exercised when interpreting the importance of Aspergillus hyphae in tracheal wash or exudate samples because the fungus may be found in the upper airway of healthy camelids.", [["hyphae", "ANATOMY", 74, 80], ["tracheal", "ANATOMY", 84, 92], ["exudate samples", "ANATOMY", 101, 116], ["upper airway", "ANATOMY", 156, 168], ["Aspergillus hyphae", "ORGANISM", 62, 80], ["exudate samples", "ORGANISM_SUBSTANCE", 101, 116], ["upper airway", "ORGANISM_SUBDIVISION", 156, 168], ["Aspergillus hyphae", "PROBLEM", 62, 80], ["tracheal wash", "TREATMENT", 84, 97], ["exudate samples", "TEST", 101, 116], ["the fungus", "PROBLEM", 125, 135], ["tracheal", "ANATOMY", 84, 92], ["upper", "ANATOMY_MODIFIER", 156, 161], ["airway", "ANATOMY", 162, 168]]], ["Fungal culture and culture characteristics may be used to identify the causative agent.", [["Fungal culture", "TEST", 0, 14], ["culture characteristics", "TEST", 19, 42]]], ["Because of the infectivity of Coccidioides, all manipulations should be done on sealed samples or within suitable biohazard hoods.", [["samples", "ANATOMY", 87, 94], ["the infectivity of Coccidioides", "PROBLEM", 11, 42], ["all manipulations", "TREATMENT", 44, 61], ["infectivity", "OBSERVATION_MODIFIER", 15, 26], ["Coccidioides", "OBSERVATION", 30, 42]]], ["Skin lesions may be aspirated or biopsied.", [["Skin lesions", "ANATOMY", 0, 12], ["Skin lesions", "CANCER", 0, 12], ["Skin lesions", "PROBLEM", 0, 12], ["lesions", "OBSERVATION", 5, 12], ["aspirated", "OBSERVATION", 20, 29]]], ["Skin testing and serum complement fixation appear to offer inconclusive results.", [["Skin", "ANATOMY", 0, 4], ["serum", "ANATOMY", 17, 22], ["Skin", "ORGAN", 0, 4], ["serum", "ORGANISM_SUBSTANCE", 17, 22], ["Skin testing", "TEST", 0, 12], ["serum complement fixation", "TEST", 17, 42]]], ["Qualitative agar gel immunodiffusion for immunoglobulin G (IgG) appears to be relatively sensitive and specific for coccidioidomycosis.", [["coccidioidomycosis", "DISEASE", 116, 134], ["immunoglobulin G", "GENE_OR_GENE_PRODUCT", 41, 57], ["IgG", "GENE_OR_GENE_PRODUCT", 59, 62], ["immunoglobulin G", "PROTEIN", 41, 57], ["IgG", "PROTEIN", 59, 62], ["Qualitative agar gel immunodiffusion", "TEST", 0, 36], ["immunoglobulin G (IgG)", "TEST", 41, 63], ["coccidioidomycosis", "PROBLEM", 116, 134], ["coccidioidomycosis", "OBSERVATION", 116, 134]]], ["A latex agglutination test to detect cryptococcal capsular antigen in body fluids is also available.", [["body fluids", "ANATOMY", 70, 81], ["cryptococcal capsular antigen", "GENE_OR_GENE_PRODUCT", 37, 66], ["body", "ORGANISM_SUBDIVISION", 70, 74], ["cryptococcal capsular antigen", "PROTEIN", 37, 66], ["A latex agglutination test", "TEST", 0, 26], ["cryptococcal capsular antigen in body fluids", "TEST", 37, 81]]], ["Most other tests have not been studied sufficiently in camelids.Tuberculosis and other Mycobacterial InfectionsSpecific drug treatments of systemic mycoses have scarcely been investigated in camelids or even ruminants.", [["Tuberculosis", "DISEASE", 64, 76], ["Mycobacterial Infections", "DISEASE", 87, 111], ["mycoses", "DISEASE", 148, 155], ["Most other tests", "TEST", 0, 16], ["Tuberculosis", "PROBLEM", 64, 76], ["other Mycobacterial Infections", "PROBLEM", 81, 111], ["systemic mycoses", "PROBLEM", 139, 155], ["Mycobacterial", "OBSERVATION_MODIFIER", 87, 100], ["Infections", "OBSERVATION", 101, 111], ["systemic", "OBSERVATION_MODIFIER", 139, 147], ["mycoses", "OBSERVATION", 148, 155]]], ["Historically, most cases have been diagnosed after death.", [["death", "DISEASE", 51, 56], ["death", "PROBLEM", 51, 56]]], ["Amphotericin B is the agent that has been most tried for the treatment of systemic mycoses in domestic species and was used unsuccessfully in one affected llama.", [["Amphotericin B", "CHEMICAL", 0, 14], ["mycoses", "DISEASE", 83, 90], ["Amphotericin B", "CHEMICAL", 0, 14], ["Amphotericin B", "SIMPLE_CHEMICAL", 0, 14], ["llama", "ORGANISM", 155, 160], ["Amphotericin B", "TREATMENT", 0, 14], ["the agent", "TREATMENT", 18, 27], ["systemic mycoses", "PROBLEM", 74, 90], ["systemic", "OBSERVATION_MODIFIER", 74, 82], ["mycoses", "OBSERVATION", 83, 90], ["domestic species", "OBSERVATION", 94, 110]]], ["Other possibilities include imidazole compounds (ketaconazole, fluconazole, miconazole, itraconazole), but their use has not been investigated sufficiently to determine dose or efficacy.Parasitic PneumoniaLungworm infestations of New World camelids appear to be rare and have not been reported in North America.", [["imidazole", "CHEMICAL", 28, 37], ["ketaconazole", "CHEMICAL", 49, 61], ["fluconazole", "CHEMICAL", 63, 74], ["miconazole", "CHEMICAL", 76, 86], ["itraconazole", "CHEMICAL", 88, 100], ["imidazole", "CHEMICAL", 28, 37], ["ketaconazole", "CHEMICAL", 49, 61], ["fluconazole", "CHEMICAL", 63, 74], ["miconazole", "CHEMICAL", 76, 86], ["itraconazole", "CHEMICAL", 88, 100], ["imidazole compounds", "SIMPLE_CHEMICAL", 28, 47], ["ketaconazole", "SIMPLE_CHEMICAL", 49, 61], ["fluconazole", "SIMPLE_CHEMICAL", 63, 74], ["miconazole", "SIMPLE_CHEMICAL", 76, 86], ["itraconazole", "SIMPLE_CHEMICAL", 88, 100], ["imidazole compounds", "TREATMENT", 28, 47], ["ketaconazole", "TREATMENT", 49, 61], ["fluconazole", "TREATMENT", 63, 74], ["miconazole", "TREATMENT", 76, 86], ["itraconazole", "TREATMENT", 88, 100], ["Parasitic PneumoniaLungworm infestations", "PROBLEM", 186, 226], ["New", "OBSERVATION_MODIFIER", 230, 233]]], ["Camelids grazed in proximity to infested cattle, sheep, or cervids should be considered at highest risk.", [["cervids", "ANATOMY", 59, 66], ["Camelids", "CHEMICAL", 0, 8], ["cattle", "ORGANISM", 41, 47], ["sheep", "ORGANISM", 49, 54], ["cattle", "SPECIES", 41, 47], ["sheep", "SPECIES", 49, 54], ["cattle", "SPECIES", 41, 47], ["sheep", "SPECIES", 49, 54]]], ["Both Dictyocaulus viviparus and D. filari appear to have the potential to infest camelids.", [["Dictyocaulus viviparus", "ORGANISM", 5, 27], ["D. filari", "ORGANISM", 32, 41], ["Dictyocaulus viviparus", "SPECIES", 5, 27], ["D. filari", "SPECIES", 32, 41], ["Dictyocaulus viviparus", "SPECIES", 5, 27], ["D. filari", "SPECIES", 32, 41], ["Dictyocaulus viviparus", "OBSERVATION", 5, 27]]], ["79 Adult worms live in the bronchi, where they produce eggs that the host coughs up and swallows.", [["bronchi", "ANATOMY", 27, 34], ["worms", "ORGANISM", 9, 14], ["bronchi", "MULTI-TISSUE_STRUCTURE", 27, 34], ["worms", "SPECIES", 9, 14], ["the host coughs", "PROBLEM", 65, 80], ["bronchi", "ANATOMY", 27, 34]]], ["Larvae hatch within the intestinal tract and are passed in feces.", [["intestinal tract", "ANATOMY", 24, 40], ["feces", "ANATOMY", 59, 64], ["Larvae", "ORGANISM", 0, 6], ["intestinal tract", "ORGAN", 24, 40], ["feces", "ORGANISM_SUBSTANCE", 59, 64], ["intestinal tract", "ANATOMY", 24, 40], ["feces", "OBSERVATION", 59, 64]]], ["Mature larvae invade through the small intestine and move through blood or lymphatics back to the lung.", [["larvae", "ANATOMY", 7, 13], ["small intestine", "ANATOMY", 33, 48], ["blood", "ANATOMY", 66, 71], ["lymphatics", "ANATOMY", 75, 85], ["lung", "ANATOMY", 98, 102], ["small intestine", "ORGAN", 33, 48], ["blood", "ORGANISM_SUBSTANCE", 66, 71], ["lymphatics back", "MULTI-TISSUE_STRUCTURE", 75, 90], ["lung", "ORGAN", 98, 102], ["larvae", "OBSERVATION", 7, 13], ["small intestine", "ANATOMY", 33, 48], ["lymphatics", "ANATOMY", 75, 85], ["lung", "ANATOMY", 98, 102]]], ["Most disease relates to the pulmonary larval migration and hence may appear within the 4 to 5 week prepatent period.", [["pulmonary", "ANATOMY", 28, 37], ["pulmonary", "ORGAN", 28, 37], ["Most disease", "PROBLEM", 0, 12], ["the pulmonary larval migration", "PROBLEM", 24, 54], ["pulmonary", "ANATOMY", 28, 37], ["larval migration", "OBSERVATION", 38, 54]]], ["Affected camelids have productive cough and dyspnea and are typically afebrile.", [["camelids", "ANATOMY", 9, 17], ["cough", "DISEASE", 34, 39], ["dyspnea", "DISEASE", 44, 51], ["Affected camelids", "PROBLEM", 0, 17], ["productive cough", "PROBLEM", 23, 39], ["dyspnea", "PROBLEM", 44, 51], ["typically afebrile", "PROBLEM", 60, 78], ["productive", "OBSERVATION_MODIFIER", 23, 33], ["cough", "OBSERVATION", 34, 39], ["typically", "OBSERVATION_MODIFIER", 60, 69], ["afebrile", "OBSERVATION", 70, 78]]], ["Diagnosis may be made by examining fresh feces using the Baermann technique.", [["feces", "ANATOMY", 41, 46], ["feces", "ORGANISM_SUBDIVISION", 41, 46], ["the Baermann technique", "TREATMENT", 53, 75]]], ["Larvae found in fresh feces are likely to be from lungworms or Strongyloides.Parasitic Pneumoniakidneys.", [["feces", "ANATOMY", 22, 27], ["Parasitic Pneumoniakidneys", "DISEASE", 77, 103], ["Larvae", "ORGANISM", 0, 6], ["feces", "ORGANISM_SUBSTANCE", 22, 27], ["Larvae", "TREATMENT", 0, 6], ["fresh feces", "PROBLEM", 16, 27], ["lungworms", "PROBLEM", 50, 59], ["Strongyloides", "PROBLEM", 63, 76], ["Parasitic Pneumoniakidneys", "PROBLEM", 77, 103], ["fresh feces", "OBSERVATION", 16, 27], ["likely to be", "UNCERTAINTY", 32, 44], ["Strongyloides", "OBSERVATION", 63, 76], ["Pneumoniakidneys", "OBSERVATION", 87, 103]]], ["Meningitis appears to be the most common neurologic form.Parasitic PneumoniaH. capsulatum infection has been reported once in Indiana, in a llama imported 7 months previously from Bolivia.", [["neurologic", "ANATOMY", 41, 51], ["Meningitis", "DISEASE", 0, 10], ["capsulatum infection", "DISEASE", 79, 99], ["capsulatum", "ORGANISM", 79, 89], ["capsulatum", "SPECIES", 79, 89], ["capsulatum", "SPECIES", 79, 89], ["llama", "SPECIES", 140, 145], ["Meningitis", "PROBLEM", 0, 10], ["Parasitic PneumoniaH", "PROBLEM", 57, 77], ["capsulatum infection", "PROBLEM", 79, 99], ["PneumoniaH", "OBSERVATION", 67, 77], ["infection", "OBSERVATION", 90, 99]]], ["72 In other species, infection has a worldwide distribution.", [["infection", "DISEASE", 21, 30], ["infection", "PROBLEM", 21, 30], ["species", "OBSERVATION", 12, 19], ["infection", "OBSERVATION", 21, 30], ["worldwide", "OBSERVATION_MODIFIER", 37, 46], ["distribution", "OBSERVATION_MODIFIER", 47, 59]]], ["Inhalation of microconidia from the soil is the putative source of infection.", [["microconidia", "CHEMICAL", 14, 26], ["infection", "DISEASE", 67, 76], ["microconidia", "PROBLEM", 14, 26], ["infection", "PROBLEM", 67, 76], ["infection", "OBSERVATION", 67, 76]]], ["Decaying vegetation and bird droppings promote the growth of the fungus.", [["Decaying vegetation", "PROBLEM", 0, 19], ["bird droppings", "PROBLEM", 24, 38], ["the fungus", "PROBLEM", 61, 71], ["vegetation", "OBSERVATION", 9, 19], ["bird droppings", "OBSERVATION", 24, 38], ["growth", "OBSERVATION_MODIFIER", 51, 57], ["fungus", "OBSERVATION", 65, 71]]], ["Within the body, the organism multiplies in the yeast form.", [["body", "ANATOMY", 11, 15], ["body", "ORGANISM_SUBDIVISION", 11, 15], ["yeast", "SPECIES", 48, 53], ["yeast", "SPECIES", 48, 53], ["body", "ANATOMY", 11, 15], ["yeast form", "OBSERVATION", 48, 58]]], ["The primary lesions of the affected llama were in the lungs, with smaller secondary lesions in the reticuloendothelial organs.Parasitic PneumoniaAspergillus infection has been reported in Texas, Wisconsin, Brazil, England, and Australia.", [["primary lesions", "ANATOMY", 4, 19], ["lungs", "ANATOMY", 54, 59], ["lesions", "ANATOMY", 84, 91], ["reticuloendothelial organs", "ANATOMY", 99, 125], ["Parasitic PneumoniaAspergillus infection", "DISEASE", 126, 166], ["lesions", "CANCER", 12, 19], ["llama", "ORGANISM", 36, 41], ["lungs", "ORGAN", 54, 59], ["lesions", "PATHOLOGICAL_FORMATION", 84, 91], ["reticuloendothelial organs", "MULTI-TISSUE_STRUCTURE", 99, 125], ["The primary lesions of the affected llama", "PROBLEM", 0, 41], ["smaller secondary lesions in the reticuloendothelial organs", "PROBLEM", 66, 125], ["Parasitic PneumoniaAspergillus infection", "PROBLEM", 126, 166], ["primary", "OBSERVATION_MODIFIER", 4, 11], ["lesions", "OBSERVATION", 12, 19], ["affected", "OBSERVATION_MODIFIER", 27, 35], ["llama", "OBSERVATION", 36, 41], ["lungs", "ANATOMY", 54, 59], ["smaller", "OBSERVATION_MODIFIER", 66, 73], ["secondary", "OBSERVATION_MODIFIER", 74, 83], ["lesions", "OBSERVATION", 84, 91], ["reticuloendothelial organs", "ANATOMY", 99, 125], ["PneumoniaAspergillus", "OBSERVATION_MODIFIER", 136, 156], ["infection", "OBSERVATION", 157, 166]]], ["[73] [74] [75] [76] [77] Aspergillosis is the most common systemic mycosis in domestic animals.", [["[73] [74] [75] [76] [77] Aspergillosis", "CHEMICAL", 0, 38], ["mycosis", "DISEASE", 67, 74], ["[73] [74] [75] [76]", "CHEMICAL", 0, 19], ["[73] [74] [75] [76] [77] Aspergillosis", "SIMPLE_CHEMICAL", 0, 38], ["Aspergillosis", "PROBLEM", 25, 38], ["Aspergillosis", "OBSERVATION", 25, 38], ["most common", "OBSERVATION_MODIFIER", 46, 57], ["systemic", "OBSERVATION_MODIFIER", 58, 66], ["mycosis", "OBSERVATION", 67, 74]]], ["The causative fungus is found worldwide on a variety of substrates.", [["The causative fungus", "PROBLEM", 0, 20], ["causative", "OBSERVATION_MODIFIER", 4, 13], ["fungus", "OBSERVATION", 14, 20]]], ["Dusty barn air is likely to have high spore counts.", [["spore", "ANATOMY", 38, 43], ["Dusty barn air", "PROBLEM", 0, 14], ["high spore counts", "PROBLEM", 33, 50], ["barn air", "OBSERVATION", 6, 14], ["high", "OBSERVATION_MODIFIER", 33, 37], ["spore counts", "OBSERVATION", 38, 50]]], ["Inhalation is the likely cause of some pulmonary infections, but others arise through hematogenous spread after invasion through erosions in the GI tract or skin.", [["pulmonary", "ANATOMY", 39, 48], ["GI tract", "ANATOMY", 145, 153], ["skin", "ANATOMY", 157, 161], ["pulmonary infections", "DISEASE", 39, 59], ["erosions", "DISEASE", 129, 137], ["pulmonary", "ORGAN", 39, 48], ["GI tract", "ORGANISM_SUBDIVISION", 145, 153], ["skin", "ORGAN", 157, 161], ["Inhalation", "TREATMENT", 0, 10], ["some pulmonary infections", "PROBLEM", 34, 59], ["hematogenous spread", "PROBLEM", 86, 105], ["invasion through erosions in the GI tract", "PROBLEM", 112, 153], ["likely cause of", "UNCERTAINTY", 18, 33], ["some", "OBSERVATION_MODIFIER", 34, 38], ["pulmonary", "ANATOMY", 39, 48], ["infections", "OBSERVATION", 49, 59], ["hematogenous", "OBSERVATION_MODIFIER", 86, 98], ["erosions", "OBSERVATION", 129, 137], ["GI tract", "ANATOMY", 145, 153], ["skin", "ANATOMY", 157, 161]]], ["The lungs, gut wall, CNS, cornea, and kidney are the most common sites of infection.", [["lungs", "ANATOMY", 4, 9], ["gut wall", "ANATOMY", 11, 19], ["CNS", "ANATOMY", 21, 24], ["cornea", "ANATOMY", 26, 32], ["kidney", "ANATOMY", 38, 44], ["sites", "ANATOMY", 65, 70], ["infection", "DISEASE", 74, 83], ["lungs", "ORGAN", 4, 9], ["gut wall", "MULTI-TISSUE_STRUCTURE", 11, 19], ["CNS", "ANATOMICAL_SYSTEM", 21, 24], ["cornea", "TISSUE", 26, 32], ["kidney", "ORGAN", 38, 44], ["infection", "PROBLEM", 74, 83], ["lungs", "ANATOMY", 4, 9], ["gut", "ANATOMY", 11, 14], ["wall", "ANATOMY_MODIFIER", 15, 19], ["CNS", "ANATOMY", 21, 24], ["cornea", "ANATOMY", 26, 32], ["kidney", "ANATOMY", 38, 44], ["most common", "OBSERVATION_MODIFIER", 53, 64], ["infection", "OBSERVATION", 74, 83]]], ["In some cases, the patient has a preexisting immunosuppressive or erosive condition such as chronic disease, corticosteroid treatment, forestomach acidosis, gastric ulceration, or enteritis.", [["forestomach", "ANATOMY", 135, 146], ["gastric", "ANATOMY", 157, 164], ["chronic disease", "DISEASE", 92, 107], ["forestomach acidosis", "DISEASE", 135, 155], ["gastric ulceration", "DISEASE", 157, 175], ["enteritis", "DISEASE", 180, 189], ["patient", "ORGANISM", 19, 26], ["corticosteroid", "SIMPLE_CHEMICAL", 109, 123], ["forestomach", "ORGAN", 135, 146], ["gastric", "ORGAN", 157, 164], ["patient", "SPECIES", 19, 26], ["erosive condition", "PROBLEM", 66, 83], ["chronic disease", "PROBLEM", 92, 107], ["corticosteroid treatment", "TREATMENT", 109, 133], ["forestomach acidosis", "PROBLEM", 135, 155], ["gastric ulceration", "PROBLEM", 157, 175], ["enteritis", "PROBLEM", 180, 189], ["erosive", "OBSERVATION_MODIFIER", 66, 73], ["chronic", "OBSERVATION_MODIFIER", 92, 99], ["disease", "OBSERVATION", 100, 107], ["corticosteroid treatment", "OBSERVATION", 109, 133], ["forestomach", "ANATOMY", 135, 146], ["acidosis", "OBSERVATION", 147, 155], ["gastric", "ANATOMY", 157, 164], ["ulceration", "OBSERVATION", 165, 175], ["enteritis", "OBSERVATION", 180, 189]]], ["Unlike most other pulmonary fungi, Aspergillus grows hyphae within the body.Parasitic PneumoniaRhizopus infection was reported in a single llama in California with dysphagia, bilateral facial paralysis, paralysis of extraocular muscles, and eventually weight loss.", [["pulmonary fungi", "ANATOMY", 18, 33], ["hyphae", "ANATOMY", 53, 59], ["body", "ANATOMY", 71, 75], ["facial", "ANATOMY", 185, 191], ["extraocular muscles", "ANATOMY", 216, 235], ["Parasitic PneumoniaRhizopus infection", "DISEASE", 76, 113], ["dysphagia", "DISEASE", 164, 173], ["facial paralysis", "DISEASE", 185, 201], ["paralysis", "DISEASE", 203, 212], ["weight loss", "DISEASE", 252, 263], ["body", "ORGANISM_SUBDIVISION", 71, 75], ["extraocular muscles", "ORGAN", 216, 235], ["most other pulmonary fungi", "PROBLEM", 7, 33], ["Aspergillus grows hyphae within the body", "PROBLEM", 35, 75], ["Parasitic PneumoniaRhizopus infection", "PROBLEM", 76, 113], ["dysphagia", "PROBLEM", 164, 173], ["bilateral facial paralysis", "PROBLEM", 175, 201], ["paralysis of extraocular muscles", "PROBLEM", 203, 235], ["eventually weight loss", "PROBLEM", 241, 263], ["pulmonary", "ANATOMY", 18, 27], ["fungi", "OBSERVATION", 28, 33], ["Aspergillus", "OBSERVATION", 35, 46], ["hyphae", "OBSERVATION", 53, 59], ["body", "ANATOMY_MODIFIER", 71, 75], ["PneumoniaRhizopus", "OBSERVATION_MODIFIER", 86, 103], ["infection", "OBSERVATION", 104, 113], ["dysphagia", "OBSERVATION", 164, 173], ["bilateral", "ANATOMY_MODIFIER", 175, 184], ["facial", "ANATOMY", 185, 191], ["paralysis", "OBSERVATION", 192, 201], ["paralysis", "OBSERVATION", 203, 212], ["extraocular muscles", "ANATOMY", 216, 235], ["weight loss", "OBSERVATION", 252, 263]]], ["On necropsy, fungal rhinitis, nodular pneumonia, and meningoencephalitis were found.Parasitic PneumoniaPneumocystis carinii infection of the lung also appears to be rare.", [["lung", "ANATOMY", 141, 145], ["fungal rhinitis", "DISEASE", 13, 28], ["pneumonia", "DISEASE", 38, 47], ["meningoencephalitis", "DISEASE", 53, 72], ["PneumoniaPneumocystis carinii infection", "DISEASE", 94, 133], ["PneumoniaPneumocystis carinii", "ORGANISM", 94, 123], ["lung", "ORGAN", 141, 145], ["PneumoniaPneumocystis carinii", "SPECIES", 94, 123], ["PneumoniaPneumocystis carinii", "SPECIES", 94, 123], ["necropsy", "TREATMENT", 3, 11], ["fungal rhinitis", "PROBLEM", 13, 28], ["nodular pneumonia", "PROBLEM", 30, 47], ["meningoencephalitis", "PROBLEM", 53, 72], ["Parasitic PneumoniaPneumocystis carinii infection of the lung", "PROBLEM", 84, 145], ["fungal rhinitis", "OBSERVATION", 13, 28], ["nodular", "OBSERVATION_MODIFIER", 30, 37], ["pneumonia", "OBSERVATION", 38, 47], ["meningoencephalitis", "OBSERVATION", 53, 72], ["PneumoniaPneumocystis", "OBSERVATION", 94, 115], ["carinii infection", "OBSERVATION", 116, 133], ["lung", "ANATOMY", 141, 145], ["appears to be", "UNCERTAINTY", 151, 164], ["rare", "OBSERVATION_MODIFIER", 165, 169]]], ["78 It is seen in a variety of species, often in individuals with reduced immune function.", [["reduced immune function", "PROBLEM", 65, 88], ["variety", "OBSERVATION_MODIFIER", 19, 26], ["species", "OBSERVATION", 30, 37], ["immune function", "OBSERVATION", 73, 88]]], ["Recently, the organism has been reclassified as a fungus, and the species found to infect animals are different from those that affect humans.", [["humans", "ORGANISM", 135, 141], ["humans", "SPECIES", 135, 141], ["humans", "SPECIES", 135, 141], ["the organism", "PROBLEM", 10, 22], ["a fungus", "PROBLEM", 48, 56], ["the species", "PROBLEM", 62, 73]]], ["Inflammation associated with infection leads to widespread, multifocal, nodular lung disease.", [["nodular lung", "ANATOMY", 72, 84], ["Inflammation", "DISEASE", 0, 12], ["infection", "DISEASE", 29, 38], ["lung disease", "DISEASE", 80, 92], ["lung", "ORGAN", 80, 84], ["Inflammation", "PROBLEM", 0, 12], ["infection", "PROBLEM", 29, 38], ["widespread, multifocal, nodular lung disease", "PROBLEM", 48, 92], ["infection", "OBSERVATION", 29, 38], ["widespread", "OBSERVATION_MODIFIER", 48, 58], ["multifocal", "OBSERVATION_MODIFIER", 60, 70], ["nodular", "OBSERVATION_MODIFIER", 72, 79], ["lung", "ANATOMY", 80, 84], ["disease", "OBSERVATION", 85, 92]]], ["Nodules may appear on radiography or other imaging studies or may be too small.", [["Nodules", "ANATOMY", 0, 7], ["Nodules", "PROBLEM", 0, 7], ["radiography", "TEST", 22, 33], ["other imaging studies", "TEST", 37, 58], ["may be", "UNCERTAINTY", 62, 68], ["too small", "OBSERVATION_MODIFIER", 69, 78]]], ["Aggregates of cysts also may be fluid in tracheal wash or BAL fluid; Pneumo cystis cysts are more likely to appear in aggregates than Cryp tococcus or other fungi affecting the lungs.", [["cysts", "ANATOMY", 14, 19], ["fluid", "ANATOMY", 32, 37], ["tracheal", "ANATOMY", 41, 49], ["BAL fluid", "ANATOMY", 58, 67], ["Pneumo cystis cysts", "ANATOMY", 69, 88], ["Cryp tococcus", "ANATOMY", 134, 147], ["lungs", "ANATOMY", 177, 182], ["cysts", "CANCER", 14, 19], ["tracheal", "ORGAN", 41, 49], ["BAL fluid", "ORGANISM_SUBSTANCE", 58, 67], ["Pneumo cystis cysts", "PATHOLOGICAL_FORMATION", 69, 88], ["Cryp tococcus", "ORGANISM", 134, 147], ["lungs", "ORGAN", 177, 182], ["Pneumo cystis", "SPECIES", 69, 82], ["Cryp tococcus", "SPECIES", 134, 147], ["cysts", "PROBLEM", 14, 19], ["fluid in tracheal wash", "PROBLEM", 32, 54], ["BAL fluid", "PROBLEM", 58, 67], ["Pneumo cystis cysts", "PROBLEM", 69, 88], ["other fungi affecting the lungs", "PROBLEM", 151, 182], ["cysts", "OBSERVATION", 14, 19], ["may be", "UNCERTAINTY", 25, 31], ["fluid", "OBSERVATION_MODIFIER", 32, 37], ["tracheal", "ANATOMY", 41, 49], ["wash", "OBSERVATION", 50, 54], ["BAL fluid", "OBSERVATION", 58, 67], ["Pneumo cystis", "OBSERVATION", 69, 82], ["more likely", "UNCERTAINTY", 93, 104], ["fungi", "OBSERVATION", 157, 162], ["lungs", "ANATOMY", 177, 182]]], ["Cyst also may be identified histopathologically.Parasitic PneumoniaAffected camelids may show a variety of signs, depending on where lesions develop.", [["Cyst", "ANATOMY", 0, 4], ["lesions", "ANATOMY", 133, 140], ["Cyst", "CANCER", 0, 4], ["lesions", "PATHOLOGICAL_FORMATION", 133, 140], ["Cyst", "PROBLEM", 0, 4], ["Parasitic PneumoniaAffected camelids", "PROBLEM", 48, 84], ["lesions", "PROBLEM", 133, 140], ["may be", "UNCERTAINTY", 10, 16], ["variety", "OBSERVATION_MODIFIER", 96, 103], ["lesions", "OBSERVATION", 133, 140]]], ["Respiratory signs include tachypnea and exercise intolerance.", [["Respiratory", "ANATOMY", 0, 11], ["Respiratory signs", "DISEASE", 0, 17], ["tachypnea", "DISEASE", 26, 35], ["exercise intolerance", "DISEASE", 40, 60], ["Respiratory signs", "TEST", 0, 17], ["tachypnea", "PROBLEM", 26, 35], ["exercise intolerance", "PROBLEM", 40, 60], ["tachypnea", "OBSERVATION", 26, 35], ["exercise intolerance", "OBSERVATION", 40, 60]]], ["The most common other signs of the respiratory form or of disseminated (mainly abdominal) infection are anorexia, weight loss, decreased activity, and obtundation.", [["respiratory", "ANATOMY", 35, 46], ["abdominal", "ANATOMY", 79, 88], ["abdominal) infection", "DISEASE", 79, 99], ["anorexia", "DISEASE", 104, 112], ["weight loss", "DISEASE", 114, 125], ["abdominal", "ORGANISM_SUBDIVISION", 79, 88], ["disseminated (mainly abdominal) infection", "PROBLEM", 58, 99], ["anorexia", "PROBLEM", 104, 112], ["weight loss", "PROBLEM", 114, 125], ["decreased activity", "PROBLEM", 127, 145], ["obtundation", "PROBLEM", 151, 162], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["disseminated", "OBSERVATION_MODIFIER", 58, 70], ["abdominal", "ANATOMY", 79, 88], ["infection", "OBSERVATION", 90, 99], ["anorexia", "OBSERVATION", 104, 112], ["decreased", "OBSERVATION_MODIFIER", 127, 136], ["activity", "OBSERVATION_MODIFIER", 137, 145]]], ["Affected camelids are usually afebrile.", [["camelids", "ANATOMY", 9, 17], ["camelids", "CANCER", 9, 17], ["Affected camelids", "PROBLEM", 0, 17], ["afebrile", "PROBLEM", 30, 38]]], ["CNS infection may occur in the spinal canal or the cranial vault.", [["CNS", "ANATOMY", 0, 3], ["spinal canal", "ANATOMY", 31, 43], ["cranial vault", "ANATOMY", 51, 64], ["infection", "DISEASE", 4, 13], ["CNS", "ANATOMICAL_SYSTEM", 0, 3], ["spinal canal", "MULTI-TISSUE_STRUCTURE", 31, 43], ["cranial vault", "MULTI-TISSUE_STRUCTURE", 51, 64], ["CNS infection", "PROBLEM", 0, 13], ["infection", "OBSERVATION", 4, 13], ["spinal canal", "ANATOMY", 31, 43], ["cranial vault", "ANATOMY", 51, 64]]], ["Signs with spinal infection include increased recumbency, progressive paresis, and hyporeflexia.", [["spinal", "ANATOMY", 11, 17], ["spinal infection", "DISEASE", 11, 27], ["paresis", "DISEASE", 70, 77], ["hyporeflexia", "DISEASE", 83, 95], ["spinal", "ORGAN", 11, 17], ["spinal infection", "PROBLEM", 11, 27], ["increased recumbency", "PROBLEM", 36, 56], ["progressive paresis", "PROBLEM", 58, 77], ["hyporeflexia", "PROBLEM", 83, 95], ["spinal", "ANATOMY", 11, 17], ["infection", "OBSERVATION", 18, 27], ["increased", "OBSERVATION_MODIFIER", 36, 45], ["recumbency", "OBSERVATION_MODIFIER", 46, 56], ["progressive", "OBSERVATION_MODIFIER", 58, 69], ["paresis", "OBSERVATION", 70, 77]]], ["Intracranial signs may include loss of cranial nerve function or cognition.Parasitic PneumoniaClinical pathology data may similarly be normal or abnormal, depending on the organs affected.", [["Intracranial", "ANATOMY", 0, 12], ["cranial nerve", "ANATOMY", 39, 52], ["organs", "ANATOMY", 172, 178], ["loss of cranial nerve function", "DISEASE", 31, 61], ["cranial nerve", "MULTI-TISSUE_STRUCTURE", 39, 52], ["organs", "ORGAN", 172, 178], ["Intracranial signs", "PROBLEM", 0, 18], ["loss of cranial nerve function", "PROBLEM", 31, 61], ["Parasitic PneumoniaClinical pathology data", "TEST", 75, 117], ["cranial nerve", "ANATOMY", 39, 52], ["may similarly be", "UNCERTAINTY", 118, 134], ["normal", "OBSERVATION", 135, 141], ["abnormal", "OBSERVATION_MODIFIER", 145, 153]]], ["Serum increases in nitrogenous waste products, hepatic enzymes, muscle enzymes, and globulins have been seen.", [["Serum", "ANATOMY", 0, 5], ["hepatic", "ANATOMY", 47, 54], ["muscle", "ANATOMY", 64, 70], ["Serum", "ORGANISM_SUBSTANCE", 0, 5], ["hepatic enzymes", "GENE_OR_GENE_PRODUCT", 47, 62], ["muscle", "ORGAN", 64, 70], ["globulins", "GENE_OR_GENE_PRODUCT", 84, 93], ["nitrogenous waste products", "PROTEIN", 19, 45], ["hepatic enzymes", "PROTEIN", 47, 62], ["muscle enzymes", "PROTEIN", 64, 78], ["globulins", "PROTEIN", 84, 93], ["Serum increases", "PROBLEM", 0, 15], ["nitrogenous waste products", "TREATMENT", 19, 45], ["hepatic enzymes", "TEST", 47, 62], ["muscle enzymes", "TEST", 64, 78], ["globulins", "TEST", 84, 93], ["increases", "OBSERVATION_MODIFIER", 6, 15], ["nitrogenous waste", "OBSERVATION", 19, 36], ["hepatic", "ANATOMY", 47, 54], ["muscle", "ANATOMY", 64, 70]]], ["Without secondary bacterial infection, hematologic changes are subtle; monocytosis and mild hyperfibrinogenemia may be seen.Parasitic PneumoniaDefinitive diagnosis requires specialized testing.", [["hematologic", "ANATOMY", 39, 50], ["bacterial infection", "DISEASE", 18, 37], ["monocytosis", "DISEASE", 71, 82], ["hyperfibrinogenemia", "DISEASE", 92, 111], ["secondary bacterial infection", "PROBLEM", 8, 37], ["hematologic changes", "PROBLEM", 39, 58], ["monocytosis", "PROBLEM", 71, 82], ["mild hyperfibrinogenemia", "PROBLEM", 87, 111], ["specialized testing", "TEST", 173, 192], ["secondary", "OBSERVATION_MODIFIER", 8, 17], ["bacterial", "OBSERVATION_MODIFIER", 18, 27], ["infection", "OBSERVATION", 28, 37], ["hematologic", "OBSERVATION", 39, 50], ["monocytosis", "OBSERVATION_MODIFIER", 71, 82], ["mild", "OBSERVATION_MODIFIER", 87, 91], ["hyperfibrinogenemia", "OBSERVATION", 92, 111], ["may be seen", "UNCERTAINTY", 112, 123]]], ["Thoracic radiography or advanced imaging techniques may reveal granu lomatous changes in the lungs, but these can also beDiaphragmatic HerniaDiaphragmatic defects account for 1% of all reported birth defects in one study.", [["Thoracic", "ANATOMY", 0, 8], ["granu lomatous", "ANATOMY", 63, 77], ["lungs", "ANATOMY", 93, 98], ["HerniaDiaphragmatic defects", "DISEASE", 135, 162], ["birth defects", "DISEASE", 194, 207], ["lungs", "ORGAN", 93, 98], ["Thoracic radiography", "TEST", 0, 20], ["advanced imaging techniques", "TEST", 24, 51], ["granu lomatous changes in the lungs", "PROBLEM", 63, 98], ["beDiaphragmatic HerniaDiaphragmatic defects", "PROBLEM", 119, 162], ["all reported birth defects", "PROBLEM", 181, 207], ["one study", "TEST", 211, 220], ["granu lomatous", "OBSERVATION", 63, 77], ["lungs", "ANATOMY", 93, 98], ["HerniaDiaphragmatic defects", "OBSERVATION", 135, 162], ["birth defects", "OBSERVATION", 194, 207]]], ["83, 84 Clinical disease is the result of compression of the lungs by herniated abdominal viscera or incarceration of those viscera.", [["lungs", "ANATOMY", 60, 65], ["abdominal viscera", "ANATOMY", 79, 96], ["viscera", "ANATOMY", 123, 130], ["lungs", "ORGAN", 60, 65], ["abdominal viscera", "ORGAN", 79, 96], ["viscera", "ORGAN", 123, 130], ["Clinical disease", "PROBLEM", 7, 23], ["compression of the lungs", "PROBLEM", 41, 65], ["herniated abdominal viscera", "PROBLEM", 69, 96], ["incarceration of those viscera", "PROBLEM", 100, 130], ["disease", "OBSERVATION", 16, 23], ["compression", "OBSERVATION", 41, 52], ["lungs", "ANATOMY", 60, 65], ["herniated", "OBSERVATION", 69, 78], ["abdominal viscera", "ANATOMY", 79, 96], ["incarceration", "OBSERVATION", 100, 113], ["viscera", "ANATOMY", 123, 130]]], ["Affected crias are likely to be in respiratory distress with tachypnea, dyspnea, and blood gas evidence of hypoxemia and hypoventilation.", [["respiratory", "ANATOMY", 35, 46], ["blood", "ANATOMY", 85, 90], ["respiratory distress", "DISEASE", 35, 55], ["tachypnea", "DISEASE", 61, 70], ["dyspnea", "DISEASE", 72, 79], ["hypoxemia", "DISEASE", 107, 116], ["hypoventilation", "DISEASE", 121, 136], ["blood", "ORGANISM_SUBSTANCE", 85, 90], ["Affected crias", "PROBLEM", 0, 14], ["respiratory distress", "PROBLEM", 35, 55], ["tachypnea", "PROBLEM", 61, 70], ["dyspnea", "PROBLEM", 72, 79], ["blood gas", "TEST", 85, 94], ["hypoxemia", "PROBLEM", 107, 116], ["hypoventilation", "PROBLEM", 121, 136], ["likely to be", "UNCERTAINTY", 19, 31], ["respiratory distress", "OBSERVATION", 35, 55], ["tachypnea", "OBSERVATION", 61, 70], ["hypoxemia", "OBSERVATION", 107, 116], ["hypoventilation", "OBSERVATION", 121, 136]]], ["\"Dog sitting\" may be an attempt to reduce pressure on the lungs.", [["lungs", "ANATOMY", 58, 63], ["lungs", "ORGAN", 58, 63], ["pressure on the lungs", "PROBLEM", 42, 63], ["lungs", "ANATOMY", 58, 63]]], ["Depending on which viscera passes through the defect and the tightness of the hernial ring, colic and shock signs may also be present.", [["viscera", "ANATOMY", 19, 26], ["hernial ring", "ANATOMY", 78, 90], ["colic", "DISEASE", 92, 97], ["shock", "DISEASE", 102, 107], ["viscera", "ORGAN", 19, 26], ["hernial ring", "MULTI-TISSUE_STRUCTURE", 78, 90], ["the defect", "PROBLEM", 42, 52], ["the tightness of the hernial ring", "PROBLEM", 57, 90], ["colic and shock signs", "PROBLEM", 92, 113], ["viscera", "ANATOMY", 19, 26], ["defect", "OBSERVATION", 46, 52], ["tightness", "OBSERVATION_MODIFIER", 61, 70], ["hernial ring", "ANATOMY", 78, 90], ["colic", "ANATOMY", 92, 97], ["shock signs", "OBSERVATION", 102, 113], ["may also be", "UNCERTAINTY", 114, 125]]], ["Diagnosis is accomplished by identifying the herniated viscera on an imaging study; radiography, ultrasonography, or crosssectional imaging techniques may all be used.", [["herniated viscera", "ANATOMY", 45, 62], ["viscera", "ORGAN", 55, 62], ["the herniated viscera", "PROBLEM", 41, 62], ["an imaging study", "TEST", 66, 82], ["radiography", "TEST", 84, 95], ["ultrasonography", "TEST", 97, 112], ["crosssectional imaging techniques", "TEST", 117, 150], ["herniated", "OBSERVATION", 45, 54], ["viscera", "ANATOMY", 55, 62]]], ["Diagnosis may also be achieved during exploratory surgery to identify the cause of the colic.", [["colic", "DISEASE", 87, 92], ["exploratory surgery", "TREATMENT", 38, 57], ["the colic", "PROBLEM", 83, 92], ["colic", "OBSERVATION", 87, 92]]], ["In that case, extreme care must be taken to avoid abrupt, severe pneumothorax on opening the abdomen or retrieving the viscera through the defect.", [["abdomen", "ANATOMY", 93, 100], ["viscera", "ANATOMY", 119, 126], ["pneumothorax", "DISEASE", 65, 77], ["abdomen", "ORGAN", 93, 100], ["viscera", "ORGAN", 119, 126], ["extreme care", "TREATMENT", 14, 26], ["abrupt, severe pneumothorax on opening the abdomen", "PROBLEM", 50, 100], ["the defect", "PROBLEM", 135, 145], ["severe", "OBSERVATION_MODIFIER", 58, 64], ["pneumothorax", "OBSERVATION", 65, 77], ["abdomen", "ANATOMY", 93, 100], ["viscera", "ANATOMY", 119, 126], ["defect", "OBSERVATION", 139, 145]]], ["One report described a 7-year-old llama gelding with incarceration of the ileum, cecum, and ascending colon within the thorax through a smooth-edged diaphragmatic defect.", [["ileum", "ANATOMY", 74, 79], ["cecum", "ANATOMY", 81, 86], ["ascending colon", "ANATOMY", 92, 107], ["thorax", "ANATOMY", 119, 125], ["diaphragmatic", "ANATOMY", 149, 162], ["llama", "ORGANISM", 34, 39], ["ileum", "MULTI-TISSUE_STRUCTURE", 74, 79], ["cecum", "MULTI-TISSUE_STRUCTURE", 81, 86], ["colon", "ORGAN", 102, 107], ["thorax", "ORGAN", 119, 125], ["diaphragmatic", "ORGAN", 149, 162], ["incarceration of the ileum, cecum, and ascending colon within the thorax", "PROBLEM", 53, 125], ["a smooth-edged diaphragmatic defect", "PROBLEM", 134, 169], ["incarceration", "OBSERVATION", 53, 66], ["ileum", "ANATOMY", 74, 79], ["cecum", "ANATOMY", 81, 86], ["ascending", "ANATOMY_MODIFIER", 92, 101], ["colon", "ANATOMY", 102, 107], ["thorax", "ANATOMY", 119, 125], ["smooth", "OBSERVATION_MODIFIER", 136, 142], ["diaphragmatic", "ANATOMY", 149, 162], ["defect", "OBSERVATION", 163, 169]]], ["83 Because of the nature of the defect, a congenital lesion was suspected.", [["lesion", "ANATOMY", 53, 59], ["congenital lesion", "DISEASE", 42, 59], ["the defect", "PROBLEM", 28, 38], ["a congenital lesion", "PROBLEM", 40, 59], ["defect", "OBSERVATION", 32, 38], ["congenital", "OBSERVATION_MODIFIER", 42, 52], ["lesion", "OBSERVATION", 53, 59]]], ["Herniation recurred 9 months after surgical repair.", [["Herniation", "DISEASE", 0, 10], ["Herniation", "PROBLEM", 0, 10], ["surgical repair", "TREATMENT", 35, 50], ["surgical repair", "OBSERVATION", 35, 50]]], ["A second report described a suspected congenital hernia found in an 18-monthold alpaca with recurrent colic episodes.", [["hernia", "ANATOMY", 49, 55], ["congenital hernia", "DISEASE", 38, 55], ["colic", "DISEASE", 102, 107], ["hernia", "PATHOLOGICAL_FORMATION", 49, 55], ["alpaca", "ORGANISM", 80, 86], ["a suspected congenital hernia", "PROBLEM", 26, 55], ["recurrent colic episodes", "PROBLEM", 92, 116], ["congenital", "OBSERVATION_MODIFIER", 38, 48], ["hernia", "OBSERVATION", 49, 55], ["recurrent", "OBSERVATION_MODIFIER", 92, 101], ["colic episodes", "OBSERVATION", 102, 116]]], ["84 In this case, the heart was found partially within the abdomen after death.", [["heart", "ANATOMY", 21, 26], ["abdomen", "ANATOMY", 58, 65], ["death", "DISEASE", 72, 77], ["heart", "ORGAN", 21, 26], ["abdomen", "ORGAN", 58, 65], ["death", "PROBLEM", 72, 77], ["heart", "ANATOMY", 21, 26], ["abdomen", "ANATOMY", 58, 65]]], ["Previous exploratory had not revealed the defect but had revealed adhesions involving the jejunum.Diaphragmatic ParalysisPhrenic nerve degeneration and diaphragmatic paralysis have been reported in the scientific literature and anecdotally in a variety of locations worldwide.", [["adhesions", "ANATOMY", 66, 75], ["jejunum", "ANATOMY", 90, 97], ["Diaphragmatic ParalysisPhrenic nerve", "ANATOMY", 98, 134], ["diaphragmatic", "ANATOMY", 152, 165], ["Diaphragmatic ParalysisPhrenic nerve degeneration", "DISEASE", 98, 147], ["diaphragmatic paralysis", "DISEASE", 152, 175], ["jejunum", "ORGAN", 90, 97], ["nerve", "MULTI-TISSUE_STRUCTURE", 129, 134], ["diaphragmatic", "ORGAN", 152, 165], ["Previous exploratory", "TEST", 0, 20], ["the defect", "PROBLEM", 38, 48], ["adhesions involving the jejunum", "PROBLEM", 66, 97], ["Diaphragmatic ParalysisPhrenic nerve degeneration", "PROBLEM", 98, 147], ["diaphragmatic paralysis", "PROBLEM", 152, 175], ["defect", "OBSERVATION", 42, 48], ["adhesions", "OBSERVATION", 66, 75], ["jejunum", "ANATOMY", 90, 97], ["ParalysisPhrenic", "ANATOMY_MODIFIER", 112, 128], ["nerve", "ANATOMY", 129, 134], ["degeneration", "OBSERVATION", 135, 147], ["diaphragmatic", "ANATOMY", 152, 165], ["paralysis", "OBSERVATION", 166, 175]]], ["85, 86 The largest study found the disorder only in alpacas less than a year old, but clinical experience suggests that all ages of camelid are susceptible, and many have demonstrated enough normal respiratory function to suggest that this is an acquired lesion.", [["respiratory", "ANATOMY", 198, 209], ["lesion", "ANATOMY", 255, 261], ["lesion", "CANCER", 255, 261], ["The largest study", "TEST", 7, 24], ["the disorder", "PROBLEM", 31, 43], ["an acquired lesion", "PROBLEM", 243, 261], ["largest", "OBSERVATION_MODIFIER", 11, 18], ["disorder", "OBSERVATION", 35, 43], ["respiratory function", "OBSERVATION", 198, 218], ["lesion", "OBSERVATION", 255, 261]]], ["86 Most clinical cases are bilaterally affected; unilateral cases may exist but may appear normal without extensive examination.Diaphragmatic ParalysisBilaterally affected camelids usually display an acute onset of progressive dyspnea, with tachypnea, flaring of the nostrils accompanied by expansion of the chest and paradoxic contraction of the abdomen during inspiration, and expansion of the abdomen during expiration.", [["Diaphragmatic", "ANATOMY", 128, 141], ["camelids", "ANATOMY", 172, 180], ["nostrils", "ANATOMY", 267, 275], ["chest", "ANATOMY", 308, 313], ["abdomen", "ANATOMY", 347, 354], ["abdomen", "ANATOMY", 396, 403], ["dyspnea", "DISEASE", 227, 234], ["tachypnea", "DISEASE", 241, 250], ["nostrils", "ORGANISM_SUBDIVISION", 267, 275], ["chest", "ORGANISM_SUBDIVISION", 308, 313], ["abdomen", "ORGAN", 347, 354], ["abdomen", "ORGAN", 396, 403], ["unilateral cases", "PROBLEM", 49, 65], ["extensive examination", "TEST", 106, 127], ["Diaphragmatic ParalysisBilaterally affected camelids", "PROBLEM", 128, 180], ["progressive dyspnea", "PROBLEM", 215, 234], ["tachypnea", "PROBLEM", 241, 250], ["flaring of the nostrils", "PROBLEM", 252, 275], ["expansion of the chest", "TEST", 291, 313], ["paradoxic contraction of the abdomen", "PROBLEM", 318, 354], ["expansion of the abdomen", "TEST", 379, 403], ["bilaterally", "ANATOMY_MODIFIER", 27, 38], ["normal", "OBSERVATION", 91, 97], ["acute", "OBSERVATION_MODIFIER", 200, 205], ["progressive", "OBSERVATION_MODIFIER", 215, 226], ["dyspnea", "OBSERVATION", 227, 234], ["tachypnea", "OBSERVATION", 241, 250], ["flaring", "OBSERVATION_MODIFIER", 252, 259], ["nostrils", "ANATOMY", 267, 275], ["expansion", "OBSERVATION", 291, 300], ["chest", "ANATOMY", 308, 313], ["paradoxic contraction", "OBSERVATION", 318, 339], ["abdomen", "ANATOMY", 347, 354], ["expansion", "OBSERVATION_MODIFIER", 379, 388], ["abdomen", "ANATOMY", 396, 403]]], ["Some appear also to have spinal neurologic signs, including weakness, ataxia, proprioceptive deficits, and knuckling, accompanied by palpable cervical instability in severe cases.", [["spinal neurologic", "ANATOMY", 25, 42], ["cervical", "ANATOMY", 142, 150], ["spinal neurologic signs", "DISEASE", 25, 48], ["weakness", "DISEASE", 60, 68], ["ataxia", "DISEASE", 70, 76], ["proprioceptive deficits", "DISEASE", 78, 101], ["knuckling", "DISEASE", 107, 116], ["cervical instability", "DISEASE", 142, 162], ["cervical", "ORGAN", 142, 150], ["spinal neurologic signs", "PROBLEM", 25, 48], ["weakness", "PROBLEM", 60, 68], ["ataxia", "PROBLEM", 70, 76], ["proprioceptive deficits", "PROBLEM", 78, 101], ["knuckling", "PROBLEM", 107, 116], ["palpable cervical instability in severe cases", "PROBLEM", 133, 178], ["spinal", "ANATOMY", 25, 31], ["neurologic", "OBSERVATION", 32, 42], ["weakness", "OBSERVATION", 60, 68], ["palpable", "OBSERVATION_MODIFIER", 133, 141], ["cervical", "ANATOMY", 142, 150], ["instability", "OBSERVATION", 151, 162], ["severe", "OBSERVATION_MODIFIER", 166, 172], ["cases", "OBSERVATION", 173, 178]]], ["Pulmonary sounds are usually normal unless the camelid has aspirated feed or saliva, although the extreme respiratory effort may increase the overall level of noise.", [["Pulmonary", "ANATOMY", 0, 9], ["respiratory", "ANATOMY", 106, 117], ["Pulmonary", "ORGAN", 0, 9], ["saliva", "ORGANISM_SUBSTANCE", 77, 83], ["Pulmonary sounds", "TEST", 0, 16], ["the extreme respiratory effort", "PROBLEM", 94, 124], ["sounds", "OBSERVATION", 10, 16], ["normal", "OBSERVATION", 29, 35], ["respiratory effort", "OBSERVATION", 106, 124]]], ["Cyanosis and poor body condition may be present but are not consistent findings.", [["body", "ANATOMY", 18, 22], ["Cyanosis", "DISEASE", 0, 8], ["body", "ORGANISM_SUBDIVISION", 18, 22], ["Cyanosis", "PROBLEM", 0, 8], ["poor body condition", "PROBLEM", 13, 32], ["poor body", "OBSERVATION_MODIFIER", 13, 22]]], ["Field treatments, usually consisting of antibiotics, steroids or NSAIDs, and mineral and vitamin supplements, yield little to no response.Diaphragmatic ParalysisBlood count and clinical chemistry usually reveal little beyond stress; muscle enzyme activities may be increased in camelids displaying extraordinary respiratory effort or Pulmonary radiography or computed tomography (CT) may reveal lesions resembling patchy granulomatous disease and tracheal or BAL samples may contain adults, eggs, or larvae.", [["Diaphragmatic", "ANATOMY", 138, 151], ["muscle", "ANATOMY", 233, 239], ["respiratory", "ANATOMY", 312, 323], ["Pulmonary", "ANATOMY", 334, 343], ["lesions", "ANATOMY", 395, 402], ["granulomatous", "ANATOMY", 421, 434], ["tracheal", "ANATOMY", 447, 455], ["BAL samples", "ANATOMY", 459, 470], ["eggs", "ANATOMY", 491, 495], ["steroids", "CHEMICAL", 53, 61], ["NSAIDs", "CHEMICAL", 65, 71], ["vitamin supplements", "CHEMICAL", 89, 108], ["steroids", "CHEMICAL", 53, 61], ["steroids", "SIMPLE_CHEMICAL", 53, 61], ["NSAIDs", "SIMPLE_CHEMICAL", 65, 71], ["mineral", "SIMPLE_CHEMICAL", 77, 84], ["vitamin", "SIMPLE_CHEMICAL", 89, 96], ["muscle", "ORGAN", 233, 239], ["lesions", "PATHOLOGICAL_FORMATION", 395, 402], ["tracheal", "MULTI-TISSUE_STRUCTURE", 447, 455], ["BAL samples", "CANCER", 459, 470], ["Field treatments", "TREATMENT", 0, 16], ["antibiotics", "TREATMENT", 40, 51], ["steroids", "TREATMENT", 53, 61], ["NSAIDs", "TREATMENT", 65, 71], ["mineral and vitamin supplements", "TREATMENT", 77, 108], ["Diaphragmatic ParalysisBlood count", "TEST", 138, 172], ["clinical chemistry", "TEST", 177, 195], ["little beyond stress", "PROBLEM", 211, 231], ["muscle enzyme activities", "TEST", 233, 257], ["extraordinary respiratory effort", "PROBLEM", 298, 330], ["Pulmonary radiography", "TEST", 334, 355], ["computed tomography (CT)", "TEST", 359, 383], ["lesions", "PROBLEM", 395, 402], ["patchy granulomatous disease", "PROBLEM", 414, 442], ["tracheal or BAL samples", "TEST", 447, 470], ["Pulmonary", "ANATOMY", 334, 343], ["lesions", "OBSERVATION", 395, 402], ["patchy", "OBSERVATION_MODIFIER", 414, 420], ["granulomatous", "OBSERVATION", 421, 434], ["tracheal", "ANATOMY", 447, 455], ["BAL", "ANATOMY", 459, 462]]], ["Benzimidazole, avermectin, and levamisole have all shown activity against lungworms in ruminants.", [["Benzimidazole", "CHEMICAL", 0, 13], ["avermectin", "CHEMICAL", 15, 25], ["levamisole", "CHEMICAL", 31, 41], ["Benzimidazole", "CHEMICAL", 0, 13], ["avermectin", "CHEMICAL", 15, 25], ["levamisole", "CHEMICAL", 31, 41], ["Benzimidazole", "SIMPLE_CHEMICAL", 0, 13], ["avermectin", "SIMPLE_CHEMICAL", 15, 25], ["levamisole", "SIMPLE_CHEMICAL", 31, 41], ["Benzimidazole", "TREATMENT", 0, 13], ["avermectin", "TREATMENT", 15, 25], ["levamisole", "TREATMENT", 31, 41]]], ["Contact animals, especially ruminant hosts, should be treated at the same time.NeoplasiaThe lung is a common site for multicentric and metastatic neoplasms, particularly lymphoma.", [["lung", "ANATOMY", 92, 96], ["site", "ANATOMY", 109, 113], ["metastatic neoplasms", "ANATOMY", 135, 155], ["lymphoma", "ANATOMY", 170, 178], ["Neoplasia", "DISEASE", 79, 88], ["neoplasms", "DISEASE", 146, 155], ["lymphoma", "DISEASE", 170, 178], ["lung", "ORGAN", 92, 96], ["metastatic neoplasms", "CANCER", 135, 155], ["lymphoma", "CANCER", 170, 178], ["Neoplasia", "PROBLEM", 79, 88], ["multicentric and metastatic neoplasms", "PROBLEM", 118, 155], ["lymphoma", "PROBLEM", 170, 178], ["lung", "ANATOMY", 92, 96], ["multicentric", "OBSERVATION_MODIFIER", 118, 130], ["metastatic", "OBSERVATION_MODIFIER", 135, 145], ["neoplasms", "OBSERVATION", 146, 155], ["lymphoma", "OBSERVATION", 170, 178]]], ["3, [80] [81] [82] At one laboratory, 23% of camelid neoplasms were found in pulmonary tissue.", [["camelid neoplasms", "ANATOMY", 44, 61], ["pulmonary tissue", "ANATOMY", 76, 92], ["neoplasms", "DISEASE", 52, 61], ["camelid neoplasms", "CANCER", 44, 61], ["pulmonary tissue", "TISSUE", 76, 92], ["camelid neoplasms", "PROBLEM", 44, 61], ["pulmonary tissue", "PROBLEM", 76, 92], ["neoplasms", "OBSERVATION", 52, 61], ["pulmonary tissue", "ANATOMY", 76, 92]]], ["Approximately 50% of camelids with lymphoma have pulmonary involvement.", [["camelids", "ANATOMY", 21, 29], ["lymphoma", "ANATOMY", 35, 43], ["pulmonary", "ANATOMY", 49, 58], ["lymphoma", "DISEASE", 35, 43], ["camelids", "CANCER", 21, 29], ["lymphoma", "CANCER", 35, 43], ["pulmonary", "ORGAN", 49, 58], ["lymphoma", "PROBLEM", 35, 43], ["pulmonary involvement", "PROBLEM", 49, 70], ["lymphoma", "OBSERVATION", 35, 43], ["pulmonary", "ANATOMY", 49, 58], ["involvement", "OBSERVATION", 59, 70]]], ["3 Primary pulmonary or thoracic neoplasms in camelids are rare and include the small percentage of lymphoma cases in which no other site is recognized as well as adenocarcinoma.", [["pulmonary", "ANATOMY", 10, 19], ["thoracic neoplasms", "ANATOMY", 23, 41], ["camelids", "ANATOMY", 45, 53], ["lymphoma", "ANATOMY", 99, 107], ["adenocarcinoma", "ANATOMY", 162, 176], ["Primary pulmonary or thoracic neoplasms", "DISEASE", 2, 41], ["lymphoma", "DISEASE", 99, 107], ["adenocarcinoma", "DISEASE", 162, 176], ["pulmonary", "ORGAN", 10, 19], ["thoracic neoplasms", "CANCER", 23, 41], ["camelids", "CANCER", 45, 53], ["lymphoma", "CANCER", 99, 107], ["adenocarcinoma", "CANCER", 162, 176], ["Primary pulmonary or thoracic neoplasms in camelids", "PROBLEM", 2, 53], ["lymphoma cases", "PROBLEM", 99, 113], ["other site", "PROBLEM", 126, 136], ["adenocarcinoma", "PROBLEM", 162, 176], ["pulmonary", "ANATOMY", 10, 19], ["thoracic", "ANATOMY", 23, 31], ["neoplasms", "OBSERVATION", 32, 41], ["small", "OBSERVATION_MODIFIER", 79, 84], ["percentage", "OBSERVATION_MODIFIER", 85, 95], ["lymphoma", "OBSERVATION", 99, 107], ["adenocarcinoma", "OBSERVATION", 162, 176]]], ["Respiratory signs rarely predominate and are difficult to distinguish from signs of general weakness.", [["Respiratory", "ANATOMY", 0, 11], ["Respiratory signs", "TEST", 0, 17], ["general weakness", "PROBLEM", 84, 100], ["weakness", "OBSERVATION", 92, 100]]], ["Camelids with severe pulmonary infiltration may show emaciation, inappetence, tachypnea, dyspnea, and exercise intolerance.", [["pulmonary", "ANATOMY", 21, 30], ["pulmonary infiltration", "DISEASE", 21, 43], ["emaciation", "DISEASE", 53, 63], ["inappetence", "DISEASE", 65, 76], ["tachypnea", "DISEASE", 78, 87], ["dyspnea", "DISEASE", 89, 96], ["exercise intolerance", "DISEASE", 102, 122], ["pulmonary", "ORGAN", 21, 30], ["severe pulmonary infiltration", "PROBLEM", 14, 43], ["emaciation", "PROBLEM", 53, 63], ["inappetence", "PROBLEM", 65, 76], ["tachypnea", "PROBLEM", 78, 87], ["dyspnea", "PROBLEM", 89, 96], ["exercise intolerance", "PROBLEM", 102, 122], ["severe", "OBSERVATION_MODIFIER", 14, 20], ["pulmonary", "ANATOMY", 21, 30], ["infiltration", "OBSERVATION", 31, 43], ["emaciation", "OBSERVATION", 53, 63], ["inappetence", "OBSERVATION_MODIFIER", 65, 76], ["tachypnea", "OBSERVATION", 78, 87], ["exercise intolerance", "OBSERVATION", 102, 122]]], ["Normal lung sounds may be difficult to auscultate because of tissue masses or effusions.", [["lung", "ANATOMY", 7, 11], ["tissue masses", "ANATOMY", 61, 74], ["effusions", "ANATOMY", 78, 87], ["effusions", "DISEASE", 78, 87], ["lung", "ORGAN", 7, 11], ["tissue masses", "CANCER", 61, 74], ["tissue masses", "PROBLEM", 61, 74], ["effusions", "PROBLEM", 78, 87], ["lung", "ANATOMY", 7, 11], ["sounds", "OBSERVATION", 12, 18], ["tissue", "ANATOMY", 61, 67], ["masses", "OBSERVATION", 68, 74], ["effusions", "OBSERVATION", 78, 87]]], ["The major differentials are chronic infection, mycobacterial disease, and fungal or parasitic pneumonia.", [["chronic infection", "DISEASE", 28, 45], ["mycobacterial disease", "DISEASE", 47, 68], ["fungal or parasitic pneumonia", "DISEASE", 74, 103], ["chronic infection", "PROBLEM", 28, 45], ["mycobacterial disease", "PROBLEM", 47, 68], ["fungal", "PROBLEM", 74, 80], ["parasitic pneumonia", "PROBLEM", 84, 103], ["major", "OBSERVATION_MODIFIER", 4, 9], ["differentials", "OBSERVATION_MODIFIER", 10, 23], ["chronic", "OBSERVATION_MODIFIER", 28, 35], ["infection", "OBSERVATION", 36, 45], ["mycobacterial disease", "OBSERVATION", 47, 68], ["fungal", "OBSERVATION_MODIFIER", 74, 80], ["parasitic", "OBSERVATION_MODIFIER", 84, 93], ["pneumonia", "OBSERVATION", 94, 103]]], ["Finding other sites of neoplastic proliferation often aids in the diagnosis, particularly with lymphoma.NeoplasiaClinicopathologic changes are usually nonspecific and include anemia, hypoproteinemia, and hypokalemia.", [["sites", "ANATOMY", 14, 19], ["neoplastic", "ANATOMY", 23, 33], ["lymphoma", "ANATOMY", 95, 103], ["lymphoma", "DISEASE", 95, 103], ["anemia", "DISEASE", 175, 181], ["hypoproteinemia", "DISEASE", 183, 198], ["hypokalemia", "DISEASE", 204, 215], ["lymphoma", "CANCER", 95, 103], ["neoplastic proliferation", "PROBLEM", 23, 47], ["lymphoma", "PROBLEM", 95, 103], ["NeoplasiaClinicopathologic changes", "PROBLEM", 104, 138], ["anemia", "PROBLEM", 175, 181], ["hypoproteinemia", "PROBLEM", 183, 198], ["hypokalemia", "PROBLEM", 204, 215], ["neoplastic proliferation", "OBSERVATION", 23, 47], ["lymphoma", "OBSERVATION", 95, 103], ["anemia", "OBSERVATION", 175, 181], ["hypoproteinemia", "OBSERVATION", 183, 198], ["hypokalemia", "OBSERVATION", 204, 215]]], ["Thoracic radiography reveals the infiltrative lesions, and ultrasonography may reveal lesions adjacent to the chest wall or effusions.", [["infiltrative lesions", "ANATOMY", 33, 53], ["lesions", "ANATOMY", 86, 93], ["chest wall", "ANATOMY", 110, 120], ["effusions", "ANATOMY", 124, 133], ["effusions", "DISEASE", 124, 133], ["infiltrative lesions", "CANCER", 33, 53], ["lesions", "PATHOLOGICAL_FORMATION", 86, 93], ["chest wall", "MULTI-TISSUE_STRUCTURE", 110, 120], ["Thoracic radiography", "TEST", 0, 20], ["the infiltrative lesions", "PROBLEM", 29, 53], ["ultrasonography", "TEST", 59, 74], ["lesions", "PROBLEM", 86, 93], ["effusions", "PROBLEM", 124, 133], ["infiltrative", "OBSERVATION_MODIFIER", 33, 45], ["lesions", "OBSERVATION", 46, 53], ["lesions", "OBSERVATION", 86, 93], ["chest", "ANATOMY", 110, 115], ["wall", "ANATOMY_MODIFIER", 116, 120], ["effusions", "OBSERVATION", 124, 133]]], ["Cytologic evaluation of effusions is most helpful with lymphoma.", [["effusions", "ANATOMY", 24, 33], ["lymphoma", "ANATOMY", 55, 63], ["effusions", "DISEASE", 24, 33], ["lymphoma", "DISEASE", 55, 63], ["lymphoma", "CANCER", 55, 63], ["Cytologic evaluation", "TEST", 0, 20], ["effusions", "PROBLEM", 24, 33], ["lymphoma", "PROBLEM", 55, 63], ["effusions", "OBSERVATION", 24, 33], ["lymphoma", "OBSERVATION", 55, 63]]], ["Biopsy may be necessary with noneffusive tumors.", [["tumors", "ANATOMY", 41, 47], ["tumors", "DISEASE", 41, 47], ["tumors", "CANCER", 41, 47], ["Biopsy", "TEST", 0, 6], ["noneffusive tumors", "PROBLEM", 29, 47], ["tumors", "OBSERVATION", 41, 47]]], ["Currently, experience with chemotherapy in New World camelids is limited.Reactive Airway DiseaseReactive airway disease has been diagnosed anecdotally in some camelids on the basis of chronic resting tachypnea with or without a cough, lack of fever, and lack of clinicopathologic abnormalities.", [["airway", "ANATOMY", 105, 111], ["Airway DiseaseReactive airway disease", "DISEASE", 82, 119], ["resting tachypnea", "DISEASE", 192, 209], ["cough", "DISEASE", 228, 233], ["fever", "DISEASE", 243, 248], ["Airway", "MULTI-TISSUE_STRUCTURE", 82, 88], ["airway", "MULTI-TISSUE_STRUCTURE", 105, 111], ["chemotherapy", "TREATMENT", 27, 39], ["Reactive Airway DiseaseReactive airway disease", "PROBLEM", 73, 119], ["chronic resting tachypnea", "PROBLEM", 184, 209], ["a cough", "PROBLEM", 226, 233], ["fever", "PROBLEM", 243, 248], ["clinicopathologic abnormalities", "PROBLEM", 262, 293], ["Airway", "ANATOMY", 82, 88], ["DiseaseReactive airway disease", "OBSERVATION", 89, 119], ["chronic", "OBSERVATION_MODIFIER", 184, 191], ["tachypnea", "OBSERVATION", 200, 209]]], ["Although this may be true, a large subset of these camelids are likely to have a more progressive condition such as fungal or mycobacterial pneumonia or thoracic abscesses or neoplasia.", [["thoracic abscesses", "ANATOMY", 153, 171], ["neoplasia", "ANATOMY", 175, 184], ["pneumonia", "DISEASE", 140, 149], ["thoracic abscesses", "DISEASE", 153, 171], ["neoplasia", "DISEASE", 175, 184], ["camelids", "CANCER", 51, 59], ["thoracic abscesses", "PATHOLOGICAL_FORMATION", 153, 171], ["neoplasia", "CANCER", 175, 184], ["a large subset of these camelids", "PROBLEM", 27, 59], ["a more progressive condition", "PROBLEM", 79, 107], ["fungal or mycobacterial pneumonia", "PROBLEM", 116, 149], ["thoracic abscesses", "PROBLEM", 153, 171], ["neoplasia", "PROBLEM", 175, 184], ["may be", "UNCERTAINTY", 14, 20], ["true", "OBSERVATION_MODIFIER", 21, 25], ["large", "OBSERVATION_MODIFIER", 29, 34], ["progressive", "OBSERVATION_MODIFIER", 86, 97], ["condition", "OBSERVATION", 98, 107], ["fungal", "OBSERVATION_MODIFIER", 116, 122], ["mycobacterial", "OBSERVATION_MODIFIER", 126, 139], ["pneumonia", "OBSERVATION", 140, 149], ["thoracic", "ANATOMY", 153, 161], ["abscesses", "OBSERVATION", 162, 171], ["neoplasia", "OBSERVATION", 175, 184]]], ["A complete evaluation, including thoracic radiography, is recommended before settling on conservative treatment.", [["thoracic", "ANATOMY", 33, 41], ["A complete evaluation", "TEST", 0, 21], ["thoracic radiography", "TEST", 33, 53], ["conservative treatment", "TREATMENT", 89, 111], ["thoracic", "ANATOMY", 33, 41]]], ["Bronchodilators or inhaled corticosteroids may lead to some improvement in these cases, especially if the problem is seasonal.ChylothoraxChylothorax has been seen at our clinic after thoracic surgery.", [["thoracic", "ANATOMY", 183, 191], ["ChylothoraxChylothorax", "DISEASE", 126, 148], ["corticosteroids", "CHEMICAL", 27, 42], ["thoracic", "ORGAN", 183, 191], ["Bronchodilators", "TREATMENT", 0, 15], ["inhaled corticosteroids", "TREATMENT", 19, 42], ["thoracic surgery", "TREATMENT", 183, 199], ["thoracic", "ANATOMY", 183, 191], ["surgery", "OBSERVATION", 192, 199]]], ["Traumatic damage to the thoracic duct was suspected.", [["thoracic duct", "ANATOMY", 24, 37], ["Traumatic damage to the thoracic duct", "DISEASE", 0, 37], ["thoracic duct", "MULTI-TISSUE_STRUCTURE", 24, 37], ["Traumatic damage to the thoracic duct", "PROBLEM", 0, 37], ["damage", "OBSERVATION", 10, 16], ["thoracic duct", "ANATOMY", 24, 37]]], ["The affected camelid had dyspnea and hypoxemia.", [["dyspnea", "DISEASE", 25, 32], ["hypoxemia", "DISEASE", 37, 46], ["The affected camelid", "PROBLEM", 0, 20], ["dyspnea", "PROBLEM", 25, 32], ["hypoxemia", "PROBLEM", 37, 46], ["dyspnea", "OBSERVATION", 25, 32], ["hypoxemia", "OBSERVATION", 37, 46]]], ["Thoracocentesis yielded characteristic milky fluid.", [["milky fluid", "ANATOMY", 39, 50], ["milky fluid", "ORGANISM_SUBSTANCE", 39, 50], ["Thoracocentesis", "TREATMENT", 0, 15], ["characteristic milky fluid", "PROBLEM", 24, 50], ["characteristic", "OBSERVATION_MODIFIER", 24, 38], ["milky fluid", "OBSERVATION", 39, 50]]], ["No specific treatment was instituted.", [["specific treatment", "TREATMENT", 3, 21], ["specific", "OBSERVATION_MODIFIER", 3, 11], ["treatment", "OBSERVATION", 12, 21]]], ["In other species, surgical repair and various medications have been used.Hemothorax and PneumothoraxHemothorax and pneumothorax are uncommon findings in New World camelids and usually are associated with thoracic trauma.", [["thoracic", "ANATOMY", 204, 212], ["Hemothorax", "DISEASE", 73, 83], ["PneumothoraxHemothorax", "DISEASE", 88, 110], ["pneumothorax", "DISEASE", 115, 127], ["thoracic trauma", "DISEASE", 204, 219], ["thoracic", "ORGANISM_SUBDIVISION", 204, 212], ["surgical repair", "TREATMENT", 18, 33], ["various medications", "TREATMENT", 38, 57], ["Hemothorax", "PROBLEM", 73, 83], ["PneumothoraxHemothorax", "PROBLEM", 88, 110], ["pneumothorax", "PROBLEM", 115, 127], ["thoracic trauma", "PROBLEM", 204, 219], ["species", "OBSERVATION_MODIFIER", 9, 16], ["surgical repair", "OBSERVATION", 18, 33], ["PneumothoraxHemothorax", "OBSERVATION", 88, 110], ["pneumothorax", "OBSERVATION", 115, 127], ["New", "OBSERVATION_MODIFIER", 153, 156], ["thoracic", "ANATOMY", 204, 212], ["trauma", "OBSERVATION", 213, 219]]], ["Dyspnea is the major clinical sign, and thoracic radiography or ultrasonography is usually necessary to confirm the diagnosis.Changes of Unknown Significance Pulmonary Alveolar Histiocytosis or Lipid PneumoniaIn one study, lipid-laden macrophages were found within the alveolar space of camelids, leading to loss of area for air exchange and type II pneumocytosis.", [["thoracic", "ANATOMY", 40, 48], ["Alveolar", "ANATOMY", 168, 176], ["lipid-laden macrophages", "ANATOMY", 223, 246], ["alveolar space", "ANATOMY", 269, 283], ["camelids", "ANATOMY", 287, 295], ["Dyspnea", "DISEASE", 0, 7], ["pneumocytosis", "DISEASE", 350, 363], ["lipid", "SIMPLE_CHEMICAL", 223, 228], ["macrophages", "CELL", 235, 246], ["alveolar space", "MULTI-TISSUE_STRUCTURE", 269, 283], ["lipid-laden macrophages", "CELL_TYPE", 223, 246], ["Dyspnea", "PROBLEM", 0, 7], ["thoracic radiography", "TEST", 40, 60], ["ultrasonography", "TEST", 64, 79], ["Pulmonary Alveolar Histiocytosis", "PROBLEM", 158, 190], ["one study", "TEST", 212, 221], ["lipid-laden macrophages", "PROBLEM", 223, 246], ["loss of area", "PROBLEM", 308, 320], ["air exchange", "PROBLEM", 325, 337], ["type II pneumocytosis", "PROBLEM", 342, 363], ["thoracic", "ANATOMY", 40, 48], ["Pulmonary", "ANATOMY", 158, 167], ["Alveolar Histiocytosis", "OBSERVATION", 168, 190], ["Lipid PneumoniaIn", "OBSERVATION", 194, 211], ["laden macrophages", "OBSERVATION", 229, 246], ["alveolar", "ANATOMY_MODIFIER", 269, 277], ["air exchange", "OBSERVATION", 325, 337], ["type II", "OBSERVATION_MODIFIER", 342, 349], ["pneumocytosis", "OBSERVATION", 350, 363]]], ["87 All affected camelids were at least 10 years old, and lesions were confined to the dorsal region of the diaphragmatic lung lobes.", [["camelids", "ANATOMY", 16, 24], ["lesions", "ANATOMY", 57, 64], ["dorsal region", "ANATOMY", 86, 99], ["diaphragmatic lung lobes", "ANATOMY", 107, 131], ["camelids", "CANCER", 16, 24], ["lesions", "PATHOLOGICAL_FORMATION", 57, 64], ["diaphragmatic lung lobes", "MULTI-TISSUE_STRUCTURE", 107, 131], ["All affected camelids", "PROBLEM", 3, 24], ["lesions", "PROBLEM", 57, 64], ["lesions", "OBSERVATION", 57, 64], ["dorsal", "ANATOMY_MODIFIER", 86, 92], ["region", "ANATOMY_MODIFIER", 93, 99], ["diaphragmatic", "ANATOMY_MODIFIER", 107, 120], ["lung", "ANATOMY", 121, 125], ["lobes", "ANATOMY_MODIFIER", 126, 131]]], ["No specific clinical signs are attributable to the condition, and its importance is unknown.Changes of Unknown Significance Pulmonary Alveolar Histiocytosis or Lipid Pneumoniaincreased recumbency, and aspiration pneumonia may lead to leukogram changes reflective of inflammation.", [["Alveolar", "ANATOMY", 134, 142], ["aspiration pneumonia", "DISEASE", 201, 221], ["inflammation", "DISEASE", 266, 278], ["specific clinical signs", "PROBLEM", 3, 26], ["Pulmonary Alveolar Histiocytosis", "PROBLEM", 124, 156], ["Lipid Pneumoniaincreased recumbency", "PROBLEM", 160, 195], ["aspiration pneumonia", "PROBLEM", 201, 221], ["leukogram changes", "PROBLEM", 234, 251], ["inflammation", "PROBLEM", 266, 278], ["Pulmonary", "ANATOMY", 124, 133], ["Alveolar Histiocytosis", "OBSERVATION", 134, 156], ["Lipid", "OBSERVATION_MODIFIER", 160, 165], ["Pneumoniaincreased recumbency", "OBSERVATION", 166, 195], ["aspiration", "OBSERVATION_MODIFIER", 201, 211], ["pneumonia", "OBSERVATION", 212, 221], ["inflammation", "OBSERVATION", 266, 278]]], ["ABG analysis reveals hypoxemia, usually accompanied by hypercapnea and often by compensated or uncompensated respiratory acidosis.", [["respiratory", "ANATOMY", 109, 120], ["hypoxemia", "DISEASE", 21, 30], ["hypercapnea", "DISEASE", 55, 66], ["respiratory acidosis", "DISEASE", 109, 129], ["ABG", "CHEMICAL", 0, 3], ["ABG analysis", "TEST", 0, 12], ["hypoxemia", "PROBLEM", 21, 30], ["hypercapnea", "PROBLEM", 55, 66], ["uncompensated respiratory acidosis", "PROBLEM", 95, 129], ["hypoxemia", "OBSERVATION", 21, 30], ["hypercapnea", "OBSERVATION", 55, 66], ["uncompensated", "OBSERVATION_MODIFIER", 95, 108], ["respiratory acidosis", "OBSERVATION", 109, 129]]], ["Vitamin, mineral, heavy metal, infectious disease, and toxicologic screenings have revealed no consistent pattern, although vitamin E was judged to be low in one group of alpaca crias.", [["Vitamin", "CHEMICAL", 0, 7], ["infectious disease", "DISEASE", 31, 49], ["vitamin E", "CHEMICAL", 124, 133], ["Vitamin", "CHEMICAL", 0, 7], ["vitamin E", "CHEMICAL", 124, 133], ["Vitamin", "SIMPLE_CHEMICAL", 0, 7], ["mineral", "SIMPLE_CHEMICAL", 9, 16], ["vitamin E", "SIMPLE_CHEMICAL", 124, 133], ["alpaca", "ORGANISM", 171, 177], ["Vitamin", "TREATMENT", 0, 7], ["toxicologic screenings", "TEST", 55, 77], ["vitamin E", "TREATMENT", 124, 133], ["infectious", "OBSERVATION", 31, 41], ["no consistent", "UNCERTAINTY", 92, 105], ["alpaca crias", "OBSERVATION", 171, 183]]], ["86 Radiography may reveal a reduction of lung field through forward bulging of the diaphragm or mild interstitial changes.", [["lung", "ANATOMY", 41, 45], ["diaphragm", "ANATOMY", 83, 92], ["interstitial", "ANATOMY", 101, 113], ["lung", "ORGAN", 41, 45], ["diaphragm", "ORGAN", 83, 92], ["interstitial", "IMMATERIAL_ANATOMICAL_ENTITY", 101, 113], ["Radiography", "TEST", 3, 14], ["a reduction of lung field", "PROBLEM", 26, 51], ["forward bulging of the diaphragm", "PROBLEM", 60, 92], ["mild interstitial changes", "PROBLEM", 96, 121], ["reduction", "OBSERVATION_MODIFIER", 28, 37], ["lung", "ANATOMY", 41, 45], ["forward", "OBSERVATION_MODIFIER", 60, 67], ["bulging", "OBSERVATION", 68, 75], ["diaphragm", "ANATOMY", 83, 92], ["mild", "OBSERVATION_MODIFIER", 96, 100], ["interstitial", "OBSERVATION", 101, 113]]], ["Fluoroscopy reveals the decreased diaphragmatic function; craniocaudal movement of the diaphragm should be more than one half the length of the adjacent thoracic vertebral body.", [["diaphragmatic", "ANATOMY", 34, 47], ["diaphragm", "ANATOMY", 87, 96], ["thoracic vertebral body", "ANATOMY", 153, 176], ["diaphragmatic", "ORGAN", 34, 47], ["diaphragm", "ORGAN", 87, 96], ["thoracic vertebral body", "MULTI-TISSUE_STRUCTURE", 153, 176], ["Fluoroscopy", "TEST", 0, 11], ["the decreased diaphragmatic function", "PROBLEM", 20, 56], ["decreased", "OBSERVATION_MODIFIER", 24, 33], ["diaphragmatic function", "OBSERVATION", 34, 56], ["craniocaudal", "OBSERVATION_MODIFIER", 58, 70], ["movement", "OBSERVATION_MODIFIER", 71, 79], ["diaphragm", "ANATOMY", 87, 96], ["length", "OBSERVATION_MODIFIER", 130, 136], ["adjacent", "ANATOMY_MODIFIER", 144, 152], ["thoracic", "ANATOMY_MODIFIER", 153, 161], ["vertebral", "ANATOMY", 162, 171], ["body", "ANATOMY_MODIFIER", 172, 176]]], ["Plethysmography reveals thoracoabdominal asynchrony, where abdominal volume decreases because of inward collapse of the abdominal musculature during inspiration.", [["thoracoabdominal", "ANATOMY", 24, 40], ["abdominal", "ANATOMY", 59, 68], ["abdominal musculature", "ANATOMY", 120, 141], ["thoracoabdominal asynchrony", "DISEASE", 24, 51], ["thoracoabdominal", "ORGAN", 24, 40], ["abdominal", "ORGANISM_SUBDIVISION", 59, 68], ["abdominal musculature", "ORGANISM_SUBDIVISION", 120, 141], ["Plethysmography", "TEST", 0, 15], ["thoracoabdominal asynchrony", "PROBLEM", 24, 51], ["abdominal volume", "PROBLEM", 59, 75], ["inward collapse of the abdominal musculature", "PROBLEM", 97, 141], ["thoracoabdominal", "ANATOMY", 24, 40], ["asynchrony", "OBSERVATION", 41, 51], ["abdominal", "ANATOMY", 59, 68], ["volume", "OBSERVATION", 69, 75], ["inward", "OBSERVATION_MODIFIER", 97, 103], ["collapse", "OBSERVATION", 104, 112], ["abdominal musculature", "ANATOMY", 120, 141], ["inspiration", "OBSERVATION_MODIFIER", 149, 160]]], ["Postmortem examination reveals axonal and myelin sheath degeneration of the phrenic nerve and neurogenic atrophy of the diaphragm.", [["axonal", "ANATOMY", 31, 37], ["myelin sheath", "ANATOMY", 42, 55], ["phrenic nerve", "ANATOMY", 76, 89], ["diaphragm", "ANATOMY", 120, 129], ["neurogenic atrophy", "DISEASE", 94, 112], ["axonal", "MULTI-TISSUE_STRUCTURE", 31, 37], ["myelin sheath", "CELLULAR_COMPONENT", 42, 55], ["phrenic nerve", "MULTI-TISSUE_STRUCTURE", 76, 89], ["diaphragm", "ORGAN", 120, 129], ["Postmortem examination", "TEST", 0, 22], ["axonal and myelin sheath degeneration of the phrenic nerve", "PROBLEM", 31, 89], ["neurogenic atrophy of the diaphragm", "PROBLEM", 94, 129], ["axonal", "ANATOMY_MODIFIER", 31, 37], ["myelin sheath", "OBSERVATION", 42, 55], ["degeneration", "OBSERVATION", 56, 68], ["phrenic nerve", "ANATOMY", 76, 89], ["neurogenic", "OBSERVATION_MODIFIER", 94, 104], ["atrophy", "OBSERVATION", 105, 112], ["diaphragm", "ANATOMY", 120, 129]]], ["Camelids showing other neurologic signs may have evidence of degeneration of other nerves or the spinal cord as well.Changes of Unknown Significance Pulmonary Alveolar Histiocytosis or Lipid PneumoniaBecause of the association between spinal neurologic signs and phrenic nerve degeneration, further diagnostic tests, including CSF analysis, cervical radiography, and possibly myelography may be indicated.", [["neurologic", "ANATOMY", 23, 33], ["nerves", "ANATOMY", 83, 89], ["spinal cord", "ANATOMY", 97, 108], ["Alveolar", "ANATOMY", 159, 167], ["spinal neurologic", "ANATOMY", 235, 252], ["phrenic nerve", "ANATOMY", 263, 276], ["cervical", "ANATOMY", 341, 349], ["spinal neurologic signs", "DISEASE", 235, 258], ["phrenic nerve degeneration", "DISEASE", 263, 289], ["nerves", "MULTI-TISSUE_STRUCTURE", 83, 89], ["spinal cord", "ORGAN", 97, 108], ["phrenic nerve", "MULTI-TISSUE_STRUCTURE", 263, 276], ["cervical", "ORGAN", 341, 349], ["other neurologic signs", "PROBLEM", 17, 39], ["degeneration of other nerves or the spinal cord", "PROBLEM", 61, 108], ["Pulmonary Alveolar Histiocytosis", "PROBLEM", 149, 181], ["Lipid PneumoniaBecause", "PROBLEM", 185, 207], ["spinal neurologic signs", "PROBLEM", 235, 258], ["phrenic nerve degeneration", "PROBLEM", 263, 289], ["further diagnostic tests", "TEST", 291, 315], ["CSF analysis", "TEST", 327, 339], ["cervical radiography", "TEST", 341, 361], ["myelography", "TEST", 376, 387], ["degeneration", "OBSERVATION", 61, 73], ["nerves", "ANATOMY", 83, 89], ["spinal cord", "ANATOMY", 97, 108], ["Pulmonary", "ANATOMY", 149, 158], ["Alveolar Histiocytosis", "OBSERVATION", 159, 181], ["Lipid PneumoniaBecause", "OBSERVATION", 185, 207], ["spinal", "ANATOMY", 235, 241], ["phrenic nerve", "ANATOMY", 263, 276], ["degeneration", "OBSERVATION", 277, 289], ["cervical", "ANATOMY", 341, 349]]], ["A variety of neurologic conditions, including vertebral body malformation, abscess, and instability, parasitic migration, tumor, degeneration, and trauma may all be causative and require treatment.", [["neurologic", "ANATOMY", 13, 23], ["vertebral body", "ANATOMY", 46, 60], ["abscess", "ANATOMY", 75, 82], ["tumor", "ANATOMY", 122, 127], ["vertebral body malformation", "DISEASE", 46, 73], ["abscess", "DISEASE", 75, 82], ["parasitic migration", "DISEASE", 101, 120], ["tumor", "DISEASE", 122, 127], ["trauma", "DISEASE", 147, 153], ["vertebral body", "MULTI-TISSUE_STRUCTURE", 46, 60], ["tumor", "CANCER", 122, 127], ["A variety of neurologic conditions", "PROBLEM", 0, 34], ["vertebral body malformation", "PROBLEM", 46, 73], ["abscess", "PROBLEM", 75, 82], ["instability", "PROBLEM", 88, 99], ["parasitic migration", "PROBLEM", 101, 120], ["tumor", "PROBLEM", 122, 127], ["degeneration", "PROBLEM", 129, 141], ["trauma", "PROBLEM", 147, 153], ["treatment", "TREATMENT", 187, 196], ["variety", "OBSERVATION_MODIFIER", 2, 9], ["vertebral", "ANATOMY", 46, 55], ["body", "ANATOMY_MODIFIER", 56, 60], ["malformation", "OBSERVATION", 61, 73], ["abscess", "OBSERVATION", 75, 82], ["instability", "OBSERVATION_MODIFIER", 88, 99], ["parasitic", "OBSERVATION_MODIFIER", 101, 110], ["migration", "OBSERVATION_MODIFIER", 111, 120], ["tumor", "OBSERVATION", 122, 127], ["degeneration", "OBSERVATION", 129, 141]]], ["Vitamin E deficiency may be a factor in nerve degeneration as well.Changes of Unknown Significance Pulmonary Alveolar Histiocytosis or Lipid PneumoniaTreatment efforts have mainly been supportive or directed at an underlying neurologic disease.", [["nerve", "ANATOMY", 40, 45], ["Alveolar", "ANATOMY", 109, 117], ["neurologic", "ANATOMY", 225, 235], ["Vitamin E", "CHEMICAL", 0, 9], ["nerve degeneration", "DISEASE", 40, 58], ["neurologic disease", "DISEASE", 225, 243], ["Vitamin E", "CHEMICAL", 0, 9], ["Vitamin E", "SIMPLE_CHEMICAL", 0, 9], ["nerve", "TISSUE", 40, 45], ["Vitamin E deficiency", "PROBLEM", 0, 20], ["nerve degeneration", "PROBLEM", 40, 58], ["Pulmonary Alveolar Histiocytosis", "PROBLEM", 99, 131], ["Lipid PneumoniaTreatment efforts", "TREATMENT", 135, 167], ["an underlying neurologic disease", "PROBLEM", 211, 243], ["deficiency", "OBSERVATION", 10, 20], ["may be a factor", "UNCERTAINTY", 21, 36], ["nerve", "ANATOMY", 40, 45], ["degeneration", "OBSERVATION", 46, 58], ["Pulmonary", "ANATOMY", 99, 108], ["Alveolar Histiocytosis", "OBSERVATION", 109, 131], ["Lipid PneumoniaTreatment", "OBSERVATION", 135, 159], ["neurologic disease", "OBSERVATION", 225, 243]]], ["Supportive treatments could include administration of nasal oxygen or mechanical ventilation.", [["nasal", "ANATOMY", 54, 59], ["oxygen", "CHEMICAL", 60, 66], ["oxygen", "CHEMICAL", 60, 66], ["nasal", "ORGANISM_SUBDIVISION", 54, 59], ["oxygen", "SIMPLE_CHEMICAL", 60, 66], ["Supportive treatments", "TREATMENT", 0, 21], ["nasal oxygen", "TREATMENT", 54, 66], ["mechanical ventilation", "TREATMENT", 70, 92], ["mechanical ventilation", "OBSERVATION", 70, 92]]], ["Treatments of the neurologic disease vary and could include antiinflammatories, antibiotics, antiparasitics, and vitamin E. Prognosis is guarded.", [["neurologic", "ANATOMY", 18, 28], ["neurologic disease", "DISEASE", 18, 36], ["vitamin", "CHEMICAL", 113, 120], ["antiparasitics", "SIMPLE_CHEMICAL", 93, 107], ["vitamin", "SIMPLE_CHEMICAL", 113, 120], ["the neurologic disease", "PROBLEM", 14, 36], ["antiinflammatories", "TREATMENT", 60, 78], ["antibiotics", "TREATMENT", 80, 91], ["antiparasitics", "TREATMENT", 93, 107], ["vitamin E.", "TREATMENT", 113, 123], ["neurologic disease", "OBSERVATION", 18, 36]]], ["Camelids that are in overt respiratory distress or have aspirated are unlikely to thrive.", [["respiratory", "ANATOMY", 27, 38], ["respiratory distress", "DISEASE", 27, 47], ["overt respiratory distress", "PROBLEM", 21, 47], ["aspirated", "PROBLEM", 56, 65], ["overt", "OBSERVATION_MODIFIER", 21, 26], ["respiratory distress", "OBSERVATION", 27, 47], ["aspirated", "OBSERVATION", 56, 65]]], ["Others appear to tolerate the respiratory compromise and slowly acclimate to it, using the accessory muscles of breathing to drive their respiratory efforts.Nonseptic Consolidation Associated with RecumbencyProlonged lateral recumbency leads to nonseptic consolidation of the ventral lung.", [["respiratory", "ANATOMY", 30, 41], ["muscles", "ANATOMY", 101, 108], ["respiratory", "ANATOMY", 137, 148], ["ventral lung", "ANATOMY", 276, 288], ["muscles", "ORGANISM_SUBDIVISION", 101, 108], ["ventral", "ORGAN", 276, 283], ["lung", "ORGAN", 284, 288], ["the respiratory compromise", "PROBLEM", 26, 52], ["Nonseptic Consolidation", "PROBLEM", 157, 180], ["Recumbency", "PROBLEM", 197, 207], ["Prolonged lateral recumbency", "PROBLEM", 207, 235], ["nonseptic consolidation of the ventral lung", "PROBLEM", 245, 288], ["respiratory compromise", "OBSERVATION", 30, 52], ["accessory muscles", "ANATOMY", 91, 108], ["Consolidation", "OBSERVATION", 167, 180], ["Recumbency", "OBSERVATION_MODIFIER", 197, 207], ["lateral", "OBSERVATION_MODIFIER", 217, 224], ["recumbency", "OBSERVATION", 225, 235], ["nonseptic", "OBSERVATION_MODIFIER", 245, 254], ["consolidation", "OBSERVATION", 255, 268], ["ventral", "ANATOMY_MODIFIER", 276, 283], ["lung", "ANATOMY", 284, 288]]], ["This is noted outwardly by progressive tachypnea or obtundation.", [["tachypnea", "DISEASE", 39, 48], ["progressive tachypnea", "PROBLEM", 27, 48], ["obtundation", "PROBLEM", 52, 63], ["progressive", "OBSERVATION_MODIFIER", 27, 38], ["tachypnea", "OBSERVATION", 39, 48], ["obtundation", "OBSERVATION", 52, 63]]], ["Mucous membranes appear normal unless extreme hypoxemia has occurred.", [["Mucous membranes", "ANATOMY", 0, 16], ["hypoxemia", "DISEASE", 46, 55], ["Mucous membranes", "CELLULAR_COMPONENT", 0, 16], ["extreme hypoxemia", "PROBLEM", 38, 55], ["normal", "OBSERVATION", 24, 30], ["extreme", "OBSERVATION_MODIFIER", 38, 45], ["hypoxemia", "OBSERVATION", 46, 55]]], ["Thoracic radiography reveals an alveolar pattern in the dependent lung.", [["alveolar", "ANATOMY", 32, 40], ["lung", "ANATOMY", 66, 70], ["alveolar", "MULTI-TISSUE_STRUCTURE", 32, 40], ["lung", "ORGAN", 66, 70], ["Thoracic radiography", "TEST", 0, 20], ["an alveolar pattern in the dependent lung", "PROBLEM", 29, 70], ["alveolar pattern", "OBSERVATION", 32, 48], ["dependent", "ANATOMY_MODIFIER", 56, 65], ["lung", "ANATOMY", 66, 70]]], ["Laboratory evaluation reveals few changes beyond hypoxemia and hypercapnia.", [["hypoxemia", "DISEASE", 49, 58], ["hypercapnia", "DISEASE", 63, 74], ["Laboratory evaluation", "TEST", 0, 21], ["few changes", "PROBLEM", 30, 41], ["hypoxemia", "PROBLEM", 49, 58], ["hypercapnia", "PROBLEM", 63, 74], ["few", "OBSERVATION_MODIFIER", 30, 33], ["hypoxemia", "OBSERVATION", 49, 58], ["hypercapnia", "OBSERVATION", 63, 74]]], ["Because the changes usually take several days to develop, respiratory acidosis is often compensated by renal retention of bicarbonate.", [["respiratory", "ANATOMY", 58, 69], ["renal", "ANATOMY", 103, 108], ["respiratory acidosis", "DISEASE", 58, 78], ["bicarbonate", "CHEMICAL", 122, 133], ["bicarbonate", "CHEMICAL", 122, 133], ["renal", "ORGAN", 103, 108], ["bicarbonate", "SIMPLE_CHEMICAL", 122, 133], ["respiratory acidosis", "PROBLEM", 58, 78], ["renal retention of bicarbonate", "TREATMENT", 103, 133], ["respiratory", "ANATOMY", 58, 69], ["acidosis", "OBSERVATION", 70, 78], ["renal", "ANATOMY", 103, 108], ["retention", "OBSERVATION", 109, 118]]], ["Hypoproteinemia or fluid administration may speed the development of consolidation.Nonseptic Consolidation Associated with RecumbencyTreatment involves attempts to elevate and reinflate the consolidated side.", [["fluid", "ANATOMY", 19, 24], ["Hypoproteinemia", "DISEASE", 0, 15], ["fluid", "ORGANISM_SUBSTANCE", 19, 24], ["Hypoproteinemia", "PROBLEM", 0, 15], ["fluid administration", "TREATMENT", 19, 39], ["consolidation", "PROBLEM", 69, 82], ["Nonseptic Consolidation", "PROBLEM", 83, 106], ["RecumbencyTreatment", "TREATMENT", 123, 142], ["fluid", "OBSERVATION", 19, 24], ["consolidation", "OBSERVATION", 69, 82], ["Consolidation", "OBSERVATION", 93, 106], ["consolidated", "OBSERVATION", 190, 202]]], ["Mechanical ventilation may help in reinflating a mildly collapsed lung but tends to lead to overinflation of the healthy side when consolidation is too severe.", [["lung", "ANATOMY", 66, 70], ["lung", "ORGAN", 66, 70], ["Mechanical ventilation", "TREATMENT", 0, 22], ["a mildly collapsed lung", "PROBLEM", 47, 70], ["consolidation", "PROBLEM", 131, 144], ["ventilation", "OBSERVATION", 11, 22], ["mildly", "OBSERVATION_MODIFIER", 49, 55], ["collapsed", "OBSERVATION", 56, 65], ["lung", "ANATOMY", 66, 70], ["overinflation", "OBSERVATION", 92, 105], ["consolidation", "OBSERVATION", 131, 144], ["too severe", "OBSERVATION_MODIFIER", 148, 158]]], ["To avoid this condition in recumbent camelids, the position should be changed laterally every 2 hours or kept sternal as much as possible.", [["this condition", "PROBLEM", 9, 23], ["recumbent camelids", "TREATMENT", 27, 45], ["sternal", "TREATMENT", 110, 117], ["sternal", "ANATOMY", 110, 117]]]], "bc2ece990b156354072b6732b46478910b5e5edd": [["M a n u s c r i p t Accurate and efficient identification of infected persons is necessary if the COVID-19 pandemic is to be optimally managed and contained.", [["persons", "ORGANISM", 70, 77], ["persons", "SPECIES", 70, 77], ["the COVID", "TEST", 94, 103], ["pandemic", "PROBLEM", 107, 115], ["infected", "OBSERVATION", 61, 69]]], ["Unfortunately, patient reported symptoms and physician examinations, especially early in the clinical course, have not been consistently helpful in diagnosing COVID-19 disease.", [["patient", "ORGANISM", 15, 22], ["COVID-19 disease", "CANCER", 159, 175], ["patient", "SPECIES", 15, 22], ["symptoms", "PROBLEM", 32, 40], ["physician examinations", "TEST", 45, 67], ["disease", "PROBLEM", 168, 175]]], ["Moreover, asymptomatic or pre-symptomatic transmission of COVID-19 disease has been described [1] .", [["COVID-19 disease", "DISEASE", 58, 74], ["asymptomatic", "PROBLEM", 10, 22], ["pre-symptomatic transmission of COVID-19 disease", "PROBLEM", 26, 74]]], ["The tragedy that is the US aircraft carrier Theodore Roosevelt, in which 60 percent of the 600 sailors who tested positive for SARS-CoV-2 infection were asymptomatic, further highlights the need for accurate laboratory diagnostics for COVID-19 disease [2] .", [["SARS-CoV-2 infection", "DISEASE", 127, 147], ["SARS-CoV-2", "ORGANISM", 127, 137], ["CoV-2", "SPECIES", 132, 137], ["SARS-CoV-2", "SPECIES", 127, 137], ["SARS", "PROBLEM", 127, 131], ["CoV", "PROBLEM", 132, 135], ["2 infection", "PROBLEM", 136, 147], ["asymptomatic", "PROBLEM", 153, 165], ["accurate laboratory diagnostics", "TEST", 199, 230], ["COVID-19 disease", "PROBLEM", 235, 251]]]], "ba99273fde965a02951ffa4e56c855d102c7e608": [["infants who presented with nonspecific clinical signs that rapidly progressed and resulted in death and who demonstrated similar pathologic findings on postmortem examinations.", [["death", "DISEASE", 94, 99], ["infants", "ORGANISM", 0, 7], ["infants", "SPECIES", 0, 7], ["nonspecific clinical signs", "PROBLEM", 27, 53], ["death", "PROBLEM", 94, 99], ["similar pathologic findings", "PROBLEM", 121, 148], ["postmortem examinations", "TEST", 152, 175], ["nonspecific", "OBSERVATION_MODIFIER", 27, 38]]], ["1 With the advent of special care nurseries in Europe during the first part of the twentieth century, the clinical description of NEC began to emerge; by the latter half, this disease was widely recognized as the most serious gastrointestinal emergency in intensive care nurseries worldwide.", [["gastrointestinal", "ANATOMY", 226, 242], ["NEC", "DISEASE", 130, 133], ["NEC", "CANCER", 130, 133], ["gastrointestinal", "ORGAN", 226, 242], ["NEC", "PROBLEM", 130, 133], ["this disease", "PROBLEM", 171, 183], ["NEC", "OBSERVATION", 130, 133], ["disease", "OBSERVATION", 176, 183]]], ["In 1965, Mizrahi and colleagues 2 first used the term necrotizing enterocolitis to describe a clinical syndrome consisting of vomiting, abdominal distension, shock, and intestinal hemorrhage and perforation.", [["abdominal", "ANATOMY", 136, 145], ["intestinal", "ANATOMY", 169, 179], ["necrotizing enterocolitis", "DISEASE", 54, 79], ["vomiting", "DISEASE", 126, 134], ["abdominal distension", "DISEASE", 136, 156], ["shock", "DISEASE", 158, 163], ["intestinal hemorrhage", "DISEASE", 169, 190], ["perforation", "DISEASE", 195, 206], ["abdominal", "ORGANISM_SUBDIVISION", 136, 145], ["intestinal", "ORGAN", 169, 179], ["Mizrahi", "TREATMENT", 9, 16], ["the term necrotizing enterocolitis", "PROBLEM", 45, 79], ["a clinical syndrome", "PROBLEM", 92, 111], ["vomiting", "PROBLEM", 126, 134], ["abdominal distension", "PROBLEM", 136, 156], ["shock", "PROBLEM", 158, 163], ["intestinal hemorrhage", "PROBLEM", 169, 190], ["perforation", "PROBLEM", 195, 206], ["necrotizing", "OBSERVATION_MODIFIER", 54, 65], ["enterocolitis", "OBSERVATION", 66, 79], ["abdominal", "ANATOMY", 136, 145], ["distension", "OBSERVATION", 146, 156], ["shock", "OBSERVATION", 158, 163], ["intestinal", "ANATOMY", 169, 179], ["hemorrhage", "OBSERVATION", 180, 190], ["perforation", "OBSERVATION", 195, 206]]], ["The initial surgical approach to this disease was formulated by Touloukian 3 and Santulli and colleagues 4 in the 1970s.", [["The initial surgical approach", "TREATMENT", 0, 29], ["this disease", "PROBLEM", 33, 45], ["surgical", "OBSERVATION", 12, 20]]], ["In 1978, Bell and colleagues 5 classified NEC into 3 stages based on the severity of the clinical presentation and recommended treatment strategies.", [["NEC", "DISEASE", 42, 45], ["treatment strategies", "TREATMENT", 127, 147], ["NEC", "OBSERVATION", 42, 45]]], ["Despite incremental advances in our understanding of the clinical presentation and pathophysiology of NEC, universal prevention of this serious and often fatal disease continues to elude us even in the twenty-first century.WHO IS AT RISK?", [["NEC", "DISEASE", 102, 105], ["NEC", "PATHOLOGICAL_FORMATION", 102, 105], ["NEC", "PROBLEM", 102, 105], ["this serious", "PROBLEM", 131, 143], ["often fatal disease", "PROBLEM", 148, 167], ["NEC", "OBSERVATION", 102, 105]]], ["HOW PREVALENT IT IS?NEC primarily affects premature infants.", [["NEC", "DISEASE", 20, 23], ["infants", "ORGANISM", 52, 59], ["infants", "SPECIES", 52, 59], ["NEC", "PROBLEM", 20, 23], ["affects", "OBSERVATION_MODIFIER", 34, 41], ["premature", "OBSERVATION", 42, 51]]], ["It is less common in term and late preterm infants.", [["infants", "ORGANISM", 43, 50], ["infants", "SPECIES", 43, 50], ["less", "OBSERVATION_MODIFIER", 6, 10], ["common", "OBSERVATION_MODIFIER", 11, 17]]], ["6, 7 Only 7% to 15% of all NEC cases occur in term or late preterm infants (Fig. 1A) .", [["NEC", "DISEASE", 27, 30], ["NEC", "CANCER", 27, 30], ["infants", "ORGANISM", 67, 74], ["infants", "SPECIES", 67, 74], ["all NEC cases", "PROBLEM", 23, 36], ["NEC", "OBSERVATION", 27, 30]]], ["7 In term infants, NEC is commonly associated with congenital heart diseases, such as hypoplastic left heart syndrome and coarctation of the aorta, which result in intestinal hypoxia and/or hypoperfusion.", [["heart", "ANATOMY", 62, 67], ["hypoplastic left heart", "ANATOMY", 86, 108], ["aorta", "ANATOMY", 141, 146], ["intestinal", "ANATOMY", 164, 174], ["NEC", "DISEASE", 19, 22], ["congenital heart diseases", "DISEASE", 51, 76], ["hypoplastic left heart syndrome", "DISEASE", 86, 117], ["coarctation of the aorta", "DISEASE", 122, 146], ["hypoxia", "DISEASE", 175, 182], ["hypoperfusion", "DISEASE", 190, 203], ["infants", "ORGANISM", 10, 17], ["heart", "ORGAN", 62, 67], ["heart", "ORGAN", 103, 108], ["aorta", "MULTI-TISSUE_STRUCTURE", 141, 146], ["intestinal", "ORGAN", 164, 174], ["infants", "SPECIES", 10, 17], ["NEC", "PROBLEM", 19, 22], ["congenital heart diseases", "PROBLEM", 51, 76], ["hypoplastic left heart syndrome", "PROBLEM", 86, 117], ["coarctation of the aorta", "PROBLEM", 122, 146], ["intestinal hypoxia", "PROBLEM", 164, 182], ["hypoperfusion", "PROBLEM", 190, 203], ["NEC", "OBSERVATION", 19, 22], ["heart", "ANATOMY", 62, 67], ["diseases", "OBSERVATION", 68, 76], ["hypoplastic", "OBSERVATION", 86, 97], ["left", "ANATOMY_MODIFIER", 98, 102], ["heart", "ANATOMY", 103, 108], ["syndrome", "OBSERVATION", 109, 117], ["coarctation", "OBSERVATION", 122, 133], ["aorta", "ANATOMY", 141, 146], ["intestinal", "ANATOMY", 164, 174], ["hypoxia", "OBSERVATION", 175, 182], ["hypoperfusion", "OBSERVATION", 190, 203]]], ["8 NEC has also been associated with other anomalies, including aganglionosis 9 and gastroschisis.", [["NEC", "DISEASE", 2, 5], ["aganglionosis", "DISEASE", 63, 76], ["gastroschisis", "DISEASE", 83, 96], ["NEC", "PROBLEM", 2, 5], ["other anomalies", "PROBLEM", 36, 51], ["aganglionosis 9", "PROBLEM", 63, 78], ["gastroschisis", "PROBLEM", 83, 96], ["anomalies", "OBSERVATION", 42, 51], ["aganglionosis", "OBSERVATION", 63, 76], ["gastroschisis", "OBSERVATION", 83, 96]]], ["10 More than 85% of all NEC cases occur in very low birth weight (VLBW) infants (<1500 g) or in very premature (VP) infants (<32 weeks of PMA).", [["NEC", "DISEASE", 24, 27], ["PMA", "CHEMICAL", 138, 141], ["NEC", "PATHOLOGICAL_FORMATION", 24, 27], ["infants", "ORGANISM", 72, 79], ["infants", "ORGANISM", 116, 123], ["infants", "SPECIES", 72, 79], ["infants", "SPECIES", 116, 123], ["all NEC cases", "PROBLEM", 20, 33]]], ["11 The prevalence of NEC varies among centers.", [["NEC", "DISEASE", 21, 24], ["NEC", "PATHOLOGICAL_FORMATION", 21, 24], ["NEC", "PROBLEM", 21, 24], ["NEC", "OBSERVATION", 21, 24], ["varies", "OBSERVATION_MODIFIER", 25, 31]]], ["Multicenter and large populationbased studies demonstrate that it is prevalent in 7% to 11% of VLBW infants.", [["infants", "ORGANISM", 100, 107], ["infants", "SPECIES", 100, 107], ["large populationbased studies", "TEST", 16, 45], ["large", "OBSERVATION_MODIFIER", 16, 21], ["populationbased", "OBSERVATION", 22, 37]]], ["[11] [12] [13] The National Institute of Child Health (NICHD) Neonatal Research Network (NRN) study reported a 7% prevalence rate of NEC in a population of 11,072 VLBW infants during 1999 to 2001.", [["NEC", "DISEASE", 133, 136], ["NEC", "PATHOLOGICAL_FORMATION", 133, 136], ["infants", "ORGANISM", 168, 175], ["infants", "SPECIES", 168, 175], ["NEC", "PROBLEM", 133, 136], ["NEC", "OBSERVATION", 133, 136]]], ["14 The Vermont Oxford Network also reported a similar prevalence rate (7.4%) in 71,808 VLBW infants during a study period from 2005 to 2006.", [["infants", "ORGANISM", 92, 99], ["infants", "SPECIES", 92, 99]]], ["15 A concurrent NICHD-NRN study from 2003 to 2007 found that the prevalence of NEC remained high (11%) among VP infants (born at 22-28 weeks of PMA, birth weight 401-1500 g).", [["NEC", "DISEASE", 79, 82], ["NEC", "PATHOLOGICAL_FORMATION", 79, 82], ["infants", "SPECIES", 112, 119], ["NEC", "PROBLEM", 79, 82], ["birth weight", "TEST", 149, 161], ["NEC", "OBSERVATION", 79, 82], ["high", "OBSERVATION_MODIFIER", 92, 96]]], ["13 The prevalence of NEC seems to be less in Europe and Canada.", [["NEC", "DISEASE", 21, 24], ["NEC", "PATHOLOGICAL_FORMATION", 21, 24], ["NEC", "PROBLEM", 21, 24], ["NEC", "OBSERVATION", 21, 24], ["seems to be", "UNCERTAINTY", 25, 36], ["less", "OBSERVATION_MODIFIER", 37, 41]]], ["A recent Swedish study found that 5.8% of infants born before 27 weeks of PMA developed NEC among a cohort of 638 infants.", [["PMA", "CHEMICAL", 74, 77], ["NEC", "DISEASE", 88, 91], ["PMA", "CHEMICAL", 74, 77], ["infants", "ORGANISM", 42, 49], ["PMA", "SIMPLE_CHEMICAL", 74, 77], ["NEC", "PATHOLOGICAL_FORMATION", 88, 91], ["infants", "ORGANISM", 114, 121], ["infants", "SPECIES", 42, 49], ["infants", "SPECIES", 114, 121], ["A recent Swedish study", "TEST", 0, 22], ["NEC", "PROBLEM", 88, 91]]], ["16 A Swiss neonatal network study reported that only 3% to 4% of infants born at less than 32 weeks of PMA during 2000 to 2004 developed NEC.", [["PMA", "CHEMICAL", 103, 106], ["NEC", "DISEASE", 137, 140], ["PMA", "CHEMICAL", 103, 106], ["infants", "ORGANISM", 65, 72], ["NEC", "PATHOLOGICAL_FORMATION", 137, 140], ["infants", "SPECIES", 65, 72], ["A Swiss neonatal network study", "TEST", 3, 33], ["NEC", "PROBLEM", 137, 140], ["NEC", "OBSERVATION", 137, 140]]], ["17 The Canadian Neonatal Network documented that 5.1% of infants born earlier than 33 weeks of PMA developed NEC during 2003 to 2008 in a population of 16,669 infants.", [["PMA", "CHEMICAL", 95, 98], ["NEC", "DISEASE", 109, 112], ["PMA", "CHEMICAL", 95, 98], ["infants", "ORGANISM", 57, 64], ["infants", "ORGANISM", 159, 166], ["infants", "SPECIES", 57, 64], ["infants", "SPECIES", 159, 166], ["NEC", "PROBLEM", 109, 112]]], ["18 Despite the improvement in survival of VLBW infants, neonatal NEC remains quite prevalent in the United States (0.3-2.4 infants per 1000 live births).", [["NEC", "DISEASE", 65, 68], ["infants", "ORGANISM", 123, 130], ["infants", "SPECIES", 47, 54], ["infants", "SPECIES", 123, 130], ["neonatal NEC", "PROBLEM", 56, 68], ["improvement", "OBSERVATION_MODIFIER", 15, 26], ["NEC", "OBSERVATION", 65, 68]]], ["19 The overall mortality for NEC ranges from 20% to 40% but approaches 100% in infants with the most severe form of the disease.", [["NEC", "DISEASE", 29, 32], ["infants", "ORGANISM", 79, 86], ["infants", "SPECIES", 79, 86], ["NEC ranges", "TEST", 29, 39], ["the disease", "PROBLEM", 116, 127], ["overall", "OBSERVATION_MODIFIER", 7, 14], ["mortality", "OBSERVATION_MODIFIER", 15, 24], ["NEC", "OBSERVATION_MODIFIER", 29, 32], ["ranges", "OBSERVATION_MODIFIER", 33, 39], ["most severe", "OBSERVATION_MODIFIER", 96, 107], ["disease", "OBSERVATION", 120, 127]]], ["12, 15, 20 Boys have a higher risk of death than girls.", [["death", "DISEASE", 38, 43], ["girls", "SPECIES", 49, 54]]], ["12 Earlier studies have reported a slight increase in the prevalence of NEC among African American and male infants, but more recent studies have failed to verify these observations.", [["NEC", "DISEASE", 72, 75], ["NEC", "PATHOLOGICAL_FORMATION", 72, 75], ["infants", "ORGANISM", 108, 115], ["infants", "SPECIES", 108, 115], ["Earlier studies", "TEST", 3, 18], ["a slight increase", "PROBLEM", 33, 50], ["NEC", "PROBLEM", 72, 75], ["slight", "OBSERVATION_MODIFIER", 35, 41], ["increase", "OBSERVATION_MODIFIER", 42, 50], ["NEC", "OBSERVATION_MODIFIER", 72, 75]]], ["12 Because NEC affects 2% to 5% of all NICU admissions and causes serious morbidity, NEC continues to impose a heavy burden on the neonatal population.", [["NEC", "DISEASE", 11, 14], ["NEC", "DISEASE", 85, 88], ["NEC affects", "PROBLEM", 11, 22], ["serious morbidity", "PROBLEM", 66, 83], ["NEC", "PROBLEM", 85, 88]]], ["19 The pathophysiology of NEC in VP infants is not completely elucidated.", [["NEC", "DISEASE", 26, 29], ["NEC", "CANCER", 26, 29], ["infants", "SPECIES", 36, 43], ["NEC", "PROBLEM", 26, 29], ["NEC", "OBSERVATION", 26, 29]]], ["Compared with NEC in term and late preterm infants in whom hypoxia-ischemia is a common precursor, recent advances in our understanding of NEC at the molecular level suggest that an inflammatory response in VP infants plays the inciting or dominant role in the pathogenesis of NEC.", [["NEC", "ANATOMY", 277, 280], ["NEC", "DISEASE", 14, 17], ["hypoxia-ischemia", "DISEASE", 59, 75], ["NEC", "DISEASE", 139, 142], ["VP", "CHEMICAL", 207, 209], ["NEC", "DISEASE", 277, 280], ["infants", "ORGANISM", 43, 50], ["NEC", "CANCER", 139, 142], ["VP infants", "ORGANISM", 207, 217], ["NEC", "PATHOLOGICAL_FORMATION", 277, 280], ["infants", "SPECIES", 43, 50], ["infants", "SPECIES", 210, 217], ["NEC", "PROBLEM", 14, 17], ["hypoxia-ischemia", "PROBLEM", 59, 75], ["NEC", "PROBLEM", 139, 142], ["an inflammatory response", "PROBLEM", 179, 203], ["NEC", "PROBLEM", 277, 280], ["NEC", "OBSERVATION", 139, 142], ["inflammatory", "OBSERVATION", 182, 194], ["dominant", "OBSERVATION_MODIFIER", 240, 248], ["NEC", "OBSERVATION", 277, 280]]], ["21, 22 Previously held beliefs that low Apgar scores, 23 umbilical catheterizations, episodes of apnea and bradycardia, respiratory distress syndrome, anemia, hypothermia, hypoxic-ischemic events, [24] [25] [26] [27] hypotension, and the use of vasoactive agents such as Indocin 25 and pressors are important contributing causes of NEC in premature infants have not been supported by large epidemiologic and more recent clinical studies.", [["umbilical", "ANATOMY", 57, 66], ["apnea", "DISEASE", 97, 102], ["bradycardia", "DISEASE", 107, 118], ["respiratory distress syndrome", "DISEASE", 120, 149], ["anemia", "DISEASE", 151, 157], ["hypothermia", "DISEASE", 159, 170], ["[24] [25] [26] [27]", "CHEMICAL", 197, 216], ["hypotension", "DISEASE", 217, 228], ["Indocin 25", "CHEMICAL", 271, 281], ["NEC", "DISEASE", 332, 335], ["Indocin 25", "CHEMICAL", 271, 281], ["[24] [25] [26] [27]", "SIMPLE_CHEMICAL", 197, 216], ["Indocin 25", "SIMPLE_CHEMICAL", 271, 281], ["NEC", "PATHOLOGICAL_FORMATION", 332, 335], ["infants", "ORGANISM", 349, 356], ["infants", "SPECIES", 349, 356], ["Apgar scores", "TEST", 40, 52], ["umbilical catheterizations", "TEST", 57, 83], ["apnea", "PROBLEM", 97, 102], ["bradycardia", "PROBLEM", 107, 118], ["respiratory distress syndrome", "PROBLEM", 120, 149], ["anemia", "PROBLEM", 151, 157], ["hypothermia", "PROBLEM", 159, 170], ["hypoxic-ischemic events", "PROBLEM", 172, 195], ["hypotension", "PROBLEM", 217, 228], ["vasoactive agents", "TREATMENT", 245, 262], ["Indocin", "TREATMENT", 271, 278], ["pressors", "TREATMENT", 286, 294], ["NEC in premature infants", "PROBLEM", 332, 356], ["clinical studies", "TEST", 420, 436], ["umbilical", "ANATOMY", 57, 66], ["catheterizations", "OBSERVATION", 67, 83], ["apnea", "OBSERVATION", 97, 102], ["respiratory distress", "OBSERVATION", 120, 140], ["anemia", "OBSERVATION", 151, 157], ["hypothermia", "OBSERVATION", 159, 170], ["hypoxic", "OBSERVATION_MODIFIER", 172, 179], ["ischemic", "OBSERVATION_MODIFIER", 180, 188], ["NEC", "OBSERVATION", 332, 335]]], ["6 Although hemorrhagic-ischemic necrosis is the terminal manifestation of NEC in premature infants, the interaction among milk substrate, microbes, and the immature host immunologic system is now thought to be key in initiating the pathogenesis of NEC (Fig. 2) .", [["milk", "ANATOMY", 122, 126], ["hemorrhagic-ischemic necrosis", "DISEASE", 11, 40], ["NEC", "DISEASE", 74, 77], ["NEC", "DISEASE", 248, 251], ["NEC", "PATHOLOGICAL_FORMATION", 74, 77], ["infants", "ORGANISM", 91, 98], ["milk", "ORGANISM_SUBSTANCE", 122, 126], ["NEC", "PATHOLOGICAL_FORMATION", 248, 251], ["infants", "SPECIES", 91, 98], ["hemorrhagic-ischemic necrosis", "PROBLEM", 11, 40], ["NEC in premature infants", "PROBLEM", 74, 98], ["NEC", "PROBLEM", 248, 251], ["hemorrhagic", "OBSERVATION_MODIFIER", 11, 22], ["ischemic", "OBSERVATION_MODIFIER", 23, 31], ["necrosis", "OBSERVATION", 32, 40], ["terminal", "OBSERVATION_MODIFIER", 48, 56], ["NEC", "OBSERVATION_MODIFIER", 74, 77], ["premature", "OBSERVATION_MODIFIER", 81, 90], ["NEC", "OBSERVATION", 248, 251]]], ["22Aggressive FeedingIn premature infants, aggressive feeding may cause stasis of milk substrate in the lumen of the GIT because of dysmotility.", [["milk", "ANATOMY", 81, 85], ["lumen", "ANATOMY", 103, 108], ["GIT", "ANATOMY", 116, 119], ["dysmotility", "DISEASE", 131, 142], ["infants", "ORGANISM", 33, 40], ["milk", "ORGANISM_SUBSTANCE", 81, 85], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 103, 108], ["GIT", "ORGANISM_SUBDIVISION", 116, 119], ["infants", "SPECIES", 33, 40], ["aggressive feeding", "TREATMENT", 42, 60], ["stasis of milk substrate", "TREATMENT", 71, 95], ["dysmotility", "PROBLEM", 131, 142], ["premature", "OBSERVATION_MODIFIER", 23, 32], ["stasis", "OBSERVATION", 71, 77], ["lumen", "ANATOMY_MODIFIER", 103, 108], ["GIT", "ANATOMY", 116, 119], ["dysmotility", "OBSERVATION", 131, 142]]], ["28 Stasis can lead to intestinal dilatation with fluid and gas and possibly to impairment of the intestinal epithelial barrier (IEB).", [["intestinal", "ANATOMY", 22, 32], ["fluid", "ANATOMY", 49, 54], ["intestinal epithelial barrier", "ANATOMY", 97, 126], ["intestinal", "ORGAN", 22, 32], ["fluid", "ORGANISM_SUBSTANCE", 49, 54], ["intestinal epithelial barrier", "TISSUE", 97, 126], ["Stasis", "PROBLEM", 3, 9], ["intestinal dilatation", "PROBLEM", 22, 43], ["fluid and gas", "PROBLEM", 49, 62], ["the intestinal epithelial barrier", "TREATMENT", 93, 126], ["Stasis", "OBSERVATION", 3, 9], ["intestinal", "ANATOMY", 22, 32], ["dilatation", "OBSERVATION", 33, 43], ["fluid", "OBSERVATION", 49, 54], ["gas", "OBSERVATION", 59, 62], ["intestinal", "ANATOMY", 97, 107], ["epithelial", "ANATOMY_MODIFIER", 108, 118]]], ["[29] [30] [31] The development of endotoxemia in stable premature infants after feeding and evidence from other studies support that the IEB of premature infants is leakier compared with that of more mature infants.", [["endotoxemia", "DISEASE", 34, 45], ["infants", "ORGANISM", 66, 73], ["infants", "ORGANISM", 154, 161], ["infants", "ORGANISM", 207, 214], ["infants", "SPECIES", 66, 73], ["infants", "SPECIES", 154, 161], ["infants", "SPECIES", 207, 214], ["endotoxemia", "PROBLEM", 34, 45], ["endotoxemia", "OBSERVATION", 34, 45], ["stable", "OBSERVATION_MODIFIER", 49, 55], ["premature", "OBSERVATION", 56, 65]]], ["[31] [32] [33] [34] Intestinal dilatation in the presence of abnormal microbial colonization (dysbiosis) can distort normal signal transduction (crosstalk) across the IEB and alter the normal message of growth and repair of enterocytes to one that instead produces excessive inflammation, apoptosis, and necrosis ( Fig. 3) .", [["Intestinal", "ANATOMY", 20, 30], ["IEB", "ANATOMY", 167, 170], ["enterocytes", "ANATOMY", 224, 235], ["inflammation", "DISEASE", 275, 287], ["necrosis", "DISEASE", 304, 312], ["[31] [32] [33", "SIMPLE_CHEMICAL", 0, 13], ["IEB", "CANCER", 167, 170], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 224, 235], ["enterocytes", "CELL_TYPE", 224, 235], ["Intestinal dilatation", "PROBLEM", 20, 41], ["abnormal microbial colonization (dysbiosis", "PROBLEM", 61, 103], ["repair of enterocytes", "TREATMENT", 214, 235], ["excessive inflammation", "PROBLEM", 265, 287], ["apoptosis", "PROBLEM", 289, 298], ["necrosis", "PROBLEM", 304, 312], ["Intestinal", "ANATOMY", 20, 30], ["dilatation", "OBSERVATION", 31, 41], ["abnormal", "OBSERVATION_MODIFIER", 61, 69], ["microbial colonization", "OBSERVATION", 70, 92], ["normal", "OBSERVATION", 185, 191], ["enterocytes", "ANATOMY", 224, 235], ["excessive", "OBSERVATION_MODIFIER", 265, 274], ["inflammation", "OBSERVATION", 275, 287], ["apoptosis", "OBSERVATION_MODIFIER", 289, 298], ["necrosis", "OBSERVATION", 304, 312]]], ["32Transfusion and NECIn recent years, several reports have attempted to establish a causal relationship between blood transfusion (BT) and NEC.", [["blood", "ANATOMY", 112, 117], ["blood transfusion", "DISEASE", 112, 129], ["NEC", "DISEASE", 139, 142], ["blood", "ORGANISM_SUBSTANCE", 112, 117], ["NEC", "PATHOLOGICAL_FORMATION", 139, 142], ["blood transfusion (BT", "TREATMENT", 112, 133], ["NEC", "PROBLEM", 139, 142], ["NEC", "OBSERVATION", 139, 142]]], ["[36] [37] [38] [39] [40] [41] [42] These studies propose that BT for anemia of prematurity in relatively stable growing premature infants increases the risk of late-onset NEC.", [["BT", "CHEMICAL", 62, 64], ["anemia", "DISEASE", 69, 75], ["prematurity", "DISEASE", 79, 90], ["NEC", "DISEASE", 171, 174], ["[36] [37] [38] [39] [40] [41] [42]", "SIMPLE_CHEMICAL", 0, 34], ["BT", "SIMPLE_CHEMICAL", 62, 64], ["infants", "ORGANISM", 130, 137], ["NEC", "PATHOLOGICAL_FORMATION", 171, 174], ["infants", "SPECIES", 130, 137], ["These studies", "TEST", 35, 48], ["BT", "TEST", 62, 64], ["anemia of prematurity", "PROBLEM", 69, 90], ["premature infants", "PROBLEM", 120, 137], ["late-onset NEC", "PROBLEM", 160, 174], ["prematurity", "OBSERVATION", 79, 90], ["stable", "OBSERVATION_MODIFIER", 105, 111], ["growing", "OBSERVATION_MODIFIER", 112, 119], ["premature", "OBSERVATION", 120, 129], ["late", "OBSERVATION_MODIFIER", 160, 164], ["-onset", "OBSERVATION_MODIFIER", 164, 170], ["NEC", "OBSERVATION", 171, 174]]], ["The authors think that additional prospective reports that use a more robust design and analysis are needed before a causative relationship can be accepted because of the weaknesses in study designs of these investigations (eg, failure to include all BT, retrospective nature of data collection, lack of appropriate case-control matching, and failure to control for confounding variables).", [["the weaknesses", "PROBLEM", 167, 181], ["these investigations", "TEST", 202, 222], ["all BT", "TEST", 247, 253], ["data collection", "TEST", 279, 294]]], ["A recently completed prospective, matched, case-control investigation that used robust methodology does not substantiate an association between BT and NEC.Microbial Mucosal Interactions and NECAt the mucosal surface, signals from microbial ligands like endotoxin (synonymous with lipopolysaccharide [LPS]), flagellin, lipoteichoic acid, peptidoglycans, and formylated peptides are communicated through a sophisticated process (crosstalk) to appropriate epithelial receptors specific for that ligand referred to as pattern recognition receptors (PRRs), including Toll-like receptors (TLRs), formylated peptide receptors, and nucleotide-binding oligomerization domains.", [["Mucosal", "ANATOMY", 165, 172], ["mucosal surface", "ANATOMY", 200, 215], ["epithelial", "ANATOMY", 453, 463], ["NEC", "DISEASE", 151, 154], ["endotoxin", "CHEMICAL", 253, 262], ["lipopolysaccharide", "CHEMICAL", 280, 298], ["LPS", "CHEMICAL", 300, 303], ["lipoteichoic acid", "CHEMICAL", 318, 335], ["nucleotide", "CHEMICAL", 624, 634], ["nucleotide", "CHEMICAL", 624, 634], ["NEC", "PATHOLOGICAL_FORMATION", 151, 154], ["mucosal surface", "CELLULAR_COMPONENT", 200, 215], ["endotoxin", "SIMPLE_CHEMICAL", 253, 262], ["lipopolysaccharide", "SIMPLE_CHEMICAL", 280, 298], ["LPS", "SIMPLE_CHEMICAL", 300, 303], ["flagellin", "GENE_OR_GENE_PRODUCT", 307, 316], ["lipoteichoic acid", "SIMPLE_CHEMICAL", 318, 335], ["peptidoglycans", "SIMPLE_CHEMICAL", 337, 351], ["epithelial", "CELL", 453, 463], ["pattern recognition receptors", "GENE_OR_GENE_PRODUCT", 514, 543], ["PRRs", "GENE_OR_GENE_PRODUCT", 545, 549], ["Toll-like receptors", "GENE_OR_GENE_PRODUCT", 562, 581], ["TLRs", "GENE_OR_GENE_PRODUCT", 583, 587], ["endotoxin", "PROTEIN", 253, 262], ["flagellin", "PROTEIN", 307, 316], ["epithelial receptors", "PROTEIN", 453, 473], ["pattern recognition receptors", "PROTEIN", 514, 543], ["PRRs", "PROTEIN", 545, 549], ["Toll-like receptors", "PROTEIN", 562, 581], ["TLRs", "PROTEIN", 583, 587], ["formylated peptide receptors", "PROTEIN", 590, 618], ["nucleotide-binding oligomerization domains", "PROTEIN", 624, 666], ["NEC", "PROBLEM", 151, 154], ["Microbial Mucosal Interactions", "PROBLEM", 155, 185], ["microbial ligands", "TEST", 230, 247], ["endotoxin", "TEST", 253, 262], ["lipopolysaccharide [LPS", "TREATMENT", 280, 303], ["flagellin, lipoteichoic acid, peptidoglycans", "TEST", 307, 351], ["formylated peptides", "PROBLEM", 357, 376], ["formylated peptide receptors", "TREATMENT", 590, 618], ["nucleotide-binding oligomerization domains", "PROBLEM", 624, 666], ["NEC", "OBSERVATION", 151, 154], ["Mucosal Interactions", "OBSERVATION", 165, 185], ["mucosal surface", "ANATOMY", 200, 215], ["microbial ligands", "OBSERVATION", 230, 247], ["lipoteichoic acid", "ANATOMY", 318, 335], ["formylated peptides", "OBSERVATION", 357, 376]]], ["35 Activation of these PRRs initiates regulatory pathways, including mitogen-activated protein kinase, nuclear factor kB (NFkB), and caspase-dependent pathways (see Fig. 3 ).", [["PRRs", "GENE_OR_GENE_PRODUCT", 23, 27], ["mitogen-activated protein kinase", "GENE_OR_GENE_PRODUCT", 69, 101], ["nuclear factor kB", "GENE_OR_GENE_PRODUCT", 103, 120], ["NFkB", "GENE_OR_GENE_PRODUCT", 122, 126], ["caspase", "GENE_OR_GENE_PRODUCT", 133, 140], ["PRRs", "PROTEIN", 23, 27], ["mitogen-activated protein kinase", "PROTEIN", 69, 101], ["nuclear factor kB", "PROTEIN", 103, 120], ["NFkB", "PROTEIN", 122, 126], ["caspase", "PROTEIN", 133, 140], ["mitogen-activated protein kinase", "TREATMENT", 69, 101], ["caspase-dependent pathways", "TREATMENT", 133, 159]]], ["22, 29, 35, [43] [44] [45] These interrelated complex pathways determine mucosal and submucosal responses.", [["mucosal", "ANATOMY", 73, 80], ["submucosal", "ANATOMY", 85, 95], ["[43] [44] [45]", "SIMPLE_CHEMICAL", 12, 26], ["mucosal", "MULTI-TISSUE_STRUCTURE", 73, 80], ["submucosal", "MULTI-TISSUE_STRUCTURE", 85, 95], ["submucosal", "ANATOMY", 85, 95]]], ["Based on the perception of interrelated signals, the response can be cytoprotective (ie, promoting growth and repair) or it can be destructive if apoptosis or inflammatory responses is triggered (see Fig. 3 ).", [["repair", "TREATMENT", 110, 116], ["apoptosis", "PROBLEM", 146, 155], ["inflammatory responses", "PROBLEM", 159, 181], ["destructive", "OBSERVATION_MODIFIER", 131, 142], ["inflammatory", "OBSERVATION_MODIFIER", 159, 171]]], ["22, 35, 44 The terminal event in NEC is hemorrhagicischemic necrosis, which is the consequence of a dysregulated inflammatory response mediated by endogenous factors that include platelet-activating factor (PAF), proinflammatory cytokines (such as tumor necrosis factor-a, interleukins 1 & 6 [IL-1, IL-6]), chemokines (MIP-2/CXCL2), NF-kB, and the complement system.", [["NEC", "ANATOMY", 33, 36], ["NEC", "DISEASE", 33, 36], ["necrosis", "DISEASE", 60, 68], ["necrosis", "DISEASE", 254, 262], ["NEC", "CANCER", 33, 36], ["platelet-activating factor", "GENE_OR_GENE_PRODUCT", 179, 205], ["PAF", "GENE_OR_GENE_PRODUCT", 207, 210], ["tumor necrosis factor-a", "GENE_OR_GENE_PRODUCT", 248, 271], ["interleukins 1 & 6", "GENE_OR_GENE_PRODUCT", 273, 291], ["IL-1", "GENE_OR_GENE_PRODUCT", 293, 297], ["IL-6", "GENE_OR_GENE_PRODUCT", 299, 303], ["MIP-2", "GENE_OR_GENE_PRODUCT", 319, 324], ["CXCL2", "GENE_OR_GENE_PRODUCT", 325, 330], ["NF-kB", "GENE_OR_GENE_PRODUCT", 333, 338], ["endogenous factors", "PROTEIN", 147, 165], ["platelet-activating factor", "PROTEIN", 179, 205], ["PAF", "PROTEIN", 207, 210], ["proinflammatory cytokines", "PROTEIN", 213, 238], ["interleukins", "PROTEIN", 273, 285], ["IL-1, IL-6", "PROTEIN", 293, 303], ["chemokines", "PROTEIN", 307, 317], ["MIP", "PROTEIN", 319, 322], ["CXCL2", "PROTEIN", 325, 330], ["NF-kB", "PROTEIN", 333, 338], ["The terminal event", "PROBLEM", 11, 29], ["NEC", "PROBLEM", 33, 36], ["hemorrhagicischemic necrosis", "PROBLEM", 40, 68], ["a dysregulated inflammatory response", "PROBLEM", 98, 134], ["endogenous factors", "PROBLEM", 147, 165], ["platelet-activating factor", "PROBLEM", 179, 205], ["PAF", "PROBLEM", 207, 210], ["proinflammatory cytokines", "PROBLEM", 213, 238], ["tumor necrosis factor", "PROBLEM", 248, 269], ["interleukins", "TEST", 273, 285], ["IL", "TEST", 293, 295], ["chemokines", "TEST", 307, 317], ["MIP", "TEST", 319, 322], ["terminal", "OBSERVATION_MODIFIER", 15, 23], ["NEC", "OBSERVATION_MODIFIER", 33, 36], ["hemorrhagicischemic", "OBSERVATION_MODIFIER", 40, 59], ["necrosis", "OBSERVATION", 60, 68], ["dysregulated", "OBSERVATION_MODIFIER", 100, 112], ["inflammatory", "OBSERVATION", 113, 125], ["proinflammatory cytokines", "OBSERVATION", 213, 238]]], ["29 Because of the relative immaturity of key gastrointestinal functions, such as digestion, absorption, motility, and abnormalities in immune responses, a premature newborn is exquisitely vulnerable to gastrointestinal injury.", [["gastrointestinal", "ANATOMY", 45, 61], ["gastrointestinal", "ANATOMY", 202, 218], ["gastrointestinal injury", "DISEASE", 202, 225], ["gastrointestinal", "ORGAN", 45, 61], ["gastrointestinal", "ORGAN", 202, 218], ["the relative immaturity of key gastrointestinal functions", "PROBLEM", 14, 71], ["abnormalities in immune responses", "PROBLEM", 118, 151], ["a premature newborn", "PROBLEM", 153, 172], ["gastrointestinal injury", "PROBLEM", 202, 225], ["immaturity", "OBSERVATION", 27, 37], ["gastrointestinal functions", "OBSERVATION", 45, 71], ["gastrointestinal", "ANATOMY", 202, 218], ["injury", "OBSERVATION", 219, 225]]], ["46 The cellular response to signal transduction as described earlier is orchestrated by the innate immune system in mucosa and submucosa.", [["cellular", "ANATOMY", 7, 15], ["mucosa", "ANATOMY", 116, 122], ["submucosa", "ANATOMY", 127, 136], ["cellular", "CELL", 7, 15], ["mucosa", "MULTI-TISSUE_STRUCTURE", 116, 122], ["submucosa", "MULTI-TISSUE_STRUCTURE", 127, 136], ["signal transduction", "TREATMENT", 28, 47], ["cellular response", "OBSERVATION", 7, 24], ["mucosa", "ANATOMY", 116, 122], ["submucosa", "ANATOMY", 127, 136]]], ["45, 47 Microbial interaction with intestinal epithelium (PRRS) signals tissue-specific functions, such as T-cell expansion and elaboration of cytokines and chemokines.", [["intestinal epithelium", "ANATOMY", 34, 55], ["tissue", "ANATOMY", 71, 77], ["T-cell", "ANATOMY", 106, 112], ["intestinal epithelium", "TISSUE", 34, 55], ["tissue", "TISSUE", 71, 77], ["T-cell", "CELL", 106, 112], ["cytokines", "PROTEIN", 142, 151], ["chemokines", "PROTEIN", 156, 166], ["PRRS", "SPECIES", 57, 61], ["intestinal epithelium (PRRS) signals tissue", "PROBLEM", 34, 77], ["T-cell expansion", "TREATMENT", 106, 122], ["cytokines and chemokines", "TREATMENT", 142, 166], ["intestinal epithelium", "ANATOMY", 34, 55]]], ["Normally after birth, exposure to LPS downregulates IL-1 receptor associated kinase 1 (IRAK), an intermediary for epithelial TLR4 signaling, and promotes tolerance to LPS.", [["epithelial", "ANATOMY", 114, 124], ["LPS", "CHEMICAL", 34, 37], ["LPS", "CHEMICAL", 167, 170], ["LPS", "SIMPLE_CHEMICAL", 34, 37], ["IL-1 receptor associated kinase 1", "GENE_OR_GENE_PRODUCT", 52, 85], ["IRAK", "GENE_OR_GENE_PRODUCT", 87, 91], ["epithelial", "CELL", 114, 124], ["TLR4", "GENE_OR_GENE_PRODUCT", 125, 129], ["LPS", "SIMPLE_CHEMICAL", 167, 170], ["IL-1 receptor associated kinase 1", "PROTEIN", 52, 85], ["IRAK", "PROTEIN", 87, 91], ["TLR4", "PROTEIN", 125, 129], ["LPS", "TEST", 34, 37], ["IL", "TEST", 52, 54], ["kinase", "TEST", 77, 83], ["epithelial TLR4 signaling", "PROBLEM", 114, 139], ["epithelial TLR4", "ANATOMY", 114, 129]]], ["19, 22, 43 This postnatal adaptation helps to achieve hostmicrobe homeostasis with microbial tolerance.", [["hostmicrobe", "ANATOMY", 54, 65], ["hostmicrobe", "SIMPLE_CHEMICAL", 54, 65], ["This postnatal adaptation", "TREATMENT", 11, 36]]], ["22, 44 Premature infants are exposed shortly after birth to a massive microbial antigenic challenge that may be distorted by frequent and prolonged use of antibiotics.", [["infants", "ORGANISM", 17, 24], ["infants", "SPECIES", 17, 24], ["a massive microbial antigenic challenge", "TREATMENT", 60, 99], ["antibiotics", "TREATMENT", 155, 166], ["may be", "UNCERTAINTY", 105, 111]]], ["As a result, the GIT of premature infants gravitates toward mounting an inflammatory response rather than establishing tolerance (T-helper-1 response).", [["GIT", "ANATOMY", 17, 20], ["GIT", "CANCER", 17, 20], ["infants", "ORGANISM", 34, 41], ["T-helper-1", "GENE_OR_GENE_PRODUCT", 130, 140], ["infants", "SPECIES", 34, 41], ["premature infants", "PROBLEM", 24, 41], ["an inflammatory response", "PROBLEM", 69, 93], ["inflammatory", "OBSERVATION", 72, 84]]], ["30, 35, 47 The premature infant seems to mimic a response that is similar to the immune-na\u00efve response demonstrated by the fetus, which is characterized by hyper-responsiveness to LPS.", [["fetus", "ANATOMY", 123, 128], ["LPS", "CHEMICAL", 180, 183], ["infant", "ORGANISM", 25, 31], ["fetus", "ORGANISM", 123, 128], ["LPS", "SIMPLE_CHEMICAL", 180, 183], ["infant", "SPECIES", 25, 31], ["hyper-responsiveness", "PROBLEM", 156, 176], ["fetus", "ANATOMY", 123, 128], ["hyper", "OBSERVATION", 156, 161]]], ["22, 48 Intestinal colonization with commensal Bifidobacterium and Lactobacillus species reduces the risk of NEC.", [["Intestinal", "ANATOMY", 7, 17], ["NEC", "DISEASE", 108, 111], ["Intestinal", "ORGAN", 7, 17], ["Bifidobacterium", "SIMPLE_CHEMICAL", 46, 61], ["Lactobacillus species", "SIMPLE_CHEMICAL", 66, 87], ["NEC", "PATHOLOGICAL_FORMATION", 108, 111], ["Intestinal colonization", "PROBLEM", 7, 30], ["commensal Bifidobacterium", "TREATMENT", 36, 61], ["Lactobacillus species", "PROBLEM", 66, 87], ["NEC", "PROBLEM", 108, 111], ["Intestinal", "ANATOMY", 7, 17], ["colonization", "OBSERVATION", 18, 30], ["commensal Bifidobacterium", "OBSERVATION", 36, 61], ["Lactobacillus species", "OBSERVATION", 66, 87], ["NEC", "OBSERVATION", 108, 111]]], ["49, 50 The frequent and prolonged use of antibiotics results in an overgrowth of potentially pathogenic species.", [["antibiotics", "TREATMENT", 41, 52], ["an overgrowth of potentially pathogenic species", "PROBLEM", 64, 111], ["frequent", "OBSERVATION_MODIFIER", 11, 19], ["overgrowth", "OBSERVATION", 67, 77], ["pathogenic species", "OBSERVATION", 93, 111]]], ["51 Distortion of intestinal microecology by exposure to broad-spectrum antibiotics may result in colonization with inflammogenic microbial consortia that are more likely to direct the immune repertoire in the direction of an inflammatory response, thereby increasing the risk for NEC.", [["intestinal", "ANATOMY", 17, 27], ["NEC", "DISEASE", 280, 283], ["intestinal", "ORGAN", 17, 27], ["NEC", "PATHOLOGICAL_FORMATION", 280, 283], ["intestinal microecology", "TREATMENT", 17, 40], ["broad-spectrum antibiotics", "TREATMENT", 56, 82], ["colonization", "PROBLEM", 97, 109], ["inflammogenic microbial consortia", "PROBLEM", 115, 148], ["an inflammatory response", "PROBLEM", 222, 246], ["NEC", "PROBLEM", 280, 283], ["intestinal", "ANATOMY", 17, 27], ["inflammatory", "OBSERVATION", 225, 237], ["NEC", "OBSERVATION", 280, 283]]], ["51, 52 Metagenomic studies indicate that intestinal microecology during the early postnatal period greatly influences the evolution of immune health.", [["intestinal", "ANATOMY", 41, 51], ["intestinal", "ORGAN", 41, 51], ["Metagenomic studies", "TEST", 7, 26], ["intestinal microecology", "PROBLEM", 41, 64], ["intestinal", "ANATOMY", 41, 51]]], ["53, 54 Infants who later develop NEC show evidence for a dysbiotic microecology before the diagnosis of NEC.", [["NEC", "DISEASE", 33, 36], ["NEC", "DISEASE", 104, 107], ["Infants", "ORGANISM", 7, 14], ["NEC", "PATHOLOGICAL_FORMATION", 104, 107], ["Infants", "SPECIES", 7, 14], ["NEC", "PROBLEM", 33, 36], ["NEC", "PROBLEM", 104, 107], ["NEC", "OBSERVATION", 104, 107]]], ["55 A recent clinical study found that exposure to broad-spectrum antibiotics for more than 10 days increased the risk of NEC by nearly threefold.", [["NEC", "DISEASE", 121, 124], ["NEC", "PATHOLOGICAL_FORMATION", 121, 124], ["A recent clinical study", "TEST", 3, 26], ["broad-spectrum antibiotics", "TREATMENT", 50, 76], ["NEC", "PROBLEM", 121, 124], ["NEC", "OBSERVATION", 121, 124]]], ["51 Recent advances in the proteomics and microecology pertinent to NEC strongly suggest that a distorted innate-immune response of premature infants increases the vulnerability to NEC.", [["NEC", "DISEASE", 67, 70], ["NEC", "DISEASE", 180, 183], ["NEC", "CANCER", 67, 70], ["infants", "ORGANISM", 141, 148], ["NEC", "PATHOLOGICAL_FORMATION", 180, 183], ["infants", "SPECIES", 141, 148], ["the proteomics", "TEST", 22, 36], ["NEC", "PROBLEM", 67, 70], ["premature infants", "PROBLEM", 131, 148], ["NEC", "PROBLEM", 180, 183]]], ["22, 55 Glucocorticoid-mediated maturation of the IEB has been shown to protect against NEC and to blunt the inflammatory response seen in NEC.", [["NEC", "ANATOMY", 87, 90], ["NEC", "ANATOMY", 138, 141], ["IEB", "CHEMICAL", 49, 52], ["NEC", "DISEASE", 87, 90], ["NEC", "DISEASE", 138, 141], ["Glucocorticoid", "GENE_OR_GENE_PRODUCT", 7, 21], ["IEB", "GENE_OR_GENE_PRODUCT", 49, 52], ["NEC", "CANCER", 87, 90], ["NEC", "PATHOLOGICAL_FORMATION", 138, 141], ["IEB", "PROTEIN", 49, 52], ["Glucocorticoid-mediated maturation of the IEB", "TREATMENT", 7, 52], ["NEC", "PROBLEM", 87, 90], ["blunt the inflammatory response", "PROBLEM", 98, 129], ["NEC", "PROBLEM", 138, 141], ["inflammatory", "OBSERVATION", 108, 120], ["NEC", "OBSERVATION", 138, 141]]], ["46, 48, 56, 57 Furthermore, the vulnerability to NEC is not unique to premature neonates, it is also seen in the older immune-compromised population.", [["NEC", "DISEASE", 49, 52], ["NEC", "PATHOLOGICAL_FORMATION", 49, 52], ["neonates", "ORGANISM", 80, 88], ["NEC", "PROBLEM", 49, 52], ["premature neonates", "PROBLEM", 70, 88], ["NEC", "OBSERVATION", 49, 52]]], ["58-60 A NEClike illness has been described in the geriatric population and in patients with human immunodeficiency virus.", [["NEClike illness", "DISEASE", 8, 23], ["human immunodeficiency virus", "DISEASE", 92, 120], ["patients", "ORGANISM", 78, 86], ["human immunodeficiency virus", "ORGANISM", 92, 120], ["patients", "SPECIES", 78, 86], ["human", "SPECIES", 92, 97], ["immunodeficiency virus", "SPECIES", 98, 120], ["human immunodeficiency virus", "SPECIES", 92, 120], ["A NEClike illness", "PROBLEM", 6, 23], ["human immunodeficiency virus", "PROBLEM", 92, 120]]], ["56, 58Hypoxic-Ischemic MechanismsUnder normal conditions, a state of high intestinal blood flow and low resting vascular resistance is maintained by nitric oxide.", [["intestinal", "ANATOMY", 74, 84], ["blood", "ANATOMY", 85, 90], ["vascular", "ANATOMY", 112, 120], ["nitric oxide", "CHEMICAL", 149, 161], ["nitric oxide", "CHEMICAL", 149, 161], ["intestinal", "MULTI-TISSUE_STRUCTURE", 74, 84], ["blood", "ORGANISM_SUBSTANCE", 85, 90], ["vascular", "MULTI-TISSUE_STRUCTURE", 112, 120], ["nitric oxide", "SIMPLE_CHEMICAL", 149, 161], ["Ischemic MechanismsUnder normal conditions", "PROBLEM", 14, 56], ["high intestinal blood flow", "PROBLEM", 69, 95], ["low resting vascular resistance", "PROBLEM", 100, 131], ["nitric oxide", "TREATMENT", 149, 161], ["Ischemic", "OBSERVATION_MODIFIER", 14, 22], ["intestinal blood", "ANATOMY", 74, 90], ["vascular resistance", "OBSERVATION", 112, 131], ["nitric oxide", "OBSERVATION", 149, 161]]], ["26 Impaired endothelial function or elaboration of proinflammatory mediators may alter the balance between vasoconstriction (as mediated by endothelin-1) and vasodilatation (as mediated by nitric oxide) and lead to a relatively ischemic state.", [["endothelial", "ANATOMY", 12, 23], ["nitric oxide", "CHEMICAL", 189, 201], ["nitric oxide", "CHEMICAL", 189, 201], ["endothelial", "CELL", 12, 23], ["endothelin-1", "GENE_OR_GENE_PRODUCT", 140, 152], ["nitric oxide", "SIMPLE_CHEMICAL", 189, 201], ["proinflammatory mediators", "PROTEIN", 51, 76], ["Impaired endothelial function", "PROBLEM", 3, 32], ["vasoconstriction", "PROBLEM", 107, 123], ["vasodilatation", "PROBLEM", 158, 172], ["nitric oxide", "TREATMENT", 189, 201], ["a relatively ischemic state", "PROBLEM", 215, 242], ["Impaired", "OBSERVATION", 3, 11], ["endothelial function", "OBSERVATION", 12, 32], ["relatively", "OBSERVATION_MODIFIER", 217, 227], ["ischemic", "OBSERVATION", 228, 236]]], ["In animal models of hypoxia-ischemia, derangements of intestinal microcirculation develop at the premucosal arteriolar inflow location with a distinct stop-and-go pattern consistent with severe vascular dysfunction.", [["intestinal", "ANATOMY", 54, 64], ["premucosal arteriolar", "ANATOMY", 97, 118], ["vascular", "ANATOMY", 194, 202], ["hypoxia-ischemia", "DISEASE", 20, 36], ["vascular dysfunction", "DISEASE", 194, 214], ["intestinal microcirculation", "MULTI-TISSUE_STRUCTURE", 54, 81], ["premucosal arteriolar", "MULTI-TISSUE_STRUCTURE", 97, 118], ["vascular", "MULTI-TISSUE_STRUCTURE", 194, 202], ["hypoxia-ischemia", "PROBLEM", 20, 36], ["intestinal microcirculation", "PROBLEM", 54, 81], ["severe vascular dysfunction", "PROBLEM", 187, 214], ["hypoxia-ischemia", "OBSERVATION", 20, 36], ["intestinal microcirculation", "ANATOMY", 54, 81], ["arteriolar", "ANATOMY_MODIFIER", 108, 118], ["inflow", "ANATOMY_MODIFIER", 119, 125], ["distinct", "OBSERVATION_MODIFIER", 142, 150], ["consistent with", "UNCERTAINTY", 171, 186], ["severe", "OBSERVATION_MODIFIER", 187, 193], ["vascular", "ANATOMY", 194, 202], ["dysfunction", "OBSERVATION", 203, 214]]], ["61 Levels of inflammatory mediators increase markedly in real-time animal models of NEC.", [["NEC", "ANATOMY", 84, 87], ["NEC", "DISEASE", 84, 87], ["NEC", "PATHOLOGICAL_FORMATION", 84, 87], ["inflammatory mediators", "PROTEIN", 13, 35], ["inflammatory mediators", "PROBLEM", 13, 35], ["NEC", "PROBLEM", 84, 87], ["inflammatory", "OBSERVATION_MODIFIER", 13, 25], ["mediators", "OBSERVATION_MODIFIER", 26, 35], ["increase", "OBSERVATION_MODIFIER", 36, 44], ["markedly", "OBSERVATION_MODIFIER", 45, 53], ["real-time", "OBSERVATION_MODIFIER", 57, 66], ["NEC", "OBSERVATION", 84, 87]]], ["[61] [62] [63] The elaboration of inflammatory mediators (eg, PAF) early in the pathogenesis of NEC may have important secondary effects on local circulation that contribute to the development of the intestinal necrosis.", [["NEC", "ANATOMY", 96, 99], ["intestinal", "ANATOMY", 200, 210], ["NEC", "DISEASE", 96, 99], ["intestinal necrosis", "DISEASE", 200, 219], ["PAF", "GENE_OR_GENE_PRODUCT", 62, 65], ["NEC", "CANCER", 96, 99], ["intestinal", "ORGAN", 200, 210], ["inflammatory mediators", "PROTEIN", 34, 56], ["PAF", "PROTEIN", 62, 65], ["inflammatory mediators", "PROBLEM", 34, 56], ["PAF", "PROBLEM", 62, 65], ["NEC", "PROBLEM", 96, 99], ["the intestinal necrosis", "PROBLEM", 196, 219], ["NEC", "OBSERVATION", 96, 99], ["intestinal", "ANATOMY", 200, 210], ["necrosis", "OBSERVATION", 211, 219]]], ["19, 27, 43, [63] [64] [65]Infectious AgentsDespite 4 decades of exhaustive search, no consistent single microbial species has been isolated from infants with NEC.", [["NEC", "DISEASE", 158, 161], ["infants", "ORGANISM", 145, 152], ["infants", "SPECIES", 145, 152], ["exhaustive search", "PROBLEM", 64, 81], ["consistent single microbial species", "PROBLEM", 86, 121], ["NEC", "PROBLEM", 158, 161], ["no consistent", "UNCERTAINTY", 83, 96], ["NEC", "OBSERVATION", 158, 161]]], ["66 Enterobacteriaceae sp are the most common, followed by Staphylococcus sp and Clostridium sp.", [["Staphylococcus sp", "ORGANISM", 58, 75], ["Clostridium sp", "ORGANISM", 80, 94], ["Staphylococcus sp", "SPECIES", 58, 75], ["Staphylococcus sp", "SPECIES", 58, 75], ["Enterobacteriaceae sp", "PROBLEM", 3, 24], ["Staphylococcus sp and Clostridium sp", "PROBLEM", 58, 94], ["most common", "OBSERVATION_MODIFIER", 33, 44], ["Staphylococcus", "OBSERVATION", 58, 72]]], ["19, [67] [68] [69] [70] Outbreaks of NEC linked to consumption of formula contaminated by Enterobacter sakazakii and breast milk contaminated by Staphylococci have occurred.", [["breast milk", "ANATOMY", 117, 128], ["NEC", "DISEASE", 37, 40], ["[67] [68] [69] [70", "SIMPLE_CHEMICAL", 4, 22], ["Enterobacter sakazakii", "ORGANISM", 90, 112], ["breast milk", "ORGANISM_SUBSTANCE", 117, 128], ["Staphylococci", "CANCER", 145, 158], ["Enterobacter sakazakii", "SPECIES", 90, 112], ["milk", "SPECIES", 124, 128], ["Enterobacter sakazakii", "SPECIES", 90, 112], ["NEC", "PROBLEM", 37, 40], ["formula", "TREATMENT", 66, 73], ["Enterobacter sakazakii", "PROBLEM", 90, 112], ["breast milk", "PROBLEM", 117, 128], ["Staphylococci", "PROBLEM", 145, 158], ["breast", "ANATOMY", 117, 123], ["Staphylococci", "OBSERVATION", 145, 158]]], ["[69] [70] [71] Although bacteria are most commonly associated with NEC, several enteric viruses (rotavirus, echovirus, coronavirus, torovirus, norovirus [NoV]) and Candida sp have also been described.", [["NEC", "DISEASE", 67, 70], ["enteric viruses", "DISEASE", 80, 95], ["rotavirus, echovirus, coronavirus, torovirus, norovirus [NoV]", "DISEASE", 97, 158], ["NEC", "PATHOLOGICAL_FORMATION", 67, 70], ["rotavirus", "ORGANISM", 97, 106], ["echovirus, coronavirus", "ORGANISM", 108, 130], ["torovirus, norovirus [NoV]", "ORGANISM", 132, 158], ["Candida sp", "ORGANISM", 164, 174], ["coronavirus", "SPECIES", 119, 130], ["NoV", "SPECIES", 154, 157], ["bacteria", "PROBLEM", 24, 32], ["NEC", "PROBLEM", 67, 70], ["several enteric viruses", "PROBLEM", 72, 95], ["rotavirus", "PROBLEM", 97, 106], ["echovirus", "PROBLEM", 108, 117], ["coronavirus", "PROBLEM", 119, 130], ["torovirus", "PROBLEM", 132, 141], ["norovirus", "PROBLEM", 143, 152], ["Candida sp", "PROBLEM", 164, 174], ["enteric viruses", "ANATOMY", 80, 95]]], ["[72] [73] [74] [75] [76] [77] [78] [79] [80] Generally, NEC occurs sporadically but may also occur in clusters or outbreaks.", [["NEC", "DISEASE", 56, 59], ["[72] [73] [74] [75] [76] [77] [78] [79] [80]", "CHEMICAL", 0, 44], ["[72] [73] [74] [75] [76] [77] [78] [79] [80]", "SIMPLE_CHEMICAL", 0, 44], ["NEC", "PATHOLOGICAL_FORMATION", 56, 59], ["NEC", "PROBLEM", 56, 59], ["NEC", "OBSERVATION", 56, 59]]], ["81 Temporal clustering of such outbreaks and their cessation with the implementation of infection control measures supports an association of these outbreaks with a single transmissible agent during a given outbreak.", [["infection", "DISEASE", 88, 97], ["such outbreaks", "PROBLEM", 26, 40], ["infection control measures", "TREATMENT", 88, 114], ["a single transmissible agent", "TREATMENT", 163, 191], ["Temporal", "OBSERVATION_MODIFIER", 3, 11], ["infection", "OBSERVATION", 88, 97]]], ["82, 83 As cited earlier, varieties of organisms, including bacteria and viruses, have been linked to outbreaks of NEC.", [["NEC", "DISEASE", 114, 117], ["NEC", "PATHOLOGICAL_FORMATION", 114, 117], ["organisms", "PROBLEM", 38, 47], ["bacteria", "PROBLEM", 59, 67], ["viruses", "PROBLEM", 72, 79], ["NEC", "PROBLEM", 114, 117], ["viruses", "OBSERVATION", 72, 79], ["NEC", "OBSERVATION", 114, 117]]], ["Among viruses, NoV, astrovirus, torovirus, coronavirus, and rotavirus have been linked with outbreaks of hemorrhagic gastroenteritis and necrotizing enterocolitis.", [["rotavirus", "DISEASE", 60, 69], ["hemorrhagic gastroenteritis", "DISEASE", 105, 132], ["necrotizing enterocolitis", "DISEASE", 137, 162], ["NoV", "ORGANISM", 15, 18], ["astrovirus", "ORGANISM", 20, 30], ["torovirus", "GENE_OR_GENE_PRODUCT", 32, 41], ["coronavirus", "ORGANISM", 43, 54], ["rotavirus", "ORGANISM", 60, 69], ["coronavirus", "SPECIES", 43, 54], ["NoV", "SPECIES", 15, 18], ["rotavirus", "SPECIES", 60, 69], ["Among viruses", "PROBLEM", 0, 13], ["NoV", "PROBLEM", 15, 18], ["astrovirus", "PROBLEM", 20, 30], ["torovirus", "PROBLEM", 32, 41], ["coronavirus", "PROBLEM", 43, 54], ["rotavirus", "PROBLEM", 60, 69], ["hemorrhagic gastroenteritis", "PROBLEM", 105, 132], ["necrotizing enterocolitis", "PROBLEM", 137, 162], ["viruses", "OBSERVATION", 6, 13], ["hemorrhagic", "OBSERVATION_MODIFIER", 105, 116], ["gastroenteritis", "OBSERVATION", 117, 132], ["necrotizing", "OBSERVATION_MODIFIER", 137, 148], ["enterocolitis", "OBSERVATION", 149, 162]]], ["75, 79, [84] [85] [86] In a recent study, compared with infants with rotavirus or norovirus enteritis, infants with astrovirus were more likely to develop NEC and the systemic inflammatory response syndrome.", [["rotavirus or norovirus enteritis", "DISEASE", 69, 101], ["astrovirus", "DISEASE", 116, 126], ["NEC", "DISEASE", 155, 158], ["systemic inflammatory response syndrome", "DISEASE", 167, 206], ["infants", "ORGANISM", 56, 63], ["rotavirus", "ORGANISM", 69, 78], ["infants", "ORGANISM", 103, 110], ["astrovirus", "ORGANISM", 116, 126], ["infants", "SPECIES", 56, 63], ["infants", "SPECIES", 103, 110], ["rotavirus", "SPECIES", 69, 78], ["norovirus enteritis", "SPECIES", 82, 101], ["a recent study", "TEST", 26, 40], ["rotavirus", "PROBLEM", 69, 78], ["norovirus enteritis", "PROBLEM", 82, 101], ["astrovirus", "PROBLEM", 116, 126], ["NEC", "PROBLEM", 155, 158], ["the systemic inflammatory response syndrome", "PROBLEM", 163, 206], ["norovirus", "OBSERVATION", 82, 91], ["systemic", "OBSERVATION_MODIFIER", 167, 175], ["inflammatory response syndrome", "OBSERVATION", 176, 206]]], ["87 Viral enterotoxin, such as the nonstructural protein (NSP4) of rotavirus, stimulates a secretory response that is Ca 11 dependent that results in watery diarrhea in mature infants but hemorrhagic enteritis or NEC in premature infants.", [["Ca", "CHEMICAL", 117, 119], ["watery diarrhea", "DISEASE", 149, 164], ["hemorrhagic enteritis", "DISEASE", 187, 208], ["NEC", "DISEASE", 212, 215], ["Ca 11", "CHEMICAL", 117, 122], ["enterotoxin", "GENE_OR_GENE_PRODUCT", 9, 20], ["NSP4", "GENE_OR_GENE_PRODUCT", 57, 61], ["rotavirus", "ORGANISM", 66, 75], ["infants", "ORGANISM", 175, 182], ["infants", "ORGANISM", 229, 236], ["Viral enterotoxin", "PROTEIN", 3, 20], ["nonstructural protein", "PROTEIN", 34, 55], ["NSP4", "PROTEIN", 57, 61], ["infants", "SPECIES", 175, 182], ["infants", "SPECIES", 229, 236], ["rotavirus", "SPECIES", 66, 75], ["Viral enterotoxin", "PROBLEM", 3, 20], ["the nonstructural protein (NSP4", "PROBLEM", 30, 61], ["rotavirus", "PROBLEM", 66, 75], ["Ca 11 dependent", "PROBLEM", 117, 132], ["watery diarrhea in mature infants", "PROBLEM", 149, 182], ["hemorrhagic enteritis", "PROBLEM", 187, 208], ["NEC in premature infants", "PROBLEM", 212, 236], ["watery", "OBSERVATION_MODIFIER", 149, 155], ["diarrhea", "OBSERVATION", 156, 164], ["hemorrhagic", "OBSERVATION_MODIFIER", 187, 198], ["enteritis", "OBSERVATION", 199, 208], ["NEC", "OBSERVATION_MODIFIER", 212, 215]]], ["75, 88 This viral enterotoxin induces an age-and dose-dependent response.", [["enterotoxin", "GENE_OR_GENE_PRODUCT", 18, 29], ["viral enterotoxin", "PROTEIN", 12, 29], ["This viral enterotoxin", "PROBLEM", 7, 29]]], ["88 NSP4 increases paracellular permeability and alters the integrity of the IEB.", [["paracellular", "ANATOMY", 18, 30], ["IEB", "ANATOMY", 76, 79], ["NSP4", "GENE_OR_GENE_PRODUCT", 3, 7], ["paracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 18, 30], ["NSP4", "PROTEIN", 3, 7], ["IEB", "PROTEIN", 76, 79], ["NSP4", "PROBLEM", 3, 7], ["paracellular permeability", "PROBLEM", 18, 43], ["increases", "OBSERVATION_MODIFIER", 8, 17], ["paracellular permeability", "OBSERVATION", 18, 43]]], ["It binds with caveolin-1 (scaffolding protein) and alters tight junction assembly.", [["tight junction", "ANATOMY", 58, 72], ["caveolin-1", "GENE_OR_GENE_PRODUCT", 14, 24], ["tight junction", "CELLULAR_COMPONENT", 58, 72], ["caveolin-1", "PROTEIN", 14, 24], ["scaffolding protein", "PROTEIN", 26, 45], ["caveolin", "TREATMENT", 14, 22], ["tight junction", "OBSERVATION", 58, 72]]], ["[89] [90] [91] Consequently, a weakened IEB permits the translocation of microbes and the initiation of endotoxemia and the inflammatory response characteristic of NEC.", [["NEC", "ANATOMY", 164, 167], ["endotoxemia", "DISEASE", 104, 115], ["NEC", "DISEASE", 164, 167], ["IEB", "SIMPLE_CHEMICAL", 40, 43], ["NEC", "PATHOLOGICAL_FORMATION", 164, 167], ["IEB", "PROTEIN", 40, 43], ["a weakened IEB", "PROBLEM", 29, 43], ["endotoxemia", "PROBLEM", 104, 115], ["the inflammatory response", "PROBLEM", 120, 145], ["NEC", "PROBLEM", 164, 167], ["endotoxemia", "OBSERVATION", 104, 115], ["inflammatory", "OBSERVATION_MODIFIER", 124, 136], ["NEC", "OBSERVATION", 164, 167]]], ["90 Regardless of whether a pathogen can be identified during a local epidemic of NEC, implementation of infection control measures are effective in stopping the outbreak.", [["NEC", "DISEASE", 81, 84], ["infection", "DISEASE", 104, 113], ["NEC", "PATHOLOGICAL_FORMATION", 81, 84], ["a pathogen", "PROBLEM", 25, 35], ["NEC", "PROBLEM", 81, 84], ["infection control measures", "TREATMENT", 104, 130], ["NEC", "OBSERVATION", 81, 84], ["infection", "OBSERVATION", 104, 113]]], ["Clinical SignsDuring the 1980s, investigators found that NEC occurred more commonly in preterm infants between 33 to 35 weeks of PMA.", [["NEC", "DISEASE", 57, 60], ["PMA", "CHEMICAL", 129, 132], ["PMA", "CHEMICAL", 129, 132], ["NEC", "PATHOLOGICAL_FORMATION", 57, 60], ["infants", "ORGANISM", 95, 102], ["PMA", "SIMPLE_CHEMICAL", 129, 132], ["infants", "SPECIES", 95, 102], ["NEC", "PROBLEM", 57, 60], ["NEC", "OBSERVATION", 57, 60]]], ["94, 95 More recent studies have found that a peak distribution of NEC occurs at 29 to 31 weeks of PMA (Fig. 4) .", [["NEC", "DISEASE", 66, 69], ["PMA", "CHEMICAL", 98, 101], ["PMA", "CHEMICAL", 98, 101], ["NEC", "PATHOLOGICAL_FORMATION", 66, 69], ["PMA", "SIMPLE_CHEMICAL", 98, 101], ["recent studies", "TEST", 12, 26], ["NEC", "PROBLEM", 66, 69], ["NEC", "OBSERVATION", 66, 69]]], ["7 This shift to an earlier PMA may be a reflection of the current practice to introduce enteral feedings earlier compared with the delayed feeding practices of the 1980s.", [["PMA", "CHEMICAL", 27, 30], ["PMA", "SIMPLE_CHEMICAL", 27, 30], ["enteral feedings", "TREATMENT", 88, 104]]], ["94, 95 The clinical presentation of NEC can range from nonspecific signs that progress insidiously over several days to a fulminant onset of gastrointestinal signs, multiorgan system dysfunction, and shock over a few hours.", [["gastrointestinal", "ANATOMY", 141, 157], ["multiorgan system", "ANATOMY", 165, 182], ["NEC", "DISEASE", 36, 39], ["gastrointestinal signs", "DISEASE", 141, 163], ["multiorgan system dysfunction", "DISEASE", 165, 194], ["shock", "DISEASE", 200, 205], ["NEC", "CANCER", 36, 39], ["gastrointestinal", "ORGAN", 141, 157], ["NEC", "PROBLEM", 36, 39], ["nonspecific signs", "PROBLEM", 55, 72], ["gastrointestinal signs", "PROBLEM", 141, 163], ["multiorgan system dysfunction", "PROBLEM", 165, 194], ["shock", "PROBLEM", 200, 205], ["NEC", "OBSERVATION", 36, 39], ["gastrointestinal", "ANATOMY", 141, 157], ["multiorgan system dysfunction", "OBSERVATION", 165, 194], ["shock", "OBSERVATION", 200, 205]]], ["6 Early signs of NEC are nonspecific and may be indistinguishable from those of sepsis.", [["NEC", "ANATOMY", 17, 20], ["NEC", "DISEASE", 17, 20], ["sepsis", "DISEASE", 80, 86], ["NEC", "CANCER", 17, 20], ["NEC", "PROBLEM", 17, 20], ["sepsis", "PROBLEM", 80, 86], ["NEC", "OBSERVATION", 17, 20], ["nonspecific", "OBSERVATION_MODIFIER", 25, 36], ["may be", "UNCERTAINTY", 41, 47], ["sepsis", "OBSERVATION", 80, 86]]], ["5, 6, 11, 29, 94, 95 Clinical signs include both intestinal and systemic perturbations.", [["intestinal", "ANATOMY", 49, 59], ["intestinal", "ORGAN", 49, 59], ["Clinical signs", "TEST", 21, 35], ["both intestinal and systemic perturbations", "PROBLEM", 44, 86], ["both", "ANATOMY_MODIFIER", 44, 48], ["intestinal", "ANATOMY", 49, 59], ["systemic perturbations", "OBSERVATION", 64, 86]]], ["Intestinal signs in early NEC can present as feeding intolerance that may manifest as increased prefeeding gastric residuals, emesis, abdominal distension, and bloody stools (hematochezia).", [["Intestinal", "ANATOMY", 0, 10], ["NEC", "ANATOMY", 26, 29], ["gastric", "ANATOMY", 107, 114], ["abdominal", "ANATOMY", 134, 143], ["NEC", "DISEASE", 26, 29], ["feeding intolerance", "DISEASE", 45, 64], ["emesis", "DISEASE", 126, 132], ["abdominal distension", "DISEASE", 134, 154], ["bloody stools", "DISEASE", 160, 173], ["hematochezia", "DISEASE", 175, 187], ["Intestinal", "ORGAN", 0, 10], ["gastric", "ORGAN", 107, 114], ["abdominal", "ORGANISM_SUBDIVISION", 134, 143], ["hematochezia", "PATHOLOGICAL_FORMATION", 175, 187], ["Intestinal signs in early NEC", "PROBLEM", 0, 29], ["feeding intolerance", "PROBLEM", 45, 64], ["increased prefeeding gastric residuals", "PROBLEM", 86, 124], ["emesis", "PROBLEM", 126, 132], ["abdominal distension", "PROBLEM", 134, 154], ["bloody stools", "PROBLEM", 160, 173], ["hematochezia", "PROBLEM", 175, 187], ["early", "OBSERVATION_MODIFIER", 20, 25], ["NEC", "OBSERVATION", 26, 29], ["feeding intolerance", "OBSERVATION", 45, 64], ["gastric", "ANATOMY", 107, 114], ["abdominal", "ANATOMY", 134, 143], ["distension", "OBSERVATION", 144, 154]]], ["Less commonly, when the stomach is involved, NEC can present as bloody emesis or a bloody gastric residual.", [["stomach", "ANATOMY", 24, 31], ["gastric", "ANATOMY", 90, 97], ["NEC", "DISEASE", 45, 48], ["emesis", "DISEASE", 71, 77], ["stomach", "ORGAN", 24, 31], ["NEC", "PATHOLOGICAL_FORMATION", 45, 48], ["gastric", "ORGAN", 90, 97], ["NEC", "PROBLEM", 45, 48], ["bloody emesis", "PROBLEM", 64, 77], ["a bloody gastric residual", "PROBLEM", 81, 106], ["stomach", "ANATOMY", 24, 31], ["gastric", "ANATOMY", 90, 97], ["residual", "OBSERVATION", 98, 106]]], ["95, 96 During the advanced stage of NEC, the abdomen may appear shiny, distended, and erythematous.", [["abdomen", "ANATOMY", 45, 52], ["NEC", "DISEASE", 36, 39], ["erythematous", "DISEASE", 86, 98], ["NEC", "CANCER", 36, 39], ["abdomen", "ORGAN", 45, 52], ["NEC", "PROBLEM", 36, 39], ["distended", "PROBLEM", 71, 80], ["erythematous", "PROBLEM", 86, 98], ["NEC", "OBSERVATION", 36, 39], ["abdomen", "ANATOMY", 45, 52], ["shiny", "OBSERVATION", 64, 69], ["distended", "OBSERVATION", 71, 80], ["erythematous", "OBSERVATION", 86, 98]]], ["Infants generally prefer to assume a frog-leg position (position of comfort, Fig. 5A ) and are hyporesponsive.", [["leg", "ANATOMY", 42, 45], ["Infants", "ORGANISM", 0, 7], ["leg", "ORGANISM_SUBDIVISION", 42, 45], ["Infants", "SPECIES", 0, 7], ["a frog-leg position", "TREATMENT", 35, 54], ["hyporesponsive", "PROBLEM", 95, 109], ["leg", "ANATOMY", 42, 45], ["hyporesponsive", "OBSERVATION", 95, 109]]], ["6,94-96 On gentle palpation, the abdomen may feel firm, tense, and tender, and a tender mass may be palpable.", [["abdomen", "ANATOMY", 33, 40], ["tender mass", "ANATOMY", 81, 92], ["6,94-96", "CHEMICAL", 0, 7], ["abdomen", "ORGAN", 33, 40], ["gentle palpation", "TEST", 11, 27], ["firm", "PROBLEM", 50, 54], ["tense", "PROBLEM", 56, 61], ["tender", "PROBLEM", 67, 73], ["a tender mass", "PROBLEM", 79, 92], ["abdomen", "ANATOMY", 33, 40], ["firm", "OBSERVATION", 50, 54], ["tense", "OBSERVATION", 56, 61], ["tender", "OBSERVATION_MODIFIER", 67, 73], ["tender", "OBSERVATION_MODIFIER", 81, 87], ["mass", "OBSERVATION", 88, 92], ["palpable", "OBSERVATION", 100, 108]]], ["Bowel perforation may cause the abdomen to appear blue or discolored.", [["Bowel", "ANATOMY", 0, 5], ["abdomen", "ANATOMY", 32, 39], ["Bowel perforation", "DISEASE", 0, 17], ["Bowel", "ORGAN", 0, 5], ["abdomen", "ORGAN", 32, 39], ["Bowel perforation", "PROBLEM", 0, 17], ["the abdomen", "PROBLEM", 28, 39], ["blue", "PROBLEM", 50, 54], ["discolored", "PROBLEM", 58, 68], ["perforation", "OBSERVATION", 6, 17], ["abdomen", "ANATOMY", 32, 39], ["blue", "OBSERVATION", 50, 54], ["discolored", "OBSERVATION", 58, 68]]], ["6, [94] [95] [96] An infant with a blue discolored abdomen secondary to isolated intestinal perforation may be indistinguishable from an infant with NEC.", [["abdomen", "ANATOMY", 51, 58], ["intestinal", "ANATOMY", 81, 91], ["intestinal perforation", "DISEASE", 81, 103], ["NEC", "DISEASE", 149, 152], ["[94] [95", "SIMPLE_CHEMICAL", 3, 11], ["infant", "ORGANISM", 21, 27], ["abdomen", "ORGANISM_SUBDIVISION", 51, 58], ["intestinal", "ORGAN", 81, 91], ["infant", "SPECIES", 137, 143], ["a blue discolored abdomen", "PROBLEM", 33, 58], ["isolated intestinal perforation", "PROBLEM", 72, 103], ["NEC", "PROBLEM", 149, 152], ["abdomen", "ANATOMY", 51, 58], ["intestinal", "ANATOMY", 81, 91], ["perforation", "OBSERVATION", 92, 103], ["NEC", "OBSERVATION", 149, 152]]], ["In a male infant, erythema or bluish discoloration of the scrotum may appear if peritoneal fluid from perforated bowel herniates into the scrotum (see Fig. 5B ).HOW DOES IT PRESENT?", [["erythema", "ANATOMY", 18, 26], ["scrotum", "ANATOMY", 58, 65], ["peritoneal fluid", "ANATOMY", 80, 96], ["bowel", "ANATOMY", 113, 118], ["scrotum", "ANATOMY", 138, 145], ["erythema", "DISEASE", 18, 26], ["infant", "ORGANISM", 10, 16], ["erythema", "PATHOLOGICAL_FORMATION", 18, 26], ["scrotum", "ORGAN", 58, 65], ["peritoneal fluid", "MULTI-TISSUE_STRUCTURE", 80, 96], ["bowel", "ORGAN", 113, 118], ["scrotum", "ORGAN", 138, 145], ["infant", "SPECIES", 10, 16], ["erythema", "PROBLEM", 18, 26], ["bluish discoloration of the scrotum", "PROBLEM", 30, 65], ["peritoneal fluid", "PROBLEM", 80, 96], ["perforated bowel herniates into the scrotum", "PROBLEM", 102, 145], ["erythema", "OBSERVATION", 18, 26], ["bluish discoloration", "OBSERVATION", 30, 50], ["scrotum", "ANATOMY", 58, 65], ["may appear", "UNCERTAINTY", 66, 76], ["peritoneal", "ANATOMY", 80, 90], ["fluid", "OBSERVATION", 91, 96], ["perforated", "OBSERVATION", 102, 112], ["bowel", "ANATOMY", 113, 118], ["scrotum", "ANATOMY", 138, 145]]], ["Clinical SignsVP infants do not manifest tenderness and guarding unless NEC is advanced.", [["tenderness", "DISEASE", 41, 51], ["NEC", "DISEASE", 72, 75], ["infants", "ORGANISM", 17, 24], ["infants", "SPECIES", 17, 24], ["tenderness", "PROBLEM", 41, 51], ["guarding", "PROBLEM", 56, 64], ["NEC", "PROBLEM", 72, 75], ["guarding", "OBSERVATION", 56, 64]]], ["Therefore, a high index of suspicion is required to establish a diagnosis of NEC if multiple subtle signs appear that produce a deviation from baseline clinical status.", [["NEC", "DISEASE", 77, 80], ["NEC", "PATHOLOGICAL_FORMATION", 77, 80], ["NEC", "PROBLEM", 77, 80], ["multiple subtle signs", "PROBLEM", 84, 105], ["a deviation from baseline clinical status", "PROBLEM", 126, 167], ["NEC", "OBSERVATION", 77, 80]]], ["6, 7 NEC can also present with bloody stools (hematochezia) without any other initial signs, especially when NEC involves the distal colon.", [["bloody stools", "ANATOMY", 31, 44], ["distal colon", "ANATOMY", 126, 138], ["NEC", "DISEASE", 5, 8], ["bloody stools", "DISEASE", 31, 44], ["hematochezia", "DISEASE", 46, 58], ["NEC", "DISEASE", 109, 112], ["colon", "ORGAN", 133, 138], ["bloody stools", "PROBLEM", 31, 44], ["hematochezia", "PROBLEM", 46, 58], ["any other initial signs", "PROBLEM", 68, 91], ["NEC", "PROBLEM", 109, 112], ["distal", "ANATOMY_MODIFIER", 126, 132], ["colon", "ANATOMY", 133, 138]]], ["If the jejunum and terminal ileum are the predominant sites of NEC, then emesis, increased gastric residuals, and/or abdominal distension are the more likely initial clinical signs.", [["jejunum", "ANATOMY", 7, 14], ["terminal ileum", "ANATOMY", 19, 33], ["sites", "ANATOMY", 54, 59], ["NEC", "ANATOMY", 63, 66], ["gastric", "ANATOMY", 91, 98], ["abdominal", "ANATOMY", 117, 126], ["NEC", "DISEASE", 63, 66], ["emesis", "DISEASE", 73, 79], ["abdominal distension", "DISEASE", 117, 137], ["jejunum", "MULTI-TISSUE_STRUCTURE", 7, 14], ["terminal ileum", "MULTI-TISSUE_STRUCTURE", 19, 33], ["NEC", "PATHOLOGICAL_FORMATION", 63, 66], ["gastric", "ORGAN", 91, 98], ["abdominal", "ORGANISM_SUBDIVISION", 117, 126], ["NEC", "PROBLEM", 63, 66], ["emesis", "PROBLEM", 73, 79], ["increased gastric residuals", "PROBLEM", 81, 108], ["abdominal distension", "PROBLEM", 117, 137], ["jejunum", "ANATOMY", 7, 14], ["terminal", "ANATOMY_MODIFIER", 19, 27], ["ileum", "ANATOMY", 28, 33], ["predominant", "OBSERVATION_MODIFIER", 42, 53], ["sites", "OBSERVATION_MODIFIER", 54, 59], ["NEC", "OBSERVATION", 63, 66], ["increased", "OBSERVATION_MODIFIER", 81, 90], ["gastric", "ANATOMY", 91, 98], ["residuals", "OBSERVATION", 99, 108], ["abdominal", "ANATOMY", 117, 126], ["distension", "OBSERVATION", 127, 137]]], ["97, 98 Occult hematochezia diagnosed by a hemoccult test correlates poorly with NEC.", [["hematochezia", "DISEASE", 14, 26], ["NEC", "DISEASE", 80, 83], ["NEC", "PATHOLOGICAL_FORMATION", 80, 83], ["Occult hematochezia", "PROBLEM", 7, 26], ["a hemoccult test", "TEST", 40, 56], ["NEC", "PROBLEM", 80, 83], ["hematochezia", "OBSERVATION", 14, 26]]], ["99 Extremely premature infants with NEC are more likely to present with abdominal distension, ileus, and emesis.", [["abdominal", "ANATOMY", 72, 81], ["NEC", "DISEASE", 36, 39], ["abdominal distension", "DISEASE", 72, 92], ["ileus", "DISEASE", 94, 99], ["emesis", "DISEASE", 105, 111], ["infants", "ORGANISM", 23, 30], ["abdominal", "ORGANISM_SUBDIVISION", 72, 81], ["infants", "SPECIES", 23, 30], ["Extremely premature infants", "PROBLEM", 3, 30], ["NEC", "PROBLEM", 36, 39], ["abdominal distension", "PROBLEM", 72, 92], ["ileus", "PROBLEM", 94, 99], ["emesis", "PROBLEM", 105, 111], ["premature", "OBSERVATION", 13, 22], ["NEC", "OBSERVATION", 36, 39], ["abdominal", "ANATOMY", 72, 81], ["distension", "OBSERVATION", 82, 92], ["ileus", "OBSERVATION", 94, 99], ["emesis", "OBSERVATION", 105, 111]]], ["They are less likely to present with pneumatosis but are more likely to develop pneumoperitoneum compared with late-term or term infants (Fig. 6A, B) .", [["pneumatosis", "DISEASE", 37, 48], ["pneumoperitoneum", "DISEASE", 80, 96], ["infants", "ORGANISM", 129, 136], ["infants", "SPECIES", 129, 136], ["pneumatosis", "PROBLEM", 37, 48], ["pneumoperitoneum", "PROBLEM", 80, 96], ["less likely", "UNCERTAINTY", 9, 20], ["pneumatosis", "OBSERVATION", 37, 48], ["more likely", "UNCERTAINTY", 57, 68], ["pneumoperitoneum", "OBSERVATION", 80, 96]]], ["Observation of a lightly bile-stained gastric residual in VP infants, especially before any feeding, is common and normally resolves as gradual advancement of feeding volumes elicits improvement in intestinal motility.", [["bile", "ANATOMY", 25, 29], ["gastric", "ANATOMY", 38, 45], ["intestinal", "ANATOMY", 198, 208], ["bile", "SIMPLE_CHEMICAL", 25, 29], ["gastric", "ORGAN", 38, 45], ["infants", "ORGANISM", 61, 68], ["intestinal", "ORGAN", 198, 208], ["infants", "SPECIES", 61, 68], ["a lightly bile-stained gastric residual in VP infants", "PROBLEM", 15, 68], ["gradual advancement of feeding volumes", "TREATMENT", 136, 174], ["bile", "ANATOMY", 25, 29], ["gastric", "ANATOMY", 38, 45], ["residual", "OBSERVATION", 46, 54], ["VP infants", "ANATOMY_MODIFIER", 58, 68], ["intestinal motility", "OBSERVATION", 198, 217]]], ["Consistent dark-green bilious gastric residual may indicate gastrointestinal obstruction and requires further investigation.", [["gastric", "ANATOMY", 30, 37], ["gastrointestinal", "ANATOMY", 60, 76], ["gastrointestinal obstruction", "DISEASE", 60, 88], ["gastric", "ORGAN", 30, 37], ["gastrointestinal obstruction", "PATHOLOGICAL_FORMATION", 60, 88], ["dark-green bilious gastric residual", "PROBLEM", 11, 46], ["gastrointestinal obstruction", "PROBLEM", 60, 88], ["further investigation", "TEST", 102, 123], ["dark", "OBSERVATION_MODIFIER", 11, 15], ["green", "OBSERVATION_MODIFIER", 16, 21], ["bilious gastric residual", "OBSERVATION", 22, 46], ["gastrointestinal", "ANATOMY", 60, 76], ["obstruction", "OBSERVATION", 77, 88]]], ["98 Systemic signs include lethargy, hypotension, poor perfusion and pallor, increased episodes of apnea and bradycardia, worsening of respiratory function, temperature instability, tachycardia, hyperglycemia, or hypoglycemia.", [["respiratory", "ANATOMY", 134, 145], ["lethargy", "DISEASE", 26, 34], ["hypotension", "DISEASE", 36, 47], ["pallor", "DISEASE", 68, 74], ["apnea", "DISEASE", 98, 103], ["bradycardia", "DISEASE", 108, 119], ["tachycardia", "DISEASE", 181, 192], ["hyperglycemia", "DISEASE", 194, 207], ["hypoglycemia", "DISEASE", 212, 224], ["Systemic signs", "TEST", 3, 17], ["lethargy", "PROBLEM", 26, 34], ["hypotension", "PROBLEM", 36, 47], ["poor perfusion", "PROBLEM", 49, 63], ["pallor", "PROBLEM", 68, 74], ["apnea", "PROBLEM", 98, 103], ["bradycardia", "PROBLEM", 108, 119], ["worsening of respiratory function", "PROBLEM", 121, 154], ["temperature instability", "PROBLEM", 156, 179], ["tachycardia", "PROBLEM", 181, 192], ["hyperglycemia", "PROBLEM", 194, 207], ["hypoglycemia", "PROBLEM", 212, 224], ["lethargy", "OBSERVATION", 26, 34], ["hypotension", "OBSERVATION", 36, 47], ["poor perfusion", "OBSERVATION", 49, 63], ["pallor", "OBSERVATION_MODIFIER", 68, 74], ["increased", "OBSERVATION_MODIFIER", 76, 85], ["episodes", "OBSERVATION_MODIFIER", 86, 94], ["apnea", "OBSERVATION", 98, 103], ["worsening", "OBSERVATION_MODIFIER", 121, 130], ["respiratory function", "OBSERVATION", 134, 154], ["hyperglycemia", "OBSERVATION", 194, 207]]], ["[95] [96] [97] [98] Abnormal laboratory tests include anemia, left shift of neutrophils, neutropenia, thrombocytopenia, metabolic acidosis, and hyponatremia.", [["neutrophils", "ANATOMY", 76, 87], ["anemia", "DISEASE", 54, 60], ["neutropenia", "DISEASE", 89, 100], ["thrombocytopenia", "DISEASE", 102, 118], ["metabolic acidosis", "DISEASE", 120, 138], ["hyponatremia", "DISEASE", 144, 156], ["neutrophils", "CELL", 76, 87], ["neutrophils", "CELL_TYPE", 76, 87], ["Abnormal laboratory tests", "PROBLEM", 20, 45], ["anemia", "PROBLEM", 54, 60], ["left shift of neutrophils", "PROBLEM", 62, 87], ["neutropenia", "PROBLEM", 89, 100], ["thrombocytopenia", "PROBLEM", 102, 118], ["metabolic acidosis", "PROBLEM", 120, 138], ["hyponatremia", "PROBLEM", 144, 156], ["anemia", "OBSERVATION", 54, 60], ["left", "ANATOMY_MODIFIER", 62, 66], ["neutrophils", "OBSERVATION", 76, 87], ["neutropenia", "OBSERVATION", 89, 100], ["thrombocytopenia", "OBSERVATION", 102, 118], ["metabolic acidosis", "OBSERVATION", 120, 138], ["hyponatremia", "OBSERVATION", 144, 156]]], ["98, 100 In some instances, NEC may present as unexplained hyponatremia.", [["NEC", "DISEASE", 27, 30], ["hyponatremia", "DISEASE", 58, 70], ["NEC", "PATHOLOGICAL_FORMATION", 27, 30], ["NEC", "PROBLEM", 27, 30], ["unexplained hyponatremia", "PROBLEM", 46, 70], ["NEC", "OBSERVATION", 27, 30], ["hyponatremia", "OBSERVATION", 58, 70]]], ["Concurrent bacteremia and sepsis occurs in 40% to 60% of NEC cases.", [["bacteremia", "DISEASE", 11, 21], ["sepsis", "DISEASE", 26, 32], ["NEC", "DISEASE", 57, 60], ["NEC", "PATHOLOGICAL_FORMATION", 57, 60], ["Concurrent bacteremia", "PROBLEM", 0, 21], ["sepsis", "PROBLEM", 26, 32], ["NEC cases", "PROBLEM", 57, 66], ["bacteremia", "OBSERVATION", 11, 21], ["sepsis", "OBSERVATION", 26, 32]]], ["97, 98, [100] [101] [102] Sepsis caused by gram-negative bacteria is more common.", [["Sepsis", "DISEASE", 26, 32], ["Sepsis", "PROBLEM", 26, 32], ["gram-negative bacteria", "PROBLEM", 43, 65], ["negative bacteria", "OBSERVATION_MODIFIER", 48, 65], ["more common", "OBSERVATION_MODIFIER", 69, 80]]], ["97, 102 Conversely, if an infant presents with sepsis caused by gram-negative bacteria and nonspecific intestinal and radiographic signs, there is a greater likelihood that NEC is the underlying cause of this illness.", [["intestinal", "ANATOMY", 103, 113], ["sepsis", "DISEASE", 47, 53], ["NEC", "DISEASE", 173, 176], ["intestinal", "ORGAN", 103, 113], ["NEC", "PATHOLOGICAL_FORMATION", 173, 176], ["sepsis", "PROBLEM", 47, 53], ["gram-negative bacteria", "PROBLEM", 64, 86], ["nonspecific intestinal and radiographic signs", "PROBLEM", 91, 136], ["NEC", "PROBLEM", 173, 176], ["this illness", "PROBLEM", 204, 216], ["sepsis", "OBSERVATION", 47, 53], ["negative bacteria", "OBSERVATION", 69, 86], ["nonspecific", "OBSERVATION_MODIFIER", 91, 102], ["intestinal", "ANATOMY", 103, 113], ["greater", "OBSERVATION_MODIFIER", 149, 156], ["NEC", "OBSERVATION", 173, 176]]], ["102 In 5% to 6% of cases, NEC may recur.", [["NEC", "DISEASE", 26, 29], ["NEC", "PATHOLOGICAL_FORMATION", 26, 29], ["NEC", "PROBLEM", 26, 29], ["NEC", "OBSERVATION", 26, 29]]], ["97, 103 Recurrence is more likely if the initial episode of NEC was associated with congenital heart disease or with rotavirus.", [["heart", "ANATOMY", 95, 100], ["NEC", "DISEASE", 60, 63], ["congenital heart disease", "DISEASE", 84, 108], ["rotavirus", "DISEASE", 117, 126], ["NEC", "PATHOLOGICAL_FORMATION", 60, 63], ["heart", "ORGAN", 95, 100], ["rotavirus", "SPECIES", 117, 126], ["NEC", "PROBLEM", 60, 63], ["congenital heart disease", "PROBLEM", 84, 108], ["rotavirus", "PROBLEM", 117, 126], ["more likely", "UNCERTAINTY", 22, 33], ["NEC", "OBSERVATION", 60, 63], ["heart", "ANATOMY", 95, 100], ["disease", "OBSERVATION", 101, 108], ["rotavirus", "OBSERVATION", 117, 126]]], ["Recurrence can also occur with cow milk protein allergy.", [["allergy", "DISEASE", 48, 55], ["cow", "ORGANISM", 31, 34], ["milk", "ORGANISM_SUBSTANCE", 35, 39], ["cow", "SPECIES", 31, 34], ["cow", "SPECIES", 31, 34], ["Recurrence", "PROBLEM", 0, 10], ["cow milk protein allergy", "PROBLEM", 31, 55]]], ["104, 105 However, NEC can recur after either medical or surgical NEC without specific risk factors.", [["NEC", "DISEASE", 18, 21], ["NEC", "DISEASE", 65, 68], ["NEC", "PATHOLOGICAL_FORMATION", 18, 21], ["NEC", "PROBLEM", 18, 21], ["surgical NEC", "PROBLEM", 56, 68]]], ["97,103Radiographic SignsIntramural gas or pneumatosis and portal venous gas are pathognomonic signs of NEC.", [["portal venous", "ANATOMY", 58, 71], ["pneumatosis", "DISEASE", 42, 53], ["NEC", "DISEASE", 103, 106], ["portal venous", "MULTI-TISSUE_STRUCTURE", 58, 71], ["NEC", "PATHOLOGICAL_FORMATION", 103, 106], ["Radiographic SignsIntramural gas", "TEST", 6, 38], ["pneumatosis", "PROBLEM", 42, 53], ["portal venous gas", "PROBLEM", 58, 75], ["NEC", "PROBLEM", 103, 106], ["gas", "OBSERVATION", 35, 38], ["pneumatosis", "OBSERVATION", 42, 53], ["portal venous", "ANATOMY", 58, 71], ["gas", "OBSERVATION", 72, 75], ["NEC", "OBSERVATION", 103, 106]]], ["They may appear even before clinical signs.", [["clinical signs", "TEST", 28, 42]]], ["The absence of these radiographic signs by no means confirms the absence of NEC.", [["NEC", "DISEASE", 76, 79], ["NEC", "PATHOLOGICAL_FORMATION", 76, 79], ["these radiographic signs", "TEST", 15, 39], ["NEC", "PROBLEM", 76, 79], ["NEC", "OBSERVATION", 76, 79]]], ["Pneumatosis is caused by gas within the Fig. 6 .", [["Pneumatosis", "DISEASE", 0, 11], ["Pneumatosis", "PROBLEM", 0, 11], ["gas", "OBSERVATION", 25, 28]]], ["(A) Probability by PMA at birth that an infant with NEC will present with intramural gas (IMG) or portal venous gas (PVG).", [["intramural gas", "ANATOMY", 74, 88], ["portal venous", "ANATOMY", 98, 111], ["NEC", "DISEASE", 52, 55], ["PMA", "CHEMICAL", 19, 22], ["PMA", "SIMPLE_CHEMICAL", 19, 22], ["portal venous", "MULTI-TISSUE_STRUCTURE", 98, 111], ["infant", "SPECIES", 40, 46], ["NEC", "PROBLEM", 52, 55], ["intramural gas", "PROBLEM", 74, 88], ["portal venous gas", "TEST", 98, 115], ["portal venous", "ANATOMY", 98, 111]]], ["There is less than 50% probability for an extremely premature (EP) infant to manifest IMG.", [["infant", "SPECIES", 67, 73], ["an extremely premature (EP)", "PROBLEM", 39, 66], ["less", "OBSERVATION_MODIFIER", 9, 13], ["premature", "OBSERVATION", 52, 61]]], ["(B) Radiographic signs that are more probable in infants with decreasing PMA.", [["PMA", "CHEMICAL", 73, 76], ["PMA", "CHEMICAL", 73, 76], ["infants", "ORGANISM", 49, 56], ["PMA", "SIMPLE_CHEMICAL", 73, 76], ["infants", "SPECIES", 49, 56], ["Radiographic signs", "TEST", 4, 22], ["decreasing PMA", "PROBLEM", 62, 76]]], ["There is more than 50% probability that an EP infant will present with these signs. bowel wall and may appear linear (like railroad tracks) or circular if gas is subserosal or bubbly if gas is submucosal (Fig. 7) .", [["bowel wall", "ANATOMY", 84, 94], ["subserosal", "ANATOMY", 162, 172], ["submucosal", "ANATOMY", 193, 203], ["bowel wall", "MULTI-TISSUE_STRUCTURE", 84, 94], ["submucosal", "MULTI-TISSUE_STRUCTURE", 193, 203], ["these signs", "TEST", 71, 82], ["subserosal", "PROBLEM", 162, 172], ["wall", "ANATOMY_MODIFIER", 90, 94], ["linear", "OBSERVATION_MODIFIER", 110, 116]]], ["106, 107 Bubbly gas lucencies could also indicate air within intraluminal fecal material.", [["fecal material", "MULTI-TISSUE_STRUCTURE", 74, 88], ["Bubbly gas lucencies", "PROBLEM", 9, 29], ["air within intraluminal fecal material", "PROBLEM", 50, 88], ["gas lucencies", "OBSERVATION", 16, 29], ["could also indicate", "UNCERTAINTY", 30, 49], ["air", "OBSERVATION", 50, 53], ["intraluminal", "ANATOMY_MODIFIER", 61, 73], ["fecal material", "OBSERVATION", 74, 88]]], ["Pneumatosis is more commonly seen in the right lower quadrant but it can be seen anywhere because necrosis may involve any section of bowel extending from the stomach to the rectum.", [["right lower quadrant", "ANATOMY", 41, 61], ["bowel", "ANATOMY", 134, 139], ["stomach", "ANATOMY", 159, 166], ["rectum", "ANATOMY", 174, 180], ["Pneumatosis", "DISEASE", 0, 11], ["necrosis", "DISEASE", 98, 106], ["lower quadrant", "ORGANISM_SUBDIVISION", 47, 61], ["bowel", "ORGAN", 134, 139], ["stomach", "ORGAN", 159, 166], ["rectum", "ORGAN", 174, 180], ["Pneumatosis", "PROBLEM", 0, 11], ["necrosis", "PROBLEM", 98, 106], ["more commonly", "OBSERVATION_MODIFIER", 15, 28], ["right", "ANATOMY_MODIFIER", 41, 46], ["lower", "ANATOMY_MODIFIER", 47, 52], ["quadrant", "ANATOMY", 53, 61], ["necrosis", "OBSERVATION", 98, 106], ["bowel", "ANATOMY", 134, 139], ["stomach", "ANATOMY", 159, 166], ["rectum", "ANATOMY", 174, 180]]], ["97, 106, 107 The amount of pneumatosis does not always relate to the severity of disease, and its disappearance does not necessarily imply pathologic or clinical improvement.", [["pneumatosis", "DISEASE", 27, 38], ["pneumatosis", "PROBLEM", 27, 38], ["disease", "PROBLEM", 81, 88], ["amount", "OBSERVATION_MODIFIER", 17, 23], ["pneumatosis", "OBSERVATION", 27, 38], ["does not always relate to", "UNCERTAINTY", 39, 64], ["severity", "OBSERVATION_MODIFIER", 69, 77], ["disease", "OBSERVATION", 81, 88], ["not necessarily imply", "UNCERTAINTY", 117, 138]]], ["7, 97, 106, 107 Other nonspecific but common abdominal radiographic findings include thickened bowel walls, dilated bowel loops, a paucity of bowel gas, and a fixed dilated loop (Fig. 8) .", [["abdominal", "ANATOMY", 45, 54], ["bowel", "ANATOMY", 95, 100], ["bowel", "ANATOMY", 116, 121], ["bowel", "ANATOMY", 142, 147], ["abdominal", "PATHOLOGICAL_FORMATION", 45, 54], ["bowel walls", "PATHOLOGICAL_FORMATION", 95, 106], ["bowel", "ORGAN", 116, 121], ["bowel", "ORGAN", 142, 147], ["common abdominal radiographic findings", "PROBLEM", 38, 76], ["thickened bowel walls", "PROBLEM", 85, 106], ["dilated bowel loops", "PROBLEM", 108, 127], ["a paucity of bowel gas", "PROBLEM", 129, 151], ["a fixed dilated loop", "PROBLEM", 157, 177], ["nonspecific", "OBSERVATION_MODIFIER", 22, 33], ["common", "ANATOMY_MODIFIER", 38, 44], ["abdominal", "ANATOMY", 45, 54], ["thickened", "OBSERVATION", 85, 94], ["bowel", "ANATOMY", 95, 100], ["walls", "ANATOMY_MODIFIER", 101, 106], ["dilated", "OBSERVATION", 108, 115], ["bowel loops", "ANATOMY", 116, 127], ["paucity", "OBSERVATION_MODIFIER", 131, 138], ["bowel", "ANATOMY", 142, 147], ["gas", "OBSERVATION", 148, 151], ["fixed", "OBSERVATION_MODIFIER", 159, 164], ["dilated", "OBSERVATION", 165, 172], ["loop", "OBSERVATION_MODIFIER", 173, 177]]], ["106, 107 Inflamed, edematous, and hemorrhagic bowel wall may be separated from each other because of thickening of bowel wall and the normal sausage-like mosaic configuration may be lost.", [["edematous", "ANATOMY", 19, 28], ["bowel wall", "ANATOMY", 46, 56], ["bowel wall", "ANATOMY", 115, 125], ["hemorrhagic", "DISEASE", 34, 45], ["bowel wall", "MULTI-TISSUE_STRUCTURE", 46, 56], ["bowel wall", "MULTI-TISSUE_STRUCTURE", 115, 125], ["edematous", "PROBLEM", 19, 28], ["hemorrhagic bowel wall", "PROBLEM", 34, 56], ["thickening of bowel wall", "PROBLEM", 101, 125], ["Inflamed", "OBSERVATION_MODIFIER", 9, 17], ["edematous", "OBSERVATION", 19, 28], ["hemorrhagic", "OBSERVATION_MODIFIER", 34, 45], ["bowel wall", "ANATOMY", 46, 56], ["thickening", "OBSERVATION", 101, 111], ["bowel", "ANATOMY", 115, 120], ["wall", "ANATOMY_MODIFIER", 121, 125], ["normal sausage", "OBSERVATION", 134, 148], ["mosaic configuration", "OBSERVATION", 154, 174], ["may be", "UNCERTAINTY", 175, 181], ["lost", "OBSERVATION_MODIFIER", 182, 186]]], ["A persistent, fixed, dilated loop may indicate a necrotic bowel loop.", [["bowel", "ANATOMY", 58, 63], ["necrotic", "DISEASE", 49, 57], ["bowel", "ORGAN", 58, 63], ["A persistent, fixed, dilated loop", "PROBLEM", 0, 33], ["a necrotic bowel loop", "PROBLEM", 47, 68], ["persistent", "OBSERVATION_MODIFIER", 2, 12], ["fixed", "OBSERVATION_MODIFIER", 14, 19], ["dilated", "OBSERVATION", 21, 28], ["may indicate", "UNCERTAINTY", 34, 46], ["necrotic", "OBSERVATION_MODIFIER", 49, 57], ["bowel loop", "OBSERVATION", 58, 68]]], ["Dilated, gas-filled loops in the central abdomen may indicate the presence of ascites or free peritoneal fluid because dilated bowel loops float (and migrate to the least dependent region of the abdomen) when peritoneal fluid is present.", [["central abdomen", "ANATOMY", 33, 48], ["ascites", "ANATOMY", 78, 85], ["peritoneal fluid", "ANATOMY", 94, 110], ["bowel", "ANATOMY", 127, 132], ["abdomen", "ANATOMY", 195, 202], ["peritoneal fluid", "ANATOMY", 209, 225], ["ascites", "DISEASE", 78, 85], ["central abdomen", "ORGANISM_SUBDIVISION", 33, 48], ["peritoneal fluid", "ORGANISM_SUBSTANCE", 94, 110], ["bowel", "ORGAN", 127, 132], ["abdomen", "ORGAN", 195, 202], ["peritoneal fluid", "MULTI-TISSUE_STRUCTURE", 209, 225], ["Dilated, gas-filled loops in the central abdomen", "PROBLEM", 0, 48], ["ascites", "PROBLEM", 78, 85], ["free peritoneal fluid", "PROBLEM", 89, 110], ["dilated bowel loops float", "PROBLEM", 119, 144], ["peritoneal fluid", "PROBLEM", 209, 225], ["gas", "OBSERVATION", 9, 12], ["filled loops", "OBSERVATION", 13, 25], ["central", "ANATOMY_MODIFIER", 33, 40], ["abdomen", "ANATOMY", 41, 48], ["may indicate the presence of", "UNCERTAINTY", 49, 77], ["ascites", "OBSERVATION", 78, 85], ["free", "OBSERVATION_MODIFIER", 89, 93], ["peritoneal", "ANATOMY", 94, 104], ["fluid", "OBSERVATION", 105, 110], ["dilated", "OBSERVATION", 119, 126], ["bowel loops", "ANATOMY", 127, 138], ["least", "OBSERVATION_MODIFIER", 165, 170], ["dependent", "OBSERVATION_MODIFIER", 171, 180], ["region", "ANATOMY_MODIFIER", 181, 187], ["abdomen", "ANATOMY", 195, 202], ["peritoneal", "ANATOMY", 209, 219], ["fluid", "OBSERVATION", 220, 225]]], ["106, 107 A paucity of bowel gas may be associated with ileus and abdominal decompression.", [["bowel", "ANATOMY", 22, 27], ["abdominal", "ANATOMY", 65, 74], ["ileus", "DISEASE", 55, 60], ["bowel", "ORGAN", 22, 27], ["abdominal", "ORGANISM_SUBDIVISION", 65, 74], ["A paucity of bowel gas", "PROBLEM", 9, 31], ["ileus", "PROBLEM", 55, 60], ["abdominal decompression", "TREATMENT", 65, 88], ["paucity", "OBSERVATION_MODIFIER", 11, 18], ["bowel", "ANATOMY", 22, 27], ["gas", "OBSERVATION", 28, 31], ["may be associated with", "UNCERTAINTY", 32, 54], ["ileus", "OBSERVATION", 55, 60], ["abdominal", "ANATOMY", 65, 74], ["decompression", "OBSERVATION", 75, 88]]], ["These nonspecific signs may not be diagnostic of NEC but nonetheless are non-reassuring and suspicious for NEC, thereby warranting immediate intervention and treatment implementation.", [["NEC", "DISEASE", 49, 52], ["NEC", "DISEASE", 107, 110], ["NEC", "PATHOLOGICAL_FORMATION", 49, 52], ["NEC", "PATHOLOGICAL_FORMATION", 107, 110], ["These nonspecific signs", "PROBLEM", 0, 23], ["NEC", "PROBLEM", 49, 52], ["NEC", "PROBLEM", 107, 110], ["immediate intervention", "TREATMENT", 131, 153], ["treatment implementation", "TREATMENT", 158, 182], ["may not be", "UNCERTAINTY", 24, 34], ["NEC", "OBSERVATION", 49, 52], ["suspicious for", "UNCERTAINTY", 92, 106], ["NEC", "OBSERVATION", 107, 110]]], ["106, 107 Pneumatosis intestinalis can extend to the portal venous circulation and typically appear as curvilinear lucencies over the hepatic silhouette in a plain radiograph (see Fig. 7 ).", [["portal venous", "ANATOMY", 52, 65], ["hepatic", "ANATOMY", 133, 140], ["portal venous", "MULTI-TISSUE_STRUCTURE", 52, 65], ["hepatic", "ORGAN", 133, 140], ["Pneumatosis intestinalis", "SPECIES", 9, 33], ["Pneumatosis intestinalis", "PROBLEM", 9, 33], ["curvilinear lucencies over the hepatic silhouette", "PROBLEM", 102, 151], ["a plain radiograph", "TEST", 155, 173], ["Pneumatosis", "OBSERVATION", 9, 20], ["intestinalis", "OBSERVATION", 21, 33], ["portal venous", "ANATOMY", 52, 65], ["circulation", "ANATOMY_MODIFIER", 66, 77], ["curvilinear", "OBSERVATION_MODIFIER", 102, 113], ["lucencies", "OBSERVATION", 114, 123], ["hepatic", "ANATOMY", 133, 140], ["silhouette", "ANATOMY_MODIFIER", 141, 151]]], ["97 A pneumoperitoneum is diagnostic of a perforated viscus.", [["viscus", "ANATOMY", 52, 58], ["viscus", "DISEASE", 52, 58], ["viscus", "CANCER", 52, 58], ["A pneumoperitoneum", "PROBLEM", 3, 21], ["a perforated viscus", "PROBLEM", 39, 58], ["pneumoperitoneum", "OBSERVATION", 5, 21], ["perforated viscus", "OBSERVATION", 41, 58]]], ["In a supine position, it may appear as a rounded or oval extraluminal lucency beneath the upper anterior abdominal wall (Fig. 9) .", [["anterior abdominal wall", "ANATOMY", 96, 119], ["upper anterior abdominal wall", "MULTI-TISSUE_STRUCTURE", 90, 119], ["a rounded or oval extraluminal lucency", "PROBLEM", 39, 77], ["rounded", "OBSERVATION_MODIFIER", 41, 48], ["oval", "OBSERVATION_MODIFIER", 52, 56], ["extraluminal", "OBSERVATION_MODIFIER", 57, 69], ["lucency", "OBSERVATION", 70, 77], ["upper", "ANATOMY_MODIFIER", 90, 95], ["anterior", "ANATOMY_MODIFIER", 96, 104], ["abdominal wall", "ANATOMY", 105, 119]]], ["When there is a large pneumoperitoneum, it may outline the falciform ligament giving it the appearance of a longitudinal strip of sutures in a football (American football and rugby but not soccer ball), leading to its designation as the football sign (see Fig. 9 ).", [["falciform ligament", "ANATOMY", 59, 77], ["falciform ligament", "TISSUE", 59, 77], ["a large pneumoperitoneum", "PROBLEM", 14, 38], ["a longitudinal strip of sutures", "TREATMENT", 106, 137], ["large", "OBSERVATION_MODIFIER", 16, 21], ["pneumoperitoneum", "OBSERVATION", 22, 38], ["falciform ligament", "ANATOMY", 59, 77], ["longitudinal", "OBSERVATION_MODIFIER", 108, 120], ["strip", "OBSERVATION_MODIFIER", 121, 126], ["sutures", "OBSERVATION", 130, 137]]], ["106,107 A cross-table lateral film may demonstrate small air collection just beneath the abdomen (see Fig. 9 ).", [["abdomen", "ANATOMY", 89, 96], ["abdomen", "ORGAN", 89, 96], ["A cross-table lateral film", "TEST", 8, 34], ["small air collection", "PROBLEM", 51, 71], ["small", "OBSERVATION_MODIFIER", 51, 56], ["air collection", "OBSERVATION", 57, 71], ["abdomen", "ANATOMY", 89, 96]]], ["A small pneumoperitoneum may be difficult to visualize on a single plain film.", [["A small pneumoperitoneum", "PROBLEM", 0, 24], ["a single plain film", "TEST", 58, 77], ["small", "OBSERVATION_MODIFIER", 2, 7], ["pneumoperitoneum", "OBSERVATION", 8, 24]]], ["A left lateral decubitus film will allow free air to rise to the top over a nondependent surface, facilitating visualization of an abnormal lucency.", [["surface", "ANATOMY", 89, 96], ["surface", "CELLULAR_COMPONENT", 89, 96], ["A left lateral decubitus film", "TEST", 0, 29], ["free air", "PROBLEM", 41, 49], ["an abnormal lucency", "PROBLEM", 128, 147], ["left", "ANATOMY_MODIFIER", 2, 6], ["lateral", "ANATOMY_MODIFIER", 7, 14], ["decubitus", "ANATOMY", 15, 24], ["free air", "OBSERVATION", 41, 49], ["top", "OBSERVATION_MODIFIER", 65, 68], ["nondependent surface", "OBSERVATION_MODIFIER", 76, 96], ["abnormal", "OBSERVATION_MODIFIER", 131, 139], ["lucency", "OBSERVATION", 140, 147]]], ["A small amount of free air may present as a small triangular or a rectangular lucency and make a definitive diagnosis of free air difficult.", [["A small amount of free air", "PROBLEM", 0, 26], ["a small triangular or a rectangular lucency", "PROBLEM", 42, 85], ["free air", "PROBLEM", 121, 129], ["small", "OBSERVATION_MODIFIER", 2, 7], ["amount", "OBSERVATION_MODIFIER", 8, 14], ["free air", "OBSERVATION", 18, 26], ["small", "OBSERVATION_MODIFIER", 44, 49], ["triangular", "OBSERVATION_MODIFIER", 50, 60], ["rectangular", "OBSERVATION_MODIFIER", 66, 77], ["lucency", "OBSERVATION", 78, 85], ["free air", "OBSERVATION", 121, 129]]], ["Sometimes free air may present as a double-wall sign when the bowel loop is outlined and gas is present along serosal and mucosal surfaces.", [["bowel", "ANATOMY", 62, 67], ["serosal", "ANATOMY", 110, 117], ["mucosal", "ANATOMY", 122, 129], ["bowel", "ORGAN", 62, 67], ["serosal", "MULTI-TISSUE_STRUCTURE", 110, 117], ["mucosal surfaces", "TISSUE", 122, 138], ["Sometimes free air", "PROBLEM", 0, 18], ["free", "OBSERVATION_MODIFIER", 10, 14], ["air", "OBSERVATION", 15, 18], ["wall", "ANATOMY_MODIFIER", 43, 47], ["bowel loop", "ANATOMY", 62, 72], ["gas", "OBSERVATION", 89, 92], ["serosal", "ANATOMY_MODIFIER", 110, 117], ["mucosal", "ANATOMY", 122, 129], ["surfaces", "ANATOMY_MODIFIER", 130, 138]]], ["106, 107 A nonionic water-soluble contrast study (typically, an upper gastrointestinal series followed by an enema) can be obtained in circumstances when anatomic gastrointestinal obstruction is suspected.", [["gastrointestinal", "ANATOMY", 70, 86], ["gastrointestinal", "ANATOMY", 163, 179], ["gastrointestinal obstruction", "DISEASE", 163, 191], ["upper gastrointestinal", "ORGANISM_SUBDIVISION", 64, 86], ["gastrointestinal", "ORGAN", 163, 179], ["A nonionic water-soluble contrast study", "TEST", 9, 48], ["an upper gastrointestinal series", "TEST", 61, 93], ["an enema", "TEST", 106, 114], ["anatomic gastrointestinal obstruction", "PROBLEM", 154, 191], ["gastrointestinal", "ANATOMY", 163, 179], ["obstruction", "OBSERVATION", 180, 191]]], ["107 Hypertonic water-soluble agents are not routinely recommended because hypovolemia can result from a shift of fluid from the intravascular space to the intestinal lumen.", [["fluid", "ANATOMY", 113, 118], ["intravascular", "ANATOMY", 128, 141], ["intestinal lumen", "ANATOMY", 155, 171], ["hypovolemia", "DISEASE", 74, 85], ["fluid", "ORGANISM_SUBSTANCE", 113, 118], ["intravascular space", "IMMATERIAL_ANATOMICAL_ENTITY", 128, 147], ["intestinal lumen", "MULTI-TISSUE_STRUCTURE", 155, 171], ["Hypertonic water-soluble agents", "TREATMENT", 4, 35], ["hypovolemia", "PROBLEM", 74, 85], ["a shift of fluid from the intravascular space", "PROBLEM", 102, 147], ["fluid", "OBSERVATION", 113, 118], ["intravascular space", "OBSERVATION", 128, 147], ["intestinal", "ANATOMY", 155, 165], ["lumen", "ANATOMY_MODIFIER", 166, 171]]], ["107UltrasoundIn situations when radiographic signs are nonspecific, the abdominal ultrasound (US) is another modality that can identify even small volumes of free gas.", [["abdominal", "ANATOMY", 72, 81], ["abdominal", "ORGANISM_SUBDIVISION", 72, 81], ["radiographic signs", "TEST", 32, 50], ["the abdominal ultrasound", "TEST", 68, 92], ["small volumes of free gas", "PROBLEM", 141, 166], ["nonspecific", "OBSERVATION_MODIFIER", 55, 66], ["abdominal", "ANATOMY", 72, 81], ["small", "OBSERVATION_MODIFIER", 141, 146], ["volumes", "OBSERVATION_MODIFIER", 147, 154], ["free gas", "OBSERVATION", 158, 166]]], ["US is also the preferred modality for visualization of abdominal fluid and ascites.", [["abdominal fluid", "ANATOMY", 55, 70], ["ascites", "ANATOMY", 75, 82], ["ascites", "DISEASE", 75, 82], ["abdominal", "ORGANISM_SUBDIVISION", 55, 64], ["fluid", "ORGANISM_SUBSTANCE", 65, 70], ["US", "TEST", 0, 2], ["abdominal fluid", "PROBLEM", 55, 70], ["ascites", "PROBLEM", 75, 82], ["abdominal", "ANATOMY", 55, 64], ["fluid", "OBSERVATION", 65, 70], ["ascites", "OBSERVATION", 75, 82]]], ["Thickness and echogenicity of the bowel wall and qualitative assessment of peristalsis can be visualized best by US color Doppler.", [["bowel wall", "ANATOMY", 34, 44], ["bowel wall", "MULTI-TISSUE_STRUCTURE", 34, 44], ["Thickness and echogenicity of the bowel wall", "PROBLEM", 0, 44], ["qualitative assessment", "TEST", 49, 71], ["color Doppler", "TEST", 116, 129], ["echogenicity", "OBSERVATION", 14, 26], ["bowel", "ANATOMY", 34, 39], ["wall", "ANATOMY_MODIFIER", 40, 44], ["peristalsis", "OBSERVATION", 75, 86]]], ["It can also be used to assess arterial perfusion of the bowel wall (Fig. 10) .", [["arterial", "ANATOMY", 30, 38], ["bowel wall", "ANATOMY", 56, 66], ["arterial", "MULTI-TISSUE_STRUCTURE", 30, 38], ["bowel wall", "MULTI-TISSUE_STRUCTURE", 56, 66], ["bowel wall", "ANATOMY", 56, 66]]], ["Portal venous gas can be more readily seen using abdominal sonography than plain film.", [["Portal venous", "ANATOMY", 0, 13], ["abdominal", "ANATOMY", 49, 58], ["Portal venous", "MULTI-TISSUE_STRUCTURE", 0, 13], ["abdominal", "ORGANISM_SUBDIVISION", 49, 58], ["Portal venous gas", "PROBLEM", 0, 17], ["abdominal sonography", "TEST", 49, 69], ["plain film", "TEST", 75, 85], ["venous", "ANATOMY", 7, 13], ["gas", "OBSERVATION", 14, 17], ["abdominal", "ANATOMY", 49, 58]]], ["107 Faingold and colleagues 108 used color Doppler sonography and demonstrated 100% sensitivity for free air and absent blood flow (necrotic gut) compared with 40% sensitivity by radiography.", [["blood", "ANATOMY", 120, 125], ["necrotic gut", "ANATOMY", 132, 144], ["necrotic", "DISEASE", 132, 140], ["blood", "ORGANISM_SUBSTANCE", 120, 125], ["gut", "ORGANISM_SUBDIVISION", 141, 144], ["color Doppler sonography", "TEST", 37, 61], ["free air", "PROBLEM", 100, 108], ["absent blood flow (necrotic gut", "PROBLEM", 113, 144], ["radiography", "TEST", 179, 190], ["free air", "OBSERVATION", 100, 108], ["blood flow", "OBSERVATION", 120, 130], ["necrotic", "OBSERVATION_MODIFIER", 132, 140]]], ["The use of computed tomography is not advocated for the diagnosis of NEC.", [["NEC", "DISEASE", 69, 72], ["NEC", "PATHOLOGICAL_FORMATION", 69, 72], ["computed tomography", "TEST", 11, 30], ["NEC", "PROBLEM", 69, 72], ["NEC", "OBSERVATION", 69, 72]]], ["107MANAGEMENT MedicalWhen an infant is suspected to have NEC, all enteral feedings and medications should be discontinued (Fig. 11) .", [["NEC", "DISEASE", 57, 60], ["infant", "ORGANISM", 29, 35], ["infant", "SPECIES", 29, 35], ["NEC", "PROBLEM", 57, 60], ["all enteral feedings", "TREATMENT", 62, 82], ["medications", "TREATMENT", 87, 98], ["NEC", "OBSERVATION", 57, 60]]], ["Prompt decompression of the GIT should be accomplished by the placement of a double-lumen gastric tube (large lumen for aspiration and small lumen for irrigation and venting) with the institution of low, constant suction.", [["GIT", "ANATOMY", 28, 31], ["gastric tube", "ANATOMY", 90, 102], ["lumen", "ANATOMY", 110, 115], ["lumen", "ANATOMY", 141, 146], ["GIT", "ORGAN", 28, 31], ["gastric tube", "MULTI-TISSUE_STRUCTURE", 90, 102], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 110, 115], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 141, 146], ["Prompt decompression of the GIT", "TREATMENT", 0, 31], ["a double-lumen gastric tube", "TREATMENT", 75, 102], ["large lumen", "TREATMENT", 104, 115], ["aspiration", "PROBLEM", 120, 130], ["small lumen", "TREATMENT", 135, 146], ["irrigation", "TREATMENT", 151, 161], ["venting", "TREATMENT", 166, 173], ["low, constant suction", "TREATMENT", 199, 220], ["decompression", "OBSERVATION", 7, 20], ["GIT", "ANATOMY", 28, 31], ["lumen", "ANATOMY_MODIFIER", 84, 89], ["gastric", "ANATOMY", 90, 97], ["tube", "OBSERVATION", 98, 102], ["large", "OBSERVATION_MODIFIER", 104, 109], ["lumen", "OBSERVATION_MODIFIER", 110, 115], ["aspiration", "OBSERVATION", 120, 130], ["small", "OBSERVATION_MODIFIER", 135, 140], ["lumen", "OBSERVATION_MODIFIER", 141, 146], ["low", "OBSERVATION_MODIFIER", 199, 202]]], ["Aspirated volume should be replaced with intravenous Ringer lactate solution with extra potassium chloride that is lost in gastric output.", [["intravenous", "ANATOMY", 41, 52], ["gastric", "ANATOMY", 123, 130], ["lactate", "CHEMICAL", 60, 67], ["potassium chloride", "CHEMICAL", 88, 106], ["lactate", "CHEMICAL", 60, 67], ["potassium chloride", "CHEMICAL", 88, 106], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 41, 52], ["Ringer", "SIMPLE_CHEMICAL", 53, 59], ["lactate", "SIMPLE_CHEMICAL", 60, 67], ["potassium chloride", "SIMPLE_CHEMICAL", 88, 106], ["gastric", "ORGAN", 123, 130], ["Aspirated volume", "PROBLEM", 0, 16], ["intravenous Ringer lactate solution", "TREATMENT", 41, 76], ["extra potassium chloride", "TREATMENT", 82, 106], ["gastric output", "TEST", 123, 137], ["volume", "OBSERVATION", 10, 16], ["gastric output", "OBSERVATION", 123, 137]]], ["It is crucial to ensure the patency of the tube.", [["tube", "ANATOMY", 43, 47], ["tube", "TISSUE", 43, 47], ["the tube", "TREATMENT", 39, 47], ["patency", "OBSERVATION_MODIFIER", 28, 35], ["tube", "OBSERVATION", 43, 47]]], ["If the abdomen continues to distend despite ongoing continuous suction, the tube should be checked for proper placement and for blockage and nasal continuous positive airway pressure should be discontinued.", [["abdomen", "ANATOMY", 7, 14], ["tube", "ANATOMY", 76, 80], ["nasal", "ANATOMY", 141, 146], ["airway", "ANATOMY", 167, 173], ["abdomen", "ORGAN", 7, 14], ["tube", "TISSUE", 76, 80], ["airway", "MULTI-TISSUE_STRUCTURE", 167, 173], ["ongoing continuous suction", "TREATMENT", 44, 70], ["the tube", "TREATMENT", 72, 80], ["proper placement", "TREATMENT", 103, 119], ["blockage", "PROBLEM", 128, 136], ["nasal continuous positive airway pressure", "TREATMENT", 141, 182], ["abdomen", "ANATOMY", 7, 14], ["tube", "OBSERVATION", 76, 80], ["nasal", "ANATOMY", 141, 146], ["airway pressure", "OBSERVATION", 167, 182]]], ["Endotracheal intubation is preferred in infants who are deteriorating and have frequent episodes of apnea.", [["Endotracheal", "ANATOMY", 0, 12], ["apnea", "DISEASE", 100, 105], ["infants", "ORGANISM", 40, 47], ["infants", "SPECIES", 40, 47], ["Endotracheal intubation", "TREATMENT", 0, 23], ["apnea", "PROBLEM", 100, 105], ["intubation", "OBSERVATION", 13, 23], ["apnea", "OBSERVATION", 100, 105]]], ["Intravascular volume must be monitored rigorously to ensure adequate tissue perfusion and may be gauged by frequent assessment of serum electrolytes, hematocrit, and urinary output.", [["Intravascular", "ANATOMY", 0, 13], ["tissue", "ANATOMY", 69, 75], ["serum", "ANATOMY", 130, 135], ["urinary", "ANATOMY", 166, 173], ["Intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 0, 13], ["tissue", "TISSUE", 69, 75], ["serum", "ORGANISM_SUBSTANCE", 130, 135], ["electrolytes", "SIMPLE_CHEMICAL", 136, 148], ["urinary", "ORGANISM_SUBSTANCE", 166, 173], ["Intravascular volume", "TEST", 0, 20], ["frequent assessment", "TEST", 107, 126], ["serum electrolytes", "TEST", 130, 148], ["hematocrit", "TEST", 150, 160], ["urinary output", "TEST", 166, 180], ["volume", "OBSERVATION", 14, 20], ["urinary", "ANATOMY", 166, 173]]], ["As a rule of thumb, anticipation of third spacing in infants with NEC will require 1.5-fold maintenance fluid plus replacement of gastric output.", [["thumb", "ANATOMY", 13, 18], ["fluid", "ANATOMY", 104, 109], ["gastric", "ANATOMY", 130, 137], ["NEC", "DISEASE", 66, 69], ["thumb", "ORGANISM_SUBDIVISION", 13, 18], ["infants", "ORGANISM", 53, 60], ["fluid", "ORGANISM_SUBSTANCE", 104, 109], ["gastric", "ORGAN", 130, 137], ["infants", "SPECIES", 53, 60], ["thumb", "PROBLEM", 13, 18], ["third spacing", "PROBLEM", 36, 49], ["NEC", "PROBLEM", 66, 69], ["fold maintenance fluid", "TREATMENT", 87, 109], ["replacement of gastric output", "TREATMENT", 115, 144], ["thumb", "ANATOMY", 13, 18], ["gastric output", "OBSERVATION", 130, 144]]], ["Failure to maintain euvolemia and proper electrolyte repletion can result in shock with hypochloremia, hyponatremia, and hypokalemia.", [["euvolemia", "DISEASE", 20, 29], ["shock", "DISEASE", 77, 82], ["hypochloremia", "DISEASE", 88, 101], ["hyponatremia", "DISEASE", 103, 115], ["hypokalemia", "DISEASE", 121, 132], ["Failure to maintain euvolemia", "PROBLEM", 0, 29], ["proper electrolyte repletion", "TREATMENT", 34, 62], ["shock", "PROBLEM", 77, 82], ["hypochloremia", "PROBLEM", 88, 101], ["hyponatremia", "PROBLEM", 103, 115], ["hypokalemia", "PROBLEM", 121, 132], ["shock", "OBSERVATION", 77, 82], ["hyponatremia", "OBSERVATION", 103, 115], ["hypokalemia", "OBSERVATION", 121, 132]]], ["Parenteral nutrition should be started early with adequate protein (3.5-4.0 g/kg/d) to maintain positive nitrogen balance and to allow the repair of injured tissue.", [["Parenteral", "ANATOMY", 0, 10], ["tissue", "ANATOMY", 157, 163], ["nitrogen", "CHEMICAL", 105, 113], ["tissue", "TISSUE", 157, 163], ["Parenteral nutrition", "TREATMENT", 0, 20], ["positive nitrogen balance", "PROBLEM", 96, 121], ["the repair of injured tissue", "TREATMENT", 135, 163], ["repair", "OBSERVATION", 139, 145], ["injured tissue", "OBSERVATION", 149, 163]]], ["6, 46, [109] [110] [111] Strict implementation of infection control measures is critical.", [["infection", "DISEASE", 50, 59], ["infection control measures", "TREATMENT", 50, 76], ["infection", "OBSERVATION", 50, 59]]], ["Following the culture of blood and urine, prompt initiation of treatment with appropriate broad-spectrum antibiotics based on known sensitivities of prevalent pathogens in the individual neonatal intensive care unit is vital.", [["blood", "ANATOMY", 25, 30], ["urine", "ANATOMY", 35, 40], ["blood", "ORGANISM_SUBSTANCE", 25, 30], ["urine", "ORGANISM_SUBSTANCE", 35, 40], ["the culture", "TEST", 10, 21], ["blood and urine", "TEST", 25, 40], ["treatment", "TREATMENT", 63, 72], ["appropriate broad-spectrum antibiotics", "TREATMENT", 78, 116], ["prevalent pathogens", "PROBLEM", 149, 168]]], ["If surgical intervention is performed, peritoneal fluid and intestinal tissue should be sent for gram stain, culture, and sensitivity.", [["peritoneal fluid", "ANATOMY", 39, 55], ["intestinal tissue", "ANATOMY", 60, 77], ["peritoneal fluid", "MULTI-TISSUE_STRUCTURE", 39, 55], ["intestinal tissue", "TISSUE", 60, 77], ["surgical intervention", "TREATMENT", 3, 24], ["peritoneal fluid and intestinal tissue", "TEST", 39, 77], ["gram stain", "TEST", 97, 107], ["culture", "TEST", 109, 116], ["sensitivity", "TEST", 122, 133], ["peritoneal", "ANATOMY", 39, 49], ["fluid", "OBSERVATION", 50, 55], ["intestinal tissue", "ANATOMY", 60, 77]]], ["The utility of a stool culture for bacteria in neonates has been questioned because fecal matter has many bacterial species.", [["fecal matter", "ANATOMY", 84, 96], ["neonates", "ORGANISM", 47, 55], ["fecal", "ORGANISM_SUBDIVISION", 84, 89], ["a stool culture", "TEST", 15, 30], ["bacteria in neonates", "PROBLEM", 35, 55], ["fecal matter", "PROBLEM", 84, 96], ["many bacterial species", "PROBLEM", 101, 123], ["bacterial species", "OBSERVATION", 106, 123]]], ["However, during outbreaks of NEC, attempts should be made to identify the infectious agent whenever possible.", [["NEC", "DISEASE", 29, 32], ["NEC", "PATHOLOGICAL_FORMATION", 29, 32], ["NEC", "PROBLEM", 29, 32], ["the infectious agent", "TREATMENT", 70, 90], ["NEC", "OBSERVATION", 29, 32], ["infectious", "OBSERVATION", 74, 84]]], ["Usual regimens include ampicillin (or a cephalosporin) and gentamicin (or other aminoglycoside).", [["ampicillin", "CHEMICAL", 23, 33], ["cephalosporin", "CHEMICAL", 40, 53], ["gentamicin", "CHEMICAL", 59, 69], ["aminoglycoside", "CHEMICAL", 80, 94], ["ampicillin", "CHEMICAL", 23, 33], ["cephalosporin", "CHEMICAL", 40, 53], ["gentamicin", "CHEMICAL", 59, 69], ["aminoglycoside", "CHEMICAL", 80, 94], ["ampicillin", "SIMPLE_CHEMICAL", 23, 33], ["cephalosporin", "SIMPLE_CHEMICAL", 40, 53], ["gentamicin", "SIMPLE_CHEMICAL", 59, 69], ["aminoglycoside", "SIMPLE_CHEMICAL", 80, 94], ["Usual regimens", "TREATMENT", 0, 14], ["ampicillin", "TREATMENT", 23, 33], ["a cephalosporin)", "TREATMENT", 38, 54], ["gentamicin", "TREATMENT", 59, 69], ["other aminoglycoside", "TREATMENT", 74, 94]]], ["The addition of a third antibiotic that provides anaerobic coverage (eg, clindamycin or metronidazole) is indicated when there is evidence of peritonitis or bowel perforation (see Fig. 11 ).", [["bowel", "ANATOMY", 157, 162], ["clindamycin", "CHEMICAL", 73, 84], ["metronidazole", "CHEMICAL", 88, 101], ["peritonitis", "DISEASE", 142, 153], ["bowel perforation", "DISEASE", 157, 174], ["clindamycin", "CHEMICAL", 73, 84], ["metronidazole", "CHEMICAL", 88, 101], ["clindamycin", "SIMPLE_CHEMICAL", 73, 84], ["metronidazole", "SIMPLE_CHEMICAL", 88, 101], ["bowel", "ORGAN", 157, 162], ["a third antibiotic", "TREATMENT", 16, 34], ["anaerobic coverage (eg", "TREATMENT", 49, 71], ["clindamycin", "TREATMENT", 73, 84], ["metronidazole", "TREATMENT", 88, 101], ["peritonitis", "PROBLEM", 142, 153], ["bowel perforation", "PROBLEM", 157, 174], ["evidence of", "UNCERTAINTY", 130, 141], ["peritonitis", "OBSERVATION", 142, 153], ["bowel", "ANATOMY", 157, 162], ["perforation", "OBSERVATION", 163, 174]]], ["Inflammation of the intestine and peritoneum is excruciatingly painful; therefore, attention to pain control and minimal handling during cares are integral parts of management.", [["intestine", "ANATOMY", 20, 29], ["peritoneum", "ANATOMY", 34, 44], ["pain", "DISEASE", 96, 100], ["intestine", "ORGAN", 20, 29], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 34, 44], ["Inflammation of the intestine and peritoneum", "PROBLEM", 0, 44], ["excruciatingly painful", "PROBLEM", 48, 70], ["pain control", "TREATMENT", 96, 108], ["integral parts of management", "TREATMENT", 147, 175], ["intestine", "ANATOMY", 20, 29], ["peritoneum", "ANATOMY", 34, 44], ["painful", "OBSERVATION_MODIFIER", 63, 70], ["minimal", "OBSERVATION_MODIFIER", 113, 120]]], ["6, 46, [109] [110] [111] Hematocrit should be monitored and packed red cells should be provided to replace occult intestinal hemorrhage.", [["red cells", "ANATOMY", 67, 76], ["intestinal", "ANATOMY", 114, 124], ["intestinal hemorrhage", "DISEASE", 114, 135], ["[109] [110] [111] Hematocrit", "SIMPLE_CHEMICAL", 7, 35], ["red cells", "CELL", 67, 76], ["intestinal", "ORGAN", 114, 124], ["packed red cells", "CELL_TYPE", 60, 76], ["Hematocrit", "TEST", 25, 35], ["packed red cells", "TREATMENT", 60, 76], ["occult intestinal hemorrhage", "PROBLEM", 107, 135], ["intestinal", "ANATOMY", 114, 124], ["hemorrhage", "OBSERVATION", 125, 135]]], ["Adjunctive treatment includes judicious correction of significant thrombocytopenia, coagulopathy, and metabolic acidosis.", [["thrombocytopenia", "DISEASE", 66, 82], ["coagulopathy", "DISEASE", 84, 96], ["metabolic acidosis", "DISEASE", 102, 120], ["Adjunctive treatment", "TREATMENT", 0, 20], ["judicious correction", "TREATMENT", 30, 50], ["significant thrombocytopenia", "PROBLEM", 54, 82], ["coagulopathy", "PROBLEM", 84, 96], ["metabolic acidosis", "PROBLEM", 102, 120], ["significant", "OBSERVATION_MODIFIER", 54, 65], ["thrombocytopenia", "OBSERVATION", 66, 82], ["coagulopathy", "OBSERVATION", 84, 96], ["metabolic acidosis", "OBSERVATION", 102, 120]]], ["Abdominal girth should be measured frequently.", [["Abdominal", "ANATOMY", 0, 9], ["Abdominal girth", "PROBLEM", 0, 15], ["girth", "ANATOMY", 10, 15]]], ["A sudden increase in abdominal girth warrants an immediate abdominal radiograph to assess for a pneumoperitoneum.", [["abdominal", "ANATOMY", 21, 30], ["abdominal", "ANATOMY", 59, 68], ["abdominal", "ORGANISM_SUBDIVISION", 21, 30], ["abdominal", "ORGANISM_SUBDIVISION", 59, 68], ["A sudden increase in abdominal girth", "PROBLEM", 0, 36], ["an immediate abdominal radiograph", "TEST", 46, 79], ["a pneumoperitoneum", "PROBLEM", 94, 112], ["sudden", "OBSERVATION_MODIFIER", 2, 8], ["increase", "OBSERVATION_MODIFIER", 9, 17], ["abdominal", "ANATOMY", 21, 30], ["abdominal", "ANATOMY", 59, 68], ["pneumoperitoneum", "OBSERVATION", 96, 112]]], ["Co-management with pediatric surgeons is recommended when a diagnosis of NEC is strongly suspected or confirmed.", [["NEC", "DISEASE", 73, 76], ["NEC", "CANCER", 73, 76], ["NEC", "PROBLEM", 73, 76], ["NEC", "OBSERVATION", 73, 76]]], ["In sick infants who are not improving despite supportive medical management and in whom NEC is suspected, consultation with a pediatric surgeon and radiologist may help to arrive at a specific diagnosis.", [["NEC", "DISEASE", 88, 91], ["infants", "ORGANISM", 8, 15], ["infants", "SPECIES", 8, 15], ["supportive medical management", "TREATMENT", 46, 75]]], ["6, 46, 107, [109] [110] [111] [112] [113] In the most premature infants, a high index of suspicion is required to make a timely diagnosis of NEC because these infants are less likely to manifest tenderness and the pathognomonic radiographic findings of NEC.", [["NEC", "DISEASE", 141, 144], ["tenderness", "DISEASE", 195, 205], ["NEC", "DISEASE", 253, 256], ["infants", "ORGANISM", 64, 71], ["NEC", "PATHOLOGICAL_FORMATION", 141, 144], ["infants", "ORGANISM", 159, 166], ["NEC", "PATHOLOGICAL_FORMATION", 253, 256], ["infants", "SPECIES", 64, 71], ["infants", "SPECIES", 159, 166], ["NEC", "PROBLEM", 141, 144], ["tenderness", "PROBLEM", 195, 205], ["the pathognomonic radiographic findings", "PROBLEM", 210, 249], ["NEC", "PROBLEM", 253, 256], ["NEC", "OBSERVATION", 141, 144], ["NEC", "OBSERVATION", 253, 256]]], ["7 By the time VP infants manifest tenderness or abdominal mass, NEC has usually progressed to an advanced stage.", [["abdominal mass", "ANATOMY", 48, 62], ["tenderness", "DISEASE", 34, 44], ["NEC", "DISEASE", 64, 67], ["infants", "ORGANISM", 17, 24], ["abdominal", "ORGANISM_SUBDIVISION", 48, 57], ["infants", "SPECIES", 17, 24], ["tenderness", "PROBLEM", 34, 44], ["abdominal mass", "PROBLEM", 48, 62], ["NEC", "PROBLEM", 64, 67], ["an advanced stage", "PROBLEM", 94, 111], ["tenderness", "OBSERVATION", 34, 44], ["abdominal", "ANATOMY", 48, 57], ["mass", "OBSERVATION", 58, 62], ["NEC", "OBSERVATION", 64, 67]]], ["7SurgicalIdentification of a pneumoperitoneum caused by bowel perforation and the presence of necrotic bowel (either may be difficult to diagnose) are 2 absolute indications for surgical intervention.", [["bowel", "ANATOMY", 56, 61], ["necrotic bowel", "ANATOMY", 94, 108], ["pneumoperitoneum", "DISEASE", 29, 45], ["bowel perforation", "DISEASE", 56, 73], ["necrotic", "DISEASE", 94, 102], ["bowel", "ORGAN", 56, 61], ["bowel", "ORGAN", 103, 108], ["a pneumoperitoneum", "PROBLEM", 27, 45], ["bowel perforation", "PROBLEM", 56, 73], ["necrotic bowel", "PROBLEM", 94, 108], ["surgical intervention", "TREATMENT", 178, 199], ["pneumoperitoneum", "OBSERVATION", 29, 45], ["bowel", "ANATOMY", 56, 61], ["perforation", "OBSERVATION", 62, 73], ["necrotic", "OBSERVATION_MODIFIER", 94, 102], ["bowel", "ANATOMY", 103, 108]]], ["Severe and persistent metabolic acidosis and/or thrombocytopenia in conjunction with a lack of improvement with medical management strongly suggest the presence of necrotic bowel and warrants surgery (see Fig. 11 ).", [["necrotic bowel", "ANATOMY", 164, 178], ["metabolic acidosis", "DISEASE", 22, 40], ["thrombocytopenia", "DISEASE", 48, 64], ["necrotic", "DISEASE", 164, 172], ["bowel", "ORGAN", 173, 178], ["Severe and persistent metabolic acidosis", "PROBLEM", 0, 40], ["thrombocytopenia", "PROBLEM", 48, 64], ["medical management", "TREATMENT", 112, 130], ["necrotic bowel", "PROBLEM", 164, 178], ["surgery", "TREATMENT", 192, 199], ["persistent", "OBSERVATION_MODIFIER", 11, 21], ["metabolic acidosis", "OBSERVATION", 22, 40], ["thrombocytopenia", "OBSERVATION", 48, 64], ["necrotic", "OBSERVATION_MODIFIER", 164, 172], ["bowel", "ANATOMY", 173, 178]]], ["7, 97, 100, 102, 110, 112, 113 The timely diagnosis of bowel perforation or dead gut can be difficult in extremely premature infants with NEC.", [["bowel", "ANATOMY", 55, 60], ["gut", "ANATOMY", 81, 84], ["bowel perforation", "DISEASE", 55, 72], ["NEC", "DISEASE", 138, 141], ["bowel", "ORGAN", 55, 60], ["gut", "ORGANISM_SUBDIVISION", 81, 84], ["infants", "ORGANISM", 125, 132], ["infants", "SPECIES", 125, 132], ["bowel perforation", "PROBLEM", 55, 72], ["dead gut", "PROBLEM", 76, 84], ["NEC", "PROBLEM", 138, 141], ["bowel", "ANATOMY", 55, 60], ["perforation", "OBSERVATION", 61, 72], ["NEC", "OBSERVATION", 138, 141]]], ["7 A negative laparotomy is just as detrimental as failure to recognize perforation early in this group of patients.", [["perforation", "DISEASE", 71, 82], ["perforation", "PATHOLOGICAL_FORMATION", 71, 82], ["patients", "ORGANISM", 106, 114], ["patients", "SPECIES", 106, 114], ["A negative laparotomy", "TREATMENT", 2, 23], ["perforation", "PROBLEM", 71, 82], ["negative", "OBSERVATION_MODIFIER", 4, 12], ["laparotomy", "OBSERVATION", 13, 23], ["perforation", "OBSERVATION", 71, 82]]], ["107 Pneumoperitoneum can be missed in about 20% of cases of bowel perforation.", [["bowel", "ANATOMY", 60, 65], ["Pneumoperitoneum", "DISEASE", 4, 20], ["bowel perforation", "DISEASE", 60, 77], ["bowel", "ORGAN", 60, 65], ["Pneumoperitoneum", "PROBLEM", 4, 20], ["bowel perforation", "PROBLEM", 60, 77], ["Pneumoperitoneum", "OBSERVATION", 4, 20], ["bowel", "ANATOMY", 60, 65], ["perforation", "OBSERVATION", 66, 77]]], ["107 In such cases, the use of a 7-point scoring system using 7 components that quantitate the presence of metabolic derangement, in conjunction with an infant's ongoing evaluation by a pediatric surgeon, has been found to optimize the timing of the surgical intervention.", [["metabolic derangement", "DISEASE", 106, 127], ["a 7-point scoring system", "TREATMENT", 30, 54], ["metabolic derangement", "PROBLEM", 106, 127], ["the surgical intervention", "TREATMENT", 245, 270], ["metabolic derangement", "OBSERVATION", 106, 127]]], ["114 These metabolic derangements include severe metabolic acidosis, severe thrombocytopenia, hypotension, hyponatremia, neutropenia, left shift of neutrophils, and positive blood culture.", [["neutrophils", "ANATOMY", 147, 158], ["blood", "ANATOMY", 173, 178], ["metabolic derangements", "DISEASE", 10, 32], ["metabolic acidosis", "DISEASE", 48, 66], ["thrombocytopenia", "DISEASE", 75, 91], ["hypotension", "DISEASE", 93, 104], ["hyponatremia", "DISEASE", 106, 118], ["neutropenia", "DISEASE", 120, 131], ["neutrophils", "CELL", 147, 158], ["blood", "ORGANISM_SUBSTANCE", 173, 178], ["neutrophils", "CELL_TYPE", 147, 158], ["These metabolic derangements", "PROBLEM", 4, 32], ["severe metabolic acidosis", "PROBLEM", 41, 66], ["severe thrombocytopenia", "PROBLEM", 68, 91], ["hypotension", "PROBLEM", 93, 104], ["hyponatremia", "PROBLEM", 106, 118], ["neutropenia", "PROBLEM", 120, 131], ["left shift of neutrophils", "PROBLEM", 133, 158], ["positive blood culture", "PROBLEM", 164, 186], ["severe", "OBSERVATION_MODIFIER", 41, 47], ["metabolic acidosis", "OBSERVATION", 48, 66], ["severe", "OBSERVATION_MODIFIER", 68, 74], ["thrombocytopenia", "OBSERVATION", 75, 91], ["hypotension", "OBSERVATION", 93, 104], ["hyponatremia", "OBSERVATION", 106, 118], ["neutropenia", "OBSERVATION", 120, 131], ["left", "ANATOMY_MODIFIER", 133, 137], ["neutrophils", "OBSERVATION", 147, 158], ["positive blood culture", "OBSERVATION", 164, 186]]], ["It is recommended that this scoring system be used only as an adjunct to careful serial clinical and radiologic evaluation of infants.", [["infants", "ORGANISM", 126, 133], ["infants", "SPECIES", 126, 133], ["careful serial clinical and radiologic evaluation", "TEST", 73, 122]]], ["108, 110, 114 With respect to the type of surgery, primary peritoneal drainage (PPD) has emerged as an alternative to laparotomy in VP infants with bowel perforation.", [["peritoneal", "ANATOMY", 59, 69], ["bowel", "ANATOMY", 148, 153], ["bowel perforation", "DISEASE", 148, 165], ["peritoneal", "MULTI-TISSUE_STRUCTURE", 59, 69], ["infants", "ORGANISM", 135, 142], ["bowel", "ORGAN", 148, 153], ["infants", "SPECIES", 135, 142], ["surgery", "TREATMENT", 42, 49], ["primary peritoneal drainage", "TREATMENT", 51, 78], ["laparotomy", "TREATMENT", 118, 128], ["bowel perforation", "PROBLEM", 148, 165], ["peritoneal", "ANATOMY", 59, 69], ["drainage", "OBSERVATION", 70, 78], ["laparotomy", "OBSERVATION", 118, 128], ["bowel", "ANATOMY", 148, 153], ["perforation", "OBSERVATION", 154, 165]]], ["100,115 Peritoneal drainage serves as a definitive treatment of some patients and as a temporizing measure for unstable sick infants until laparotomy can be performed after their stabilization.", [["Peritoneal", "ANATOMY", 8, 18], ["Peritoneal", "MULTI-TISSUE_STRUCTURE", 8, 18], ["patients", "ORGANISM", 69, 77], ["infants", "ORGANISM", 125, 132], ["patients", "SPECIES", 69, 77], ["infants", "SPECIES", 125, 132], ["Peritoneal drainage", "TREATMENT", 8, 27], ["a definitive treatment", "TREATMENT", 38, 60], ["a temporizing measure", "TREATMENT", 85, 106], ["laparotomy", "TREATMENT", 139, 149], ["Peritoneal", "ANATOMY", 8, 18], ["drainage", "OBSERVATION", 19, 27]]], ["[115] [116] [117] [118] [119] The choice of PPD or laparotomy as a primary surgical intervention has been argued for a decade.", [["PPD", "CHEMICAL", 44, 47], ["PPD", "PROBLEM", 44, 47], ["laparotomy", "TREATMENT", 51, 61], ["a primary surgical intervention", "TREATMENT", 65, 96], ["laparotomy", "OBSERVATION", 51, 61]]], ["[116] [117] [118] In their review of only 2 randomized controlled trials, Rao and colleagues 116 report that there were no differences with respect to mortality and duration for total parenteral nutrition between the drainage and laparotomy.", [["parenteral", "ANATOMY", 184, 194], ["total parenteral nutrition", "TREATMENT", 178, 204], ["the drainage", "TREATMENT", 213, 225], ["laparotomy", "TREATMENT", 230, 240], ["drainage", "OBSERVATION", 217, 225], ["laparotomy", "OBSERVATION", 230, 240]]], ["However, these studies did not distinguish between isolated perforation and NEC.", [["perforation", "DISEASE", 60, 71], ["NEC", "DISEASE", 76, 79], ["NEC", "PATHOLOGICAL_FORMATION", 76, 79], ["these studies", "TEST", 9, 22], ["isolated perforation", "PROBLEM", 51, 71], ["NEC", "PROBLEM", 76, 79], ["perforation", "OBSERVATION", 60, 71], ["NEC", "OBSERVATION", 76, 79]]], ["120 Neither of these two trials reached the recruitment target nor showed improved survival from PPD or laparotomy.", [["laparotomy", "TREATMENT", 104, 114], ["laparotomy", "OBSERVATION", 104, 114]]], ["One of these two trials [Necrotizing Enterocolitis Trial (NET) from the United Kingdom] found that 74% of infants initially treated with PPD required a rescue laparotomy.", [["Necrotizing Enterocolitis", "DISEASE", 25, 50], ["infants", "ORGANISM", 106, 113], ["infants", "SPECIES", 106, 113], ["Necrotizing Enterocolitis", "PROBLEM", 25, 50], ["PPD", "PROBLEM", 137, 140], ["a rescue laparotomy", "TREATMENT", 150, 169], ["Necrotizing", "OBSERVATION_MODIFIER", 25, 36], ["Enterocolitis", "OBSERVATION", 37, 50], ["laparotomy", "OBSERVATION", 159, 169]]], ["The second NICHD NRN trial did not encourage rescue laparotomy (which nonetheless was allowed) and did not distinguish NEC from isolated intestinal perforation (IIP).", [["intestinal", "ANATOMY", 137, 147], ["NEC", "DISEASE", 119, 122], ["intestinal perforation", "DISEASE", 137, 159], ["IIP", "DISEASE", 161, 164], ["intestinal", "ORGAN", 137, 147], ["rescue laparotomy", "TREATMENT", 45, 62], ["NEC", "PROBLEM", 119, 122], ["isolated intestinal perforation", "PROBLEM", 128, 159], ["intestinal", "ANATOMY", 137, 147], ["perforation", "OBSERVATION", 148, 159]]], ["[117] [118] [119] This latter trial, conducted in extremely low birth weight infants ( 1000 g), found that laparotomy had an advantage over PPD with respect to the likelihood of survival and better neurodevelopmental outcome at 18 to 22 months of age.", [["infants", "SPECIES", 77, 84], ["laparotomy", "TREATMENT", 107, 117], ["laparotomy", "OBSERVATION", 107, 117]]], ["120 Death or impairment occurred in 78% of the drainage group and in 66% of the laparotomy group.SurgicalThe ability to accurately distinguish NEC from IIP is important when making a comparison between PPD and laparotomy because mortality associated with NEC is greater than with IIP.", [["Death", "DISEASE", 4, 9], ["NEC", "DISEASE", 143, 146], ["IIP", "DISEASE", 152, 155], ["NEC", "DISEASE", 255, 258], ["NEC", "CANCER", 143, 146], ["impairment", "PROBLEM", 13, 23], ["the drainage group", "TREATMENT", 43, 61], ["the laparotomy group", "TREATMENT", 76, 96], ["Surgical", "TREATMENT", 97, 105], ["NEC", "PROBLEM", 143, 146], ["PPD", "TEST", 202, 205], ["laparotomy", "TREATMENT", 210, 220], ["mortality", "PROBLEM", 229, 238], ["NEC", "PROBLEM", 255, 258], ["impairment", "OBSERVATION", 13, 23], ["laparotomy", "OBSERVATION", 80, 90], ["NEC", "OBSERVATION", 143, 146], ["IIP", "OBSERVATION", 152, 155], ["laparotomy", "OBSERVATION", 210, 220], ["NEC", "OBSERVATION", 255, 258], ["greater", "OBSERVATION_MODIFIER", 262, 269]]], ["120,121 A large, single-center, prospective study showed that bowel perforation in infants with severe NEC who were treated with primary laparotomy fared better than infants treated with a PPD.", [["bowel", "ANATOMY", 62, 67], ["bowel perforation", "DISEASE", 62, 79], ["NEC", "DISEASE", 103, 106], ["bowel", "ORGAN", 62, 67], ["infants", "ORGANISM", 83, 90], ["infants", "ORGANISM", 166, 173], ["infants", "SPECIES", 83, 90], ["infants", "SPECIES", 166, 173], ["prospective study", "TEST", 32, 49], ["bowel perforation", "PROBLEM", 62, 79], ["severe NEC", "PROBLEM", 96, 106], ["primary laparotomy", "TREATMENT", 129, 147], ["a PPD", "TREATMENT", 187, 192], ["large", "OBSERVATION_MODIFIER", 10, 15], ["bowel", "ANATOMY", 62, 67], ["perforation", "OBSERVATION", 68, 79], ["severe", "OBSERVATION_MODIFIER", 96, 102], ["NEC", "OBSERVATION", 103, 106], ["laparotomy", "OBSERVATION", 137, 147]]], ["100, 121, 122 Conversely, infants with IIP fared better with PPD.", [["IIP", "DISEASE", 39, 42], ["infants", "ORGANISM", 26, 33], ["infants", "SPECIES", 26, 33]]], ["These investigators devised the 7-point metabolic derangement score and used it in conjunction with ultrasonography or contrast imaging to distinguish NEC from IIP.SurgicalOther traditional surgical procedures at laparotomy include debridement and the resection of clearly necrotic bowel and creation of an enterostomy.", [["necrotic bowel", "ANATOMY", 273, 287], ["NEC", "DISEASE", 151, 154], ["IIP", "DISEASE", 160, 163], ["necrotic", "DISEASE", 273, 281], ["NEC", "PATHOLOGICAL_FORMATION", 151, 154], ["bowel", "ORGAN", 282, 287], ["ultrasonography", "TEST", 100, 115], ["contrast imaging", "TEST", 119, 135], ["NEC from IIP", "PROBLEM", 151, 163], ["SurgicalOther traditional surgical procedures", "TREATMENT", 164, 209], ["laparotomy", "TREATMENT", 213, 223], ["debridement", "TREATMENT", 232, 243], ["the resection", "TREATMENT", 248, 261], ["clearly necrotic bowel", "PROBLEM", 265, 287], ["an enterostomy", "TREATMENT", 304, 318], ["surgical", "OBSERVATION", 190, 198], ["laparotomy", "OBSERVATION", 213, 223], ["debridement", "OBSERVATION", 232, 243], ["resection", "OBSERVATION", 252, 261], ["necrotic", "OBSERVATION_MODIFIER", 273, 281], ["bowel", "ANATOMY", 282, 287], ["enterostomy", "OBSERVATION", 307, 318]]], ["113, 120, 121 Sometimes multiple excisions are needed to preserve bowel length.", [["bowel", "ANATOMY", 66, 71], ["bowel", "ORGAN", 66, 71], ["multiple excisions", "TREATMENT", 24, 42], ["excisions", "OBSERVATION", 33, 42], ["bowel", "ANATOMY", 66, 71], ["length", "OBSERVATION_MODIFIER", 72, 78]]], ["Viable ends of bowel are exteriorized as stomas with the distal end as a mucous fistula.", [["bowel", "ANATOMY", 15, 20], ["stomas", "ANATOMY", 41, 47], ["mucous fistula", "ANATOMY", 73, 87], ["mucous fistula", "DISEASE", 73, 87], ["bowel", "ORGAN", 15, 20], ["stomas", "PATHOLOGICAL_FORMATION", 41, 47], ["mucous fistula", "PATHOLOGICAL_FORMATION", 73, 87], ["a mucous fistula", "PROBLEM", 71, 87], ["bowel", "ANATOMY", 15, 20], ["exteriorized", "OBSERVATION", 25, 37], ["stomas", "OBSERVATION", 41, 47], ["distal", "OBSERVATION_MODIFIER", 57, 63], ["end", "OBSERVATION_MODIFIER", 64, 67], ["mucous", "ANATOMY", 73, 79], ["fistula", "OBSERVATION", 80, 87]]], ["Sometimes single stoma with a Hartmann pouch is created.", [["stoma", "ANATOMY", 17, 22], ["stoma", "PATHOLOGICAL_FORMATION", 17, 22], ["a Hartmann pouch", "TREATMENT", 28, 44], ["stoma", "OBSERVATION", 17, 22], ["Hartmann pouch", "OBSERVATION", 30, 44]]], ["In this procedure, a colostomy or ileostomy is created and the distal limb is closed by suturing it and placing it back in the peritoneal cavity as a temporary measure until the patient is ready for re-anastomosis.", [["distal limb", "ANATOMY", 63, 74], ["peritoneal cavity", "ANATOMY", 127, 144], ["distal limb", "ORGANISM_SUBDIVISION", 63, 74], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 127, 144], ["patient", "ORGANISM", 178, 185], ["patient", "SPECIES", 178, 185], ["this procedure", "TREATMENT", 3, 17], ["a colostomy", "TREATMENT", 19, 30], ["ileostomy", "TREATMENT", 34, 43], ["suturing", "TREATMENT", 88, 96], ["a temporary measure", "TREATMENT", 148, 167], ["re-anastomosis", "TREATMENT", 199, 213], ["colostomy", "OBSERVATION", 21, 30], ["ileostomy", "OBSERVATION", 34, 43], ["distal", "ANATOMY_MODIFIER", 63, 69], ["limb", "ANATOMY", 70, 74], ["closed", "OBSERVATION", 78, 84], ["suturing", "OBSERVATION", 88, 96], ["peritoneal", "ANATOMY", 127, 137], ["cavity", "OBSERVATION", 138, 144]]], ["110, 113, 123 PATHOLOGY Coagulation (hemorrhagic-ischemic) necrosis, inflammation, and bacterial overgrowth are salient features of the histopathology of NEC.", [["NEC", "ANATOMY", 154, 157], ["hemorrhagic", "DISEASE", 37, 48], ["necrosis", "DISEASE", 59, 67], ["inflammation", "DISEASE", 69, 81], ["bacterial overgrowth", "DISEASE", 87, 107], ["NEC", "DISEASE", 154, 157], ["NEC", "PATHOLOGICAL_FORMATION", 154, 157], ["PATHOLOGY Coagulation", "TEST", 14, 35], ["hemorrhagic-ischemic) necrosis", "PROBLEM", 37, 67], ["inflammation", "PROBLEM", 69, 81], ["bacterial overgrowth", "PROBLEM", 87, 107], ["NEC", "PROBLEM", 154, 157], ["hemorrhagic", "OBSERVATION_MODIFIER", 37, 48], ["ischemic", "OBSERVATION_MODIFIER", 49, 57], ["necrosis", "OBSERVATION", 59, 67], ["inflammation", "OBSERVATION", 69, 81], ["bacterial", "OBSERVATION_MODIFIER", 87, 96], ["overgrowth", "OBSERVATION", 97, 107], ["NEC", "OBSERVATION", 154, 157]]], ["Reparative tissue changes, such as epithelial regeneration, formation of granulation tissue, and fibrosis, are found in twothirds of cases and provide evidence for a duration of tissue injury/reparation processes of at least several days.", [["tissue", "ANATOMY", 11, 17], ["epithelial", "ANATOMY", 35, 45], ["granulation tissue", "ANATOMY", 73, 91], ["tissue", "ANATOMY", 178, 184], ["fibrosis", "DISEASE", 97, 105], ["tissue", "TISSUE", 11, 17], ["epithelial", "TISSUE", 35, 45], ["granulation tissue", "TISSUE", 73, 91], ["tissue", "TISSUE", 178, 184], ["Reparative tissue changes", "PROBLEM", 0, 25], ["epithelial regeneration", "PROBLEM", 35, 58], ["granulation tissue", "PROBLEM", 73, 91], ["fibrosis", "PROBLEM", 97, 105], ["tissue injury", "PROBLEM", 178, 191], ["tissue", "OBSERVATION", 11, 17], ["epithelial regeneration", "OBSERVATION", 35, 58], ["granulation tissue", "OBSERVATION", 73, 91], ["fibrosis", "OBSERVATION", 97, 105], ["tissue", "ANATOMY", 178, 184], ["injury", "OBSERVATION", 185, 191]]], ["124, 125 Damage to the intestinal tract may range from mucosal injury to full-thickness necrosis with focal perforation.", [["intestinal tract", "ANATOMY", 23, 39], ["mucosal", "ANATOMY", 55, 62], ["necrosis", "DISEASE", 88, 96], ["perforation", "DISEASE", 108, 119], ["intestinal tract", "ORGANISM_SUBDIVISION", 23, 39], ["mucosal", "ORGAN", 55, 62], ["Damage to the intestinal tract", "PROBLEM", 9, 39], ["mucosal injury", "PROBLEM", 55, 69], ["full-thickness necrosis", "PROBLEM", 73, 96], ["focal perforation", "PROBLEM", 102, 119], ["intestinal tract", "ANATOMY", 23, 39], ["mucosal", "ANATOMY", 55, 62], ["injury", "OBSERVATION", 63, 69], ["full-thickness", "OBSERVATION_MODIFIER", 73, 87], ["necrosis", "OBSERVATION", 88, 96], ["focal", "OBSERVATION_MODIFIER", 102, 107], ["perforation", "OBSERVATION", 108, 119]]], ["Gas bubbles (pneumatosis intestinalis) can be seen in mucosa, submucosa, and serosal surfaces (Fig. 12) .", [["mucosa", "ANATOMY", 54, 60], ["submucosa", "ANATOMY", 62, 71], ["serosal surfaces", "ANATOMY", 77, 93], ["pneumatosis intestinalis", "DISEASE", 13, 37], ["mucosa", "MULTI-TISSUE_STRUCTURE", 54, 60], ["submucosa", "MULTI-TISSUE_STRUCTURE", 62, 71], ["serosal surfaces", "TISSUE", 77, 93], ["Gas bubbles (pneumatosis intestinalis", "PROBLEM", 0, 37], ["bubbles", "OBSERVATION_MODIFIER", 4, 11], ["pneumatosis intestinalis", "OBSERVATION", 13, 37], ["mucosa", "ANATOMY", 54, 60], ["submucosa", "ANATOMY", 62, 71], ["serosal", "ANATOMY_MODIFIER", 77, 84], ["surfaces", "OBSERVATION_MODIFIER", 85, 93]]], ["125 Although NEC can involve the gut from the stomach to the distal colon (NEC totalis), disease is most commonly found in the terminal ileum and ascending colon.", [["gut", "ANATOMY", 33, 36], ["stomach", "ANATOMY", 46, 53], ["distal colon", "ANATOMY", 61, 73], ["NEC totalis", "ANATOMY", 75, 86], ["terminal ileum", "ANATOMY", 127, 141], ["ascending colon", "ANATOMY", 146, 161], ["NEC", "DISEASE", 13, 16], ["NEC totalis", "DISEASE", 75, 86], ["NEC", "CANCER", 13, 16], ["gut", "ORGANISM_SUBDIVISION", 33, 36], ["stomach", "ORGAN", 46, 53], ["distal colon", "ORGAN", 61, 73], ["ileum", "MULTI-TISSUE_STRUCTURE", 136, 141], ["colon", "ORGAN", 156, 161], ["NEC", "PROBLEM", 13, 16], ["disease", "PROBLEM", 89, 96], ["NEC", "OBSERVATION", 13, 16], ["stomach", "ANATOMY", 46, 53], ["distal", "ANATOMY_MODIFIER", 61, 67], ["colon", "ANATOMY", 68, 73], ["terminal", "ANATOMY_MODIFIER", 127, 135], ["ileum", "ANATOMY", 136, 141], ["ascending", "ANATOMY_MODIFIER", 146, 155], ["colon", "ANATOMY", 156, 161]]], ["Rotavirus-associated NEC most often involves the distal colon.", [["NEC", "ANATOMY", 21, 24], ["distal colon", "ANATOMY", 49, 61], ["Rotavirus", "DISEASE", 0, 9], ["NEC", "DISEASE", 21, 24], ["Rotavirus", "ORGANISM", 0, 9], ["NEC", "PATHOLOGICAL_FORMATION", 21, 24], ["colon", "ORGAN", 56, 61], ["Rotavirus-associated NEC", "PROBLEM", 0, 24], ["NEC", "OBSERVATION", 21, 24], ["distal", "ANATOMY_MODIFIER", 49, 55], ["colon", "ANATOMY", 56, 61]]], ["75 NEC can cause focal disease or manifest as multiple large diffuse necrotic areas alternating with patches of unaffected bowel.", [["bowel", "ANATOMY", 123, 128], ["NEC", "DISEASE", 3, 6], ["necrotic", "DISEASE", 69, 77], ["bowel", "ORGAN", 123, 128], ["NEC", "PROBLEM", 3, 6], ["focal disease", "PROBLEM", 17, 30], ["multiple large diffuse necrotic areas", "PROBLEM", 46, 83], ["unaffected bowel", "PROBLEM", 112, 128], ["focal", "OBSERVATION_MODIFIER", 17, 22], ["disease", "OBSERVATION", 23, 30], ["multiple", "OBSERVATION_MODIFIER", 46, 54], ["large", "OBSERVATION_MODIFIER", 55, 60], ["diffuse", "OBSERVATION_MODIFIER", 61, 68], ["necrotic", "OBSERVATION_MODIFIER", 69, 77], ["areas", "OBSERVATION", 78, 83], ["unaffected", "OBSERVATION", 112, 122], ["bowel", "ANATOMY", 123, 128]]], ["Serosal exudation without obvious perforation can also occur.", [["perforation", "DISEASE", 34, 45], ["Serosal exudation", "PROBLEM", 0, 17], ["obvious perforation", "PROBLEM", 26, 45], ["exudation", "OBSERVATION", 8, 17], ["without", "UNCERTAINTY", 18, 25], ["obvious", "OBSERVATION_MODIFIER", 26, 33], ["perforation", "OBSERVATION", 34, 45]]], ["In mild stages of NEC, intense congestion of superficial mucosa can result in focal necrosis of villous tips and epithelial sloughing into bowel lumen.", [["NEC", "ANATOMY", 18, 21], ["superficial mucosa", "ANATOMY", 45, 63], ["villous tips", "ANATOMY", 96, 108], ["epithelial", "ANATOMY", 113, 123], ["bowel lumen", "ANATOMY", 139, 150], ["NEC", "DISEASE", 18, 21], ["necrosis", "DISEASE", 84, 92], ["NEC", "PATHOLOGICAL_FORMATION", 18, 21], ["mucosa", "MULTI-TISSUE_STRUCTURE", 57, 63], ["villous tips", "TISSUE", 96, 108], ["epithelial", "TISSUE", 113, 123], ["bowel lumen", "MULTI-TISSUE_STRUCTURE", 139, 150], ["NEC", "PROBLEM", 18, 21], ["intense congestion of superficial mucosa", "PROBLEM", 23, 63], ["focal necrosis of villous tips", "PROBLEM", 78, 108], ["epithelial sloughing into bowel lumen", "PROBLEM", 113, 150], ["mild", "OBSERVATION_MODIFIER", 3, 7], ["stages", "OBSERVATION_MODIFIER", 8, 14], ["NEC", "OBSERVATION", 18, 21], ["intense", "OBSERVATION_MODIFIER", 23, 30], ["congestion", "OBSERVATION", 31, 41], ["superficial mucosa", "ANATOMY", 45, 63], ["focal", "OBSERVATION_MODIFIER", 78, 83], ["necrosis", "OBSERVATION", 84, 92], ["villous tips", "OBSERVATION", 96, 108], ["epithelial", "ANATOMY_MODIFIER", 113, 123], ["sloughing", "OBSERVATION", 124, 133], ["bowel", "ANATOMY", 139, 144], ["lumen", "ANATOMY_MODIFIER", 145, 150]]], ["124, 125 NEC: Past, Present, and FutureDIFFERENTIAL DIAGNOSIS IIPIt is more common for extremely premature infants with NEC to develop pneumoperitoneum than pneumatosis.", [["NEC", "DISEASE", 120, 123], ["pneumoperitoneum", "DISEASE", 135, 151], ["pneumatosis", "DISEASE", 157, 168], ["infants", "ORGANISM", 107, 114], ["infants", "SPECIES", 107, 114], ["extremely premature infants", "PROBLEM", 87, 114], ["NEC", "PROBLEM", 120, 123], ["pneumoperitoneum", "PROBLEM", 135, 151], ["pneumatosis", "PROBLEM", 157, 168], ["pneumoperitoneum", "OBSERVATION", 135, 151], ["pneumatosis", "OBSERVATION", 157, 168]]], ["7 This population is also more vulnerable to IIP.", [["IIP", "DISEASE", 45, 48], ["more vulnerable", "OBSERVATION_MODIFIER", 26, 41]]], ["Infants with IIP are generally more stable but they can develop peritonitis and sepsis syndrome mimicking NEC.", [["IIP", "DISEASE", 13, 16], ["peritonitis", "DISEASE", 64, 75], ["sepsis", "DISEASE", 80, 86], ["NEC", "DISEASE", 106, 109], ["Infants", "ORGANISM", 0, 7], ["NEC", "PATHOLOGICAL_FORMATION", 106, 109], ["Infants", "SPECIES", 0, 7], ["peritonitis", "PROBLEM", 64, 75], ["sepsis syndrome", "PROBLEM", 80, 95], ["NEC", "PROBLEM", 106, 109], ["peritonitis", "OBSERVATION", 64, 75], ["sepsis", "OBSERVATION", 80, 86]]], ["25, 100, 102 Generally, IIP presents during the first week of life and has been commonly associated with early indocin prophylaxis against intraventricular hemorrhage or patent ductus arteriosus ( Table 1) .", [["intraventricular", "ANATOMY", 139, 155], ["IIP", "DISEASE", 24, 27], ["indocin", "CHEMICAL", 111, 118], ["intraventricular hemorrhage", "DISEASE", 139, 166], ["patent ductus arteriosus", "DISEASE", 170, 194], ["indocin", "CHEMICAL", 111, 118], ["indocin", "SIMPLE_CHEMICAL", 111, 118], ["ductus arteriosus", "MULTI-TISSUE_STRUCTURE", 177, 194], ["early indocin prophylaxis", "TREATMENT", 105, 130], ["intraventricular hemorrhage", "PROBLEM", 139, 166], ["patent ductus arteriosus", "PROBLEM", 170, 194], ["hemorrhage", "OBSERVATION", 156, 166], ["patent", "OBSERVATION", 170, 176], ["ductus arteriosus", "ANATOMY", 177, 194]]], ["25 Pathologically IIP is a focal perforation without an inflammatory component.", [["IIP", "DISEASE", 18, 21], ["a focal perforation", "PROBLEM", 25, 44], ["an inflammatory component", "PROBLEM", 53, 78], ["Pathologically", "OBSERVATION_MODIFIER", 3, 17], ["IIP", "OBSERVATION", 18, 21], ["focal", "OBSERVATION_MODIFIER", 27, 32], ["perforation", "OBSERVATION", 33, 44], ["without", "UNCERTAINTY", 45, 52], ["inflammatory", "OBSERVATION_MODIFIER", 56, 68]]], ["It is not associated with feeding and does not present as hemorrhagic ischemic necrosis.", [["hemorrhagic", "DISEASE", 58, 69], ["necrosis", "DISEASE", 79, 87], ["hemorrhagic ischemic necrosis", "PROBLEM", 58, 87], ["not associated with", "UNCERTAINTY", 6, 25], ["hemorrhagic", "OBSERVATION_MODIFIER", 58, 69], ["ischemic", "OBSERVATION_MODIFIER", 70, 78], ["necrosis", "OBSERVATION", 79, 87]]], ["25 In contrast with the multifactorial pathogenesis of NEC, IIP usually develops suddenly without clinical evidence of intestinal inflammation.", [["NEC", "ANATOMY", 55, 58], ["intestinal", "ANATOMY", 119, 129], ["NEC", "DISEASE", 55, 58], ["IIP", "DISEASE", 60, 63], ["intestinal inflammation", "DISEASE", 119, 142], ["NEC", "PATHOLOGICAL_FORMATION", 55, 58], ["intestinal", "ORGAN", 119, 129], ["NEC", "PROBLEM", 55, 58], ["intestinal inflammation", "PROBLEM", 119, 142], ["multifactorial", "OBSERVATION_MODIFIER", 24, 38], ["NEC", "OBSERVATION", 55, 58], ["evidence of", "UNCERTAINTY", 107, 118], ["intestinal", "ANATOMY", 119, 129], ["inflammation", "OBSERVATION", 130, 142]]], ["25 The propensity for these focal lesions to occur in the watershed areas of terminal ileum or jejunum supports the theory of arterial occlusion with embolism.", [["focal lesions", "ANATOMY", 28, 41], ["terminal ileum", "ANATOMY", 77, 91], ["jejunum", "ANATOMY", 95, 102], ["arterial", "ANATOMY", 126, 134], ["arterial occlusion", "DISEASE", 126, 144], ["embolism", "DISEASE", 150, 158], ["focal lesions", "PATHOLOGICAL_FORMATION", 28, 41], ["ileum", "MULTI-TISSUE_STRUCTURE", 86, 91], ["jejunum", "MULTI-TISSUE_STRUCTURE", 95, 102], ["arterial", "MULTI-TISSUE_STRUCTURE", 126, 134], ["these focal lesions", "PROBLEM", 22, 41], ["arterial occlusion", "PROBLEM", 126, 144], ["embolism", "PROBLEM", 150, 158], ["focal", "OBSERVATION_MODIFIER", 28, 33], ["lesions", "OBSERVATION", 34, 41], ["watershed", "ANATOMY_MODIFIER", 58, 67], ["terminal", "ANATOMY_MODIFIER", 77, 85], ["ileum", "ANATOMY", 86, 91], ["jejunum", "ANATOMY", 95, 102], ["arterial", "ANATOMY", 126, 134], ["occlusion", "OBSERVATION", 135, 144], ["embolism", "OBSERVATION", 150, 158]]], ["25, [126] [127] [128] Arterial rectae are end arteries that supply intestinal villi.", [["Arterial rectae", "ANATOMY", 22, 37], ["end arteries", "ANATOMY", 42, 54], ["intestinal villi", "ANATOMY", 67, 83], ["[126] [127] [128] Arterial rectae", "SIMPLE_CHEMICAL", 4, 37], ["arteries", "MULTI-TISSUE_STRUCTURE", 46, 54], ["intestinal villi", "MULTI-TISSUE_STRUCTURE", 67, 83], ["Arterial rectae", "TEST", 22, 37], ["arteries", "ANATOMY", 46, 54], ["intestinal villi", "ANATOMY", 67, 83]]], ["[126] [127] [128] Persistence of right to left shunt through a patent foramen ovale or PDA during the early critical postnatal period presents a scenario for arterial embolism that potentially can create lesions similar to IIP, especially when these lesions occur near the antimesenteric border.", [["arterial", "ANATOMY", 158, 166], ["lesions", "ANATOMY", 204, 211], ["lesions", "ANATOMY", 250, 257], ["antimesenteric border", "ANATOMY", 273, 294], ["patent foramen ovale", "DISEASE", 63, 83], ["arterial embolism", "DISEASE", 158, 175], ["IIP", "DISEASE", 223, 226], ["arterial", "MULTI-TISSUE_STRUCTURE", 158, 166], ["lesions", "PATHOLOGICAL_FORMATION", 204, 211], ["lesions", "PATHOLOGICAL_FORMATION", 250, 257], ["right to left shunt", "TREATMENT", 33, 52], ["a patent foramen ovale", "PROBLEM", 61, 83], ["PDA", "PROBLEM", 87, 90], ["arterial embolism", "PROBLEM", 158, 175], ["lesions", "PROBLEM", 204, 211], ["these lesions", "PROBLEM", 244, 257], ["right", "ANATOMY_MODIFIER", 33, 38], ["left", "ANATOMY_MODIFIER", 42, 46], ["shunt", "OBSERVATION", 47, 52], ["patent", "OBSERVATION", 63, 69], ["foramen", "ANATOMY_MODIFIER", 70, 77], ["ovale", "OBSERVATION", 78, 83], ["PDA", "OBSERVATION", 87, 90], ["arterial", "ANATOMY", 158, 166], ["embolism", "OBSERVATION", 167, 175], ["lesions", "OBSERVATION", 204, 211], ["lesions", "OBSERVATION", 250, 257], ["antimesenteric", "ANATOMY_MODIFIER", 273, 287], ["border", "ANATOMY_MODIFIER", 288, 294]]], ["25SepsisSepsis can masquerade in a manner similar to NEC.", [["25SepsisSepsis", "CHEMICAL", 0, 14], ["NEC", "DISEASE", 53, 56], ["NEC", "PATHOLOGICAL_FORMATION", 53, 56], ["NEC", "PROBLEM", 53, 56], ["NEC", "OBSERVATION", 53, 56]]], ["6 Many intestinal and systemic signs of sepsis also are characteristic of NEC.", [["intestinal", "ANATOMY", 7, 17], ["sepsis", "DISEASE", 40, 46], ["NEC", "DISEASE", 74, 77], ["intestinal", "ORGAN", 7, 17], ["NEC", "PATHOLOGICAL_FORMATION", 74, 77], ["sepsis", "PROBLEM", 40, 46], ["NEC", "PROBLEM", 74, 77], ["intestinal", "ANATOMY", 7, 17], ["systemic", "OBSERVATION_MODIFIER", 22, 30], ["sepsis", "OBSERVATION", 40, 46], ["NEC", "OBSERVATION", 74, 77]]], ["Specifically, ileus, hypotension, respiratory deterioration, thrombocytopenia, metabolic acidosis, left shift of neutrophils and neutropenia, and systemic inflammatory response syndrome (SIRS) also occur with septic shock unaccompanied by intestinal inflammation.", [["respiratory", "ANATOMY", 34, 45], ["neutrophils", "ANATOMY", 113, 124], ["intestinal", "ANATOMY", 239, 249], ["ileus", "DISEASE", 14, 19], ["hypotension", "DISEASE", 21, 32], ["respiratory deterioration", "DISEASE", 34, 59], ["thrombocytopenia", "DISEASE", 61, 77], ["metabolic acidosis", "DISEASE", 79, 97], ["neutropenia", "DISEASE", 129, 140], ["systemic inflammatory response syndrome", "DISEASE", 146, 185], ["SIRS", "DISEASE", 187, 191], ["septic shock", "DISEASE", 209, 221], ["intestinal inflammation", "DISEASE", 239, 262], ["neutrophils", "CELL", 113, 124], ["intestinal", "ORGAN", 239, 249], ["neutrophils", "CELL_TYPE", 113, 124], ["ileus", "PROBLEM", 14, 19], ["hypotension", "PROBLEM", 21, 32], ["respiratory deterioration", "PROBLEM", 34, 59], ["thrombocytopenia", "PROBLEM", 61, 77], ["metabolic acidosis", "PROBLEM", 79, 97], ["left shift of neutrophils", "PROBLEM", 99, 124], ["neutropenia", "PROBLEM", 129, 140], ["systemic inflammatory response syndrome", "PROBLEM", 146, 185], ["SIRS", "PROBLEM", 187, 191], ["septic shock", "PROBLEM", 209, 221], ["intestinal inflammation", "PROBLEM", 239, 262], ["ileus", "OBSERVATION", 14, 19], ["hypotension", "OBSERVATION", 21, 32], ["respiratory deterioration", "OBSERVATION", 34, 59], ["thrombocytopenia", "OBSERVATION", 61, 77], ["metabolic acidosis", "OBSERVATION", 79, 97], ["left", "ANATOMY_MODIFIER", 99, 103], ["neutrophils", "OBSERVATION", 113, 124], ["neutropenia", "OBSERVATION", 129, 140], ["systemic", "OBSERVATION_MODIFIER", 146, 154], ["inflammatory response syndrome", "OBSERVATION", 155, 185], ["septic shock", "OBSERVATION", 209, 221], ["intestinal", "ANATOMY", 239, 249], ["inflammation", "OBSERVATION", 250, 262]]], ["114 Although sepsis and SIRS are complications of NEC, it is important to exclude NEC as the underlying cause of sepsis.", [["sepsis", "DISEASE", 13, 19], ["SIRS", "DISEASE", 24, 28], ["NEC", "DISEASE", 50, 53], ["NEC", "DISEASE", 82, 85], ["sepsis", "DISEASE", 113, 119], ["NEC", "PATHOLOGICAL_FORMATION", 50, 53], ["NEC", "PATHOLOGICAL_FORMATION", 82, 85], ["sepsis", "PROBLEM", 13, 19], ["SIRS", "PROBLEM", 24, 28], ["NEC", "PROBLEM", 50, 53], ["NEC", "PROBLEM", 82, 85], ["sepsis", "PROBLEM", 113, 119], ["sepsis", "OBSERVATION", 13, 19], ["SIRS", "OBSERVATION", 24, 28], ["NEC", "OBSERVATION", 50, 53], ["sepsis", "OBSERVATION", 113, 119]]], ["The following two findings, if present, favor the diagnosis of NEC:SepsisNew-onset hyponatremia (<130 mEq/L) that cannot be explained by dilution or by treatment with diuretics (Generally, this finding appears early before significant clinical illness develops.)", [["NEC", "DISEASE", 63, 66], ["Sepsis", "DISEASE", 67, 73], ["hyponatremia", "DISEASE", 83, 95], ["illness", "DISEASE", 244, 251], ["diuretics", "SIMPLE_CHEMICAL", 167, 176], ["NEC", "PROBLEM", 63, 66], ["Sepsis", "PROBLEM", 67, 73], ["onset hyponatremia", "PROBLEM", 77, 95], ["diuretics", "TREATMENT", 167, 176], ["significant clinical illness", "PROBLEM", 223, 251], ["NEC", "OBSERVATION", 63, 66], ["Sepsis", "OBSERVATION", 67, 73], ["hyponatremia", "OBSERVATION", 83, 95]]], ["Hematochezia (blood in the stool, not occult blood) that may appear early in the disease process or later after resolution of ileusSepsisThe differential diagnosis also includes other causes of anatomic and functional intestinal obstruction (eg, malrotation, intestinal atresia, intussusceptions, aganglionosis); conditions that can result in intestinal ischemia (eg, volvulus, critical coarctation of the aorta, hypoplastic left heart syndrome); omphalitis; and milk protein intolerance.", [["blood", "ANATOMY", 14, 19], ["stool", "ANATOMY", 27, 32], ["blood", "ANATOMY", 45, 50], ["intestinal", "ANATOMY", 218, 228], ["intestinal", "ANATOMY", 259, 269], ["intestinal", "ANATOMY", 343, 353], ["aorta", "ANATOMY", 406, 411], ["hypoplastic left heart", "ANATOMY", 413, 435], ["Hematochezia", "DISEASE", 0, 12], ["ileus", "DISEASE", 126, 131], ["Sepsis", "DISEASE", 131, 137], ["intestinal obstruction", "DISEASE", 218, 240], ["malrotation", "DISEASE", 246, 257], ["intestinal atresia", "DISEASE", 259, 277], ["intussusceptions", "DISEASE", 279, 295], ["aganglionosis", "DISEASE", 297, 310], ["intestinal ischemia", "DISEASE", 343, 362], ["volvulus", "DISEASE", 368, 376], ["coarctation of the aorta", "DISEASE", 387, 411], ["hypoplastic left heart syndrome", "DISEASE", 413, 444], ["omphalitis", "DISEASE", 447, 457], ["milk protein intolerance", "DISEASE", 463, 487], ["blood", "ORGANISM_SUBSTANCE", 14, 19], ["stool", "ORGANISM_SUBDIVISION", 27, 32], ["blood", "ORGANISM_SUBSTANCE", 45, 50], ["intestinal", "ORGAN", 218, 228], ["intestinal", "ORGAN", 259, 269], ["intestinal", "ORGAN", 343, 353], ["aorta", "MULTI-TISSUE_STRUCTURE", 406, 411], ["heart", "ORGAN", 430, 435], ["milk", "ORGANISM_SUBSTANCE", 463, 467], ["Hematochezia (blood in the stool", "PROBLEM", 0, 32], ["occult blood", "PROBLEM", 38, 50], ["the disease process", "PROBLEM", 77, 96], ["ileusSepsis", "PROBLEM", 126, 137], ["anatomic and functional intestinal obstruction (eg", "PROBLEM", 194, 244], ["malrotation", "PROBLEM", 246, 257], ["intestinal atresia", "PROBLEM", 259, 277], ["intussusceptions", "PROBLEM", 279, 295], ["aganglionosis", "PROBLEM", 297, 310], ["intestinal ischemia (eg", "PROBLEM", 343, 366], ["volvulus", "PROBLEM", 368, 376], ["critical coarctation of the aorta", "PROBLEM", 378, 411], ["hypoplastic left heart syndrome", "PROBLEM", 413, 444], ["omphalitis", "PROBLEM", 447, 457], ["milk protein intolerance", "PROBLEM", 463, 487], ["stool", "ANATOMY", 27, 32], ["may appear", "UNCERTAINTY", 57, 67], ["early", "OBSERVATION_MODIFIER", 68, 73], ["disease", "OBSERVATION", 81, 88], ["ileus", "OBSERVATION_MODIFIER", 126, 131], ["Sepsis", "OBSERVATION", 131, 137], ["intestinal", "ANATOMY", 218, 228], ["obstruction", "OBSERVATION", 229, 240], ["intestinal", "ANATOMY", 259, 269], ["atresia", "OBSERVATION", 270, 277], ["aganglionosis", "OBSERVATION", 297, 310], ["intestinal", "ANATOMY", 343, 353], ["ischemia", "OBSERVATION", 354, 362], ["volvulus", "OBSERVATION", 368, 376], ["coarctation", "OBSERVATION", 387, 398], ["aorta", "ANATOMY", 406, 411], ["hypoplastic", "OBSERVATION", 413, 424], ["left", "ANATOMY_MODIFIER", 425, 429], ["heart", "ANATOMY", 430, 435], ["syndrome", "OBSERVATION", 436, 444], ["milk protein intolerance", "OBSERVATION", 463, 487]]], ["8, 9, 105OUTCOMES AND COMPLICATIONSThe overall mortality rate in NEC is between 20% and 40% but varies with the severity and extent of gut necrosis.", [["gut", "ANATOMY", 135, 138], ["NEC", "DISEASE", 65, 68], ["necrosis", "DISEASE", 139, 147], ["gut", "ORGANISM_SUBDIVISION", 135, 138], ["mortality rate", "TEST", 47, 61], ["NEC", "PROBLEM", 65, 68], ["the severity", "PROBLEM", 108, 120], ["gut necrosis", "PROBLEM", 135, 147], ["NEC", "OBSERVATION", 65, 68], ["gut", "ANATOMY", 135, 138], ["necrosis", "OBSERVATION", 139, 147]]], ["[129] [130] [131] Mortality is inversely related to PMA at birth.", [["PMA", "CHEMICAL", 52, 55], ["PMA", "CHEMICAL", 52, 55], ["PMA", "SIMPLE_CHEMICAL", 52, 55]]], ["6, 15 Other complications of NEC include intestinal strictures, enterocutaneous fistula, intra-abdominal abscess, cholestasis, and short-bowel syndrome.", [["intestinal", "ANATOMY", 41, 51], ["enterocutaneous fistula", "ANATOMY", 64, 87], ["intra-abdominal abscess", "ANATOMY", 89, 112], ["bowel", "ANATOMY", 137, 142], ["NEC", "DISEASE", 29, 32], ["intestinal strictures", "DISEASE", 41, 62], ["enterocutaneous fistula", "DISEASE", 64, 87], ["intra-abdominal abscess", "DISEASE", 89, 112], ["cholestasis", "DISEASE", 114, 125], ["short-bowel syndrome", "DISEASE", 131, 151], ["NEC", "PATHOLOGICAL_FORMATION", 29, 32], ["intestinal strictures", "PATHOLOGICAL_FORMATION", 41, 62], ["enterocutaneous fistula", "PATHOLOGICAL_FORMATION", 64, 87], ["intra-abdominal abscess", "PATHOLOGICAL_FORMATION", 89, 112], ["bowel", "ORGAN", 137, 142], ["NEC", "PROBLEM", 29, 32], ["intestinal strictures", "PROBLEM", 41, 62], ["enterocutaneous fistula", "PROBLEM", 64, 87], ["intra-abdominal abscess", "PROBLEM", 89, 112], ["cholestasis", "PROBLEM", 114, 125], ["short-bowel syndrome", "PROBLEM", 131, 151], ["NEC", "OBSERVATION", 29, 32], ["intestinal", "ANATOMY", 41, 51], ["strictures", "OBSERVATION", 52, 62], ["enterocutaneous fistula", "OBSERVATION", 64, 87], ["intra-abdominal", "ANATOMY", 89, 104], ["abscess", "OBSERVATION", 105, 112], ["cholestasis", "OBSERVATION", 114, 125], ["short", "OBSERVATION_MODIFIER", 131, 136], ["bowel", "ANATOMY", 137, 142], ["syndrome", "OBSERVATION", 143, 151]]], ["7, 130, 131 Intestinal and liver failure can also occur that requires transplantation.", [["Intestinal", "ANATOMY", 12, 22], ["liver", "ANATOMY", 27, 32], ["liver failure", "DISEASE", 27, 40], ["Intestinal", "MULTI-TISSUE_STRUCTURE", 12, 22], ["liver", "ORGAN", 27, 32], ["Intestinal and liver failure", "PROBLEM", 12, 40], ["transplantation", "TREATMENT", 70, 85], ["Intestinal", "ANATOMY", 12, 22], ["liver", "ANATOMY", 27, 32], ["failure", "OBSERVATION", 33, 40], ["transplantation", "OBSERVATION", 70, 85]]], ["Strictures typically occur 3 to 8 weeks after the acute episode but can also present several months later.", [["Strictures", "DISEASE", 0, 10], ["Strictures", "PROBLEM", 0, 10], ["the acute episode", "PROBLEM", 46, 63], ["3 to 8", "OBSERVATION_MODIFIER", 27, 33], ["acute", "OBSERVATION_MODIFIER", 50, 55], ["episode", "OBSERVATION", 56, 63]]], ["97 Contrast enema is indicated if signs of subacute intestinal obstruction appear several weeks after the acute episode of NEC.", [["intestinal", "ANATOMY", 52, 62], ["intestinal obstruction", "DISEASE", 52, 74], ["NEC", "DISEASE", 123, 126], ["intestinal obstruction", "PATHOLOGICAL_FORMATION", 52, 74], ["NEC", "PATHOLOGICAL_FORMATION", 123, 126], ["Contrast enema", "TREATMENT", 3, 17], ["subacute intestinal obstruction", "PROBLEM", 43, 74], ["NEC", "PROBLEM", 123, 126], ["subacute", "OBSERVATION_MODIFIER", 43, 51], ["intestinal", "ANATOMY", 52, 62], ["obstruction", "OBSERVATION", 63, 74], ["acute", "OBSERVATION_MODIFIER", 106, 111], ["NEC", "OBSERVATION", 123, 126]]], ["The colon is the most common site for stricture development, but strictures can also occur in the ileum or jejunum.", [["colon", "ANATOMY", 4, 9], ["site", "ANATOMY", 29, 33], ["stricture", "ANATOMY", 38, 47], ["strictures", "ANATOMY", 65, 75], ["ileum", "ANATOMY", 98, 103], ["jejunum", "ANATOMY", 107, 114], ["stricture", "DISEASE", 38, 47], ["strictures", "DISEASE", 65, 75], ["colon", "ORGAN", 4, 9], ["stricture", "PATHOLOGICAL_FORMATION", 38, 47], ["strictures", "PATHOLOGICAL_FORMATION", 65, 75], ["ileum", "MULTI-TISSUE_STRUCTURE", 98, 103], ["jejunum", "ORGAN", 107, 114], ["stricture development", "PROBLEM", 38, 59], ["strictures", "PROBLEM", 65, 75], ["colon", "ANATOMY", 4, 9], ["stricture", "OBSERVATION", 38, 47], ["strictures", "OBSERVATION", 65, 75], ["ileum", "ANATOMY", 98, 103], ["jejunum", "ANATOMY", 107, 114]]], ["97, 98 Diffuse pneumatosis increases the risk for strictures.", [["pneumatosis", "DISEASE", 15, 26], ["strictures", "DISEASE", 50, 60], ["strictures", "PATHOLOGICAL_FORMATION", 50, 60], ["Diffuse pneumatosis", "PROBLEM", 7, 26], ["strictures", "PROBLEM", 50, 60], ["Diffuse", "OBSERVATION_MODIFIER", 7, 14], ["pneumatosis", "OBSERVATION", 15, 26], ["strictures", "OBSERVATION", 50, 60]]], ["97, 98 Risks of all comorbidities of prematurity increase with NEC, including neurodevelopmental, motor, sensory, and cognitive problems.", [["prematurity", "DISEASE", 37, 48], ["NEC", "DISEASE", 63, 66], ["neurodevelopmental, motor, sensory, and cognitive problems", "DISEASE", 78, 136], ["all comorbidities of prematurity", "PROBLEM", 16, 48], ["NEC", "PROBLEM", 63, 66], ["neurodevelopmental, motor, sensory, and cognitive problems", "PROBLEM", 78, 136], ["prematurity", "OBSERVATION", 37, 48], ["NEC", "OBSERVATION", 63, 66]]], ["[129] [130] [131] [132] [133] [134]FUTURE DIRECTIONS PredictionThe prediction of infants at an increased risk of NEC may be possible in the future through the use of methods that are currently available at a few research facilities.", [["NEC", "DISEASE", 113, 116], ["[129] [130] [131] [132", "SIMPLE_CHEMICAL", 0, 22], ["infants", "ORGANISM", 81, 88], ["infants", "SPECIES", 81, 88], ["NEC", "PROBLEM", 113, 116], ["methods", "TREATMENT", 166, 173], ["NEC", "OBSERVATION", 113, 116], ["may be possible", "UNCERTAINTY", 117, 132]]], ["These methods use noninvasive indicators, such as profiling of the fecal microbiome, 55 and the identification of the expression of inflammatory proteins from buccal epithelium using buccal swab collection.", [["fecal microbiome", "ANATOMY", 67, 83], ["buccal epithelium", "ANATOMY", 159, 176], ["buccal swab", "ANATOMY", 183, 194], ["buccal epithelium", "TISSUE", 159, 176], ["buccal swab", "MULTI-TISSUE_STRUCTURE", 183, 194], ["inflammatory proteins", "PROTEIN", 132, 153], ["noninvasive indicators", "TEST", 18, 40], ["the fecal microbiome", "TEST", 63, 83], ["inflammatory proteins", "PROBLEM", 132, 153], ["buccal epithelium", "PROBLEM", 159, 176], ["buccal swab collection", "PROBLEM", 183, 205], ["fecal microbiome", "ANATOMY", 67, 83], ["inflammatory", "OBSERVATION_MODIFIER", 132, 144], ["buccal epithelium", "ANATOMY", 159, 176]]], ["135 The determination of oxidative stress by measuring concentrations of non-protein-bound iron, advanced oxidation protein products, and total hydroxides in cord blood has been reported to be useful in predicting which VP infants are at risk for NEC but requires additional validation.", [["cord blood", "ANATOMY", 158, 168], ["iron", "CHEMICAL", 91, 95], ["NEC", "DISEASE", 247, 250], ["iron", "CHEMICAL", 91, 95], ["hydroxides", "CHEMICAL", 144, 154], ["iron", "SIMPLE_CHEMICAL", 91, 95], ["cord blood", "ORGANISM_SUBSTANCE", 158, 168], ["VP", "ORGANISM", 220, 222], ["infants", "ORGANISM", 223, 230], ["advanced oxidation protein products", "PROTEIN", 97, 132], ["infants", "SPECIES", 223, 230], ["oxidative stress", "PROBLEM", 25, 41], ["non-protein-bound iron", "TREATMENT", 73, 95], ["advanced oxidation protein products", "TREATMENT", 97, 132], ["total hydroxides in cord blood", "TREATMENT", 138, 168], ["NEC", "PROBLEM", 247, 250], ["additional validation", "TREATMENT", 264, 285], ["NEC", "OBSERVATION", 247, 250]]], ["136Predisposing Factors and Management PlanningEarlier noninvasive diagnosis of NEC through the use of abdominal sonography in infants with nonspecific clinical and radiographic signs and through the assessment of metabolic derangement may result in more timely and appropriate medical treatment and surgical intervention.", [["abdominal", "ANATOMY", 103, 112], ["NEC", "DISEASE", 80, 83], ["metabolic derangement", "DISEASE", 214, 235], ["NEC", "PATHOLOGICAL_FORMATION", 80, 83], ["abdominal", "ORGANISM_SUBDIVISION", 103, 112], ["infants", "ORGANISM", 127, 134], ["infants", "SPECIES", 127, 134], ["Management", "TREATMENT", 28, 38], ["NEC", "PROBLEM", 80, 83], ["abdominal sonography", "TEST", 103, 123], ["radiographic signs", "TEST", 165, 183], ["the assessment", "TEST", 196, 210], ["metabolic derangement", "PROBLEM", 214, 235], ["appropriate medical treatment", "TREATMENT", 266, 295], ["surgical intervention", "TREATMENT", 300, 321], ["NEC", "OBSERVATION", 80, 83], ["abdominal", "ANATOMY", 103, 112], ["metabolic derangement", "OBSERVATION", 214, 235]]], ["107, 112 However, no studies have demonstrated improved clinical outcomes caused by facilitated diagnosis and management.", [["studies", "TEST", 21, 28], ["management", "TREATMENT", 110, 120]]], ["Future trials comparing outcomes of peritoneal drainage with laparotomy should include distinguishing NEC from IIP.", [["peritoneal", "ANATOMY", 36, 46], ["NEC", "DISEASE", 102, 105], ["IIP", "DISEASE", 111, 114], ["peritoneal", "MULTI-TISSUE_STRUCTURE", 36, 46], ["NEC", "PATHOLOGICAL_FORMATION", 102, 105], ["Future trials", "TREATMENT", 0, 13], ["peritoneal drainage", "TREATMENT", 36, 55], ["laparotomy", "TREATMENT", 61, 71], ["NEC from IIP", "PROBLEM", 102, 114], ["peritoneal", "ANATOMY", 36, 46], ["drainage", "OBSERVATION", 47, 55], ["laparotomy", "OBSERVATION", 61, 71], ["NEC", "OBSERVATION", 102, 105]]], ["100Perforation Versus NECClinical studies suggest that the isolated perforation occurs when the intestinal mucosa has been weakened by processes, such as local ischemia-reperfusion or thromboembolism.", [["intestinal mucosa", "ANATOMY", 96, 113], ["perforation", "DISEASE", 68, 79], ["thromboembolism", "DISEASE", 184, 199], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 96, 113], ["Perforation", "PROBLEM", 3, 14], ["NECClinical studies", "TEST", 22, 41], ["the isolated perforation", "PROBLEM", 55, 79], ["the intestinal mucosa", "PROBLEM", 92, 113], ["local ischemia-reperfusion", "PROBLEM", 154, 180], ["thromboembolism", "PROBLEM", 184, 199], ["isolated", "OBSERVATION_MODIFIER", 59, 67], ["perforation", "OBSERVATION", 68, 79], ["intestinal mucosa", "ANATOMY", 96, 113], ["weakened", "OBSERVATION", 123, 131], ["local", "OBSERVATION_MODIFIER", 154, 159], ["ischemia-reperfusion", "OBSERVATION", 160, 180], ["thromboembolism", "OBSERVATION", 184, 199]]], ["Conversely, NEC involves both infectious and inflammatory mechanisms.", [["NEC", "DISEASE", 12, 15], ["NEC", "PATHOLOGICAL_FORMATION", 12, 15], ["NEC", "PROBLEM", 12, 15], ["both infectious and inflammatory mechanisms", "PROBLEM", 25, 68], ["NEC", "OBSERVATION", 12, 15], ["both", "OBSERVATION_MODIFIER", 25, 29], ["infectious", "OBSERVATION", 30, 40], ["inflammatory", "OBSERVATION_MODIFIER", 45, 57]]], ["137 Designing strategies to prevent the occurrence of NEC and to improve outcomes of infants who develop NEC should consider these diagnoses as fundamentally different disease processes.", [["NEC", "DISEASE", 54, 57], ["NEC", "DISEASE", 105, 108], ["NEC", "CANCER", 54, 57], ["infants", "ORGANISM", 85, 92], ["infants", "SPECIES", 85, 92], ["NEC", "PROBLEM", 54, 57], ["NEC", "PROBLEM", 105, 108], ["fundamentally different disease processes", "PROBLEM", 144, 185], ["NEC", "OBSERVATION", 54, 57]]], ["The focus of NEC research is shifting from concentrating on the distinct nature of this disease to understanding the unique characteristics of immune-na\u00efve premature patients.", [["NEC", "DISEASE", 13, 16], ["patients", "ORGANISM", 166, 174], ["patients", "SPECIES", 166, 174], ["NEC research", "PROBLEM", 13, 25], ["this disease", "PROBLEM", 83, 95], ["immune-na\u00efve premature patients", "PROBLEM", 143, 174], ["focus", "OBSERVATION_MODIFIER", 4, 9], ["NEC", "OBSERVATION", 13, 16]]], ["Hence, investigative and interventional techniques aimed at ensuring a more appropriate and mature intestinal immune response should be tested as preventative strategies.", [["intestinal", "ANATOMY", 99, 109], ["intestinal", "ORGAN", 99, 109], ["interventional techniques", "TREATMENT", 25, 50], ["preventative strategies", "TREATMENT", 146, 169], ["intestinal", "ANATOMY", 99, 109]]]], "PMC7108345": [["BackgroundThe non-enveloped Saffold viruses are presently nine picornavirus genotypes assigned to the species Theilovirus, genus Cardiovirus.", [["non-enveloped", "ORGANISM", 14, 27], ["Saffold viruses", "ORGANISM", 28, 43], ["Saffold viruses", "SPECIES", 28, 43], ["The non-enveloped Saffold viruses", "PROBLEM", 10, 43], ["nine picornavirus genotypes", "PROBLEM", 58, 85], ["the species Theilovirus", "TEST", 98, 121], ["genus Cardiovirus", "PROBLEM", 123, 140], ["non-enveloped", "OBSERVATION_MODIFIER", 14, 27], ["Saffold viruses", "OBSERVATION", 28, 43]]], ["SAFV-1 was first defined in 2007 having been the putative cause of fever of unknown origin in a child in 1981.1 SAFVs include an approximately 8 kb positive-sense single-stranded RNA genome (Fig. 1).", [["fever", "DISEASE", 67, 72], ["SAFV-1", "GENE_OR_GENE_PRODUCT", 0, 6], ["SAFVs", "CANCER", 112, 117], ["SAFV", "PROTEIN", 0, 4], ["8 kb positive-sense single-stranded RNA genome", "DNA", 143, 189], ["child", "SPECIES", 96, 101], ["SAFV-1", "SPECIES", 0, 6], ["SAFV", "TEST", 0, 4], ["fever", "PROBLEM", 67, 72], ["fever", "OBSERVATION", 67, 72]]], ["Since the first definition, SAFV-2,2 SAFV-3,3 SAFV-4\u2013SAFV-84 and SAFV-95 have been described along with a suggestion that more genotypes remain to be characterised.6 Cell culture is in general known to be an inefficient method of routine virus detection but it can be used for study of SAFV.", [["Cell", "ANATOMY", 166, 170], ["SAFV-4\u2013SAFV-84", "CHEMICAL", 46, 60], ["SAFV-95", "CHEMICAL", 65, 72], ["SAFV", "GENE_OR_GENE_PRODUCT", 28, 32], ["SAFV-4", "ORGANISM", 46, 52], ["SAFV-84", "CELL", 53, 60], ["SAFV-95", "CELL", 65, 72], ["Cell", "CELL", 166, 170], ["SAFV", "CANCER", 286, 290], ["SAFV-2,2 SAFV-3,3 SAFV-4\u2013SAFV-84", "DNA", 28, 60], ["SAFV", "DNA", 65, 69], ["SAFV-95", "SPECIES", 65, 72], ["SAFV", "SPECIES", 286, 290], ["SAFV", "TEST", 28, 32], ["SAFV", "TEST", 37, 41], ["SAFV", "TEST", 46, 50], ["SAFV", "TEST", 53, 57], ["SAFV", "TEST", 65, 69], ["Cell culture", "TEST", 166, 178], ["routine virus detection", "TEST", 230, 253], ["SAFV", "PROBLEM", 286, 290]]], ["The SAFVs are predicted to encode a single polyprotein and in silico analysis suggest that a classical picornavirus post-translational proteolytic cleavage pattern ensues (Fig. 1).BackgroundMost SAFV genotypes have been identified from acute gastroenteritis (AGE) cases; only the SAFV-2 genotype was initially discovered in the airways; the nasopharynx of children with a common cold, otitis media and pneumonia.2 Interestingly, the distinctly respiratory human rhinoviruses (HRV) have also been found in the gut7, 8, 9 calling into question any automatic assumption that SAFVs are restricted to causing AGE just because they are found in stools.", [["airways", "ANATOMY", 328, 335], ["nasopharynx", "ANATOMY", 341, 352], ["acute gastroenteritis", "DISEASE", 236, 257], ["AGE", "DISEASE", 259, 262], ["otitis media", "DISEASE", 385, 397], ["pneumonia", "DISEASE", 402, 411], ["respiratory human rhinoviruses", "DISEASE", 444, 474], ["SAFVs", "GENE_OR_GENE_PRODUCT", 4, 9], ["SAFV", "GENE_OR_GENE_PRODUCT", 195, 199], ["SAFV-2", "GENE_OR_GENE_PRODUCT", 280, 286], ["airways", "MULTI-TISSUE_STRUCTURE", 328, 335], ["nasopharynx", "ORGAN", 341, 352], ["children", "ORGANISM", 356, 364], ["human", "ORGANISM", 456, 461], ["rhinoviruses", "ORGANISM", 462, 474], ["SAFVs", "SIMPLE_CHEMICAL", 572, 577], ["AGE", "SIMPLE_CHEMICAL", 604, 607], ["stools", "ORGANISM_SUBSTANCE", 639, 645], ["SAFVs", "DNA", 4, 9], ["children", "SPECIES", 356, 364], ["human", "SPECIES", 456, 461], ["human rhinoviruses", "SPECIES", 456, 474], ["a single polyprotein", "PROBLEM", 34, 54], ["silico analysis", "TEST", 62, 77], ["a classical picornavirus post-translational proteolytic cleavage pattern", "PROBLEM", 91, 163], ["BackgroundMost SAFV genotypes", "PROBLEM", 180, 209], ["acute gastroenteritis", "PROBLEM", 236, 257], ["the SAFV", "TEST", 276, 284], ["a common cold, otitis media", "PROBLEM", 370, 397], ["pneumonia", "PROBLEM", 402, 411], ["the distinctly respiratory human rhinoviruses", "PROBLEM", 429, 474], ["acute", "OBSERVATION_MODIFIER", 236, 241], ["gastroenteritis", "OBSERVATION", 242, 257], ["airways", "ANATOMY", 328, 335], ["nasopharynx", "ANATOMY", 341, 352], ["otitis", "OBSERVATION", 385, 391], ["pneumonia", "OBSERVATION", 402, 411], ["distinctly", "OBSERVATION_MODIFIER", 433, 443], ["respiratory human rhinoviruses", "OBSERVATION", 444, 474], ["stools", "OBSERVATION", 639, 645]]], ["Other SAFV detections have been made in the nasopharynx of patients with tonsillitis,10, 11 pharyngitis,11 herpangina11 and in cerebrospinal fluid specimens.12, 13, 14 These are often accompanied by fever, cough and rhinorrhoea.", [["nasopharynx", "ANATOMY", 44, 55], ["cerebrospinal fluid specimens", "ANATOMY", 127, 156], ["tonsillitis", "DISEASE", 73, 84], ["pharyngitis", "DISEASE", 92, 103], ["fever", "DISEASE", 199, 204], ["cough", "DISEASE", 206, 211], ["rhinorrhoea", "DISEASE", 216, 227], ["SAFV", "GENE_OR_GENE_PRODUCT", 6, 10], ["nasopharynx", "ORGAN", 44, 55], ["patients", "ORGANISM", 59, 67], ["cerebrospinal fluid specimens", "ORGANISM_SUBSTANCE", 127, 156], ["patients", "SPECIES", 59, 67], ["Other SAFV detections", "TEST", 0, 21], ["tonsillitis", "PROBLEM", 73, 84], ["11 pharyngitis", "PROBLEM", 89, 103], ["herpangina11", "TEST", 107, 119], ["cerebrospinal fluid specimens", "TEST", 127, 156], ["fever", "PROBLEM", 199, 204], ["cough", "PROBLEM", 206, 211], ["rhinorrhoea", "PROBLEM", 216, 227], ["nasopharynx", "ANATOMY", 44, 55], ["tonsillitis", "OBSERVATION", 73, 84], ["cerebrospinal fluid", "ANATOMY", 127, 146], ["fever", "OBSERVATION", 199, 204], ["cough", "OBSERVATION", 206, 211], ["rhinorrhoea", "OBSERVATION", 216, 227]]], ["Currently, SAFVs are described as orphan viruses lacking a consensus disease association15, 16 despite >90% of the population having serological evidence of past exposure.15 It is therefore important to examine a range of disease states for this ubiquitous virus, to establish a link between detection and illness.", [["illness", "DISEASE", 306, 313], ["SAFVs", "GENE_OR_GENE_PRODUCT", 11, 16], ["SAFVs", "PROTEIN", 11, 16], ["SAFVs", "PROBLEM", 11, 16], ["a consensus disease association15", "PROBLEM", 57, 90], ["this ubiquitous virus", "PROBLEM", 241, 262], ["illness", "PROBLEM", 306, 313]]], ["The first step is the development of assays that can detect viral variants and their implementation by others.ObjectivesWe sought to design are reverse transcriptase real-time PCR (RT-rtPCR), for application to respiratory tract specimens, that could concurrently detect all known SAFV genotypes with confirmation using a VP1-based conventional PCR genotyping assay.", [["respiratory tract specimens", "ANATOMY", 211, 238], ["SAFV", "GENE_OR_GENE_PRODUCT", 281, 285], ["reverse transcriptase", "PROTEIN", 144, 165], ["SAFV", "SPECIES", 281, 285], ["assays", "TEST", 37, 43], ["viral variants", "PROBLEM", 60, 74], ["PCR", "TEST", 176, 179], ["RT-rtPCR", "TEST", 181, 189], ["application to respiratory tract specimens", "TEST", 196, 238], ["all known SAFV genotypes", "PROBLEM", 271, 295], ["a VP1", "TEST", 320, 325], ["conventional PCR genotyping assay", "TEST", 332, 365], ["respiratory tract", "ANATOMY", 211, 228]]], ["Our diagnostic workflow may support enhanced epidemiology studies worldwide.RT-rtPCR screening assay and conventional genotyping RT-PCR assays ::: Study designWe developed a diagnostic assay targeting a portion of the 5\u2032 untranslated region (5\u2032 UTR) that is predicted to detect all SAFVs.", [["5\u2032 untranslated region", "DNA", 218, 240], ["5\u2032 UTR", "DNA", 242, 248], ["SAFVs", "DNA", 282, 287], ["RT-rtPCR screening assay", "TEST", 76, 100], ["conventional genotyping RT-PCR assays", "TEST", 105, 142], ["a diagnostic assay", "TEST", 172, 190]]], ["Its design was based on all publicly available 5\u2032 UTR sequences (alignments included known SAFV-1, 2, 3, 5, 6 genotypes and a range of unclassified SAFV sequences prepared in Geneious Pro 5.6.", [["SAFV-1", "GENE_OR_GENE_PRODUCT", 91, 97], ["3", "GENE_OR_GENE_PRODUCT", 102, 103], ["UTR sequences", "DNA", 50, 63], ["SAFV", "DNA", 91, 95], ["SAFV sequences", "DNA", 148, 162], ["UTR sequences", "TEST", 50, 63], ["known SAFV", "TEST", 85, 95], ["unclassified SAFV sequences", "TEST", 135, 162]]], ["Defined SAFV-4, 7\u20139 5\u2032 UTRs remain absent from public databases).", [["SAFV-4, 7\u20139 5\u2032", "CHEMICAL", 8, 22], ["SAFV-4, 7\u20139 5\u2032", "DNA", 8, 22], ["UTRs", "DNA", 23, 27], ["SAFV", "TEST", 8, 12], ["UTRs", "PROBLEM", 23, 27]]], ["The newly developed SAFV RT-rtPCR employed 0.4 \u03bcM of each oligonucleotide primer (TIB-MOLBIOL, Germany; Table 1) and 0.1 \u03bcM of each dual-labelled fluorogenic oligoprobe (SAFV_TM) in a 20 \u03bcL one-step RT-PCR reaction mix (SensiFAST OneStep Mix, Bioline, Australia) including RNase inhibitor and 5 mM MgCl2.", [["MgCl2", "CHEMICAL", 298, 303], ["MgCl2", "CHEMICAL", 298, 303], ["RNase", "GENE_OR_GENE_PRODUCT", 273, 278], ["MgCl2", "SIMPLE_CHEMICAL", 298, 303], ["SAFV RT-rtPCR", "DNA", 20, 33], ["dual-labelled fluorogenic oligoprobe", "DNA", 132, 168], ["RNase", "PROTEIN", 273, 278], ["SAFV RT-rtPCR", "TEST", 20, 33], ["each oligonucleotide primer", "TEST", 53, 80], ["TIB", "TEST", 82, 85], ["PCR reaction", "TEST", 202, 214], ["mix", "TEST", 215, 218], ["RNase inhibitor", "TREATMENT", 273, 288], ["5 mM MgCl2", "TREATMENT", 293, 303], ["TIB", "ANATOMY", 82, 85]]], ["After 2 \u03bcL of nucleic acid extract was added and reverse transcribed for 20 min at 45 \u00b0C, the mixes were incubated at 94 \u00b0C for 2 min then cycled through 55 rounds of 94 \u00b0C for 15 s and 60 \u00b0C for 60 s using a RotorGene 3000, 6000 or RGQ (QIAGEN, Australia) to acquire fluorescence data at the final (annealing and extension) step of each cycle.", [["nucleic acid extract", "CHEMICAL", 14, 34], ["nucleic acid", "SIMPLE_CHEMICAL", 14, 26], ["nucleic acid extract", "TREATMENT", 14, 34], ["fluorescence data", "TEST", 268, 285]]], ["Assay sensitivity was determined using a specific in vitro transcribed RNA (ivtRNA; Fig. 1, Table 1) created based on a previously described approach.17 Briefly, ivtRNA was subjected to two treatments with DNase (Turbo, Life Technologies), each followed by column purification (ISOLATE RNA Mini Kit, Bioline).", [["DNase", "GENE_OR_GENE_PRODUCT", 206, 211], ["ivtRNA", "PROTEIN", 162, 168], ["DNase", "PROTEIN", 206, 211], ["Assay sensitivity", "TEST", 0, 17], ["a previously described approach", "TREATMENT", 118, 149], ["DNase (Turbo, Life Technologies", "TREATMENT", 206, 237], ["column purification", "TREATMENT", 257, 276]]], ["The stock RNA was used to determine the analytical sensitivity of each assay after testing a 10-fold dilution series.", [["The stock RNA", "TREATMENT", 0, 13], ["a 10-fold dilution series", "TREATMENT", 91, 116]]], ["The last dilution to yield a positive result (defined below) was taken as the limit of analytical sensitivity.", [["analytical sensitivity", "TEST", 87, 109]]], ["The ivtRNA copy number was calculated using the optical density to approximate the mass of RNA in the stock solution at 260 nm, determining the number of moles by establishing the molecular weight of the ivtRNA and then multiplying by 6.02 \u00d7 1023 (Avogadro's number).", [["ivtRNA", "GENE_OR_GENE_PRODUCT", 4, 10], ["ivtRNA", "RNA", 204, 210], ["mass", "OBSERVATION", 83, 87]]], ["A positive diagnostic result was defined by the presence of a sigmoidal curve that crossed an arbitrary threshold of 0.05, before 45 cycles, during an experiment in which duplicate non-template controls did not cross the threshold.RT-rtPCR screening assay and conventional genotyping RT-PCR assays ::: Study designIn order to confirm the SAFV genotype of a positive patient specimen, nucleic acids from each were added to a conventional nested RT-PCR targeting VP1 (underlined, Fig. 1).4 Apart from the RT step (as above) both rounds of PCR cycled mixes through four rounds of 95 \u00b0C for 60 s, 55 \u00b0C for 60 s and 68 \u00b0C for 90 s followed by 35 rounds of 95 \u00b0C for 30 s, 53 \u00b0C for 30 s, 68 \u00b0C for 90 s.4 A final extension incubation at 68 \u00b0C occurred for 10 min.", [["specimen", "ANATOMY", 374, 382], ["nucleic acids", "CHEMICAL", 384, 397], ["SAFV", "CANCER", 338, 342], ["patient", "ORGANISM", 366, 373], ["nucleic acids", "SIMPLE_CHEMICAL", 384, 397], ["VP1", "ORGANISM", 461, 464], ["VP1", "DNA", 461, 464], ["patient", "SPECIES", 366, 373], ["a sigmoidal curve", "TEST", 60, 77], ["an arbitrary threshold", "TEST", 91, 113], ["RT-rtPCR screening assay", "TEST", 231, 255], ["conventional genotyping RT-PCR assays", "TEST", 260, 297], ["nucleic acids", "TEST", 384, 397], ["a conventional nested RT-PCR", "TREATMENT", 422, 450], ["VP1", "TEST", 461, 464], ["the RT step", "TREATMENT", 499, 510], ["PCR", "TEST", 537, 540], ["A final extension incubation", "TREATMENT", 701, 729]]], ["The first round PCR contained 3 mM MgCl2, the second contained 5 mM.Specimen details and statistics ::: Study designSpecimens (n= 1, 215) for respiratory virus testing originated from a convenience population of inpatients and outpatients (53.0% male) aged two days to 95 years (mean 22.6 years, median 4.0, inter quartile range 44.5) presenting to Queensland hospitals with symptoms of ARI.", [["MgCl2", "CHEMICAL", 35, 40], ["ARI", "DISEASE", 387, 390], ["MgCl2", "CHEMICAL", 35, 40], ["MgCl2", "SIMPLE_CHEMICAL", 35, 40], ["inpatients", "ORGANISM", 212, 222], ["outpatients", "ORGANISM", 227, 238], ["outpatients", "SPECIES", 227, 238], ["The first round PCR", "TEST", 0, 19], ["Study designSpecimens", "TEST", 104, 125], ["respiratory virus testing", "TEST", 142, 167], ["symptoms", "PROBLEM", 375, 383], ["ARI", "PROBLEM", 387, 390], ["round", "OBSERVATION_MODIFIER", 10, 15], ["3 mM", "OBSERVATION_MODIFIER", 30, 34], ["MgCl2", "OBSERVATION_MODIFIER", 35, 40], ["5 mM", "OBSERVATION_MODIFIER", 63, 67], ["ARI", "OBSERVATION", 387, 390]]], ["Specimens (81\u2013189 per month; Fig. 2) were mostly nasopharyngeal aspirates (48.1% of specimens) and nasopharyngeal swabs (31.8%) and most specimens were tested from autumn (36.5% of all specimens; Fig. 2).", [["Specimens", "ANATOMY", 0, 9], ["nasopharyngeal aspirates", "ANATOMY", 49, 73], ["specimens", "ANATOMY", 84, 93], ["nasopharyngeal swabs", "ANATOMY", 99, 119], ["specimens", "ANATOMY", 137, 146], ["specimens", "ANATOMY", 185, 194], ["nasopharyngeal aspirates", "MULTI-TISSUE_STRUCTURE", 49, 73], ["specimens", "CANCER", 84, 93], ["nasopharyngeal swabs", "CANCER", 99, 119], ["specimens", "CANCER", 137, 146], ["Specimens", "TEST", 0, 9], ["Fig.", "TEST", 29, 33], ["nasopharyngeal aspirates", "TEST", 49, 73], ["specimens", "TEST", 84, 93], ["nasopharyngeal swabs", "TEST", 99, 119], ["most specimens", "TEST", 132, 146], ["autumn", "TEST", 164, 170], ["all specimens", "TEST", 181, 194], ["nasopharyngeal", "ANATOMY", 49, 63], ["aspirates", "OBSERVATION", 64, 73], ["nasopharyngeal", "ANATOMY", 99, 113]]], ["Other samples included nasal swabs (n= 66; 5.4%), throat swabs (n= 43; 3.5%) and bronchoalveolar lavage (n= 17; 1.4%).", [["samples", "ANATOMY", 6, 13], ["nasal swabs", "ANATOMY", 23, 34], ["throat swabs", "ANATOMY", 50, 62], ["bronchoalveolar lavage", "ANATOMY", 81, 103], ["nasal swabs", "MULTI-TISSUE_STRUCTURE", 23, 34], ["bronchoalveolar lavage", "MULTI-TISSUE_STRUCTURE", 81, 103], ["Other samples", "TEST", 0, 13], ["nasal swabs", "TEST", 23, 34], ["throat swabs", "TEST", 50, 62], ["bronchoalveolar lavage", "TEST", 81, 103], ["nasal", "ANATOMY", 23, 28], ["throat", "ANATOMY", 50, 56], ["bronchoalveolar lavage", "OBSERVATION", 81, 103]]], ["Nucleic acids were extracted as previously described.18", [["Nucleic acids", "SIMPLE_CHEMICAL", 0, 13], ["Nucleic acids", "TEST", 0, 13], ["acids", "OBSERVATION_MODIFIER", 8, 13]]]], "474e12e66c6210b9b692365e7bd439a421012fb6": [["slight excess of soluble antigens lead to the accumulation of immune complexes, not enough cleared from the circulation by the innate immune system [5] .", [["soluble antigens", "PROTEIN", 17, 33], ["immune complexes", "PROTEIN", 62, 78], ["slight excess of soluble antigens", "PROBLEM", 0, 33], ["immune complexes", "PROBLEM", 62, 78], ["excess", "OBSERVATION_MODIFIER", 7, 13], ["immune complexes", "OBSERVATION", 62, 78]]], ["These antigen-antibody complexes precipitate inside the tissues, in particular blood vessels, inducing a severe inflammatory state by the action of complement anaphylatoxins (C3a and C5a), which in turn stimulate the release of histamine from mast cells and the recruitment of phagocytes, in primis neutrophils, the main responsible for the tissue damage [5] .", [["tissues", "ANATOMY", 56, 63], ["blood vessels", "ANATOMY", 79, 92], ["mast cells", "ANATOMY", 243, 253], ["phagocytes", "ANATOMY", 277, 287], ["primis neutrophils", "ANATOMY", 292, 310], ["tissue", "ANATOMY", 341, 347], ["histamine", "CHEMICAL", 228, 237], ["histamine", "CHEMICAL", 228, 237], ["antigen-antibody", "GENE_OR_GENE_PRODUCT", 6, 22], ["tissues", "TISSUE", 56, 63], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 79, 92], ["complement", "GENE_OR_GENE_PRODUCT", 148, 158], ["anaphylatoxins", "GENE_OR_GENE_PRODUCT", 159, 173], ["C3a", "GENE_OR_GENE_PRODUCT", 175, 178], ["C5a", "GENE_OR_GENE_PRODUCT", 183, 186], ["histamine", "SIMPLE_CHEMICAL", 228, 237], ["mast cells", "CELL", 243, 253], ["phagocytes", "CELL", 277, 287], ["primis neutrophils", "CELL", 292, 310], ["tissue", "TISSUE", 341, 347], ["antigen-antibody complexes", "PROTEIN", 6, 32], ["complement anaphylatoxins", "PROTEIN", 148, 173], ["C3a", "PROTEIN", 175, 178], ["C5a", "PROTEIN", 183, 186], ["mast cells", "CELL_TYPE", 243, 253], ["phagocytes", "CELL_TYPE", 277, 287], ["primis neutrophils", "CELL_TYPE", 292, 310], ["These antigen-antibody complexes", "TEST", 0, 32], ["a severe inflammatory state", "PROBLEM", 103, 130], ["complement anaphylatoxins", "PROBLEM", 148, 173], ["C3a and C5a)", "TREATMENT", 175, 187], ["histamine from mast cells", "TREATMENT", 228, 253], ["the tissue damage", "PROBLEM", 337, 354], ["tissues", "ANATOMY", 56, 63], ["vessels", "ANATOMY", 85, 92], ["severe", "OBSERVATION_MODIFIER", 105, 111], ["inflammatory", "OBSERVATION", 112, 124], ["mast cells", "OBSERVATION", 243, 253]]], ["On histopathology, the result of this process inside the walls of blood vessels is depicted by an acute necrotizing vasculitis with neutrophilic infiltration, karyorrhexis and fibrinoid necrosis, the so called \u00ableukocytoclastic vasculitis\u00bb (LCV), also reported in the English medical literature by the term \u00abhypersensitivity vasculitis\u00bb [6] ; platelet aggregation correlates with hypercoagulability and thrombosis, disorders described in course of COVID-19, too [7] .", [["walls", "ANATOMY", 57, 62], ["blood vessels", "ANATOMY", 66, 79], ["neutrophilic", "ANATOMY", 132, 144], ["fibrinoid", "ANATOMY", 176, 185], ["platelet", "ANATOMY", 343, 351], ["vasculitis", "DISEASE", 116, 126], ["karyorrhexis", "DISEASE", 159, 171], ["necrosis", "DISEASE", 186, 194], ["\u00ableukocytoclastic vasculitis\u00bb", "DISEASE", 210, 239], ["vasculitis", "DISEASE", 325, 335], ["platelet aggregation", "DISEASE", 343, 363], ["hypercoagulability", "DISEASE", 380, 398], ["thrombosis", "DISEASE", 403, 413], ["COVID-19", "CHEMICAL", 448, 456], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 66, 79], ["platelet", "CELL", 343, 351], ["histopathology", "TEST", 3, 17], ["this process", "PROBLEM", 33, 45], ["an acute necrotizing vasculitis", "PROBLEM", 95, 126], ["neutrophilic infiltration", "PROBLEM", 132, 157], ["karyorrhexis", "PROBLEM", 159, 171], ["fibrinoid necrosis", "PROBLEM", 176, 194], ["\u00ableukocytoclastic vasculitis\u00bb", "PROBLEM", 210, 239], ["the term \u00abhypersensitivity vasculitis", "PROBLEM", 298, 335], ["platelet aggregation", "PROBLEM", 343, 363], ["hypercoagulability", "PROBLEM", 380, 398], ["thrombosis", "PROBLEM", 403, 413], ["disorders", "PROBLEM", 415, 424], ["COVID", "TEST", 448, 453], ["walls", "ANATOMY_MODIFIER", 57, 62], ["blood vessels", "ANATOMY", 66, 79], ["acute", "OBSERVATION_MODIFIER", 98, 103], ["necrotizing", "OBSERVATION_MODIFIER", 104, 115], ["vasculitis", "OBSERVATION", 116, 126], ["neutrophilic infiltration", "OBSERVATION", 132, 157], ["fibrinoid", "OBSERVATION_MODIFIER", 176, 185], ["necrosis", "OBSERVATION", 186, 194], ["thrombosis", "OBSERVATION", 403, 413]]], ["The just mentioned fibrinoid necrosis represents a specific pattern of tissue injury, which occurs once antigen-antibody complexes are deposited in the walls of blood vessels along with fibrin and complement anaphylatoxins; therefore, it can be considered a diagnostic clue of immune-mediated vasculitides from type 3 hypersensitivity [8] .", [["fibrinoid", "ANATOMY", 19, 28], ["tissue", "ANATOMY", 71, 77], ["walls", "ANATOMY", 152, 157], ["blood vessels", "ANATOMY", 161, 174], ["necrosis", "DISEASE", 29, 37], ["tissue injury", "DISEASE", 71, 84], ["vasculitides", "DISEASE", 293, 305], ["hypersensitivity", "DISEASE", 318, 334], ["fibrinoid", "TISSUE", 19, 28], ["tissue", "TISSUE", 71, 77], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 161, 174], ["fibrin", "GENE_OR_GENE_PRODUCT", 186, 192], ["anaphylatoxins", "GENE_OR_GENE_PRODUCT", 208, 222], ["antigen-antibody complexes", "PROTEIN", 104, 130], ["fibrin", "PROTEIN", 186, 192], ["fibrinoid necrosis", "PROBLEM", 19, 37], ["tissue injury", "PROBLEM", 71, 84], ["antigen-antibody complexes", "TEST", 104, 130], ["fibrin and complement anaphylatoxins", "PROBLEM", 186, 222], ["immune-mediated vasculitides", "PROBLEM", 277, 305], ["type 3 hypersensitivity", "PROBLEM", 311, 334], ["fibrinoid", "OBSERVATION_MODIFIER", 19, 28], ["necrosis", "OBSERVATION", 29, 37], ["tissue", "ANATOMY", 71, 77], ["injury", "OBSERVATION", 78, 84], ["walls", "ANATOMY_MODIFIER", 152, 157], ["blood vessels", "ANATOMY", 161, 174], ["fibrin", "OBSERVATION", 186, 192], ["anaphylatoxins", "OBSERVATION", 208, 222]]], ["LCV is preceded by a viral infection, such as hepatitis B, hepatitis C and HIV, in a relevant percentage of cases [6] .", [["viral infection", "DISEASE", 21, 36], ["hepatitis B", "DISEASE", 46, 57], ["hepatitis C", "DISEASE", 59, 70], ["HIV", "DISEASE", 75, 78], ["hepatitis B", "ORGANISM", 46, 57], ["hepatitis C", "ORGANISM", 59, 70], ["HIV", "ORGANISM", 75, 78], ["HIV", "SPECIES", 75, 78], ["hepatitis B", "SPECIES", 46, 57], ["HIV", "SPECIES", 75, 78], ["a viral infection", "PROBLEM", 19, 36], ["hepatitis B", "PROBLEM", 46, 57], ["hepatitis C", "PROBLEM", 59, 70], ["HIV", "PROBLEM", 75, 78], ["viral", "OBSERVATION_MODIFIER", 21, 26], ["infection", "OBSERVATION", 27, 36]]], ["The onset time of type 3 hypersensitivity varies from days to weeks depending on the presence or not of memory cells against the precipitating antigen; clinical features emerge approximately 10 days after initial antigenic challenge [8] .", [["memory cells", "ANATOMY", 104, 116], ["hypersensitivity", "DISEASE", 25, 41], ["memory cells", "CELL", 104, 116], ["memory cells", "CELL_TYPE", 104, 116], ["type 3 hypersensitivity varies", "PROBLEM", 18, 48], ["memory cells", "PROBLEM", 104, 116], ["the precipitating antigen", "PROBLEM", 125, 150], ["initial antigenic challenge", "TREATMENT", 205, 232]]], ["During the Severe Acute Respiratory Syndrome (SARS) outbreak in 2002-2003, caused by SARS-CoV-2 predecessor (SARS-CoV), it was observed that the acute respiratory distress syndrome, one the most serious complications of the disease, significantly overlapped with antiviral immunoglobulin G (IgG) seroconversion [9] ; besides, it was found that patients who developed more quickly the anti-spike neutralizing antibody showed a higher risk of dying from the disease [10] .", [["respiratory", "ANATOMY", 151, 162], ["Acute Respiratory Syndrome", "DISEASE", 18, 44], ["SARS", "DISEASE", 46, 50], ["respiratory distress syndrome", "DISEASE", 151, 180], ["CoV-2", "ORGANISM", 90, 95], ["SARS-CoV", "ORGANISM", 109, 117], ["immunoglobulin G", "GENE_OR_GENE_PRODUCT", 273, 289], ["IgG", "GENE_OR_GENE_PRODUCT", 291, 294], ["patients", "ORGANISM", 344, 352], ["antiviral immunoglobulin G", "PROTEIN", 263, 289], ["IgG", "PROTEIN", 291, 294], ["anti-spike neutralizing antibody", "PROTEIN", 384, 416], ["patients", "SPECIES", 344, 352], ["SARS-CoV", "SPECIES", 85, 93], ["SARS-CoV", "SPECIES", 109, 117], ["the Severe Acute Respiratory Syndrome", "PROBLEM", 7, 44], ["SARS", "PROBLEM", 85, 89], ["the acute respiratory distress syndrome", "PROBLEM", 141, 180], ["the disease", "PROBLEM", 220, 231], ["antiviral immunoglobulin G (IgG) seroconversion", "TREATMENT", 263, 310], ["the anti-spike neutralizing antibody", "TEST", 380, 416], ["the disease", "PROBLEM", 452, 463], ["Severe", "OBSERVATION_MODIFIER", 11, 17], ["Acute", "OBSERVATION_MODIFIER", 18, 23], ["Respiratory Syndrome", "OBSERVATION", 24, 44], ["acute", "OBSERVATION_MODIFIER", 145, 150], ["respiratory", "OBSERVATION", 151, 162], ["distress syndrome", "OBSERVATION", 163, 180], ["disease", "OBSERVATION", 224, 231]]], ["Translating our current findings on COVID-19, these alarming data can be now explained by a life-threatening escalation from T h 2 immune response to type 3 hypersensitivity with the subsequent deposition of antigen-antibody complexes, particularly inside the walls of blood vessels, to such an extent as to generate a systemic vasculitis in the context of an immune complex J o u r n a l P r e -p r o o f disease (Fig. 1) .", [["walls", "ANATOMY", 260, 265], ["blood vessels", "ANATOMY", 269, 282], ["hypersensitivity", "DISEASE", 157, 173], ["vasculitis", "DISEASE", 328, 338], ["COVID-19", "CELL", 36, 44], ["T h 2", "CELL", 125, 130], ["antigen-antibody complexes", "GENE_OR_GENE_PRODUCT", 208, 234], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 269, 282], ["antigen-antibody complexes", "PROTEIN", 208, 234], ["COVID", "TEST", 36, 41], ["type 3 hypersensitivity", "PROBLEM", 150, 173], ["the subsequent deposition of antigen-antibody complexes", "PROBLEM", 179, 234], ["a systemic vasculitis", "PROBLEM", 317, 338], ["disease", "PROBLEM", 406, 413], ["walls", "ANATOMY_MODIFIER", 260, 265], ["blood vessels", "ANATOMY", 269, 282], ["systemic", "OBSERVATION_MODIFIER", 319, 327], ["vasculitis", "OBSERVATION", 328, 338], ["disease", "OBSERVATION", 406, 413]]], ["Preexisting endothelial dysfunctions due to atherosclerosis could worsen the deposition process in elderly and middle-aged patients [11] ; since the smooth muscle cells in tunica media of blood vessels are able to produce interleukin-6 (IL-6) [12], a key myokine of inflammation and of the cytokine release syndrome, their inflammatory involvement can justify well the described \u00abcytokine storm\u00bb in COVID-19 critical patients, a dramatic phenomenon remained not fully elucidated up to date.", [["endothelial", "ANATOMY", 12, 23], ["smooth muscle cells", "ANATOMY", 149, 168], ["tunica media", "ANATOMY", 172, 184], ["blood vessels", "ANATOMY", 188, 201], ["endothelial dysfunctions", "DISEASE", 12, 36], ["atherosclerosis", "DISEASE", 44, 59], ["inflammation", "DISEASE", 266, 278], ["endothelial", "CELL", 12, 23], ["patients", "ORGANISM", 123, 131], ["smooth muscle cells", "CELL", 149, 168], ["tunica", "TISSUE", 172, 178], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 188, 201], ["interleukin-6", "GENE_OR_GENE_PRODUCT", 222, 235], ["IL-6) [12", "GENE_OR_GENE_PRODUCT", 237, 246], ["patients", "ORGANISM", 417, 425], ["smooth muscle cells", "CELL_TYPE", 149, 168], ["interleukin-6", "PROTEIN", 222, 235], ["cytokine", "PROTEIN", 290, 298], ["patients", "SPECIES", 123, 131], ["patients", "SPECIES", 417, 425], ["Preexisting endothelial dysfunctions", "PROBLEM", 0, 36], ["atherosclerosis", "PROBLEM", 44, 59], ["the deposition process", "PROBLEM", 73, 95], ["the smooth muscle cells", "PROBLEM", 145, 168], ["interleukin-6 (IL", "TEST", 222, 239], ["inflammation", "PROBLEM", 266, 278], ["the cytokine release syndrome", "PROBLEM", 286, 315], ["their inflammatory involvement", "PROBLEM", 317, 347], ["a dramatic phenomenon", "PROBLEM", 427, 448], ["endothelial dysfunctions", "OBSERVATION", 12, 36], ["atherosclerosis", "OBSERVATION", 44, 59], ["deposition", "OBSERVATION_MODIFIER", 77, 87], ["middle", "OBSERVATION_MODIFIER", 111, 117], ["smooth muscle", "ANATOMY", 149, 162], ["tunica", "ANATOMY_MODIFIER", 172, 178], ["blood vessels", "ANATOMY", 188, 201], ["inflammation", "OBSERVATION", 266, 278], ["inflammatory", "OBSERVATION_MODIFIER", 323, 335]]]]}